[
  {
    "id": "OBGYN_Ch1_1",
    "question_text": "\nAnatomy of Female Pelvic Organs",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_5",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_2",
    "question_text": "\nThe Physiology of Conception",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_32",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_3",
    "question_text": "\nMaternal Pelvis and Fetal Skull",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_48",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_4",
    "question_text": "\nPlacenta and Fetal Membranes",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_66",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_5",
    "question_text": "\nSexual Development, Puberty and Adolescence",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_88",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_6",
    "question_text": "\nPhysiological Changes During Pregnancy",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_110",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_7",
    "question_text": "\nDiagnosis of Pregnancy and Antenatal Care",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_127",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_8",
    "question_text": "\nAntenatal Investigations",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_145",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_9",
    "question_text": "\nObstetrical Imaging",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_159",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_10",
    "question_text": "\nNormal Labour",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_177",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_11",
    "question_text": "\nAbnormal Labour",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_205",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_12",
    "question_text": "\nInduction and Augmentation of Labour",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_221",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_13",
    "question_text": "\nMalpresentations",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_235",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_14",
    "question_text": "\nOperative Vaginal Delivery",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_260",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_15",
    "question_text": "\nCaesarean Section and Vaginal Birth After Caesa...",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_272",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_16",
    "question_text": "\nPuerperium",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_286",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_17",
    "question_text": "\nMultifetal Pregnancy",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_304",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_18",
    "question_text": "\nEctopic Pregnancy",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_332",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_19",
    "question_text": "\nAbortion and Medical Termination of Pregnancy",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_349",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_20",
    "question_text": "\nAntepartum Hemorrhage",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_372",
    "question_text": "\nChapter\nTitle\nPage",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_21",
    "question_text": "\nPostpartum Haemorrhage",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_393",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_22",
    "question_text": "\nPreterm Labor and Postterm Pregnancy",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_416",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_23",
    "question_text": "\nGestational Trophoblastic Diseases",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_435",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_24",
    "question_text": "\nAnemia in Pregnancy",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_454",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_25",
    "question_text": "\nHypertensive Disorders in Pregnancy",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_467",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_26",
    "question_text": "\nDiabetes in Pregnancy",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_490",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_27",
    "question_text": "\nCardiovascular Conditions in Pregnancy",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_504",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_28",
    "question_text": "\nRhesus Isoimmunization",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_520",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_29",
    "question_text": "\nHepatic Disorders and Infections in Pregnancy",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_533",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_30",
    "question_text": "\nDisorders of Menstruation",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_554",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_31",
    "question_text": "\nUro-gynecology",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_571",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_32",
    "question_text": "\nProlapse",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_591",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_33",
    "question_text": "\nFibroid",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_614",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_34",
    "question_text": "\nEndometriosis and Adenomyosis",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_639",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_35",
    "question_text": "\nDisorders of Ovary",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_657",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_36",
    "question_text": "\nContraception and Sterilization",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_670",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_37",
    "question_text": "\nVaginal Infections",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_699",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_38",
    "question_text": "\nVulval Infections",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_716",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_39",
    "question_text": "\nPelvic Inflammatory Disease",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_731",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_40",
    "question_text": "\nGenital Tuberculosis",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_751",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_41",
    "question_text": "\nInfertility",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_761",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_42",
    "question_text": "\nPerimenopause, Menopause and Post-Menopausal Bl...",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_785",
    "question_text": "\nChapter\nTitle\nPage",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_43",
    "question_text": "\nOvarian Tumors",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_797",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_44",
    "question_text": "\nVulval & Vaginal Malignancy",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_820",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_45",
    "question_text": "\nCarcinoma Cervix",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_829",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_46",
    "question_text": "\nCarcinoma Endometrium",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_850",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_47",
    "question_text": "\nInstruments",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_864",
    "question_text": "\nAnatomy of Female Pelvic Organs\nQuestion 1:\nWhich of the following is not a part of the vulva?\nLabia majora\nVestibule\nGreater vestibular glands\nCervix\nQuestion 2:\nWhich of the following statements is false regarding labia majora?\nThey join posteriorly to form the posterior commissure\nIt is homologous to scrotum in male\nThe round ligament terminates at its posterior end\nIt contains sebaceous glands and apocrine glands\nQuestion 3:\nA patient presented to the gynecology OPD with the following finding. Which structure in men is homologous to the affected structure?\n\nProstate gland\nCowper\u2019s gland\nGlands of Littre\nMeibomian glands\nQuestion 4:\nWhat is the pH of the vagina before puberty?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_1.jpeg",
      "OBGYN_img_2.jpeg",
      "OBGYN_img_3.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_7",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_4",
    "question_text": "5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_6",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_4",
    "question_text": "2\nQuestion 5:\nWhich of the following is incorrect about relations of the vagina?\nBladder - anterior\nBartholin\u2019s gland - posterior\nLevator ani - latera\nPouch of Douglas - posterior\nQuestion 6:\nIdentify the type of hymen.\n\nCribriform hymen\nParous hymen\nFimbriated hymen\nSeptate hymen\nQuestion 7:\nA patient with uterine prolapse and urethrocele has weakness in the superficial and deep perineal muscles. What level of support is lost here?\nLevel 1\nLevel 2\nLevel 3\nLevel 4\nQuestion 8:\nAnteflexion of the uterus is at the level of \t.\nExternal os\nInternal os\nUpper part of vagina\nLower part of vagina\nQuestion 9:\nA G3P2L2 woman presents in her third trimester with vaginal leaking. On PV examination, the anterior lip of the cervix can be palpated. What is the position of her uterus and the igament that maintains this position?\nAnteverted uterus - Round ligament\nAnteflexed uterus - Round ligament\nAnteverted uterus - Uterosacral ligament\nAnteflexed uterus - Broad ligament\nQuestion 10:\nA multiparous woman presented with a urethrocele, due to weakness of the urogenita diaphragm. What is this structure also known as?\nRectangular ligament\nTriangular ligament\nPyramidal ligament\nPear shaped ligament\nQuestion 11:\nWhat is the cavity of the uterus lined by?\nSingle layer of ciliated columnar epithelium\nDouble layer of ciliated columnar epithelium\nSingle layer of ciliated cuboidal epithelium\nDouble layer of ciliated cuboidal epithelium\nQuestion 12:\nA woman with regular menstrual cycles is undergoing an ultrasound on the 14th day of her cycle. What will the endometrial thickness be?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_4.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_0",
    "question_text": "5 mm\n4 mm\n11 mm\n14 mm\nQuestion 13:\nWhich of the following statements is false regarding uterine anatomy?\nRound ligaments receive their blood supply from Sampson's artery\nTransverse cervical ligaments are also called cardinal ligaments\nUterine innervation is by the pudendal nerve plexus\nLymphatic drainage is primarily to the obturator, internal and external iliac nodes.\nQuestion 14:\nA gynecologist is performing a hysterectomy. She accidentally nicks the ureter in the ureteric canal as it pierces the Mackenrodt's ligaments. Which vessels are likely to be damaged here?\nUterine artery above and the uterine plexus of veins below\nUterine plexus of veins above and the uterine artery below\nOvarian artery above and the uterine artery below\nUterine artery above and the ovarian artery below\nQuestion 15:\nYou take a culture swab from the portio vaginalis of a woman having foul smelling vaginal discharge. What is this region also known as?\nSupra vaginal part of cervix\nVaginal part of cervix\nFornix of the vagina\nIntroitus of the vagina\nQuestion 16:\nWhat is the cervix: corpus ratio before puberty?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_1",
    "question_text": "2",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch1_2",
    "question_text": "1",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch2_1",
    "question_text": "3",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch2_3",
    "question_text": "1\nQuestion 17:\nThe remnants of Wolffian ducts in females are located in\t.\nPouch of Douglas\nLeaves of broad ligament\nUterovesical pouch\nIliac fossa\nQuestion 18:\nWhich of the following is false about the contents of the broad ligament?\nOvarian vessels in its infundibulopelvic part\nIt contains the uterine arteries\nUreter is present the lower portion\nOvarian ligament in its anterior fold\nQuestion 19:\nWhere are Peg cells seen?\nVagina\nVulva\nOvary\nFallopian tubes\nQuestion 20:\nWhat is the longest part of the fallopian tube?\nInterstitium\nIsthmus\nAmpulla\nInfundibulum\nQuestion 21:\nWhere is the tunica albuginea of the adult ovary derived from?\nThe surface epithelium\nThe sub epithelial connective tissue layer\nThe parenchymatous zone\nZona vasculosa\nQuestion 22:\nDuring the histopathological examination of an ovarian mass, Call-Exner bodies are seen. In which of the following layers are these structures seen?\nGranulosa cell layer\nTheca interna\nDiscus proligerus\nCumulus oophorus\nQuestion 23:\nWhere is the sympathetic nerve supply of ovary derived from?\nT10-T11\nT9-T10\nS2-S4\nL4-L5\nQuestion 24:\nBleeding during normal menstruation occurs due to rupture of\nBasilar artery\nSpiral artery\nArcuate artery\nRadial artery\nQuestion 25:\nA uterine artery embolization is being planned for a patient with uterine fibroids. Blood flow in which of the following arteries will not be affected by this procedure?\nSpiral artery\nSampson's artery\nVaginal artery\nArcuate artery\nQuestion 26:\nA patient with stress incontinence required surgical management. While performing a Burch colposuspension, the surgeon approached the space of Retzius. What is this space also known as?\nPrevesical or presacral space\nPresacral or prerectal space\nPresacral or retropubic space\nPrevesical or retropubic space\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_1",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_2",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_3",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_4",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_5",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_6",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_7",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_8",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_9",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_10",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_11",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_12",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_13",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_14",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_15",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_16",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_17",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_18",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_19",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_20",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_21",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_22",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_23",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_24",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_25",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_26",
    "question_text": "\nd\nSolution to Question 1:\nCervix is not a part of the vulva. The vulva includes:\nMons veneris\nLabia majora\nLabia minora\nClitoris\nVestibule\nVestibular bulb\nGreater vestibular glands.\nThe vulva is posteriorly related to the perineum.\nThe triangular space bounded by clitoris, labia minora and fourchette is the vestibule. It is present between the labia minora anteriorly and the introitus posteriorly. The posterior part of the vestibule between the fourchette and the vaginal introitus is called fossa navicularis. The vestibule has 4 openings:\nUrethral opening\nVaginal orifice opening\nBartholin\u2019s duct on either side\nDucts of paraurethral glands\n\nSolution to Question 2:\nThe round ligament terminates at the anterior end of the labia majora.\nThe labia majora lie on either side of the vulva and join posteriorly to form the posterior commissure. The inner side is hairless. Labia majora are homologous to the scrotum in males. The labia majora and the mons veneris contain:\nHair follicles\nSebaceous glands\nModified sweat glands, known as apocrine glands\nThe labia minora are two cutaneous folds between the labia major. Anteriorly they enclose the clitoris and unite with each other in front and behind the clitoris to form prepuce and frenulum respectively. The labia minora are homologous to the ventral aspect of the penis.\nThe clitoris is a small erectile body lying in the anterior-most part of the vulva. The clitoris is homologous to glans penis.\n\nSolution to Question 3:\nThe given image shows a Bartholin's cyst, which involves the Bartholin's glands. These glands are homologous to the male bulbourethral or Cowper glands.\nThe ducts of Bartholin's glands open in the groove between the hymen and the labia minora at approximately 5 and 7 o\u2019clock positions. They are stimulated by sexual arousal. The glands contain columnar cells that secrete mucus with lubricant properties. Contraction of the bulbospongiosus muscle expresses gland secretions.\nBartholin's cyst occurs due to obstruction of the ducts of the Bartholin's glands by proteinaceous material, or due to infection. Symptomatic or recurrent cysts may require marsupialization or gland excision. An infected Bartholin's cyst can lead to an Bartholin's abscess. This requires surgical drainage.\n\nSolution to Question 4:\nThe pH of the vagina before puberty is 7. In adult females, the pH is acidic.\nDoderlein's bacilli (Lactobacillus sp.) are part of the normal vaginal flora. They produce lactic acid from glycogen in the vaginal epithelium and make the vaginal pH acidic. They are present in newborns and disappear in 10-14 days. They reappear at puberty and disappear after menopause. Vaginal flora also includes microbes such as Clostridium welchii.\nVaginal defence mechanisms are influenced by estrogen. In newborns, maternal estrogens maintain the defence mechanisms for 10-14 days. After that, the levels wane. During puberty, the circulating estrogen maintains the defence mechanism.\nNote: The pH is higher in the upper part of the vagina due to mixing with alkaline cervical mucus.\nPeriod\nVaginal pH\nDoderlein bacteri a\nTypes of cells\nBirth-2 week s",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_5.jpeg",
      "OBGYN_img_6.jpeg",
      "OBGYN_img_7.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_4",
    "question_text": "5\n+\n-",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_2",
    "question_text": "weeks-pube rty\n>7\n-\nParabasal cells\nPuberty",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_4",
    "question_text": "4.5\nsparse\nSuperficial & intermediate\nReproductiv e",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_4",
    "question_text": "5\nplenty\nSuperficial & intermediate\nPregnancy",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_3",
    "question_text": "\u0161-4.1\nplenty\nIntermediate\nPostmenopa use\n>7\n-\nParabasal\nSolution to Question 5:\nBartholin\u2019s gland is present lateral to the vagina. The vagina is related to the following structures:\nAnteriorly:\nBladder (upper 1/3rd)\nUrethra (lower 2/3rd)\nPosteriorly\nPouch of Douglas\nAmpulla of the rectum\nPerineal body\nLaterally\nMackenrodt's ligament\nLevator ani\nBartholin's glands\n\nSolution to Question 6:\nThe given image shows cribriform hymen because it has multiple small openings. Based on the shape of its opening, the hymen may be classified as:\nOther variants of the hymen:\nThe hymen is lined by stratified squamous epithelium on both sides. The hymen is most commonly torn posterolaterally or posteriorly. It is replaced by tags after childbirth which are called as carunculae myrtiformes.\nHymen\nDescription\nAnnular\nOval central opening\nCrescen tic\nSemilunar central opening\nVertical\nVertical slit-like opening\nSeptate",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_8.jpeg",
      "OBGYN_img_9.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_2",
    "question_text": "lateral openings partitioned by a bridge of hymenal tissu e\nCribrifo rm\nMultiple small openings\nVariants\nDescription\nAbsence of hymen\nCongenital deformity.\nInfantile\nSmall central linear opening.\nImperforate\nNo opening\nFimbriated\nFree margin has symmetrical indentations anteriorly\nRing or fringe-like\nA narrow ring of thick memb rane is present all around the vaginal orificeIt can easily di stend during sexual intercour se without rupturing the hym en\n\nSolution to Question 7:\nIn the given case scenario, level 3 supports including the superficial and deep perineal muscles are lost. This causes urethrocele.\nDeLancey's levels of support are used to describe the supports of the genital organs.\nSolution to Question 8:\nAnteflexion of the uterus is seen at the level of the internal os. (Mnemonic - V for version, V for vagina)\nThe uterus normally lies in a position of anteversion and anteflexion.\nIn the anteverted position, the external os is directed downward and backwards. On vaginal examination, the fingers come in contact with the anterior lip of the cervix as it is the lowest part.\nWhen the uterus is retroverted, the cervix is directed downward and forwards. The lowest part of the cervix becomes either the external os or its posterior lip.\nAngle of Anteversion\nAngle of Anteflexion\nThe angle between thecervix and vagina\nThe angle betweencervix and uterus",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_10.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_90",
    "question_text": "o",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_120",
    "question_text": "o\n\n\nSolution to Question 9:\nIn the given clinical scenario, the uterus is anteverted as the anterior lip of the cervix was palpable. The round ligament helps maintain the anteversion of the uterus during pregnancy.\nHowever, the anteversion in the non-pregnant uterus is maintained by both the uterosacral ligament and round ligament.\n(Mnemonic - V for version, V for vagina)\nThe uterus normally lies in a position of anteversion and anteflexion.\nIn the anteverted position, the external os is directed downward and backwards. On vaginal examination, the fingers come in contact with the anterior lip of the cervix as it is the lowest part.\nWhen the uterus is retroverted, the cervix is directed downward and forwards. The lowest part of the cervix becomes either the external os or its posterior lip.\nAnteflexion is seen at the level of the internal os.\nAngle of anteversion\nAngle of anteflexion\nAngle between thecervix and vagina\nAngle betweencervix and uter us",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_11.jpeg",
      "OBGYN_img_12.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_90",
    "question_text": "o",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch3_120",
    "question_text": "o\n\nSolution to Question 10:\nThe urogenital diaphragm is also known as the triangular ligament.\nThe urogenital diaphragm extends from the pubic arch anteriorly to the central point of the perineum posteriorly and consists of two layers of fascia through which pass the vagina and the urethra. The central point of the female perineum lies between the vagina and the rectum.\nUrogenital triangle:\nPresent between 2 ischiopubic rami\nStretching transversely across the rami there are 3 membranes.\nFrom above downwards the membranes are as follows:\nSuperior fascia of urogenital diaphragm\nInferior fascia of urogenital diaphragm\nMembranous layer of superficial perineal fascia\n\nSolution to Question 11:\nThe uterine cavity is lined by a single layer of ciliated columnar epithelium. The wall of the uterus consists of 3 layers:\nPerimetrium is the serous coat adherent to the underlying muscle.\nMyometrium - it consists of thick bundles of muscles that form 3 distinct layers during pregnancy:\nOuter longitudina\nInner circular\nMiddle interlacing called living ligature\nEndometrium - It is the mucous lining of the cavity. It consists of lamina propria and surface epithelium which is a single layer of ciliated columnar epithelium.\nSolution to Question 12:\nDuring ovulation, the thickness of the endometrium is around 11 mm.\nPhase\nEndometrial thickne ss\nImmediately after menstruati on",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_13.jpeg",
      "OBGYN_img_14.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch4_1",
    "question_text": "2 mm\nEarly proliferative phase",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch4_5",
    "question_text": "7 mm\nSecretory phase",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch4_7",
    "question_text": "16 mm\nPhase\tEndometrial thickne\nss\nPhase\tEndometrial thickne\nss\nPreovulatory phase\nup to11 mm\nPostmenopausal\n<4 mm\nPostmenopausal - abnormal, requires biopsy\n>4 mm\nSolution to Question 13:\nThe uterus is innervated by the fibers of the uterovaginal plexus, also known as the Frankenhauser ganglion.\nOption A: Round ligaments receive their blood supply from Sampson's artery which represents the anastomosis of the uterine artery and ovarian artery.\nOption B: The cardinal ligaments are also called transverse cervical ligaments or Mackenrodt ligaments. They consist primarily of perivascular connective tissue. They attach to the posterolateral pelvic walls near the origin of the internal iliac artery and surround the vessels supplying the uterus and vagina.\nOption D: Lymphatic drainage of the uterus is primarily to the obturator and internal and external iliac nodes. One theory of endometriosis, states lymphatic spread as cause for seeding in the pelvis.\nSolution to Question 14:\nThe uterine artery above and uterine venous plexus below are likely to be damaged here, as the ureter is present between these vessels.\nThe ureter pierces the Mackenrodt's ligament, forming the ureteric canal. In this canal, the ureter is crossed by the uterine artery above and the uterine plexus of veins below, thus being present in between the uterine vessels.\nThe ureteric canal provides the necessary room for normal peristalsis, without pressure from the surrounding structures. After leaving the ureteric canal, the ureter passes forwards and medially to reach the bladder. It is 1-2 cm away from the cervix.\n\nSolution to Question 15:\nPortio vaginalis or exocervix is the other name for the vaginal part of the cervix.\nCervix is the lowermost part of the uterus extending from the histological internal os to the external os. It is cylindrical in shape measuring 2.5 cm in length and diameter.\nCervix is made up of 10% muscle and the rest is collagen, elastin, and proteoglycan. The lining of the cervix has the following parts:\nExocervix - also known as portio vaginalis. It is lined by non keratinized stratified squamous epithelium.\nEndocervix - it is lined by high columnar, ciliated epithelium.\nEndocervical glands - secrete alkaline mucus. When enlarged, they form swellings called Nabothian follicles/cysts.\nTransformation zone - the epithelium gradually changes from columnar to squamous in this region.\nSolution to Question 16:\nThe cervix:corpus ratio before puberty is 2:1.\nThe relationship between the length of the cervix and that of the body of the uterus varies with age.\nAge\nCervix/Corpus ratio\nBefore puberty",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_15.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch4_2",
    "question_text": "1\nAt puberty",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_1",
    "question_text": "2\nAge\nCervix/Corpus ratio\nReproductive a ge",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_1",
    "question_text": "3 or 1:4\nAfter menopau se",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_2",
    "question_text": "1 - however, the uterus and cervix are both atrophied\nSolution to Question 17:\nThe Gartner's duct is a remnant of the Wolffian ducts in women. These are located in the broad ligament and the vagina.\nThe Gartner's duct is an embryological remnant of the mesonephric duct/Wolffian duct formed during the development of the urinary and reproductive organs. It runs parallel to, but below, the fallopian tube in the mesosalpinx. The duct passes downwards by the side of the uterus to the level of the internal os where it passes into the tissues of the cervix. It then runs forwards to reach the anterolateral aspect of the vaginal wall and may reach as far down as the hymen.\nThe duct can sometimes form a cyst in the broad ligament or in the vagina. It is called Gartner\u2019s cyst. It is a benign condition and can be treated with marsupialization.\n\nSolution to Question 18:\nThe ovarian ligaments are contained in the posterior fold of the broad ligament. The broad ligament contains the following parts:\nMesosalpinx - it lies between the fallopian tube and ovarian ligament. It contains the pelvic vessels - anastomoses between uterine and ovarian arteries. The ovary is attached via ovarian igament through the posterior folds to the mesovarium.\nMesometrium - it contains the ovarian vessels within the infundibulopelvic ligament.\nThe ureter is present in the inferomedial part of the broad ligament. It is related to the uterine artery here and may be damaged during hysterectomy.\nNote: Broad ligament is not a support of the uterus.\nSolution to Question 19:\nPeg cells are seen in the fallopian tubes.\nA peg cell is a non-ciliated epithelial cell within the fallopian tube. These cells are also known as intercalated or intercalary cells whose function is not yet known.\nThe image below shows pale ciliated cells (arrows) and narrow, dark, non-ciliated peg cells\n(arrowheads).\n\nSolution to Question 20:\nThe longest and widest part of the fallopian tube is the ampulla (5 cm).\nSolution to Question 21:\nTunica albuginea of the adult ovary is derived from the sub-epithelial connective tissue layer. Structure of the ovary:\nSurface epithelium - a single layer of cuboidal cells is present, which later gives rise to the surface epithelium of the adult ovary. It is morphologically continuous with the mesothelium of the peritoneum.\nThe subepithelial connective tissue layer - gives rise to the tunica albuginea of the adult ovary and the basement membrane beneath the surface epithelium.\nThe parenchymatous zone - becomes the cortex and contains the egg nests and ovarian follicles.\nZona vasculosa - becomes the medulla and contains the blood vessels. Hilar cells present here are homologous to interstitial cells of testes. They can rarely produce hilar cell tumors of the ovary.\n\nSolution to Question 22:\nCall-Exner bodies are formed by granulosa cells present within the granulosa cell layer of the ovary.\nThey are small, distinctive, glandlike structures filled with acidophilic material, resembling immature follicles. They are characteristically seen in granulosa cell tumors of the ovary.\nThe image below shows Call-Exner bodies (circled in black).\n\nGraafian follicle:\nThe mature Graafian follicle is spheroidal or ovoid in shape. It contains pent-up secretion known as the liquor folliculi. The lining consists of:\nTheca externa\nTheca interna - contain the theca cells\nGranulosa cell layer\nCumulus oophorus - projection of granulosa cells into the cavity of the Graafian follicle. It is also called the discus proligerus.\n\nSolution to Question 23:\nThe efferent preganglionic sympathetic fibres to the ovary are derived from the T10-T11 spinal levels.\nThese fibres travel to the prevertebral ganglia, where they synapse. The postganglionic sympathetic fibres arising from these ganglia contribute to the ovarian plexus, which innervates the ovary.\nThe ovarian plexus is a network of nerves comprising:\nPostganglionic sympathetic fibres\nPreganglionic parasympathetic fibres from the sacral outflow (S2-S4)\nVisceral afferent fibres (responsible for transmitting sensory signals) The ovarian plexus has two parts based on its connections:\nUpper part: Derived from branches of the renal plexus and aortic plexus\nLower part: Derived from the superior and inferior hypogastric plexuses.\nSolution to Question 24:\nRupture of the spiral arteries causes bleeding during normal menstruation. This is a branch of the uterine artery.\nThe blood supply of the uterus is as follows:\nUterine artery\uf0aeArcuate artery\uf0aeRadial artery\uf0aeBasal artery\uf0aeSpiral artery\n\nSolution to Question 25:\nIn the given case scenario, blood flow in the vaginal artery will not be affected, as it is not a branch of the uterine artery. The vaginal artery is a branch of the anterior division of the internal\niliac artery.\nIt is homologous to the inferior vesical artery in males. It supplies the vagina and the base of the bladder in women. It should not be confused with vaginal branches of the uterine artery.\nBranches of the uterine artery:\nUreteric branch\nVaginal branches (descending) - these unite to form the anterior and posterior azygos arteries of the vagina\nCircular cervical branch\nSampson's artery - it runs in under the round ligament. It represents the anastomosis of the uterine artery and ovarian artery.\nArcuate--&gt; Radial--&gt; Basal--&gt; Spiral and straight arterioles of the functional layer of the endometrium\n\nSolution to Question 26:\nThe space of Retzius is the other name for prevesical or retropubic space.\nBurch colposuspension is a procedure done to relieve stress urinary incontinence. If an extraperitoneal approach is selected, the retropubic space is entered by perforating the transversalis fascia layer of the anterior abdominal wall.\nOnce the retropubic space is dissected, the bladder neck and the vaginal fascia underneath are identified. The bladder is mobilized to the opposite side. At each side of the bladder neck, two to four, preferably non\u25a0absorbable sutures are placed in the space of Retzius.\nNote:The presacral space is a retroperitoneal space that lies between the peritoneum of the posterior abdominal wall and the sacrum. It contains the superior and inferior hypogastric plexuses. The sacral sympathetic trunk lies against the sacrum\u2019s ventral surface.\n\nThe Physiology of Conception\nQuestion 1:\nWhen do germ cells appear in the yolk sac?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_16.jpeg",
      "OBGYN_img_17.jpeg",
      "OBGYN_img_18.jpeg",
      "OBGYN_img_19.jpeg",
      "OBGYN_img_20.jpeg",
      "OBGYN_img_21.jpeg",
      "OBGYN_img_22.jpeg",
      "OBGYN_img_23.jpeg",
      "OBGYN_img_23.jpeg",
      "OBGYN_img_24.jpeg",
      "OBGYN_img_25.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_3",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_7",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_2",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_5",
    "question_text": "weeks\nQuestion 2:\nWhen does the ovary contain the maximum number of oogonia?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_5",
    "question_text": "th month of intrauterine life",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_7",
    "question_text": "th month of intrauterine life\nAt birth",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_3",
    "question_text": "rd month of intrauterine life\nQuestion 3:\nA man with oligospermia has completed his course of hormonal treatment. After how many days will you test his sperm count?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_50",
    "question_text": "60 days",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_60",
    "question_text": "70 days",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_80",
    "question_text": "90 days",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_70",
    "question_text": "80 days\nQuestion 4:\nWhat is the time taken for capacitation of the sperm?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_2",
    "question_text": "4 hours",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_4",
    "question_text": "6 hours",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_6",
    "question_text": "8 hours",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_8",
    "question_text": "10 hours\nQuestion 5:\nWhich of the following statements is true about the resumption of meiosis-I?\nIt is not hormone dependent\nResumed due to LH\nResumed due to FSH\nResumed due to GnRH\nQuestion 6:\nIn which of the following steps does reductional division occur?\nPrimary to secondary spermatocyte\nSecondary spermatocyte to spermatid\nGerm cells to spermatogoniu\nSpermatogonium to primary spermatocyte\nQuestion 7:\nWhich of the following is incorrect about the primary oocyte?\nIt is formed after meiosis I\nIt forms the primordial follicle\nIt gets arrested in diplotene\nIt is diploid\nQuestion 8:\nAn embryologist is preparing embryos for implantation. When is zona hatching expected to occur?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_2",
    "question_text": "days after fertilization",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_5",
    "question_text": "days after fertilization",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_7",
    "question_text": "days after fertilization",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_9",
    "question_text": "days after fertilization\nQuestion 9:\nYou are performing intrauterine insemination during the ovulatory period in a patient with infertility. When will you expect implantation to occur?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_6",
    "question_text": "\u201310 days after fertilization",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_3",
    "question_text": "\u20135 days after fertilization",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch5_14",
    "question_text": "\u201319 days after fertilization",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_1",
    "question_text": "\u20132 days after fertilization\nQuestion 10:\nThe following figure shows the transverse section of the uterus with an implanted zygote. Identify structure A.\n\nDecidua basalis\nDecidua parietalis\nDecidua capsularis\nUterine cavity\nQuestion 11:\nWhat do the Langhans cells form?\nInner cell mass\nMorula\nCytotrophoblast\nSyncytiotrophoblast\nQuestion 12:\nIdentify the structure marked A.\n\nPrimordial follicle\nPrimary oocyte\nTheca interna\nGranulosa cells\nQuestion 13:\nIn which part of the fallopian tube does fertilization occur?\nAmpulla\nIsthmus\nInterstitial\nInfundibular\nQuestion 14:\nA newborn is admitted to the NICU with the following teratoma. Which embryonic layers is this derived from?\n\nEndoderm and ectoder\nEndoderm and mesoder\nMesoderm and ectoder\nEndoderm, mesoderm, ectoder\nQuestion 15:\nIdentify the structure marked as A.\n\nYolk sac\nAllantois\nFuture umbilical cord\nTail end\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_26.jpeg",
      "OBGYN_img_27.jpeg",
      "OBGYN_img_28.jpeg",
      "OBGYN_img_29.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_1",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_2",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_3",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_4",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_5",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_6",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_7",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_8",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_9",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_10",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_11",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_12",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_13",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_14",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_15",
    "question_text": "\nb\nSolution to Question 1:\nGerm cells appear in the yolk sac in the 3rd week.\nThe sequence of events in primordial germ cell formation and migration are:",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_2",
    "question_text": "nd week - Germ cells are formed in the epiblast.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_3",
    "question_text": "rd week - Germ cells move through the primitive streak and migrate to the wall of the yolk sac.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_4",
    "question_text": "th week - Germ cells begin to migrate from the yolk sac to gonads.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_5",
    "question_text": "th week - Germ cell migration is complete.\nGametes are derived from these primordial germ cells.\nSolution to Question 2:\nThe ovary contains the maximum number of oogonia at the 5th month of intrauterine life. The number of oogonia is estimated to be 7 million.\nOogenesis is the process wherein oogonia differentiate into mature oocytes. It begins before birth. At birth, there are approximately 2 million primordial follicles. At the initiation of puberty, the follicle count is less than 400,000, of which less than 500 are destined to ovulate. Every month, 15\u201320 follicles are released, out of which one matures to form the ovum.\nSolution to Question 3:\nThe sperm count is tested 80-90 days after hormonal treatment, as the average time is taken for spermatogenesis is 74 days, and approximately 14 days to reach the ejaculatory ducts.\nThe effect of hormonal therapy on the early phase of spermatogenesis is reflected in the ejaculated sperm concentration after three months.\nSpermatogenesis is the process of the formation of sperms from spermatogonia. Approximately 100 million sperms are produced daily.\nIn patients diagnosed with oligospermia, hormonal treatment is carried out using FSH, hCG, or testosterone. Improvements in sperm count can take a few months, hence the course is usually for 3-6 months. Normal spermatogenesis occurs after this time period.\nSpermiogenesis refers to the series of changes that occur in the formation of spermatozoa from spermatids. These are:\nAcrosome formation\nCondensation of the nucleus\nFormation of the neck, middle piece, and tail\nShedding of cytoplasm as residual bodies Complete motility is obtained in the epididymis.\n\nSolution to Question 4:\nThe time taken for the capacitation of sperms is 6-8 hours (approximately 7 hours).\nSperms have to undergo two changes in the female reproductive tract to be able to fertilise the ovum:\nCapacitation\nIt is the functional maturation of the spermatozoa.\nIt occurs in the fallopian tube and involves epithelial interactions between the sperm and the ucosal surface of the tube.\nThe glycoprotein coat and seminal plasma proteins are removed.\nOnly capacitated sperms can pass through the corona cells and undergo the acrosomal reaction.\nAcrosomal reaction\nIt occurs after binding to zona pellucida, induced by zona proteins.\nEnzymes such as acrosin and trypsin-like protein are released to penetrate the zona pellucida\nCa2+ plays an important role.\n\nSolution to Question 5:\nMeiosis-I in the primary oocyte is resumed after LH surge.\n\nSolution to Question 6:\nMeiosis I or reductional division occurs in the transition from primary spermatocyte to secondary spermatocyte.\nMeiosis takes place in germ cells to generate male and female gametes. Meiosis involves two stages of cell division, namely, meiosis I and II.\nMeiosis I produces two haploid cells. Because the ploidy is reduced from diploid to haploid, meiosis I is referred to as a reductional division. Meiosis II is an equational division analogous to mitosis, resulting in the creation of four haploid daughter cells.\n\nSolution to Question 7:\nThe secondary oocyte is formed after meiosis I.\nPrimordial germ cells divide by mitosis to form oogonia. The majority of the oogonia divide by mitosis, however, some enter meiosis I and are arrested in the diplotene stage of prophase and are now called primary oocytes. Primary oocytes have not yet completed meiosis, hence they are diploid. The primary oocyte along with surrounding epithelial cells forms the primordial follicle.\nMeiosis I is completed after LH surge during puberty. Hence at the completetion of meiosis I, secondary oocyte is produced.\n\nSolution to Question 8:\nZona hatching occurs at around 5 days after fertilization. Fertilization is divided into the following phases:\nPenetration of the corona radiata\nPenetration of the zona pellucida\nFusion of the oocyte and sperm cell membranes\nAfter fertilisation, the zygote differentiates to form the morula and then the blastocyst. The zona pellucida disappears at this stage, which is called zona hatching. The trophoblasts (outer cell mass) are now able to associate with the endometrium during implantation.\nSolution to Question 9:\nThe fertilized ovum implants by 6\u201310 days in the uterine cavity. Implantation involves:\nApposition: Initial contact of the blastocyst to the uterine wall\nAdhesion: Increased physical contact between the blastocyst and uterine epitheliu\nInvasion: Penetration and invasion of syncytiotrophoblast and cytotrophoblasts into the endometriu\nA successful implantation requires receptive endometrium primed with estrogen and progesterone released by the corpus luteum.\n\nSolution to Question 10:\nIn the given image, the decidua basalis is marked as A. This part of the decidua forms the placenta.\n\nImplantation occurs 6 to 7 days after fertilization. After implantation, the endometrium is called the decidua. It is of the following types:\nDecidua basalis - present over chorion frondosum. Decidua basalis and chorion frondosum for the placenta.\nDecidua capsularis - present over abembryonic pole.\nDecidua parietalis - present on the opposite side of the uterus.\nThe villi cover the entire surface of the chorion during the early weeks. As the fetus grows, the villi on the embryonic pole continue to grow, giving rise to the chorion frondosum. At\nthe abembryonic pole, the villi degenerate. By the third month, this side of the chorion becomes smooth, and is called the chorion laeve.\n\nAs the fetus grows, the chorion laeve comes into contact with the decidua parietalis on the opposite side of the uterus, and fusion occurs. Thus, the uterine lumen is obliterated. The amnion and chorion fuse, to form the amniochorionic membrane. Rupture of the amniochorionic membrane during labor is called 'breaking of waters'.\nNote: Superfetation can theoretically occur till the time the uterine lumen is not obliterated.\n\nSolution to Question 11:\nLanghans cells form the cytotrophoblast.\nThe cells of the blastocyst differentiate into an outer trophectoderm and an inner cell mass. The trophectoderm is further differentiated into:\nAn inner mononuclear cellular layer called cytotrophoblast or Langhans layer made of Langhans cells.\nAn outer layer of multinucleated syncytium called syncytiotrophoblast. The blastomere further divides to form the morula.\n\nSolution to Question 12:\nThe structure marked A is primary oocyte. Primary oocytes are the germ cells seen in the medullary region of the ovary. These enlarge at the beginning of the growth phase.\nDuring this cell growth period, many oocytes undergo degeneration, both before and after birth. A single layer of flattened follicular cells that were derived originally from the germinal epithelium soon surrounds the primary oocytes. The structure that is formed is now called a primordial follicle. These are seen first in the medulla and later in the cortex.\n\n\nSolution to Question 13:\nFertilization usually occurs in the ampulla of the fallopian tube.\nDuring ovulation, the ovum is released and it enters the fallopian tube. It is propelled towards the uterine cavity by the peristaltic action of the fallopian tubes, prostaglandins in the male seminal fluid and oxytocin. It can only be fertilized within 24 hours of ovulation. If coitus takes place during this period, the spermatozoa swimming up into the tubes meet the ovum in the ampulla.\nSolution to Question 14:\nThe given image shows an oropharygeal teratoma, which contains derivatives from all three germ layers.\nThe tumor may include gut, bone, skin, and teeth. These tumors arise from pluripotent stem cells that differentiate into any of three germ layers forming tissues of all three germ layers.\nSolution to Question 15:\nThe structure marked A is the allantois.\nThe posterior wall of the yolk sac forms the allantois on the 16th day of development. Its distal portion forms the urachus which forms the median umbilical ligament.\nThe given image shows an embryo at the end of the third week.\n\nMaternal Pelvis and Fetal Skull\nQuestion 1:\nThe anatomical classification of the pelvis based on shape was given by \t.\nCaldwell and Moloy\nMcAfee and Johnson\nPage and Sher\nBurns and Marshall\nQuestion 2:\nAn obese woman with dysmenorrhea and irregular periods is diagnosed with dystocia dystrophia syndrome. What type of pelvis is seen here?\nAndroid pelvis\nPlatypelloid pelvis\nAnthropoid pelvis\nGynecoid pelvis\nQuestion 3:\nWhich of the following is false about anthropoid pelvis?\nSacral angle is more than 90\u00b0\nIschial spines are not prominent\nSide walls are convergent\nLong and curved pubic arch\nQuestion 4:\nA 28-year-old term primigravida gave birth to a male baby by face to pubis delivery. Which type of pelvis is this mode of delivery commonly seen with?\nGynecoid pelvis\nAnthropoid pelvis\nAndroid pelvis\nPlatypelloid pelvis\nQuestion 5:\nAn obstetrician performing clinical pelvimetry finds that the smallest transverse diameter is 8 cm. Which of the following parameters has she assessed?\nInterspinous diameter\nObstetric conjugate\nTrue conjugate\nIntertuberous diameter\nQuestion 6:\nDuring clinical pelvimetry, the obstetrician determines the diagonal conjugate to be X cm. What is the obstetric conjugate?\nX+1 cm\nX+2 cm\nX-1 cm\nX-2 cm\nQuestion 7:\nA diabetic primigravida is suspected to have cephalopelvic disproportion. What should her obstetric conjugate be for a trial of labor to be conducted?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_30.jpeg",
      "OBGYN_img_31.jpeg",
      "OBGYN_img_32.jpeg",
      "OBGYN_img_33.jpeg",
      "OBGYN_img_32.jpeg",
      "OBGYN_img_34.jpeg",
      "OBGYN_img_35.jpeg",
      "OBGYN_img_36.jpeg",
      "OBGYN_img_37.jpeg",
      "OBGYN_img_34.jpeg",
      "OBGYN_img_38.jpeg",
      "OBGYN_img_39.jpeg",
      "OBGYN_img_40.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_8",
    "question_text": "5 cm\n9 cm",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_9",
    "question_text": "5 cm\n10 cm\nQuestion 8:\nWhich of the following parameters cannot be viewed in lateral plate X-ray pelvimetry?\nDiagonal conjugate\nTrue conjugate\nBispinous diameter\nInclination of the pelvis\nQuestion 9:\nA P1A1 woman with a history of obstructed labor is being evaluated for a contracted pelvis. CT pelvis shows both sacral alae are absent. What is the type of pelvis seen here?\nNaegele pelvis\nRobert pelvis\nKyphotic pelvis\nRachitic pelvis\nQuestion 10:\nA patient with prolonged second stage of labor is referred to the district hospital. You suspect her to have a contracted pelvis. Which of the following is true about this condition?\nTransverse diameter of inlet is 10 cm\nAnteroposterior diameter of inlet is 12 cm\nTransverse diameter of inlet is 12 cm\nAnteroposterior diameter of inlet is 14 cm\nQuestion 11:\nWhich of the following is the smallest diameter of the fetal head?\nBiparietal diameter\nSuboccipitofrontal diameter\nSuboccipitobregmatic diameter\nBitemporal diameter\nQuestion 12:\nA 32-year-old woman in labor is referred to a tertiary care center. On PV examination, the resident notes that the fetus is in brow presentation, and the largest diameter of the fetal skull\nis engaged. Identify this diameter.\nOccipitofrontal\nBiparietal\nSubmentovertical\nMentovertical\nQuestion 13:\nA G6P5L5 woman presented to the casualty with abdominal pain. The PV examination findings are given below. What is the engaging diameter?\nSuboccipito-bregmatic diameter\nSuboccipito-frontal diameter\nOccipito-frontal diameter\nOccipito-posterior position\nQuestion 14:\nHow many fontanelles are present in a newborn?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_5",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_2",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_4",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch6_6",
    "question_text": "\nQuestion 15:\nA 24-year-old primigravida delivered a full-term male baby by assisted forceps delivery. The next day, you note a swelling over the infant's head that is limited by suture lines. Which of the following is true regarding the swelling?\nTension in the swelling varies on crying\nIt may cause jaundice\nIt contains edematous fluid\nUsually present at birth\nQuestion 16:\nThe pediatrician notices a diffuse, reddish scalp swelling in a newborn born by vacuum extraction. Which of the following is not a characteristic of this condition?\nIt crosses the midline.\nIt crosses the suture line.\nIt does not disappear within 2-3 days.\nIt is a diffuse edematous swelling of the soft tissues of the scalp.\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch7_1",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch7_2",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch7_3",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch7_4",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch7_5",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch7_6",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch7_7",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch7_8",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch7_9",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch7_10",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch7_11",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch7_12",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch7_13",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch7_14",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch7_15",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch7_16",
    "question_text": "\nc\nSolution to Question 1:\nThe anatomical classification of the pelvis based on shape was given by Caldwell and Moloy.\nThe greatest transverse diameter of the pelvic inlet divides the pelvis into anterior and posterior segments. The shapes of these segments help classify the pelvis as follows:\nGynecoid\nAnthropoid\nAndroid\nPlatypelloid\nThe various differences between these types is summarised below:\nGynecoid\nAnthropoid\nAndroid\nPlatypelloid\nShape\nRound\nAnteroposteriorly ova l\nTriangular/ Heart-sha ped\nTransversely oval / Fl at bowl shaped\nSacral angl e\n>90\u00b0\n>90\u00b0\n<90\u00b0\n>90\u00b0\nSide walls\nStraight or slightly di vergent\nStraight or divergent\nConvergent\nDivergent\nIschial spin es\nNot prominent\nNot prominent\nProminent\nNot prominent\nSubpubican gle\nWide (85\u00b0)\nSlightly narrow\nNarrow\nVery wide (>90\u00b0)\nFetal Positi on\nOccipitolateralObliqu e occipitoanterior\nDirect occipitoanterio rOccipitoposterior\nOccipitolateralObliqu e occipitoposterior\nOccipitolateral\nEngaging d iameter\nTransverse / oblique\nAnteroposterior\nTransverse / oblique\nTransverse\nDelivery\nNo difficulty\nFace-to-pubis - most common.\nDeep transverse arres t is common.Difficult delivery with an incre ased chance of perine al injuries\nNo difficulty\n\nOption B: McAfee and Johnson's regimen is for the conservative management of placenta previa. Option C: Page's and Sher's classification system is used to grade abruptio placentae.\nOption D: Burns and Marshall maneuver is used in breech delivery.\nSolution to Question 2:\nIn dystocia dystrophia syndrome, an android pelvis is seen. Dystocia dystrophia syndrome:\nThe patient is stockily built with a bull neck, broad shoulders, and short thighs. She is obese with a male distribution of hair.\nSubfertile, with dysmenorrhea, oligomenorrhea, or irregular periods.\nThere is an increased incidence of pre-eclampsia and a tendency for postmaturity.\nThe pelvis is of the android type. The occipito-posterior position is common.\nDuring labor, there is a tendency for deep transverse arrest or outlet dystocia, leading to difficult nstrumental delivery or cesarean section.\nThere is a chance of lactation failure.\nSolution to Question 3:\nThe anthropoid pelvis has straight side walls, not convergent side walls.\nG ven below are the differences between various types of pelvis as per Caldwell-Moloy classification.\nGynecoid\nAnthropoid\nAndroid\nPlatypelloid\nShape\nRound\nAnteroposteriorly ova l\nTriangular/ Heart-sha ped\nTransversely oval / Fl at bowl shaped\nSacral angl e\n>90\u00b0\n>90\u00b0\n<90\u00b0\n>90\u00b0\nSide walls\nStraight or slightly di vergent\nStraight or divergent\nConvergent\nDivergent\nIschial spin es\nNot prominent\nNot prominent\nProminent\nNot prominent\nSubpubican gle\nWide (85\u00b0)\nSlightly narrow\nNarrow\nVery wide (>90\u00b0)\nFetal Positi on\nOccipitolateralObliqu e occipitoanterior\nDirect occipitoanterio rOccipitoposterior\nOccipitolateralObliqu e occipitoposterior\nOccipitolateral\nEngaging d iameter\nTransverse / oblique\nAnteroposterior\nTransverse / oblique\nTransverse\nGynecoid\tAnthropoid\tAndroid\tPlatypelloid\nGynecoid\tAnthropoid\tAndroid\tPlatypelloid\nGynecoid\tAnthropoid\tAndroid\tPlatypelloid\nGynecoid\tAnthropoid\tAndroid\tPlatypelloid\nGynecoid\tAnthropoid\tAndroid\tPlatypelloid\nDelivery\nNo difficulty\nFace-to-pubis - most common.\nDeep transverse arres t is common.Difficult delivery with an incre ased chance of perine al injuries\nNo difficulty\n\nSolution to Question 4:\nFace to pubis delivery is most commonly associated with anthropoid pelvis.\nAs the anthropoid pelvis is wider posteriorly, the fetal occiput occupies the posterior segment of the pelvis. Thus, the fetus is present in the occipitoposterior position which leads to a high chance of face-to-pubis delivery.\n\n\nSolution to Question 5:\nThe interspinous diameter is the smallest transverse pelvic diameter.\nThe interspinous diameter or bispinous diameter is measured in the mid pelvis. It is the distance between the tips of two ischial spines. Normally, it is 10-10.5 cm.\nIt is useful in predicting obstructed labor. If the interspinous diameter is too small, the baby's head may get stuck at a higher station.\nNote: The obstetric conjugate is the smallest anteroposterior pelvic diameter measuring 10 cm.\n\nSolution to Question 6:\nThe obstetric conjugate is X-2cm where X is the diagonal conjugate. Anteroposterior diameters of the pelvis:\nTrue conjugate or the anteroposterior diameter, extends from the upper most margin of the symphysis pubis to the sacral promontory. It is normally 11 cm.\nObstetrical conjugate is the shortest distance between the sacral promontory and the symphysis pubis. It is normally 10 cm. It is estimated indirectly by subtracting 1.5\u20132 cm from the diagonal conjugate.\nDiagonal conjugate is determined by measuring the distance from the lowest margin of the symphysis to the sacral promontory. It is normally 12cm. It is measured clinically.\n\nSolution to Question 7:\nIn the given case scenario, a trial of labor or vaginal delivery can be allowed if the obstetric conjugate is 10cm or more.\nThe obstetric conjugate is the shortest distance between the sacral promontory and the symphysis pubis. Normally, it is 10 cm or more.\nThe diagonal conjugate measures 12cm and the true conjugate measures 11cm.\nClinically, only the diagonal conjugate is assessed by measuring the distance between the base of the examiner's fingers and the fingertip touching the sacral promontory. This determines\nthe lowest margin of the symphysis to the sacral promontory. The obstetric conjugate is estimated indirectly by subtracting 1.5\u20132 cm from the diagonal conjugate.\nNote: Overt diabetes can cause fetal macrosomia during pregnancy. Thus, it may lead to cephalopelvic disproportion.\n\nG ven below is an image of the lateral plane in CT pelvimetry, showing the anteroposterior diameters of the pelvis. Line no. 4 is the obstetric conjugate and line no. 5 is the pelvic outlet.\n\nSolution to Question 8:\nThe bispinous diameter can be viewed in the anteroposterior view and not the lateral plate pelvimetry.\nX-ray pelvimetry is done using 3 views:\nAnteroposterior - Transverse diameter and bispinous diameter is determined.\nLateral - Obstetric conjugate, sacral curve and pelvic inclination are seen.\nOutlet - Outlet diameters are determined.\nNote: CT pelvimetry is preferred over X-ray pelvimetry due to the lower dose of radiation delivered.\nG ven below are images of CT pelvimetry, anteroposterior and lateral views respectively. The marked diameters are as follows:\n- Interspinous diameter\n- Intertuberous diameter\n- Obstetric conjugate\n- Pelvic outlet\n\nSolution to Question 9:\nThe type of pelvis seen here is Robert's pelvis. In it, the pelvis is transversely contracted and the ala on both sides are absent and the sacrum is fused with the innominate bones.\nOption A: In Naegele's pelvis, there is arrested development of one ala of the sacrum.\nOption C: Kyphotic pelvis occurs secondary to the kyphotic changes of the vertebral column either following tuberculosis or rickets.\nOption D: In rachitic pelvis, due to softening of bones, flattening of the pelvis occurs.\nSolution to Question 10:\nTo make a diagnosis of contracted pelvis, the transverse diameter of the pelvic inlet should be 10cm.\nThe pelvic inlet is considered to be contracted if:\nthe greatest transverse diameter is &lt; 12 cm or\nthe shortest anteroposterior diameter is &lt; 10 cm.\nThe anteroposterior diameters of the pelvic inlet are the true conjugate, diagonal conjugate and obstetric conjugate. These extend between the sacral promontory and symphysis pubis. The obstetric conjugate is the shortest diameter, normally measuring 10 cm.\nThe transverse diameter of the pelvic inlet is at a right angle to the obstetric conjugate. It extends between the linea terminalis on either side. Normally, the transverse diameter is about 13 cm.\n\n\nSolution to Question 11:\nAmong the given options, the bitemporal diameter is the smallest. It is the distance between the anteroinferior ends of the coronal suture and usually measures 8 cm. This is the smallest engaging diameter.\nOption A: The biparietal diameter is a transverse diameter between two parietal eminences, measuring 9.5cm.\nOption B: The suboccipitofrontal diameter is an anteroposterior diameter, measuring 10 cm. Option C: The suboccipitobregmatic diameter is an anteroposterior diameter, measuring 9.5 cm.\nNote: The bimastoid diameter is a transverse diameter. It is the smallest diameter in the fetal skull at about 7.5 cm. However it is not clinically relevant as it does not engage.\nSolution to Question 12:\nIn brow presentation, the mentovertical diameter is engaged which is the longest diameter of the fetal skull. Normally, it measures 14 cm.\nThe mentovertical diameter extends from the midpoint of the chin to the highest point on the sagittal suture.\nEngaging diameters of the fetal skull vary with the attitude of the fetal head as given below:\nDiameters\nAttitude of the hea d\nSuboccipitobregma tic\nComplete flexion\nDiameters\tAttitude of the hea d\nDiameters\tAttitude of the hea d\nSuboccipito-frontal\nIncomplete flexion\nOccipitofrontal\nMarked deflexion\nMento-vertical\nPartial extension\nSubmentovertical\nIncomplete extensi on\nSubmentobregmati c\nComplete extension\nSolution to Question 13:\nIn the given clinical scenario, the engaging diameter is the suboccipito-bregmatic diameter. It is engaged when the fetus is in vertex presentation with an attitude of complete flexion of the head.\nThe table given below shows the engaging diameter with each attitude of the fetal head.\nDiameters\nAttitude of the hea d\nSuboccipitobregma tic\nComplete flexion\nSuboccipito-frontal\nIncomplete flexion\nOccipitofrontal\nMarked deflexion\nMento-vertical\nPartial extension\nSubmentovertical\nIncomplete extensi on\nSubmentobregmati c\nComplete extension\nSolution to Question 14:\nNewborns have a total of 6 fontanelles. These are fibrous, membrane-covered gaps between cranial bones.\nThe fontanelles seen in newborns are:\nAnterior fontanelle:\nIt is also called bregma.\nDiameter ranges from 0.6-3.6 cm, with a mean of 2.1 cm.\nIt completely closes by 24 months of age.\nPosterior fontanelle:\nIt is also called lambda.\nDiameter ranges from 0.5-0.7 cm.\nIt completely closes by 2 months of age.",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_41.jpeg",
      "OBGYN_img_41.jpeg",
      "OBGYN_img_41.jpeg",
      "OBGYN_img_42.jpeg",
      "OBGYN_img_43.jpeg",
      "OBGYN_img_44.jpeg",
      "OBGYN_img_44.jpeg",
      "OBGYN_img_45.jpeg",
      "OBGYN_img_46.jpeg",
      "OBGYN_img_47.jpeg",
      "OBGYN_img_48.jpeg",
      "OBGYN_img_49.jpeg",
      "OBGYN_img_50.jpeg",
      "OBGYN_img_51.jpeg",
      "OBGYN_img_52.jpeg",
      "OBGYN_img_44.jpeg",
      "OBGYN_img_43.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch7_2",
    "question_text": "sphenoid fontanelles",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch7_2",
    "question_text": "mastoid fontanelles\nNote: A third fontanelle between the anterior and posterior fontanels is associated with hypothyroidism and Down's syndrome.\n\nSolution to Question 15:\nIn the given clinical picture, the swelling over the infant's head is likely to be a cephalhematoma. Infants with cephalohematomas are at a heightened risk of developing jaundice because as the blood breaks down, the levels of bilirubin increase.\nCephalohematoma is a collection of blood in between the pericranium and the flat bone (subperiosteal) of the skull, usually unilateral and over a parietal bone.It is never present at birth but gradually develops after 12\u201324 h. The swelling is limited by the suture lines of the skull as the pericranium is fixed to the margins of the bone\nOption A: Tension in the swelling varies with crying in meningocele. Option C: Edematous fluid collects in caput succedaneum.\nOption D: Caput succedaneum may be present at birth.\n\nSolution to Question 16:\nThe given case scenario is suggestive of caput succedaneum which disappears within 2-3 days.\nIn vertex presentation, labor forces alter the shape of the fetal head. In prolonged labor, before complete cervical dilatation, the portion of the fetal scalp immediately over the cervical os becomes edematous. A swelling is formed is due to the stagnation of fluid in the layers of the scalp beneath the girdle of contact. This is known as caput succedaneum.\nThe swelling is diffuse, boggy, and not limited by the suture lines. It resolves spontaneously within 2-3 days after birth. It is a result of the static position of the head for a long period of time.\nChignon is a type of artificial caput succedaneum, which is a swelling produced on the fetal head because of the scalp getting sucked into the cup during vacuum extraction.\n\nPlacenta and Fetal Membranes\nQuestion 1:\nHow is the normal placenta described?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_53.jpeg",
      "OBGYN_img_1.jpeg",
      "OBGYN_img_54.jpeg",
      "OBGYN_img_1.jpeg",
      "OBGYN_img_54.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch8_1",
    "question_text": "and 2",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch8_2",
    "question_text": "and 3",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch9_1",
    "question_text": "and 3",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch9_1",
    "question_text": ",2 and 3\nQuestion 2:\nWhat does a placental cotyledon comprise of?\nPortions of the basal plate divided by clefts\nPortions of the chorionic plate divided by cleft\nArea supplied by multiple truncal chorionic villi\nArea supplied by one spiral artery\nQuestion 3:\nWhich of the following does not contribute to the prevention of rejection of fetus?\nDecidual natural killer cells\nDecidual stromal cells\nTrophoblasts\nMaternal leucopenia\nQuestion 4:\nAt what period of gestation are the weights of the fetus and placenta equal?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch9_14",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch9_15",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch9_17",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch9_21",
    "question_text": "weeks\nQuestion 5:\nWhat is the uteroplacental blood flow at term?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch9_350",
    "question_text": "600 ml/mi",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch9_250",
    "question_text": "450 ml/mi",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch9_500",
    "question_text": "750 ml/mi",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch9_800",
    "question_text": "1050 ml/mi\nQuestion 6:\nWhich of the following is false about human chorionic gonadotropin?\nAlpha subunit is identical to LH, FSH, TSH\nIt causes involution of corpus luteum\nMaximum level is seen at 60-70 days of gestatio\nDetected in serum 8-9 days after fertilisatio\nQuestion 7:\nWhich of the following cannot cross the placenta?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch10_1",
    "question_text": "and 2\nOnly 3",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch10_2",
    "question_text": "and 3",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch10_3",
    "question_text": "and 4\nQuestion 8:\nA primigravida delivered a baby at term with a birth weight of 1.9 kg via normal vaginal delivery. The placenta delivered appears as shown in the image below. What is this condition k own as?\n\nPlacenta succenturiata\nPlacenta marginata\nCircumvallate placenta\nCircummarginate placenta\nQuestion 9:\nFollowing a normal vaginal delivery, the placenta delivered by controlled cord traction appeared as shown below. What is this condition known as?\n\nBilobate placenta\nPlacenta succenturiata\nPlacenta membranacea\nPlacenta marginata\nQuestion 10:\nThe USG scan of a multiparous woman at 30 weeks of gestation showed the presence of an accessory placental lobe. Which complication will you not anticipate in her?\nPreterm delivery\nPostpartum haemorrhage\nVasa previa\nSubinvolutio\nQuestion 11:\nWhich of the following types of morbidly adherent placenta is shown in the given image?\n\nPlacenta increta\nFocal placenta accreta\nPlacenta percreta\nTotal placenta accreta\nQuestion 12:\nWhat contributes to the formation of amniotic fluid during early pregnancy?\nFetal urine\nFetal extracellular fluid\nUltrafiltrate of maternal plasma\nUltrafiltrate of fetal plasma\nQuestion 13:\nWhile performing the USG assessment of a woman at 28 weeks of gestation, you note her amniotic fluid index to be 12.8. When does this parameter reach its maximum value in a normal pregnancy?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_1.jpeg",
      "OBGYN_img_55.jpeg",
      "OBGYN_img_1.jpeg",
      "OBGYN_img_56.png",
      "OBGYN_img_1.jpeg",
      "OBGYN_img_57.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch10_32",
    "question_text": "weeks of gestatio",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch10_33",
    "question_text": "weeks of gestatio",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch10_34",
    "question_text": "weeks of gestatio",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch10_35",
    "question_text": "weeks of gestatio\nQuestion 14:\nWhich of the following is not a function of amniotic fluid?\nMaintain temperature\nBacteriostatic property\nProvide nutrition in the form of fat and protei\nPrevent ascending infection to uterine cavity during labor\nQuestion 15:\nWhen does keratinization of fetal skin occur?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch10_12",
    "question_text": "18 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch10_22",
    "question_text": "25 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch10_26",
    "question_text": "30 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch10_16",
    "question_text": "20 weeks\nQuestion 16:\nWhich of the following statements is false about amniotic fluid?\nComposition remains same throughout pregnancy\nMajor source is fetal urine after 20 weeks\nIt is primarily reabsorbed by fetal swallowing\nIt is alkaline in nature\nQuestion 17:\nA multigravida presents at 34 weeks of gestation with preterm premature rupture of membranes. On examination, the amniotic fluid is golden-colored. Which condition will you suspect here?\nRh-incompatibility\nFetal death\nFetal distress\nIntrauterine growth restrictio\nQuestion 18:\nUltrasound findings of a few patients are given below. Which of the following patients have oligohydramnios?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch11_1",
    "question_text": "and 2",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch11_2",
    "question_text": "and 3",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch11_2",
    "question_text": "and 4",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch11_2",
    "question_text": ", 3 and 4\nQuestion 19:\nA 24-year-old primigravida at 30 weeks of gestation came for a regular antenatal checkup. On examination, size of the uterus corresponds to 26 weeks of gestation and the fetal heart rate is 130 beats/min. On ultrasound, AFI is 4. Which fetal anomaly would you suspect?\nRenal agenesis\nNeural tube defect\nOesophageal atresia\nCleft palate\nQuestion 20:\nA 30-year-old G3P2L2 woman with multifetal pregnancy is diagnosed with polyhydramnios. What is the amniotic fluid volume required to diagnose it as this condition?\n&gt;1000 ml\n&gt;1500 ml\n&gt;2000 ml\n&gt;2500 ml\nQuestion 21:\nA lady at 30 weeks of gestation came for an antenatal check-up. On examination, the uterus corresponds to 34 weeks of gestation and FHR is normal. Ultrasound revealed an AFI of 26 cm. Which fetal anomaly is most likely to be seen with this condition?\nPosterior urethral valve\nCleft palate\nPolycystic kidney disease\nBladder exstrophy\nQuestion 22:\nA routine ultrasound of a multigravida at 28 weeks of gestation revealed an AFI of 27cm. Which of the following cannot cause the given condition?\nDiabetes mellitus\nPreeclampsia\nEsophageal atresia\nOpen spina bifida\nQuestion 23:\nA 28-year-old G2P1L1 at 35 weeks of gestation is complaining of difficulty in breathing. On examination, flanks are full, and abdominal girth is 160cm. Ultrasound determined that the SDP is 10cm. What is the next step in management?\nIntravenous furosemide\nIndomethacin therapy\nAmniocentesis\nArtificial rupture of membranes\nQuestion 24:\nA female presents with 35 weeks and 3 days of gestation, AFI = 5 and there is no end-diastolic blood flow. What is the management?\nImmediate terminatio\nGive surfactant and wait till 36 weeks\nDo Doppler everyday to check for reversio\nTerminate after 37 weeks\nQuestion 25:\nWhich of the following statements is false about the umbilical cord?\nIt has one artery and two veins\nIt contains a gelatinous substance called Wharton's jelly\nPresence of a single umbilical artery is associated with congenital anomalies\nNormal average umbilical cord length is 50-60 cms\nQuestion 26:\nUltrasound of a 24-year-old primigravida at 20 weeks of gestation shows the presence of a single umbilical artery. No other gross fetal anomalies were detected. Which of the following is true regarding this finding?\nIt is an insignificant finding\nOccurs in 10% of newborns\nIt is an indicator of increased risk of malformations of the fetus\nEqually common in newborns of diabetic and non-diabetic mothers\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_1",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_2",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_3",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_4",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_5",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_6",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_7",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_8",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_9",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_10",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_11",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_12",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_13",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_14",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_15",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_16",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_17",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_18",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_19",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_20",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_21",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_22",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_23",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_24",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_25",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_26",
    "question_text": "\nc\nSolution to Question 1:\nThe normal human placenta is discoid, deciduate, and hemochorial.\nThe term deciduate means that the placenta is shed at the time of parturition. Hemochorial means that the maternal blood directly comes in contact with the fetal trophoblasts.\nThe image given below shows a normal human placenta.\n\nSolution to Question 2:\nA placental cotyledon is comprised of portions of the basal plate divided by clefts. It is the functional unit of the placenta.\nA placental cotyledon or placental lobule constitutes one truncal or main stem villi and its ramifications (rami). Each lobule is supplied by a single truncal branch of the chorionic artery. Each lobule also has a single vein. The lobules constitute functional units of placental architecture.\nThe fetal surface is the chorionic plate. The umbilical cord inserts in the center of the chorionic plate.\nNote: The entire placenta is supplied by chorionic villi while each cotyledon is only supplied by a single main stem villus with its branches.\n\n\nSolution to Question 3:\nMaternal leucopenia is not seen in pregnancy, instead leucocytosis is seen. This plays no part in the prevention of rejection of fetus.\nThe fetus is a semiallogenic graft inside the maternal body as half of its genes are from the father. Uterine transplantation immunity contributes to the survival of the fetus in spite of it being semiallogenic. This occurs due to the following factors:\nDecidual natural killer cells are inefficient, and therefore are unable to attack the 'foreign' fetal cells.\nDecidual stromal cells work with natural killer cells to allow trophoblastic invasion.\nVillous trophoblastic cells don't express HLA antigens and therefore, they are non-immunogenic.\nSolution to Question 4:\nAt 17 weeks, the weights of the fetus and placenta are equal.\nIn the first trimester, the placental growth is more rapid than that of the fetus. By approximately 17 weeks, the placental weight and fetal weight are almost equal. And by term, placental weight is approximately 1/6th of the fetal weight.\nSolution to Question 5:\nThe uteroplacental blood flow at term is 500-750 ml/min.\nSolution to Question 6:\nHuman chorionic gonadotropin (hCG) does not cause involution of the corpus luteum, but it maintains corpus luteum function.\nhCG is produced by the syncitiotrophoblasts of the placenta. It is a glycoprotein hormone with two subunits. The alpha-subunit is similar to LH, FSH and TSH. The beta-subunit is specific and is measured by pregnancy tests.\nhCG can be detected in maternal blood 8 days after fertilisation. Thus, it can help in diagnosis of pregnancy even before the period is missed. Its levels nearly doubles every 48 hours in early pregnancy reaching a maximum of 50000 - 100000 IU/L by 60-70 days of gestation. Then the level starts falling reaching a minimum at 16 weeks, which continues throughout pregnancy.\nThe various placental hormones and their functions are given below. Other placental hormones include:\nGnRH, TRH, GHRH, Growth hormone variant (hGH-V)\nParathyroid hormone-releasing protein (PTH-rP)\nInhibi\nActivi\nRelaxi\nPlacental hormones\nFunctions\nHuman chorionic gonadotrop in (hCG)Structurally similar t o - LH, FSH, TSH\nMaintains corpus luteum fun ctionRegulates testosterone s ecretion from fetal testesStim ulates maternal thyroid\nPlacental hormones\tFunctions\nPlacental hormones\tFunctions\nPlacental lactogen (PL)Struct urally similar to - GH, Prolac tin\nHelps the mother adapt to fet al energy requirements\nCorticotropin-releasing horm one (CRH)\nVascular and myometrial sm ooth muscle relaxationInitiati on of parturitionStimulates p lacental ACTH production\nPlacental adrenocorticotropic hormone (ACTH)\nStimulates fetal and maternal adrenal glucocorticoid produ ction\nSolution to Question 7:\nAlbumin and IgM cannot cross the placenta.\nHigh molecular weight substances such as proteins (e.g., albumin, IgM, IgA) cannot cross the placenta, except IgG.\nSubstances which can cross the placenta are as follows:\nNote: Maternal hormones like insulin, steroid hormones, and thyroid hormones cross the placenta very slowly, and only in amounts enough to support fetal development. However, calcitonin and parathormone do not cross the placenta.\nSubstances\nMechanism\nO2CO2WaterElectrolytesAne sthetic agents\nSimple diffusion\nImmunoglobulin G(molecula r weight 160,000 Da)\nEndocytosis via Fc receptors in the trophoblast\nGlucose\nFacilitated diffusion via gluco se transport proteins (GLUTs)\nAmino acids\nTransport-protein-mediated active transport\nLipids:GlycerolEssential fatty acidsLDL\nEndocytosis via specific recep tors\nMinerals:IodineIron (unidire ctional from mother to fetus) CalciumPhosphorus\nCarrier-mediated active trans port\nVitamins:Vit AVit CVit D\nCarrier-mediated active trans port\nSolution to Question 8:\nThe given image shows a circumvallate placenta. The membranes at the periphery are thickened and consist of a double fold of chorion and amnion.\nNormally, the chorionic plate and basal plates are of the same size. In conditions of extrachorial placentation, the chorionic plate is smaller than the basal plate. There are two types of extrachorial placentation:\nCircummarginate placenta - In this type, the space between the fetal membranes and the basal plate is filled up by fibrin and old hemorrhage.\nCircumvallate placenta - In this type, the peripheral chorion is thickened into a ridge composed of a double fold of chorion and amnion. Complications associated with circumvallate placenta are:\nPreterm delivery\nAbortions\nIUGR\nAntepartum hemorrhage\nRetained placenta and membranes\n\n\nOption A: Placenta succenturiata has one or more small lobes of the placenta placed at varying distances from the main placental margins.\nOptions B &amp; D: Placenta marginata or circummarginate placenta - a thin margin is present between the chorionic and basal plates.\nSolution to Question 9:\nThe given image shows a placenta with a small, accessory lobe. This condition is known as placenta succenturiata.\nA succenturiate placenta contains single or multiple accessory lobes. Accessory lobes are attached to the main lobe by a membrane that has a leash of blood vessels.\nOption A: Bilobate placenta - it consists of two placental lobes. The cord inserts between the two lobes.\nOption C: Placenta membranacea - entire surface of the fetal membranes are covered by functioning villi and the placenta develops as a thin membranous structure occupying the entire periphery of the chorion.\nOption D: Placenta marginata - chorionic plate is smaller than the basal plate, and a thin margin is present between the chorionic and basal plates.\nSolution to Question 10:\nThe given scenario of the presence of an accessory placental lobe is suggestive of placenta succenturiata. Preterm delivery is not a complication seen in this condition.\nComplications of placenta succenturiata include:\nRetained placenta\nPostpartum hemorrhage (PPH)\nSubinvolution of uterus\nSepsis\nPlacental polyp formatio\nVasa previa - vessels overlying the accessory lobes can cross the cervix. Their rupture can lead to hemorrhage from the fetus\nNote: Preterm delivery is a complication associated with circumvallate placenta.\nSolution to Question 11:\nThe given image shows placenta increta.\nMorbidly adherent placenta occurs due to the partial or total absence of the decidua basalis and imperfect development of the fibrinoid or Nitabuch layer. It is of three types:\nPlacenta accreta - villi are attached to the myometrium.\nPlacenta increta - villi invade deep into the myometrium.\nPlacenta percreta - villi penetrate through the entire myometrium and to or through the serosa. Based on the adherence of placental lobules, all three types of morbidly adherent placenta can be:\nTotal - involving all lobules of the placenta\nFocal - involving a single lobule or part of a lobule of the placenta\nMorbidly adherent placenta can lead to torrential post-partum hemorrhage. It is managed via C-section and peripartum hysterectomy.\n\nSolution to Question 12:\nUltrafiltrate of maternal plasma contributes to the formation of amniotic fluid during early pregnancy.\nAmniotic fluid is formed by:\nEarly pregnancy - ultrafiltrate of maternal plasma.\nSecond trimester - the extracellular fluid that diffuses through the fetal skin and thus reflects the composition of fetal plasma.\nAfter 20 weeks - keratinization of fetal skin prevents diffusion across the skin. Hence, fetal urine forms amniotic fluid.\nNote: Fetal kidneys start producing urine at 12 weeks (8\u201311 weeks), and by 18 weeks, they produce 7 to 14 mL per day.\nSolution to Question 13:\nThe amniotic fluid index (AFI) is a measure of the amniotic volume which is maximum at 34 weeks of gestation.\nThe volume of amniotic fluid at each week is variable. The volume gradually increases till 32-34 weeks of gestation. At 34 weeks, it is maximum and thereafter there is a gradual reduction till term.\nAmniotic fluid volume is a passive reflector of the fetal condition. Its volume is determined by the following:\nAny alteration in fetal homeostasis, caused by fetal and maternal conditions, affects the amniotic fluid volume. Thus, AFI is measured as a part of the biophysical score.\nPathway\nVolume in ml\nFetal urination\n+1000\nFetal swallowing\n-750\nFetal lung fluid secretion\n+350\nIntramembranous flow acros s fetal vessels on the placenta l surface\n-350\nSolution to Question 14:\nThe nutritive value of amniotic fluid is negligible because amniotic fluid is predominantly water. It contains the following:\nWater - 98\u201399%\nSolids 1\u20132% - Organic, inorganic, suspended particles Functions of amniotic fluid during pregnancy:\nIt acts as a shock absorber and prevents trauma to the fetus\nTemperature regulation of the uterine environment\nIt distends the amniotic sac and thereby allows for growth and free movement of the fetus.\nIt has no nutritive function, as it is mostly formed by water.\nBacteriostatic property\nFunctions of amniotic fluid during labor:\nThe amnion and chorion are combined to form a hydrostatic wedge which helps in dilatation of the cervix.\nDuring uterine contraction, it prevents any interference in placental circulation so long as the membranes remain intact.\nIt protects the umbilical cord by providing a cushion between the fetus and the umbilical cord during contractio\nIt flushes the birth canal at the end of the first stage of labor and by its aseptic action protects the fetus and prevents ascending infection to the uterine cavity.\nSolution to Question 15:\nKeratinization of fetal skin occurs at 22\u201325 weeks. Therefore, diffusion across fetal skin does not occur after this period. So fetal plasma does not contribute to amniotic fluid formation after this time period.\nSolution to Question 16:\nThe composition of amniotic fluid is not the same throughout pregnancy but changes later in pregnancy due to contamination by fetal urinary metabolites.\nIn early pregnancy, it is identical to plasma in composition as it is mainly composed of a transudate of plasma. In late pregnancy, as amniotic fluid is primarily formed by fetal urination, the composition is altered. Disorders of the fetal kidney can lead to oligohydramnios.\nFetal swallowing is the primary method of resorption of amniotic fluid. Disorders of swallowing in the fetus can cause polyhydramnios.\nAmniotic fluid is alkaline in nature and this helps in differentiating it from vaginal secretions which are acidic. This forms the basis of the nitrazine paper test used for the diagnosis\nof premature rupture of membranes.\nSolution to Question 17:\nGolden-colored amniotic fluid is seen in Rh incompatibility. This appearance is due to presence of excess bilirubin in the amniotic fluid due to hemolysis of fetal RBCs.\nColor of amniotic fluid\nConditions\nPale straw\nNear-term due to exfoliated l anugo hairs, exfoliated cells f rom fetal skin\nGreen\nMeconiumListeria infection\nGolden-yellow\nRh-incompatibility\nSaffron\nPost-maturity\nBlood-stained\nLow lying placentaVasa previ a\nDark maroon\nAltered blood in accidental h emorrhage\nBrown (Tobacco juice)\nIntrauterine fetal demise\nSolution to Question 18:\nAmong the given options, an AFI of 4.5cm (&lt;5cm) or an SDP of 1.8cm (&lt;2cm) indicate oligohydramnios.\nOligohydramnios means an abnormally decreased amount of amniotic fluid (liquor volume is\n&lt;200ml). It is diagnosed using ultrasound parameters such as:\nSingle deepest pocket (SDP) - The largest vertical pocket of amniotic fluid identified in the sagittal plane on ultrasound is the SDP. The normal range of SDP is between 2 to\n8cm. Oligohydramnios is diagnosed if SDP &lt; 2cm.\nAmniotic fluid index (AFI) - It is the sum of the deepest pocket of amniotic fluid from each quadrant of the abdomen. The normal range of AFI is between 5 to 25 cm. Oligohydramnios is diagnosed if AFI &lt; 5cm.\nSolution to Question 19:\nThe given case scenario is suggestive of oligohydramnios. It is associated with renal agenesis. Oligohydramnios has the following features:\nFundal height less than period of gestatio\nFetal parts easily palpable\nAFI &lt;5cm\nSDP &lt;2cm\nSolution to Question 20:\nPolyhydramnios is an abnormal increase in amniotic fluid. It is defined as the presence of amniotic fluid volume &gt;2000ml. Ultrasound parameters used to diagnose polyhydramnios are:\nAFI &gt; 25 cm\nSDP &gt; 8 cm\nSolution to Question 21:\nThe given clinical picture is suggestive of polyhydramnios. It can be seen with a fetus having a cleft palate as fetal swallowing is impaired by this anomaly.\nPolyhydramnios has the following features:\nFundal height greater than period of gestatio\nFetal parts are not well palpable\nAFI &gt;25cm\nSDP &gt;8cm\nSolution to Question 22:\nThe given case scenario is suggestive of polyhydramnios. Preeclampsia is a cause for oligohydramnios, and not polyhydramnios.\nSolution to Question 23:\nThe given case scenario is suggestive of polyhydramnios associated with respiratory distress. In such cases, therapeutic amniocentesis termed amnioreduction is done.\nAmnioreduction helps in polyhydramnios by:\nRelieving respiratory distress by reducing mechanical pressure on the diaphragm\nMay improve obstructive uropathy\nMay lower the preterm delivery risk if the patient has preterm labor or premature rupture of membranes\nOption A: Diuretics have no role in this condition.\nOption B: Indomethacin therapy used to be given earlier as it reduced amnionic fluid volume. However, it is not given anymore due to the risk of premature closure of ductus arteriosus.\nOption D: Artificial rupture of membranes (ARM) is avoided as:\nIt cannot be employed in a patient with an unfavourable cervix.\nOnce ARM is done, delivery needs to be performed. In this case, preterm delivery would occur, hence ARM is avoided.\nARM should be used with caution in patients with chronic polyhydramnios. It can lead to sudden decompression of the uterus causing placental abruption. Thus, controlled ARM is done i these patients.\nSolution to Question 24:\nThe given case scenario is suggestive of fetal compromise. The management in this patient is immediate termination of pregnancy. Since this pregnancy has crossed 34 weeks, it can\nbe terminated by cesarean section.\nAbnormal flow patterns in the umbilical artery:\nReduced end-diastolic flow indicates uteroplacental insufficiency (S/D ratio increases)\nAbsent end-diastolic flow suggests fetal compromise, hence the pregnancy is terminated by C-section if &gt;34 weeks.\nReverse end-diastolic flow suggests impending doom of death, hence the pregnancy is terminated by C-section if &gt;32 weeks.\n\nSolution to Question 25:\nThe umbilical cord normally has two arteries and one vein. The presence of a single umbilical artery is the most common vascular anomaly of the cord. It is associated with congenital anomalies such as genitourinary and cardiac anomalies.\nThe umbilical cord is a tube that connects the fetus to the placenta. It contains umbilical vessels and an obliterated allantois duct, all surrounded by Wharton's jelly and contained within an outer layer of amnion. Maternal blood enters the fetus through the umbilical vein, and blood exits the fetus via the two umbilical arteries. Wharton's jelly is a gelatinous mucopolysaccharide that protects the umbilical vessels. Local collections of Wharton's jelly produce false knots in the cord.\nThe average length of the umbilical cord is between 40-70 cm at term. A long cord can form a loop around the fetus' neck and can cause asphyxia. A short cord can result in cord rupture during labor.\nSolution to Question 26:\nA single umbilical artery is the most common aberration of vessel number in the umbilical cord. It indicates an increased risk of congenital malformations in the fetus.\nA single umbilical artery is seen in the following conditions:\nTwin pregnancy\nGestational diabetes/Overt diabetes\nEpilepsy\nOligohydramnios\nPolyhydramnios\nPreeclampsia\nAntepartum hemorrhage\nIt is frequently associated with congenital malformations of the fetus (20\u201325%) such as:\nCardiovascular anomalies\nGenitourinary anomalies\nTrisomy 18\nIt increases the risks of adverse obstetric outcomes like:\nAbortio\nFetal aneuploidy\nPrematurity\nIntrauterine growth restriction (IUGR)\nPerinatal mortality\nSexual Development, Puberty and Adolescence\nQuestion 1:\nWhich of the following determines the sex of the fetus?\nYp11\nYp10\nYq11\nYq10\nQuestion 2:\nWhen does the sexual differentiation of the fetus occur?",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_1.jpeg",
      "OBGYN_img_58.jpeg",
      "OBGYN_img_1.jpeg",
      "OBGYN_img_59.jpeg",
      "OBGYN_img_1.jpeg",
      "OBGYN_img_60.jpeg",
      "OBGYN_img_1.jpeg",
      "OBGYN_img_61.jpeg",
      "OBGYN_img_1.jpeg",
      "OBGYN_img_62.jpeg",
      "OBGYN_img_1.jpeg",
      "OBGYN_img_63.jpeg",
      "OBGYN_img_2.jpeg",
      "OBGYN_img_64.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_5",
    "question_text": "th week of development",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_7",
    "question_text": "th week of development",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_8",
    "question_text": "th week of development",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_6",
    "question_text": "th week of development\nQuestion 3:\nWhere is the lower part of the vagina derived from?\nGenital ridge\nUrogenital sinus\nMullerian duct\nUrogenital folds\nQuestion 4:\nWhat is the vaginal epithelium derived from?\nEpithelium of urogenital sinus\nEpithelium of mesonephric duct\nEndoderm of genital ridge\nEpiderm of genital ridge\nQuestion 5:\nWhich of the following structures in women is homologous to gubernaculum testis in men?\nRound ligament\nBroad ligament\nUterosacral ligament\nCardinal ligament\nQuestion 6:\nWhich of the following is not a derivative of the paramesonephric duct?\nAppendix of testis\nFallopian tube\nUterus\nGartner's duct\nQuestion 7:\nWhat is the most common developmental abnormality of the uterus?\nDidelphys\nArcuate\nBicornuate\nSeptate\nQuestion 8:\nGiven below is the hysterosalpingogram of a woman who presented with infertility. Identify the uterine anomaly seen.\n\nUterus dideplphys unicollis\nBicornuate uterus\nComplete septate uterus\nCannot be determined\nQuestion 9:\nA woman with unilateral renal agenesis presents to your clinic with a history of recurrent abortions. You suspect uterine didelphys. Which of the following would be the next best investigation?\n\u00e7aparoscopy\nIntravenous pyelography\nHysterosalpingography\nUltrasonography\nQuestion 10:\nA \u00e84-year-old woman visits the infertility clinic with a complaint of recurrent abortions. Upon investigations, she is found to have a septate uterus. Which of the following corrective procedures has the best obstetric outcome?\n\u2018ones metroplasty\nStrassmann metroplasty\nTompkins metroplasty\nTranscervical resection of septum\nQuestion 11:\nWhat is the sequence of pubertal changes in girls?\nThelarche\uf0aePubarche\uf0aeMenarche\nPubarche\uf0aeThelarche\uf0aeMenarche\nPubarche\uf0aeMenarche\uf0aeThelarche\nMenarche\uf0aeThelarche\uf0aePubarche\nQuestion 12:\nWhich of the following effects of puberty are not mediated by estrogen?\nHair growth\nCervical mucus secretion\nVaginal cornification\nMenstruation\nQuestion 13:\nYou are examining an 18-year-old woman and it appears she has mature adult breasts. What is the Tanner stage of breast development in her?\nB3\nB4\nB5\nB6\nQuestion 14:\nAn adolescent girl is brought to OPD with a history of delayed menses. On examination, you note the following developmental changes. What is the Tanner staging?\nTanner \u00e8\nTanner 3\nTanner 4\nTanner 5\nQuestion 15:\nUntil which age is the growth rate of boys and girls similar?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_2.jpeg",
      "OBGYN_img_65.png"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_10",
    "question_text": "years",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_10",
    "question_text": "5 years",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_11",
    "question_text": "years",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_11",
    "question_text": "5 years\nQuestion 16:\nA 13-year-old girl presents to the OBG clinic with complaints of heavy menstrual bleeding. She attained menarche 4 months back. What pattern of bleeding would you expect in this patient?\nIrregular and often shortened\nIrregular and often prolonged\nRegular and often shortened\nRegular and often prolonged\nQuestion 17:\nWhat is diagnostic criterion for considering puberty to be delayed in girls?\nAbsence of menstruation by the age of 14 years\nAbsence of secondary sexual characters by the age of 14 years\nAbsence of menstruation by the age of 15 years\nAbsence of secondary sexual characters by the age of 1\u00e8 years\nQuestion 18:\nA 13-year-old girl is brought to the pediatrician with complaints of short stature and absence of menses. On examination, breasts are Tanner's stage 1. What is the most common cause of her condition?\nIdiopathic\nConstitutiona\nPolycystic ovarian disease\nTurner's syndrome\nQuestion 19:\nA 16-year-old girl with primary amenorrhea has the following features. What is the most probable diagnosis?\nTesticular feminizing syndrome\nGonadal dysgenesis\n\u02dcallmann syndrome\nTurner syndrome\nQuestion 20:\nIn which of the following conditions do secondary sexual characters appear to be normal?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch12_4",
    "question_text": "and 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_1",
    "question_text": ", 3 and 5\n\u00e8, 3 and 4",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_1",
    "question_text": ", 3, 4 and 5\nQuestion 21:\nA 16-year-old girl has come to your clinic with primary amenorrhea. On evaluation, height and secondary sexual characteristics are normal for her age. Ultrasound showed ovaries but no uterus was seen. Her karyotype is 46XX. What is the diagnosis?\nMullerian agenesis\nAndrogen insensitivity syndrome\n\u02dcallman syndrome\nSwyer syndrome\nQuestion 22:\nA 14-year-old girl presented with cyclical abdominal pain and a midline hypogastric lump. She has not achieved menarche yet. On examination, a bluish bulge is noted on parting the labia. What is the likely cause of her condition?\nBartholin cyst\nTransverse vaginal septum\nImperforate hymen\nEndometrioma\nQuestion 23:\nA 16-year-old girl is brought to the clinic by her mother with complaints of failure of onset of menses. On examination, her height is 150 cm, her breasts are underdeveloped, and sparse pubic hair is present. Ultrasound shows a small uterus and no gonads are visible. Which of the following statements is incorrect about her condition?\n\u02dcaryotype may have a Y chromosome\n\u00e7H and FSH levels will be low\nPregnancy can occur with ovum donation\nEstrogen and progesterone supplementation is the treatment\nQuestion 24:\nA 16-year-old girl with primary amenorrhea has come to your clinic. On examination, thelarche is absent. She has a normal stature, and her karyotype is 46XX. Which investigation would you prefer to perform first?\nSerum testosterone\nUSG pelvis\n\u00e7H, FSH levels\nHysterosalpingogram\nQuestion 25:\nA \u00e85-year-old female came with complaints of 4 months of amenorrhea. Her FSH and \u00e7H were elevated above the normal value, thyroid function tests were normal. Which is the next step in management ?\nEstimate serum estradiol values\nGive progesterone and stop after 10 days for withdrawal bleeding\nCheck USG for polycystic ovaries\nDo a urine pregnancy test\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_1",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_2",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_3",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_4",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_5",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_6",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_7",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_8",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_9",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_10",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_11",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_12",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_13",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_14",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_15",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_16",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_17",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_18",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_19",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_20",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_21",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_22",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_23",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_24",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_25",
    "question_text": "\na\nSolution to Question 1:\nThe sex of the fetus is determined by Yp11, which is a region present on the short arm of the Y chromosome.\nIt contains the SRY gene, which produces the protein called the testis determining factor. This causes the gonads to develop into the testes. The target gene for SRY which favours testis differentiation is SOX9.\nIf SRY gene or Y chromosome are absent, the gonads develop as ovaries. The genes that favor this are:\nWnT4\nRspo\nDAX1\nSolution to Question 2:\nSexual differentiation of the fetus occurs only after the 7th week of development.\nThe chromosomal and genetic sex of an embryo is determined at fertilization by the kind of sperm that fertilizes the ovum (X or Y). However, male and female morphological characteristics begin developing after the 7th week. At the end of the 6th week of development, it is impossible to distinguish between the two sexes.\nSolution to Question 3:\nThe lower part of the vagina is derived from the urogenital sinus. Option A: The ovary and the testis are derived from the genital ridge.\nOption C: The upper part of the vagina is derived from the paramesonephric duct or Mullerian duct. The uterus develops from the fusion of the right and left paramesonephric ducts in the midline.\nOption D: The labia minora and the ventral aspect of the penis are derived from the urogenita folds.\n\nSolution to Question 4:\nThe vaginal epithelium is derived from the epithelium of the urogenital sinus. The epithelium of urogenital sinus is formed by the endoderm.\n\u203aote: Urogenital sinus epithelium stains positive for FOXA1, and Mullerian duct epithelium stains positive for PAX\u00e8. In \u00e8017, immunohistochemical testing done on embryos revealed vagina epithelium showed positive immunostaining for both FOXA1 and PAX\u00e8.\nSolution to Question 5:\nThe round ligament in women is homologous to gubernaculum testis in men. Homologous structures are those that have the same embryological origin.\nSolution to Question 6:\nThe Gartner's duct is not derived from the paramesonephric duct. It is a remnant of the mesonephric/ Wolffian duct.\nSolution to Question 7:\nThe most common developmental abnormality of the uterus is septate uterus, followed by bicornuate uterus.\nSolution to Question 8:\nIn a hysterosalpingogram, the uterine anomaly cannot be determined as the external contour of the uterus cannot be seen.\nHysterosalpingography (HSG) provides excellent information about the interior contour of the uterine cavity. However, it doesn't show the external contour, so it cannot distinguish between uterine anomalies such as didelphys, bicornuate, septate or arcuate uteruses.\nTransvaginal 3-D ultrasonography (3D TV-US) is very accurate for the diagnosis and differentiation of uterine anomalies. It is the first and only mandatory step in the assessment of the uterine cavity in patients with a suspected uterine anomaly.\nPelvic MRI without contrast provides excellent delineation of both internal and external uterine contours. It should be reserved for patients in whom 3D TV-US is not possible.\nSolution to Question 9:\nUltrasonography (USG) is performed to confirm a diagnosis of uterus didelphys.\nUterine didelphis is a congenital condition that occurs when the incomplete fusion of Mullerian ducts that form the uterus during embryonic development leads to the development of two separate uterine cavities and two cervices, each with its own set of endometrial lining.\nIt is commonly associated with renal anomalies such as unilateral renal agenesis, severe renal hypoplasia, etc, and is often associated with recurrent pregnancy loss, preterm labour, malpresentation, and prematurity.",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_2.jpeg",
      "OBGYN_img_66.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_3",
    "question_text": "D ultrasound, a non-invasive test, visualizes both the external (serosal) and interna (endometrial) uterine contours, effectively identifying anomalies. Hysterosalpingography (Option C) shows only the internal contour, making it unable to distinguish between conditions like didelphys, bicornuate, septate, or arcuate uterus.\n\nThe USG findings in didelphys uterus are two widely separated uterine horns and a deep fundal indentation.\n\u00e7aparoscopy and hysteroscopy, being invasive diagnostic procedures, should be reserved for cases where simultaneous surgical treatment is planned following a comprehensive non-invasive assessment of a Mullerian anomaly. (Option A)\nIntravenous pyelography is used to diagnose congenital renal anomalies. (Option B)\n\nSolution to Question 10:\nTranscervical hysteroscopic resection of the septum has the best obstetric outcome.\nThe procedure involves the resection of the septum under hysteroscopic guidance. Hence, it doesn't scar the uterus and avoids the necessity of cesarean sections for future pregnancies improving obstetric outcomes.\nMetroplasty is the surgical resection of the intrauterine septum. This is done by approaching the uterus transabdominally via 3 methods:\n\u2018ones metroplasty\nStrassmann metroplasty\nTompkins metroplasty\nAll of these methods are not preferred nowadays as they cause uterine scarring.\nSolution to Question 11:\nThe sequence of pubertal changes in girls is thelarche \uf0ae pubarche \uf0ae menarche.\nPuberty marks the normal physiologic transition from childhood to sexual and reproductive maturity. The order of changes in puberty are:\nThelarche - It refers to breast budding, and is the first visible sign. It indicates the competency of the hypothalamo-pituitary-ovarian axis. It appears between the age of 9-11 years, and is described using Tanner staging.\nAdrenarche - It refers to the generation of androgens (estrogen and testosterone) from the adrenal gland.\nPubarche - It refers to the development of pubic hair, and occurs usually 6 months after thelarche. It is also described using Tanner staging.\nMenarche - It refers to the first occurrence of menstruation. Growth spurt usually occurs between ages 10.5 to 13.5 years.\nSolution to Question 12:\nPubarche or the development of axillary and pubic hair is not mediated by estrogen. It occurs due to testosterone in both sexes. Around 50% of testosterone comes from the ovaries and the rest from the adrenal gland.\nPuberty in girls involves breast development (thelarche), an increase in adrenal androgen secretion (adrenarche), and the beginning of menstrual cycles (menarche).\nEstrogen has the following actions during puberty:\nBreast development\nDevelopment of the reproductive tract\nStarting of menstruation (option D)\nIncreased fat in the hips\nRegulation of pubertal growth spurt\nVaginal cornification (option C)\nCervical mucus production (option B)\nEpiphyseal closure\nMaintenance of bone formation - acts against parathyroid hormone.\nSolution to Question 13:\nThe Tanner staging of the breast, in case of mature adult breast, is denoted as B5.\n\nSolution to Question 14:\nThe breast elevated as a small mound and pigmented, slightly curved pubic hair is seen in Tanner stage \u00e8.\nTanner stagi ng\nBreast changes\nPubic hair changes\nStage 1\nB1 - Denotes the prepubertal breast. At this infantile stage, only the papilla is elevated.\nP1 - \u203ao pubic hair\nStage \u00e8\nB\u00e8 - Denotes thelarche. The breast buds are palpable, are ola enlarges and the breast is elevated like a small mound.\nP\u00e8 - The appearance of pigm ented hair sparsely over the l abia, either long or slightly c urved.\nStage 3\nB3 - There is further enlarge ment of the breast and its are ola without separation of its c ontours.\nP3 - Darker, coarser and curl y hair\nStage 4\nB4 - Preferential growth of th e areola and nipple leads to f ormation of a secondary mou nd over the mound of the bre ast.\nP4 - Preadult stage cover sho rt inverted triangular distribu tion.\nStage 5\nB5 - Formation of the mature adult breast.\nP5 - Adult inverted triangular distributuion.\nSolution to Question 15:\nThe growth rate of boys and girls is similar till the age of 10.5 years.\nThe growth spurt in girls overtakes that of boys for 1-\u00e8 years and reaches a plateau. In boys, the growth spurt starts later and continues for a longer duration. As a result, boys grow taller than girls in terms of final height.\nSolution to Question 16:\nThe given case scenario is suggestive of puberty menorrhagia. Menstruation tends to be irregular and often prolonged.\nSince the hypothalamo-pituitary-ovarian axis is maturing, initial cycles are\nanovulatory. Therefore, the pattern of bleeding is irregular. Also, as the endometrium is under the prolonged influence of estrogen, it gets thickened more than normal. Shedding of this thickened endometrium leads to prolonged bleeding.\nSolution to Question 17:\nPuberty would be considered to be delayed in any girl who has not started menstruating by the age of 15 years.\nDelayed puberty in girls can be declared on the basis of \u00e8 grounds. These are:\n\u203ao secondary sexual characters are present by 13 years of age.\nSecondary sexual characters are present, but no menses have occurred by 15 years of age. If any one of these is present, it's considered to be a case of delayed puberty.\nPrecocious puberty is considered if breast development or onset of puberty occurs in children less than 8 years of age.\nSolution to Question 18:\nThe given case scenario is suggestive of delayed puberty. The most common cause of this condition is constitutional.\nPuberty is considered to be delayed if:\nBreast development doesn't occur by 13 years in girls.\nTesticular enlargement doesn't occur by 14 years in boys. Causes of delayed puberty:\nConstitutional or physiological delay (most common)\nChronic anovulation - PCOS\nAnatomical:\nOutlet obstruction\nGonadal agenesis\nAndrogen insensitivity syndrome\nHypergonadotropic hypogonadism - E.g., Premature ovarian failure\nHypogonadotropic hypogonadism - e.g., \u02dcallman syndrome\nPrecocious puberty is considered if signs of puberty are seen in children less than 8 years of age. Causes of precocious puberty:\nIdiopathic (most common)\nCentra\nC\u203aS tumors\nInfections\nTumors producing\nEstrogen\nTestosterone\nhCG\nCongenital adrenal hyperplasia\nThe protocol followed for evaluation of delayed puberty in girls is given below.\n\nSolution to Question 19:\nThe scenario of a 16-year-old girl with absent secondary sexual characters, normal stature, with XX karyotype and high FSH and \u00e7H is suggestive of pure gonadal dysgenesis.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_2.jpeg",
      "OBGYN_img_67.jpeg",
      "OBGYN_img_2.jpeg",
      "OBGYN_img_68.jpeg",
      "OBGYN_img_2.jpeg",
      "OBGYN_img_69.jpeg",
      "OBGYN_img_2.jpeg",
      "OBGYN_img_70.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_46",
    "question_text": "XX and 46 XY gonadal dysgenesis without the phenotype of Turner's syndrome (short stature, webbed neck) is described as pure gonadal dysgenesis. It is characterized by the presence of primary amenorrhea with or without normal secondary sexual characteristics.\nOption A: Testicular feminizing syndrome occurs in karyotype XY. Secondary sexual characters are present and the uterus is absent.\nOption C: \u02dcallmann syndrome is a form of hypogonadotropic hypogonadism. GnRH synthesis is reduced, therefore FSH and \u00e7H are low, and secondary sexual characters are absent.\nOption D: Turner syndrome is associated with short stature and karyotype X0. Secondary sexua characters and the uterus is present, but the ovaries are streaked.\n\nSolution to Question 20:\nSecondary sexual characters appear normal in the following:\nImperforate hymen\nTransverse vaginal septum\nAbsent vagina and functioning uterus\nAbsent vagina and nonfunctioning uterus - Mayer\u2013Rokitansky\u2013\u02dc\u00fcster\u2013Hauser syndrome\n[MR\u02dcH]\nResistant ovary syndrome\nIn androgen insensitivity syndrome, secondary sexual characteristics may or may not develop normally. The genotype is XY, however a female phenotype develops. These patients have\nwell-developed breasts, but they have scanty body hair. This is because growth of sexual hair is only mediated via androgens. Thus, secondary sexual characters cannot be considered normal.\n\nSolution to Question 21:\nThe given case scenario is suggestive of Mullerian agenesis. It is differentiated from androgen insensitivity syndrome as follows:\nOption C: \u02dcallman syndrome is hypogonadotropic hypogonadism. There is a lack of GnRH synthesis, and sexual development is delayed. Uterus is present.\nOption D: Swyer syndrome is pure gonadal dysgenesis. The karyotype is XY and the uterus is underdeveloped.\nPresentation\nMullerian agenes is\nAndrogen insensitivity /Testi cular feminization syndrome\nInheritance pattern\nSporadic\nX-linked recessive\n\u02dcaryotype",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_2.jpeg",
      "OBGYN_img_70.jpeg",
      "OBGYN_img_71.jpeg",
      "OBGYN_img_2.jpeg",
      "OBGYN_img_70.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_46",
    "question_text": ", XX",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_46",
    "question_text": ", XY\nPresentation\tMullerian agenes\tAndrogen insensitivity /Testi\nis\tcular feminization syndrome\nPresentation\tMullerian agenes\tAndrogen insensitivity /Testi\nis\tcular feminization syndrome\nPresentation\tMullerian agenes\tAndrogen insensitivity /Testi\nis\tcular feminization syndrome\nBreast development\nPresent\nPresent\nAxillary and pubic hair\nPresent\nAbsent\nUterus\nAbsent\nAbsent\nGonad\nOvary\nTestis (Intraabdominal)\nTestosterone\nFemale levels\nMale levels\nAssociated anomaly\nPresent\nAbsent\n\nSolution to Question 22:\nThe given case scenario is suggestive of an imperforate hymen, which has led to cryptomenorrhoea. This is a condition where menstruation occurs but is not visible due to an obstruction of the outflow tract.\nThe menstrual fluid gets collected in the reproductive tract. When this collection occurs in the vagina, it is known as hematocolpos. If the collection extends to the uterus, it is known as hematometra. The collection of blood in the fallopian tubes is called hematosalpinx.\nThe most common causes of cryptomenorrhea are:\nIntact/imperforate hymen - a bluish convex bulge is seen.\nTransverse vaginal septum - a pinkish concave covering is seen Ultrasound pelvis confirms the diagnosis.\nManagement:\nImperforate hymen - A simple cruciate incision of the hymen allows the free drainage of the collected menstrual blood, and leads to normal reproductive function.\nTransverse vaginal septum - Extensive dissection and vaginoplasty is required.\nOption A: Bartholin's cyst appears as a swelling on the inner side of the labia majora. \u00e7arger cysts can bulge across the introitus. Small cysts can remain asymptomatic.\nOption D: Endometriomas are endometriotic lesions seen on the ovary. They present as adnexa masses. Endometriosis is a complication in cryptomenorrhea, due to retrograde menstruation.\nSolution to Question 23:\nThe given clinical scenario is suggestive of gonadal dysgenesis. Hence, the patient will have high \u00e7H and FSH levels as it is a condition of hypergonadotrophic hypogonadism.\nGonadal dysgenesis is the most frequent cause of premature ovarian failure. In this disorder, a normal complement of germ cells is present in the early fetal ovary. However, oocytes undergo accelerated atresia, and the ovary is replaced by a fibrous streak. This is called a streak gonad.\nThere are two types of gonadal dysgenesis:\nPure gonadal dysgenesis:\n\u02dcaryotypes seen:",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_2.jpeg",
      "OBGYN_img_72.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_46",
    "question_text": "XX is seen in pure gonadal dysgenesis due to FSH gene mutation.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_46",
    "question_text": "XY - Swyer syndrome\nAssociated with primary amenorrhoea\nThey are phenotypically female due to:\nAbsence of testosterone\nAbsence of Anti-Mullerian hormone secretion by testes\nThe underdeveloped gonad ultimately fails, which is indicated by elevated gonadotropin (\u00e7H,\nFSH) levels\nThe presence of a Y chromosome can result in a germ cell tumor in the dysgenetic gonad\nTreatment:\nHormone replacement therapy - with estrogen and progesterone\nInfertility - Pregnancy can occur with a donated ovum \u00e8. Mixed gonadal dysgenesis:\n\u02dcaryotypes seen:",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_45",
    "question_text": "X0 - e.g. Turner's syndrome",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_46",
    "question_text": "XX",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_46",
    "question_text": "XY\nMosaicism\nDysgenetic gonad can develop into a germ cell tumor.\nSolution to Question 24:\nThe given case scenario is suggestive of primary amenorrhea. The first line of investigation in primary amenorrhea should be hormonal assay (\u00e7H, FSH, estrogen).\nFollowing this investigation, USG pelvis and MRI pelvis can be performed to enable the anatomical assessment.\n\u00e7H and FSH levels help to assess whether it is a hypogonadotropic or hypergonadotropic condition. The hormone replacement therapy is planned based on \u00e7H and FSH levels.\nThe various types of hypogonadism are as follows:\n\u203aote: In a patient with primary amenorrhea with absent sexual characteristics, the first line of investigation is hormonal assay (\u00e7H and FSH levels).\nType of Hypogonad ism\n\u00e7H/F SH\nEstro gen\nPrimary defect\nHypergonadotropic\nHigh\n\u00e7ow\nOvary\nHypogonadotropic\n\u00e7ow\n\u00e7ow\nHypothalamus/Pituita ry\nEugonadotropic\n\u203aor ma\n\u203aorm a\nVaried\nSolution to Question 25:\nThe given clinical scenario is suggestive of premature ovarian failure. The next step in management would be to check serum estradiol levels to evaluate amenorrhea.\nCategories of amenorrhea are based on gonadotrophin and estrogen levels as follows:\nHypergonadotropic hypogonadism - also known as premature ovarian failure.\nHypogonadotropic hypogonadism\nEugonadotropic hypogonadism\nHypergonadotropic hypogonadism/premature ovarian failure is present when:\nOvarian function is decreased/absent - Serum estrogen levels are low. Serum prolactin is high.\n\u00e7H and FSH (gonadotropins) levels are high, as sex-steroid feedback is absent. Differential diagnosis of premature ovarian failure:\nGonadal dysgenesis\nSpecific gene defects\nFragile X (FMR1 premutation)\nGalactosemia\nIatrogenic\nOvarian surgery\nGonadal radiation\nSystemic chemotherapy\nAutoimmune disease\nToxins\nViruses\nMiscellaneous\n\u203aote: Since FSH, \u00e7H, and TFT are already estimated, it suggests that all preliminary tests (including UPT) are done. Moreover, serum FSH and \u00e7H values are quite low during pregnancy. This is due to the inhibitory effects of elevated estrogen and progesterone.\nPhysiological Changes During Pregnancy\nQuestion 1:\nWhich of the following is true about vaginal changes in a normal pregnancy?\nDecreased number of Lactobacilli\nIncreased glycogen metabolism in the epithelium\npH &gt; 6.8\nEpithelial thinning\nQuestion 2:\nIn pregnancy, vaginal cytology shows a predominance of \t.\nIntermediate cells\nSuperficial cells\nBasal cells\nParabasal cells\nQuestion 3:\nA 28-year-old woman has come for pre-conceptional counselling. Her BMI is 30 kg/m2 and she is worried about weight gain during pregnancy. How much weight should she gain during pregnancy?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_5",
    "question_text": "9 kg",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_8",
    "question_text": "11 kg",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_10",
    "question_text": "13 kg",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_14",
    "question_text": "16 kg\nQuestion 4:\nIn pregnancy, the diaphragm is elevated by \t.\n3 cm\n2 cm\n4 cm\n5 cm\nQuestion 5:\nA pregnant woman at her 30th week of pregnancy undergoes a pulmonary function test. Provided there is no respiratory abnormality, which of the following would be decreased?\nRespiratory rate\nVital capacity\nFunctional residual capacity\nInspiratory capacity\nQuestion 6:\nWhich of the following statements is true about prolactin levels in pregnancy?\nLowest in pregnancy and increases after delivery\nHighest at term and reduces after delivery\nIncreases during pregnancy and plateaus during lactation\nPulsatile release during pregnancy\nQuestion 7:\nWhich of the following produce estrogen and progesterone in the first two months of pregnancy?\nCorpus albicans\nAdrenal gland\nPlacenta\nCorpus luteum\nQuestion 8:\nA pregnant woman presents to an antenatal clinic for the first time during the second trimester. In view of a family history of thyroid disorders, a thyroid function test is sent for. Altered levels of which of the following would not be a cause for concern?\nFree T3 leve\nFree T4 leve\nTotal T3 leve\nTSH leve\nQuestion 9:\nWhich of the following do not synthesise relaxin during pregnancy?\nPlacenta\nFetal adrenal gland\nCorpus luteum\nDecidua\nQuestion 10:\nWhich among the given features is not a major physiological change in pregnancy?\nInsulin resistance\nIncrease in BMR\nHypothyroidism\nIncrease in blood volume\nQuestion 11:\nA pregnant woman with diabetes mellitus is advised to increase her insulin dose as pregnancy is characterised by insulin resistance. Which of the following is not implicated in this phenomenon?\nHuman placental lactogen\nProgesterone\nhCG\nEstrogen\nQuestion 12:\nWhich of the following changes are not seen in the renal system during pregnancy?\nIncrease in kidney size\nIncrease in serum creatinine\nIncreased GFR\nIncreased renal blood flow\nQuestion 13:\nWhich of the following is increased during pregnancy?\nSerum potassium\nHemoglobin concentration\nTotal oxygen carrying capacity of blood\nSerum iron concentration\nQuestion 14:\nWhich of the following is not a physiological change seen in pregnancy?\nIncrease in intravascular volume\nIncrease in cardiac output\nDecrease in systolic BP\nIncrease in peripheral vascular resistance\nQuestion 15:\nA primigravida presents in the 2nd trimester complaining that her slippers do not fit anymore. On examination, her pulse is 88/min and blood pressure is 130/84mm Hg. You note bilateral pitting edema up to the level of ankles. What would you advise her?\nOral furosemide\nOral labetalo\nRestrict salt intake\nBed rest\nQuestion 16:\nWhich of the following is not a physiological change seen during pregnancy?\nPulmonary blood flow is increased by 2,500 mL/min\nBlood flow to the skin decreases to 300 mL/min\nBlood flow to the uterus increases to 750 mL/min\nRenal blood flow increases by 400 mL/min\nQuestion 17:\nA 23-year-old primigravida presents to the antenatal clinic at 30 weeks of gestation. During examination, which of the following cardiovascular findings would not be a cause for alarm?\nS3\nS4\nFixed split S2\nPericardial knock\nQuestion 18:\nWhich of the following coagulation factors are increased in pregnancy?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_2",
    "question_text": ", 3, 4",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch13_2",
    "question_text": ", 3, 4, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_1",
    "question_text": ", 2, 3, 4, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_1",
    "question_text": ", 2, 3\nQuestion 19:\nA 24-year-old primigravida at 38 weeks of gestation presents to the antenatal clinic with complaints of dizziness on lying down for the past one week. She feels better on sitting up or turning to the side. What is the cause of this condition?\nIncreased abdominal pressure\nInferior vena caval compression\nAortic compression\nIncreased uteroplacental blood flow\nQuestion 20:\nWhich of the following is true regarding the sensitivity of uterine musculature?\nEnhanced by progesterone\nInhibited by estrogen\nEnhanced by both estrogen and progesterone\nEnhanced by estrogen and inhibited by progesterone\nQuestion 21:\nA pregnant woman has cramps in her legs. What will you suggest her to relieve the pain?\nExtend knee and dorsiflex foot\nFlex knee and dorsiflex foot\nExtend knee and plantar flex foot\nFlex knee and plantar flex foot\nQuestion 22:\nTheca lutein cysts are not associated with which of the following conditions?\nAnti-D allo-immunization\nFetal hydrops\nNormal pregnancy\nHyperprolactinemia\nQuestion 23:\nIn which trimester does acute fatty liver manifest most commonly during pregnancy?\nFirst trimester\nSecond trimester\nThird trimester\nBoth (a) and (b)\nQuestion 24:\nWhat does the term 'placental sign' denote?\nAlteration of fetal heart rate on pressing the head into the pelvis\nSpotting on the expected date of period in early months of pregnancy\nPermanent lengthening of the cord in 3rd stage of labor\nSlight gush of bleeding in 3rd stage of labor\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_1",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_2",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_3",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_4",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_5",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_6",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_7",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_8",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_9",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_10",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_11",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_12",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_13",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_14",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_15",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_16",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_17",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_18",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_19",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_20",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_21",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_22",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_23",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_24",
    "question_text": "\nb\nSolution to Question 1:\nThere is an increase in the metabolism of glycogen in the vaginal epithelium during normal pregnancy.\nThe changes in the vagina during pregnancy include:\nIncreased vascularity and hyperemia resulting in a violet/purplish color characteristic of Chadwick's sign\nVaginal epithelium undergoes marked proliferation (option D) with the extension of the squamocolumnar junction downwards\nVaginal pH decreases and becomes more acidic (option C) and varies from 3.5-6.0.\nIncrease in the number of Lactobacillus acidophilus (option A). It metabolizes the glycogen stores and causes an increased production of lactic acid. Therefore, the pH becomes acidic.\nIncreased volume of cervical secretion during pregnancy results in the production of thick white vaginal discharge.\nSolution to Question 2:\nDuring pregnancy, vaginal cytology shows a predominance of intermediate cells.\nSolution to Question 3:\nThe patient in the given question is obese. The recommended gestational weight gain in such a patient is 5-9 kg.\nIdeally, weight gain should depend on the pre-pregnancy BMI (body mass index) level. The gestational weight gain recommended for each BMI category by the Institute of Medicine (IOM) are as follows:\nCategory\nBMI (in kg/ m2)\nRecommended weight gain\nUnderwe ight\n<18.5",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_12",
    "question_text": "5\u201318 kg\nNormal",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_18",
    "question_text": "5\u201324.9",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_11",
    "question_text": "5\u201314 kg\nOverweig ht",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_25",
    "question_text": "\u201329.9",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_7",
    "question_text": "\u201311.5 kg\nObese\n>30",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_5",
    "question_text": "9.1 kg\nSolution to Question 4:\nThe diaphragm is elevated by 4 cm in pregnancy.\nThe anatomical changes in the respiratory system during pregnancy are:\nElevation of diaphragm by 4 cm\nTransverse diameter of chest increases by 2 cm\nChest circumference increases by 5-7 cm\nSubcostal angle increases from 68 degrees to 103 degrees\nSolution to Question 5:\nFunctional residual capacity decreases in pregnancy.\nThe changes in the respiratory system during pregnancy are:\n(Mnemonic: TIMM increases in pregnancy)\nIncrease\nDecrease\nUnaffected\nTidal volumeInspiratory capa cityMinute O2uptakeMinute ventilation\nFunctional residual capacityE xpiratory reserve volumeResi dual volumeTotal lung capaci ty\nRespiratory rateVital capacity Inspiratory reserve volume\n\nSolution to Question 6:\nThe maternal plasma prolactin level is highest at term and reduces after delivery. Despite this high level, milk secretion does not occur during pregnancy due to the action of estrogen and\nprogesterone.\nProlactin secretion returns to the nonpregnant level a few weeks after delivery. The levels of estrogen and progesterone fall and hence, prolactin can promote milk secretion even at a lesser concentration.\nSolution to Question 7:\nIn the first two months of pregnancy, estrogen and progesterone are produced by the corpus luteum.\nIt functions maximally during the second month of pregnancy and thereafter contributes relatively little. Estrogen is synthesized in the placenta from the 7th week and progesterone from the 8th week.\nSolution to Question 8:\nTotal T3 levels are altered throughout pregnancy.\nTotal T3 and total T4 increase due to stimulation of thyroid tissue by hCG during the early period of gestation. However, there is no change in free T3 and T4 due to an increase in thyroid-binding globulin (TBG).\nThis leads to a transient fall in TSH during the early weeks of gestation. The level of TSH becomes normal during the second and third trimester.\nHormone secretion during pregnancy:\nIncreased\nGH\nInsulin\nProlactin\nAldosterone\nTestosterone\nTotal T3, T4\nDecreased\nLH\nFSH\nDHEAS (dihydroepiandosterone)\nUnchanged\nTSH\nADH (vasopressin)\nFree T3, T4\nSolution to Question 9:\nRelaxin is not synthesised by the fetal adrenal gland in a pregnant woman. It is synthesised by corpus luteum, decidua and placenta.\nRelaxin is a placental protein hormone. Plasma levels peak between 8 and 12 weeks of gestation and decline thereafter to lower levels that persist until term.\nFunctions of relaxin are:\nRelaxation of myometrium and quiescence of early pregnancy\nEnhancement of the glomerular filtration rate\nEndometrial vascular remodelling by inducing secretion of VEGF\nSolution to Question 10:\nAmong the given features hypothyroidism is not a major physiological change in pregnancy.\nThe \uf0b0 -subunits of hCG and TSH are identical. An increase in hCG during pregnancy stimulates thyroid and leads to a decrease in TSH levels. The thyroid undergoes enlargement and boosts the production of hormones. This is accompanied by increased production of thyroid-binding globulin(TBG). All these changes increase total T4 and T3 in the first trimester. But the physiologically important free T4 and T3 levels remain unchanged. Hence, physiologically pregnant women remain euthyroid.\nOption A: Normal pregnancy is characterized by insulin resistance and hyperinsulinemia. Human placental lactogen(hPL) secreted during pregnancy, helps in adaptation to fetal energy requirements. Insulin resistance causes prolonged hyperglycemia and glucose flow to the fetus. It also favours protein synthesis. To counterbalance the increased insulin resistance and prevent maternal hyperglycemia, maternal insulin levels are increased.\nOption B: By the 3rd trimester, there is an increase in the maternal basal metabolic rate by 10 to 20% in comparison to a nonpregnant woman.\nOption D: During normal pregnancy, mean arterial pressure and vascular resistance decrease, while blood volume and cardiac output rate increase. This helps in meeting metabolic demands of the enlarged uterus, provide nutrients to rapidly growing placenta and fetus, safeguard mother against the effects of parturition-associated blood loss.\nSolution to Question 11:\nhCG is not implicated in insulin resistance during pregnancy.\nAs the fetus is dependant on maternal glucose for sustenance, the blood glucose levels are maintained at a high level in the mother. In response to this, the insulin level in the mother increases, which reduces the maternal blood glucose. To counteract this, the placenta secretes certain hormones which increase insulin resistance in the mother. This resistance is maximal between 24 to 28 weeks.\nHormones increasing insulin resistance include:\nHuman placental lactogen - Increases lipolysis and liberation of free fatty acids\nProgesterone and estrogen\nPlacental growth hormone - Major determinant of maternal insulin resistance after mid-pregnancy\nCortiso\nProlactin\nSolution to Question 12:\nSerum creatinine levels decrease during normal pregnancy from a mean of 0.7 mg/dL to 0.5 mg/dL.\nPhysiological changes in the renal system during pregnancy include:\nIncrease in:\nRenal blood flow(+80%)\nGFR(+50%)\nCreatinine clearance\nGlucosuria\nDecrease in:\nPlasma osmolality\nCreatinine\nUric acid\nNa/K/C\nAnatomical changes in the renal system during pregnancy include:\nBoth kidneys enlarge by 1 cm\nHydroureter and hydronephrosis - More common on the right side due to dextrorotation of the uterus\nCongestion of the bladder causing decreased bladder capacity\nIncreased bladder pressure and intraurethral pressure\nSolution to Question 13:\nThe total oxygen-carrying capacity of the blood increases during pregnancy.\nDuring pregnancy, there is an increase in total haemoglobin (Hb) resulting in increased total oxygen-carrying capacity of the blood. However, there is a relative decrease in Hb concentration (hematocrit) due to a greater increase in plasma volume. This decreases oxygen-carrying capacity per unit volume of blood.\nMaternal iron stores are not sufficient to meet the increased demand during pregnancy and hence the serum iron and ferritin concentration falls.\nThe plasma volume expansion also lowers serum potassium.\nSolution to Question 14:\nDecrease in peripheral vascular resistance is a physiological change seen in pregnancy. Cardiovascular parameters that increase in pregnancy are:\nCardiac output\nStroke volume\nHeart rate\nCardiovascular parameters that decrease in pregnancy are:\nPeripheral vascular resistance (due to smooth muscle relaxation by progesterone)\nBoth diastolic BP and systolic BP (decrease in DBP &gt; SBP)\nMean arterial BP\nArtery venous O2 gradient\nSolution to Question 15:\nThe clinical features are suggestive of physiological edema during pregnancy for which the most appropriate treatment is bed rest.\nIt occurs due to increased venous pressure of the inferior extremities by the gravid uterus pressing on the common iliac veins.\nFeatures of physiological edema in pregnancy are:\nSlight degree of ankle edema\nUsually confined to one leg, more commonly the right leg\nNot associated with any other features of preeclampsia (like BP&gt;140/90mm Hg, proteinuria)\nDisappears with rest\nOther cardiac, renal and hematological pathologies are absent\nSolution to Question 16:\nThe blood flow to the skin and mucous membranes increases during pregnancy to a maximum of 500 mL/min by the 36th week. Symptoms experienced during pregnancy such as increased heat sensation, sweating or having a stuffy nose can be explained by the increased blood flow.\nRegional distribution of blood flow during pregnancy:\nUterine blood flow - increased from 50 mL/min in the non-pregnant state to about 750 mL near term.\nPulmonary blood flow - increased by 2,500 mL/min.\nRenal blood flow - increases by 400 mL/min at 16th week and remains at this level till term.\nSolution to Question 17:\nS3 is normally heard during pregnancy.\nThe third heart sound (S3) occurs due to rapid diastolic filling in hypervolemic states such as pregnancy, anemia or thyrotoxicosis. Hypervolemia is a normal physiological change during pregnancy.\nThe auscultation of a fixed split S2, fourth heart sound (S4) or a pericardial knock are suggestive of cardiac pathology.\nSolution to Question 18:\nAll clotting factors increase in pregnancy except factors XI and XIII. Pregnancy is a hypercoagulable state with physiological changes such as:\nAll clotting factors are increased (except factors XI and XIII)\nFibrinogen levels are also increased\nThe viscosity of blood decreases due to hemodilution\nClotting time and bleeding time is unaffected\nThe most common cause of decreased platelet count in pregnancy is benign gestational thrombocytopenia. This is due to hemodilution and increased platelet consumption and the women are generally asymptomatic.\nSolution to Question 19:\nThe clinical features are suggestive of supine hypotension syndrome due to inferior vena caval compression.\nDuring late pregnancy, the gravid uterus produces a compression effect on the inferior vena cava (IVC) when the patient is in the supine position. To compensate, there will be an opening up of the collaterals of paravertebral and azygous veins.\nWhen collaterals fail to open, venous return of the heart is reduced leading to hypotension, tachycardia, and syncope. The normal blood pressure is quickly restored by turning the patient to lateral position.\nSolution to Question 20:\nThe sensitivity of uterine musculature is enhanced by estrogen and inhibited by progesterone.\nEstrogen stimulates the synthesis of myometrial contractile proteins through cAMP. This increases the excitability of uterine muscles and the frequency of action potentials.\nProgesterone decreases the frequency and intensity of uterine contractions. This helps to prevent the expulsion of the implanted ovum. However, it increases the amplitude of contraction.\nSolution to Question 21:\nExtension at the knee joint and dorsiflexion at the ankle joint helps in stretching the calf muscles which relieves the pain.\nLeg cramps are minor ailments during pregnancy mostly due to a deficiency of diffusible serum calcium or elevation of serum phosphorus. Management includes massaging the leg, stretching exercises, application of local heat, and supplementation of vitamin B1 and calcium.\nSolution to Question 22:\nTheca lutein cysts are not seen in hyperprolactinemia.\nTheca-lutein cysts are benign ovarian lesions resulting from exaggerated physiological follicle stimulation. They are usually associated with markedly elevated serum levels of hCG.\nTheca lutein cysts are found in association with:\nLarge placenta\nDiabetes\nAnti-D alloimmunization\nMultifetal gestations\nFetal hydrops\nGestational trophoblastic disease - Molar pregnancy\nReduced hCG clearance - Chronic renal failure\nThey may also be found in normal pregnancy due to an exaggerated response of the ovaries to normal circulating levels of hCG.\nSolution to Question 23:\nAcute fatty liver of pregnancy (AFLP) occurs most commonly in the third trimester or early postpartum period.\nRisk factors include Pre-eclampsia/HELLP syndrome, male fetus, previous history of AFLP, and multiple gestations.\nAFLP (acute yellow atrophy or acute fatty metamorphosis) is the most common cause of acute liver failure in pregnancy. It usually occurs in the later stages of pregnancy, particularly in\nthe third trimester. It occurs due to fetal deficiency of long-chain acyl-coenzyme A dehydrogenase (LCHAD) or poor placental mitochondrial function.\nThe patients present with persistent nausea and vomiting, progressive jaundice, and epigastric pain. Features like acute hemolysis, hypoglycemia, hypertension, proteinuria, thrombocytopenia, and edema can also be present. Symptoms may progress to fulminant hepatic failure with encephalopathy, disseminated intravascular coagulation, and death.\nLiver function tests such as AST, ALT, and serum bilirubin levels are raised. Hypofibrinogenemia, hypocholesterolemia, and prolonged clotting time can be seen. An elevated d-dimer is\nseen. Microscopy reveals a characteristic microvesicular fatty infiltration.\nThe condition worsens till delivery after which the hepatic dysfunction resolves. A trial of labor by induction or delivery by Cesarean is done. Intensive supportive measures including blood transfusion should be provided.\nThe clinical and laboratory findings of acute liver diseases in pregnancy are as follows:\nThe condition worsens till delivery after which the hepatic dysfunction resolves. Appropriate management is immediate termination of pregnancy irrespective of gestational age by induction or delivery by Cesarean (for obstetric reasons) is done. Intensive supportive measures including blood transfusion should be provided.\nDisorders\nHELLP syndrome\nObstetric cholestasis\nAcute fatty liver of pre gnancy\nViral hepa titis\nOnset in pregnanc y\nMid to late\nLate\nLate\nVariable\nDifferentiating fea tures\nEpigastric pain, hypert ension,elevatedindirect bilirubin\nPrurituselevateddirect bilirubin\nSigns ofliver failurelike hypoglycemia\nFever\nAST (U/L)\n\uf0a3300\n\uf0a3200",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_2.jpeg",
      "OBGYN_img_73.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_200",
    "question_text": "800",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch14_2000",
    "question_text": "+\nBilirubin (mg/dL)",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch15_1",
    "question_text": "4",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch15_1",
    "question_text": "5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch15_4",
    "question_text": "10",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch15_5",
    "question_text": "20\nPlatelets\n\uf0af\uf0af\nNormal\n\uf0af\uf0af\n\uf0af\nFibrinogen\nNormal\nNormal\n\uf0af\uf0af\uf0af\nNormal\nDisorders\tHELLP syndrome\tObstetric cholestasis\tAcute fatty liver of pre\tViral hepa\ngnancy\ttitis\nDisorders\tHELLP syndrome\tObstetric cholestasis\tAcute fatty liver of pre\tViral hepa\ngnancy\ttitis\nDisorders\tHELLP syndrome\tObstetric cholestasis\tAcute fatty liver of pre\tViral hepa\ngnancy\ttitis\nDisorders\tHELLP syndrome\tObstetric cholestasis\tAcute fatty liver of pre\tViral hepa\ngnancy\ttitis\nDisorders\tHELLP syndrome\tObstetric cholestasis\tAcute fatty liver of pre\tViral hepa\ngnancy\ttitis\nD-dimer\n\uf0ad\nNormal\n\uf0ad\nNormal\nProthrombin time\nNormal\nNormal\n\uf0ad\uf0ad\n\uf0ad\nHemolysis\n\uf0ad\uf0ad\nNo\n\uf0ad\uf0ad\uf0ad\nNo\nSolution to Question 24:\nSpotting on the expected date of menstruation in the early months of pregnancy is known as placental sign.\nCyclic bleeding may occur up to 12 weeks of pregnancy until the decidual space is obliterated by the fusion of decidua parietalis with decidua capsularis. The bleeding is usually scanty and lasts for a shorter duration than in a regular menstrual cycle.\nOption A: Slowing of the fetal heart rate (FHR) on pressing the head down into the pelvis is suggestive of placenta previa (especially of posterior type) and is called Stallworthy\u2019s sign. The fetal heart rate recovers as soon as the pressure is released.\nOptions C and D: Permanent lengthening of the cord and slight gush of bleeding in 3rd stage of labor are suggestive of separation of the placenta.\nDiagnosis of Pregnancy and Antenatal Care\nQuestion 1:\nWhat is the duration of the 4th trimester in pregnancy?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch15_6",
    "question_text": "weeks postpartum",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch15_12",
    "question_text": "weeks postpartum",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch15_4",
    "question_text": "weeks postpartum",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch15_38",
    "question_text": "to 40 weeks of pregnancy\nQuestion 2:\nWhat is the ideal number of antenatal visits?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch15_12",
    "question_text": "14",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch15_6",
    "question_text": "8",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch15_7",
    "question_text": "9",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch15_10",
    "question_text": "11\nQuestion 3:\nWhich of the following statements is not true about parity?\nParity refers to the number of previous pregnancies reaching viability\nIf a woman has twins, the parity remains one\nIf a woman has a stillborn child, her parity decreases\nMultipara is a woman who has completed 2 or more pregnancies past the period of viability\nQuestion 4:\nA 30-year-old woman came to the OPD with a twin pregnancy at 10 weeks of gestation. She has a 3-year-old female child who was born at term and had 2 first trimester abortions previously. Which of the following is the correct representation of her obstetric score.\nG4 P2 L1 A2\nG4 P1 A2 L1\nG5 P0 L1 A2\nG5 P1 A2 L1\nQuestion 5:\nA lady who is 38 weeks pregnant comes to the OPD for a routine checkup. She has a history of normal twin delivery at term 4 years ago. What is her gravida and para score?\nG2P2\nG2P1\nG3P2\nG3P1\nQuestion 6:\nA woman whose obstetric score is G2 P1 L1 had an LMP of Jan 9th 2017. Calculate the EDD according to Naegele\u2019s rule.\nSeptember 19\nOctober 19\nOctober 16\nSeptember 16\nQuestion 7:\nThe recommended calorie intake for a pregnant woman in the second trimester, who is a sedentary worker would increase by \t.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch15_600",
    "question_text": "kcal/day",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch15_520",
    "question_text": "kcal/day",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch15_450",
    "question_text": "kcal/day",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch15_350",
    "question_text": "kcal/day\nQuestion 8:\nA pregnant lady of 49 kg is in her first trimester. What are her additional calorie requirements in this trimester?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch15_500",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch15_300",
    "question_text": "\nContinue same diet",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch15_600",
    "question_text": "\nQuestion 9:\nA 22-year-old pregnant woman at 13 weeks of gestation informs you about accidental exposure to radiation from a chest X-ray at 7 weeks of gestation. What should be the next step advised to her?\nContinue pregnancy\nTerminate pregancy\nPre-invasive diagnostic test\nChromosome screening\nQuestion 10:\nYou notice an obstetrics resident performing the following manoeuvres on a 37-week primigravida. Choose the correctly matched set.\n",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_3.jpeg",
      "OBGYN_img_74.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch16_1",
    "question_text": "a, 2-c, 3-b, 4-d",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch16_1",
    "question_text": "a, 2-b, 3-c, 4-d",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch16_1",
    "question_text": "b, 2-a, 3-d, 4-c",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch16_1",
    "question_text": "c, 2-b, 3-a, 4-d\nQuestion 11:\nA dusky hue of the vestibule and anterior vaginal wall visible at about 8 weeks of pregnancy is called \t.\nHegar's sign\nChadwick's sign\nOsiander's sign\nPalmer's sign\nQuestion 12:\nA primigravida comes for a routine ANC visit at 22 weeks of gestation. Which of the following signs would you not expect?\nChloasma\nQuickening\nLightening\nBraxton Hick's contraction\nQuestion 13:\nWhich of the following statements is not true regarding uterine souffle?\nIt is a soft blowing systolic murmur heard on the sides of pregnant uterus\nThe sound is synchronous with the maternal pulse\nIt is due to increased blood flow through the umbilical arteries\nIt can also be heard in a large fibroid\nQuestion 14:\nA 32-year-old woman nearing her due date was admitted following regular contractions. You note that the head is at +1 station. Where is the exact position of the head?\nAt the perineum\nJust below ischial spine\nJust above ischial spine\nHigh up in the false pelvis\nQuestion 15:\nWhile examining a pregnant woman, you measure her fundal height to be 32 cm and the station of the fetal head is at -2. What could be the probable weight of the fetus?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch16_2",
    "question_text": "3Kg",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch16_3",
    "question_text": "5Kg",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch16_3",
    "question_text": "1Kg",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch16_4",
    "question_text": "0Kg\nQuestion 16:\nAll of the following are components of Manning score except \t.\nNon stress test (NST)\nOxytocin challenge test\nFetal body movement\nRespiratory activity of fetus\nQuestion 17:\nA 28-year-old G2P1 woman presents to the antenatal clinic at 24 weeks for a routine check-up. USG shows a normal for gestational age fetus in frank breech position, with no other abnormalities. What is the next best step in \u25a0management?\n75gm oral glucose tolerance test\nNon-stress test\nExternal cephalic version\nImmediate lower segment Caesarean section\nQuestion 18:\nWhich of the following vaccines is absolutely contraindicated in pregnancy?\nHepatitis B\nCholera\nRabies\nMMR\nQuestion 19:\nA newly married couple planning for pregnancy has come to your clinic for preconception counselling. Which of the following drugs will you prescribe to the patient to decrease the chances of having neural tube defects in the baby?\nVitamin B9\nVitamin B12\nVitamin C\nVitamin B6\nQuestion 20:\nWhich of the following conditions would not cause raised beta-hCG levels in pregnancy?\nDown's syndrome\nMultifetal pregnancy\nSpontaneous abortion\nRh-incompatibility\nQuestion 21:\nWhich of the following is not considered as a factor for a high-risk pregnancy?\nObesity\nPolyhydramnios\nAnaemia\nPrevious manual removal of placenta\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch17_1",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch17_2",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch17_3",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch17_4",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch17_5",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch17_6",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch17_7",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch17_8",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch17_9",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch17_10",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch17_11",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch17_12",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch17_13",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch17_14",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch17_15",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch17_16",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch17_17",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch17_18",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch17_19",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch17_20",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch17_21",
    "question_text": "\nd\nSolution to Question 1:\nThe duration of the fourth trimester is 12 weeks postpartum.\nThe concept of fourth trimester was introduced to address common concerns raised by women in puerperium such as post-partum pain, breastfeeding related problems, stress and postpartum depression, and lack of awareness of newborn care. The components of postpartum care for the 4th trimester include:\nDedicated care team\nLactation support\nInfant feeding plan\nReproductive life plan\nContraception\nAddressing complications of pregnancy\nAssessment of cardiovascular risk\nMental health assessment\nChronic health conditions\nACOG recommendation for postpartum visits:\nInitial visit: 3 weeks postpartum\nFinal visit: 12 weeks postpartum\nGovernment of India recommendation for postpartum visits.\nFirst visit: 1st day after delivery\nSecond visit: 3rd day after delivery\nThird visit: 7th day after delivery\nFourth visit: 6 weeks after delivery\nSolution to Question 2:\nThe ideal number of antenatal visits is 12-14.\nThe antenatal visits should ideally be: monthly once up to 28 weeks, once in two weeks between 28-36 weeks, and once weekly visits from 36 weeks onwards.\nThis translates to a total of 12-15 visits.\nThe WHO increased the minimum number of antenatal visits from 4 to 8 visits to reduce perinatal mortality.\nIn the Indian scenario, the earlier minimum of 4 visits were implemented as follows:",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch18_1",
    "question_text": "st visit: within 12 weeks (preferably as soon as pregnancy is suspected)",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch18_2",
    "question_text": "nd visit: between 14-26 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch18_3",
    "question_text": "rd visit: between 28-34 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch18_4",
    "question_text": "th visit: between 36 weeks and term\nA booked case is one that has at least 3 antenatal visits with two visits in the third trimester.\nSolution to Question 3:\nIf a female has stillbirth, her parity does not decrease.\nParity is determined by the number of previous pregnancies reaching a period of viability, which is 28 weeks in India.\nMultifetal pregnancies, such as twins or triplets, count as one for the purpose of this notation. The current pregnancy is not included in this count.\nMultipara refers to a woman who has completed two or more pregnancies past the period of viability. When the pregnancy is preceded by five or more previous viable pregnancies, the woman is called a grand multipara.\nNote: Gravida indicates the number of times the mother has been pregnant, regardless of whether these pregnancies were carried to term. The current pregnancy is included in this count.\nSolution to Question 4:\nThe obstetric score is G4 P1 A2 L1.\nThe obstetric score is used to summarise the past obstetric history as follows:\nG - Gravidity, denoting the total number of pregnancies, including the present one\nP - Parity, denoting the total number of pregnancies crossing the period of viability\nThis includes both live births and stillbirths\nThe current pregnancy is not included\nA - Abortus or the number of pregnancies that were lost for any reason, including induced abortions or miscarriages.\nL - Living children\nMultifetal pregnancies count as one for both gravida and para. A pregnant woman who delivers twins will be expressed as primipara.\nThe GTPAL system includes the following:\nGravida\nTerm (&gt;37 weeks)\nPreterm (20w - 36w 6d)\nAbortions (&lt;20 weeks)\nNumber of living children\nNote: The period of viability is when the fetus is capable of independent existence. The WHO defines it to be 24 weeks while the Indian definition is 28 weeks.\nSolution to Question 5:\nThe woman has had two pregnancies in total - the previous twin pregnancy and the current pregnancy, hence the gravida score is 2. The first pregnancy resulted in delivery at term (crossed viable period), hence her para score is 1 (parity doesn't include current pregnancy). Hence, her obstetric score would be G2P1 (Gravida - 2, Para - 1).\nMultifetal pregnancies count as one for both gravida and para. A pregnant woman who delivers twins for the first time is expressed as primipara.\nThe obstetric score is used to summarise the past obstetric history as follows:\nG - Gravidity, denoting the total number of pregnancies, including the present one\nP - Parity, denoting the total number of pregnancies crossing the period of viability. This includes both live births and stillbirths. The current pregnancy is not included.\nA - Abortion is the termination of pregnancy, either spontaneous or induced, before fetal viability.\nL - Living children.\nThe GTPAL system includes the following:\nGravida\nTerm (&gt;37 weeks)\nPreterm (20w - 36w 6d)\nAbortions (&lt;20 weeks)\nNumber of living children\nNote: The period of viability is when the fetus is capable of independent existence. The WHO defines it to be 24 weeks while the Indian definition is 28 weeks.\nSolution to Question 6:\nAs per Naegele\u2019s rule, the EDD (expected date of delivery) of this woman is October 16, 2017.\nNaegele\u2019s rule states that EDD is obtained by adding 7 days and subtracting 3 months from the LMP (the 1st day of the last menstrual period). Another method is adding 9 months and 7\ndays to LMP. Less than 5% of births follow Naegele's rule.\nIt is based on a 28-day regular cycle. If the cycle is shorter/longer than 28 days, corrected EDD is calculated as follows:\nFor a 35-day cycle, add another 7 (35-28=7) days to the calculated EDD to get the corrected EDD.\nFor a 25-day cycle, subtract 3 (28-25=3) days from the calculated EDD to get the corrected EDD.\nNaegele\u2019s rule cannot be followed in IVF pregnancies. Considering the human embryo takes 266 days to develop, EDD is calculated in IVF pregnancies by the following method:\nSame day as fertilization (day 0): EDD = date of transfer + 266 days",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch18_3",
    "question_text": "days after fertilization (day 3): EDD = date of transfer + 263 days",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch18_5",
    "question_text": "days after fertilization (day 5): EDD = date of transfer + 261 days\nSolution to Question 7:\nThe recommended calorie intake for a pregnant woman in the second trimester would increase by\n~ 350 kcal/day.\nSolution to Question 8:\nThe pregnant lady can continue the same diet since there are no additional calorie requirements in the first trimester.\nPregnancy requires an additional 80,000 kcal, mostly during the last 20 weeks. To meet this demand, a caloric increase of 100 to 300 kcal/d is recommended during pregnancy. This greater intake, however, should not be divided equally during the course of pregnancy. The Institute of Medicine (2006) recommends adding 0, 340, and 452 kcal/d to the estimated nonpregnant energy requirements in the first, second, and third trimesters respectively.\nWhenever caloric intake is inadequate, protein is metabolized rather than being spared for its vital role in fetal growth and development.\nSolution to Question 9:\nIn the given clinical case, the patient should be advised to continue the pregnancy.\nThe radiation dose to the fetus during the declared term of pregnancy should be less than 1 mSv. In chest X-ray PA view, the absorbed dose of radiation by the fetus is less than 0.1 mSv. Hence, pregnancy can be continued.\nAn X-ray has a very limited role in obstetric imaging. There are very few indications where an X-ray will be useful:\nFetal: congenital malformation of the fetus and neonates, skeletal malformations, birth injuries like fractures or dislocations.\nMaternal: Patients having cardiopulmonary disease may require an X-ray chest during pregnancy and that should be done beyond 12 weeks.\nRadiation can cause fetal morbidity (FGR, genetic mutations, neurologic abnormalities, mental retardation, childhood leukemia) and mortality. The risks are high with radiation after the first 2 weeks postconception and within the first trimester (period of organogenesis).\nRadiation during pregnancy can damage the early phase of the embryo but the risk can be minimized by using the \u201810-day rule\u2019. This rule states that no woman should be exposed to an X-ray for a nonurgent indication outside 10 days from her last period during the reproductive period unless the pregnancy is excluded.\nThe given table below shows the absorbed radiation by the fetus in different diagnostic radiation procedures:",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch19_1",
    "question_text": "cGy = 10 mSv\nProcedure\nDose (c Gy)\nAbdominal X-ra y",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch19_0",
    "question_text": "1-0.3\nPelvic X-ray",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch19_0",
    "question_text": "5-1.1\nChest X-ray\n<0.001\nAbdominal CT",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch19_0",
    "question_text": "4-0.8\nChest CT",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch19_0",
    "question_text": "002-0.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch19_2",
    "question_text": "\nAbdominopelvic CT",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch19_2",
    "question_text": "5-3.5\nVentilation scan",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch19_0",
    "question_text": "007-0.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch19_5",
    "question_text": "\nPET scan",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch20_1",
    "question_text": "1.5\nSolution to Question 10:\nFetal pole, lie, presenting part, engagement, and attitude of fetal head are assessed by Leopold's manoeuvres:\nFundal grip (first Leopold):\nAssesses the uterine fundus.\nHelps in identification of fetal lie and determination of fetal pole at the fundus.\nThe breech gives the sensation of a large, irregular mass.\nThe head feels hard and round and is more mobile.\nLateral grip (second Leopold):\nAssesses the fetal orientation.\nThe palms are placed on either side of the maternal abdomen, and gentle but deep pressure is exerted.\nThe back is felt on one side as a hard, resistant structure.\nThe fetal extremities are felt on the other side as numerous small, irregular, mobile parts are felt.\nFetal orientation can be determined by noting whether the back is directed anteriorly, transversely, or posteriorly.\nThe position of the anterior shoulder is mainly assessed by this grip.\nPawlik's grip / 1st pelvic grip (third Leopold):\nAssesses the presenting part in respect to the true pelvis.\nThe thumb and fingers of one hand grasp the lower portion of the maternal abdomen just above the symphysis pubis.\nIf the presenting part is not engaged, a movable mass will be felt, usually the head.\nDeep pelvic grip / 2nd pelvic grip (fourth Leopold):\nAssesses the engagement, attitude of the fetal head and determine the degree of descent.\nThe examiner faces the mother's feet, and the fingertips of both hands are positioned on either side of the presenting part.\nThey exert inward pressure and then slide along the axis of the pelvic inlet.\nIf the head has already descended into the pelvis, the anterior shoulder or the space created by the neck may be differentiated readily from the head.\nIt is the only grip performed facing the feet.\n\nSolution to Question 11:\nA dusky hue of the vestibule and anterior vaginal wall visible at about 8th week of pregnancy is called Chadwick\u2019s sign or Jacquemier\u2019s sign. The discoloration is due to local vascular congestion.\nSolution to Question 12:\nLightening is felt in the 3rd trimester (38th week) in a primigravida. It is a sense of relief from the pressure symptoms due to engagement of the presenting part.\nThe 2nd trimester of pregnancy is characterised by the following:\nSign\nFeature\nSeen at\nChloasma\nPigmentation over forehead a nd cheeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_3.jpeg",
      "OBGYN_img_75.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch20_24",
    "question_text": "weeks\nSign\tFeature\tSeen at\nSign\tFeature\tSeen at\nSign\tFeature\tSeen at\nBreast changes\nAppearance of secondary are ola.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch20_20",
    "question_text": "weeks\nUterine changes- size and Br axton Hick contractions\nIrregular, infrequent spasmo dic and painless contractions without any effect on dilatati on of cervix.\nBegin in early pregnancy and continue till term\nPalpation of fetal parts and a ctive fetal movements",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch20_20",
    "question_text": "weeks\nBallotment of uterus\nFeeling of floating object insi de uterus on bimanual exami nation. Not exclusive to preg ancy",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch20_16",
    "question_text": "to 20 weeks\nAuscultation of fetal heart so unds\nMostconclusivesign of pregna ncy",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch20_18",
    "question_text": "to 20 weeks by stethoscop e and 10 weeks by doppler\nQ ickening\nFeeling of life inside womb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch20_16",
    "question_text": "to 20 weeks\nSolution to Question 13:\nUterine souffle is due to an increase in blood flow through the dilated uterine vessels, not umbilical vessels.\nIt is a soft blowing systolic murmur heard low down at the sides of the uterus, better heard on the left side.\nUterine Souffle\nFetal/Funic Souffle\nSoft, blowing sound\nSharp, whistling sound\nSynchronous withmaternal p ulse\nSynchronous withfetal pulse.\nCaused by the passage of blo od through dilateduterine ves sels\nCaused by the rush of blood t hrough theumbilical arteries\nIt can also be heard in a large uterine fibroid\nWhen present it isdiagnostic of pregnancy\nSolution to Question 14:\n+1 station of the fetal head refers to it being just below the ischial spine.\nThe station of the head is expressed in relation to ischial spines as they are the most prominent bony projections felt on internal examination. The level of ischial spines is halfway between the pelvic inlet and outlet. This level is known as station zero (0).\nThe station is stated in minus figures if it is above the spines (\u20131 cm, \u20132 cm, \u20133 cm, \u20134 cm and \u20135 cm) and in plus figures if it is below the spines (+1 cm, +2 cm, +3 cm, +4 cm and +5 cm).\n\nSolution to Question 15:\nThe fetal weight in the above case is 3.1Kg.\nIn the above case, fetal weight can be estimated using Johnson's formula. Height of uterus is 32cm, the station is \u20132 implying the head is above the ischial spines. Therefore, it is calculated as follows: [32-12] x 155 = 3100 grams = 3.1Kg\nEstimation of fetal weight:\nJohnson\u2019s formula: This is only applicable in vertex presentation.\nIf station of head is below the level of the ischial spine: [Height of uterus above pubic symphysis\n(in cm)-11] x 155 in grams\nIf station of head is above the level of the ischial spine: [Height of uterus above pubic symphysis\n(in cm)-12] x 155 in grams\nSonography: Fetal weight has been estimated by combining a number of biometric data, e.g. biparietal diameter (BPD), head circumference (HC), abdominal circumference (AC) and femur length (FL), using the following formulae:\nShepard\u2019s formula\nHadlock\u2019s formula.\n\nSolution to Question 16:\nThe oxytocin challenge test is not a component of Manning score.\nEarlier, oxytocin challenge test/contraction stress test was done after a non-reactive NST to confirm the diagnosis of hypoxia. However, it is associated with the risk of initiating labor and is hence not done.\nBiophysical profile (BPP)/Manning score components: (Mnemonic: BATMaN)\nBreathing movements of the fetus\nAmniotic fluid voulme\nTone of fetus\nMovements of fetus\nNon-stress Test (NST)\nNormal score: 8-10; Abnormal: &lt;5 Modified Biophysical score:\nVAST (Vibroacoustic stimulation test)/NST\nAmniotic fluid index\nA score &lt;4 indicates the need for urgent delivery.\nSolution to Question 17:\n75gm oral glucose tolerance test (OGTT) is the most appropriate next step of management. The screening strategy for detecting gestational diabetes mellitus (GDM) recommends performing blood glucose testing at 24-28 weeks in case of average risk.\nBreech presentation at 24 weeks is not a cause for concern because it can spontaneously rotate and becomes cephalic at term. Hence, external cephalic version (ECV) and immediate caesarean section are not indicated at this time.\nSolution to Question 18:\nMMR is absolutely contraindicated in pregnancy.\nKilled vaccines are safe in pregnancy while live vaccines (MMR, BCG, varicella) are contraindicated in pregnancy.\nEven though yellow fever vaccine is a live vaccine, it is recommended in endemic areas or during outbreaks. Pregnant women and nursing mothers should be counselled on the potential benefits and risks of vaccination.\nSolution to Question 19:\nPreconceptional intake of vitamin B9 (folic acid) results in decreased incidence of neural tube defects like spina bifida, encephalocele, and anencephaly.\nAll women of reproductive age should be given 400 \u00b5g of folic acid daily. Women, who had fetal neural tube defects in the previous pregnancy, should be given 4 mg of folic acid daily beginning 1 month before conception to about 12 weeks of pregnancy.\nSolution to Question 20:\nBeta-hCG levels are reduced in the case of spontaneous abortion.\nHuman chorionic gonadotropin (hCG) is detectable in the plasma of pregnant women as early as 7-8 days after conception by radioimmunoassay. It doubles every 2 days and reaches a maximum level at 9 weeks. Thereafter, it declines to reach the lower level at 20 weeks and disappears from circulation 2 weeks postpartum.\nIncreased levels of beta-hCG are found in:\nMultiple preganancies\nRh isoimmunization\nDown's syndrome\nChoriocarcinoma\nHydatidiform mole\nDecreased levels of beta-hCG are found in:\nEctopic pregnancies\nImpending spontaneous abortion\nMissed abortion\nEdward syndrome.\nSolution to Question 21:\nPrevious manual removal of the placenta does not indicate a high-risk pregnancy.\nThe high-risk pregnancies according to the Pregnancy Risk Assessment Monitoring System by the CDC are:\nCurrent pregnancy complicat ions\nObstetric history\nOther disorders\nPreterm labor (<37 Wks) and Post-term (> 42 wk)\nIntrauterine growth restrictio n\nCardiovascularfactorslike chr onic hypertension, severe hea rt failure, andrenaldisorders\nPreterm premature rupture o f membranes\nStillbirth\nMetabolicdisorderslike Obesi ty,Insulin-dependent diabete s, Previous endocrine ablatio n, Thyroid disorders\nModerate to severe preeclam psia\nLate abortion (16\u201320 wk)\nHematologicalproblems like s ickle cell disease, severe ane miaThrombophilia\nPolyhydramnios (hydramnios)\nor oligohydramnios\nFetal exchange transfusion (\nRh incompatibility)\nInfections(malaria, HIV) and Autoimmunedisorders\nUterine rupture\nMultifetal pregnancy\nEpilepsy\nAntepartum hemorrhage (Pla centa previa, and Abruptio pl acenta)\nPrevious brachial plexus inju ry\nAnatomicabnormalitieslike ut erine malformationand cervic al incompetence\nFetal tachycardia or bradycar dia for >30 min\nAbnormal fetal position\nExposure toteratogenslike alc ohol, drugs, smoking\nFetal weight < 2.5 kg or >4kg\nPrevious h/o myomectomy, r epair of complete perineal te ar, vesicovaginal fistula, and stress incontinence\nFamilyhistory of diabetes, hy pertension ormultiple pregna ncy and congenital malforma tion\nChorioamnionitis\nLowsocioeconomic status\nProlapsed cord\nAbnormal cervical cytologic fi ndings\nFetal acidosis pH \uf0a37\nAntenatal Investigations\nQuestion 1:\nWhich of the following statements is false about non-invasive prenatal testing?\nIt uses cell-free circulating fetal DNA in the maternal serum\nIt is used for the diagnosis of trisomy 13, 18 and 21\nIt can be performed after 10 weeks of gestation\nIt is done after the routine first trimester ultrasound assessment\nQuestion 2:\nA pregnant woman has a fetus with Down's syndrome. Triple test done at 15-16 weeks will have \t.\nLow MSAFP, high hCG, low UE3\nHigh MSAFP, low hCG, high UE3\nLow MSAFP, high hCG, high UE3\nHigh MSAFP, low hCG, low UE3\nQuestion 3:\nWhich of the following is not included in the quadruple screening test?\nInhibin B\nUnconjugated Estriol (E3)\nAFP\nhCG\nQuestion 4:\n\u2018uadruple testing is done during:",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_3.jpeg",
      "OBGYN_img_76.jpeg",
      "OBGYN_img_3.jpeg",
      "OBGYN_img_77.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch20_9",
    "question_text": "11 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch20_12",
    "question_text": "14 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch20_15",
    "question_text": "20 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch20_22",
    "question_text": "28 weeks\nQuestion 5:\nResults of the quadruple screening test are tabulated below for three congenital anomalies. Choose the correctly matched set.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch21_1",
    "question_text": "Trisomy 21; 2- Trisomy 18; 3- Neural tube defect",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch21_1",
    "question_text": "Trisomy 18; 2- Trisomy 21; 3- Neural tube defect",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch21_1",
    "question_text": "Trisomy 21; 2- Neural tube defect; 3- Trisomy 18",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch21_1",
    "question_text": "Trisomy 18; 2- Trisomy 13; 3- Neural tube defect\nQuestion 6:\nIn which of the following conditions is an increased level of alpha fetoprotein seen?\nGestational trophoblastic diseases\nMolar pregnancy\nUnder estimated gestational age\nSpontaneous abortion\nQuestion 7:\nIncreased maternal serum alpha-fetoprotein is detected in a primigravida. What is the next step in management?\nRepeat measurement of MSAFP at a later date\nTargeted sonography\nAmniocentesis\nTermination of pregnancy\nQuestion 8:\nWhich of the following statements is true regarding alpha fetoprotein?\nMSAFP is detected at 16-18 weeks of gestation\nDiabetic patients have increased AFP levels\nMSAFP is unrelated to period of gestation\nLowest fetal AFP is seen around 13 weeks of gestation\nQuestion 9:\nDuring genetic counseling, a pregnant woman states that both she and her husband have sickle cell trait. You offer the option of chorionic villus sampling for prenatal diagnosis. What is the best time to perform this procedure?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch21_6",
    "question_text": "8 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch21_7",
    "question_text": "9 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch21_9",
    "question_text": "10 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch21_11",
    "question_text": "13 weeks\nQuestion 10:\nWhich of the following is not true about amniocentesis?\nTraditionally done between 16-20 weeks\nLimb reduction defect is a known complication\nDown's syndrome can be diagnosed\nApproximately 20 to 30 mL is collected for fetal karyotyping\nQuestion 11:\nA 28-year-old woman presents with 6 weeks of amenorrhea and a positive urine pregnancy test. She states her brother had cystic fibrosis and asks if her child might have the same.\nWhich of the following methods would not be useful for prenatal diagnosis of this condition?\nAmniocentesis\nCordocentesis\nChorionic villous sampling\nFetal skin biopsy\nQuestion 12:\nA G2P1 woman at 35 weeks of pregnancy presents with complaints of decreased fetal movement. What is the next step in management?\nObservation\nNon-stress test\nBiophysical profile\nInduce labour\nQuestion 13:\nThe CTG shown in the image below may be seen in which of the following conditions?\n\nHead compression\nCord compression\nFetal hypoxia\nNorma\nQuestion 14:\nA 35-year-old G2P1 at 38 weeks of gestation came to the labor room with complaints of decreased fetal movements. Non-stress test was done and late decelerations were noted. What does this indicate?\nHead compression\nCord compression\nFetal hypoxia\nBreech presentation\nQuestion 15:\nA pregnant woman brings her son to the hospital for routine immunization. While awaiting his turn, she realizes that her seat is stained with blood. She is rushed to the nearby antenatal clinic. Pulse - 96/min, BP - 110/80 mmHg. Vaginal bleeding is noted and her NST is shown below. What is the likely diagnosis?\n\nPlacenta previa\nVasa previa\nBattledore placenta\nAbruptio placentae\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_3.jpeg",
      "OBGYN_img_78.jpeg",
      "OBGYN_img_3.jpeg",
      "OBGYN_img_79.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch22_1",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch22_2",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch22_3",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch22_4",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch22_5",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch22_6",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch22_7",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch22_8",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch22_9",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch22_10",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch22_11",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch22_12",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch22_13",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch22_14",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch22_15",
    "question_text": "\nb\nSolution to Question 1:\nNon-invasive prenatal testing (NIPT) is used for the screening of trisomy 13, 18 and 21 and Turner's syndrome. It is not a diagnostic test.\nIt is a novel genetic test that uses cell-free circulating fetal DNA in the maternal serum for screening of chromosomal anomalies.\nDNA from the fetus is found circulating in the maternal blood in two forms - either inside the intact fetal cells or as cell-free DNA from the breakdown of placental fetal cells. In NIPT, the cell-free chromosome fragments are measured and the quantitative differences from normal fetuses are noted.\nNIPT can be performed after 10 weeks of gestation and is recommended after the routine\nfirst-trimester ultrasound assessment in high-risk pregnancies or if either 1st or 2nd-trimester screening becomes positive. Its disadvantage is that it is very expensive and it can be used for screening of only a few chromosomal anomalies such as trisomy 13, 18, and 21 and it doesn't analyse the entire karyotype.\nSolution to Question 2:\nThe triple test findings in pregnancies with fetal Down\u2019s syndrome are characterized by:\nLow MSAFP (maternal serum alpha-fetoprotein) levels, approximately 0.7 MoM (multiples of median).\nLow unconjugated estriol levels, approximately 0.8 MoM.\nHigh hCG levels, approximately 2.0 MoM.\nThe triple test is done between 15-18 weeks for the diagnosis of Down's syndrome.\nVarious antenatal screening tests for aneuploidy are as follows:\nFirst-trimester screening with biochemical analytes (\uf0af) PAPP-A and (\uf0ad) hCG and USG measurement of NT (\uf0ad) can improve the detection rate (87%) of Down\u2019s syndrome. For confirmation, a prenatal genetic study (CVS, amniocentesis or cordo\u25a0centesis) has to be performed.\nSecond-trimester screening (quad screening) at 15\u201318 weeks: (\uf0af) MSAFP, (\uf0af) uE3, (\uf0ad) inhibin A and (\uf0ad) hCG can detect trisomy 21 in 85% of cases with a false-positive rate of 0.9%. When it is combined with first-trimester screening, the detection rate is increased to 95%.\nDual test (1sttrimester)\nTriple test (2ndtrimester)\n\u2018uadruple test (2ndtrimester)\nBeta HCG\nBeta HCG\nBeta HCG\nPAPPA\nUnconjugated estriol\nUnconjugated estriol\nThis can be combined with n uchal translucency by USG\nMSAFP\nMSAFP\nSeruminhibin A\nSolution to Question 3:\nInhibin B is not a component assayed under the quad-screening test. Dimeric inhibin-A is evaluated in this screening test.\n\u2018uadruple testing is done in the second trimester between 15-21 weeks of gestation. It comprises:\nMaternal serum AFP\nHuman chorionic gonadotropin\nUnconjugated estriol (E3)\nDimeric inhibin A\nThe following table summarizes the findings of the quad-screening test in various conditions. Various antenatal screening tests for aneuploidy are as follows:\nParameter\nTrisomy 21\nTrisomy 18\nNeural tube defect or abdomi nal wall defect\nMSAFP\nLow\nLow\nHigh\n\uf062 hCG\nHigh\nLow\nNormal\nUnconjugated estri ol\nLow\nLow\nNormal\nInhibin A\nHigh\nNormal/ Low\nNormal\nDual test (1sttrimester)\nTriple test (2ndtrimester)\n\u2018uadruple test(2ndtrimester)",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch23_1",
    "question_text": "Beta HCG2. PAPPA (Pregn ancy-associated plasma prote in A)This can be combined w ith nuchal translucency by U SG",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch23_1",
    "question_text": "Beta HCG2. Unconjugated estriol3. MSAFP",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch23_1",
    "question_text": "Beta HCG2. Unconjugated estriol3. MSAFP4. Serum inh ibin\nSolution to Question 4:\nThe quadruple screening test is ideally done in the second trimester, during 15-20 weeks of gestation. The most accurate values are seen during 16-18 weeks of gestation.\nIt is the measurement of maternal serum alpha-fetoprotein (MSAFP), unconjugated estriol, hCG, and inhibin-A.\nIn Down's syndrome (trisomy 21) or Edward's syndrome (trisomy 18), quadruple-marker screenings do not provide any added benefit over first-trimester screenings. It is generally used as a stand-alone test if screening is done for the first time in the second trimester or if first-trimester screening is not available.\nTrisomy 21\nTrisomy 18\nNeural tube defect or abdomi nal wall defect\nTrisomy 13/ Patau syndro me\nMSAFP\nLow\nLow\nHigh\nNormal\n\uf062 hCG\nHigh\nLow\nNormal\nNormal\nUnconjugated estri ol\nLow\nLow\nNormal\nNormal\nInhibin A\nHigh\nNormal/ Low\nNormal\nHigh\nSolution to Question 5:\n\u2018uadruple testing is done in the second trimester between 15-21 weeks of gestation and involves the following parameters:\nMaternal serum alpha fetal protein (MSAFP)\n\uf062 hCG\nUnconjugated estrio\nInhibin A\nParameter\nTrisomy 21/ Downs syndr ome\nTrisomy 18/ Edward syndr ome\nNeural tube defect or abdom inal wall defect\nMSAFP\nLow\nLow\nHigh\nParameter\tTrisomy 21/ Downs syndr\tTrisomy 18/ Edward syndr\tNeural tube defect or abdom ome\tome\tinal wall defect\nParameter\tTrisomy 21/ Downs syndr\tTrisomy 18/ Edward syndr\tNeural tube defect or abdom ome\tome\tinal wall defect\nParameter\tTrisomy 21/ Downs syndr\tTrisomy 18/ Edward syndr\tNeural tube defect or abdom ome\tome\tinal wall defect\nParameter\tTrisomy 21/ Downs syndr\tTrisomy 18/ Edward syndr\tNeural tube defect or abdom ome\tome\tinal wall defect\n\uf062 hCG\nHigh\nLow\nNormal\nUnconjugated estri ol\nLow\nLow\nNormal\nInhibin A\nHigh\nNormal/Low\nNormal\nSolution to Question 6:\nIn underestimated gestational age, there is an increased level of maternal serum alpha fetoprotein\n(MSAFP).\nElevated levels of MSAFP are seen in:\nUnderestimated gestational age\nSevere oligohydramnios\nMultifetal pregnancy\nNeural tube defects\nAbdominal wall defects- Omphalocele, Gastroschisis\nHepatoma\nEndodermal sinus tumour\nReduced levels of MSAFP are seen in:\nOverestimated gestational age\nOverweight mother\nGestational trophoblastic diseases\nSpontaneous abortion\nTrisomy 18 and 21\nSolution to Question 7:\nThe next best step is targeted sonography. Maternal serum alpha-fetoprotein (MSAFP) levels are only used as a screening test and must be followed by a diagnostic test.\nAmniocentesis is a diagnostic test for amniotic fluid AFP measurement. It was once considered the standard for the diagnosis of open neural tube disorders but has been replaced in most centers by targeted sonography.\nDefects in fetal integuments, such as ventral wall and neural tube defects, permit fetal AFP to leak into the amnionic fluid. This results in increased MSAFP levels. This is detected on screening performed from 15 to 20 weeks of gestation.\nConditions with elevated MSAFP:\nWrong gestational age\nNeural tube defects\nMultiple pregnancies\nRenal anomalies\nConditions with decreased MSAFP:\nTrisomies (Down's syndrome)\nGestational trophoblastic disease.\nSolution to Question 8:\nThe maternal serum AFP screening is generally performed from 15-20 weeks of gestation. Hence, it is detected in this period.\nAlpha-fetoprotein (AFP) is the major serum protein in the embryo and fetus. It is produced by the yolk sac and fetal liver.\nOption B: Diabetic patients have low levels of AFP.\nOption C: Gestational age influences the MSAFP levels. The maternal serum concentration increases by approximately 15% per week during the second trimester.\nOption D: At about 13 weeks of gestation, the AFP concentration in the fetal serum and amniotic fluid are highest, after which it declines. Conversely, AFP is found in steadily increasing quantities in maternal serum after 12 weeks.\nSolution to Question 9:\nThe best time to perform chorionic villous sampling is 11-13 weeks.\nChorionic villus sampling:\nStudy material\nChorionic villi from trophobl astic cells\nTime",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch23_10",
    "question_text": "to 13 weeks(transcervically) 10 weeks to term (transabdo minally)\nIndications\nTo detect chromosomal abno rmalities such as Down syndr ome.To detect inborn errors of metabolism like phenylket onuria.For DNA analysis in h emoglobinopathies, thalasse mia, and sickle cell anemia.\nChorionic villus sampling:\nChorionic villus sampling:\nComplications\nAbortion (CVS> Amniocentes is)Limb reduction defects an d oro-mandibular defects (wh en done before 10 weeks)\nDrawback\nNot suitable for the detection of neural tube defects.\nSolution to Question 10:\nLimb reduction defect is a complication of chorionic villous sampling.\nAmniocentesis\nStudy material\nAmniotic fluid with amniocyt es\nTime",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch23_16",
    "question_text": "20 weeks\nEarly amniocentesis",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch23_11",
    "question_text": "14 weeks (associated with i ncreased fetal loss, foot defor mities)\nDiagnostic indications\nSex-linked disorders, karyoty ping, inborn errors of metabo lism, neural tube defects\nTherapeutic indication s\nAbortion induction, decompr ession of uterus in acute hydr amnios, amnioinfusion in oli gohydramnios\nProcedure\nUnder direct sonographic gui dance, a20\u201322 gauge spinal n eedleis directed into a clear p ocket of amniotic fluid while avoiding the fetus and umbili cal cord.Approximately 20 to 30 mL of fluid is collected.\nComplication\nChorioamnionitis, premature Rupture Of Membranes (PR OM), fetal trauma/loss, fetom aternal hemorrhage.\nSolution to Question 11:\nFetal skin biopsy is not a recommended method of prenatal diagnosis of cystic fibrosis. It is done to detect inherited skin conditions such as:\nIchthyosis\nEpidermolysis bullosa\nOculocutaneous albinism\nInvasive procedures for prenatal diagnosis of CFTR gene mutations in cystic fibrosis include:\nChorionic villus sampling (CVS)\nAmniocentesis\nCordocentesis or percutaneous umbilical blood sampling (PUBS)\nSolution to Question 12:\nIn case of reduced fetal movements, the first step of management is to do a non-stress test (NST).\nInterpretation of NST:\nReactive\n\uf0b32 accelerations of &gt;15 beats/minute above the baseline and longer than 15 seconds in duration are present in a 20-minute observation\nReassure the patient and send back home\nNon-reactive - biophysical profile (BPP) has to be assessed.\nSolution to Question 13:\nThe given CTG shows early deceleration which is seen in cases of head compression.\nSolution to Question 14:\nThe given scenario is suggestive of fetal hypoxia. Late decelerations are seen on an NST in this condition.\nDeceleration is a decrease in fetal heart rate below the baseline by 15 bpm for more than 15 seconds. Absent variability of FHR with late decelerations is an indication for immediate Cesarean section.\n\nSolution to Question 15:\nThe given clinical scenario along with the NST showing a sinusoidal pattern point towards a diagnosis of vasa previa.\nVasa previa is a condition where fetal vessels travel within the membranes and overlie the cervical os. Hence, there can be bleeding during cervical dilatation or membrane rupture.\nFetal mortality is high due to fetal exsanguination. When bleeding is present in vasa previa, an emergency cesarean section is indicated.\nCauses of sinusoidal pattern on NST include:\nSevere fetal anemia - Rh isoimmunisation, vasa previa, fetomaternal hemorrhage, or twin to twin transfusion\nOpioids - meperidine, morphine, alphaprodine, butorphano\nAmnionitis\nFetal distress\nUmbilical cord occlusion.\n\nObstetrical Imaging\nQuestion 1:\nA 26-year-old woman presents with 2 months of amenorrhea and a positive UPT. On ultrasound examination, all of the following are assessed except \t.\nFetal number\nFetal cardiac activity\nAmniotic fluid volume\nCrown rump length\nQuestion 2:\nA primigravida presents to the antenatal clinic for the first time at 18 weeks of amenorrhea. She does not remember her LMP and no ultrasound scans were done in the first trimester. In this situation, gestational age can be most accurately estimated by which of the following parameters?\nCrown rump length\nBiparietal diameter\nFemur length\nAbdominal circumference\nQuestion 3:\nA 25-year-old woman presented with complaints of 7 weeks of amenorrhea and a positive UPT. Her ultrasound scan is shown below. What does the red arrowhead represent?\n\nYolk sac\nDecidua parietalis\nDecidua capsularis\nChorion\nQuestion 4:\nHead circumference is measured from which of the following ultrasonographic views?\nTransthalamic view\nBitemporal view\nTranscranial view\nBimastoid view\nQuestion 5:\nWhat is the normal range of femur length to abdominal circumference ratio?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_3.jpeg",
      "OBGYN_img_80.jpeg",
      "OBGYN_img_3.jpeg",
      "OBGYN_img_81.jpeg",
      "OBGYN_img_3.jpeg",
      "OBGYN_img_82.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch23_44",
    "question_text": "- 50",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch23_20",
    "question_text": "- 24",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch23_50",
    "question_text": "- 40",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch23_30",
    "question_text": "- 40\nQuestion 6:\nA woman presents at 33-weeks of gestation and the umbilical artery Doppler imaging shows the following finding. What is the next step of management?\n\nContinue pregnancy till term\nImmediate termination of pregnancy\nTerminate the pregnancy at 34 weeks of gestation\nContinue steroids until term\nQuestion 7:\nWhich of the following statements is true regarding the first-trimester ultrasound?\nA gestational sac can first be seen 4 weeks after LMP\nAccuracy of USG dating decreases after the 1st trimester\nYolk sac is the first sign of pregnancy on USG\nA normal gestational sac implants in the midline of the endometrial cavity\nQuestion 8:\nWhat is the ideal time for nuchal translucency evaluation?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_3.jpeg",
      "OBGYN_img_83.png"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch23_6",
    "question_text": "8 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch23_11",
    "question_text": "14 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch23_14",
    "question_text": "16 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch23_16",
    "question_text": "20 weeks\nQuestion 9:\nWhich of the following are sonographic markers for Down's syndrome?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch24_1",
    "question_text": "and 2",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch24_1",
    "question_text": ", 4 and 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch24_1",
    "question_text": ", 2, 3 and 4",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch24_1",
    "question_text": "and 3\nQuestion 10:\nThe anomaly scan of a G3A2 woman is given below. Identify the sign.\n\nBanana sign\nLemon sign\nMickey Mouse sign\nHumming bird sign\nQuestion 11:\nA doctor tells a 31-year-old woman, who is 20 weeks pregnant, that her baby has a developmental defect. She has come to you for a second opinion. The following USG finding is seen. Identify the defect.\n\nAnencephaly\nOmphalocele\nCystic hygroma\nEncephalocele\nQuestion 12:\nWhat is Robert's sign?\nGas shadow in bowe\nGas shadow in portal vein\nGas shadow in heart\nGas shadow in cranium\nQuestion 13:\nWhat is the frequency of a transabdominal transducer?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_4.jpeg",
      "OBGYN_img_84.jpeg",
      "OBGYN_img_4.jpeg",
      "OBGYN_img_85.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch24_20000",
    "question_text": "hertz",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch24_4",
    "question_text": "6 megahertz",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch24_5",
    "question_text": "10 megahertz",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch24_10",
    "question_text": "15 megahertz\nQuestion 14:\nWhen is fetal cardiac activity first detected on transabdominal USG?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch24_5",
    "question_text": "th week",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch24_4",
    "question_text": "th week",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch24_6",
    "question_text": "th week",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch24_9",
    "question_text": "th week\nQuestion 15:\nA pregnant woman has her first antenatal visit in the 8th month of gestation. On examination, the uterus corresponds to 30 weeks and the fetal heart rate is 136/min. What is the best parameter for the estimation of fetal age by USG in this patient?\nFemur length\nBiparietal diameter\nAbdominal circumference\nCrown rump length\nQuestion 16:\nWhich of the following is false regarding sonography in pregnancy?\nMust follow ALARA principle\nAll machines must display thermal index\nTissue heating is higher with shorter examination time\nRisks are greater during organogenesis than later in pregnancy\nQuestion 17:\nA pregnant diabetic woman presents for a routine antenatal visit during the third trimester. During the evaluation, you perform obstetrical Doppler imaging. Which among the following would indicate fetal compromise?\nIncreased pulsatalilty index in umbilical artery\nDecreased systolic/diastolic ratio\nIncreased cerebral artery flow\nAbsent end diastolic flow\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_1",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_2",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_3",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_4",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_5",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_6",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_7",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_8",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_9",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_10",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_11",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_12",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_13",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_14",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_15",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_16",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_17",
    "question_text": "\nd\nSolution to Question 1:\nAmniotic fluid volume is assessed on ultrasound in the second and third trimesters. Ultrasonographic evaluation during the first trimester includes:\nGestational sac size, location, and number\nEmbryo and/or yolk sac identification\nCrown-rump length\nFetal number, including amnionicity and chorionicity of multifetal gestations\nEmbryonic/fetal cardiac activity\nMaternal uterus, adnexa, and cul-de-sac\nFetal nuchal translucency.\nSolution to Question 2:\nIn the second trimester, the parameter to assess gestational age most accurately is the biparietal diameter (BPD). Accuracy varies from 7 to 10 days.\nBPD is measured in the transthalamic view, at the level of the thalamus and cavum septum pellucidum (CSP). It is measured from the outer edge of the skull in the near field to the inner edge of the skull in the far field.\nTrimes ter\nParameter\nFirst\nCrown rump length (CRL)\nSecond\nBiparietal diameter (BPD)\nThird\nFemur length (FL)\nSolution to Question 3:\nThe red arrowhead represents the yolk sac. The yellow arrowhead shows the double ring - outer decidua parietalis and inner decidua capsularis.\nIt is referred to as the double decidua sign and is seen in the first trimester transvaginal sonogram. It is useful to confirm an early intrauterine location for the pregnancy.\n\nSolution to Question 4:\nHead circumference (HC) is measured from the transthalamic view by placing an ellipse around the outer edge of the skull\nHC can also be calculated from the biparietal diameter (BPD) and occipital-frontal diameter\n(OFD).\n\nSolution to Question 5:\nThe normal range for the femoral length (FL) to abdominal circumference (AC) ratio is 20-24 percent.\nLow FL/AC (&lt; 16) ratio suggests a lethal skeletal dysplasia, particularly if other skeletal abnormalities are present.\nSolution to Question 6:\nThe umbilical artery Doppler depicts reversal of end-diastolic flow or REDF (waves appearing below the baseline) which is seen in intrauterine growth restriction. As the period of gestation has exceeded 32 weeks, the pregnancy can be terminated.\nIn case of absent end-diastolic flow (AEDF), the waves just touch the baseline, but don't appear below it. This suggests a fetal compromise, hence the pregnancy is terminated by C-section if &gt;34 weeks.\nReversed end-diastolic flow (REDF) suggests impending fetal death, hence the pregnancy is terminated by C-section if &gt;32 weeks.\n\nSolution to Question 7:\nThe accuracy of determining gestational age using ultrasound is the highest in the first trimester and decreases afterwards.\nOption A: Gestational sac is reliably seen at 5 weeks of gestation on transvaginal sonography(TVS).\nOption C: The first sign of pregnancy seen on sonography is the gestational sac. Visualisation of the yolk sac within the gestational sac confirms an intrauterine location for pregnancy.\nOption D: A normal gestational sac implants eccentrically in the endometrium, whereas a pseudosac is seen in the midline of the endometrial cavity.\nSolution to Question 8:\nNuchal translucency evaluation, a component of first-trimester aneuploidy screening, is done between 11-14 weeks.\nIt represents the maximum thickness of the subcutaneous translucent area between the skin and soft tissue, overlying the fetal spine, at the back of the neck. When the nuchal translucency is increased, the risk of fetal aneuploidy and structural anomalies such as heart defects is significantly elevated.\nFirst trimester aneuploidy screening combines two maternal serum analytes and a sonographic measurement:\nHuman chorionic gonadotropin (hCG)\nPregnancy-associated plasma protein A (PAPP-A)\nNuchal translucency (NT)\nIt is performed between 11 and 14 weeks of gestation. In cases of fetal Down syndrome, the first-trimester serum-free \uf062-hCG level is higher and the PAPP-A level is lower. With trisomy 18 and trisomy 13, levels of both analytes are lower.\nNote: Nuchal fold is a normal fold of skin seen at the back of the fetal neck during the second trimester of pregnancy. Increased nuchal fold thickness is associated with fetal aneuploidy.\n\nSolution to Question 9:\nUltrasound markers for Down's syndrome:\nFirst trimester\nNuchal translucency &gt;3 mm\nSecond trimester\nEchogenic intracardiac focus\nVentriculomegaly\nNuchal thickness &gt;6 mm\nEchogenic bowe\nHypoplastic/absent nasal bone\nShortened humerus, femur\nMild pylectasis\nAberrant subclavian artery.\nSolution to Question 10:\nThe given image shows banana sign.\nAn abnormal anterior curvature of cerebellum along with effacement of cisterna magna produces this appearance. It is seen in spina bifida associated with Arnold-Chiari malformation.\n\nLemon sign: Axial USG image of the fetal head at the level of the biparietal diameter shows inward concavity of both frontal bones instead of the normally seen convexity. This gives the head the appearance of a lemon. It has a strong association with spina bifida and is very useful for detecting this condition.\n\nSolution to Question 11:\nThe given ultrasound image shows an open defect in the calvaria and skin leading to the exposure of the cranial neural tube. This is consistent with the diagnosis of anencephaly.\nAnencephaly results from incomplete closure of the neural tube. It is one of the earliest detectable congenital defects that can be detected as early as 10 to 11 weeks of gestation. Screening can also be done by serum estimation of maternal serum alpha-fetoprotein (MSAFP). The following are the radiological signs seen in anencephaly.\nFrog eye sign - Absence of cranial calvaria, prominent orbits thereby resembling the face of a frog.\nShower cap sign - The absence of the cranium could lead to the protrusion of a disorganized mass of brain tissue. This resembles a shower cap giving rise to a characteristic triangular facia appearance.\nNeural-tube defects can be prevented with pre-conceptional supplementation of folic acid. A dose of 4 mg daily is recommended in subsequent pregnancies.\nThe frog eye and showercap signs are shown below:\n\nOption B: Omphalocele is a midline anterior abdominal wall defect through which the solid abdominal viscera and/or bowel may herniate. The extruded abdominal contents are covered in a sac. Given below is an ultrasound image of the fetus suggestive of an omphalocele (asterix).\n\nCystic hygroma is a congenital multiloculated lymphatic lesion that is classically found in the left posterior triangle of the neck. It occurs as a result of sequestration or obstruction of developing lymph vessels. This defect can be picked up in a first-trimester ultrasound. The images below show the MRI and USG appearance of cystic hygroma, respectively:\n\n\nEncephalocele is caused due to defects in the skull through which the meninges and/or neural tissue herniate. The squamous part of the occipital bone is the most frequently affected bone.\nThe image shows a newborn with encephalocele.\n\nSolution to Question 12:\nRobert's sign is a gas shadow in the fetal heart. It is seen in fetal demise in utero and may appear as early as 12 hours.\nOther sonographic signs seen in fetal demise in utero are:\nAbsent fetal heartbeat\nAbsent fetal movements\nOccasional findings\nOverlapping of skull bones - Spalding's sign\nGross distortion of fetal anatomy (maceration)\nSoft tissue edema - skin &gt;5 mm\nEchogenic amniotic fluid (fetal demise fragments)\nUncommon findings\nThrombus in fetal heart\nGas shadow in the fetal heart - Robert's sign.\nSolution to Question 13:\nThe frequency of trans abdominal transducer is 4-6 megahertz (MHz) since a lower frequency penetrates better.\nOn the other hand, a vaginal transducer has a frequency of 5-10 megahertz since a higher frequency yields a better image with minimal penetration.\nSolution to Question 14:\nThe cardiac activity of the fetus is first detected on transabdominal USG (TAS) at the 6th week of intrauterine life.\nFetal structure\nTVS(we eks)\nTAS(we eks)\nGestational sac",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_4.jpeg",
      "OBGYN_img_86.jpeg",
      "OBGYN_img_4.jpeg",
      "OBGYN_img_87.jpeg",
      "OBGYN_img_88.jpeg",
      "OBGYN_img_89.jpeg",
      "OBGYN_img_2.jpeg",
      "OBGYN_img_64.jpeg",
      "OBGYN_img_4.jpeg",
      "OBGYN_img_90.jpeg",
      "OBGYN_img_4.jpeg",
      "OBGYN_img_91.png",
      "OBGYN_img_4.jpeg",
      "OBGYN_img_92.png",
      "OBGYN_img_4.jpeg",
      "OBGYN_img_5.jpeg",
      "OBGYN_img_93.png",
      "OBGYN_img_94.jpeg",
      "OBGYN_img_5.jpeg",
      "OBGYN_img_95.jpeg",
      "OBGYN_img_5.jpeg",
      "OBGYN_img_96.png",
      "OBGYN_img_5.jpeg",
      "OBGYN_img_97.jpeg",
      "OBGYN_img_5.jpeg",
      "OBGYN_img_98.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_4",
    "question_text": "5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_5",
    "question_text": "5\nYolk sac",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_5",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_6",
    "question_text": "\nCardiac activit y",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_6",
    "question_text": "- 6.5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch25_6",
    "question_text": "- 7\nSolution to Question 15:\nFemur length is the best parameter for the estimation of fetal age by USG in the 3rd trimester. Best USG parameters for estimation of fetal age:\nTrimes ter\nParameter\nFirst\nCrown-rump length (CR L)\nTrimes ter\nParameter\nSecond\nBiparietal diameter (BPD)\nThird\nFemur length (FL)\nSolution to Question 16:\nTissue heating is higher with longer examination time.\nSonography should be performed in compliance with the ALARA principle which is As Low As Reasonably Achievable. The theoretical risks are greater during organogenesis (8-15 weeks) than later in pregnancy.\nAll sonography machines must display 2 indices - the thermal index and the mechanical index.\nSolution to Question 17:\nAbsent end diastolic flow indicates fetal compromise in Doppler. Umbilical artery vessels:\nThey are characterized by forward low-resistance flow.\nAs gestation increases, there is a gradual fall in all the resistance indices so the amount of forward diastolic flow increases.\nS/D ratio decreases as the period of gestation increases. Abnormal flow patterns in umbilical artery:\nReduced end-diastolic flow - Uteroplacental insufficiency (systolic/diastolic ratio increases)\nAbsent end-diastolic flow - Fetal compromise (hence pregnancy is terminated by cesarean section if &gt;34 weeks)\nReverse end-diastolic flow - Impending death (pregnancy is terminated irrespective of gestational age)\nDoppler of the middle cerebral artery helps in detecting fetal anemia. Increased fetal diastolic flow in the middle cerebral artery with absent diastolic flow in the aorta implies fetal acidemia.\n\nNormal Labour\nQuestion 1:\nWhich of the following acts as the primary trigger for onset of labour in pregnant women?\nACTH in mother\nACTH in fetus\nProstaglandin\nOxytocin\nQuestion 2:\nAll of the following changes are seen during cervical ripening in a patient except \t.\nCollagen fibril diameter is increased\nCollagen fibrils are tightly packed\nIncrease in glycosaminoglycans\nStromal invasion with inflammatory cells\nQuestion 3:\nAn obstetrician performs the following procedure for labor induction in a patient. What is the reflex elicited in the process?\n\nAndrews reflex\nJohnsons reflex\nGails reflex\nFerguson reflex\nQuestion 4:\nWhich of the following image shows the Duncan method?\n\nA\nB\nC\nD\nQuestion 5:\nIn which stage of labour, is the following expelled?\n\nSecond\nThird\nFourth\nFirst\nQuestion 6:\nAll of the following are included in the first stage of labour for a pregnant woman except:\nEffacement of cervix\nDilatation of cervix\nCrowning of fetal head\nFetal descent beginning\nQuestion 7:\nWhat does fetal position refer to?\nPart of presentation which lies over the internal os\nRelation of different parts of fetus to one another\nRelation of the denominator to different quadrants of the pelvis\nPart of fetus lying in the lower segment of uterus\nQuestion 8:\nA senior resident examines a primigravida in labour and informs that the fetus is cephalic in attitude of flexion. What is the most common presenting part of this fetus?\nVertex\nSinciput\nOcciput\nFace\nQuestion 9:\nThe ultrasonogram shows the diameter of the fetal head which is taken as a reference for engagement. Which diameter does this refer to?\n\nBiparietal diameter\nBitemporal diameter\nOccipitofrontal diameter\nSuboccipitofrontal diameter\nQuestion 10:\nWhich of the following is not a part of a partograph?\nFetal heart rate\nMaternal heart rate\nMaternal temperature\nFetal temperature\nQuestion 11:\nWhat are the cardinal movements of labour?\nEngagement\u2014descent\u2014flexion\u2014internal rotation\u2014extension\u2014external rotation\u2014expulsion\nEngagement\u2014flexion\u2014descent\u2014internal rotation\u2014extension\u2014expulsion\nEngagement\u2014flexion\u2014descent\u2014external rotation\u2014expulsion\nEngagement\u2014extension\u2014internal rotation\u2014external rotation\u2014expulsion\nQuestion 12:\nA multigravida with gestational diabetes mellitus was admitted in labour at term and progressed to full dilatation. The fetal vertex failed to descend beyond -3 station. The descent of the fetus is facilitated by all except:\nExtension and straightening of the fetal body\nPressure of amniotic fluid\nUterine contractions and retractions\nWell-flexed head\nQuestion 13:\nWhich of the following is a prerequisite for internal rotation of the fetal head for a woman in labor?\nStraightening of fetal body\nTone of transversus abdominis\nWell-extended head\nTone of levator ani muscles\nQuestion 14:\nWhich of the following statements is true regarding the internal rotation of the fetal head?\nOcciput turns towards the transverse axis\nRotation is not essential when the fetus is unusually sma\nInternal rotation is followed by external rotation\nRotation is earlier in primigravida than in multigravida\nQuestion 15:\nWhat is the minimum rate of cervical dilatation in primigravida during active labour?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_5.jpeg",
      "OBGYN_img_99.jpeg",
      "OBGYN_img_5.jpeg",
      "OBGYN_img_100.jpeg",
      "OBGYN_img_5.jpeg",
      "OBGYN_img_101.jpeg",
      "OBGYN_img_5.jpeg",
      "OBGYN_img_102.jpeg",
      "OBGYN_img_5.jpeg",
      "OBGYN_img_103.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_1",
    "question_text": "5 cm/hr",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_1",
    "question_text": "2 cm/hr",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_1",
    "question_text": "7 cm/hr\n2 cm/hr\nQuestion 16:\nWhich of the following is part of the WHO guidelines for the management of second stage of labor?\nDo a routine episiotomy\nManual support to perineum to maintain flexion of head\nNever give warm compress to the perineum\nPerform labor in lithotomy position\nQuestion 17:\nModified Robson's classification class 1 includes:\nNulliparous, singleton, cephalic, induced labour\nNulliparous, singleton, cephalic, spontaneous labour\nMultiparous without previous CS, spontaneous labour\nMultiparous without previous CS, induced/CS before labour\nQuestion 18:\nIdentify the fetal position in the given image.\n\nRight occipito-posterior\nLeft occipito-anterior\nLeft occipito-posterior\nRight occipito-anterior\nQuestion 19:\nUterine contractions are palpable when its intensity is more than     .\n10 mm Hg\n15 mmHg\n20 mmHg\n40 mmHg\nQuestion 20:\nA primigravida presents to the labor room at 39 weeks of gestation. On examination, you notice the fetal head has appeared at the vulva. Which of the following maneuvers can be used to assist the delivery of the head?\nPrague maneuver\nLovset's maneuver\nPinard's maneuver\nRitgen's maneuver\nQuestion 21:\nWhich dermatome is pain in the early stage of labor limited to?\nT10-L1\nS1-S3\nL4-L5\nL2-L3\nQuestion 22:\nA young primigravida at 39 weeks of gestation presented to the casualty crying of intense abdominal pain. She was diagnosed to be in labour. Which of the following is not a characteristic of this pain?\nPainful uterine contraction\nRelieved by enema and sedatives\nFormation of bag of waters\nProgressive descent of presenting part\nQuestion 23:\nYou notice the gynecology resident administer the nerve block seen in the image before performing an episiotomy. Which nerve roots are blocked?\n\nL1,2,3\nL2,3\nS2,3,4\nL5,S1,S2\nQuestion 24:\nParacervical block relieves pain from all except:\nCervix\nUterus\nLower third of vagina\nUpper third of vagina\nQuestion 25:\nAll of the following are indications for early clamping of cord in a new born baby except:\nRh isoimmunization\nPostdated pregnancy\nBirth asphyxia\nMaternal diabetes\nQuestion 26:\nWhich of the following is not a sign of placental separation in stage 3 of parturition of a pregnant woman?\nSchroeder's sign\nShortening of cord\nSuprapubic bulge\nKustner's sign\nQuestion 27:\nWhich of the following is false regarding the modified WHO partogram?\nRight side of alert line indicates immediate referral to First Referral Unit (FRU)\nAlert and action line are separated by a difference of 4 hours\nEach small square in partogram is equal to 1 hour\nPartograph recording should be started once the cervical dilatation reaches 4 cm\nQuestion 28:\nIdentify the following instrument commonly used in obstetrics.\n\nMayo scissors\nCurved scissors\nSuture remover\nEpisiotomy scissors\nQuestion 29:\nA nursing assistant posted in the obstetric care unit was asked to monitor the progress of labour. After how much dilatation of the cervix, should she start the documentation?\n2cm\n5cm\n4cm\n6cm\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_6.jpeg",
      "OBGYN_img_104.jpeg",
      "OBGYN_img_6.jpeg",
      "OBGYN_img_105.jpeg",
      "OBGYN_img_6.jpeg",
      "OBGYN_img_106.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_1",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_2",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_3",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_4",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_5",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_6",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_7",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_8",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_9",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_10",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_11",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_12",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_13",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_14",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_15",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_16",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_17",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_18",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_19",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_20",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_21",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_22",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_23",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_24",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_25",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_26",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_27",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_28",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_29",
    "question_text": "\nb\nSolution to Question 1:\nThe fetal ACTH causes an increase in estrogen acting as the onset of labour in pregnant women. It results in the growth of the fetal adrenal gland which has the capacity for steroid biosynthesis i.e. estrogen.\nDaily steroid production of fetal adrenal glands near term is more than in adults.\n\nSolution to Question 2:\nCollagen fibrils are loosely packed during cervical ripening. Changes in cervical ripening:\nCollagen fibril diameter is increased, and there is increased spacing between fibrils leading to increased tissue compliance\nIncrease in the amount of proteoglycan and glycosaminoglycan within the matrix\nStromal invasion with inflammatory cells\nSolution to Question 3:\nStripping of membranes is depicted in the image, which elicits the Ferguson reflex.\nFetal ejection reflex or Ferguson reflex is a phenomenon in which mechanical stretching of the internal cervix enhances uterine activity. Release of oxytocin from the maternal pituitary has been suggested but not proven.\nIt is seen in stripping/sweeping and artificial rupture of membranes. Both of these are methods of induction of labor. It is associated with an increase in blood levels of\nprostaglandin F2\uf0b0 metabolite, also known as dinoprost/carboprost.\nSolution to Question 4:\nImage B shows the Duncan method of placental separation.\n\nComparison between two types of placental separation methods:\nBrandt Andrew's method or controlled cord traction is a manoeuvre of expressing the placenta from the uterus in the third stage of labour.\nOne hand grasps the umbilical cord while the other is placed on the mother's abdomen with the fi ngers over the anterior surface of the uterus. While the hand on the abdomen is pressed backwar ds and slightly upward, the other applies gentle traction on the cord.\nType III placenta previa is a type of incomplete or partial central placenta previa. Here, the placenta covers the internal os partially i.e. it covers the internal os when closed but does not entirely do so when fully dilated.\nSchultze method\nDuncan method\nSeparation begins from the c enter of the placenta to the p eriphery.\nSeparation begins from the p eriphery to the center.\nBlood does not escape extern ally, as the blood pours into t he membrane sac.\nBlood escapes from the vagin a as the blood collects betwee n the membranes and the ute rine wall.\nSolution to Question 5:\nThe placenta and membranes are expelled in the third stage of labour.\nThe clinical stages of labour may be summarized as follows:\nStages of labou r\nDefinition\nFirst\nTrue labour pain tofull dilata tion of cervix\nSecond\nFull dilatation of cervix toexp ulsion of fetus\nThird\nExpulsion of fetus toexpulsio n of placenta\nFourth\nOne hour observationafter th e expulsion of placenta\nSolution to Question 6:\nThe encirclement of the largest head diameter by the vulval ring is called crowning. This occurs in the second stage of labour.\nFirst stage of labour is divided into 2 phases:\nLatent phase\nActive phase\nThe onset of true labour pain up to 6cm cervical dilatation\nFrom \uf0b3 6cm cervical dilatatio n with regular uterine contra ctions\nDuration:10-12 hours- nullipa ra6-8 hours- multipara\nRate of cervical dilatation:1.2 cm/hr- nullipara1.5 cm/hr- m ultipara\nMainly cervicaleffacementocc urs\nMainly cervicaldilatationoccu rs\nSolution to Question 7:\nFetal position refers to the bony fixed point of reference on presenting part with respect to different quadrants of the pelvis.\nDefinition of various terminologies used for fetus in-utero:\nTerm:\nDefinition:\nLie\nRelationship of the long axis of fetus to the long axis of th e maternal spine\nTerm:\tDefinition:\nTerm:\tDefinition:\nPresentation\nPart of the fetus occupying th e lower pole of the pelvis\nPresenting pa rt\nPart of the presentation whic h overlies the internal os\nAttitude\nThe relation of the different parts of the fetus to one anot her\nDenominator\nAn arbitrary bony fixed point on the presenting part which comes in relation with the va rious quadrants of the mater nal pelvis\nPosition\nRelation of the denominator to the different quadrants of the pelvis\nEngagement\nWhen the biparietal diameter has passed the plane of the p elvic brim, the head is said to be engaged.\nSolution to Question 8:\nThe most common presenting part when the fetus is in attitude of flexion is vertex.\nAttitude\nPresenting part\nComplete flexion\nVertex (occipitoanterior)\nIncomplete flexio n\nVertex (sinciput)\nDeflexion\nVertex (occipitoposterior)\nPartial extension\nBrow\nComplete extensi on\nFace\n\nSolution to Question 9:\nThe fetal head is said to be engaged when the biparietal diameter (shown in the image) passes through the pelvic brim. Engagement of fetal head is with reference to this biparietal diameter.\nIt is the greatest transverse diameter in an occiput presentation. It also reflects the gestational age in the second trimester, with a variation of 7-10 days.\nBPD is measured in the transthalamic view, at the level of the thalamus and cavum septum pellucidum (CSP). It is measured from the outer edge of the skull in the near field to the inner edge of the skull in the far field.\n\nSolution to Question 10:\nFetal temperature is not a part of a partograph.\nAssessment of progress of labor is best done by partograph. Components of partograph:\nPatient identification\nFetal heart rate recorded every 30 min\nPulse recorded every 30 min\nBlood pressure and temperature recorded every 4 h\nUterine contractions recorded every 30 min\nOxytocin-dose and concentration\nUrine analysis\nVaginal examination done every 4 hours\nState of membranes and colour of liquor\nSolution to Question 11:\nThe cardinal movements of labour are engagement, descent, flexion, internal rotation, extension, external rotation, expulsion.\n(Mnemonic: Every Day FIRE Raises Extremely)\nEvery: Engagement\nDay: Descent\nF: Flexion\nIR: Internal rotation\nE: Extension\nRaises: external Rotation\nExtremely: Expulsion\nThe most common presentation is cephalic and presenting part is vertex. Head enters the pelvis through transverse diameter majorly and left occipito transverse is the commonest fetal position. Internal rotation of fetal head occurs at the level of ischial spine. In a vertex delivery, the baby's head is delivered by extension and in a breech delivery, the baby's head is delivered by flexion.\nThe best time to give episotomy is after crowning has occured.\n\nSolution to Question 12:\nA well-flexed head facilitates internal rotation, not the descent of the presenting part. The descent of the fetus is brought about by:\nPressure of amniotic fluid\nDirect pressure of the fundus upon the breech with contractions\nBearing-down efforts of maternal abdominal muscles\nExtension and straightening of the fetal body\nSolution to Question 13:\nThe tone of levator ani muscles is a prerequisite for internal rotation of the head. Prerequisites of internal rotation of the head are as follows:\nWell-flexed head\nEfficient uterine contraction\nFavorable shape at mid-pelvic plane\nTone of the levator ani muscles\nSolution to Question 14:\nInternal rotation is not essential in the completion of labor when the fetus is unusually small.\nInternal rotation begins with the occiput turning away from the transverse axis. In\nmajority, internal rotation is completed by the time the head reaches the pelvic floor. Internal rotation is followed by extension of the head, which is then followed by external rotation.\nRotation occurs earlier in multigravida than primigravida whereas engagement occurs earlier in primigravida than multigravida.\nSolution to Question 15:\nDuring active labor, the minimal rate of cervical dilatation in primigravida is 1.2 cm/hr. First stage of labour is divided into 2 phases:\nThe cervical dilatation ranges from a minimal rate of 1.2 cm - 6.8 cm/hr in nullipara. Also, the multiparas progress faster in the active phase of labor with a minimal dilatation rate of 1.5 cm/hr.\nFriedman curve is the sigmoid curve plotting the pattern of cervical dilatation during the latent and active phase of normal labour.\nLatent phase\nActive phase\nThe onset of true labor pain up to 6 cm cervical dilatation\nStarts from \uf0b3 6 cm cervical di latation with regular uterine contractions\nDuration:12 h (nullipara)8 h (\nmultipara)\nThe minimum rate of cervical dilatation:1.2 cm/h (nullipar a)1.5 cm/h (multipara)\nConcerned with cervicaleffac ement\nConcerned with cervicaldilata tion\n\nSolution to Question 16:\nThe practice of guarding the perineum during delivery of the fetal head is part of the WHO management guidelines for the second stage of labor.\nThe fingers of one hand support the perineum, while the second hand applies pressure to the fetal head to control the speed of crowning. The advantage of this is to prevent perineal tears.\nThe second stage of labor begins with full dilatation of the cervix and ends with the delivery of the fetus.\nThe main events include the descent of the fetus (bearing down by the mother, uterine contractions), cardinal movements of labor, and delivery of the fetus.\nManagement of the second stage of labor:\nThe most common position used is the dorsal position with the hips flexed, knees flexed and abduction of the thighs. WHO recommends any position of choice including the upright position.\nWHO recommendations for the prevention of perineal tears include warm compresses to the perineum, perineal massage, guarding the perineum, and modified Ritgen's maneuver.\nModified Ritgen's maneuver: A sterile towel or pad is held in one hand and placed over the perineum; the other hand applies gentle downward pressure on the occiput to promote flexion and controlled delivery of the head (ensuring the smallest diameter of the head passes through the outlet). Once the occiput is born\u2013with gentle pressure, the head is extended\u2013forehead, nose, and mouth are then delivered.\nWHO doesn't recommend fundal pressure and routine episiotomy. Other options:\nOption A: A liberal or routine episiotomy is discouraged. Episiotomy is indicated in cases of:\nShoulder dystocia\nBreech delivery\nFetal macrosomia\nOperative vaginal deliveries\nPersistent occiput posterior positions\nOption C: Manual techniques, such as massage or application of warm compresses, are recommended for healthy pregnant women requesting pain relief during labor.\nOption D: The position that is most comfortable to the mother i.e. upright/squatting position is encouraged. This position gives:\ness discomfort and difficulty in bearing down\ness labor pain\ness perineal/vaginal trauma and wound infections\nSecond stage\nNulliparous\nMultiparous\nMean/average duration",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_6.jpeg",
      "OBGYN_img_107.jpeg",
      "OBGYN_img_6.jpeg",
      "OBGYN_img_108.jpeg",
      "OBGYN_img_6.jpeg",
      "OBGYN_img_109.jpeg",
      "OBGYN_img_6.jpeg",
      "OBGYN_img_110.jpeg",
      "OBGYN_img_6.jpeg",
      "OBGYN_img_111.jpeg",
      "OBGYN_img_6.jpeg",
      "OBGYN_img_112.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_50",
    "question_text": "minutes",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_30",
    "question_text": "minutes\nMaximum duration",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch26_2",
    "question_text": "hours (+1 with epidural)",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch27_1",
    "question_text": "hour (+1 with epidural)\nSecond stage\nNulliparous\nMultiparous\nWHO maximum duration of 2nd stage/diagnosis of arrest",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch27_3",
    "question_text": "hours",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch27_2",
    "question_text": "hours\nSolution to Question 17:\nClass 1 of modified Robson's classification includes nullipara, equal to or &gt;37 weeks, single, cephalic, spontaneous labor.\nIt is the most widely accepted classification system available for analyzing characteristics of delivering women worldwide. It consists of 10 patient population categories. The basis for these categories include:\nParity\nOnset of labor and mode of delivery\nGestational age\nFetal presentation\nNo. of fetuses\nThe modified Robson system classification is as follows:\nClass 1\nNullipara, equal to or >37 we eks, single, cephalic, spontan eous labor\nClass 2\nNullipara, equal to or >37 we eks, single, cephalic2a:induce d labor2b:CS before labor\nClass 3\nMultipara, equal to or >37 we eks, single, cephalic, spontan eous labor (excludes previous CS)\nClass 4\nMultipara, equal to or >37 we eks, single, cephalic4a:induce d labor4b:CS before labor\nClass 5\nMultipara, previous CS, equa l to or >37 weeks, single, cep halic\nClass 6\nNullipara, single, breech\nClass 7\nMultipara, single, breech (inc luding previous CS)\nClass 8\nMultiple pregnancies (with or without previous CS)\nClass 1\nNullipara, equal to or >37 we eks, single, cephalic, spontan eous labor\nClass 9\nSingleton pregnancy, oblique\n/transverse lie (with or witho ut previous CS)\nClass 10\nSingle, cephalic <37 weeks (i ncluding previous CS)\nSolution to Question 18:\nIn the given vertex presentation, the fetal position is right occipitoanterior.\nFetal position refers to the relation of the denominator (arbitrary bony fixed point on the presenting part), with respect to different quadrants of the maternal pelvis. In vertex presentation, the denominator is taken as the occiput (which is close to the triangular posterior fontanelle).\nTo determine the fetal position the following two steps are followed:\nDetermine the direction in which the occiput is facing:\nTowards the pubic symphysis - occipito-anterior\nTowards the sacral promontory - occipito-posterior\nMidway between pubic symphysis and sacral promontory - occipito-transverse\nDetermine if the occiput is facing the left or the right in relation to the materal pelvis\n\nSolution to Question 19:\nUterine contractions are palpable when the intensity is &gt;10 mmHg.\nUterine contractions cause cervical dilatation at 15 mmHg and are painful beyond 15 mmHg. Units for measuring the intensity of uterine contractions are mmHg and Montevideo units (MV). 1 MV = intensity of uterine contractions x number of contractions in 10 min.\nDuring labour, normal uterine contractions are between 190 and 300 MV and at the time of delivery, it is 300 MV.\nStage of labou r\nPressure",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_6.jpeg",
      "OBGYN_img_113.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch28_1",
    "question_text": "st",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch28_40",
    "question_text": "\u201350 m\nmHg",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch28_2",
    "question_text": "nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch28_100",
    "question_text": "\u2013120\nmmHg",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch28_3",
    "question_text": "rd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch28_100",
    "question_text": "\u2013120\nmmHg\nSolution to Question 20:\nRitgen's maneuver is done for delivery of head in normal labor.\nThis maneuver is done when the head distends the vulva and perineum enough to open the vaginal introitus to a diameter of &gt;5 cm. A towel is draped and a gloved hand may be used to exert forward pressure on the chin of the fetus through the perineum. The other hand exerts pressure superiorly against the occiput.\nThis maneuver allows controlled delivery of the head.\n\nSolution to Question 21:\nPain in the early stage of labor is limited to dermatomes T10-L1. This is of uterine origin.\nPain in the late stage of labour is due to dilatation of cervix and perineal stretching. The nerves carrying the pain include S2,3,4.\nSolution to Question 22:\nTrue labor pain is not relieved by enema and sedatives. It is characterized by the following:\nPainful uterine contractions at regular intervals\nThe frequency of contractions increases gradually\nThe intensity and duration of contractions increase progressively\nAssociated with 'show'- extrusion of the mucus plug that had previously filled the cervical cana during pregnancy\nProgressive effacement and dilatation of the cervix\nProgressive descent of the presenting part\nFormation of the 'bag of forewaters' i.e., bulging fluid-filled amniotic membrane presenting in front of the fetal head\nNot relieved by enema or sedatives\nFalse labour pain is seen more in primigravidae than in parous women. It usually appears prior to the onset of true labor pain by 1 or 2 weeks in primigravidae and by a few days in multiparae.\nSuch pains are probably due to stretching of the cervix and lower uterine segment with consequent irritation of the neighboring ganglia.\nFeatures\nTrue labour pains\nFalse labour pain s\nCervical dilatation and efface ment\nPresent\nAbsent\nPain\nLower abdomen and back, ra diating to thighs\nLower abdomen only\nShow\nPresent\nAbsent\nBag of water\nFormed\nAbsent\nRelief with enema\nNo\nYes\nSolution to Question 23:\nThe nerve roots blocked in pudendal nerve block are S2,3,4. It is blocked just above the tip of the ischial spine by piercing the sacrospinous ligament.\nPudendal nerve block can be used for:\nAnalgesia in the second stage of labor\nEpisiotomy repair\nPelvic floor relaxation for outlet instrument delivery\nMinor procedures of the lower vagina and perineum\nPerineal analgesia prior to application of vacuum/forceps\nPudendal block does not impact the cervix or upper vagina. It is ineffective for pain relief associated with uterine manipulation such as manual extraction of the placenta.\nSolution to Question 24:\nPain from the lower third of the vagina is relieved by pudendal block, not paracervical block.\nParacervical block relieves the pain of uterine contractions and cervical dilatation. It also relieves pain from upper third of the vagina. It is not useful at the time of episiotomy as the lower part of the vagina is not anesthetized.\nNote: Paracervical block is no longer considered safe as it causes fetal bradycardia. Epidural analgesia is preferred when complete relief of pain is needed throughout labour.\nSolution to Question 25:\nPostdated pregnancy is not an indication for early cord clamping. Early cord clamping is indicated in:\nBirth asphyxia\nRh isoimmunization\nDiabetic mother\nThe benefits of delayed cord clamping for up to 60 seconds is an increase in total body iron stores, expand blood volume and a decrease in anemia incidence in the neonate.\nOn the other hand, delayed cord clamping can lead to a higher hemoglobin concentration, which increases risks for hyperbilirubinemia and extended hospitalization for neonatal phototherapy. Delayed cord clamping can also hinder timely neonatal resuscitation.\nAccording to AIIMS Protocols in Neonatology, in uncomplicated preterm birth, delayed cord clamping should be attempted. This is done for a minimum time of 60 seconds after delivery for preterm infants not requiring immediate resuscitation after birth. It states that DCC must be done even if the mother has an HIV infection. But as per the NACO guidelines, early cord clamping is advised.\nSolution to Question 26:\nLengthening of the umbilical cord is seen in placental separation. Signs of placental separation:\nThe uterus becomes globular, firm, and ballottable (earliest sign to appear)\nSchroeder's sign - Slight rise of fundal height as the separated placenta comes down in the lower segment and uterus rests over it\nSlight suprapubic bulging due to separated placenta distending the lower segment.\nKustner's sign - On pushing, the uterus cephalad with a hand on the abdomen, the cord no onger recedes\nA sudden gush of blood\nPermanent lengthening of cord\nNote: Schroeder's ring is a constriction ring/contraction ring formed due to incoordinate uterine action.\nSolution to Question 27:\nEach small square in a modified WHO partogram is equal to 30 minutes. Each small square in a composite WHO partogram is equal to 1 hour.\nSolution to Question 28:\nThe instrument given in the picture is episiotomy scissors. The angulation in the scissor is to prevent the extension of pelvic tears into the anal margins and obstetric anal sphincter injuries / complete perineal tears.\nComplications of episiotomy:\nThey can be immediate or remote.\nImmediate complications include an extension of the incision into the rectum, vulval hematoma, wound dehiscence and injury to anal sphincter.\nRemote complications include dyspareunia, chances of perineal lacerations in subsequent labor and scar endometriosis (rare).\nMayo scissors are long and stout scissors. They can be blunt-tipped/pointed tip/straight or curved. Straight mayo scissors are designed for cutting body tissues near the surface of a wound. They are also used to cut sutures and are also known as suture-cutting scissors.\nCurved mayo scissors allow much deeper penetration into the wound and are used to cut thick tissues such as those found in the uterus, muscles, breast, and foot. Mayo scissors used for dissection are placed in tissue with the tips closed. The scissors are then opened so that the tips open and spread out the tissue during the dissection process.\n\n\nSolution to Question 29:\nThe WHO Labour Care Guide begins the documentation of labour progression at 5 cm of cervical dilatation.\nThe WHO Labour Care Guide is a tool designed to help health personnel involved in labour care. It aims to\nGuide the monitoring and help in the documentation of the progress of labour.\nGuide the health professionals to offer supportive care throughout labour.\nAssist doctors in promptly identifying and addressing emerging labour complications.\nPrevent the use of unnecessary interventions in labour.\nSupport audits and quality improvement.\nThe differences between the WHO-modified partograph and the latest WHO Labour Care Guide are tabulated below:\nNote: Previously the answer to the question was 4 cm (according to the modified WHO patograph). However, this information is outdated, therefore the answer to this question has been revised per the latest WHO guidelines.\nWHO modified partograph\nWHO Labour Care Guide\nDocumentation of labour pro gression begins at4 cmof cerv ical dilatation.\nDocumentation of labour pro gression begins at5 cmof cerv ical dilatation.\nFixed1 cm/hour \u2018alert\u2019 and \u2018ac tion\u2019lines\nTime-based cut-offsforeach c entimetreof cervical dilatatio n to guide the obstetrician to take action. For example, at 5 cm of cervical dilatation, if t here is no progress >6 hours, action needs to be taken.\nMonitoring of labour is restri cted to thefirst stageonly.\nMonitoring ofthe second stag e of labouris included\nNo section on supportive car e interventions\nAddition of a section onsupp ortive careof the mother- lab our companionship, pain reli ef, oral fluid intake and postu re\nDocumentation ofstrength, d uration, and frequencyof uter ine contractions\nDocumentation ofonlythedur ation and frequency of uterin e contractions\n\nAbnormal Labour\nQuestion 1:\nA young woman delivered her baby on the way to the hospital. While examining her, you notice a perineal tear. This injury could have been prevented by all except:\nMaintaining flexion of head\nTimely episiotomy as a routine\nSlow delivery of the head in between contractions\nEffective perineal guard\nQuestion 2:\nWhat is the most common cause of true cephalopelvic disproportion in India?\nMalpresentations\nRickets\nTraum\nOccipito posterior position\nQuestion 3:\nYou are monitoring uterine contractions in a term primigravida in labor. You find that the contractions are uncoordinated and the frequency is about 8 contractions every 10 minutes. Which of the following is incorrect regarding your finding?\nCommonly associated with occipito posterior\nIt is common in nulliparous labour\nOxytocin administration is beneficial\nManagement includes wait and watch policy\nQuestion 4:\nA 37-week primigravida has mild labor pains for 20 hours and the cervix is persistently 1 cm dilated but non-effaced. What would be the appropriate management?\nSedation and wait\nAugmentation with oxytocin\nCesarean section\nAmniotomy\nQuestion 5:\nA 34-year-old G3P2L2 woman presents to the ER with hypotension and severe abdominal pain. On examination, fetal parts are palpable over the abdomen. USG abdomen revealed a large uterine wall defect. Which of the following is not a feature of this condition?\nMaternal bradycardi\nFetal bradycardi\nVaginal bleeding\nHematuri\nQuestion 6:\nA young primigravida at 36 weeks of gestation came with complaints of decreased perception of fetal movements for the past 2 days. NST is non-reactive and on ultrasound fetal cardiac activity is absent. What will be the best management in this patient?\nForceps extraction\nWait for spontaneous expulsion\nCesarean section\nArtificial rupture of membranes\nQuestion 7:\nA G2P1L0 woman presents to OPD at 36 weeks of gestation for a routine visit. She mentions that she has a history of prior stillbirth at 37 weeks. What is the best time for delivery in this patient?\nImmediately",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_7.jpeg",
      "OBGYN_img_114.jpeg",
      "OBGYN_img_7.jpeg",
      "OBGYN_img_115.jpeg",
      "OBGYN_img_7.jpeg",
      "OBGYN_img_116.jpeg",
      "OBGYN_img_7.jpeg",
      "OBGYN_img_117.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch28_37",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch28_38",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch28_39",
    "question_text": "weeks\nQuestion 8:\nA pregnant woman presents with obstructed labor and is grossly dehydrated. Investigations reveal fetal demise. What will be the management?\nCraniotomy\nDecapitation\nCesarean section\nForceps extraction\nQuestion 9:\nThe partogram of a 28 year old G2P1 is shown below. What is the next step in management?\n\nWait and watch\nOxytocin infusion\nForceps delivery\nCesarean section\nQuestion 10:\nAfter successful delivery of the baby, the obstetrician witnesses that the episiotomy performed has extended backwards beyond the perineal body. Which among the following structures is likely to be injured in this case?\nExternal anal sphicter\nIschiocavernosus\nBulbospongiosis\nUrethral sphincter\nQuestion 11:\nA midwife is examining a pregnant woman in labour when she noticed that the cord is prolapsed. What should be the next immediate step of management?\nGently replace the cord inside the vagin\nInform the doctor and shift to OT\nPut her in Trendelenberg position\nDo vaginal examination and find the fetal presentation\nQuestion 12:\nAbdominal examination of a 28-year-old primigravida, who is in the second stage of labour, reveals retraction ring between the active upper segment and the distended lower segment. Which would best describe this ring?\nPhysiological retraction ring\nPathological retraction ring\nPhysiological contraction band\nPathological contraction band\nQuestion 13:\nA 26-year-old term primigravida presents to the clinic for a regular check-up. On examination, uterus corresponds to term and head of the fetus is non-engaged. What is the most common cause for this finding?\nCephalopelvic disproportion\nDeflexed head\nTransverse lie\nBreech\nQuestion 14:\nWhich of the following is not a cardinal movement occurring during labor?\nFlexion\nExtension\nInternal rotation\nAsynclitism\nQuestion 15:\nA 28-year-old primigravida is brought to the labour room in the latent phase of labor. How long will you wait till you declare her latent phase to be prolonged?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_7.jpeg",
      "OBGYN_img_118.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch28_12",
    "question_text": "hours",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch28_14",
    "question_text": "hours",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch28_18",
    "question_text": "hours",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch28_20",
    "question_text": "hours\nQuestion 16:\nAll of the following findings are seen in the partogram of a patient except:\n\nArrest of dilatation\nArrest of descent\nFetal distress\nUterine tachysystole\nQuestion 17:\nA 26-year-old primigravida presents with labour pains. At 39 weeks of gestation, she was diagnosed with prolonged phase of labour. Which of the following is false regarding this condition?\nGreater than 14 hrs in nullipar\nOxytocin stimulation given\nExcessive sedation can prolong this phase\nMorphine is used in management\nQuestion 18:\nProtracted active phase dilatation in a multiparous woman is when cervical dilatation is\n.\n&lt; 1 cm/hour\n&lt;1.2 cm/hour\n&lt; 1.5 cm/hour\n&lt;2 cm/hour\nQuestion 19:\nWhich among the following is false with respect to active phase of labor?\nThe minimum rate of cervical dilatation is 1.2cm/hr in nullipara\nArrest of dilatation is cessation of dilatation for &gt;2 hours\nArrest of descent is cessation of descent for &gt;1 hour\nPoor cervical dilatation causes prolonged active phase\nQuestion 20:\nProtracted descent in labor in a nullipara is\n&lt;1 cm /hour\n&lt;1.2 cm /hour",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_7.jpeg",
      "OBGYN_img_118.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_1",
    "question_text": "5 cm /hour\n&lt;2 cm /hour\nQuestion 21:\nA multigravida is posted for C-section due to arrest of descent in labor. It is defined as no descent for\n&gt; 0.5 hr\n&gt;1 hr\n&gt;1.5 hr\n&gt;2 hr\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_1",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_2",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_3",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_4",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_5",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_6",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_7",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_8",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_9",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_10",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_11",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_12",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_13",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_14",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_15",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_16",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_17",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_18",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_19",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_20",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch29_21",
    "question_text": "\nb\nSolution to Question 1:\nPerineal injury cannot be prevented in normal labor by routine timely episiotomy. Routine episiotomy is associated with an increased incidence of disruption of anal sphincters and rectal tears.\nIndications of episiotomy:\nShoulder dystoci\nBreech delivery\nFetal macrosomi\nOperative vaginal deliveries\nPersistent occiput posterior positions Methods of prevention of perineal laceration:\nAvoid delivery by early extension\nDeliver head in between contractions\nPerform timely episiotomy when indicated (not routine).\nSolution to Question 2:\nThe most common cause of true cephalopelvic disproportion (CPD) in India is rickets.\nThe most common cause of true CPD in developing countries is vitamin D deficiency and rickets. In developed countries, it is trauma to the pelvis. It occurs due to pelvic dystocia (larger fetus and smaller pelvis).\nRelative CPD is the most common type of CPD. It is caused due to fetal malposition\n(occipitoposterior position/brow presentation).\nSolution to Question 3:\nThe given clinical finding is suggestive of uterine tachysystole. Oxytocin administration is not beneficial here as it leads to hyperstimulation of the uterus.\nTachysystole (hypertonic uterine dysfunction):\nThe uterine contractions are uncoordinated and increased in frequency (&gt;5 contractions in 10 minutes)\nContractions occur with an increase in the baseline tone without rest in between them\nIt is associated with late active phase dysfunction i.e., when the cervix is almost 7 cm dilated\nThe most common cause is occipito-posterior position. Hence, a wait and watch policy is dopted\nIt is more common in nulliparous females\nOxytocin administration leads to hyperstimulation of the uterus and is not recommended. Hypotonic uterine dysfunction:\nUterine contractions are inadequate\nIt is associated with early active phase\nIt is more common in nulliparous females.\nSolution to Question 4:\nThe given clinical scenario is suggestive of either false labor pain or prolonged latent phase. The appropriate management is to sedate the patient and wait.\nFalse labor can be differentiated from the latent phase of labor by therapeutic rest i.e., the patient is sedated with morphine.\nAugmentation with oxytocin is done only in those patients who even after therapeutic rest continue to be in prolonged latent phase.\nThere is no indication of cesarean section unless cephalopelvic disproportion is\npresent. Amniotomy is not useful and should be avoided in patients with prolonged latent phase.\nSolution to Question 5:\nThe given clinical scenario is suggestive of uterine rupture. Maternal tachycardia is seen in this condition.\nClinical features of uterine rupture:\nMaternal tachycardi\nFetal bradycardia/absent fetal heart sounds\nHypotension\nAbdominal tenderness\nPalpable fetal parts on per abdomen examination\nBandl\u2019s ring\nBleeding per vagin\nHematuri\nCommon causes of uterine rupture are previous caesarean delivery, myomectomy, silent rupture (in previous pregnancy), excess use of oxytocin, grand multipara, uterine overdistension, obstructed labour, difficult forceps delivery, placenta percreta\nSolution to Question 6:\nThe given clinical picture is suggestive of intrauterine fetal death (IUFD). The best management for such cases at 36 weeks is waiting for spontaneous expulsion.\nForceps extraction is only necessary if spontaneous expulsion doesn't take place.\nArtificial rupture of membranes (ARM) is not done due to the risk of infections. Cesarean section is avoided as far as possible in case of fetal death.\nWaiting till term is not recommended in cases of uterine infections, disseminated intravascular coagulation, and psychological upset.\nSolution to Question 7:\nThe best time for elective delivery in patients with a history of previous stillbirth is 39 weeks, either by induction or cesarean section.\nThe recommendations for the management of subsequent pregnancy after stillbirth is as follows:\nUltrasonographic screening for fetal growth restriction after 28 weeks\nKick counts starting from 28 weeks of gestation\nAntepartum fetal surveillance starting at 32 weeks or 1-2 weeks earlier than prior stillbirth\nSupport and reassurance\nLabor induction is suitable in such cases. Cesarean delivery is done for those with contraindication to induction.\nSolution to Question 8:\nThe best management in the given clinical scenario is cesarean section.\nObstructive labor management involves administering intravenous fluids to correct dehydration, providing antibiotics to prevent infection, and promptly performing a cesarean section to relieve the obstruction. If the fetus is alive, an immediate cesarean section is typically performed.\nManagement of obstructed labor never involves a wait-and-watch approach or augmenting with oxytocin.\nClinical features of obstructed labor include maternal exhaustion, dehydration, tachycardia, tachypnea, genital sepsis, postpartum hemorrhage, and shock.\nOn P/A examination the upper uterine segment is tender and tonically contracted. The lower uterine segment is thin and stretched. A groove/depression is felt between the upper uterine segment and the lower uterine segment. This is called a Bandls ring.\nComplications of obstructed labor include rupture of the uterus and vesicovaginal fistula.\nSolution to Question 9:\nThe above partogram shows a case of obstructed labour and management is caesarean section.\nThere is a secondary arrest of dilatation for &gt;2 hours and arrest of descent for &gt;1 hour. The patient has adequate uterine contractions as shown. The amniotic fluid is stained with meconium and there is fall in fetal heart rate which indicates that the baby is in distress.\nThere is no place for wait and watch and use of oxytocin to stimulate uterine contractions in obstructed labor.\nForceps can be applied only when the cervix is fully dilated and the head is low down.\nSolution to Question 10:\nExternal anal sphincter is the structure injured in an episiotomy extended posteriorly beyond the perineal body.\nPerineal tear have been divided into four degrees:\nFirst degree- laceration is restricted to the skin of the fourchette\nSecond degree- muscles of the perineal body are torn through\nThird degree- the tear extends partially backward through the external sphincter of the anus\nFourth degree- the external anal sphincter is torn and anal mucosa is also involved\nA central tear of the perineum is when the head penetrates first through the posterior vaginal wall, then through the perineal body and appears through the skin of the perineum. It usually occurs in patients with a contracted outlet.\nSolution to Question 11:\nIn this scenario the midwife should put the pregnant women in a Trendelenburg position or in an exaggerated and elevated Sims\u2019 position with a pillow or wedge under the hip or thigh.\nCaesarean section is the recommended treatment of choice for cord prolapse. Prior to performing the procedure, several measures can be taken to alleviate cord compression. These measures involve:\nManually elevating the fetal presenting part using two fingers or the entire hand through the vagin\nPositioning the patient in steep Trendelenburg, exaggerated Sim's position, or knee-chest position\nFilling the bladder with 500\u2013700 cc or more of saline (known as the Vagos method)\nAfter the diagnosis of cord prolapse is made, it is crucial not to attempt cord replacement. Such attempts are not only ineffective but also result in the inevitable rupture of the membranes, leading to cord prolapse.\n\nSolution to Question 12:\nBandl's ring refers to pathological retraction ring. It is formed in cases of obstructed labour.\nThe upper segment of the uterus contracts and retracts vigourously in an attempt to overcome the obstruction while the lower segment dilates.\nWith each contraction there is myometrial shortening so that the actively contracting upper segment becomes progressively thicker and shorter. The passive lower segment is progressively stretched and becomes thinner.\nThe junction between the two segments stands out prominently as a pathological retraction ring.\n\nSchroeder's constriction ring is formed due to incordinate uterine action when there is localized spastic contraction of a ring of circular muscle fibres of the uterus. It is formed due to injudicious use of oxytocin and premature rupture of membranes (PROM).\n\nSolution to Question 13:\nThe most common cause of non-engagement at term in a primigravida is deflexed head followed by cephalopelvic disproportion.\nNon-engagement at the onset of active phase of labour is a risk factor for caesarean section.\nThe problems of prolonged labour are that the woman is exposed to high risk of infection, ketosis and obstructed labour while the fetus faces the danger of asphyxia and infection.\nSolution to Question 14:\nAsynclitism is not a cardinal movement during labor.\nAsynclitism refers to the position of a baby in the uterus such that the head of the baby is presenting first and is tilted to the shoulder. This causes the fetal head to no longer be in line with the birth canal.\nModerate degrees of asynclitism are the rule in normal labor. However, if severe, this condition is common reason for cephalopelvic disproportion even with an otherwise normal sized pelvis.\nAsynclitism can be of 2 types:\nWhen the sagittal suture lies anteriorly, the posterior parietal bone becomes the leading presenting part and is called posterior asynclitism.\nWhen the sagittal suture lies posteriorly, the anterior parietal bone becomes the leading presenting part and is called anterior asynclitism.\n\nSolution to Question 15:\nLatent phase is said to be prolonged in a primigravida if it lasts for more than 20 hours. Friedman defined prolonged latent phase as:\nA nullipara who has not entered the active phase by 20 hours after the onset of the latent phase\nA multipara who has not entered the active phase by 14 hours after the onset of the latent phase\nSolution to Question 16:\nThe above partogram shows secondary arrest of dilatation for &gt;2 hour, arrest of descent for\n&gt;1 hour and a fall in fetal heart rate suggestive of fetal distress.\nThese are characteristic findings of obstructed labour and management is caesarean section.\nSolution to Question 17:\nThe given clinical features suggest that the patient is in latent phase of labor. Latent phase is said to be prolonged if it is:\n&gt;20 h in nullipar\n&gt;14 h in multipar\nCauses of prolonged latent phase:\nExcessive sedation/epidural analgesi\nPoor cervical conditions (thick, uneffaced)\nFalse labour (most common cause in multipara)\nFriedman's curve is used in the diagnosis of prolonged labour. It is the sigmoid curve plotting the pattern of cervical dilatation during the latent and active phase of normal labour.\n\nManagement includes morphine administration, rest and oxytocin stimulation.\nSolution to Question 18:\nProtracted active phase dilatation in a multiparous woman is when cervical dilatation is less than",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_7.jpeg",
      "OBGYN_img_119.jpeg",
      "OBGYN_img_7.jpeg",
      "OBGYN_img_120.jpeg",
      "OBGYN_img_7.jpeg",
      "OBGYN_img_121.jpeg",
      "OBGYN_img_7.jpeg",
      "OBGYN_img_122.jpeg",
      "OBGYN_img_6.jpeg",
      "OBGYN_img_112.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch30_1",
    "question_text": "5 cm/hour.\nSolution to Question 19:\nPoor cervical dilatation causes a prolonged latent phase.\nArrest of cervical dilatation is defined as the lack of cervical dilatation for \uf0b3 2 hours during the active phase of labour.\nAccording to the Obstetric Care Consensus Committee, when cervical dilatation has reached \uf0b3 6 cm with ruptured membranes, and there is no cervical change despite 4 hours of adequate uterine contractions or 6 hours of inadequate contractions, a cesarean delivery is warranted.\nSolution to Question 20:\nThe protracted descent in labor in a nullipara is less than 1 cm/hour.\nSolution to Question 21:\nArrest of descent in labor in a multigravida is no descent for more than 1 hour.\nInduction and Augmentation of Labour\nQuestion 1:\nWhat is the technique of stimulating uterine contractions in a pregnant patient prior to the onset of spontaneous labour known as?\nAugmentatio\nInductio\nStimulatio\nTerminatio\nQuestion 2:\nWhich of the following is not a contraindication for the induction of labor?\nPelvic tumor\nHerpes infectio\nHeart disease\nHistory of lower transverse cesarean section in last three pregnancies\nQuestion 3:\nA 30-year-old G3P2 woman was admitted to the ward at 40 weeks of gestation for induction of labor. You were asked to calculate her Bishop's score. What should be the minimum score before performing this procedure?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch30_3",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch30_5",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch30_6",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch30_8",
    "question_text": "\nQuestion 4:\nDuring rounds in the postnatal ward, you notice a patient's case sheet mentioning she had uterine tachysystole following labor induction. What is the criteria for this diagnosis?\nMore than 5 contractions in a 5-min period\nMore than 5 contractions in a 10-min period\nMore than 10 contractions in a 5-min period\nMore than 10 contractions in a 10-min period\nQuestion 5:\nA primigravida was admitted to the labor room at 41 weeks of gestation for the induction of labor. What is the dose of misoprostol used for this procedure?\n25 mg",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch30_25",
    "question_text": "mcg\n50 mg",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch30_50",
    "question_text": "mcg\nQuestion 6:\nOxytocin is being given for augmentation of labour in a multigravida admitted to the labour room. Which of the following is not a mechanism of action of this drug?\nReceptor mediation through G-protein coupled receptors\nActivation of voltage mediated Ca channel\nProduction of prostaglandins\nCompetitive blocking of acetylcholine receptors\nQuestion 7:\nIn which of the following patients would you perform a controlled artificial rupture of membranes?\nG3P2 lady with absent fetal cardiac activity at 34 weeks of gestatio\nMultigravida with HIV at 36 weeks of gestatio\nG2P1 lady with AFI of 28 cm at 38 weeks of gestatio\nTerm primigravida with red, tender, vesicular lesions on her vulva\nQuestion 8:\nAn obstetrician performs the following procedure for labor induction in a patient. Which of the following is false about the reflex elicited here?\n\nOccurs due to pressure at the external os of cervix\nIt is associated with increased level of PGF2\uf0b0\nArtificial rupture of membranes initiates this reflex\nIt is an example of positive feedback mechanism\nQuestion 9:\nAll of the following are true about laminaria tents except:\nHygroscopic osmotic cervical dilator\nLeads to the release of endogenous prostaglandins\nRipening the cervix\nNo effect on Bishop's score\nQuestion 10:\nA nursing assistant posted in the obstetric care unit was asked to plot a partograph to monitor the progress of labour. Where should she start marking the cervical dilatation?\nRight of alert line\nLeft of alert line\nRight of action line\nOn the action line\nQuestion 11:\nYou are monitoring the number, duration, and intensity of uterine contractions in a",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_7.jpeg",
      "OBGYN_img_123.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch30_34",
    "question_text": "year-old G2P1 woman with a term pregnancy. How long should they last for you to classify them as moderate?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch30_20",
    "question_text": "\u2013 40 seconds\n&lt; 10 seconds",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch30_10",
    "question_text": "20 seconds\n&gt;40 seconds\nQuestion 12:\nA G2P1 woman with polyhydramnios, presents to the clinic with respiratory distress at 38 weeks of gestation. The obstetrician plans for induction of labor. What is a safe method of induction in this patient?\nHigh rupture of membranes\nProstaglandins\nAbdominal amniocentesis followed by oxytocin drip\nLow rupture of membranes\nQuestion 13:\nGiven below is the partograph of a primigravida in labor. What should be the next step in managing her condition?\n\nWait and watch\nInduction of labor by prostaglandins\nCaesarean sectio\nInduction of labor by mechanical methods\nQuestion 14:\nWhat is the half-life of oxytocin?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_8.jpeg",
      "OBGYN_img_124.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch31_1",
    "question_text": "3 mi",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch31_3",
    "question_text": "5 mi",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch32_1",
    "question_text": "2 mi",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch32_6",
    "question_text": "8 mi\nQuestion 15:\nDuring your OBG rotations, one of the senior residents asks you to induce labor in a primigravida admitted at 40 weeks of gestation. Identify the following device that you will use for the same.\n\nLippes loop\nCervidil vaginal insert\nMisoprostol vaginal insert\nMirena\nQuestion 16:\nAccording to the WHO Labour Care Guidelines, documentation of labour progress begins at a cervical dilatation of -\n3 cm\n4 cm\n6 cm\n5 cm\nQuestion 17:\nWhich of the following modifications have been made in the WHO Labour care guidelines as compared to the modified partograph",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_8.jpeg",
      "OBGYN_img_125.png"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch33_1",
    "question_text": ", 2, 4",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch33_1",
    "question_text": ", 4, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch33_2",
    "question_text": ", 4, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch34_1",
    "question_text": ", 3, 4\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch34_1",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch34_2",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch34_3",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch34_4",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch34_5",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch34_6",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch34_7",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch34_8",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch34_9",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch34_10",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch34_11",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch34_12",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch34_13",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch34_14",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch34_15",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch34_16",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch34_17",
    "question_text": "\nb\nSolution to Question 1:\nThe technique of stimulating uterine contractions prior to the onset of spontaneous labor is known as induction of labor.\nIt can be done irrespective of the rupture of membranes.\nAugmentation is the enhancement of spontaneous contractions that are considered inadequate because of failed cervical dilation and fetal descent.\nSolution to Question 2:\nHeart disease is currently not considered a contraindication for the induction of labor. Vaginal delivery is preferred in such patients.\nSolution to Question 3:\nThe minimum Bishop Score required before proceeding with induction of labour is 6.\nA Bishop score &gt;8 conveys a high likelihood of a successful induction. The latest guidelines state that a cut-off score of 6 can be used to choose between pharmacological and mechanical methods of induction.\nThis score is calculated based on the:\nstation of the fetal head\ndilation of cervix\ncervical length\nposition of cervix\nconsistency of the cervix.\nThis score is an important determinant of a successful induction.\nSolution to Question 4:\nUterine tachysystole is defined as &gt;5 contractions in a 10 min period and may occur in spontaneous or stimulated labor. It should always be qualified by the presence or absence of fetal heart rate abnormalities. Tachysystole interrupts maternal blood flow to the placenta during contractions and may lead to a reduction in fetal oxygenation. It is also associated with placental abruption.\nIt is caused by pharmacological agents used for cervical ripening and induction such as misoprostol (both oral and vaginal) and dinoprostone. Management includes stopping oxytocin infusion and terbutaline 0.25 mg SC.\nSolution to Question 5:\nMisoprostol (PGE1) is given as 25mcg 3-6 hourly vaginally or 25mcg 2 hourly orally for the induction of labor.\nIt is associated with the following side effects:\nUterine tachysystole\nMeconium stained amniotic fluid\nUterine rupture\nSolution to Question 6:\nCompetitive blocking of acetylcholine is not a mechanism of action of oxytocin. Mechanism of action of oxytocin is as follows:\nReceptor mediation through G protein-coupled receptors\nActivation of voltage-gated Ca channel leading to calcium entry\nProstaglandin production by a positive feedback mechanism. This induces production of more prostaglandins and stronger contractions.\nSolution to Question 7:\nControlled artificial rupture of membranes (ARM) is performed in a patient with amniotic fluid index (AFI) \uf0b3 25 cm. This points towards a diagnosis of polyhydramnios.\nThis is because if ARM is not done under controlled conditions in these patients, it can cause sudden decompression of the fetus. This can lead to abruption of placenta.\nContraindications to ARM:\nIntrauterine fetal death\nActive genital herpes infectio\nMaternal HIV-AIDS\nSolution to Question 8:\nStripping of membranes is being depicted in the image, which elicits the Ferguson reflex. It is also known as the fetal ejection reflex and is seen due to the pressure at the internal os of the cervix.\nIt is associated with an increase in blood levels of a prostaglandin F2\uf0b0 metabolite, also known as dinoprost. This is released due to mechanical stretching of the internal os. This enhances the uterine activity and causes release of more prostaglandins. It is an example of a positive feedback mechanism.\nSolution to Question 9:\nThe Bishop's score is rapidly improved by the use of laminaria tents.\nIt is a mechanical cervical dilator and acts by hygroscopic osmotic action, leading to slow dilatation of the cervix. The gentle dilatation by laminaria tents induces an endogenous synthesis of prostaglandins causing a softening of the cervix. This is useful in cervical ripening before induction of labour.\nSolution to Question 10:\nIn a partograph, the first marking of cervical dilatation should be made on the left of the alert line. In a normal partograph, the plotting remains on the left of the alert line.\n\nSolution to Question 11:\nModerate uterine contractions last for 20\u201340 s.\nWeak contractions last for &lt;20 s and strong contractions are &gt;40 s.\nDuring active labour, uterine contractions are 5 min apart for 1 hour, i.e., \uf0b3 12 contractions in 1 hour. This is accompanied by cervical dilatation of \uf0b33\u20135 cm.\n\nSolution to Question 12:\nAbdominal amniocentesis followed by oxytocin drip is a safe method for induction of labor in polyhydramnios.\nAbdominal amniocentesis drains a good amount of liquor (amnioreduction), after which the oxytocin infusion can be started. This will minimize the sudden decompression and reduce the risk of placental separation, cord prolapse and change in lie of the fetus.\nAlthough polyhydramnios does not constitute an absolute contraindication for the application of prostaglandins, these substances should be administered with caution. There is a marked increase in the incidence of postpartum hemorrhage and amniotic fluid embolism with their use.\nHence, amnioreduction is a preferred mode of treatment in polyhydramnios.\nSolution to Question 13:\nAs the plotting on the above partograph has crossed the action line, the next step of management is Caesarean section.\nSolution to Question 14:\nThe half-life of oxytocin is approximately 3\u20135 min. Therefore, once oxytocin infusion is stopped, its concentration in plasma rapidly falls.\nSolution to Question 15:\nThis is an image of a cervidil vaginal insert. It is used for cervical ripening and improves the Bishop's score.\nIt contains 10 mg of dinoprostone designed to release at a rate of approximately 0.3 mg/hr over 10-hours.\nSolution to Question 16:\nAccording to the WHO Labour Care Guidelines, documentation of labour progress begins at a cervical dilatation of 5cm.\nWHO Labour Care Guidelines:\nTime axis - examination findings are plotted every one hour\nAlert column- has values which if reached indicates the need for urgent medical interventio\nActive first stage - findings are plotted every hour upto 12 hours. If the first stage continues, a ew sheet is used.\nSecond stage - plotted every hour upto 3 hours\nSection 1: Preliminary informatio\nName, parity, labour onset, active labour diagnosis (date), ruptured membranes (date&amp;time),\nrisk factors\nSection 2: Supportive care\nCompanionship\nPain relief\nOral fluid\nPosture\nSection 3: Baby\nBaseline FHR\nFHR deceleratio\nAmniotic fluid\nFetal positio\nCaput\nMoulding\nSection 4: Vitals\nPulse, SBP, DBP, temperature, and urine for proteins are recorded every 4 hours\nSection 5: Labour progress\nCount the number of uterine contractions over a 10-minute period.\nAssess the duration of contractions\nCervical dilatation: starts at 5 cm and is plotted as \u02dc; it is assessed every hour. For example - if the cervical dilatation remains at 5cm for \uf0b3 6hrs, it indicates the need for urgent intervention. Similarly, the cut-offs for - 6cm is \uf0b3 5hrs; \u2122cm is \uf0b3 3hrs; 8cm is \uf0b3 2.5hrs; \u0161cm is \uf0b3 2 hrs\nDescent - plotted as O\nSection 6: Medicatio\nOxytoci\nMedicine\nIV fluids\n\u2122) Section \u2122: Shared decision making\nAssessment\nPla\n*Fetal position, vitals of the mother and cervical dilatation can be assessed at 4 hourly if the labour is progressing adequately\n*If birth is not completed by 3 hours from the start of the active second stage in nulliparous and 2 hours in multiparous women, intervention is needed\n\nSolution to Question 17:\nWHO modified partograph\nWHO Labour Care Guide\nDocumentation of labour pro gression begins at4 cmof cerv ical dilatation.\nDocumentation of labour pro gression begins at5 cmof cerv ical dilatation.\nFixed1 cm/hour \u2018alert\u2019 and \u2018ac tion\u2019lines\nTime-based cut-offsforeach c entimeterof cervical dilatatio n to guide the obstetrician to take action. For example, at 5 cm of cervical dilatation, if t here is no progress >6 hours, action needs to be taken.\nMonitoring of labour is restri cted to thefirst stageonly.\nMonitoring ofsecond stage of labouris included\nNo section on supportive car e interventions\nAddition of a section onsupp ortive careof the mother- lab our companionship, pain reli ef, oral fluid intake and postu re\nDocumentation ofstrength, d uration, and frequencyof uter ine contractions\nDocumentation ofonlythedur ation and frequency of uterin e contractions\n\n\nMalpresentations\nQuestion 1:\nA woman with gestational diabetes mellitus is admitted to the labour room. The delivery of the baby's shoulder is delayed after the delivery of the head. When is shoulder dystocia considered?\nHead to shoulder delivery time &gt;30 sec\nHead to shoulder delivery time &gt;45 sec\nHead to shoulder delivery time &gt;60 sec\nHead to shoulder delivery time &gt;120 sec\nQuestion 2:\nA 25-year-old primigravida with a history of gestational diabetes mellitus is in active labour. After delivery of the head, turtle sign was noticed. Which of the following can be used for the management of this patient?\nB, C, E, and F\nA, D, E, and F\nA, B, C, and D\nA, B, D, and F\nQuestion 3:\nThe first manoeuvre for shoulder dystocia consists of:\nForceful adduction by extension of legs on abdomen\nForceful adduction by flexion of legs on abdomen\nForceful abduction of legs by extending them on abdomen\nForceful abduction of legs by flexing them on abdomen\nQuestion 4:\nA G2P1 obese woman was diagnosed with arrest of descent during labour. Identify the following manoeuvre performed for this patient.\n\nRubin manoeuvre\nMcRoberts manoeuvre\nZavanelli manoeuvre\nWood corkscrew manoeuvre\nQuestion 5:\nWhich of these steps would you undertake for the management of a patient with shoulder dystocia along with performing the McRoberts manoeuvre?\nApply fundal pressure\nRotate posterior shoulder to \u017d0 degrees\nFlex the legs over the abdomen\nApply suprapubic pressure\nQuestion 6:\nWhat is the most common fetal malpresentation?\nOccipitoposterior\nFace presentation\nBreech presentation\nBrow presentation\nQuestion 7:\nIn which of the following conditions is Vagos method used?\nCord prolapse\nShoulder presentation\nImpacted breec\nCompound presentation\nQuestion 8:\nA pregnant woman presented to the clinic with the following fetal presentation. What is the likely diagnosis?\n\nStargazer breec\nComplete breec\nFlexed breec\nFrank breec\nQuestion 9:\nA multigravida presented to the clinic at 36 weeks of gestation. She was found to have a breech presentation clinically and on sonography. Which of the following is not an indication for cesarean section in this type of presentation?\nHyperextended fetus\nFlexed breec\nFootling breec\nSevere IUGR\nQuestion 10:\nA footling breech comes under \t type of breech presentation.\nFrank\nComplete\nFlexed\nIncomplete\nQuestion 11:\nA neonate is noted to have Klumpke's paralysis of the left arm following delivery. Which of the following is not a risk factor for the associated fetal presentation?\nPreeclampsia\nHydrocephaly\nTwins\nPlacenta previa\nQuestion 12:\nWhat is the most common cause of the following presentation?\n\nPrematurity\nHydrocephalus\nPlacenta previa\nPolyhydramnios\nQuestion 13:\nThe following procedure is planned for a pregnant woman at 3\u2022 weeks of gestation. What is an absolute contraindication for this?\n\nPlacenta previa\nSevere pre-eclampsia\nPrevious LSCS\nMultifetal gestation\nQuestion 14:\nA multiparous woman presents in labour at 38 weeks of gestation. On examination, the uterus appears asymmetrical and fundal height is less than the period of amenorrhea. On fundal grip, the fetal pole is not palpable and in pelvic grip, the lower pole of the uterus is empty. What is the likely fetal presentation?\nVertex\nShoulder\nBrow\nBreec\nQuestion 15:\nAn obstetrician is performing a breech delivery. Which of the following manoeuvres can be used for chin to pubis delivery?\nPinards manoeuvre\nZanavelli manoeuvre\nPrague manoeuvre\nLovset manoeuvre\nQuestion 16:\nWhich of the following methods is not used for delivery of the aftercoming head in breech?\nBurns-Marshall method\nMauriceau-Smellie-Veit method\nPiper's forceps\nKeilland's forceps\nQuestion 17:\nWhich of the following is not used in the management of entrapment of aftercoming head?\nDuhrssens incision\nIV nitroglycerin\nZavanelli manoeuvre\nKristellar manoeuvre\nQuestion 18:\nA woman in labour presented to the ER. A vaginal breech delivery was planned for her. What statement regarding the management is false?\nBreech identified for the first time during delivery is a contraindication for vaginal delivery\nBreech delivery is done in an hospital where a facility for emergency cesarean delivery is available\nContinous FHR monitoring is required for breech delivery during labour\nShould be done by a skilled obstetrician\nQuestion 19:\nOn doing PV examination of a woman in labour, mouth with hard alveolar margins and malar eminence is palpable. Which of the following is not a cause of this fetal presentation?\nAnencephaly\nTumour of neck of fetus\nMultiparity\nGynecoid pelvis\nQuestion 20:\nA multiparous woman was admitted to the labour room at term with complaints of draining per vaginum. On examination, the uterus corresponds to term size, presentation is cephalic and the presenting part is face. Which diameter is engaged in this type of presentation?\nMentovertical\nSubmentovertical\nOccipitofrontal\nSuboccipitofrontal\nQuestion 21:\nA G2P1 woman presented to the clinic at 40 weeks of gestation. On examination, the uterus corresponds to term size and the fetal head is mobile. What is the most common cause to be suspected here?\nTrue cephalopelvic disproportion\nOccipitoposterior\nPlacenta previa\nFull bladder of mother\nQuestion 22:\nA 34-year-old G2P1 woman in labour was admitted to the hospital at 38 weeks of gestation. On examination, the fetus was found to be in occipitoposterior position. What is the most appropriate management?\nEmergency caesarean section\nWait and watch for progress of labour\nPrepare for forceps delivery\nPrepare for ventouse delivery\nQuestion 23:\nWhat is the most common complication seen in face to pubis delivery?\nIntracranial injury\nCephalhematoma\nParaurethral tears\nComplete perineal tears\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_8.jpeg",
      "OBGYN_img_126.jpeg",
      "OBGYN_img_8.jpeg",
      "OBGYN_img_127.jpeg",
      "OBGYN_img_8.jpeg",
      "OBGYN_img_128.jpeg",
      "OBGYN_img_8.jpeg",
      "OBGYN_img_129.jpeg",
      "OBGYN_img_8.jpeg",
      "OBGYN_img_128.jpeg",
      "OBGYN_img_8.jpeg",
      "OBGYN_img_130.jpeg",
      "OBGYN_img_8.jpeg",
      "OBGYN_img_131.jpeg",
      "OBGYN_img_8.jpeg",
      "OBGYN_img_132.jpeg",
      "OBGYN_img_8.jpeg",
      "OBGYN_img_133.png"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_1",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_2",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_3",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_4",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_5",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_6",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_7",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_8",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_9",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_10",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_11",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_12",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_13",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_14",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_15",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_16",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_17",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_18",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_19",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_20",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_21",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_22",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch35_23",
    "question_text": "\nd\nSolution to Question 1:\nShoulder dystocia is defined as head to shoulder delivery time of more than 60 seconds. It occurs when either the anterior or the posterior fetal shoulder gets impacted on the maternal symphysis or on the sacral promontory respectively.\nPrelabour risk factors:\nDiabetes Mellitus\nObesity\nPostdatism and prior history\nExcessive weight gain during pregnancy Intrapartum risk factors:\nProlonged 1st and 2nd stage of labour\nInstrumental delivery\nAugmentation of labour with oxytocin\nSolution to Question 2:\nA patient with gestational diabetes and the presence of turtle sign is suggestive of shoulder dystocia. Mc Robert's manoeuvre, Wood's corkscrew manoeuvre, Gaskin's\nmanoeuvre, and Rubin's manoeuvre are all used in its management.\nShoulder dystocia occurs when either the anterior or the posterior fetal shoulder gets impacted on the maternal pelvis. Turtle sign may be seen which refers to the recoil of the fetal head against the perineum.\nManagement of labour in case of shoulder dystocia:",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch36_1",
    "question_text": "st line of management - Mc Roberts manoeuvre (flexion and abduction of thigh)",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch36_2",
    "question_text": "nd line of management - Rubin's (rotation of the easily accessible shoulder by 30-45\u00b0), Woods corkscrew manoeuvre (rotate the posterior shoulder to 180o in a cork screw fashion) ; OR Gaskin (all four's position)\nLast line of management - Zavanelli manoeuvre (head is rotated to its pre-restitution position and caesarian section is performed); OR procedures such as cleidotomy (fracture of the clavicle of the baby); symphysiotomy (divide pubic symphysis of mother)\nIn a case of bilateral shoulder dystocia, directly proceed to perform cesarean section after doing Zavanelli manoeuvre.\n\n\n\nSolution to Question 3:\nThe given clinical scenario is suggestive of shoulder dystocia. Mc Roberts manoeuvre is the first manoeuvre to be performed in shoulder dystocia. It involves flexion and abduction of\nthe maternal hips, positioning the maternal thighs on her abdomen.\nSolution to Question 4:\nThe given clinical scenario is suggestive of shoulder dystocia and the manoeuvre shown above is the McRoberts manoeuvre. This is the most effective intervention and should be the first manoeuvre to be performed in shoulder dystocia.\nMcRoberts manoeuvre:\nFlexion and abduction of the maternal hips (positioning the maternal thighs on her abdomen).\nThe pelvic rotation which occurs due to the straightening of the sacrum tends to free the impacted anterior shoulder of the baby.\nSuprapubic pressure may be used simultaneously.\nThe lateral cutaneous nerve of the thigh is the most common nerve to get injured during this manoeuvre.\nIf the first line of management fails, proceed with internal rotational manoeuvres such as Rubin's and Wood corkscrew in McRoberts position.\nRubin's manoeuvre:\nInternal rotational manoeuver used to deliver the baby in case of shoulder dystocia.\nIt involves dislodging the easily accessible shoulder towards the anterior aspect of the chest from under the pubic symphysis by 30-45\u00b0 while staying in the McRoberts' position.\nPressure is applied on the scapular aspect (posteriorly) of the shoulder.\n\nWood corkscrew manoeuvre:\nInternal rotational manoeuver used to deliver the baby in case of shoulder dystocia.\nIt involves dislodging the posterior shoulder by 180\u00b0 in a corkscrew fashion to lie beneath the pubic symphysis while staying in McRobert's position.\nPressure is applied on the clavicular aspect (anteriorly) of the shoulder.\n\nSolution to Question 5:\nApplying a gentle suprapubic pressure is the first step in the management of shoulder dystocia along with McRoberts manoeuvre. Fundal pressure is not a method of delivery in such cases.\nHernandez and Wendel suggested the use of a shoulder dystocia drill to better organize emergency management:\nCall for help and mobilize labour assistants, anaesthesia and pediatric doctors.\nAn attempt at traction is tried followed by episiotomy to afford room posteriorly.\nApply pressure suprapubically, not fundally, with the palm or fist, directing the pressure on the anterior shoulder.\nThis should be both downward (below the pubic bone) and laterally (toward the baby's face or sternum) in conjunction with the McRoberts manoeuvre.\nThese manoeuvres will resolve most cases of shoulder dystocia. If the above-listed steps fail, the following steps may be attempted, and any of the manoeuvres may be repeated:\nRubin's manoeuvre\nWoods corkscrew manoeuvre\nGaskin (all four's position)\nZavanelli manoeuvre\nCleidotomy (fracture of the clavicle of baby)\nSymphysiotomy (divide pubic symphysis of mother).\nSolution to Question 6:\nThe most common fetal malpresentation is the breech presentation.\nThe most common breech presentation in primigravida is frank breech and in multigravida, it is flexed/complete breech. It is most commonly seen with prematurity.\nIn breech presentation:\nThe most common position is left sacroanterior\nThe engaging diameter is bitrochanteric.\nCord prolapse is common in footling presentation and rare in frank breech.\nHowever, among all malpresentations, cord prolapse is most common in transverse lie.\nSolution to Question 7:\nVagos method is used in cord prolapse.\nVagos method is also known as the bladder filling method. Here, the bladder is distended with saline to push the presenting part higher up, thereby preventing compression in case of cord prolapse. The bladder is filled with 400\u2013\u202250 mL of normal saline with a Foley\u2019s catheter. Then, the balloon is inflated and the catheter is clamped.\nSolution to Question 8:\nThe given clinical scenario is suggestive of frank breech. Breech presentation can be divided into the following:\nIncomplete: Breech with extended legs, footling, knee presentation\nComplete: Breech with flexed legs\nBreech type\nDescription\nPresenting part\nFrank breech(with extended l egs)\nThighs flexed on the trunk, le gs extended at the knee joint.\nButtocks and genitalia\nFootling\nBoth thighs and legs are parti ally extended\nFoot\nKnee\nThighs extended, Knee flexed\nKnee\nComplete/flexed\nBoth thighs and legs are flexe d.\nButtocks, genitalia, foot\n\nSolution to Question 9:\nFlexed breech is not an indication for cesarean section in breech presentation. This baby can be delivered vaginally.\nFactors favouring cesarean delivery of the breech fetus:\nLarge fetus (&gt; 3800 to 4000 g)\nSevere IUGR\nFootling presentation (due to risk of cord prolapse)\nHyperextended head\nContracted pelvis\nPrevious cesarean section\nPreterm breec\nPrimi with breec\nTwins, with the first baby in the breec\nLack of surgeon experience\nPatient requests for cesarean delivery.\nSolution to Question 10:\nA footling breech is a type of incomplete breech presentation with one or more feet below the breech.\nBreech presentation can be divided into the following:\nIncomplete: Breech with extended legs, footling or knee presentation\nComplete: Breech with flexed legs\nBreech type\nDescription\nPresenting part\nFrank breech(with extended l egs)\nThighs flexed on trunk, legs e xtended at knee joint.\nButtocks and genitalia\nFootling\nBoth thighs and legs are parti ally extended\nFoot\nKnee\nThighs extended, knee flexed\nKnee\nComplete/flexed\nBoth thighs and legs are flexe d.\nButtocks, genitalia, foot\n\nSolution to Question 11:\nKlumpke's paralysis is associated with difficult breech delivery, which is due to hyperabduction of the arm during traction and delivery of the fetus. Preeclampsia is not a risk factor for breech presentation.\nRisk factors for breech presentation:\nEarly gestational age\nAbnormal amnionic fluid volume\nMultifetal gestation\nHydrocephalus\nAnencephaly\nUterine anomalies\nPlacenta previa\nFundal placental implantation\nHigh parity with uterine relaxation\nPrior breech delivery\nPrior cesarean delivery\nSmoking.\n\nSolution to Question 12:\nThe presentation depicted in the image is breech presentation. The most common cause of this presentation is prematurity.\nThe incidence of breech at term is 3%. At 28 weeks of pregnancy, 20% of women have a breech presentation. The fetus undergoes spontaneous version usually between 30 - 34 weeks thereby correcting its position by itself.\nPersistent breech occurs when this spontaneous version is prevented by any of the following causes:\nIntrauterine death of the fetus\nAnomalies such as trisomy 13, 18, 21\nAnomalies of uterus (septate/bicornuate)\nOligohydramnios and polyhydramnios\nTwins\nShort cord\nHydrocephalus\nPlacenta previa\nContracted pelvis\nRecurrent/habitual breech is when breech recurs in 3 or more pregnancies. It is usually due to uterine anomalies and cornufundal attachment of the placenta.\nSolution to Question 13:\nPlacenta previa is an absolute contraindication for external cephalic version (ECV).\nRelative contraindications for ECV:\nearly labor\noligohydramnios\nruptured membranes\nknown nuchal cord\nstructural uterine abnormalities\nfetal-growth restriction\nmultifetal gestation\nprior abruption or its risk factors\nsevere pre-eclampsia and hypertension\nprevious LSCS\n\u0161ote: In twin gestation, with a cephalic-noncephalic presentation, after the delivery of the first twin, an internal podalic version or intrapartum external cephalic version can be attempted for the second non-cephalic twin. However, ECV in this case, can lead to an increased incidence of fetal distress when compared with the internal podalic version. Hence, ECV is only a relative contraindication in twin pregnancy.\nPrevious LSCS is a relative contraindication for ECV. However, it is not attempted often and needs to be performed with caution.\nSolution to Question 14:\nThe given examination findings are suggestive of transverse lie. The likely fetal presentation is shoulder presentation.\nThe most common cause of transverse lie is prematurity. In term pregnancy, it is commonly seen in patients with placenta previa. Although the most common cause of cord prolapse is transverse lie, hand prolapse is also frequently seen in such conditions. The transverse lie is managed by the caesarean section.\nIn a twin pregnancy, management of 1st twin with a transverse lie is caesarean section whereas the 2nd twin is managed by internal podalic version.\nSolution to Question 15:\nIn a breech presentation, chin to pubis delivery can be done by Prague manoeuvre.\nRarely, the back of the fetus fails to rotate to the anterior. In such cases, rotation of the posteriorly oriented back of the fetus to the anterior may be achieved by using stronger traction on the fetal legs or bony pelvis.\nIf this still does not succeed, the fetus still may be delivered using the modified Prague manoeuvre. This consists of two fingers of one hand grasping the shoulders of the back-down fetus from below while the other hand draws the feet up and over the maternal abdomen.\nIf the back is oriented anteriorly, extraction may be accomplished using the Mauriceau manoeuvre and delivering the fetus back down.\n\nSolution to Question 16:\nDelivery of the aftercoming head in breech is not done with the help of Keilland's forceps. These forceps are used for the rotation of the fetal head. It is not used anymore.\nThe methods used for delivery of the aftercoming head include the following:\nBurns-Marshall manoeuvre: When the occiput is seen under the pubic symphysis, steady traction is given on the feet. The baby is swung in an arc towards the mother's abdomen. Simultaneous suprapubic pressure is given and the head is born by flexion.\n\nMalar flexion and shoulder traction (modified Mauriceau-Smellie-Veit technique):\nThe baby is placed on the supinated left forearm (preferred) with the limbs hanging on either side. The middle and the index fingers of the left hand are placed over the malar bones. The ring and little fingers of the pronated right hand are placed on the child\u2019s right shoulder. The index finger is placed on the left shoulder and the middle finger is placed on the suboccipital region.\nTraction is now given in a downward and backward direction till the nape of the neck is visible under the pubic arch. The assistant gives suprapubic pressure during the period to maintain flexion. The fetus is carried in an upward and forward direction toward the mother\u2019s abdomen releasing the face and brow. Lastly, the trunk is depressed to release the occiput and vertex.\n\nThe image below shows Piper's forceps, identified by its distinct perineal curve.\n\n\nSolution to Question 17:\nThe management of entrapment of aftercoming head does not involve Kristellar manoeuvre.\nKristeller manoeuvre is the application of uterine fundal pressure during the second stage of labour to shorten the second stage of labour. This should be used sparingly used as it leads to avulsion of the levator ani.\nAn incompletely dilated cervix will constrict around the neck and impede the delivery of the aftercoming head in breech.\nManagement options:\nWith gentle traction on the fetal body, the cervix may be manually slipped over the occiput.\nIf this is not successful, then D\u00fchrssen incisions may be necessary. These are a set of three incisions in the cervix:\nCan be made at the 2 and 10 o'clock position on the cervix. An additional incision at the 6 o\u2019clock position is sometimes needed.\nDone for delivery of aftercoming head in breech or delivery of head through an incompletely dilated cervix.\nThere is a significant risk of haemorrhage; the cervical incision may extend upwards within the broad ligament causing broad ligament haematoma.\n\nOther alternatives include intravenous nitroglycerin, typically 100 \uf06dg, to provide cervical relaxation. General anaesthesia with halogenated agents is another option.\nAs a last resort, the following methods are used:\nZavanelli manoeuvre: It involves the replacement of the fetal head into the pelvis followed by cesarean delivery. This is performed for the protruding head and intractable shoulder dystocia.\nSymphysiotomy: The intervening symphyseal cartilage and ligamentous supports are cut to widen the symphysis pubis. It is also used to aid the delivery of an entrapped aftercoming head.\nSolution to Question 18:\nBreech identified for the first time during delivery is not a contraindication for normal delivery. Vaginal breech delivery is considered when:\nFetal weight is between 1.5 kg and 3.5 kg\nThere is an adequate pelvis\nThe presentation is frank breec\nThe fetal head is flexed\nThere are no medical or obstetric complications\nFacilities for emergency cesarean section are available (anesthetists, neonatologists) (option B)\nFacilities for continuous labor monitoring are available (option C)\nA skilled obstetrician is present (option D)\nDetailed informed consent has been obtained, explaining the risks of vaginal breech delivery Cesarean delivery for breech presentation is considered in the following cases:\nLack of operator experience\nPatient's request for cesarean delivery\nPrior perinatal death or neonatal birth trauma\nLarge fetus: &gt; 3800 to 4000 g\nSevere IUGR, term weight &lt;2.5kg to 2.8kg\nIncomplete breech presentation\nOligohydramnios\nFetal anomaly incompatible with vaginal delivery\nHyperextended head\nContracted pelvis\nPrior cesarean delivery\nPreterm breec\nTwins, with the first baby in the breech position\nSolution to Question 19:\nThe given clinical scenario is suggestive of face presentation. Gynecoid pelvis is not a cause of this fetal presentation.\nCauses of face presentation:\nAnencephaly (most common cause)\nIntrauterine deat\nMultiparity\nPrematurity\nTwist of cord around the neck\nAnthropoid pelvis\nPlatypelloid pelvis\nTumours of neck of the fetus.\nSolution to Question 20:\nEngaging diameter in face presentation is submentovertical and submentobregmatic.\nPresentation\nEngaging diameter\nMeasure ment\nVertex (Complete flexion)\nSuboccipitobregma tic\n\u017d.5 cm\nVertex (Incomplete flexion)\nSuboccipitofrontal\n10 cm\nVertex (Marked Deflexion)\nOccipitofrontal",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_9.jpeg",
      "OBGYN_img_134.jpeg",
      "OBGYN_img_9.jpeg",
      "OBGYN_img_135.jpeg",
      "OBGYN_img_9.jpeg",
      "OBGYN_img_136.jpeg",
      "OBGYN_img_9.jpeg",
      "OBGYN_img_137.jpeg",
      "OBGYN_img_9.jpeg",
      "OBGYN_img_138.jpeg",
      "OBGYN_img_9.jpeg",
      "OBGYN_img_139.jpeg",
      "OBGYN_img_9.jpeg",
      "OBGYN_img_140.jpeg",
      "OBGYN_img_9.jpeg",
      "OBGYN_img_141.jpeg",
      "OBGYN_img_9.jpeg",
      "OBGYN_img_142.jpeg",
      "OBGYN_img_9.jpeg",
      "OBGYN_img_143.jpeg",
      "OBGYN_img_10.jpeg",
      "OBGYN_img_144.jpeg",
      "OBGYN_img_10.jpeg",
      "OBGYN_img_145.jpeg",
      "OBGYN_img_10.jpeg",
      "OBGYN_img_146.jpeg",
      "OBGYN_img_10.jpeg",
      "OBGYN_img_147.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch36_11",
    "question_text": "5 cm\nFace ( Incomplete extension)\nSubmentovertical",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch36_11",
    "question_text": "5 cm\nFace\nSubmentobregmati c\n\u017d.5 cm\nBrow\nMentovertical\n14 cm\n\nSolution to Question 21:\nOccipitoposterior position (OP) is the most common cause of a mobile head at term.\nIt is the most common fetal malposition. It is an abnormal position seen in the vertex presentation, not an abnormal presentation.\nOccipitoposterior position is commonly seen in android pelvis/deflexed head.\nThe engaging diameter of this position is sub-occipitofrontal/occipitofrontal.\nThe most common type in occipitoposterior position is right OP.\nA persistent occipitoposterior position results from a failure of internal rotation prior to birth.\nCephalopelvic disproportion (CPD) is a disproportion in the size of the fetus relative to the maternal pelvis. This can result in the failure of progress of labour in the second stage. This usually occurs due to fetal malposition e.g., extended or asynclitic fetal head, occipitoposterior or transverse position. It is also seen in malpresentations like mentum posterior, brow.\nThe diagnosis of CPD is subjective. However, true CPD may occur if the fetus has a large anomaly e.g., teratoma or conjoined twin, or in cases of a large fetus. It can also occur when the maternal pelvis is small or deformed like after pelvic trauma.\nSolution to Question 22:\nThe most appropriate management for pregnant women in labour whose fetus is in occipitoposterior position is to wait and watch for progress of labour. In a majority of cases, the occiput rotates through 3/8th of the circle and the baby is born as occipitoanterior.\nHence, when the diagnosis of occipitoposterior is made, labour is allowed to proceed normally when there are good uterine contractions and favourable pelvis.\nIndications of caesarean section in occipitoposterior position:\nArrest of labour\nInadequate uterine contraction\nFetal distress\nOther obstetrical indications.\nSolution to Question 23:\nThe most common complication seen in face to pubis delivery is complete perineal tears.\nIn face to pubis delivery, the occiput is posterior, and therefore, the largest biparietal diameter (\u017d.4 cm) distends the perineum rather than the smaller bitemporal diameter (8 cm). A liberal episiotomy helps to avoid perineal tears.\nOperative Vaginal Delivery\nQuestion 1:\nA forceps delivery is being planned for a patient with prolonged second stage of labour. Which of the following is not a prerequisite for this procedure?\nBladder should be empty\nNo suspicion of cephalopelvic disproportion\nWell engaged hea\nPartially dilated cervix\nQuestion 2:\nAll of the following are criteria for the use of the following instrument except:\n\nFetal skull has reached pelvic floor\nFetal head is on the perineum\nScalp is visible at the introitus without separating the labia\nRotation of fetal head is more than 45 degrees\nQuestion 3:\nWhich of the following is true about instrumental vaginal delivery?\nFull cervical dilatation is the only prerequisite\nForceps can be used for delivery of the after-coming head of breech\nVentouse cannot be used in rotational occipitotransverse/ posterior delivery\nEngaged head is not a prerequisite\nQuestion 4:\nA 25-year-old woman at 35 weeks of gestation is wheeled into the labour room following the onset of labor. A forceps delivery is planned for her. Which of the following is not a contraindication for this?\nFetal haemophilia\nMentoposterior face presentation\nIncompletely dilated cervix\nPreterm labor\nQuestion 5:\nWhat is the given device used for?\n\nVaginal delivery\nSuction and evacuation\nContinuous fetal monitoring\nFetal scalp pH monitoring\nQuestion 6:\nA 28-year-old G2P1 woman with a history of mitral valve prolapse was planned for ventouse delivery. Which statement is true regarding the mode of delivery planned for this patient?\nMinor scalp abrasions and subgaleal hematomas in newborns are frequently seen\nIt can be applied when fetal head is above the level of ischial spine\nMaternal trauma is seen more frequently when compared to forceps\nIt cannot be used when fetal head is not fully rotate\nQuestion 7:\nContraindications of ventouse include all except:\nPreterm delivery\nDeep transverse arrest\nFace presentation\nFetal coagulopathy\nQuestion 8:\nYou are an intern posted in the labor room assisting the delivery of a primigravida in labor. The obstetrician planned for a ventouse delivery because of maternal exhaustion. She asked you to help place the ventouse cup. Where would you place it?\nOn the sagittal suture 3 cm in front of posterior fontanelle\nOn the sagittal suture 3 cm behind of anterior fontanelle\nOn the posterior fontanelle\nOn the coronal suture 6 cm away from anterior fontanelle\nQuestion 9:\nA 24-year-old term primigravida was brought to the hospital in labor. Prophylactic ventouse was used due to ineffective expulsive efforts by the mother. What is the maximum negative pressure used in this procedure?\n1 kg/ sq. cm",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_10.jpeg",
      "OBGYN_img_148.jpeg",
      "OBGYN_img_10.jpeg",
      "OBGYN_img_149.png",
      "OBGYN_img_10.jpeg",
      "OBGYN_img_150.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch36_0",
    "question_text": "9 kg/ sq. cm",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch36_0",
    "question_text": "8 kg/ sq. cm",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch36_0",
    "question_text": "6 kg/ sq. cm\nQuestion 10:\nA prophylactic ventouse was planned for an anaemic pregnant woman. Delivery through this mode should occur within\t.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch36_4",
    "question_text": "pulls over 30 min",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch36_4",
    "question_text": "pulls over 15-20 min",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch36_5",
    "question_text": "pulls over 15- 20 min",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch36_3",
    "question_text": "pulls over 15-20 min\nQuestion 11:\nA 24-year-old primigravida delivered a full-term male baby by assisted forceps delivery. What is not an advantage of this mode of delivery?\nNo maternal effort is neede\nQuick in case of fetal distress\nCan be used in preterm\nPromotes autorotation\nQuestion 12:\nWhat is the advantage of ventouse over forceps?\nLess expertise require\nDelivery failure is less\nCan be used in preterm hea\nNo maternal effort is neede\nQuestion 13:\nDuring a routine check-up of a multigravida at 32 weeks of gestation, the fetus was found to be in breech presentation. The obstetrician planned to do an external cephalic version. What is the ideal time to do this procedure?\nIn labour\nAt 39 weeks\nAt 37 weeks\nAt 34 weeks\nQuestion 14:\nA 25-year-old multigravida at 36 weeks presents for routine ANC. On examination, a hard, ballotable structure is felt at the fundus. NST is reactive. The obstetrician performs the following procedure on her. When will this procedure be contraindicated?\n\nIntra-uterine growth restriction\nFlexed breech\nMultiparity\nUnengaged fetus\nQuestion 15:\nAt which angle would you perform a mediolateral episiotomy in a primigravida?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_8.jpeg",
      "OBGYN_img_133.png"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch36_15",
    "question_text": "degrees",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch36_45",
    "question_text": "degrees",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch36_60",
    "question_text": "degrees",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch36_30",
    "question_text": "degrees\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch37_1",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch37_2",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch37_3",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch37_4",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch37_5",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch37_6",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch37_7",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch37_8",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch37_9",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch37_10",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch37_11",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch37_12",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch37_13",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch37_14",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch37_15",
    "question_text": "\nc\nSolution to Question 1:\nCompletely dilated cervix is a prerequisite for forceps delivery. Prerequisites for forceps delivery:\nExperienced operator\nEngaged hea\nRuptured membranes\nVertex presentation\nCompletely dilated cervix\nPrecisely assessed fetal head position\nCephalopelvic disproportion not suspecte\nAbsent fetal coagulopathy or bone demineralization disorder\nBefore operative vaginal delivery, the bladder should be emptied to provide additional pelvic space and minimize bladder trauma.\nSolution to Question 2:\nThe image shows Wrigley's forceps, which is a type of outlet forceps. Rotation of the fetal head should not exceed 45 degrees for the application of outlet forceps. This is because it increases the risk of vaginal wall lacerations.\nSolution to Question 3:\nForceps can be used for delivery of the aftercoming head of breech. The advantages are as follows:\nDelivery can be controlled by giving pull directly on the head and the force is not transmitte through the neck.\nFlexion is better maintained.\nMucus can be sucked out from the mouth more effectively. Prerequisites for instrumental vaginal delivery:\nRuptured membranes vertex presentation\nCephalopelvic disproportion not suspecte\nNo fetal coagulopathy or bone demineralization disorder\nCompletely dilated cervix\nPrecisely assessed fetal head position\nEngaged hea\nExperienced operator\nNote: Ventouse can be used for occipitotranverse or posterior position.\nSolution to Question 4:\nForceps can be used to deliver a preterm baby where it is believed to form a protective cage. Vacuum is contraindicated in these cases.\nContraindications of forceps delivery:\nUnengaged hea\nCephalopelvic disproportion\nMalpresentations like brow and face (mentoposterior position)\nCervix not completely dilate\nInability to define position\nFetal coagulopathy or osteogenesis imperfecta\nNote: Forceps delivery is only reserved for mentoanterior position.\nSolution to Question 5:\nThe image shown is a vacuum delivery system. It is used for vacuum-assisted vaginal delivery of the fetus.\nTheoretical advantages of ventouse (vacuum extraction) compared to forceps include:\nSimpler requirements for positioning of the fetal hea\nAvoidance of space occupying blades within the vagina\nLower maternal trauma rates\nSolution to Question 6:\nMinor scalp abrasions and subgaleal hematomas in newborns are more frequently seen with ventouse delivery than with forceps delivery.\nMaternal morbidity is seen more with forceps deliveries and perinatal morbidity is seen more with vacuum deliveries.\nMaternal morbidity seen in operative vaginal deliveries include:\nIncreased third and fourth-degree vaginal lacerations\nPelvic floor disorders\nPostpartum hemorrhage\nPerinatal morbidity seen in operative vaginal deliveries include:\nVacuum-assisted perinatal injuries: Cephalohematoma, subgaleal hemorrhage, retinal hemorrhage, neonatal jaundice secondary to these hemorrhages, shoulder dystocia, clavicular fracture, intracranial hemorrhage, and scalp lacerations.\nForceps-assisted perinatal injuries: Higher rates of facial nerve injury, brachial plexus injury, epressed skull fracture, and corneal abrasion.\nIn cardiac patients, vaginal delivery is preferred. It is conducted with the laboring woman in an upright or left decubitus position. Prophylactic use of vacuum is done to cut short the second stage of labor. This is to minimize aortocaval compression. Caesarean section is not preferred since it is associated with more blood loss and higher thromboembolic and infection risk.\nSolution to Question 7:\nDeep transverse arrest is an indication for ventouse delivery.\nIn ventouse delivery technique, suction is created within a cup placed on the fetal scalp such that traction on the cup aids fetal expulsion. The important step in ventouse extraction is proper cup placement over the flexion point.\nThe vacuum is gradually created by increasing the suction in increments of 0.2 kg/cm2 every 2 minutes until a total negative pressure of 0.8 kg/cm2 is reached. Progressive descent should accompany each traction attempt.\nSolution to Question 8:\nAn important step in vacuum extraction is proper cup placement over the flexion point. It is a point on the sagittal suture that lies 3 cm in front of the posterior fontanelle.\nAdvantages of correct positioning of cup in vacuum extraction:\nMaximum traction\nMinimum cup detachment\nTwisting of fetal head is avoide\nSmallest head diameter is delivered through the pelvic outlet\nSuccess rate is improve\nFetal scalp injury rates are lowere\nPerineal trauma is reduced because the smallest fetal head diameter distends the vulva\n\nSolution to Question 9:\nThe maximum negative pressure used in ventouse is 0.8 kg/cm2\nGradual vacuum creation is recommended. This is generated by increasing the suction in increments of 0.2 kg/cm2 every 2 minutes. This is done until a total negative pressure of 0.8 kg/cm2 is reached.\nThis slow incremental approach would allow for a more firm attachment of the vacuum cup to the fetal head and thereby a lower failure rate.\nSolution to Question 10:\nDelivery with ventouse should occur within 3 pulls over 15-20 min.\nSolution to Question 11:\nAutorotation is seen with vacuum extraction and not assisted forceps delivery. Advantages of ventouse over forceps:\nNo need of anaesthesia\nLess expertise require\nLess maternal injuries\nPromotes autorotation\nDoes not occupy the sides\nLess traction force neede Advantages of forceps over ventouse:\nNo maternal effort is neede\nQuick in case of fetal distress\nCan be used in face and breech\nCan be used in preterm\nLess cephalohematoma\nDelivery failure is less\nSolution to Question 12:\nThe advantage of ventouse over forceps is that less expertise is required in this technique. Advantages of ventouse over forceps:\nNo need of anaesthesia\nLess expertise require\nLess maternal injuries\nPromotes autorotation\nDoes not occupy the sides\nLess traction force neede Advantages of forceps over ventouse:\nNo maternal effort is neede\nQuick in case of fetal distress\nCan be used in face and breech\nCan be used in preterm\nLess cephalohematoma\nDelivery failure is less\nSolution to Question 13:\nThe ideal time to do external cephalic version is 37 weeks. This procedure is attempted in a woman who has completed 36 weeks of gestation and has a breech fetal presentation.\nBefore 37 weeks, a breech presentation has a high likelihood of correcting spontaneously. Moreover, if performed too early, there is time to return back to breech.\nAfter 37 weeks, the success rates of ECV are very low. Although it can be performed until the early stages of labour, it is not recommended.\nSolution to Question 14:\nThe procedure shown here is external cephalic version. A relative contraindication for this procedure is intra-uterine growth restriction.\nSolution to Question 15:\nThe mediolateral episiotomy is directed at an angle of 60 degrees.\nThe mediolateral episiotomy incision starts in the midline at the fourchette and is directed at an angle 60 degrees from the midline. This 60-degree angle takes into consideration a distortion of perineal anatomy during crowning and ultimately yields an incision that is 45 degrees from the midline following delivery.\nCaesarean Section and Vaginal Birth After Caesarean (VBAC)\nQuestion 1:\nWhen should an elective caesarean section ideally be performed?\nAfter 37 weeks\nAfter 38 weeks\nAfter 40 weeks\nAfter 39 weeks\nQuestion 2:\nA 28-year-old pregnant woman is set to undergo an elective LSCS 2 days later. What is the ideal time to administer antibiotics to this patient?",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_10.jpeg",
      "OBGYN_img_151.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch37_24",
    "question_text": "hours before surgery",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch37_6",
    "question_text": "hours before surgery\nAfter cord clamping",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch37_30",
    "question_text": "60 min before surgery\nQuestion 3:\nThe partogram of a 26-year-old G2P1 woman is shown below. What is the prophylactic antibiotic of choice for this patient before definitive management is done?\n\nAzithromycin\nCefazolin\nDoxycycline\nCiprofloxacin\nQuestion 4:\nYou are asked to administer antibiotic prophylaxis against infective endocarditis to a patient posted for elective LSCS. What condition does the patient likely have?\nAtrial septal defect\nProsthetic valves\nVentricular septal defect\nPatent ductus arteriosus\nQuestion 5:\nA 25-year-old obese pregnant woman is scheduled for caesarean section. While going through her file, you find that she is allergic to penicillin. What is/are the antibiotic(s) you would prescribe for her?\nClindamycin 600 mg alone\nClindamycin 900 mg plus an aminoglycoside\nClindamycin 900 mg alone\nClindamycin 600 mg plus an aminoglycoside\nQuestion 6:\nA woman with preeclampsia presents with haemorrhage at 38 weeks of gestation. You decide to perform a caesarean section and terminate the pregnancy. What is the anaesthesia of choice?\nCombined spinal epidural anaesthesia\nSingle shot spinal anesthesia\nGeneral anaesthesia\nEpidural anesthesia\nQuestion 7:\nAn elective cesarean section is being performed in a primigravida due to suspected cephalopelvic disproportion. In which of the following abdominal incisions are the recti muscles transected?\n",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_7.jpeg",
      "OBGYN_img_118.jpeg",
      "OBGYN_img_10.jpeg",
      "OBGYN_img_152.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch37_4",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch37_3",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch38_1",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch38_2",
    "question_text": "\nQuestion 8:\nAll of the following are benefits of using a transverse abdominal incision for caesarean delivery in a patient except\t.\nWide operating space\nLow fascial wound dehiscence\nDecreased postoperative pain\nLow risk of incisional hernia\nQuestion 9:\nAn elective C-section is being performed in a primigravida due to suspected contracted pelvis. After opening the abdomen through a modified Pfannenstiel incision, the obstetrician makes a low transverse uterine incision. How should this incision be extended?\nBy applying lateral and slightly upward pressure with each index finger\nBy applying lateral and slightly downward pressure with each index finger\nBy applying lateral and slightly upward pressure with each thumb\nBy applying lateral and slightly downward pressure with each thumb\nQuestion 10:\nThe highest risk of uterine rupture is seen with\t.\nMultiple low-transverse incisions\nT-shaped incision\nLow-vertical incision\nSingle low-transverse incision\nQuestion 11:\nAn obstetrician performing a C-section exteriorises the uterus before performing uterine repair. All of the following are true about this procedure except\t.\nIncision and bleeding points are easily visualized and repaire\nRelaxed/atonic uterus can be recognized quickly and massage applie\nVomiting and discomfort is caused by traction due to exteriorization\nAdnexal exposure is low so tubal sterilization is difficult\nQuestion 12:\nWhich of the following is not an indication for peripartum hysterectomy?\nUterine atony\nCervical cancer\nUterine rupture\nCervical laceration\nQuestion 13:\nWhat is the most common fetal injury associated with caesarean section?\nSkull fracture\nCephalohematoma\nSkin laceration\nClavicular fracture\nQuestion 14:\nAn elective caesarean section is planned for a pregnant woman with a cardiac ailment. Which of the following complications is she not at an increased risk for?\nThromboembolism\nChorioamnionitis\nMendelson syndrome\nHaemorrhage\nQuestion 15:\nWhich of the following statements is true regarding the instrument shown below?\n\nA and B\nB and C\nA and C\nOnly C\nQuestion 16:\nThe risk factors for venous thromboembolism after caesarean section include all except\t.\nPreeclampsia\nObesity\nParity &gt; 3\nAge &lt; 35 years\nQuestion 17:\nA 28-year-old multigravida with a history of C-section is being considered for vaginal delivery. The presence of which of the following features would categorise this procedure as low risk?\nTransverse incision in prior caesarean\nBreech presentation\nPreeclampsia\nClassical incision in prior caesarean\nQuestion 18:\nA trial of scar is performed on a G2P1L1 woman. The risk of which of the following complications is increased in this baby when compared to their elder sibling?\nBirth trauma\nHypoxic ischemic encephalopathy\nTransient tachypnea of new born\nNeonatal sepsis\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_10.jpeg",
      "OBGYN_img_153.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch39_1",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch39_2",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch39_3",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch39_4",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch39_5",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch39_6",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch39_7",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch39_8",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch39_9",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch39_10",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch39_11",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch39_12",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch39_13",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch39_14",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch39_15",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch39_16",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch39_17",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch39_18",
    "question_text": "\nb\nSolution to Question 1:\nAn elective caesarean section should ideally be performed after 39 weeks. It is not done before 39 weeks of gestation as there is an increased risk of:\nComplications related to prematurity including respiratory problems\nNeonatal adaptation problems such as hypothermia and hypoglycemia\nSolution to Question 2:\nAccording to ACOG guidelines, the ideal time to administer antibiotics is within a time period of 60 mins prior to the planned caesarean section.\nAntimicrobial administration before surgical incision has been shown to lower postoperative infection rates without adverse neonatal effects, as compared with drug administration after umbilical cord clamping. A 1 g dose of cefazolin is an efficacious and cost-effective choice.\nFor emergency delivery, antibiotic prophylaxis should be given as soon as possible.\nSolution to Question 3:\nThe above partogram is suggestive of obstructed labour and the definitive management in this case is caesarean section. Cefazolin is an efficacious and cost-effective choice for antibiotic prophylaxis before caesarean section.\nAccording to the partogram, there is a secondary arrest of dilatation for &gt;2 hours and arrest of descent for &gt;1 hour. The amniotic fluid is stained with meconium and there is fall in fetal heart rate indicating fetal distress. Hence, the management plan is to perform a caesarean section.\nThe recommended prophylactic drug is a single intravenous dose of a \uf062-lactam antimicrobial. This could either be a cephalosporin or an extended-spectrum penicillin derivative. A 1 g dose of cefazolin is usually given. For obese women, a 2 g dose is better to provide an adequate coverage.\nSolution to Question 4:\nAntibiotic prophylaxis against infective endocarditis before surgical procedures is recommended in patients with prosthetic valves, prior history of endocarditis, and unrepaired cyanotic heart diseases.\nPregnant women at the highest risk for endocarditis are those with cyanotic cardiac disease, prosthetic valves, or both. However, endocarditis prophylaxis is not required if the patient is already receiving intrapartum prophylaxis with broad-spectrum antibiotics to prevent endometritis.\nAntibiotic prophylaxis is not recommended for atrial septal defect (ASD). The risk of endocarditis with ASD is negligible. Bacterial endocarditis is associated with unrepaired ventricular septal\ndefects where antibiotic prophylaxis is recommended. Similarly, prophylaxis for bacterial endocarditis is indicated at delivery for unrepaired patent ductus arteriosus.\nSolution to Question 5:\nIn an obese pregnant woman who is allergic to penicillin, a dose of 900 mg clindamycin with an aminoglycoside is used for antibiotic prophylaxis.\nIn women with significant penicillin or cephalosporin allergy, a single 600 mg intravenous dose of clindamycin combined with a weight-based dose of aminoglycoside is recommended. For obese women, a 900 mg dose is preferred.\nSolution to Question 6:\nGeneral anaesthesia is the anaesthesia of choice here since the patient presents with haemorrhage.\nGeneral anaesthesia may be indicated for emergency cesarean delivery in patients with a reassuring airway examination. It is also recommended for patients with severe coagulopathy where neuraxial anesthesia is contraindicated.\nSpinal anesthesia is not preferred when the operation is expected to result in blood loss or in a previously haemorrhaging patient. It is because in such cases the development of severe hypovolemia is likely which is a contraindication for this type of anaesthesia.\nSolution to Question 7:\nThe recti muscles are transected in the Maylard incision for caesarean delivery which is marked as\n'2' in the given image.\nIt is a variation of the Pfannenstiel incision in which the rectus abdominis muscles are sectioned transversely to permit wider access to the pelvis. It is also known as the Mackenrodt incision.\nThe various incisions mentioned in the image are:\nIncision '1' - Midline vertical incision is made in the middle extending from just below the umbilicus to just above the symphysis pubis. This is used less commonly compared to the transverse abdominal incision.\nIncision '3' - Joel Cohen is a straight incision higher than the Pfannenstiel incision. The fascia was incised transversely in the midline then extended laterally with blunt finger dissection; finger dissection was used to separate the rectus muscles vertically and laterally.\nIncision '4' - Pfannenstiel incision is the most common incision made in caesarean delivery. It follows Langer lines of skin tension. A transverse and slightly curvilinear incision is made in the skin and subcutaneous tissue 3 cm above the superior border of the pubic symphysis.\nThis is stretched laterally for 12-15 cm to accommodate the delivery of the fetus. Following this, the rectus sheath is incised transversely and rectus muscles are separated in the middle to gain entry to the peritoneum.\n\nSolution to Question 8:\nTransverse abdominal incisions offer a narrow operating space.\nSolution to Question 9:\nIn a C-section, the incision on the uterus can be extended by using lateral and slightly upward pressure applied with each index finger.\nIf the lower uterine segment is thick, then cutting laterally and then slightly upward with bandage scissors will extend the incision.\nNote: When scissors are used, the index and middle fingers of the non-dominant hand should be insinuated between the myometrium and the fetal parts to prevent fetal laceration.\nSolution to Question 10:\nA T-shaped incision has the highest risk of uterine rupture among the given options. Among all the incisions, a previous classical cesarean incision has the highest risk of rupture but it is not an option here.\nOverall, the maximum risk of uterine rupture is in patients who have had a previous upper segment uterine rupture. Women with single prior low-transverse hysterotomy have the lowest risk of symptomatic scar separation.\nSolution to Question 11:\nAdnexal exposure is high and hence tubal sterilization is easy.\nAfter delivery of the placenta, the uterus is lifted through the incision onto the draped abdominal wall. The fundus is covered with a moistened laparotomy sponge and this is known as exteriorisation of uterus.\nBenefits of exteriorization:\nRelaxed, atonic uterus can be recognized quickly and massage applied.\nThe incision and bleeding points are more easily visualized and repaired.\nAdnexal exposure is superior, and thus, tubal sterilization is easier. Drawbacks of exteriorization:\nIntraoperative nausea and vomiting\nNeed for additional uterotonics\nLonger time duration to the first recognized bowel movement The below image shows the exteriorisation of the uterus.\n\nSolution to Question 12:\nCervical cancer is not an indication for peripartum hysterectomy. Indications for peripartum hysterectomy include:\nUterine atony - when every other method fails to control PPH\nUterine extension\nUterine rupture\nPostpartum uterine infection\nCervical laceration\nLeiomyoma - large leiomyomas in a woman with completed family\nOvarian neoplasia\nSolution to Question 13:\nSkin laceration is the most common fetal injury associated with caesarean section. Other injuries seen include:\nCephalohematoma\nBrachial plexus injury\nClavicular fracture\nSkull fracture\nFacial nerve palsy\nSolution to Question 14:\nElective caesarean section decreases the risk of chorioamnionitis.\nMaternal complications increase with caesarean section when compared with vaginal deliveries. Some of these complications include:\nPost-operative infection\nHaemorrhage\nThromboembolism\nAnaesthesia-related complications\nMendelson syndrome/ aspiration pneumonitis\nSolution to Question 15:\nThe given image shows a pneumatic compression device. It is used in women who are not on any thromboprophylaxis and planned for cesarean section (statement A) and it is discontinued once the patient starts ambulating post-surgery (statement C).\nThe device is used because pregnancy and surgery increase the risk of thromboembolism.\nAccording to recent guidelines, patients with no additional risk factors and not placed on any pharmacological thromboprophylaxis are placed on pneumatic compression devices before\ncesarean delivery. Patients undergoing cesarean delivery with additional risk factors are put on both pneumatic compression devices and pharmacological therapy (UFH or LMWH).\nUFH-unfractionated heparin, LMWH-lower molecular weight heparin. Indications of pharmacological thromboprophylaxis:\nInherited coagulation disorder\nOverweight or obese patient\nHeart failure\nFamily history of deep vein thrombosis or pulmonary embolism\nSolution to Question 16:\nAge &gt;35 years is a risk factor for venous thromboembolism after caesarean section. The other risk factors include:\nEmergency cesarean\nObesity\nParity &gt;3\nCaesarean hysterectomy\nConcurrent infection\nPreeclampsia\nPrior deep-vein thrombosis or thrombophilia\nSolution to Question 17:\nTransverse incision in prior caesarean section is a low risk factor in vaginal birth after cesarean\n(VBAC).\nRisk factors for VBAC:\nHigh risk -\nClassical or T-incision in prior cesarean\nPrior rupture\nObstetrical contraindication such as placenta previa\nInadequate facilities Low risk -\nTransverse incision in prior cesarean\nPrior vaginal delivery\nSufficient personnel and equipment\nSolution to Question 18:\nHypoxic ischemic encephalopathy (HIE) in neonates has a higher incidence with trial of scar or VBAC as compared to elective cesarean.\nUterine rupture is a dangerous complication of VBAC. This leads to hemorrhage which can cause the baby to be hypoxic eventually leading to permanent brain damage from hypoxic-ischemic encephalopathy. This results in developmental delay and cerebral palsy.\nBirth trauma, transient tachypnea of newborn (TTN) and neonatal sepsis are more commonly seen with elective caesarean in comparison to VBAC.\nPuerperium\nQuestion 1:\nWhen does puerperium begin?\nSoon after delivery of fetus\nSoon after expulsion of placenta\nAfter the fourth stage of labour",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_11.jpeg",
      "OBGYN_img_154.jpeg",
      "OBGYN_img_11.jpeg",
      "OBGYN_img_155.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch39_24",
    "question_text": "hours after child birth\nQuestion 2:\nHow long does early puerperium last?\nUp to 24 hrs after delivery\nUp to 48 hrs after delivery\nUp to 72 hrs after delivery\nUp to 1 week after delivery\nQuestion 3:\nWhat is the weight of the uterus immediately after delivery?\n300 g\n100 g\n1000 g\n500 g\nQuestion 4:\nWhich of the following is true regarding puerperium?\nThe number of muscle fibres decrease\nThe myometrial cell size decreases\nThe uterus weighs 1000g by 1 week postpartum\nThere is decreased activity of uterine collagenase\nQuestion 5:\nAfter how many weeks of postpartum will the uterus becomes a pelvic organ?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch40_1",
    "question_text": "week",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch40_2",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch40_4",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch40_6",
    "question_text": "weeks\nQuestion 6:\nWhen does the uterus return to pregravid size sonographically?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch40_2",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch40_4",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch40_6",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch40_8",
    "question_text": "weeks\nQuestion 7:\nExternal os reverts back to the pre-pregnant state by how many weeks?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch40_4",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch40_6",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch40_12",
    "question_text": "weeks\nNever returns\nQuestion 8:\nEndometrial regeneration following delivery starts by which day?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch40_5",
    "question_text": "th day",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch40_6",
    "question_text": "th day",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch40_7",
    "question_text": "th day",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch40_10",
    "question_text": "th day\nQuestion 9:\nA 34-year-old woman has just delivered a boy by spontaneous vaginal delivery. How often should her BP be recorded for the next 2 hours?\nEvery 5 minutes\nEvery 15 minutes\nEvery 30 minutes\nEvery 1 hour\nQuestion 10:\nA woman on post-natal day 1 presented with abdominal pain which worsens when she is breastfeeding. What is this known as?\nAfter-labour\nInvolutional pain\nUterine colic\nAfterpains\nQuestion 11:\nWhat would be the average duration of lochial discharge in a puerperal woman?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch40_5",
    "question_text": "15 days",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch40_10",
    "question_text": "20 days",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch40_24",
    "question_text": "36 days",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch40_36",
    "question_text": "42 days\nQuestion 12:\nWhat is the contribution of postpartum diuresis to weight loss?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch41_1",
    "question_text": "2 kg",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch41_2",
    "question_text": "3 kg",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch41_3",
    "question_text": "4 kg",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch41_4",
    "question_text": "5 kg\nQuestion 13:\nWhat is the single most important galactopoetic hormone in post-natal women?\nOxytocin\nProlactin\nEstrogen\nProgesterone\nQuestion 14:\nA woman presents with numbness and paraesthesia along the anterolateral thigh two days after vaginal delivery. Which nerve is likely involved in this condition?\nFemoral nerve\nIliohypogastric nerve\nIlioinguinal nerve\nLateral femoral cutaneous nerve\nQuestion 15:\nWhich among the following is the most common presentation of postpartum nerve injury?\nFacial palsy\nWrist drop\nFoot drop\nClaw hand\nQuestion 16:\nPuerperal fever is defined as a temperature of \t.\n\uf0b3 37 .2 \u00b0C\n\uf0b3 37.5 \u00b0C\n\uf0b3 38 \u00b0C\n\uf0b3 38. 5 \u00b0C\nQuestion 17:\nA 30-year-old woman presents with high-grade fever and foul-smelling lochia 2 days after vaginal delivery. Lower abdominal tenderness is elicited on examination. Her WBC count is 25,000/ microlitre. Which is the commonest route for the spread of her likely condition?\nLymphatic\nDirect invasion\nHematogenous\nAerosol\nQuestion 18:\nWhat is the first line of treatment of mastitis in a lactating mother?\nDicloxacillin\nCefazolin\nCeftriaxone\nAmpicillin\nQuestion 19:\nA nursing mother in her third week postpartum presents with breast pain and difficulty in breastfeeding. On examination, warmth and tenderness over the left breast are noted. Her temperature is 38.3 \u00b0C and her WBC count is 13,000/mm3. Which of the following is false regarding this condition?\n\nMost common etiological agent is streptococcus\nImmediate source of infection is the infant's nose and throat\nComplication includes toxic shock syndrome\nIncidence is less than 1 %\nQuestion 20:\nA mother started to feel sad and tearful over the first two weeks following childbirth. She felt overwhelmed by the responsibilities of nursing her baby and changing diapers in the middle of the night. She felt that she was a failure as a mother. What is false regarding this condition?\nIt is observed 4-5 days after delivery\nLowered tryptophan levels have been noticed\nNearly 50% of women suffer from this problem\nAntidepressants are the treatment of choice\nQuestion 21:\nA lady was discharged after a normal vaginal delivery. On the third day, she came back with fever, tachycardia, and seizures. Fundus showed papilledema with no focal deficits. What is the most probable diagnosis?\nSubarachnoid haemorrhage\nMeningitis\nAcute migraine\nCortical vein thrombosis\nQuestion 22:\nA mother, previously on OCPs, comes with her 2-week-old baby to the OPD. She informs you that she is currently breastfeeding her child and enquires about re-starting contraception.\nWhen would you recommend she start using contraceptives?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_11.jpeg",
      "OBGYN_img_156.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch41_3",
    "question_text": "rd postpartum week",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch41_3",
    "question_text": "rd postpartum month",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch41_4",
    "question_text": "th postpartum month",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch41_6",
    "question_text": "th postpartum month\nQuestion 23:\nA woman presents to the OPD with complaints of amenorrhoea for the past year. She has a history of postpartum hemorrhage and lactational failure. What is the probable diagnosis?\nSheehan's syndrome\nRotor syndrome\nProlactinoma\nAcromegaly\nQuestion 24:\nA woman presents with fever on the 3rd postpartum day and is put on antibiotics. Fever is still not brought under control. On further investigation, she is diagnosed to have septic pelvic thrombophlebitis. Which among the following is the next course of treatment for her?\nStop antibiotics and start heparin\nAntibiotics+Heparin\nSurgical embolectomy\nHysterectomy\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_1",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_2",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_3",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_4",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_5",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_6",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_7",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_8",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_9",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_10",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_11",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_12",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_13",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_14",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_15",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_16",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_17",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_18",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_19",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_20",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_21",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_22",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_23",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_24",
    "question_text": "\nb\nSolution to Question 1:\nPuerperium begins as soon as the placenta is expelled and lasts for approximately 6 weeks.\nIt is the period following childbirth during which body tissues revert back approximately to the pre-pregnant state, both anatomically and physiologically.\nPuerperium can be divided as follows:\nImmediate puerperium: within 24 hours\nEarly puerperium: up to 7 days\nRemote/late puerperium: up to 6 weeks or 42 days.\nSolution to Question 2:\nEarly puerperium is considered to last up to 1 week after delivery. Puerperium can be divided as follows:\nImmediate puerperium: within 24 hours\nEarly puerperium: up to 7 days\nRemote/late puerperium: up to 6 weeks or 42 days\nSolution to Question 3:\nImmediately following delivery, the uterus weighs 1000 g.\nInvolution of the uterus occurs due to a decrease in the size of muscle fibers.\nTime following delivery\nFeatures\nWeight of the uteru s\nImmediately following delive ry\nUterus corresponds to 20 we eks gestational ageFundus lie s just below the umbilicus\n1000 g",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch42_48",
    "question_text": "hours\nMyometrial involution starts\n-",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch43_1",
    "question_text": "week\nRapid involution of uterus\n500 g",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch43_2",
    "question_text": "weeks\nThe uterus becomes apelvico rgan\n300 g",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch43_4",
    "question_text": "weeks\nClinically,involution is compl ete\n100 g",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch43_6",
    "question_text": "8 weeks\nUterus returns to normal (pr e-pregnant) sizeSonographica lly,involution is complete at 8 weeks\n60 g\nSolution to Question 4:\nDuring puerperium, the number of muscle fibers is not decreased, but there is a substantial reduction in the myometrial cell size.\nThere is an increased activity of uterine collagenases and release of proteolytic enzymes.\nWithin the puerperal uterus, larger blood vessels become obliterated by hyaline changes. These vessels are gradually resorbed and replaced by smaller ones.\nTime following delivery\nFeatures\nWeight of the uteru s\nImmediately following delive ry\nUterus corresponds to 20 we eks gestational ageFundus lie s just below the umbilicus\n1000 g",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch43_48",
    "question_text": "hours\nMyometrial involution starts\n-",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch44_1",
    "question_text": "week\nRapid involution of uterus\n500 g",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch44_2",
    "question_text": "weeks\nThe uterus becomes apelvico rgan\n300 g",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch44_4",
    "question_text": "weeks\nClinically,involution is compl ete\n100 g",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch44_6",
    "question_text": "8 weeks\nUterus returns to normal (pr e-pregnant) sizeSonographica lly,involution is complete at 8 weeks\n60 g\nSolution to Question 5:\nThe uterus becomes a pelvic organ by 2 weeks of postpartum.\nInvolution of the uterus occurs due to a decrease in the size of muscle fibers.\nTime following delivery\nFeatures\nWeight of the uteru s\nImmediately following delive ry\nUterus corresponds to 20 we eks gestational ageFundus lie s just below the umbilicus\n1000 g",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch44_48",
    "question_text": "hours\nMyometrial involution starts\n-",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch45_1",
    "question_text": "week\nRapid involution of uterus\n500 g",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch45_2",
    "question_text": "weeks\nThe uterus becomes apelvico rgan\n300 g",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch45_4",
    "question_text": "weeks\nClinically,involution is compl ete\n100 g",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch45_6",
    "question_text": "8 weeks\nUterus returns to normal (pr e-pregnant) sizeSonographica lly,involution is complete at 8 weeks\n60 g\nSolution to Question 6:\nThe uterus and endometrium return to pregravid size by 8 weeks when assessed by sonography. On clinical examination, the involution of the uterus is complete by 4 weeks.\nTime following delivery\nFeatures\nWeight of the uteru s\nImmediately following delive ry\nUterus corresponds to 20 we eks gestational ageFundus lie s just below the umbilicus\n1000 g",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch45_48",
    "question_text": "hours\nMyometrial involution starts\n-",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch46_1",
    "question_text": "week\nRapid involution of uterus\n500 g",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch46_2",
    "question_text": "weeks\nThe uterus becomes apelvico rgan\n300 g",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch46_4",
    "question_text": "weeks\nClinically,involution is compl ete\n100 g",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch46_6",
    "question_text": "8 weeks\nUterus returns to normal (pr e-pregnant) sizeSonographica lly,involution is complete at 8 weeks\n60 g\nSolution to Question 7:\nExternal os never returns back to normal whereas the contour of the cervix takes 6 weeks to regain normalcy.\n\nSolution to Question 8:\nEndometrial regeneration starts by 7th day and is completed by the 10th day. Regeneration of the epithelium at the placental site takes about 6 weeks.\nEndometrium regenerates from zona basalis which remains intact and is the source of new endometrium. This arises from proliferation of the endometrial glandular remnants and the stroma of the interglandular connective tissue.\nSolution to Question 9:\nFor the first 2 hours following delivery, blood pressure and pulse should be recorded every 15 minutes.\nTemperature is assessed every 4 hours for the first 8 hours after delivery.\nSolution to Question 10:\nThe given clinical scenario is suggestive of afterpains which are seen during puerperium.\nIn primiparous women, the uterus tends to remain tonically contracted following delivery. In multiparous women, it often contracts vigorously at intervals and gives rise to afterpains, which are similar to but milder than labor contractions.\nThese are more pronounced as parity increases and worsen when the infant suckles, likely because of oxytocin release. Afterpains gradually decrease in intensity and become mild by the third day.\nSolution to Question 11:\nThe average duration of lochial discharge in a postpartum woman is about 24-36 days. The average amount of discharge for the first week is 250 mL.\nThe lochial discharge appears as follows:\nName\nColour\nTiming after deliver y\nContent\nLochia rubr a\nRed\nFirst few days\nBlood, decidua, fetal membra nes, vernix, lanugo, meconiu m\nLochia sero sa\nYellowish/Pi nk\nAfter 3-4 days\nWBC, cervical mucus, microo rganisms\nLochia alba\nPale White\nAfter 10th day\nDecidua, cells, WBC, mucin, cholesterol crystals, and fat c ells\nSolution to Question 12:\nPostpartum diuresis results in a relatively rapid weight loss of 2 to 3 kg.\nDecreased estrogen levels are associated with the diuresis of excess extracellular fluid accumulated during pregnancy.\nSolution to Question 13:\nProlactin is the single most important galactopoietic hormone in postnatal women.\nFunction\nDefinition\nHormone\nMammogene sis\nBreast growth and developm ent\nEstrogen (ductal growth)Prog esterone (alveolar growth)\nLactogenesis\nInitiation of milk secretion\nProlactin\nGalactokines is\nEjection of milk\nOxytocin\nGalactopoies is\nMaintainence of lactation\nProlactin\nSolution to Question 14:\nThe given clinical features are suggestive of meralgia paraesthetica which is caused by injury to the lateral femoral cutaneous nerve.\nThe lateral femoral cutaneous nerve is at risk of injury during prolonged pushing with hip flexion as the nerve is compressed under the inguinal ligament.\nIt is the most common obstetrical neuropathy after vaginal delivery, followed by femoral nerve involvement.\nNote: The nerves most commonly injured during cesarean section are the iliohypogastric and ilioinguinal nerves.\nSolution to Question 15:\nThe most common postpartum nerve injury is an injury to the peroneal nerve causing foot drop.\nThe lateral femoral cutaneous nerve is the most commonly injured nerve after vaginal delivery followed by femoral neuropathies.\nObstetrical neuropathies are due to the pressure on branches of the lumbosacral nerve plexus during labor. They can manifest as complaints of intense neuralgia or cramp-like pains extending down one or both legs as soon as the head descends into the pelvis. Footdrop can be secondary to injury at the level of the lumbosacral plexus, sciatic nerve, or common fibular (peroneal) nerve.\nInjury of the iliohypogastric and ilioinguinal nerves may occur with cesarean delivery, which may manifest as an inguinal hernia and loss of sensation at the pubic region respectively.\nNote: Since there are no options relating to intense neuralgia in the lower limb, foot drop becomes the best possible answer.\nSolution to Question 16:\nPuerperal fever is defined as the temperature of 38 \u00b0C or higher (100.4 \u00b0F) recorded on 2 separate occasions 24 hours apart within the first 10 days following delivery. This excludes the first 24 hours.\nIn the first 24 hours, a slight rise of temperature is not uncommon and hence the first 24 hours are excluded while defining puerperal pyrexia.\nNote: Generally, fever in an adult is defined as an oral temperature of &gt;37.5 \u00b0C.\nSolution to Question 17:\nThe given clinical scenario of high-grade fever, foul-smelling lochia, and pelvic tenderness is suggestive of puerperal sepsis. The most common route of spread of this condition is direct spread.\nStreptococcus sp. is the most important causative organism of puerperal sepsis. The commonest manifestation is endometritis.\nThe route of delivery is an important risk factor for the development of puerperal sepsis (cesarean&gt; vaginal). The most common site of puerperal infection is the placental site in vaginal delivery and uterine incision in cesarean section.\nThe only proven way of decreasing uterine infection following cesarean section is administrating a single dose of ampicillin or 1st generation cephalosporin at the time of caesarean delivery.\nSolution to Question 18:\nDicloxacillin is the first line of treatment for mastitis in lactating mothers and should be taken for 10-14 days.\nMastitis refers to the infection of the breast parenchymal tissue. The most common organism causing breast infection is Staphylococcus aureus. It is common in new mothers at the beginning of lactation who are inexperienced with breastfeeding or during weaning when nipple trauma occurs due to the infant's growing teeth.\nClinical features of mastitis include:\nFever and malaise\nLocalized pain and tenderness\nPurulent nipple discharge\nRedness and swelling of the affected breast\nPositive fluctuation test\nA culture from nipple discharge or test-needle aspiration of the cellulitic area is done to confirm the organism and its antibiotic sensitivity. An ultrasonogram of the involved breast is done to exclude abscess. They are treated with antibiotics and adequate breast support. Choice of antibiotics in lactational mastitis:\nDicloxacillin 500 mg 4 times a day is to be started empirically.\nErythromycin is given to women who are penicillin-sensitive.\nIf the infection is caused by resistant, penicillinase-producing Staphylococcus species then vancomycin, clindamycin, or trimethoprim-sulfamethoxazole is given for at least 10 days.\nSolution to Question 19:\nThe clinical vignette of breast pain, fever, and leucocytosis with the image showing a red and swollen breast suggests a diagnosis of mastitis. The most common etiological agent is Staphylococcus aureus.\nMastitis refers to infection of the breast parenchymal tissue. Symptoms usually appear in the 3rd or 4th week. The infection is usually unilateral, with the source of infection being the infant's nose and throat. Predisposing factors are fissures, abrasions, and nipple cracks.\nManagement:\nBreastfeeding should be continued. If the infant is unable to nurse on the inflamed breast, the mother may resort to breast pumping. When nursing bilaterally, suckling is best started on the uninvolved breast.\nDicloxacillin is the first line of treatment of mastitis. Erythromycin is given to women who are penicillin-sensitive.\nIf an abscess forms, surgical treatment is done.\nSolution to Question 20:\nThe given clinical scenario is suggestive of puerperal blues. It is also known as 3 day blues/baby blues/maternity blues. It is treated by reassurance and psychological support.\nFeatures\nPuerperal blues\nPost-partum depression\nOnset",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_11.jpeg",
      "OBGYN_img_157.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch46_4",
    "question_text": "5 daysafter delivery",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch46_4",
    "question_text": "6 monthsafter delivery/abo rtion\nCause\nSudden decrease in hormone levels\nMultifactorial\nFeatures\tPuerperal blues\tPost-partum depression\nFeatures\tPuerperal blues\tPost-partum depression\nFeatures\tPuerperal blues\tPost-partum depression\nDuration\nLasts for a few days to 2-3 we eks\n-\nIncidence in postpartum mot hers",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch46_50",
    "question_text": "%",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch46_10",
    "question_text": "20%\nTreatment\nReassurance and psychologic al support\nAntidepressants (Fluoxetine/\nParoxetine)\nRecurrence rate",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch46_25",
    "question_text": "%",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch46_50",
    "question_text": "100%\nSolution to Question 21:\nThe given clinical situation likely suggests cortical vein thrombosis. Risk factors:\nPregnancy and puerperium\nOral contraceptives\nProthrombotic conditions\nMost common clinical presentation is headache with or without vomiting, papilledema, or focal deficits.\nInvestigations:\nBrain MRI with MR venography - most sensitive\nCT - normal in 30 % of cases.\nOption A: Subarachnoid hemorrhage - As there are no focal deficits, this diagnosis is unlikely.\nOption B: Meningitis - The patient would have presented with neck rigidity or photophobia. Moreover, the presence of early papilledema goes against acute meningitis.\nOption C: Acute migraine - It does not present with seizures.\nSolution to Question 22:\nLactating women should start using contraceptives in the 3rd postpartum month. Progesterone-only methods are the hormonal contraception of choice in a lactating mother. Efficacy of contraceptives used in postpartum period: Levonorgestrel IUD/ Implant &gt; DMPA\n&gt; Progestin-only pill.\nContraception should be ideally started after the resumption of ovulation. However, there are no contraindications for the use of contraceptives as early as 4-6 weeks in lactating women and immediately in non-lactating women.\nLactating mother\nNon-lactating mother\nOvulation occurs after 10 wee ks\nOvulation occurs after 4 wee ks\nUse contraceptive in3rd post- partum month\nUse contraceptive in3rd post- partum week.\nSolution to Question 23:\nThe clinical scenario points to a diagnosis of Sheehan's syndrome.\nSheehan's syndrome (SS) is postpartum hypopituitarism secondary to the necrosis of the pituitary gland. It usually results from severe hypotension or shock caused by massive hemorrhage during or after delivery. Patients with SS have varying degrees of anterior pituitary hormone deficiency. The hyperplastic enlargement of the pituitary, which occurs normally during pregnancy, increases the risk of infarction.\nAffected women may have persistent hypotension, tachycardia, hypoglycemia, and lactation failure. The most prominent symptoms are lactation failure (due to a deficiency of prolactin) and postpartum amenorrhea (due to a deficiency of gonadotropins). Because\ndeficiencies of some or all pituitary-responsive hormones may develop after the initial insult, Sheehan syndrome can be heterogeneous and may not be identified for years.\nIt can present acutely as pituitary apoplexy, an endocrine emergency, characterized by a sudden onset of headache, nausea, visual deficits, and in severe cases,\nsevere hypoglycemia, hypotension and shock, CNS hemorrhage, and death. Also, it can present late with the following features:\nLoss of pubic and axillary hair\nHypothyroidism due to decreased TSH secretion\nAdrenal insufficiency due to low ACTH\nTreatment is by hormone replacement - first glucocorticoids, later - thyroid hormone, sex steroids, vasopressin and growth hormones are given. If there is evidence of progressive visual loss, cranial nerve involvement or loss of consciousness, immediate surgical decompression must be carried out. Fertility can be achieved in these women with hMG and hCG. Clomiphene is ineffective.\nOption B: Rotor syndrome is a type of hereditary hyperbilirubinemia with autosomal recessive inheritance. Affected individuals have mild jaundice and hyperbilirubinemia.\nOption C: Prolactinoma or pituitary adenoids is the condition of hyperprolactinemia diagnosed by a prolactin level &gt;200 \uf06dg/L. It usually presents with infertility, amenorrhea, and galactorrhea.\nOption D: Acromegaly is characterized by the signs and symptoms pertaining to excessive growth hormone secretion.\nSolution to Question 24:\nAntibiotics plus heparin is the next course of treatment for septic pelvic thrombophlebitis.\nSeptic pelvic thrombophlebitis refers to the presence of an endovascular thrombus in the setting of associated bacterial or fungal infection.\nThe treatment of septic pelvic thrombophlebitis is broad-spectrum antibiotics plus anticoagulation. Anticoagulation is thought to prevent further thrombosis and reduce the spread of septic emboli.\nMultifetal Pregnancy\nQuestion 1:\nWhat is the most common type of multifetal pregnancy?\nMonozygotic dichorionic diamniotic\nDizygotic dichorionic diamniotic\nMonozygotic monochorionic diamniotic\nMonozygotic monochorionic monoamniotic\nQuestion 2:\nWhat is the time of division of the inner cell mass in a diamniotic monochorionic pregnancy?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch47_1",
    "question_text": "st - 2nd day",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch47_4",
    "question_text": "th \u2013 8th day",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch47_8",
    "question_text": "th - 12th day",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch47_10",
    "question_text": "th - 14th day\nQuestion 3:\nWhich of the following statements is false regarding multifetal pregnancies?\nNumber of embryos implanted affects the risk of twinning\nIsograft is done between monozygotic twins\nTwins of opposite sex are usually dizygotic\nSame sex twins having same blood group are always monozygotic\nQuestion 4:\nThe examination findings of a pregnant woman are suggestive of her having conjoined twins. Which is the most common type of such twins?\nCraniopagus\nThoracopagus\nPyopagus\nCephalopagus\nQuestion 5:\nWhich of the following can be used to calculate the incidence of multifetal gestation?\nTei index\nHellin's rule\nCHOP score\nKleihauer-Betke test\nQuestion 6:\nIn which of the following instances is there an increased chance of twinning?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch48_1",
    "question_text": ", 4, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch48_3",
    "question_text": ", 4, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch48_2",
    "question_text": ", 3, 4",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch49_1",
    "question_text": ", 2, 3\nQuestion 7:\nIn superfecundation, which of the following is seen?\nFertilisation of 2 ova released at the same time by sperms released at single intercourse\nFertilisation of 2 ova released in the same cycle by sperms released at intercourse on 2 different ccasion\nBoth of the above\nNone of the above\nQuestion 8:\nWhich of the following statements is false regarding the condition given in the image?\n\nIt is more common in monochorionic pregnancies\nIt cannot be detected by sonography\nIt is diagnosed usually after delivery\nMorbidity in the co-twin is due to hypotension\nQuestion 9:\nA woman is diagnosed to have twins during her dating scan. What is the most common presentation in such pregnancies?\nBoth vertex",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_11.jpeg",
      "OBGYN_img_158.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch49_1",
    "question_text": "st vertex and 2nd transverse",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch49_1",
    "question_text": "st breech and 2nd vertex",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch49_1",
    "question_text": "st vertex and 2nd breech\nQuestion 10:\nThe best time to identify the type of twin pregnancy on ultrasound is:",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch49_18",
    "question_text": "22 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch49_24",
    "question_text": "28 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch49_11",
    "question_text": "14 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch49_14",
    "question_text": "18 weeks\nQuestion 11:\nA 35-year-old woman conceived after being treated for infertility. Her USG scan is given below. What is her diagnosis?\n\nDichorionic diamniotic twins\nMonochorionic diamniotic twins\nMonochorionic monoamniotic twins\nSingleton pregnancy with uterine septum\nQuestion 12:\nA primigravida presents to the ANC clinic for the first time at 14 weeks of gestation. She complains of excessive nausea and vomiting. On examination, fundal height is midway between pubic symphysis and umbilicus. The T sign in seen on USG. What is her diagnosis?\nDichorionic diamniotic twins\nMonochorionic diamniotic twins\nMonochorionic monoamniotic twins\nDizygotic twins\nQuestion 13:\nWhich of the following images depicts monochorionic diamniotic pregnancy?\n",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_11.jpeg",
      "OBGYN_img_159.png",
      "OBGYN_img_11.jpeg",
      "OBGYN_img_160.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch49_3",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch49_4",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch50_1",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch50_2",
    "question_text": "\nQuestion 14:\nA mother with twin pregnancy underwent routine USG. Estimated fetal weights were calculated for both twins. What is the criteria to diagnose pathological discordant growth in this pregnancy?\nDifference of &gt;25% with larger twin as index\nDifference of &lt;50% with larger twin as index\nDifference of &gt;50% with smaller twin as index\nDifference of &gt;20% with larger twin as index\nQuestion 15:\nIn a woman receiving artificial reproductive therapy, the inner cell mass divides on the 7th day. Which of the following complications is not seen in the resulting multifetal pregnancy?\nTwin twin transfusion syndrome\nDiscordant growth\nCord entanglement\nAcardiac twin\nQuestion 16:\nWhat is the most common type of placental vascular anastomoses seen in monochorionic twin pregnancies?\nArtery \u2013 vein\nVein \u2013 vein\nArtery \u2013 artery\nBoth A and B\nQuestion 17:\nA 26-year-old woman, pregnant with twins, is diagnosed to have twin-twin transfusion syndrome. Which of the following statements is true regarding the recipient twin in this condition?\nOliguria is seen\nIt is called the stuck twin\nPulmonary hypoplasia is seen\nCongestive cardiac failure develops\nQuestion 18:\nThe ultrasound findings in a monochorionic diamniotic twin pregnancy are indicative of poly-oli syndrome. What is the pathology seen in this condition?\nArtery - artery anastomosis\nVein \u2013 vein anastomosis\nDeep artery \u2013 vein anastomosis\nSuperficial artery - vein anastomosis\nQuestion 19:\nUltrasound findings in a twin pregnancy are given below:\nStage I\nStage II\nStage III\nStage IV\nQuestion 20:\nAn anxious mother pregnant with twins was recently diagnosed with twin-twin transfusion syndrome. She wants to know the possible fetal outcome of the pregnancy. Which of the following investigations can be used to predict this?\nDeepest vertical pocket - USG\nFetal hemoglobin estimation\nMPI - ventricle Doppler\nPeak systolic velocity - MCA Doppler\nQuestion 21:\nWhat is/are the placental vascular abnormality that can be seen in the condition depicted in the image given below?\n\nArtery \u2013 artery anastomosis\nVein \u2013 vein anastomosis\nArtery \u2013 vein anastomosis\nBoth A and B\nQuestion 22:\nA 25-year-old woman, pregnant with twins, goes into labour. Following the vaginal delivery of the first twin, she was taken to the OT for internal version. What could have been the possible indication for this procedure?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_11.jpeg",
      "OBGYN_img_161.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch50_2",
    "question_text": "nd twin breech presentation",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch50_2",
    "question_text": "nd twin knee presentation",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch50_2",
    "question_text": "nd twin transverse lie",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch50_2",
    "question_text": "nd twin shoulder presentation\nQuestion 23:\nIdentify this condition.\n\nTwin to Twin Transfusion Syndrome\nMonochorionic diamniotic pregnancy\nMonochorionic monoamniotic pregnancy\nDichorionic diamniotic pregnancy\nQuestion 24:\nA pregnant woman was diagnosed with triplets on ultrasound. The obstetrician has planned to do a selective fetal reduction of one of the fetuses to improve the outcome of the pregnancy. What is the ideal timing and the method for the procedure?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_11.jpeg",
      "OBGYN_img_162.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch50_10",
    "question_text": "13 weeks with intracardiac KCl",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch50_7",
    "question_text": "9 weeks with intracardiac KCl",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch50_14",
    "question_text": "16 weeks with intraumbilical KCl",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch50_9",
    "question_text": "12 weeks with intraumbilical KCl\nQuestion 25:\nA 35-year-old primigravida who conceived after in-vitro fertilization therapy came for an antenatal checkup at 38 weeks of gestation. Her obstetric history revealed that she was pregnant with DCDA twins. On examination, the first twin was found to be in a breech position and the maternal blood pressure was found to be greater than 140/90 mm Hg on two occasions with grade 1+ proteinuria. What should be done next?\nMonitor BP and terminate pregnancy if BP rises\nImmediate Caesarean section\nTerminate pregnancy at 40 weeks of gestation\nInduce labour with PGE2 gel\nQuestion 26:\nA 26-year-old primigravida with dichorionic diamniotic twins presents to the clinic in active labor. The first twin is delivered vaginally but the second has a transverse lie. A trial of ECV was unsuccessful. What is not a complication of the procedure performed next for the delivery of the second twin?\nFace presentation\nUterine atony\nUterine rupture\nVaginal laceration\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_1",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_2",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_3",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_4",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_5",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_6",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_7",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_8",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_9",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_10",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_11",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_12",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_13",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_14",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_15",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_16",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_17",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_18",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_19",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_20",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_21",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_22",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_23",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_24",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_25",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch51_26",
    "question_text": "\na\nSolution to Question 1:\nThe most common type of multifetal pregnancy is dizygotic twinning, which is always dichorionic diamniotic.\nThe incidence of dizygotic twins is 80% among twins. Of the monozygotic twins, monochorionic diamniotic is the most common (13-14%).\nZygosity refers to the type of conception while chorionicity refers to the type of placentation.\nTypes of twin pregnancies:\nDizygotic: 2 ova are fertilized by 2 sperms to form 2 separate zygotes.\nMonozygotic: Single zygote (1 ovum fertilized by 1 sperm) divides into 2.\nFeature\nMonozygotic\nDizygotic\nPhenotype\nIdentical\nNon-identical\nGenotype\nIdentical\nNon-identical\nIncidence",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch52_1",
    "question_text": "250 (constant worldwide)\nVaries with demograp hy\nIncidence after ART\nIncreases\nIncreases\nPerinatal complication s\nHigh\nLow\n\nSolution to Question 2:\nDiamniotic monochorionic pregnancy occurs if the division of inner cell mass takes place between 4th - 8th day after fertilization.\nThe timing of the division of zygote for each type of twinning is given below.\nMonozygotic twin types\nTime of zygote division\nDichorionic diamniotic\n<72 hours\nMonochorionic diamniotic (\nmore common)",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_11.jpeg",
      "OBGYN_img_163.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch52_4",
    "question_text": "8 days\nMonochorionic monoamnioti c",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch52_8",
    "question_text": "12 days\nMonozygotic twin types\tTime of zygote division\nMonozygotic twin types\tTime of zygote division\nConjoined twins\n>12 days\nSolution to Question 3:\nSame sex twins of the same blood group are not always monozygotic but can also be dizygotic twins as well. The genetic relationship between dizygotic twins is the same as any siblings.\nOption A: More the number of embryos transferred in IVF, more is the risk of twinning. Hence, single embryo transfer is being recommended by the American Society for Reproductive Medicine (2017) to prevent twin gestation.\nOption B: Isograft is done between monozygotic twins as they have HLA homology.\nOption C: Twins of the opposite sex are usually dizygotic. Rarely, somatic mutations or chromosomal aberrations can change the sex of 1 or both of the monozygotic twins.\nSolution to Question 4:\nThoracopagus is the most common type of conjoined twins.\nDivision of the inner cell mass after the 12th day of fertilization results in the development of conjoined or Siamese twins. Based on the parts of the body joined, they are of the following types:\nVentral\nRostral\nOmphalopagus (abdomen)\nThoracopagus (upper chest)\nCephalopagus (head)\nCaudal\nIschiopagus (conjoined spines at 180 angle)\nLateral\nParaphagus (side by side fusion with a shared pelvis)\nDorsal\nCraniopagus (skull)\nRachipagus (vertebral arches)\nPyopagus (pelvis)\nSharing of organs is common among conjoined twins. MRI imaging is done later in pregnancy for the evaluation of organ sharing between conjoined twins who are being planned for surgical separation.\n\nSolution to Question 5:\nThe incidence of multiple pregnancies is calculated by Hellin\u2019s rule.\nAccording to this rule, incidence= 1 : 80(n-1), where n is the number of fetuses. Factors affecting the incidence of twin pregnancies are:\nMonozygotic\nART\nDizygotic\nRace\nHeredity\nMaternal age\nParity\nFamily history of twinning\nGood nutritional status\nInfertility therapy\nOption A: Tei index or myocardial performance index (MPI) is calculated using ventricular doppler imaging. It is used to assess cardiac function in TTTS.\nOption C: CHOP score is used for cardiac evaluation of recipient twin in TTTS.\nOption D: Kleihauer-Betke test is used to evaluate the approximate volume of fetomaternal hemorrhage in cases of Rh-D alloimmunization.\nSolution to Question 6:\nIncreasing maternal age, family history of twinning, and conception after stopping OCPs increase the risk of twinning.\nTaller, well-built women have an increased risk of twinning compared to shorter undernourished women. IVF increases the risk of twinning but single embryo transfer reduces the risk of multifetal pregnancies.\nFactors affecting the incidence of twin pregnancies:\nMonozygotic\nART\nDizygotic\nRace\nHeredity\nMaternal age\nParity\nFamily history of twinning\nGood nutritional status\nInfertility therapy\nNote- A family history of twinning (maternal and paternal) causes an increased chance of twinning. It is seen that maternal history of twinning has a higher chance of twinning as compared to a paternal history of twinning.\nSolution to Question 7:\nSuperfecundation is the fertilization of two different ova released in the same cycle, by two separate acts of coitus within a short period of time.\nSuperfecundation is the fertilization of two different ova in the same menstrual cycle (as suggested by the same gestational age) by separate acts of coitus. It can occur even after artificial reproductive therapy. Hence, after embryo transfer, intercourse must be avoided. Heteropaternal superfecundation is used to refer to instances of two different males fathering fraternal twins.\nThis leads to the possibility of twins also being half-siblings. This may give rise to the doubt of adultery and infidelity.\nSuperfetation is the fertilization of two ova released in different menstrual cycles. This is not seen in humans. The nidation and development of one fetus over another fetus is theoretically possible until the decidual space is obliterated by 14-16 weeks of pregnancy.\nSolution to Question 8:\nThe above image shows fetus compressus which appears as a tan ovoid mass compressed against the fetal membranes. It can be detected early by sonography.\nIn multifetal pregnancies, if one of the fetuses dies early in pregnancy, the surviving fetus continues to develop normally. It can lead to the following outcomes:\nFactors affecting the prognosis of the surviving twin:\nGestational age at fetal death: 2nd and 3rd trimester deaths increase the risk of morbidity in the surviving twin\nChorionicity: Monochorionic twins with early fetal death have an increased risk of morbidity in the surviving twin. This is due to neurological abnormality and vascular anastomoses.\nDuration between fetal demise and delivery of surviving twin\nSurviving twin may be born preterm leading to an increased risk of fetal demise\nDeath in the surviving twin occurs mostly due to vascular anastomoses between the twins. The surviving twin can develop sudden hypotension due to these anatomoses after fetal demise.\nOutcome\nType\nDisappears\nVanishing twin\nGets compressed\nFetus compres sus\nFlattened through desiccatio n\nFetus papyrace us\nSolution to Question 9:\nThe most common presentation in twins is both vertex/ cephalo-cephalic presentation (60%). The other presentations include:\nCephalo-Breech (20%)\nBreech-Cephalic (10%)\nBreech-Breech (6-10%)\nTransverse-Transverse (Rarest)\nMode of delivery depends on the presentation of the 1st twin as:\nPresentation of the 1st twin\nMode of deliver y\nVertex\nVaginal\nBreech\nCaesarean secti on\nTransverse\nCaesarean secti on\nSolution to Question 10:\nThe best time to identify the type of twin pregnancy on ultrasound is 11-14 weeks.\nTwin pregnancies should ideally be dated when the crown\u2013rump length (CRL) measurement is between 45 and 84 mm (i.e. 11 + 0 to 13 + 6 weeks of gestation).\nChorionicity should be ideally determined between 11 + 0 and 13 + 6 weeks of gestation (the earliest time to identify chorionicity is 7 weeks). This is done using the membrane thickness at the site of insertion of the amniotic membrane into the placenta. The T\u25a0sign (in monochorionic twins) or lambda sign (in dichorionic twins) can be seen here. As the determination of chorionicity is most accurate when the amnion and chorion have not yet been fused, the first\u25a0trimester scan in twin pregnancy is highly important.\nMarkers of dichorionicity include 4 layers of membranes between the twins, membrane thickness\n&gt;2mm, different sex of twins, 2 different placentas, and positive twin peak sign.\nWomen with an uncomplicated dichorionic twin pregnancy should have a first\u25a0trimester scan, a detailed second\u25a0trimester scan, and scans every 4 weeks thereafter.\nWomen with uncomplicated monochorionic twins should have a first\u25a0trimester scan and then scans every 2 weeks from 16 weeks onwards. This is done in order to detect TTTS and TAPS in a timely manner.\nSolution to Question 11:\nThe given image shows the twin peak sign which is seen in dichorionic diamniotic twins. This is also known as the lambda sign or delta sign.\nIn dichorionic twins, the intervening membrane between the twins has 4 layers i.e. 2 chorions and 2 amnions. The placenta protrudes from the base to the space between the 2 amnion layers. This gives rise to the twin peak sign i.e. triangle with the base at placenta and apex in the intervening membrane.\n\nSonographic assessment of dichorionicity is done by observing the following:\nNumber of placental masses - 2\nPresence of intervening membrane - twin peak or lambda or delta sign\nThickness of intervening membranes \uf0b3 2mm\nThe best time of delivery of dichorionic diamniotic twins is 38 weeks.\nSolution to Question 12:\nThe given clinical scenario and the T sign seen on USG points towards a diagnosis of monochorionic diamniotic twins.\nThe T sign is formed at the point at which the amnions meet the placenta. In monochorionic diamniotic twins, the separating membrane is made up only by the two amniotic membranes with no intervening chorion. This can be seen in the latter part of the first trimester or the beginning of the second trimester.\nSymptoms of multifetal pregnancy:\nIncreased nausea and vomiting in early months\nPalpitations and shortness of breath\nIncreased swelling of legs, varicose veins and haemorrhoids\nUnusual rate of uterine growth\nExcessive fetal movements Signs of multifetal pregnancy:\nIncreased weight gain\nHypertension\nBarrel shaped abdomen\nIncreased fundal height and abdominal girth\nMultiple fetal parts\nPalpation of 2 fetal heads\nFHS at different spots with FHR difference of at least 10bpm\nMonochorionic diamniotic pregnancy is terminated between 34-37 weeks+6 days. The below image shows the T sign.\n\nSolution to Question 13:\nThe USG in image 2 depicts monochorionic diamniotic pregnancy. It is identified by the T sign.\nIn monochorionic diamniotic twins, the intervening membrane has only 2 layers (i.e) 2 amnions. This thin membrane is seen ending at the common placenta giving rise to the T sign.\n\nSonographic assessment of monochorionicity is done by observing the following:\nSingle placental mass\nPresence of intervening membrane - T sign\nThin intervening membrane &lt;2mm\nThe best time of delivery of monochorionic diamniotic twins is 34 - 37weeks + 6 days. Image 1: Dichorionic twins with twin peak or lambda sign\nImage 3: Monochorionic monoamniotic twins with no intervening membranes between them Image 4: Triplets with 3 separate gestational sacs\nSolution to Question 14:\nA difference in estimated fetal weight of &gt;20% with larger twin as index is one of the criteria for diagnosing discordant growth.\nDiscordant growth is the unequal size/ weight among the fetuses in a multifetal gestation. It can be diagnosed by either of the following:\nEstimated fetal weight difference &gt; 20%\nDiscordance = (weight of larger twin - weight of smaller twin/weight of larger twin) x 100\nDiscordant growth in monochorionic twins is due to placental vascular anastomoses. In dichorionic twins, it occurs due to differences in genetic growth potential and suboptimal implantation site for one of the fetuses.\nSolution to Question 15:\nThe division of the inner cell mass on the 7th day will result in monochorionic diamniotic type of twin pregnancy. Cord entanglement is seen in monoamniotic twins and not in diamniotic twins.\nThe timing of the division of zygote for each type of twinning is given below.\nComplications in monochorionic diamniotic twins occur due to placental vascular anastomoses. They include:\nTwin-twin transfusion syndrome (TTTS)\nTwin reversed arterial perfusion (TRAP) or acardiac twin\nTwin anaemia polycythemia syndrome (TAPS)\nMonochorionic monoamniotic twins have a high fetal death rate. This is due to the following complications:\nPreterm birth\nCongenital anomalies\nLow birth weight\nCord entanglement\nMonozygotic types\nTime of zygote division\nDichorionic diamniotic\n<72 hours\nMonochorionic diamniotic (\nmore common)",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_12.jpeg",
      "OBGYN_img_164.jpeg",
      "OBGYN_img_12.jpeg",
      "OBGYN_img_165.jpeg",
      "OBGYN_img_12.jpeg",
      "OBGYN_img_166.png",
      "OBGYN_img_12.jpeg",
      "OBGYN_img_167.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch52_4",
    "question_text": "8 days\nMonochorionic monoamnioti c",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch52_8",
    "question_text": "12 days\nConjoined twins\n>12 days\nSolution to Question 16:\nArtery-vein anastomoses are most commonly seen in monochorionic pregnancies. All monochorionic placentas have anastomoses that can be:\nSuperficial artery-vein\nDeep artery-vein\nArtery-artery\nVein-vein\nOne vessel with connections to multiple arteries and veins\nThese anastomoses are not functional as long as the fetuses are hemodynamically balanced. When a pressure gradient develops between the fetuses, complications can occur like:\nTTTS - Twin-twin transfusion syndrome\nTAPS - Twin anemia polycythemia sequence\nTRAP - Twin reversed arterial perfusion\nThe most common complication in monochorionic twins is twin-twin transfusion syndrome\n(TTTS). Deep artery-vein anastomosis is the pathology seen in this condition.\nSolution to Question 17:\nCongestive heart failure is seen in the recipient twin.\nTwin-twin transfusion syndrome is a deep arteriovenous anastomotic complication seen\nin monochorionic diamniotic twins. Deoxygenated blood from the donor enters through the anastomosis into a shared cotyledon for oxygen exchange. Oxygenated blood is taken up by the recipient twin causing imbalance in the blood volumes.\nDiagnosis of TTTS depends on 2 USG criteria:\nMonochorionic diamniotic gestation\nHydramnios (DVP&gt;8cm) in one twin and oligohydramnios (DVP&lt;2cm) in the other twin Treatment modalities for TTTS:\nSerial amnioreduction\nLaser ablation of vascular placental anastomoses\nSelective fetal termination\nNote: Donor twin is called the stuck twin as the oligohydramnios limits fetal movement.\nDonor twin characteristics\nRecipient twin characteristics\nOliguria\nPolyuria\nOligohydramnios\nPolyhydramnios\nHypotension\nHypertension\nAnaemia\nPolycythemia\nActivation of renin-angiotens in-aldosterone system (RAAS)\nActivation of atrial natriureti c peptide (ANP)\nRenal failure, growth restricti on, pulmonary hypoplasia, co ntractures\nCongestive cardiac failure, pr emature rupture of membran es\nSolution to Question 18:\nIn poly - oli or polyhydramnios - oligohydramnios syndrome, the basic pathology is the presence of a deep artery-vein anastomosis.\nTTTS can present as poly-oli syndrome or twin oligohydramnios polyhydramnios syndrome (TOPS). This is usually seen in mid-pregnancy. In this syndrome, there is decreased donor renal perfusion, causing oliguria and oligohydramnios. Because of the anastomosis, the recipient twin\nhas increased renal perfusion and increased urine production causing polyhydramnios.\nDonor twin characteristics\nRecipient twin characteristics\nOliguria\nPolyuria\nOligohydramnios\nPolyhydramnios\nHypotension\nHypertension\nAnemia\nPolycythemia\nRenal failure\nCongestive cardiac failure\nGrowth restriction\nPremature rupture of membr anes\nPulmonary hypoplasia\nHyperbilirubinemia\nContractures\nSolution to Question 19:\nThe given USG findings are indicative of twin-twin transfusion syndrome (TTTS) with twin A being the recipient and twin B being the donor twin. Oligohydramnios (AFI&lt;5cm), absent urine and abnormal Doppler flow findings in the donor twin indicate stage III of twin-twin transfusion syndrome according to Quintero staging.\nQuintero staging system for TTTS classification:\nStag e\nUSG findings\nI\nDiscordant amniotic fluid vol umes + urine visible in donor' s bladder\nII\nDiscordant amniotic fluid vol umes + urine not visible in d onor's bladder\nIII\nStage II + abnormal Doppler studies of umbilical artery/vei n or ductus venosus\nIV\nAscites or frank hydrops in ei ther twin\nV\nDeath of either twin\nSolution to Question 20:\nIn twin-twin transfusion syndrome (TTTS), the fetal outcome depends on the cardiac function of the recipient twin. Tei index or myocardial performance index (MPI) is used to assess the\nventricular function using doppler.\nOption A: Deepest vertical pocket on USG is used to diagnose polyhydramnios-oligohydramnios in TTTS.\nOptions B and D: Fetal haemoglobin and MCA peak systolic velocity are used to diagnose TAPS\n(Twin anaemia polycythemia syndrome).\nSolution to Question 21:\nThe given image shows an acardius acephalus fetus. This refers to the acardiac twin seen in twin reversed arterial perfusion (TRAP). Both artery-artery and vein-vein anastomosis can be seen in TRAP.\nTRAP is a placental vascular anastomotic complication seen in monochorionic twins. In this disorder, deoxygenated blood from the donor twin enters the recipient twin through the anastomosis and supplies the lower half of the recipient\u2019s body. Hence, the heart and upper body of the recipient is poorly developed.\nThe below image depicts the circulation pattern seen in TRAP.\n\nBased on the supply of deoxygenated blood, the recipient twin might have the following fates: The donor twin develops high output cardiac failure.\nThe treatment for this condition is radiofrequency ablation of the acardiac or recipient twin.\nFate\nType\nLower body is perfused with f ailed head growth\nAcardius acephalus\nPartially developed head with identifiable limbs\nAcardius myelecephal us\nFate\tType\nFate\tType\nNo recognizable structure\nAcardius amorphous\nSolution to Question 22:\nThe second twin being in transverse lie is the only indication for internal version in modern obstetrics.\nIn a twin pregnancy, if the first twin has vertex presentation, vaginal delivery can be performed. Following the vaginal delivery of the first twin, if the second twin is in transverse lie, it is corrected by external version (preferably cephalic) into a longitudinal lie. If external version fails and the membranes are intact, internal version is done under general anaesthesia, followed by breech extraction.\nIf the membranes are ruptured, caesarean section is done immediately. Mode of delivery depends on the presentation of the 1st twin:\nPresentation of the 1st twin\nMode of deliver y\nVertex\nVaginal\nBreech\nCaesarean secti on\nTransverse\nCaesarean secti on\nSolution to Question 23:\nThe given specimen depicts a monochorionic monoamniotic pregnancy as:",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_12.jpeg",
      "OBGYN_img_168.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch52_2",
    "question_text": "umbilical cords are arising from 1 placenta (monochorionic)\nNo intervening amniotic membrane is attached to the placenta. This means that both fetuses must have been inside a single amniotic cavity (monoamniotic).\nOption B: In Monochorionic diamniotic pregnancy, on gross examination, there will be 1 placenta and intervening 2 layers of amnion attached to the placenta. In this type of pregnancy, each fetus will have its own amniotic cavity (diamniotic) with a shared placenta (monochorionic). This is seen if the fertilized zygote divides into 2 between 4-8 days.\nThe below given gross image of monochorionic diamniotic pregnancy shows two umbilical cords arising separately from the placenta with the intervening amniotic membrane held by the forceps.\n\nOption D: In dichorionic diamniotic pregnancy each fetus has it\u2019s own amnion &amp; chorion. The placentas here may be fused or separate. This is seen in dizygotic twins as well as monozygotic twins that divide within 0-4 days.\nOption A: Twin to twin transfusion syndrome (TTTS) most commonly complicates monochorionic (single placenta) twin pregnancy. In TTTS blood is transfused from the donor twin to the recipient twin through the abnormal vascular connections within the placenta leaving the donor anemic while the recipient becomes polycythemic.\nThe box below describes the type of amnion and chorion seen in different types of twins depending on the time of division.\nDizygotic twins\nDichorionic diamniotic\nMonozygotic twins- division occurs within0-4 days4-8 day s8-12 days>13 days\nDichorionic diamnioticMono chorionic diamnioticMonoch orionic monoamnioticMonoc horionic monoamniotic conjo ined twins\n\nSolution to Question 24:\nSelective fetal reduction is done between 10-13 weeks via intracardiac injection of KCl.\nIn multi-chorionic multifetal gestations, selective reduction of the smallest or anomalous fetus/fetuses is done to increase the chance of survival of the other fetuses.\nLaser ablation or bipolar coagulation of the umbilical cord of the targeted fetus is done. This protects the surviving fetuses from the adverse effects of the drug.\nSolution to Question 25:\nImmediate cesarean section is done as the first twin is in breech presentation. Uncomplicated dichorionic diamniotic twin pregnancies are terminated at 38 weeks of gestation.\nTiming of delivery depends on the type of twin pregnancy:\nThe mode of delivery depends on the 1st twin:\nAfter delivery of 1st twin, if the 2nd twin is in breech, assisted breech delivery is done. If the 2nd twin is in a transverse lie, the internal podalic version is done under GA in the OT followed by breech extraction.\nComplications in attempting vaginal delivery in non-vertex presentation (i.e) transverse and breech:\nInterlocking of twins\nFetal head trapping above the cervix\nUmbilical cord prolapse\nAccording to ACOG criteria (2019), preeclampsia requires proteinuria of grade 2+ or more. In the case of pre-eclampsia, termination of pregnancy must be done at 37 weeks. According to the updated criteria, this patient does not have pre-eclampsia. Hence, a Caesarean section can be done at 38 weeks as for any uncomplicated DCDA twin pregnancy.\nType of twin pregnancy\nTiming of delivery\nDichorionic diamniotic",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_12.jpeg",
      "OBGYN_img_169.png",
      "OBGYN_img_11.jpeg",
      "OBGYN_img_163.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch52_38",
    "question_text": "weeks\nMonochorionic diamniotic",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch52_34",
    "question_text": "- 37 weeks + 6 days\nMonochorionic monoamn iotic",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch52_32",
    "question_text": "- 34 weeks by Caesarean s ection",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch53_1",
    "question_text": "st twin presentatio n\nMode of delive ry\nVertex\nVaginal\nBreech\nCesarean secti on\nTransverse\nCesarean secti on\nSolution to Question 26:\nThe given clinical procedure is suggestive of internal podalic version for the second twin. Shoulder presentation, and not face presentation, is a complication of this procedure.\nThe complications seen with internal podalic version are as follows:\nMaternal-\nFailure of the procedure\nUterine rupture\nVaginal and perineal trauma\nPlacental abruption\nPostpartum haemorrhage\nAscending infection\nAnaesthetic risks\nFetal-\nCord prolapse\nShoulder presentation with prolapsed arm\nSkeletal injury (femur, hips, humerus, skull)\nVisceral injury (kidney, liver, spleen)\nNeural injury (facial nerve)\nHypoxic brain injury\nDeath\nEctopic Pregnancy\nQuestion 1:\nArrange the following sites of ectopic pregnancy from the most common to the least common.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch53_3",
    "question_text": "&gt;2&gt;4&gt;1",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch54_1",
    "question_text": "&gt;2&gt;3&gt;4",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch54_2",
    "question_text": "&gt;4&gt;1&gt;3",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch54_3",
    "question_text": "&gt;1&gt;4&gt;2\nQuestion 2:\nWhich of the following factors maximally increases the risk of tubal pregnancy?\nIntrauterine device\nPelvic Inflammatory disease\nPrior tubal surgery\nArtificial reproductive technique\nQuestion 3:\nThe fall in which of the following hormone/s leads to endometrial sloughing in ectopic gestation?\nhCG\nEstrogen\nEstrogen and Progesterone\nProgesterone and hCG\nQuestion 4:\nWhich type of tubal pregnancy ruptures at a later stage?\nAmpullary\nInterstitial\nFimbrial\nIsthmic\nQuestion 5:\nWhich of the following clinical features is not seen in a patient with ruptured ectopic pregnancy?\nShoulder tip pain\nDecidual cast\nVertigo and syncope\nShock index of 0.7\nQuestion 6:\nA woman presented with complaints of amenorrhoea for 6 weeks and a history of prior ectopic pregnancy. Serial serum beta hCG levels were estimated in her. Which of the following findings will increase the suspicion of ectopic gestation in her?\nLow levels with prolonged doubling time\nHigh levels with decreased doubling time\nUndetectable\nDouble the expected value\nQuestion 7:\nA patient presented with 6 weeks of amenorrhoea and a positive UPT. TVS revealed a tubal ectopic pregnancy. Which of the following findings can be usually picked up on colour Doppler?\nEnhanced blood flow pattern in the uterine artery\nArias stella reaction\nRing of fire pattern\nWhirlpool sign\nQuestion 8:\nA pregnant woman came for routine antenatal USG. Which of the following features is suggestive of a pseudogestational sac?\nPresence of yolk sac\nIntradecidual sac sign\nCentral location\nDouble decidual sign\nQuestion 9:\nA patient with suspected tubal pregnancy underwent transvaginal ultrasound which was inconclusive. What is the next step of management?\nLaparotomy\nDiagnostic laparoscopy\nSerum \uf062 hCG levels\nMethotrexate therapy\nQuestion 10:\nA pregnant woman is diagnosed with unruptured ectopic gestation. Which of the following is not an indication for expectant management in this patient?\nInitial serum beta hCG level of 200 mIU/mL\nGestational sac size of 5 cm\nAsymptomatic\nAbsence of fetal cardiac activity\nQuestion 11:\nA primigravida in her first trimester came for a routine ANC. USG findings revealed an empty uterine cavity. Serum beta hCG was measured and was found to be 1700 IU/mL. All of the following drugs can be used in managing this patient except:\nPotassium chloride\nMethotrexate\nActinomycin\nOxytocin\nQuestion 12:\nA patient with unruptured ectopic pregnancy is planned for medical management with methotrexate. What is the multi-dose protocol for this drug?\n1 mg/kg on days 1, 2, 5, and 8",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch54_0",
    "question_text": "1 mg/kg on days 1, 3, 5, and 7",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch54_0",
    "question_text": "1 mg/kg on days 1, 4, 6, and 8\n1 mg/kg on days 1, 3, 5, and 7\nQuestion 13:\nWhich of the following must be avoided by a patient with tubal pregnancy on methotrexate?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch54_1",
    "question_text": ", 3, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch54_1",
    "question_text": ", 4, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch54_2",
    "question_text": ", 3, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch55_1",
    "question_text": ", 2, 4\nQuestion 14:\nA 30-year-old woman was brought to the casualty in a drowsy state with complaints of bleeding PV associated with abdominal pain and a history of amenorrhoea for 8 weeks. On examination, BP was 90/60 mmHg, PR was 140 bpm, and UPT was positive. What is the next step of management?\nAdmit to the ICU\nResuscitation and emergency laparotomy\nSuction and evacuation\nFAST followed by laparoscopic salpingectomy\nQuestion 15:\nMatch the following criteria used for the diagnosis of ectopic pregnancy:",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch55_1",
    "question_text": "A, 2-C, 3-B",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch55_2",
    "question_text": "B, 3-A, 4-C",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch56_1",
    "question_text": "B, 2-C, 4-A",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch56_1",
    "question_text": "C, 2-A, 3-B\nQuestion 16:\nAn O-ve primigravida underwent surgery for ectopic pregnancy at 13 weeks of gestation. What will be the dose of anti-D immunoglobulin to be given to her?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch56_300",
    "question_text": "\uf06dg",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch56_75",
    "question_text": "\uf06dg",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch56_100",
    "question_text": "\uf06dg",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch56_150",
    "question_text": "\uf06dg\nQuestion 17:\nA 30-year-old female patient (G2P0A1) with a history of FSH therapy and in vitro fertilization presented with lower abdominal pain, vomiting, and vaginal discharge. On examination, she was hemodynamically stable. Transvaginal ultrasound showed a viable intrauterine pregnancy of 8 weeks associated with a heterogeneous right adnexal mass showing a positive bagel sign. What is the most appropriate management?\nMethotrexate\nMTP\nSurgery\nExpectant management\nQuestion 18:\nMethotrexate was administered to a patient with unruptured ectopic pregnancy. At what serum beta hCG levels will this drug be most effective?\n&lt;7000 IU/L\n&lt;5000 IU/L\n&lt;6000 IU/L\n&lt;10000 IU/L\nQuestion 19:\nStuddiford\u2019s criteria is used for the diagnosis of\nOvarian pregnancy\nCervical pregnancy\nTubal pregnancy\nAbdominal pregnancy\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_1",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_2",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_3",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_4",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_5",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_6",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_7",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_8",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_9",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_10",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_11",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_12",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_13",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_14",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_15",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_16",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_17",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_18",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_19",
    "question_text": "\nd\nSolution to Question 1:\nThe order of the most common site to the least common site in the fallopian tube for ectopic pregnancy is ampulla&gt;isthmus&gt;fimbriae&gt;interstitium.\nAn ectopic pregnancy is any pregnancy implanted outside of the endometrial cavity. Extrauterine sites: The most common site of ectopic pregnancy is the extrauterine fallopian tube.\nTubal - 97% (most common)\nAmpulla - 55%\nIsthmus\nInfundibulum\nInterstitium\nOvarian\nAbdominal\nIntrauterine ectopic sites:\nCervical\nCaesarean scar\nRudimentary horn of a bicornuate uterus\nHeterotopic pregnancy\nSolution to Question 2:\nPrior tubal surgery for ectopic pregnancy has the highest risk of tubal pregnancy among the given options.\nRisk factors for ectopic pregnancy:\nPrior ectopic pregnancy\nPrior tubal surgery for ectopic, recanalization of tube post-sterilization\nPelvic inflammatory disease - most common cause for ectopic pregnancy\nInfertility\nArtificial reproductive therapy\nEndometriosis\nSmoking\nMaternal age &gt;40 years\nContraceptive methods - intrauterine device, progesterone-only pills\nSolution to Question 3:\nEndometrial sloughing in ectopic gestation is due to the fall in the levels of progesterone and hCG.\nDuring normal pregnancy, endometrium is maintained by the high levels of hCG and progesterone. In ectopic pregnancy, a fall in the levels of these hormones will cause endometrial sloughing and uterine bleeding. If the decidua is expelled as a single piece through the cervix, it is called a decidual cast.\nSolution to Question 4:\nInterstitial tubal pregnancy ruptures at a later stage i.e. at 12-16 weeks. This is because pregnancy at this site is closer to the uterine myometrium which provides support as pregnancy progresses.\nIsthmic and ampullary pregnancies terminate by tubal rupture. However, isthmic pregnancy ruptures earlier. Ampullary and infundibular pregnancy can terminate by tubal abortion as well.\nSolution to Question 5:\nA shock index of &gt;0.85 is seen in a case of ruptured ectopic pregnancy. There is massive blood loss (SBP&lt;110 mmHg) sometimes leading to shock.\nThe shock index is calculated as HR/systolic BP.\nOption A: Sub-diaphragmatic blood irritates the phrenic nerve. This causes a referred pain at the shoulder tip. This is called as Danforth sign.\nOption B: The expulsion of decidua in a single piece through the cervix is called a decidual cast. This is due to the fall in the levels of \uf062 hCG and progesterone.\nOption C: Vertigo and syncope are due to reflex vasomotor disturbances due to peritoneal irritation from hemoperitoneum.\nCondition\nRange of shock ind ex\nNormal value of shock index\n(non-pregnant)",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_0",
    "question_text": "5 - 0.7\nNormal value of shock index in pregnancy (i.e) obstetrical shock index",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_0",
    "question_text": "7 - 0.8\nSignificant or massive blood l oss",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_0",
    "question_text": "9 - 1.1\nSolution to Question 6:\nLow levels of \uf062 hCG and prolonged doubling time increase the suspicion of ectopic pregnancy.\nUrine pregnancy test is very sensitive and found positive in most ectopic pregnancies. Hence, serial serum \uf062 hCG levels are estimated to detect ectopic pregnancy. In early normal pregnancy, the doubling time of \uf062 hCG concentrations in plasma is 1.4 to 2 days.\nSolution to Question 7:\nRing of fire pattern is seen on color doppler in a tubal ectopic pregnancy. This is due to placental blood flow in the tubal pregnancy.\nThis finding may also be seen in corpus luteum cysts but the wall is less echogenic compared to tubal ectopic.\nOption A: There is an enhanced blood flow pattern outside the uterine cavity in case of ectopic pregnancy.\n\nOption B: Arias-Stella reaction/phenomenon is a histological finding. It is an atypical endometrial change due to the action of progesterone on the endometrial tissue seen in normal, ectopic, and molar pregnancies.\nOn histology, there are:\nlarge cells with abundant eosinophilic or vacuolated cytoplasm\nnuclear enlargement\nhyperchromasia\n\nOption D: Whirlpool sign refers to the twisted ovarian pedicle seen on USG of ovarian torsion.\nSolution to Question 8:\nCentral location is a feature of the pseudogestational sac seen in ectopic pregnancies.\nPseudogestational sac is a collection of fluid between the endometrial layers, surrounded by a thick decidua. Its presence increases the suspicion of ectopic pregnancy.\nDifferences between pseudogestational sac and true gestational sac:\nFeature\nPseudogestational sa c\nTrue gestational sa c\nLocation within the endomet rial cavity\nCentral\nEccentric\nShape\nUsually ovoid\nUsually round\nFetal and yolk sac poles\nAbsent\nPresent\nDouble ring sign\nAbsent\nSeen\nIntradecidual sign\nAbsent\nSeen\nSolution to Question 9:\nIn the given scenario, the next step would be to confirm the tubal ectopic by measuring serum \uf062 hCG. This can be used to differentiate tubal ectopic pregnancy from missed abortion and early intrauterine pregnancy.\nIf the level is \uf0b32000 IU/L, ectopic pregnancy is suspected. If the level is &lt;1500 IU/L, a repeat serum \uf062 hCG is taken after 48 hours. If the levels are:\nDoubled - early intrauterine pregnancy\nDecreased - abortion\nIncreased but less than doubled value - ectopic pregnancy Investigations for ectopic pregnancy:\nSerum \uf062 hCG - lower levels compared to normal pregnancy, prolonged doubling time\nTransvaginal ultrasound - empty uterine cavity, fluid in pouch of Douglas, adnexal mass\nColour Doppler - ring of fire pattern\nLaparoscopy\nDilatation and curettage - decidua identified without villi\nSerum progesterone\nCuldocentesis\nDiagnostic laparoscopy may be done when the diagnosis is still uncertain after serial \uf062-hCG monitoring and repeat ultrasonography. In high-risk situations, such as a history of previous ectopic pregnancy, earlier diagnostic laparoscopy is considered.\n\nSolution to Question 10:\nA gestational sac size of &lt;4 cm is an indication of expectant management.\nExpectant management is done only in the case of unruptured tubal pregnancy. In this, observation is done till there is spontaneous resolution. It can be done but is not preferred due to prolonged follow-up and uncertainty in resolution.\nThe indications are:\nInitial serum \uf062 hCG &lt;1500 IU/L\nFalling serum \uf062 hCG levels\nGestational sac size &lt;4 cm\nNo fetal cardiac activity on TVS\nNo evidence of rupture or bleeding on TVS\nSolution to Question 11:\nOxytocin is not used in the management of unruptured ectopic pregnancy. Indications for medical management of unruptured tubal ectopic pregnancy:\nHemodynamically stable patient\nSerum \uf062 hCG &lt;5000 IU/L\nTubal diameter &lt;4 cm\nNo fetal cardiac activity\nNo intra-abdominal haemorrhage\nMedical management of unruptured tubal ectopic:\nDirect local therapy (laparoscopy or USG guidance) -\nMethotrexate\nPotassium chloride\nActinomycin\nHyperosmolar glucose\nPGF2\uf0b0\nSystemic therapy - single dose of methotrexate 50 mg/m2 IM\nFollow-up after medical management is done by measuring the decline in serial serum \uf062 hCG.\nSolution to Question 12:\nIn the multi-dose protocol, methotrexate is given at a dose of 1 mg/kg as an IM injection on alternate days 1, 3, 5, and 7.\nThis regimen is continued on alternating days until the hCG level drops by 15% over two days. Up to 4 doses may be given. Along with this, leucovorin rescue (folinic acid) is given at 0.1 mg/kg after 24 hrs (on days 2, 4, 6, and 8) to buffer the side effects of methotrexate.\nNote: If the decline is \uf0b315%, the patient is followed up weekly till the levels fall to &lt;10 IU/L.\nMTX Protocol\nMulti-dose regimen\nSingle-dose regimen\nDose\n1 mg/kg(+ 0.1 mg/kg LEU)\n50 mg/m2(Body surface area)\nRegimen\nAlternate daily doses\nDay 0\nhCG measurement\nDays 0, 1, 3, 5, 7\nDays 0, 4, 7\nTreatment success\nhCG declines >15%from thep revious value\nhCG declines >15%betweenD ay 4 and 7\nWhen to administer addition al dose",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_12.jpeg",
      "OBGYN_img_170.jpeg",
      "OBGYN_img_12.jpeg",
      "OBGYN_img_171.jpeg",
      "OBGYN_img_12.jpeg",
      "OBGYN_img_172.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_2",
    "question_text": "nd, 3rdor 4thdose to be give n if hCG does not decline 15\n% from the previous value. M aximum 4 doses\nSecond dose onDay 7if hCG d oes not decline 15%\nSolution to Question 13:\nSunlight exposure, sexual intercourse and NSAIDs must be avoided when patients are on methotrexate therapy.\nThe following should be avoided when methotrexate therapy has been initiated for the treatment of ectopic gestation:\nNonsteroidal anti-inflammatory drugs - can cause reduced renal blood flow and delay drug excretion\nAlcohol - can predispose to concurrent hepatic enzyme elevation\nSunlight - may provoke methotrexate-related dermatitis\nSexual intercourse - can rupture the ectopic pregnancy\nPhenytoin, tetracyclines, salicylates, and sulfonamides - can increase serum methotrexate levels\nSolution to Question 14:\nThe given clinical scenario is suggestive of ruptured ectopic pregnancy which must be immediately managed with simultaneous resuscitation and laparotomy. On laparotomy, salpingectomy is the definitive surgery.\nDiagnosis of ruptured ectopic pregnancy is made based on clinical features:\nAmenorrhoea for 6-8 weeks followed by bleeding PV\nAbdominal pain\nHemodynamically unstable\nUrine pregnancy test - positive\nSurgical treatment of ectopic pregnancy includes salpingectomy or salpingostomy, performed either through laparoscopy or laparotomy.\nManagement of suspected ruptured ectopic pregnancy consists of initial resuscitation and stabilization, followed by point-of-care ultrasound (FAST) to identify intraperitoneal free fluid and surgical exploration.\nLaparotomy is done for hemodynamically unstable patients with ruptured ectopic pregnancies. Salpingectomy is the treatment of choice and is done with preservation of the ipsilateral ovary and its vascular supply.\nFor patients wishing to preserve future fertility, if the contralateral fallopian tube is damaged, salpingostomy is preferred. However, salpingostomy may result in inadequate evacuation of the products of conception and a recurrence of symptoms. Therefore, after a patient undergoes salpingostomy, it is important check the \uf062-hCG level on a weekly basis to ensure that it reaches zero.\nThe image given below shows a laparoscopic visualization of a tubal pregnancy.\n\nSolution to Question 15:\nSpiegelberg\u2019s criteria used for the diagnosis of ovarian pregnancy include intact ipsilateral tube, pregnancy occupying ovary connected by the utero-ovarian ligament.\nStuddiford\u2019s criteria used for the diagnosis of primary abdominal pregnancy include the presence of normal bilateral tubes and pregnancy related to the peritoneal surface.\nRubin's criteria used for the diagnosis of cervical pregnancy includes presence of soft, enlarged cervix and closed internal os and partially opened external os.\nEctopic pregnan cy\nCriteria\nAbdominal\nStuddifor d\nCervical\nRubin\nOvarian\nSpiegelbe rg\nSolution to Question 16:\nAnti-D is given at a dose of 300 \uf06dg intramuscularly for alloimmunization after surgical management of ectopic pregnancy.\nThe dose of anti-D in a surgically treated case of ectopic is 50 \uf06dg if gestation &lt;12 weeks. If the gestation is &gt;12 weeks, 300 \uf06dg of anti-D is given intramuscularly.\nAnti-D is not given when the ectopic is treated with medical methods.\nSolution to Question 17:\nThe given clinical scenario is suggestive of heterotopic pregnancy. Surgery is the ideal treatment in heterotopic pregnancy.\nA normal uterine pregnancy co-existing with an extrauterine (ectopic) pregnancy is termed a heterotopic pregnancy. Although heterotopic pregnancy can occur spontaneously, it is more likely after ART and ovulation induction.\nTubal ring sign also referred to as bagel sign is one of the ultrasound signs of a tubal ectopic. It comprises an echogenic ring that surrounds an unruptured ectopic pregnancy.\nUSG image showing bagel sign or tubal ring sign:\n\nMethotrexate is not to be given as it harms even the normal intrauterine fetus. Although potassium chloride may be injected into the sac of the ectopic, the safer method would be surgery to remove the ectopic.\nSolution to Question 18:\nMethotrexate is most effective when given at \uf062 hCG levels are &lt;5000 IU/L.\nMethotrexate is given at a dose of 50 mg/m2 of body surface area. Monitoring is done by measuring \uf062 hCG levels on days 4 and 7. If the decline is \uf0b315% of the initial value, the patient is followed up weekly till the levels fall to &lt;10 IU/L. If the decline is &lt;15%, a 2nd dose of methotrexate is given on day 7.\nSolution to Question 19:\nStuddiford\u2019s criteria is used for the diagnosis of primary abdominal pregnancy.\nPrimary abdominal pregnancy is the rarest type of ectopic gestation. The conceptus implants on the peritoneal surface of the abdomen.\nStuddiford\u2019s criteria:\nThe presence of normal bilateral tubes and ovaries with no evidence of recent or past pregnancy.\nNo evidence of a uteroperitoneal fistula.\nThe presence of pregnancy, related exclusively to the peritoneal surface, early enough to eliminate the possibility of secondary implantation\nCriteria used in the diagnosis of ectopic pregnancy are:\nCervical pregnancy: Paalman and McElin (clinical criteria); Rubin's criteria (histological criteria)\nOvarian pregnancy: Spiegelberg\u2019s criteria\nAbortion and Medical Termination of Pregnancy\nQuestion 1:\nAbortion is the expulsion of fetus weighing \t.\n&lt;250 g\n&lt;500 g\n&lt;750 g\n&lt;1000 g\nQuestion 2:\nA patient presented with vaginal bleeding following 6 weeks of amenorrhoea. Her UP\u20ac was positive. \u00c5hat is the most \u201aommon \u201aause of this \u201aondition?\n\u0192uteal phase defe\u201at\n\u201enfe\u201ations\n\u2026hromosomal abnormalit\u2020\n\u2026ervi\u201aal in\u201aompeten\u201ae\nQuestion 3:\nA patient presented with a spontaneous abortion at 7 weeks of gestation. \u00c5hi\u201ah of the following is the least likel\u2020 \u201ahromosomal abnormalit\u2020 that \u201aan lead to this \u201aondition?\n\u20acrisom\u2020 16\n\u20acrisom\u2020 1\n\u20acrisom\u2020 21\n\u20acrisom\u2020 22\nQuestion 4:\nA woman with 6 weeks of amenorrhea had a positive urine pregnan\u201a\u2020 test. \u20ache following finding was seen on transabdominal U\u2021\u02c6. \u00c5hat is the most probable diagnosis?\n\n\u2021ingleton pregnan\u201a\u2020\n\u2030issed abortion\nAnen\u201aephal\u2020\n\u2030olar pregnan\u201a\u2020\nQuestion 5:\n\u0160ou are examining a primigravida with \u201aomplete abortion. \u00c5hi\u201ah of the following findings would \u2020ou not expe\u201at?\nUterus smaller than period of amenorrhea\n\u2039pen \u201aervi\u201aal os\nUterus firm on palpation\n\u20acra\u201ae amounts of vaginal bleeding\nQuestion 6:\n\u0152e\u201aurrent mis\u201aarriage is the loss of:\n\uf0b3\u00e7 \u201aonse\u201autive pregnan\u201aies before 20 weeks\n\uf0b32 \u201aonse\u201autive pregnan\u201aies before 20 weeks\n\uf0b3\u00e7 \u201aonse\u201autive pregnan\u201aies after 2\u017d weeks\n\uf0b32 \u201aonse\u201autive pregnan\u201aies before 2\u00e8 weeks\nQuestion 7:\n\u00c5hi\u201ah of the following \u201aonditions does not usuall\u2020 \u201aause re\u201aurrent mis\u201aarriages?\nAsherman s\u2020ndrome\nPol\u2020\u201a\u2020sti\u201a ovarian s\u2020ndrome\nBi\u201aornuate uterus\n\u201enfe\u201ations\nQuestion 8:\nA primigravida had a spontaneous abortion at 1\u00e8 weeks. \u2039n examination, the fetus was morphologi\u201aall\u2020 normal. \u2018urther investigations were performed upon the patient's insisten\u201ae and the results are given below. \u00c5hat is the likel\u2020 diagnosis?\n\u2021\u2020philis\nAnti-phospholipid antibod\u2020 s\u2020ndrome\nHemophilia B\n\u2018a\u201ator \u2019 \u0192eiden mutation\nQuestion 9:\nA woman \u201aomes to the \u201aasualt\u2020 at 1\u00e8 weeks of gestation with \u201aomplaints of vaginal bleeding.\n\u2021he has a histor\u2020 of two earl\u2020 pregnan\u201a\u2020 losses. U\u2021\u02c6 reveals the absen\u201ae of fetal \u201aardia\u201a a\u201ativit\u2020. \u00c5hi\u201ah of the following investigations need not be done in this patient?\nExtensive infe\u201ation work-up\n\u2021erum prola\u201atin level\nAntiphospholipid antibodies\nParental kar\u2020ot\u2020ping\nQuestion 10:\nA pregnant lad\u2020 with a \u25a0histor\u2020 of re\u201aurrent abortions is now diagnosed to have antiphospholipid s\u2020ndrome. \u00c5hat would be the best mode of treatment for her?\nAspirin onl\u2020\nAspirin+heparin\nAspirin+heparin+steroids\nAspirin+steroids\nQuestion 11:\nA \u02c6\u00e7A\u00e7 patient was admitted to the hospital with \u201aatastrophi\u201a AP\u0192\u2021 following a spontaneous abortion. \u00c5hi\u201ah of the following is false about this \u201aondition?\n\u201et is a rapidl\u2020 progressive thromboemboli\u201a disorder\nAt least 2 organ s\u2020stems should be involved to make a diagnosis\n\u201enfe\u201ations \u201aan a\u201at as a trigger\n\u201e\u2019\u201e\u02c6 \u201aan be used for treatment\nQuestion 12:\n\u00c5hi\u201ah of the following features \u201aan be seen in a patient with \u201aervi\u201aal in\u201aompeten\u201ae?\nPainful vaginal bleeding at &lt;20 weeks\n\u0152epeated mid-trimester painless \u201aervi\u201aal dilatation\n\u0152epeated third trimester painless \u201aervi\u201aal dilatation\nBleeding per vaginum in the first trimester\nQuestion 13:\n\u00c5hi\u201ah of the following in\u201arease the risk of developing \u201aervi\u201aal in\u201aompeten\u201ae?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_12.jpeg",
      "OBGYN_img_172.jpeg",
      "OBGYN_img_173.jpeg",
      "OBGYN_img_13.jpeg",
      "OBGYN_img_174.jpeg",
      "OBGYN_img_13.jpeg",
      "OBGYN_img_175.png"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch57_2",
    "question_text": ", \u00e7, \u017d",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch58_1",
    "question_text": ", 2, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch58_1",
    "question_text": ", \u00e7, \u017d",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch58_2",
    "question_text": ", \u017d, 5\nQuestion 14:\n\u20ache transvaginal ultrasound of a pregnant woman is given below. \u00c5hat are the \u201autoff values of the parameters marked A and B for a diagnosis of \u201aervi\u201aal in\u201aompeten\u201ae?\n\nA &gt;1\u201am and B &lt;25mm\nA &lt;25 mm and B &gt;1\u201am\nA &gt;2 \u201am and B &lt;\u00e75mm\nA &gt;2.5\u201am and B &lt;25mm\nQuestion 15:\nA 26-\u2020ear-old woman presents with 6 weeks of amenorrhea and a positive UP\u20ac. Her past obstetri\u201a histor\u2020 was signifi\u201aant for 2 mid-trimester abortions. \u2039n U\u2021\u02c6, \u201aervi\u201aal length was 20 mm and no bulging membranes were seen. \u00c5hat is the next step in her management?\nExpe\u201atant management\n\u201emmediate res\u201aue \u201aer\u201alage\nProph\u2020la\u201ati\u201a \u201aer\u201alage at 12 weeks\n\u201emmediate termination of pregnan\u201a\u2020\nQuestion 16:\nA patient with \u201aervi\u201aal insuffi\u201aien\u201a\u2020 is posted for \u2030\u201aDonald's pro\u201aedure. \u00c5hi\u201ah of the following is not a \u201aontraindi\u201aation for this surger\u2020?\nPla\u201aental abruption\nPremature membrane rupture\n\u2026ervi\u201aal dilation &gt;\u017d \u201am\n&gt;20 weeks of gestation\nQuestion 17:\nA woman with \u201aervi\u201aal in\u201aompeten\u201ae is posted for proph\u2020la\u201ati\u201a \u2030\u201aDonald's \u201aer\u201alage. \u00c5hi\u201ah of the following statements is false about this pro\u201aedure?\n\u0152emoval of stit\u201ah must be done b\u2020 \u00e77th week\nA mersilene tape is tied around the \u201aervix\nDone at the level of internal os\n\u2026horioamnionitis is a post-operative \u201aompli\u201aation\nQuestion 18:\nA 20-\u2020ear-old female patient \u201aame for medi\u201aal termination of pregnan\u201a\u2020. \u2018rom whom will\n\u2020ou obtain \u201aonsent for the pro\u201aedure?\nPatient and her male partner\n\u2039nl\u2020 the patient\nPatient's guardian\nPatient's \u201aaregiver\nQuestion 19:\nA patient with \u201aontra\u201aeptive failure re\u2022uires \u2030\u20acP at 5 weeks of gestation. \u0160ou plan to use a medi\u201aal method of abortion in her \u201aase. \u00c5hi\u201ah of the following is not a \u201aontraindi\u201aation for this?\n\u201entrauterine devi\u201ae in situ\n\u0192ong term \u201aorti\u201aosteroids therap\u2020\nUn\u201aontrolled h\u2020pertension\n\u2026hroni\u201a diabetes mellitus\nQuestion 20:\nA 2\u00e7-\u2020ear-old pregnant rape vi\u201atim was posted for a su\u201ation and eva\u201auation pro\u201aedure. \u20achis pro\u201aedure \u201aan be done up to     of gestation.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_13.jpeg",
      "OBGYN_img_176.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch58_6",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch58_12",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch59_1",
    "question_text": "\u00e8 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch59_20",
    "question_text": "weeks\nQuestion 21:\n\u0160ou have performed \u2030\u20acP on a multigravida at 10 weeks of gestation. As a part of post-op advi\u201ae, \u2020ou must pres\u201aribe her a proph\u2020la\u201ati\u201a antibioti\u201a. \u00c5hi\u201ah of the following drugs would\n\u2020ou prefer?\nDox\u2020\u201a\u2020\u201aline 200 mg orall\u2020\nAzithrom\u2020\u201ain 500 mg orall\u2020\nAmoxi\u201aillin 250 mg orall\u2020\n\u2026efotaxime 1 g iv\nQuestion 22:\n\u0160ou are about to administer misoprostol to a woman who re\u2022uires \u2030\u20acP in the \u00e8th week of her pregnan\u201a\u2020. \u00c5hat is the dose of this drug when given b\u2020 the mu\u201aosal route, a\u201a\u201aording to \u00c5H\u2039 guidelines?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch59_200",
    "question_text": "m\u201ag",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch59_600",
    "question_text": "m\u201ag\n\u017d00 m\u201ag\n\u00e800 m\u201ag\nQuestion 23:\n\u00c5hi\u201ah of the following statements is false regarding the methods of \u2030\u20acP?\nPain is more in medi\u201aal methods of abortion\n\u201en\u201aomplete abortion is more \u201aommon in medi\u201aal methods\nBleeding is prolonged in surgi\u201aal methods\n\u2018ailure rate is low in surgi\u201aal methods of abortion\nQuestion 24:\nA 21-\u2020ear-old woman is brought in a drows\u2020 state from a PH\u2026 with \u201aomplaints of fever, severe lower abdominal pain, and purulent vaginal dis\u201aharge. Her mother revealed that she had had an unsafe abortion a week ago. \u2039n examination, her abdomen was distended, BP was \u00e80/60 mmHg, P\u0152 was 1\u017d0 bpm, and \u0152\u0152 was \u00e76 breaths/ minute. \u00c5hi\u201ah of the following is not a \u201aausative agent of her present \u201aondition?\n\u2021trepto\u201ao\u201a\u201aus p\u2020ogenes\n\u2026lostridium perfringens\n\u2026lostridium sordellii\nEs\u201aheri\u201ahia \u201aoli\nQuestion 25:\n\u00c5hi\u201ah of the following is not a risk fa\u201ator for stillbirth?\n\u2030aternal diabetes and h\u2020pertension\n\u201elli\u201ait drug abuse b\u2020 the mother\nUntreated seizure disorder in pregnan\u201a\u2020\nPregnan\u201a\u2020 following assisted reprodu\u201ative te\u201ahnolog\u2020\nQuestion 26:\nA \u2020oung female has histor\u2020 of a spontaneous abortion. \u2021he has had amenorrhea sin\u201ae then. Her \u2018\u2021H now is 6 m\u201eU/ml. \u00c5hi\u201ah of the following \u201aan be a \u201aause for her amenorrhea?\nPituitar\u2020 d\u2020sfun\u201ation\n\u2039varian d\u2020sfun\u201ation\n\u2018irst pregnan\u201a\u2020\nUterine s\u2020ne\u201ahiae\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_1",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_2",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_3",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_4",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_5",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_6",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_7",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_8",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_9",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_10",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_11",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_12",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_13",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_14",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_15",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_16",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_17",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_18",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_19",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_20",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_21",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_22",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_23",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_24",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_25",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch60_26",
    "question_text": "\nd\nSolution to Question 1:\nA\u201a\u201aording to \u00c5H\u2039, abortion is defined as pregnan\u201a\u2020 termination or loss before 20 weeks of gestation or with a fetus weighing &lt;500 g.\n\u2021ome \u201aommon \u201aauses of spontaneous abortion are:\n\u2026hromosomal abnormalities\n\u0192uteal phase defe\u201ats\nDiabetes mellitus and th\u2020roid disorders\n\u2026ervi\u201aal in\u201aompeten\u201ae\nAntiphospholipid antibod\u2020 s\u2020ndrome\n\u2030aternal infe\u201ations\nAl\u201aohol and \u201aigarette smoking\nSolution to Question 2:\n\u20ache given \u201alini\u201aal s\u201aenario is suggestive of first-trimester abortion whi\u201ah is most \u201aommonl\u2020\n\u201aaused b\u2020 \u201ahromosomal abnormalities.\nAutosomal trisomies are the most \u201aommon (50%) geneti\u201a abnormalit\u2020 overall. \u2039f these, the most\n\u201aommon trisom\u2020 involved in abortions is trisom\u2020 16. \u20acurner s\u2020ndrome (monosom\u2020 X) is the single most \u201aommon \u201ahromosomal abnormalit\u2020 in mis\u201aarriages.\n\u2026auses of spontaneous abortion are:\n\u02c6eneti\u201a -\n\u02dcumeri\u201aal \u201ahromosomal abnormalities\n\u2026hromosomal rearrangements\n\u2030endelian etiolog\u2020\nEndo\u201arine -\n\u0192uteal phase defe\u201ats\n\u20ach\u2020roid abnormalities\nDiabetes mellitus\nAnatomi\u201aal -\n\u2026ervi\u201aal in\u201aompeten\u201ae\n\u2026ongenital uterine malformations\nUterine fibroid\nUterine s\u2020ne\u201ahiae\n\u201enfe\u201atious (\u20ac\u2039\u0152\u2026H infe\u201ations)\n\u201emmunologi\u201aal -\nAntiphospholipid antibod\u2020 s\u2020ndrome\nAutoimmunit\u2020\n\u2030aternal illness -\n\u2026\u2020anoti\u201a heart diseases\nHemoglobinopathies\nEnvironmental -\n\u0152adiation exposure\nAl\u201aohol\n\u2026igarette smoking\nSolution to Question 3:\n\u20ache least likel\u2020 \u201ahromosomal abnormalit\u2020 involved in first-trimester abortions is trisom\u2020 1.\n\u20ache most \u201aommon \u201ahromosomal abnormalit\u2020 in first trimester abortions is trisom\u2020. \u20ache \u201aommon trisomies are:\nEdwards s\u2020ndrome (\u20acrisom\u2020 1\u00e8)\nDown s\u2020ndrome (\u20acrisom\u2020 21)\nPatau s\u2020ndrome (\u20acrisom\u2020 1\u00e7)\n\u20acrisomies 16 and 22\n\u20acurner s\u2020ndrome (\u2030onosom\u2020 X) is the single most fre\u2022uent \u201ahromosomal abnormalit\u2020. \u201et usuall\u2020 results in abortion.\nSolution to Question 4:\n\u20ache given U\u2021\u02c6 image shows an empt\u2020 gestational sa\u201a whi\u201ah is seen in missed abortion before 12 weeks. At this gestational age, the entire ovum is \u201aovered b\u2020 the \u201ahorioni\u201a villi giving rise to the empt\u2020 gestational sa\u201a.\n\u201ef this \u201aondition o\u201a\u201aurs be\u2020ond 12 weeks of gestation, a dead fetus is seen on U\u2021\u02c6. \u20achis is not pre\u201aeded b\u2020 an\u2020 warning signs and the fetus is not expelled outside spontaneousl\u2020.\n\n\nSolution to Question 5:\n\u20ache \u201aervi\u201aal os is \u201alosed in \u201aomplete abortion.\n\n\nSolution to Question 6:\n\u0152e\u201aurrent mis\u201aarriage is defined as \uf0b3\u00e7 \u201aonse\u201autive pregnan\u201a\u2020 losses at \uf0a3 20 weeks or with a fetal weight &lt;500 g.\n\u201et \u201aan be of 2 t\u2020pes:\nPrimar\u2020 re\u201aurrent mis\u201aarriage where there are multiple losses in a woman who has never delivered a liveborn\n\u2021e\u201aondar\u2020 re\u201aurrent mis\u201aarriage where multiple pregnan\u201a\u2020 losses o\u201a\u201aur in a patient who has had a prior live birt\nSolution to Question 7:\n\u201enfe\u201ations do not usuall\u2020 \u201aause re\u201aurrent mis\u201aarriages.\n\u2026ommon \u201aauses of re\u201aurrent mis\u201aarriage:\nParental \u201ahromosomal abnormalities\nAnatomi\u201aal fa\u201ators -\nUterine s\u2020ne\u201ahiae or Asherman s\u2020ndrome\nUterine leiom\u2020omas\n\u2026ongenital genital tra\u201at anomalies\n\u201emmunologi\u201aal fa\u201ators -\nAntiphospholipid antibod\u2020 s\u2020ndrome\nEndo\u201arine fa\u201ators -\n\u0192uteal phase defe\u201at\nPol\u2020\u201a\u2020sti\u201a ovarian s\u2020ndrome\nSolution to Question 8:\n\u20ache given lab findings are suggestive of anti-phospholipid antibod\u2020 s\u2020ndrome(AP\u0192\u2021).\n\u2026riteria for diagnosis of antiphospholipid antibod\u2020 s\u2020ndrome:\n\u2026lini\u201aal \u201ariteria -\n\u2039bstetri\u201a\n\u20achree or more unexplained \u201aonse\u201autive spontaneous abortions before 10 weeks\n\u2039ne or more deaths of a morphologi\u201aall\u2020 normal fetus at or be\u2020ond 10 weeks\n\u2021evere pre-e\u201alampsia ne\u201aessitating deliver\u2020 before \u00e7\u017d weeks\n\u2019as\u201aular\n\u2039ne or more episodes of arterial, venous, or small vessel thrombosis in an\u2020 tissue or organ \u0192aborator\u2020 \u201ariteria -\nPresen\u201ae of lupus anti\u201aoagulant\nPresen\u201ae of \u201eg\u02c6 or \u201eg\u2030 anti-\u201aardiolipin antibodies\nPresen\u201ae of \u201eg\u02c6 or \u201eg\u2030 anti-beta-2 gl\u2020\u201aoprotein \u201e antibodies\nAt least one \u201alini\u201aal and one laborator\u2020 \u201ariteria is needed for the diagnosis.\n\u02dcon-spe\u201aifi\u201a tests for lupus anti\u201aoagulant are in\u201areased aP\u20ac\u20ac, \u2122aolin \u201alotting time, and dilute \u0152ussell viper venom time.\nSolution to Question 9:\n\u20ache given \u201alini\u201aal s\u201aenario is suggestive of re\u201aurrent abortions, and extensive infe\u201ation workup is not done.\nEven though re\u201aurrent abortions are defined as \uf0b3\u00e7 pregnan\u201a\u2020 losses, investigations must be done after 2 \u201aonse\u201autive losses.\nDiagnosti\u201a evaluation of re\u201aurrent pregnan\u201a\u2020 loss based on etiolog\u2020 is given as follows:\nEtiolog\u2020\nDiagnosti\u201a evaluation\n\u02c6eneti\u201a\nParental kar\u2020ot\u2020ping\nAnatom i\u201a\nH\u2020sterosalpingograph\u2020Ultras ound\u2021aline-infusion sonogra ph\u2020\nEtiolog\u2020\tDiagnosti\u201a evaluation\nEtiolog\u2020\tDiagnosti\u201a evaluation\nEndo\u201ari ne\n\u20ac\u2021H\u20acesting for insulin resist an\u201ae\u2021erum prola\u201atin level\u2039v arian reserve testingAntith\u2020r oid antibodies\n\u201enfe\u201atio us\n\u02dco evaluation is re\u201aommend ed unless the patient has evid en\u201ae of \u201ahroni\u201a endometritis/\n\u201aervi\u201aitis on examination, or is immuno\u201aompromised\nAutoim mune\nAnti\u201aardiolipin antibod\u2020 level s (\u201eg\u02c6 and \u201eg\u2030)\u0192upus anti\u201ao agulantHomo\u201a\u2020steine\u2018a\u201ator  \u2019 \u0192eidenProthrombin promo ter mutationA\u201ativated protei n \u2026 resistan\u201ae\nSolution to Question 10:\n\u20ache best mode of treatment for a pregnant woman with antiphospholipid s\u2020ndrome(AP\u2021) is aspirin and heparin.\nAP\u2021 is a prothromboti\u201a disorder (autoantibod\u2020-mediated thrombophilia) affe\u201ating both arterial and venous s\u2020stems.\nPatients present with re\u201aurrent pregnan\u201a\u2020 loss due to thrombosis of uteropla\u201aental vessels, poor pla\u201aental perfusion, and prevention of normal de\u201aidual \u201ahanges after z\u2020gote implantation. \u20ache\u2020 ma\u2020 also present with preterm deliver\u2020, pre-e\u201alampsia, intrauterine growth restri\u201ation (\u201eU\u02c6\u0152), and fetal death.\n\u2026riteria for AP\u2021 in\u201alude:\nat least one otherwise unexplained fetal death at or be\u2020ond 10 weeks;\nat least one preterm birth before \u00e7\u017d weeks gestation be\u201aause of e\u201alampsia, severe pree\u201alampsia, pla\u201aental insuffi\u201aien\u201a\u2020; or\nat least three unexplained \u201aonse\u201autive spontaneous abortions before 10 weeks.\nAspirin (60-\u00e80mg dail\u2020) with heparin (5000-10,000 U sub\u201autaneousl\u2020 ever\u2020 12h) is the most effe\u201ative therap\u2020 for AP\u2021. \u20acreating AP\u2021 with onl\u2020 aspirin (option A) is not re\u201aommended as heparin is \u201aru\u201aial in preventing thrombus formation at the de\u201aidual-thromboti\u201a interfa\u201ae,\n\u2026orti\u201aosteroids (option \u2026, D) should not be used in primar\u2020 AP\u2021 (without an asso\u201aiated\n\u201aonne\u201ative tissue disorder) but are indi\u201aated in patients with pre-existing s\u2020stemi\u201a lupus er\u2020thematosus (\u2021\u0192E) and AP\u2021 (se\u201aondar\u2020 AP\u2021).\nSolution to Question 11:\n\u2026atastrophi\u201a antiphospholipid antibod\u2020 s\u2020ndrome (\u2026AP\u2021) is a \u201aompli\u201aation of AP\u0192A s\u2020ndrome, in whi\u201ah \uf0b3\u00e7 organ s\u2020stems are involved. \u201et is also known as Asherson s\u2020ndrome.\n\u201et is seen in both primar\u2020 and se\u201aondar\u2020 AP\u0192A s\u2020ndrome. \u20acriggering fa\u201ators in\u201alude infe\u201ations, trauma, and obstetri\u201a \u201aauses. \u201e\u2019\u201e\u02c6 \u201aan be used in \u2026AP\u2021 when the first-line therapies with aspirin and heparin have failed.\n\u02dcote: Asherman s\u2020ndrome is an a\u201a\u2022uired \u201aondition \u201ahara\u201aterised b\u2020 formation of intrauterine adhesions or s\u2020ne\u201ahiae.\nSolution to Question 12:\n\u2026ervi\u201aal in\u201aompeten\u201ae or insuffi\u201aien\u201a\u2020 is \u201ahara\u201aterized b\u2020 repeated mid-trimester painless\n\u201aervi\u201aal dilatation. Es\u201aape of amnioti\u201a fluid followed b\u2020 painless expulsion of produ\u201ats of\n\u201aon\u201aeption \u201aan also be seen.\n\u0152isk fa\u201ators for \u201aervi\u201aal in\u201aompeten\u201ae:\n\u2026ongenital uterine anomalies\nA\u201a\u2022uired -\nDilatation and \u201aurrettage\nDilatation and eva\u201auation\n\u2019aginal operative deliver\u2020 through an undilated \u201aervix\nAmputation of \u201aervix\n\u2030ultiple gestations\nPrior preterm birt\nSolution to Question 13:\n\u201en-utero exposure to DE\u2021, twin pregnan\u201a\u2020, and bi\u201aornuate uterus in\u201arease the risk of \u201aervi\u201aal in\u201aompeten\u201ae.\n\u2039ffsprings born to pregnant mothers who were treated with dieth\u2020lstilbestrol ma\u2020 develop\n\u201aervi\u201aal h\u2020poplasia and malformation. \u20ache\u2020 ma\u2020 also present with \u201aervi\u201aal in\u201aompeten\u201ae during their 2nd trimester.\n\u2026ervi\u201aal in\u201aompeten\u201ae \u201aan be seen following \u2030\u20acP with surgi\u201aal methods and not with medi\u201aal methods.\n\u20ache retentive power of the internal os ma\u2020 be \u201aompromised b\u2020 anatomi\u201aal abnormalities like bi\u201aornuate uterus and overdistended uterus due to twin gestations.\n\u0152isk fa\u201ators for \u201aervi\u201aal in\u201aompeten\u201ae:\n\u2026ongenital uterine anomalies\nA\u201a\u2022uired -\nDilatation and \u201aurrettage\n\u201endu\u201aed abortion b\u2020 dilatation and eva\u201auation\n\u2019aginal operative deliver\u2020 through an undilated \u201aervix\nAmputation of \u201aervix\n\u2030ultiple gestations\nPrior preterm birt\nSolution to Question 14:\n\u201en the given image, the parameter marked A is funnelling of the internal os and the parameter marked B is \u201aervi\u201aal length. \u2018unnelling of internal os and \u201aervi\u201aal length &lt;25 mm are diagnosti\u201a of \u201aervi\u201aal in\u201aompeten\u201ae on transvaginal ultrasound.\n\n\nSolution to Question 15:\n\u20ache given \u201alini\u201aal s\u201aenario is suggestive of \u201aervi\u201aal in\u201aompeten\u201ae. \u201et \u201aan be managed with proph\u2020la\u201ati\u201a \u201aervi\u201aal \u201aer\u201alage done between 12 and 1\u017d weeks of gestation.\n\u0152es\u201aue or emergen\u201a\u2020 \u201aer\u201alage is done an\u2020time within 2\u017d weeks of gestation. \u201et should onl\u2020 be done when there is bulging of membranes through the dilated \u201aervix.\n\u201envestigations for \u201aervi\u201aal in\u201aompeten\u201ae:\n\u201en inter\u201aon\u201aeptional period -\nPassage of number 6 - \u00e8 Hegar's dilator be\u2020ond the internal os without resistan\u201ae or pain\n\u2018unnel-shaped shadow in premenstrual h\u2020stero\u201aervi\u201aograph\u2020\nDuring pregnan\u201a\u2020 -\nPer spe\u201aulum examination showing \u201aervi\u201aal dilatation with herniation of membranes\nU\u2021\u02c6 revealing \u201aervi\u201aal length &lt;2.5 \u201am and funnelling of internal os &gt;1 \u201am\nSolution to Question 16:\n\u2030\u201aDonald's pro\u201aedure is a t\u2020pe of \u201aervi\u201aal \u201aer\u201alage. \u201et \u201aan be done up to 2\u017d weeks of gestation.\n\u2026ontraindi\u201aations to \u201aervi\u201aal \u201aer\u201alage are:\nAbsolute\n&gt;2\u017d weeks of gestation\nA\u201ative labour\nA\u201ative vaginal bleeding\nAbruptio pla\u201aenta\nPremature rupture of membranes\n\u2026horioamnionitis\n\u2021evere uterine irritabilit\u2020\n\u2018etal death or defe\u201at\n\u0152elative\nProlapsed membranes\n\u2019aginal spotting\nSolution to Question 17:\n\u201en \u2030\u201aDonald's \u201aer\u201alage, a nonabsorbable suture, su\u201ah as \u2030ersilene, is pla\u201aed as a purse-string suture as high as possible at the level of the internal os, positioned at the jun\u201ation where the rugose vaginal epithelium transitions to the smooth vaginal portion of the \u201aervix, below the bladder.\nAnother \u201aer\u201alage pro\u201aedure is \u2030odified \u2021hirodker's te\u201ahni\u2022ue. \u201en this, a non-absorbable (mersilene) tape is passed sub\u201autaneousl\u2020 through a transverse anterior in\u201aision and is tied posteriorl\u2020.\n\u0152emoval of \u201aer\u201alage should be done b\u2020 \u00e77 weeks of gestation. \u201et \u201aan be removed earlier in \u201aase of preterm labour.\n\u2026ompli\u201aations of \u201aervi\u201aal \u201aer\u201alage:\n\u2021lipping of suture\n\u2026horioamnionitis\n\u0152upture of membranes\nAbortion or preterm labour\n\u2026ervi\u201aal la\u201aeration or s\u201aarring\n\nSolution to Question 18:\n\u2039nl\u2020 the patient's \u201aonsent is re\u2022uired for medi\u201aal termination of pregnan\u201a\u2020 (\u2030\u20acP) and her male partner's \u201aonsent is not re\u2022uired.\n\u2026onsent of parent/guardian is needed if the age of the patient is &lt;1\u00e8 \u2020rs or if the patient is mentall\u2020 ill.\nSolution to Question 19:\n\u2026hroni\u201a diabetes mellitus is not a \u201aontraindi\u201aation to medi\u201aal termination of pregnan\u201a\u2020 (\u2030\u20acP)\nwith medi\u201aal methods.\n\u2026ontraindi\u201aations to medi\u201aal methods of abortion are:\n\u00c5omen with in situ intrauterine devi\u201ae\n\u2021evere anemia, \u201aoagulopath\u2020, or anti\u201aoagulant use\n\u0192ong term \u201aorti\u201aosteroid therap\u2020\n\u2021evere liver, renal, pulmonar\u2020, or \u201aardiovas\u201aular disease\n\u201enherited porph\u2020ria\nUn\u201aontrolled h\u2020pertension\n\u2026ontraindi\u201aations to surgi\u201aal methods of abortion are:\n\u2021u\u201ation and eva\u201auation - uterine size &gt;10 weeks\n\u201entrauterine instillation of h\u2020pertoni\u201a solution - \u201aardiovas\u201aular or renal lesion and severe anaemia\nSolution to Question 20:\n\u2021u\u201ation and eva\u201auation \u201aan be done up to 12 weeks of gestation. \u201et is a method of termination of pregnan\u201a\u2020 in the first-trimester.\n\u20ache various methods of termination of pregnan\u201a\u2020 are:\n\u20aciming\n\u2030edi\u201aal methods\n\u2021urgi\u201aal methods",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_13.jpeg",
      "OBGYN_img_177.jpeg",
      "OBGYN_img_13.jpeg",
      "OBGYN_img_178.jpeg",
      "OBGYN_img_13.jpeg",
      "OBGYN_img_179.jpeg",
      "OBGYN_img_13.jpeg",
      "OBGYN_img_180.jpeg",
      "OBGYN_img_13.jpeg",
      "OBGYN_img_181.jpeg",
      "OBGYN_img_13.jpeg",
      "OBGYN_img_182.jpeg",
      "OBGYN_img_13.jpeg",
      "OBGYN_img_183.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch61_1",
    "question_text": "st trimester(up to 12 weeks)\n\u2030ifepristone\u2030ifepristone an d \u2030isoprostol\u2030ethotrexate a nd \u2030isoprostol\u20acamoxifen an d \u2030isoprostol\n\u2030enstrual regulation\u2019a\u201auum aspiration (\u2030\u2019A/E\u2019A)\u2021u\u201atio n eva\u201auation and/or \u201aurettag eDilatation and eva\u201auation - \u0152apid method\u2021low method",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch61_2",
    "question_text": "nd trimester(1\u00e7 - 20 weeks)\n\u2030isoprostolDinoprostone\u2026ar boprost\nDilatation and eva\u201auation\u201entr auterine instillation of h\u2020per osmoti\u201a solutions\u2039x\u2020to\u201ain in fusionH\u2020sterotom\u2020\nSolution to Question 21:\nDox\u2020\u201a\u2020\u201aline is the preferred drug for post-abortal antibioti\u201a proph\u2020laxis in this \u201aase. \u2039ral dox\u2020\u201a\u2020\u201aline 100 mg is given 1 hour before surgi\u201aal eva\u201auation. 200 mg is given after the pro\u201aedure is \u201aomplete.\n\u20ache best method of \u2030\u20acP at 7-12 weeks is b\u2020 su\u201ation and eva\u201auation. \u2018ollowing this pro\u201aedure, antibioti\u201a proph\u2020laxis is given with dox\u2020\u201a\u2020\u201aline.\nSolution to Question 22:\n\u2030isoprostol is given at a dose of \u00e800 m\u201ag b\u2020 mu\u201aosal route for \u2030\u20acP.\n\u2030u\u201aosal misoprostol administration has in\u201areased effi\u201aa\u201a\u2020 and minimizes gastrointestinal side effe\u201ats. Hen\u201ae, it is preferred over oral administration.\n\u00c5H\u2039 guidelines for medi\u201aal management in indu\u201aed abortion for &lt;12 weeks of gestation:\n\u2026ombined regimen (re\u201aommended): 200 mg of oral \u2030ifepristone followed 1-2 da\u2020s later b\u2020 \u00e800 m\u201ag of bu\u201a\u201aal, vaginal, or sublingual misoprostol\n\u2030isoprostol onl\u2020 regimen (alternative): \u00e800 \uf06dg misoprostol administered vaginall\u2020, sublinguall\u2020, or bu\u201a\u201aall\u2020\nSolution to Question 23:\nBleeding is prolonged and unpredi\u201atable in medi\u201aal methods of abortion.\n\u2026omparison of drawba\u201aks of medi\u201aal and surgi\u201aal methods of \u2030\u20acP:\n\u2018a\u201ator\n\u2030edi\u201aal methods\n\u2021urgi\u201aal methods\n\u201envasiveness\nUsuall\u2020 not invasive\n\u201envasive\nPain\n\u2030ore\n\u0192ess\n\u2019aginal bleeding\nProlonged, unpredi\u201atable\n\u0192ight, predi\u201atable\n\u201en\u201aomplete aborti on\n\u2030ore \u201aommon\nUn\u201aommon\n\u2018ailure rate",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch61_2",
    "question_text": "5%",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch62_1",
    "question_text": "%\n\u2021evere bleeding",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch62_0",
    "question_text": "1%",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch62_0",
    "question_text": "1%\n\u201enfe\u201ation rate\n\u0192ow\n\u0192ow\nAnesthesia\nUsuall\u2020 not given\nAlwa\u2020s given\n\u20acime involved\n\u2030ultiple visits for follow-up\nUsuall\u2020 one visit\u02dco follow-up s re\u2022uired\nSolution to Question 24:\n\u20ache given \u201alini\u201aal s\u201aenario is suggestive of toxi\u201a sho\u201ak s\u2020ndrome (\u20ac\u2021\u2021) following septi\u201a abortion. Es\u201aheri\u201ahia \u201aoli \u201aan be dete\u201ated in septi\u201a abortion, but it is not a \u201aausative agent for\n\u20ac\u2021\u2021.\n\u2039rganisms \u201aausing toxi\u201a sho\u201ak s\u2020ndrome in septi\u201a abortion:\n\u2021trepto\u201ao\u201a\u201aus p\u2020ogenes\n\u2026lostridium perfringens\n\u2026lostridium sordellii\n\u2026lini\u201aal features of septi\u201a abortion:\n\u2018ever with \u201ahills and rigors\nAbdominal or \u201ahest pain\nDiarrhoea and vomiting\n\u0152enal angle tenderness\n\u2039ffensive purulent vaginal dis\u201aharge.\n\u2026lini\u201aal grading of septi\u201a abortion:\n\u02c6rade \u201e - infe\u201ation lo\u201aalized in the uterus\n\u02c6rade \u201e\u201e - infe\u201ation spreads to parametrium, tubes, ovaries, or pelvi\u201a peritoneum\n\u02c6rade \u201e\u201e\u201e - generalized peritonitis, endotoxi\u201a sho\u201ak, jaundi\u201ae, or a\u201aute renal failure Empiri\u201aal antibioti\u201a therap\u2020 in septi\u201a abortion is started for the broadest mi\u201arobial \u201aoverage.\nPipera\u201aillin-tazoba\u201atam or \u201aarbapenem and \u201alindam\u2020\u201ain are given intravenousl\u2020. Antibioti\u201as \u201aan be \u201ahanged on\u201ae \u201aulture sensitivit\u2020 reports are available.\nSolution to Question 25:\nAn untreated seizure disorder in pregnan\u201a\u2020 is not a risk fa\u201ator for stillbirth. However, the use of\n\u201aertain anti-epilepti\u201a drugs like valproate \u201aould lead to the development of neural tube defe\u201ats in the bab\u2020.\n\u0152e\u201aent studies haven't \u201aonsistentl\u2020 shown that untreated women with epileps\u2020 fa\u201ae a higher risk, though it's hard to rule out entirel\u2020 be\u201aause those who manage without medi\u201aation usuall\u2020 have milder s\u2020mptoms. \u0152e\u201aent resear\u201ah found that birth defe\u201ats were more \u201aommon in \u201ahildren of women who used anti\u201aonvulsants.\n\u0152isk fa\u201ators for stillbirth are:\nAdvan\u201aed maternal age\nAfri\u201aan-Ameri\u201aan ra\u201ae\n\u2021moking\n\u201elli\u201ait drug use\n\u2030aternal medi\u201aal diseases - overt diabetes or \u201ahroni\u201a h\u2020pertension\nAssisted reprodu\u201ative te\u201ahnolog\u2020\n\u02dculliparit\u2020\n\u2039besit\u2020\nPrevious adverse pregnan\u201a\u2020 out\u201aomes - prior preterm birth or \u201eU\u02c6\u0152\n\u02dcote: \u2021tillbirth rates appear to be slightl\u2020 in\u201areased in pregnan\u201aies \u201aon\u201aeived via assisted reprodu\u201ative te\u201ahnolog\u2020.\nSolution to Question 26:\n\u20ache development of uterine s\u2020ne\u201ahiae is the most likel\u2020 \u201aause of amenorrhoea in the given \u201alini\u201aal s\u201aenario.\n\u2026ertain t\u2020pes of spontaneous abortions su\u201ah as inevitable, in\u201aomplete and missed abortions might re\u2022uire medi\u201aal assistan\u201ae for \u201aomplete removal of produ\u201ats of \u201aon\u201aeption in\u201aluding pro\u201aedures su\u201ah as dilatation and \u201aurettage.\n\u2019igorous uterine \u201aurettage in earl\u2020 pregnan\u201a\u2020 damages the basal la\u2020er of endometrium leading to s\u201aarring and adhesions in the uterus that interferes with normal endometrial growth and shedding.\u20achis \u201aauses the \u201alini\u201aal feature of se\u201aondar\u2020 amenorrhea as seen in this patient.\n\u20achis intrauterine adhesions are known as uterine s\u2020ne\u201ahiae or Asherman s\u2020ndrome.\nAs there is no defe\u201at in the h\u2020pothalamo-pituitar\u2020-ovarian axis in the asherman s\u2020ndrome, the levels of \u2018\u2021H remain within the normal range of \u017d - 25 \u201eU/\u0192 as seen in this patient.\n\u201en the \u201aase of Pituitar\u2020 d\u2020sfun\u201ation (option A) the \u2018\u2021H levels are usuall\u2020 de\u201areased.\n\u201en ovarian d\u2020sfun\u201ation (option B) the negative feedba\u201ak of ovarian hormones (estrogen) on pitutar\u2020 and h\u2020pothalamus is lost. Hen\u201ae, the levels of \u2018\u2021H is in\u201areased (\uf0b3 25 \u201eU).\nAsherman s\u2020ndrome is \u201ahara\u201aterised b\u2020 a spe\u201atrum of intra uterine s\u201aarring in\u201aluding thin adhesions, dense bands, or \u201aomplete obliteration of the uterine \u201aavit\u2020. \u201et o\u201a\u201aurs due to endometrial damage following vigorous \u201aurettage, usuall\u2020 in mis\u201aarriage, or ele\u201ative abortion. Damage ma\u2020 also o\u201a\u201aur from other uterine surgeries su\u201ah as m\u2020ome\u201atom\u2020 or \u201aesarean deliver\u2020 or from an infe\u201ation related to an intrauterine devi\u201ae.\nDepending on the degree of s\u201aarring, patients ma\u2020 present with amenorrhea, h\u2020pomenorrhea or re\u201aurrent pregnan\u201a\u2020 loss due to inade\u2022uate pla\u201aentation.\nAsherman s\u2020ndrome shows multiple filling defe\u201ats on h\u2020sterosalpingograph\u2020 (H\u2021\u02c6) or\nsaline-infusion sonograph\u2020. Definitive diagnosis re\u2022uires h\u2020steros\u201aop\u2020. H\u2020steros\u201aopi\u201a l\u2020sis of adhesions is the preferred surgi\u201aal treatment for the s\u2020ndrome.\nAntepartum Hemorrhage\nQuestion 1:\nAntepartum hemorrhage is defined as bleeding from the genital tract after \t.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch62_22",
    "question_text": "nd week of pregnancy",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch62_24",
    "question_text": "th week of pregnancy",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch62_26",
    "question_text": "th week of pregnancy",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch62_28",
    "question_text": "th week of pregnancy\nQuestion 2:\nWhat is the most common cause of antepartum haemorrhage?\nAbruptio placenta\nPlacenta previa\nLocal trauma\nCervical varicosities\nQuestion 3:\nTransvaginal ultrasound findings in a multiparous woman revealed a low lying placenta. What does this mean?\nPlacental edge within 2 cm from the internal os\nPlacental edge within 3 cm from the internal os\nPlacental edge within 4 cm from the internal os\nPlacenta overlying the internal os\nQuestion 4:\nWhich of the following types are included in the major degrees of placenta previa?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch62_5",
    "question_text": "only",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch62_4",
    "question_text": "and 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch63_1",
    "question_text": ", 2, 3 and 4",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch63_3",
    "question_text": ", 4 and 5\nQuestion 5:\nA 30-year-old multiparous woman presented at 32 weeks of gestation with complaints of recurrent painless vaginal bleeding. On examination, fundal height corresponded to gestational age and fetal heart rate was 140 bpm. Which of the following is not a risk factor for this condition?\nPre eclampsia\nMultifetal gestation\nCigarette smoking\nArtificial reproductive technology\nQuestion 6:\nPer speculum examination findings in a pregnant woman with vaginal bleeding showed placenta protruding through the cervical os. What is the type of placenta previa in this case?\nType 1\nType 2\nType 3\nType 4\nQuestion 7:\nA patient at 34 weeks of gestation presented with placenta previa. Which of the following is false about this condition?\nPainful recurrent vaginal bleeding is seen\nThe size of the uterus corresponds to gestational age\nThe uterus is relaxed\nFloating head can be palpated\nQuestion 8:\nAbdominal examination during a routine antenatal checkup gave a positive Stallworthy sign. What could be the most probable cause?\nConcealed abruptio placenta\nVasa previa\nPosterior placenta previa\nCord compression\nQuestion 9:\nA G2P1 woman presents to the casualty at 30 weeks with a history of self-limiting painless bleeding PV 3 hours ago. On examination, BP - 110/70 mmHg and PR - 80 bpm. What is the next best step in management?\nTransvaginal ultrasound to confirm the diagnosis\nStart injection corticosteroids for fetal lung maturity\nImmediate caesarean section\nExpectant management till 37 weeks\nQuestion 10:\nA G2P1L1 woman at 30 weeks of gestation was rushed to the casualty with complaints of painless vaginal bleeding. She had woken up to find herself in a pool of blood. On examination, her vitals were unstable. Active bleeding per vaginum was present. Which of the following complications would not be anticipated in her?\nBirth asphyxia\nPreterm labour\nPrecipitate labour\nPostpartum haemorrhage\nQuestion 11:\nTransvaginal ultrasound in a multiparous woman at 32 weeks confirmed placenta previa. Her vitals are stable and there is no active bleeding PV. What is the next step in management?\nImmediate caesarean delivery\nImmediate induction and vaginal delivery\nManage as per McAfee and Johnson method\nManage as per Sher and Page grading\nQuestion 12:\nSuitable cases for expectant management in case of placenta previa include all except:\nAssured fetal well-being\nDuration of pregnancy &gt;37 weeks\nMother in good health\nNo active vaginal bleeding\nQuestion 13:\nWhat is the most common cause of consumptive coagulopathy in obstetrics?\nIntrauterine death\nAmniotic fluid embolis\nSepsis\nPlacental abruption\nQuestion 14:\nWhich of the following does not increase the risk of placental abruption?\nPre-eclampsia\nCigarette smoking\nPost term pregnancy\nTwin pregnancy\nQuestion 15:\nWhich of the following clinical features can be seen in a patient presenting with accidental haemorrhage?\nPainless bleeding PV\nUterus is tender\nUterine size is disproportionately small\nPositive Stallworthy sign\nQuestion 16:\nA multiparous woman at 34 weeks of gestation presented with bleeding per vaginum and was diagnosed to have grade 2 abruptio placenta. Which of the following features may be seen in her?\nHypovolemic shock\nAnuria\nCoagulation defect\nFetal distress\nQuestion 17:\nA 23-year-old primigravida at 32 weeks of gestation presents to the labour room with lower abdominal pain. Her vitals are BP - 90/60 mmHg and PR - 120 bpm. Fetal distress was noted and she was taken up for a caesarean section. The uterus appears as shown below. Which of the following is true regarding this condition?\n\nIt is seen in revealed abruptio placenta\nIt is an indication for hysterectomy\nIt is a case of uteroplacental apoplexy\nBroad ligament is spared\nQuestion 18:\nColour doppler studies in a patient with velamentous cord insertion revealed fetal vessels which were overlying the cervical os. Which of the following is false regarding her condition?\nMaternal mortality is high\nBleeding is triggered by membrane rupture\nBleeding is managed by category I caesarian section\nApt test is diagnostic\nQuestion 19:\nSample from a patient with bleeding PV at 30 weeks showed a positive Apt test. What is the most probable cause?\nCervical polyp\nVasa previa\nAbruptio placenta\nPlacenta previa\nQuestion 20:\nWhich of the following investigations can be used in the antenatal diagnosis of vasa previa in a patient with no history of bleeding PV?\nSinger's alkali denaturation test\nTransabdominal ultrasound\nColour doppler\nMRI\nQuestion 21:\nA multiparous woman at term presents to the labour room with bleeding per vaginum and ruptured membranes. NST shows fetal distress and sinusoidal heart rate pattern. How will you manage this patient?\nRapid induction and delivery by vacuu\nRapid induction and delivery by forceps\nImmediate LSCS\nAdopt Vagos method and rapid vaginal delivery\nQuestion 22:\nThe classical triad of amniotic fluid embolism includes all except \t.\nMetabolic acidosis\nHypotension\nHypoxia\nDIC\nQuestion 23:\nA G2P1L1 woman presented with placental abruption and was delivered by normal vaginal delivery. The next day, she develops petechiae, cold extremities, and her BP drops to 90/60 mmHg. Her blood reports show increased FDP, D-dimer, and decreased platelets. Which of the following is not used in the management of her condition?\nEpsilon-aminocaproic acid\nPacked RBCs transfusion\nIntravenous fluids\nCryoprecipitate\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_14.jpeg",
      "OBGYN_img_184.png"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_1",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_2",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_3",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_4",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_5",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_6",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_7",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_8",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_9",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_10",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_11",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_12",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_13",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_14",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_15",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_16",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_17",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_18",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_19",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_20",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_21",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_22",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_23",
    "question_text": "\na\nSolution to Question 1:\nAntepartum haemorrhage (APH) is defined as bleeding from or into the genital tract after 28 weeks of gestation up to the delivery of the baby. The lower limit is the period of viability and the upper limit includes the 1st and 2nd stages of labour.\nCauses of APH:\nPlacental causes:\nAbruptio placenta (most common)\nPlacenta previa (2nd most common)\nCircumvallate placenta\nCircummarginate placenta\nFetal causes:\nVasa previa\nExtraplacental causes (local cervicovaginal lesions):\nLocal trauma\nVaricose veins\nCervical polyp\nCarcinoma cervix.\nNote: According to RCOG criteria, the lower limit for APH is 24 weeks. However, in India, the period of viability is 28 weeks, so it is taken as the lower limit for APH.\nSolution to Question 2:\nAbruptio placenta is the most common cause of antepartum haemorrhage (APH).\nPlacental abruption or abruptio placenta is the premature separation of a normally situated placenta. The bleeding can be revealed, concealed or mixed type.\nCauses of APH:\nPlacental causes:\nAbruptio placenta (most common)\nPlacenta previa (2nd most common)\nCircumvallate placenta\nCircummarginate placenta\nFetal causes:\nVasa previa\nExtraplacental causes (local cervicovaginal lesions):\nLocal trauma\nVaricose veins\nCervical polyp\nCarcinoma cervix.\nSolution to Question 3:\nIn low lying placenta, the edge of the placenta lies within 2 cm from the internal os but does not cover the internal os.\nPlacenta previa is a condition where the placenta is implanted over the lower uterine segment\n(partially or completely).\nACOG classification of placenta previa:\nTrue placenta previa - placenta covers the internal os partially or completely\nLow lying placenta - placenta does not cover the internal os but the edge is within 2 cm of the internal os\nSolution to Question 4:\nMajor degree of placenta previa includes posterior marginal, partial and complete central. Clinical classification of placenta previa:\nMild degree\nType I or lateral or low lying\nType II anterior or anterior marginal\nMajor degree\nType II posterior or posterior marginal or dangerous placenta previa\nType III or partial central\nType IV or complete\nOlder (Browne's) classification of placenta previa:\nType\nPosition\nDefinition\nType I\nLateral\nThe placenta dips into the lo wer segment but does not rea ch up to the os\nType II\nMarginal\nThe placental edge reaches th e os\nType III\nIncomplete or partial central\nThe placenta partially covers the internal os\nType IV\nComplete or central\nThe placenta completely cove rs the internal os\n\nSolution to Question 5:\nThe given clinical scenario is suggestive of placenta previa. Pre-eclampsia is a risk factor for abruptio placenta, not placenta previa.\nPainless bleeding PV, fundal height proportional to gestational age and presence of FHS are the differentiating features of placenta previa from abruptio placenta.\nRisk factors for placenta previa are:\nDemographic factors\nMaternal age &gt;35 years\nMultiparity\nCigarette smoking\nClinical factors\nPrior caesarean section\nPast history of placenta previa\nArtificial reproductive technology\nMultifetal pregnancy\nSuccenturiate lobe.\nSolution to Question 6:\nPlacenta protruding through the internal os on per speculum examination indicates complete placenta previa or type IV placenta previa.\nOlder (Browne's) classification of placenta previa:\nCervical digital examination must only be done in suspected cases of placenta previa in an operation theater with provisions for cesarean section kept ready.\nType\nPosition\nDefinition\nType I\nLateral\nThe placenta dips into the lo wer segment but does not rea ch up to the os\nType II\nMarginal\nThe placental edge reaches th e os\nType III\nIncomplete or partial central\nThe placenta partially covers the internal os\nType IV\nComplete or central\nThe placenta completely cove rs the internal os\n\nSolution to Question 7:\nPainless recurrent vaginal bleeding is seen in placenta previa. Clinical features of placenta previa:\nBleeding per vaginum - sudden onset, painless, recurrent, bright red in colour, sometimes a history of warning haemorrhage is present\nUterus - relaxed, soft, no tenderness, size proportional to the period of gestation\nFloating head i.e., persistent displacement of fetal head as it cannot be pushed down into the pelvis\nFetal heart sound - present\nStallworthy sign - seen in low lying placenta, especially the posterior type. Slowing of fetal heart rate (FHR) on pressing the head down into the pelvis, which recovers promptly as pressure is relieved, is called Stallworthy sign.\nSolution to Question 8:\nStallworthy sign is observed in posterior placenta previa.\nThe slowing of fetal heart rate on pressing the head down into the pelvis, which recovers promptly when the pressure is relieved, is called Stallworthy sign.\nNote: This sign is not always significant as this could also occur in normal pregnancies due to fetal head compression.\nSolution to Question 9:\nThe given clinical scenario is suggestive of antepartum haemorrhage (APH) due to placenta previa (painless bleeding PV). The next step in the management is to confirm the diagnosis with transvaginal ultrasound (TVS) as the patient is stable.\nTransabdominal ultrasound (TAS) is used to detect the cause of APH.\nIf the placenta is in the lower uterine segment on TAS, confirmation of placenta previa is done by TVS. TVS provides a clearer image of the relationship between the edge of the placenta and the internal cervical os than TAS.\nApproach to placenta previa after confirmation with TVS:\nMinor placenta previa - repeat USG at 36 weeks\nMajor placenta previa or accreta - USG at 32 weeks followed by elective caesarean delivery\nBleeding present - individual management\nOn TAS, if the placenta is in the upper uterine segment with evidence of retroplacental blood clot, abruptio placenta is suspected.\nPer vaginal examination in placenta previa must not be done as it may further separate the placenta and cause excessive bleeding. However, transvaginal ultrasound is safe as long as the probe is 2-3 cm away from the cervix.\nSolution to Question 10:\nThen given clinical scenario is suggestive of placenta previa and precipitate labour is not a complication. Precipitate labour is seen in abruptio placenta and uterine tachysystole.\nVaginal bleeding in placenta previa is sudden in onset, recurrent, painless, unrelated to activity, and often occurs during sleep.\nComplications of placenta previa: Maternal complications:\nFetal complications:\nLow birth weight\nAsphyxia\nIntrauterine death\nBirth injuries\nCongenital malformations.\nPeriod\nComplication\nAntepart um\nAntepartum haemorrhageMa lpresentationPreterm labour\nPeriod\tComplication\nPeriod\tComplication\nIntrapart um\nEarly rupture of membranesS low dilatation of cervix\nPostpart um\nPostpartum haemorrhage\nPuerperi um\nSepsisSubinvolution\nSolution to Question 11:\nIn the given clinical scenario, the next best step of management is conservative management till 37 weeks i.e., McAfee and Johnson's regimen.\nThe aim of conservative management is to continue the pregnancy for fetal maturity without compromising maternal health.\nPrerequisites:\nBlood for transfusion\nFacilities for cesarean section\nSelection of cases for expectant management for placenta previa:\nMother is hemodynamically stable (Hb &gt;10 g% and/or hematocrit &gt; 30%)\nDuration of pregnancy &lt;37 weeks\nNo active vaginal bleeding\nFetus reactive on cardiotocography and no congenital anomalies on USG Conduct of expectant treatment:\nCorticosteroids for fetal lung maturity\nBed rest or pelvic rest\nPeriodic monitoring of mother for bleeding PV\nFetal surveillance with USG\nTocolytics if contractions are present\nAnti-D to all Rh-negative unsensitized women\nOption A: Immediate caesarean section after resuscitation is done if the patient is unstable.\nOption B: Vaginal delivery is considered when the edge of the placenta is &gt;2 cm away from the internal os.\nOption D: Sher and Page grading is for abruptio placenta.\nSolution to Question 12:\nThe duration of pregnancy must be less than 37 weeks for expectant management which was advocated by McAfee and Johnson.\nThe aim of conservative management is to continue the pregnancy for fetal maturity without compromising maternal health.\nPrerequisites:\nAvailability of blood for transfusion\nFacilities for cesarean section available\nSelection of cases for expectant management for placenta previa:\nMother is hemodynamically stable (Hb &gt;10 g% and/or hematocrit &gt; 30%)\nDuration of pregnancy &lt;37 weeks\nNo active vaginal bleeding\nFetus normal on USG and reactive on CTG Conduct of expectant treatment:\nCorticosteroids for fetal lung maturity\nBed rest or pelvic rest\nPeriodic monitoring of mother for bleeding pv\nFetal surveillance with USG\nTocolytics if contractions are present\nAnti-D to all Rh-negative (unsensitized) women.\nSolution to Question 13:\nPlacental abruption is the most common cause of severe consumptive coagulopathy in obstetrics.\nConsumptive coagulopathy, also known as disseminated intravascular coagulation (DIC), is a pathologic disruption of hemostasis. It is characterized by systemic activation of blood coagulation, which results in thrombosis and fibrin deposition in the small blood vessels throughout the body.\nOther causes of DIC in pregnancy:\nAmniotic fluid embolis\nSepsis\nPreeclampsia and HELLP syndrome\nAcute fatty liver of pregnancy\nPostpartum haemorrhage.\nSolution to Question 14:\nPost term pregnancy does not increase the risk of abruptio placenta. Risk factors for placental abruption:\nPrior abruption\nIncreased age and parity\nPre-eclampsia and chronic hypertension\nChorioamnionitis\nPreterm ruptured membranes\nMultifetal gestation\nCocaine use\nCigarette smoking\nUterine leiomyomas\nSingle umbilical artery.\nSolution to Question 15:\nAbruptio placenta is also known as accidental haemorrhage or premature separation of placenta. Tender uterus is seen in abruptio placenta.\nAbruptio placenta is defined as premature separation of a normally situated placenta. It is of the following types:\nConcealed\nRevealed\nMixed\nClinical features of abruptio placenta:\nIn mixed type, features of concealed variety will be predominant.\nFeatures\nRevealed\nConcealed\nGeneral conditi on\nProportionate to visible bloo d loss\nShock may be pronounced w hich may be out of proportio n to visible bleeding.\nSymptoms\nAbdominal discomfort or pai n followed by bleeding\nAbdominal acute intense pai nNo or minimal bleeding\nUterine height\nProportionate to the period o f gestation\nMaybe disproportionately enl arged\nFHS\nUsually present\nUsually absent\nSolution to Question 16:\nGrade 2 abruptio placenta is characterized by fetal distress. Sher and Page clinical classification of placental abruption:\nGrade 0 of abruptio placenta is seen in an asymptomatic patient, where a retroplacental clot is observed only after delivery of placenta.\nFeature\nGrade 1\nGrade 2\nGrade 3\nVaginal bleeding\nSlight\nMild to moderate\nModerate to severe or concea led type\nUterine tenderness\nMinimal\nPresent\nMarked\nMaternal BP and pulse rat e\nUnaffect ed\nBP maintainedPulse rate incr eased\nHypovolemic shockAnuria\nFetal condition\nFHS go od\nFetal distress\nFetal death\nMaternal fibrinogen\nUnaffect ed\nDecreased\nCoagulation defect\nSolution to Question 17:\nThe given image shows a couvelaire uterus or uteroplacental apoplexy which is seen in severe forms of concealed abruptio placenta.\nThere is massive extravasation of blood into the uterine musculature up to the serosa. Thus, the uterus has a port wine colour, which can be patchy or diffuse. They can also extend to the broad ligament, ovaries and peritoneal cavity.\nIt is usually observed during caesarean section. It is not an indication of hysterectomy.\nSolution to Question 18:\nThe doppler findings are suggestive of vasa previa. Maternal mortality is not seen in vasa previa, but fetal mortality is seen.\nVasa previa is a condition where fetal vessels travel within the membranes and overlie the cervical os. Hence, there can be bleeding during cervical dilatation or membrane rupture.\nFetal mortality is high and is due to fetal exsanguination.\n\nInvestigations of vasa previa:\nColour flow Doppler (TVS)\nSinger's alkali denaturation test - to detect nucleated red blood cells\nApt test (alkali denaturation test) - to detect fetal haemoglobin Management of vasa previa:\nNo bleeding",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_14.jpeg",
      "OBGYN_img_185.jpeg",
      "OBGYN_img_14.jpeg",
      "OBGYN_img_186.jpeg",
      "OBGYN_img_14.jpeg",
      "OBGYN_img_187.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_28",
    "question_text": "32 weeks - antenatal corticosteroids",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_30",
    "question_text": "34 weeks - admission for surveillance\n\uf0b337 weeks - elective caesarean section\nBleeding present\nCategory I emergency caesarean section is done (immediate threat to the life of mother or fetus and decision delivery interval &lt;30 mins)\nSolution to Question 19:\nApt test is an alkali denaturation test to detect fetal haemoglobin (HbF). It is positive in vasa previa and Rh incompatibility.\nApt test is based on the principle that HbF is resistant to alkali denaturation, while HbA is not. It is done by taking the blood sample in a test tube containing water and adding 10% NaOH. Maternal blood turns yellow-brown, while fetal blood remains pink in the test tube.\nBleeding due to vasa previa must be managed immediately with an emergency caesarean section. Hence, Apt test is not practically done in all cases.\nOther options: Bleeding due to cervical polyp, placenta previa, and abruptio placenta is of maternal origin. So, Apt test will be negative in these cases.\nSolution to Question 20:\nThe antenatal diagnosis of vasa previa can be done by colour doppler.\nVasa previa is a condition where fetal vessels travel within the membranes and overlie the cervical os. Hence, there can be bleeding during cervical dilatation or membrane rupture.\nFetal mortality is high due to fetal exsanguination. Investigations of vasa previa:\nColour flow Doppler (TVS)\nSinger's alkali denaturation test - to detect nucleated red blood cells\nApt test - to detect fetal haemoglobin Management of vasa previa:\nNo bleeding",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_28",
    "question_text": "32 weeks - antenatal corticosteroids",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_30",
    "question_text": "34 weeks - admission for surveillance\n\uf0b337 weeks - elective caesarean section\nBleeding present\nEmergency caesarean section done by category I\nOptions A and B: Colour Doppler is superior to MRI and TAS in the antenatal diagnosis of vasa previa.\nOption D: Singer's alkali denaturation test to detect fetal RBCs can be used in intrapartum diagnosis of vasa previa (as there might be bleeding).\nSolution to Question 21:\nThe given clinical scenario is suggestive of vasa previa since bleeding is associated with fetal distress and sinusoidal pattern in NST. Actively bleeding vasa previa in a term gestation is managed by immediate LSCS.\nSinusoidal pattern in CTG is a regular, smooth, undulating signal resembling a sine wave. It can be seen in conditions associated with severe fetal anemia like:\nAnti-D allo-immunisation\nFetal-maternal haemorrhage\nTwin-to-twin transfusion syndrome\nRuptured vasa previa\nAcute fetal hypoxia\nInfection\nCardiac malformations\nHydrocephalus\nGastroschisis\nSinusoidal pattern on CTG:\n\nManagement of vasa previa:\nNo bleeding",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_14.jpeg",
      "OBGYN_img_188.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_28",
    "question_text": "32 weeks - antenatal corticosteroids",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_30",
    "question_text": "34 weeks - admission for surveillance\n\uf0b337 weeks - elective caesarean section\nBleeding present\nEmergency caesarean section\nNote: Vagos method is used in the management of umbilical cord prolapse.\nSolution to Question 22:\nThe classical triad of amniotic fluid embolism does not include metabolic acidosis. Classical triad of amniotic fluid embolism:\nHypotension\nHypoxia\nDIC\nConditions predisposing to the development of amniotic fluid embolism:\nRapid labour\nMeconium-stained amniotic fluid\nTears in uterine and other large pelvic veins\nOlder maternal age\nPost-term pregnancy\nLabour induction or augmentation\nEclampsia\nCesarean/forceps/vacuum delivery\nPlacental abruption/placenta previa\nPolyhydramnios.\nSolution to Question 23:\nThe given clinical scenario is suggestive of disseminated intravascular coagulation (DIC).\nEpsilon-aminocaproic acid and tranexamic acid are not used in the treatment of DIC. Evaluation and management of DIC:\nVigorous restoration and maintenance of circulation to treat hypotension\nCrystalloids and colloids to treat hypotension\nWhole blood and packed cells\nFresh frozen plasma - contains fibrinogen, antithrombin III, factors V, XI, XII\nCryoprecipitate - contains fibrinogen, factor VIII, von Willebrand\u2019s factor, factor XIII\nPlatelet replacement if low\nIdentification of the cause:\nAbruptio placenta\nPPH\nHELLP syndrome\nAmniotic fluid embolis\nSepsis\nAcute fatty liver\nAssess the fetal condition and plan for termination of pregnancy.\nPostpartum Haemorrhage\nQuestion 1:\nIn a patient who has completed the 3rd stage of labor following vaginal delivery, what is the minimum amount of blood loss required for her to be diagnosed with postpartum hemorrhage?\n500 mL\n750 mL\n1000 mL\n1500 mL\nQuestion 2:\nA grand multipara had continuous, moderate vaginal bleeding immediately after delivery. W at could be the most probable cause of bleeding in this patient?\nUterine atony\nRetained tissues\nGenital tract trauma\nUterine inversion\nQuestion 3:\nW ich of the following is the most probable cause of bleeding per vaginum occurring 24 ours after delivery?\nEpisiotomy wound\nRetained cotyledon\nPlacenta accreta\nUterine atony\nQuestion 4:\nW ich of the following is not a cause of secondary PPH?\nRetained cotyledon\nEndometritis\nPlacental polyp\nPlacenta previa\nQuestion 5:\nW ich of the following complications during pregnancy does not increase the risk of PPH?\nOligohydramnios\nFibroid uterus\nPre eclampsia\nMacrosomia\nQuestion 6:\nIn a patient with GDM complicating pregnancy, there was severe bleeding following the delivery of the placenta. On abdominal palpation, the fundus felt soft and later became hard on massaging. Which of the following is not a risk factor for this condition?\nObesity\nHigh parity\nProlonged labour\nUterine rupture\nQuestion 7:\nW ich of the following is not included in the active management of the third stage of labor to prevent postpartum hemorrhage?\nUterotonic within 1 minute of delivery\nDelayed clamping, cutting and ligation of cord\nGentle massage of uterus\nControlled cord traction\nQuestion 8:\nA patient with pre-eclampsia presents with profuse bleeding after delivery. Which of the following drugs can be used in the medical management of this patient?\nMethergine\nCarboprost\nMisoprostol\nDinoprost\nQuestion 9:\nIn a case of atonic PPH, a methyl PGF2 alpha derivative was given every 15 mins as a uterotonic. What is the maximum number of times the drug can be administered?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_5",
    "question_text": "times\n\u00e8 times",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_15",
    "question_text": "times",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_32",
    "question_text": "times\nQuestion 10:\nAs per 2017 WHO guidelines for the treatment of PPH, which of the following statements is true?\nUterine massage is not recommended in PPH when oxytocin is administered\nIntravenous colloids are the recommended fluids for initial resuscitation\nIf the PPH is not responsive to uterotonics, uterine artery embolisation is the next step\nTranexamic acid is administered early in all cases of PPH\nQuestion 11:\nFollowing normal vaginal delivery, a patient developed PPH and lost about 700mL of blood. Her PR was 100 bpm and her BP was 100/60mmHg. What is the value and corresponding interpretation of her shock index?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_0",
    "question_text": "7 - normal",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_0",
    "question_text": "7 - significant",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_1",
    "question_text": "- significant",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_1",
    "question_text": "- normal\nQuestion 12:\nA patient was referred to the casualty from a district hospital with atonic PPH. Which of the following measures is least likely to be done?\nCarry out uterine massage\nUse non-pneumatic anti-shock garment to stabilize the patient\nContinuous iv infusion of oxytocin\nVolume resuscitation with iv crystalloids\nQuestion 13:\nA 35-year-old multipara with atonic PPH continues to bleed profusely despite medical management and tamponade. Which of the following methods cannot be used to reduce bleeding in this patient?\nHysterectomy\nThermal endometrial ablation\nInternal iliac artery ligation\nAngiographic selective artery embolisation\nQuestion 14:\nIdentify the instrument in the image given below.\n\nBakri balloon\nFoley's catheter\nSengstaken blakemore tube\nCondom catheter\nQuestion 15:\nW at is the capacity of balloon tamponade to arrest PPH?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_14.jpeg",
      "OBGYN_img_189.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_100",
    "question_text": "- 250 mL",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_300",
    "question_text": "- 500 mL",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_500",
    "question_text": "- 750 mL",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch64_700",
    "question_text": "- 900 mL\nQuestion 16:\nA P3 woman bleeds profusely after delivery of the placenta. You initiate oxytocin infusion. The patient continues to bleed and the uterus fails to contract despite bimanual compression. S e becomes tachycardic and hypotensive. What is the next best step in her management?\nTight intrauterine packing with gauze\nBalloon tamponade\nLigation of uterine arteries\nHysterectomy\nQuestion 17:\nA pregnant lady delivered her baby unattended while she was on the way to the hospital.\nW ile examining her, you note a perineal tear in which the anal sphincter is disrupted. This tear is classified as\t.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch65_1",
    "question_text": "st degree",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch65_2",
    "question_text": "nd degree",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch65_3",
    "question_text": "rd degree",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch65_4",
    "question_text": "th degree\nQuestion 18:\nIdentify B lynch suture from the image given below.\n",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_14.jpeg",
      "OBGYN_img_190.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch66_1",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch66_2",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch66_3",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch66_4",
    "question_text": "\nQuestion 19:\nA patient with severe PPH is shifted to the emergency OT for B lynch compression sutures. W ich of the following statements is false about this procedure?\nThe suture loops over the fundus\nNot used in atonic PPH\nUterine cavity is compressed antero-posteriorly\nUterine ischaemic necrosis is a complication\nQuestion 20:\nW ich of the following statements are true?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_1",
    "question_text": ", 2, 3",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_1",
    "question_text": ", 3, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_1",
    "question_text": ", 4, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_1",
    "question_text": ", 2, 4\nQuestion 21:\nIn a patient with hydramnios complicating pregnancy, the third stage of labour was managed by applying fundal pressure and controlled traction of the cord. On palpation, the uterus was still soft and boggy. Within a few minutes, there was moderate bleeding per vaginum following which a reddish-purple mass was expelled. The patient then developed hypotension, bradycardia and went into shock. What is the most probable diagnosis?\nAmniotic fluid embolism\nAtonic postpartum haemorrhage\nUterine inversion\nPlacenta accreta\nQuestion 22:\nW ich among the following is the most potent drug to control PPH?\nOxytocin\nMethergin\nCarboprost\nMisoprostol\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_1",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_2",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_3",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_4",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_5",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_6",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_7",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_8",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_9",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_10",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_11",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_12",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_13",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_14",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_15",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_16",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_17",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_18",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_19",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_20",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_21",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch67_22",
    "question_text": "\nc\nSolution to Question 1:\nPostpartum haemorrhage (PPH) in vaginal delivery is defined as a blood loss of more than 500 ml after completion of the third stage of labour.\nIn Caesarean section, blood loss of more than 1000 mL from the genital tract is called PPH. Depending upon the amount of blood loss, PPH can be:\nMinor (&lt;1L)\nMajor (&gt;1L)\nSevere (&gt;2L)\nIn most cases, the magnitude of haemorrhage cannot be assessed accurately as visual estimates are unreliable.\nNote: as per the latest ACOG guidelines, PPH is defined as cumulative blood loss \uf0b31000 mL or bleeding associated with hypovolaemia in the first 24 hours after birth, irrespective of the route of delivery. It is added that despite the new definition, blood loss &gt;500 mL in a vaginal delivery should raise suspicion and mandates further evaluation.\nSolution to Question 2:\nUterine atony is the most common cause of postpartum haemorrhage in a grand multipara.\nUterine atony is the failure of the uterus to contract sufficiently after delivery. Contraction helps to arrest bleeding from vessels at the placental implantation site.\nTypes of PPH:\nPrimary/early: Haemorrhage occurring within 24 hours of childbirth. Uterine atony is the most common cause of primary PPH.\nSecondary/late: Hemorrhage occurring after 24 hours and up to 12 weeks postpartum. Retained placenta is the most common cause.\nThe risk factors for atonic uterus include:\nPrimiparity or grand multiparity\nPrevious PPH\nOverdistended uterus as in multiple pregnancies, hydramnios, macrosomia\nPrecipitate labour\nProlonged labour\nUterine malformations\nUterine fibroid\nInduction of labour with prostaglandins or oxytocin\nPlacental abnormalities like placenta previa, accreta, increta, percreta, or abruptio placenta\nObesity\nAge &gt;40 years\nNote: Uterine inversion occurs rarely and causes secondary PPH.\nSolution to Question 3:\nRetained cotyledon is the most probable cause of late or secondary PPH i.e., bleeding that occurs after 24 hours of delivery.\nOther options are causes of early PPH. Types of PPH include:\nPrimary/early: Haemorrhage occurring within 24 hours of childbirth. The causes are: (mnemonic 4T)\nTone: Atonic PPH (\u00e80%)\nTrauma: Traumatic PPH\nThrombin: Coagulopathy\nTissue: retained products of conception Risk Factors for primary PPH:\nAtonic PPH:\nPrimiparity or grand multiparity\nPrevious PPH\nOverdistended uterus as in multiple pregnancy, hydramnios, macrosomia\nPrecipitate labour\nProlonged labour\nUterine malformations\nUterine fibroid\nInduction of labour with prostaglandins or oxytocin\nPlacental abnormalities like placenta previa/accreta/increta/percreta/abruptio placenta\nObesity\nAge &gt;40 years Traumatic PPH:\nInstrumental delivery\nEpisiotomy\nPrecipitate labour\nMacrosomia Coagulopathy:\nSepsis\nIUD\nHELLP syndrome\nSecondary/ late PPH: Hemorrhage occurring after 24 hours and up to 12 weeks postpartum. Causes include:\nRetained parts of cotyledon or membranes\nEndometritis\nAbnormal involution of placental site\nSecondary haemorrhage from caesarean section wound\nPlacental polyp\nInfected fibroid\nUterine AV fistula\nPuerperal uterine inversion\nCarcinoma cervix.\nSolution to Question 4:\nPlacenta previa does not cause secondary postpartum hemorrhage. It causes primary postpartum hemorrhage.\nTypes of PPH:\nPrimary/early: Hemorrhage occurring within 24 hours of childbirth.\nSecondary/ late: Hemorrhage occurring after 24 hours and up to 12 weeks postpartum. Causes and risk factors for PPH:\nThe image below shows the prevention and management of PPH:\nPrimary PPH\nSecondary PPH\nAtonic PPH\nTraumatic PPH\nCoagulopath y\nPrimiparity or grand multipa rity\nInstrumental deliver y\nSepsis\nRetained bits of cotyledon or membranes\nPlacental abnormalities like p lacenta previa/accreta/increta\n/percreta/abruptio placenta\nPrecipitate labour\nHELLP synd rome\nSecondary haemorrhage fro m Caesarean section wound\nOverdistended uterus as in m ulti-gestational pregnancy, hy dramnios, macrosomia\nMacrosomia\nIUD\nPuerperal uterine inversion\nInduction of labour with pros taglandins or oxytocin\nEpisiotomy\nAbnormal involution of place ntal site\nProlonged labour\nInfected fibroid\nPrecipitate labour\nEndometritis\nPrevious h/o PPH\nPlacental polyp\nObesity\nCarcinoma of cervix\nAge >40 years\nUterine av fistula\n\nSolution to Question 5:\nOligohydramnios does not increase the risk of PPH. However, polyhydramnios can increase the risk by causing uterine atony, due to an overdistended uterus.\nRisk factors for primary PPH:\nAtonic PPH:\nPrimiparity or grand multiparity\nPrevious PPH\nOverdistended uterus as in multi-gestational pregnancy, hydramnios, macrosomia\nPrecipitate labour\nProlonged labour\nUterine malformations\nUterine fibroid\nInduction of labour with prostaglandins or oxytocin\nPlacental abnormalities like placenta previa/accreta/increta/percreta/ abruptio placenta\nObesity\nAge &gt;40 years Traumatic PPH:\nInstrumental delivery\nEpisiotomy\nPrecipitate labour\nMacrosomia Coagulopathy:\nSepsis\nIUD\nHELLP syndrome Causes of secondary PPH:\nRetained bits of cotyledon or membranes\nEndometritis\nAbnormal involution of placental site\nSecondary haemorrhage from Caesarean section wound\nPlacental polyp\nInfected fibroid\nUterine av fistula\nPuerperal uterine inversion\nCarcinoma cervix.\nSolution to Question 6:\nIn the above scenario, a soft uterus that becomes hard on massaging indicates an atonic uterus. Uterine rupture is a risk factor of traumatic PPH, not atonic PPH.\nUterine atony is the failure of the uterus to contract sufficiently after delivery. Thus, bleeding from the placental implantation site is not arrested.\nGDM complicating pregnancy can cause macrosomia, which is a risk factor of this condition. Risk factors for atonic PPH:\nPrimiparity or grand multiparity\nPrevious PPH\nOverdistended uterus as in multi-gestational pregnancy, hydramnios, macrosomia\nPrecipitate labour\nProlonged labour\nUterine malformations\nUterine fibroid\nInduction of labour with prostaglandins or oxytocin\nPlacental abnormalities like placenta previa/accreta/increta/percreta/ abruptio placenta\nObesity\nAge &gt;40 years\nSolution to Question 7:\nAs per the latest guidelines, uterine massage is no longer a core component of Active Management of the Third Stage of Labor (AMTSL) that is performed for the prevention of postpartum hemorrhage (PPH).\nUterine massage or fundal massage is not recommended as an intervention to prevent PPH in women who have already received prophylactic uterotonics such as oxytocin (core component of AMTSL). Hence, it is now an optional component of AMTSL that is done in patients with uterine atony as a part of the management of PPH.\nAMTSL is recommended by the WHO to prevent postpartum hemorrhage (PPH). Uterotonics are the most important components in AMTSL to do so.\nThe currently recommended components of AMTSL are as follows:\nNote: In the event that uterine atony is diagnosed during the assessment of uterine tone, uterine massage can be performed to control PPH.",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_14.jpeg",
      "OBGYN_img_191.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_1",
    "question_text": "\nInjectinguterotonicswithin1 minuteof delivery of the baby or immediately after delivery of theanterior shoulder\nMost importantstepOxytocin 10 IU im/iv infusion is thepre ferred uterotonic.(Not recom mendedby WHO-carboprost)",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_2",
    "question_text": "\nDelayed cord clamping\nDone within1-3 minsof delive ry\u00e80 mlof additional blood g oes to the fetusPreventsfetal anemia",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_3",
    "question_text": "\nDelivery of placenta by contr olled cord traction: Modified Brandt Andrews technique\nThe uterus is pushed upward s and backwardThe traction o f cord is downwards and forw ards",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_4",
    "question_text": "\nIntermittent assessment of ut erine tone\nDone every 15 mins for 2 hou rs\nSolution to Question 8:\nPPH in a patient with pre-eclampsia can be treated with misoprostol. It is a PGE1 analogue used as a second line uterotonic in the treatment of PPH.\nThe drug of choice for PPH in normal patients is oxytocin.\nOption A: Methergine and other ergot derivatives cause dangerous hypertension in pre-eclampsia. Options B and D: Carboprost and Dinoprost cause severe hypertension in pre-eclampsia.\nMedical Management of PPH:\nDrug\nDose\nSide effects\nContraindications\nOxytocin",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_10",
    "question_text": "40 U in 1L crystalloid(nev er given as iv bolus)\nWater intoxication\n-\nMethergi ne",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_0",
    "question_text": "2 mg\nHypertension\nPre-eclampsia\nCarbopro st",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_0",
    "question_text": "25 mg (\u00e8 doses max)\nDiarrhoeaHypertensionVomi ting\nBronchial asthmaCardiac, re nal or hepatic diseases\nMisopros tol",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_600",
    "question_text": "1000 mcg\nFeverTachycardia\n-\nSolution to Question 9:\nCarboprost is a methyl PGF2 alpha derivative. The normal dosage is 0.25mg. The maximum dose is 2mg.\nSo, 2/0.25 = \u00e8 times.\nCarboprost is a 15-methyl PGF2 alpha derivative used as a 2nd line drug in the treatment of PPH that is unresponsive to oxytocin.\nSide effects:\nDiarrhoea\nHypertension\nNausea\nVomiting Contraindications:\nBronchial asthma\nSuspected amniotic fluid embolism\nActive cardiac, renal or hepatic diseases.\nSolution to Question 10:\nEarly administration of tranexamic acid is done in all cases of PPH. Tranexamic acid for the treatment of PPH is used as follows:\nTranexamic acid should be given in all cases of PPH, regardless of the cause.\nEarly use of iv tranexamic acid (i.e) within 3 hours of birt\nFixed-dose of 1 g in 10 mL (100 mg/mL) iv at 1 mL per minute\nIf bleeding continues after 30 minutes, the second dose of 1 g iv is given\nOption A: Uterine massage must be done in addition to oxytocin in all cases of PPH. This will help in the contraction of an atonic uterus. In normal patients, uterine massage is not compulsory as per AMTSL.\nOption B: IV crystalloids are the recommended fluids for resuscitation. Option C: Balloon tamponade is the next step after uterotonics.\nSolution to Question 11:\nS ock index = 1 and it indicates significant blood loss. The shock index is calculated as HR/systolic BP. Here, PR=100 and systolic BP=100.\nS ock Index = 100/100 = 1\nIf the shock index is 0.9 \u2013 1.1, it indicates massive blood loss and the need for intensive resuscitation.\nDescription\nRange of shock ind ex\nNormal value of shock index\n(non-pregnant)",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_0",
    "question_text": "5 - 0.7\nNormal value of shock index in pregnant (i.e) Obstetrical s hock index",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_0",
    "question_text": "7 - 0.\u00e8\nSignificant or massive blood l oss",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_0",
    "question_text": "9 - 1.1\nSolution to Question 12:\nUsing a non-pneumatic anti-shock garment (NASG) is not one of the first measures for the management of atonic PPH. NASG is used to reduce bleeding and stabilize the patient for shifting to tertiary centers.\nThe below image shows a non-pneumatic anti-shock garment.\n\nNon-pneumatic anti-shock garment (NASG) works by applying circumferential counterpressure. It decreases blood flow to the abdomen, pelvis, and lower extremities. It increases the blood flow to the heart, lungs, and brain.\nFirst step measures in the management of PPH must be done immediately and simultaneously. This includes:\nContinuous iv oxytocin infusion\nFundal massage and bimanual uterine compression\nVolume resuscitation with crystalloids\nInsertion of Foley\u2019s catheter to monitor urine output\nAlert the anesthesia team to begin a manual exploration of the uterus under GA to check for:\nRetained placental fragments\nUterine abnormalities\nLacerations\nRupture\nBlood transfusion should be done if vitals are still unstable\nIf bleeding still continues, further steps are taken depending on the patient profile:\nBalloon tamponade\nSurgical methods:\nB lynch compression sutures\nUterine artery ligation\nInternal iliac artery ligation\nAngiographic embolization\nHysterectomy.\nSolution to Question 13:\nThermal endometrial ablation is a treatment modality for Abnormal Uterine Bleeding (AUB). It is not used in the treatment of PPH.\nIn patients who are unresponsive to initial resuscitation and medical management, the following methods can be used:\nBalloon tamponade\nSurgical methods:\nB lynch compression sutures\nUterine artery ligation\nInternal iliac artery ligation\nAngiographic embolization\nHysterectomy.\nSolution to Question 14:\nThe image shows a Bakri balloon. It is used in uterine tamponade in patients with atonic PPH who are unresponsive to medical management.\nThe Bakri balloon has a three-way valve and a separate tubing to drain the blood from the uterine cavity.\n\nIt acts by stimulating uterine contraction and direct hemostatic pressure to the open uterine sinuses (tamponade effect).\nThe maximum capacity of the balloon is 500mL. It is inflated with normal saline (200-500mL) and can be retained for up to 12 hours. Success rates are high and it can be used to avoid hysterectomy.\nOther options: Sengstaken Blakemore tube, condom catheter, and 34F Foley with 60mL balloon are other instruments that can be used for uterine tamponade.\nThe image below depicts Sengstaken Blakemore tube.\n\nThe image below depicts Foley's catheter.\n\nSolution to Question 15:\nThe capacity of balloon tamponade to arrest PPH is 300 to 500 mL.\nBakri balloon is used in uterine tamponade in cases of atonic PPH unresponsive to medical management.\nInsertion of Bakri balloon requires three team members.\nOne to perform abdominal sonography during the procedure.\nAnother member places the deflated balloon into the uterus and stabilizes it.\nThe third member instills fluid to inflate the balloon.\nInitially, rapid infusion of at least 150 mL of normal saline is done. It is followed by further infusion over a few minutes up to 300 to 500 mL.\n\nSolution to Question 16:\nBalloon tamponade is the next step in the management of atonic PPH unresponsive to medical management and bimanual uterine massage.\n\nOption A: Tight intrauterine packing has become unpopular due to the dangers of concealed bleeding and infections. It can be used in low-resource settings while shifting the patient to tertiary care centers.\nOption C: Uterine artery ligation is done when tamponade fails (Bakri balloon and compression sutures).\nOption D: Hysterectomy is the last option when all the other treatment modalities fail. Usually, the uterus contracts and bleeding stops with ligation or embolization. However, hysterectomy is done sooner rather than later in cases of placenta accreta and uterine rupture.\nSolution to Question 17:\nThe perineal tears in which anal sphincter is disrupted are classified as third-degree perineal tear.\nSolution to Question 18:\nImage 1 depicts B lynch suture.\n\nAll these stitches are types of uterine compression sutures. They used to surgically oppose the walls of the uterus to arrest bleeding in case of atonic PPH.\nSolution to Question 19:\nThe procedure is B-lynch compression sutures and it is used in atonic PPH.\nB lynch suture is a technique to arrest hemorrhage in severe postpartum atony.\n\nThe suture bites are taken over the lower uterine segment anteriorly. Then it is looped over the fundus to go posterior. Another bite is taken posteriorly. Then it is looped back over the fundus and taken anteriorly. The final bite is taken over the lower uterine segment and the free ends are tied in a surgical knot.\nThe uterus is compressed antero-posteriorly.\nThe success rate is high.\nIschaemic uterine necrosis is a complication of this procedure.\nSolution to Question 20:\nStatements 1, 2 and 3 are true.\nStatement 4: Hematomas &lt;5 cm can be managed conservatively with cold compress. Larger ematomas need to be explored surgically.\nStatement 5: Lower uterine segment rupture causes supra-levator hematoma. Types of pelvic hematomas:\nFeature\nInfralevator hematoma\nSupralevator hematoma\nIncidence\nCommon\nRare\nLocation\nBelow the levator ani\nAbove the levator ani\nCauses\nImproper hemostasis during repair of vaginal/ perineal tea rs or episiotomy wound\nExtension of cervical lacerati on, lower uterine segment ru pture\nPresentati on\nSevere pain with rectal tenes mus\nUnexplained shock with feat ures of internal haemorrhage\nTreatment\nSmall hematomas can be con servatively managed with col d compress\nLaparotomy\nSolution to Question 21:\nThe most probable diagnosis is uterine inversion.\nHydramnios is a risk factor for uterine inversion due to uterine over-distension. Fundal pressure while the uterus is atonic (soft, relaxed, and boggy) causes uterine inversion. It results in haemorrhage followed by complete uterine inversion protruding out of the vulva. Neurogenic type of shock develops due to stretching of the infundibulopelvic ligament and the ovaries.\nOption A: Amniotic fluid embolism causes cardiac arrest, acute hypoxia and severe haemorrhage.\nOption B: There was only moderate bleeding per vaginum and soft uterus. But since there is protrusion of the uterus per vaginum, the most probable diagnosis is uterine inversion.\nOption D: Placenta accreta rarely causes uterine inversion.\nUterine inversion is an extremely rare but life-threatening complication in the 3rd stage of labor, in which the uterus is turned inside out partially or completely.\nCauses:\nMost common cause is mismanagement of 3rd stage of labour\nSpontaneous\nPlacenta accreta (rarely)\nFeatures:\nShock immediately after delivery\nThe degree of shock is out of proportion to the amount of bleeding\nShock is either neurogenic or hemorrhagic\nPer abdomen examination - fundus of the uterus is not palpable. Management of uterine inversion:\nVaginal operatio ns\nAbdominal operati ons\nHydrostatic meth od\n\u0161ustner\nHuntingtons\nO Sullivan\nSpinelli\nHaultain\nOguch\nSolution to Question 22:\nCarboprost is the most potent drug to control PPH.\nThough oxytocin is the most commonly used drug for the prevention and treatment of PPH, Carboprost is highly efficacious than oxytocin in treating PPH. If the question would have been \"Drug of choice to treat PPH\" then the answer will be Oxytocin.\nInitially for PPH, oxytocin or methergin (ergometrine) is given. If it fails to control the bleeding then Misoprostol is given.\nDrug\nUse in PPH\nOxytocin\nDOC to prevent and treat PP H\nMethergin\nDrug to prevent and treat PP H\nCarboprost(PGF 2)\nBest drug to control PPH\nMisoprostol(PG E1)",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_14.jpeg",
      "OBGYN_img_192.jpeg",
      "OBGYN_img_14.jpeg",
      "OBGYN_img_193.jpeg",
      "OBGYN_img_15.jpeg",
      "OBGYN_img_194.jpeg",
      "OBGYN_img_15.jpeg",
      "OBGYN_img_195.jpeg",
      "OBGYN_img_15.jpeg",
      "OBGYN_img_196.jpeg",
      "OBGYN_img_15.jpeg",
      "OBGYN_img_196.jpeg",
      "OBGYN_img_15.jpeg",
      "OBGYN_img_197.jpeg",
      "OBGYN_img_15.jpeg",
      "OBGYN_img_198.jpeg",
      "OBGYN_img_199.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_2",
    "question_text": "nd line drug to treat PPH\nPreterm Labor and Postterm Pregnancy\nQuestion 1:\nPreterm labour is defined as when the labour starts before",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_35",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_36",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_37",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_38",
    "question_text": "weeks\nQuestion 2:\nWhich of the following is not a risk factor for preterm labour?\nPregnancy following artificial reproductive technique\nAsymptomatic bacteriuria\nPeriodontal disease\nProgesterone intake\nQuestion 3:\nLate preterm births include births between \t.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_30",
    "question_text": "32 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_32",
    "question_text": "34 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_34",
    "question_text": "36 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_36",
    "question_text": "38 weeks\nQuestion 4:\nA 31-year-old G3P2 woman presents at 29 weeks of gestation with a blood-tinged vaginal discharge. She is suspected to have preterm labour. Which of the following findings will not help confirm her diagnosis?\nBishop score of 5\nCervical dilatation of 24 mm\nCervical length of 32 mm\nFetal fibronectin &gt; 50ng/ml\nQuestion 5:\nWhich of the following cannot be used to predict preterm labour in a patient having irregular uterine contractions at 30 weeks of gestation?\nIL-6\nTNF alpha\nFetal fibronectin\nIL-2\nQuestion 6:\nA 30-year-old G2P1L0 woman came for a routine antenatal checkup at 20 weeks of gestation. She is worried about preterm labour as her previous baby was born preterm. What will be the timing and cut-off limit for fetal fibronectin (fFN) assay to predict this condition?\n&gt;34 weeks, fFN &gt;15 ng/mL\n&lt;37 weeks, fFN &gt;1.5 ng/mL",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_20",
    "question_text": "24 weeks, fFN &gt;5 ng/mL",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_24",
    "question_text": "34 weeks, fFN &gt;50 ng/mL\nQuestion 7:\nA pregnant woman presented with blood-tinged vaginal discharge at 35 weeks of gestation. A nitrazine paper test was performed on her. What is this test used to detect?\nFetal hemoglobin in vasa previa\nFetal blood cells in Rh isoimmunisation\nPremature rupture of membranes\nAbruptio placenta\nQuestion 8:\nA sample of the vaginal fluid from the posterior fornix of a patient gave a positive nitrazine paper test. Which of the following conditions does not give a false positive result?\nAbruptio placenta\nRecent sexual intercourse\nBacterial vaginosis\nOligohydramnios\nQuestion 9:\nTransvaginal sonography in a case of clinically suspected preterm labour revealed a short cervix and funnelling of the internal os. What is the shape of the cervix that is likely to be seen here?\nU\nT\nC\nO\nQuestion 10:\nA multigravida presents with preterm premature rupture of membranes. According to RCOG guidelines, which of the following antibiotics is preferred for her?\nAmpicillin\nAmoxicillin\nErythromycin\nAzithromycin\nQuestion 11:\nA primigravida at 30 weeks of gestation presents with labour pains but her membranes were intact. You decide to start her on corticosteroids and a tocolytic. Which of the following drugs will not be useful in this case?\nMagnesium sulphate\nNifedipine\nIndomethacin\nProgesterone\nQuestion 12:\nA primigravida at 32 weeks of gestation was admitted for management of preterm labour. Which of the following tocolytics would be preferred for this?\nNifedipine\nGlyceryl trinitrate\nRitodrine\nMagnesium sulphate\nQuestion 13:\nWhich of the following is not a contraindication for tocolysis in a patient with preterm labour?\nChorioamnionitis\nFetal distress\nAnencephaly\nPlacenta previa\nQuestion 14:\nA G3P1A1 woman presents with preterm labour at 27 weeks of gestation. She tells you that her previous child who was born preterm developed cerebral palsy. Which of the following drugs can you use to reduce the incidence of this condition?\nTerbutaline\nAtosiban\nMagnesium sulphate\nNifedipine\nQuestion 15:\nA primigravida was administered tocolytics and corticosteroids for preterm labour. The following day, she suddenly started coughing and gasping for air. On examination, her BP\nwas 160/100 mmHg and SpO2 was 80% in room air. Which of the following drugs could have caused this?\nAtosiban\nDexamethasone\nIndomethacin\nRitodrine\nQuestion 16:\nWhich of the following tocolytics can cause multiple fractures in the fetus if given for a prolonged duration?\nAtosiban\nMagnesium sulphate\nNifedipine\nNitric oxide\nQuestion 17:\nPost-term pregnancy refers to pregnancy continuing beyond \t.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_41",
    "question_text": "weeks of gestation",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_42",
    "question_text": "weeks of gestation",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_44",
    "question_text": "weeks of gestation",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_40",
    "question_text": "weeks of gestation\nQuestion 18:\nA woman presented for an antenatal checkup 2 weeks past her EDD. Which of the following is not an etiological factor for her condition?\nAnencephaly\nSedentary habit\nPrimiparity\nMaternal stress\nQuestion 19:\nYou have performed an artificial rupture of membranes in a primigravida for augmentation of labour. You note the amniotic fluid to be saffron-coloured. What is the likely diagnosis?\nPostmaturity\nRh incompatibility\nIntrauterine death\nConcealed placental abruption\nQuestion 20:\nA newborn baby was found to have wrinkled, patchy skin, a long thin body and long nails. Which of the following could be a cause for his condition?\nPlacental aromatase deficiency\nPlacental progesterone deficiency\nPlacental pregnenolone deficiency\nPlacental sulphatase deficiency\nQuestion 21:\nA G2P1L1 woman came for a routine ANC at 41 weeks of gestation. On examination, her Bishop score was 2. She was admitted for fetal monitoring and induction. Which of the following complications would you not anticipate in the fetus even if her pregnancy continues further?\nShoulder dystocia\nPolycythemia\nCord compression\nHyperglycemia\nQuestion 22:\nA primigravida was admitted at 42 weeks for induction of labour. Which of the following conditions is she not at an increased risk for?\nPostpartum hemorrhage\nMeconium stained liquor\nShoulder dystocia\nOligohydramnios\nQuestion 23:\nThe term small for gestational age implies birth weight\n&lt;10th percentile\n&lt;15th percentile\n&lt;2.5 kg\n&lt;2 kg\nQuestion 24:\nWhat is the normal pH of amniotic fluid?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_8",
    "question_text": "1 - 8.7",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_7",
    "question_text": "1 - 7.3",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_6",
    "question_text": "1 - 6.3",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch68_6",
    "question_text": "5 - 6.9\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_1",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_2",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_3",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_4",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_5",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_6",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_7",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_8",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_9",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_10",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_11",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_12",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_13",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_14",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_15",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_16",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_17",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_18",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_19",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_20",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_21",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_22",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_23",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_24",
    "question_text": "\nb\nSolution to Question 1:\nPreterm labour is defined as when labour starts before 37 completed weeks (&lt;259 days) counting from the first day of the last menstrual period.\nTiming of deliver y\nTerminolog y\n<33 weeks\nEarly prete rm",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_34",
    "question_text": "to 36 weeks\nLate preter m",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_37",
    "question_text": "to 38 weeks\nEarly term",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_39",
    "question_text": "to 40 weeks\nFull term\nSolution to Question 2:\nProgesterone intake is not a risk factor for preterm labour. Progesterone is used for prophylaxis of preterm labour.\nRisk factors for preterm labour:\nMaternal history -\nPrevious history of spontaneous abortion or preterm delivery\nArtificial reproductive technique\nAsymptomatic bacteriuria or recurrent UTI\nSmoking\nMaternal stress\nPregnancy complications -\nPre-eclampsia\nAntepartum haemorrhage\nPROM\nOverdistended uterus - polyhydramnios, multiple pregnancy\nCervical incompetence\nUterine malformations\nIntrauterine death\nMaternal chronic diseases -\nHypertension\nNephritis\nDiabetes\nSevere anaemia\nPeriodontal diseases\nOption A: Multifetal pregnancies are common following artificial reproductive techniques and can be associated with preterm labour.\nOption B: Asymptomatic bacteriuria or bacterial vaginosis can cause spontaneous preterm labour. Option C: Chronic diseases like periodontal disease increase the risk of preterm labour.\nSolution to Question 3:\nLate preterm births include births between 34 to 36 weeks of gestational age.\nTiming of deliver y\nTerminolog y\n<33 weeks\nEarly prete rm",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_34",
    "question_text": "to 36 weeks\nLate preter m",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_37",
    "question_text": "to 38 weeks\nEarly term",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_39",
    "question_text": "to 40 weeks\nFull term\nSolution to Question 4:\nA cervical length of 32 mm (3 cm) does not help in confirming preterm labour as it is highly unlikely when the cervical length is &gt;3 cm. The length of the cervix in preterm labour, as measured in transvaginal ultrasound is \uf0a32.5 cm.\nPreterm labor is the onset of labor before 37 completed weeks of pregnancy (less than 259 days of gestation).\nFeatures of preterm labor:\nUterus - regular contractions at least one in every 10 minutes, with/without pain\nCervix - dilatation &gt;2 cm and effacement &gt;80%\nTVS - length of cervix &lt;2.5 cm and funneling of the internal os &gt;1 cm\nPelvic pressure, backache, vaginal discharge or bleeding PV Predictors of preterm labor:\nClinical predictors:\nHistory of prior preterm birth\nMultiple pregnancies\nPresence of genital tract infection\nSymptoms of preterm labour\nBiophysical predictors:\nUterine contractions \uf0b34/hour\nBishop score \uf0b34\nCervical length (TVS) \uf0a325 mm\nBiochemical predictors:\nFetal fibronectin (fFN) in cervical/vaginal discharge &gt;50 ng/mL\nIncreased levels of IL-6, IL-8, TNF-alpha\nThe best predictors of preterm labor in a woman with a previous history of preterm birth are fetal fibronectin &gt;50ng/ml and cervical length &lt;2.5cm on TVS.\nSolution to Question 5:\nIL-2 is not a biochemical predictor of preterm labour. Biochemical predictors of preterm labor:\nFetal fibronectin\nIL 6\nIL 8\nTNF\uf0b0\nInvestigations of preterm labour:\nFetal fibronectin &gt;50 ng/ml\nTVS - length of cervix \uf0a32.5 cm\nUrine culture\nHigh vaginal swab\nMaternal salivary estriol\nUterine activity monitoring\nSolution to Question 6:\nFetal fibronectin value of &gt;50 ng/mL in the cervicovaginal discharge between 24 and 34 weeks is predictive of preterm labor.\nFibronectin is a glycoprotein that binds the fetal membranes to the decidua. It is normally found in the cervicovaginal discharge before 22 weeks and after 37 weeks of gestation.\nIt is measured using an enzyme-linked immunosorbent assay. When the test is negative, it reassures that the delivery will not occur within the next 7 days.\nSolution to Question 7:\nThe nitrazine paper test is used to detect premature rupture of membranes.\nThe nitrazine paper test detects the pH of the secretions from the vaginal pool. It turns blue at pH\n&gt;6. Amniotic fluid is slightly alkaline with a pH of 7.1 - 7.3 and vaginal secretions have a pH of",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_4",
    "question_text": "5 - 6.0.\nFalse-positive nitrazine test can be seen in contamination of the discharge with blood, semen, and bacterial infections.\nThe below image shows the nitrazine paper.\n\nOption A: Fetal hemoglobin in vasa previa is detected by Apt test.\nOption B: Estimation of the volume of fetal blood entering the maternal circulation in Rh isoimmunisation is done by Kleihauer-Betke test.\nOption D: In abruptio placenta, the diagnosis is mainly based on clinical features.\nSolution to Question 8:\nOligohydramnios shows a false negative nitrazine paper test.\nNitrazine paper test detects the pH of the secretions from the vaginal pool. It turns blue at pH\n&gt;6. Amniotic fluid is slightly alkaline with a pH of 7.1 - 7.3 and vaginal secretions have a pH of",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_15.jpeg",
      "OBGYN_img_200.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_4",
    "question_text": "5 - 6.0.\nFalse-positive nitrazine test can be seen in contamination of the discharge with blood, semen, and bacterial infections. False-negative nitrazine test can be seen in the case of scanty amniotic fluid.\nSolution to Question 9:\nU-shaped cervix is seen on tranvaginal sonography (TVS) in preterm labour.\nOn TVS, the cervix should be assessed to determine whether funnelling (internal os width &gt;5 mm) is present.\nThe following is a TVS image showing a V-shaped cervix:\nShape of cervi x\nInference\nT shaped\nNormal\nShape of cervi\tInference x\nShape of cervi\tInference x\nY shaped\nSuspicion of preterm labour\nV shaped\nFunneling of internal os\nU shaped\nIncompetent osPreterm labo ur\n\nSolution to Question 10:\nAccording to RCOG guidelines, erythromycin is the preferred antibiotic in the case of PPROM\n(preterm premature rupture of membranes).\nSpontaneous rupture of membranes before the onset of labour between 28 to 37 weeks is called preterm premature rupture of membranes.\nIf PPROM occurs between 28 to 34 weeks, prophylactic antibiotics and corticosteroids are given to the patient.\nSolution to Question 11:\nThe given clinical scenario is suggestive of preterm labour with intact membranes and progesterone is not used as a tocolytic in these cases.\nProgesterone can be used for the prophylaxis of preterm labour in women with a previous history of spontaneous preterm labour.\nGlucocorticoid therapy is given in preterm labour when the period of gestation is &lt;34 weeks to hasten fetal lung maturity. Short term therapy with tocolytics is given in conjunction with steroids for 1-3 days to delay labour for at least 48 hours or to transfer the patient to a tertiary centre (with\nNICU).\nTocolytics that can be given as short term therapy include:\nTerbutaline\nMagnesium sulphate\nIndomethacin\nNifedipine\nAtosiban\nSolution to Question 12:\nNifedipine is the preferred tocolytic as it has minimum maternal side effects.\nAccording to ACOG guidelines, the use of tocolytics in preterm labour does not prolong gestation but may delay delivery upto 48 hours. Hence, short-term therapy with tocolytics is given for 1-3 days to delay labour for the action of corticosteroid therapy or to transfer the patient to a tertiary centre (with NICU).\nTocolytics used in preterm labour and their side effects:\nTocolytics\nMaternal side effects\nFetal/ neonatal side effects\nBeta-adrenergic agonists:Rito drineTerbutalineIsoxsuprine\nHeadache, palpitations, tachy cardia, hypotension, pulmon ary edema, cardiac failure, A RDS\nFetal heart failure, intrauteri ne deathNeonatal hypoglyce mia, intraventricular haemor rhage\nCalcium channel blockers:Nif edipineNicardipineVerapamil\nHypotension, headache, flush ing, nausea\n-\nOxytocin antagonists:Atosiba n(not approved for use in Ind ia)\nNausea, vomiting, chest pain\n-\nMagnesium sulphate\nFlushing, perspiration, heada che, muscle weakness, respir atory paralysis\nNeonatal cardiac arrest, letha rgy, hypotonia, respiratory d epression\nCOX inhibitors:Indomethaci nSulindac\nHeartburn, asthma, GI bleedi ng, thrombocytopenia, renal i njury, platelet dysfunction, ol igohydramnios\nConstriction of ductus arterio sus, pulmonary hypertension, intrauterine growth restricti on\nSolution to Question 13:\nPlacenta previa is not a contraindication for tocolysis. In placenta previa, nifedipine and magnesium sulphate are used as tocolytics.\nContraindications to tocolysis:\nChorioamnionitis\nPreeclampsia/Eclampsia\nAdvanced labour\nFetal distress\nIntra-uterine death\nCongenital anomalies not compatible with life\nPregnancy &gt;34 weeks\nAbruptio placenta\nSolution to Question 14:\nMagnesium sulphate has a neuroprotective effect and hence decreases the risk of developing cerebral palsy.\nMagnesium sulphate can be used for neuroprotection in preterm labour when the pregnancy is\n&lt;32 weeks. The dose is 4 g IV over 20 mins followed by an infusion of 1 g/hr.\nSolution to Question 15:\nThe given clinical scenario is suggestive of acute pulmonary edema which is a side effect of the tocolytic ritodrine.\nAcute pulmonary edema in pregnancy can be due to:\nNon-cardiogenic causes -\nPre-eclampsia\nAcute haemorrhage\nSepsis\nTocolysis with ritodrine and magnesium sulphate\nVigorous IV fluid therapy\nCardiogenic causes\nTocolytics used in preterm labour and their side effects:\nTocolytics\nMaternal side effects\nFetal/ neonatal side effects\nBeta-adrenergic agonists:Rito drineTerbutalineIsoxsuprine\nHeadache, palpitations, tachy cardia, hypotension, pulmon ary edema, cardiac failure, A RDS\nFetal heart failure, intrauteri ne deathNeonatal hypoglyce mia, intraventricular haemor rhage\nCalcium channel blockers:Nif edipineNicardipineVerapamil\nHypotension, headache, flush ing, nausea\n-\nTocolytics\tMaternal side effects\tFetal/ neonatal side effects\nTocolytics\tMaternal side effects\tFetal/ neonatal side effects\nTocolytics\tMaternal side effects\tFetal/ neonatal side effects\nOxytocin antagonists:Atosiba n(not approved for use in Ind ia)\nNausea, vomiting, chest pain\n-\nMagnesium sulphate\nFlushing, perspiration, heada che, muscle weakness, respir atory paralysis\nNeonatal cardiac arrest, letha rgy, hypotonia, respiratory d epression\nCOX inhibitors:Indomethaci nSulindac\nHeartburn, asthma, GI bleedi ng, thrombocytopenia, renal i njury, platelet dysfunction, ol igohydramnios\nConstriction of ductus arterio sus, pulmonary hypertension, intrauterine growth retardati on\nSolution to Question 16:\nMagnesium sulphate can cause multiple fractures and hypocalcemia in a preterm baby.\nThe FDA warned against prolonged use of magnesium sulphate to arrest preterm labour. The antagonistic effect of magnesium lowers the calcium levels in the fetus. This causes bone thinning and fractures in fetuses exposed to the drug for more than 5 to 7 days.\nSolution to Question 17:\nACOG defines post-term pregnancy as a pregnancy continuing beyond 42 completed weeks of gestation.\nFor clinical purposes, a pregnancy continuing beyond 2 weeks of the expected date of delivery\n(&gt; 294 days) is called a post-term pregnancy.\nInaccurate LMP is the most common cause of misdiagnosis of post-term pregnancy. Hence, early ultrasound dating is important to determine fetal gestational age.\nSolution to Question 18:\nMaternal stress is associated with preterm labour, not post-term pregnancy. Etiological factors of post-term pregnancy are:\nInaccurate LMP\nHeredity\nPrimiparity\nPrevious prolonged pregnancy\nSedentary habits\nElderly multipara\nAnencephaly\nPlacental sulphatase deficiency\nSolution to Question 19:\nSaffron-coloured amniotic fluid is seen in postmaturity.\nSolution to Question 20:\nThe given clinical scenario is suggestive of postmaturity syndrome which can occur due to placental sulphatase deficiency.\nEtiology of post-term pregnancy:\nWrong dates - inaccurate LMP (most common)\nHeredity\nPrevious prolonged pregnancy\nAnencephaly\nPlacental sulphatase deficiency (leads to decreased estrogen synthesis)\nPrimipara/ elderly multipara\nFeatures of postmaturity syndrome in a newborn:\nWrinkled, patchy, peeling skin, particularly prominent on the palms and soles\nLong, thin body suggesting wasting\nLong nails\nEyes open and unusually alert\nLooks old and worried\nNote: Placental aromatase deficiency causes disorder of sexual development of fetus.\nSolution to Question 21:\nIn the given scenario, the pregnancy continuing further would cross 42 weeks of gestation and thus turn into a post-term pregnancy. Hypoglycemia is seen in a post-term neonate.\nComplications of post-term pregnancy:\nDuring labour:\nFetal hypoxia\nLabour dysfunction\nMacrosomia\nShoulder dystocia\nOligohydramnios\nCord compression\nBirth trauma\nMeconium aspiration\nIntracranial haemorrhage\nFollowing birth:\nMeconium aspiration syndrome\nHypoxia\nHypoglycemia\nPolycythemia\nNeonatal convulsions\nSolution to Question 22:\nThe risk of post-partum haemorrhage does not increase in post-term pregnancy.\nComplications of post-term pregnancy are due to placental insufficiency and placental ageing. It manifests as placental infarcts and calcifications. During post-term pregnancy, diminished placental function can cause oligohydramnios.\nComplications of post-term pregnancy are:\nDuring labour:\nFetal hypoxia\nLabour dysfunction\nMacrosomia\nShoulder dystocia\nOligohydramnios\nCord compression\nBirth trauma\nMeconium aspiration\nFollowing birth:\nChemical pneumonitis, atelectasis, pulmonary hypertension (due to meconium aspiration)\nHypoxia\nHypoglycemia\nPolycythemia\nNeonatal convulsions\nSolution to Question 23:\nSmall for gestational age implies birthweight is &lt;10th percentile for gestational age. With respect to the size, a newborn can be appropriate, small or large for gestational age.\nBirth weight\nTerminology\n<10th percentile\nSmall for gestational age\n>90th percentile\nLarge for gestational age\nBetween 10th and 90th perce ntile\nAppropriate for gestational a ge\nSolution to Question 24:\nThe normal pH of the amniotic fluid is 7.1 - 7.3\nThe normal pH of the vaginal secretions is 4.5 - 5.5. In premature rupture of membranes (PROM), the pH of the vaginal secretions becomes 6 - 6.2 as the amniotic fluid mixes with it. This forms the basis for nitrazine paper test.\nGestational Trophoblastic Diseases\nQuestion 1:\nWhat is the chromosome number of a partial hydatidiform mole?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_15.jpeg",
      "OBGYN_img_201.png"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_46",
    "question_text": "XX",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_45",
    "question_text": "XY",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_69",
    "question_text": "XY",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch69_69",
    "question_text": "XXY\nQuestion 2:\nWhich of the following statements is false regarding hydatidiform moles?\nComplete moles show diffuse trophoblastic hyperplasia\nFetal tissue is seen in partial mole\nEarly USG is sensitive for partial moles\nComplete moles have higher malignant potential\nQuestion 3:\nWhich of the following is not associated with the development of a hydatidiform mole?\nMaternal age &gt;40 years\nPrevious history of GTD\nAB blood group\nVitamin C deficiency\nQuestion 4:\nA 20-year-old primigravida with bleeding PV was diagnosed to have a complete hydatidiform mole. Which of the following is not true in this condition?\nSerum \uf062-hCG levels are highly elevated\nUrine pregnancy test is negative\nTheca lutein cysts are rare\nSerum free T4 levels normalise after uterine evacuation\nQuestion 5:\nA pregnant woman at 12 weeks of gestation presents with spotting PV, hyperemesis, and lower abdominal pain for the past 2 days. USG done is shown below. What is the most probable diagnosis?\n\nMissed abortion\nComplete mole\nPartial mole\nChoriocarcinoma\nQuestion 6:\nA primigravida at 12 weeks of gestation presented with complaints of the expulsion of grape-like vesicles PV for the past day. A diagnosis of molar pregnancy was made on USG examination. Incidentally, the following adnexal lesion was also noted. What is the lesion?\n\nMucinous cystadenoma\nMultilocular endometrial cysts\nTheca lutein cyst\nPolycystic ovarian disease\nQuestion 7:\nA patient who was treated for molar pregnancy came for follow-up after 4 months. Her USG revealed a large, twisted theca lutein cyst. How will you manage this patient?\nUntwisting of the cyst\nLaparoscopic oophorectomy\nWait and watch\nTransabdominal aspiration under USG guidance\nQuestion 8:\nA pregnant woman at 14 weeks of gestation complains of excessive vomiting and mild vaginal bleeding for 2 weeks. On examination, fundal height corresponds to 16 weeks and fetal heart sounds are absent. USG shows a snowstorm appearance and no fetus. What is the best step of management?\nChemotherapy\nHysterectomy\nSuction and evacuation\nSerum beta hCG\nQuestion 9:\nA 36-year-old woman underwent suction evacuation for a hydatidiform mole. Which of the following statements is true regarding her follow-up with \uf062-hCG estimation?\nStart estimation 72 hours following evacuation\nTwice weekly estimation for a month following evacuation\nMonthly follow-up for 6 months after three consecutive normal values\nAfter 6 months of follow-up, regular yearly estimation should be done\nQuestion 10:\nWhich of the following are complications that can be seen in a patient with molar pregnancy?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_15.jpeg",
      "OBGYN_img_202.jpeg",
      "OBGYN_img_16.jpeg",
      "OBGYN_img_203.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch70_1",
    "question_text": ", 2, and 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch70_1",
    "question_text": ", 2, 3 and 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch70_2",
    "question_text": ", 3 and 4",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch71_1",
    "question_text": ", 3, 4 and 5\nQuestion 11:\nGestational trophoblastic neoplasm does not include\nPartial mole\nChoriocarcinoma\nPlacental site trophoblastic tumo\nInvasive mole\nQuestion 12:\nAll of the following are non-molar trophoblastic neoplasms except \t.\nChoriocarcinoma\nPlacental site trophoblastic tumo\nInvasive mole\nEpithelioid trophoblastic tumo\nQuestion 13:\nWhat is the most common non-metastatic gestational trophoblastic neoplasia that develops following hydatidiform mole?\nChoriocarcinoma\nPlacental site trophoblastic tumou\nChorioadenoma destruens\nEpithelioid trophoblastic tumou\nQuestion 14:\nWhich of the following are risk factors for malignant change in a patient with molar pregnancy?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch71_1",
    "question_text": ", 2, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch71_2",
    "question_text": ", 3, 4",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_1",
    "question_text": ", 2, 4",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_1",
    "question_text": ", 3, 4\nQuestion 15:\nAll of the following can be indicators of choriocarcinoma except:\nIncreased number of theca lutein cysts\nPersistently enlarged uterus\nPlateau of high serum hCG\nSuburethral nodule\nQuestion 16:\nA patient with a history of molar pregnancy was treated with suction and evacuation. Which method of contraception would you not recommend for her?\nBarrier methods\nIntrauterine contraceptive device\nOral contraceptive pills\nDepot medroxyprogesterone acetate\nQuestion 17:\nWhat will be the WHO score in a patient with low-risk gestational trophoblastic neoplasia?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_0",
    "question_text": "3",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_0",
    "question_text": "5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_0",
    "question_text": "6",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_0",
    "question_text": "7\nQuestion 18:\nA patient was diagnosed to have choriocarcinoma two years post-evacuation of molar pregnancy. Which of the following is the most common site of metastasis in this patient?\nVagina\n\u2022idney\nLive\nOvaries\nQuestion 19:\nA case of gestational trophoblastic neoplasm is detected to have metastasis in the lungs. It is considered as stage \t.\nI\nII\nIII\nIV\nQuestion 20:\nA 43-year-old woman presents with complaints of hemoptysis, vaginal bleeding, and abdominal pain for 7 days. Chest X-ray is shown below. Transabdominal USG revealed a solid mass occupying the uterus which was found to be choriocarcinoma with a WHO score of 8.\nHow would you manage this patient?\n\nHysterectomy\nR-CHOP\nEMA-CO\nMVAC\nQuestion 21:\nPlacental-site trophoblastic tumor arises from \t.\nCytotrophoblast\nSyncytiotrophoblast\nIntermediate trophoblast\nChorionic villi\nQuestion 22:\nA 26-year-old woman with a history of early miscarriage presented with amenorrhoea. Her serum beta hCG levels were persistently low and USG revealed a single solid mass in the uterine fundus. Histopathological examination of the biopsy showed abundant intermediate trophoblastic cells. What is the next step of management?\nMethotrexate\nActinomycin D\nEMA-CO regimen\nHysterectomy\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_16.jpeg",
      "OBGYN_img_204.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_1",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_2",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_3",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_4",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_5",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_6",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_7",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_8",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_9",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_10",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_11",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_12",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_13",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_14",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_15",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_16",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_17",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_18",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_19",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_20",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_21",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_22",
    "question_text": "\nd\nSolution to Question 1:\nPartial hydatidiform mole has a 69XXY or 69XYY karyotype.\nHydatiform mole belongs to the benign group of gestational trophoblastic diseases (GTD). It is an abnormality in chorionic villi making them partly proliferative and degenerative, thereby resulting in the formation of multiple small cysts. Based on the portion of the chorionic villi involved, they could be complete (diffused) or partial (focal)\nSolution to Question 2:\nEarly ultrasonography is not highly sensitive in a patient with partial molar pregnancy. However, USG features like thickened, multicystic placenta along with fetal tissue or even a fetus may be seen.\nHydatidiform mole or molar pregnancy is an abnormal condition of the placenta. It is characterized by trophoblastic proliferation and stromal edema. They are classified into complete and partial moles based on the absence or presence of embryonic elements.\nPathogenesis of complete and partial moles are as follows:\n\n\nSolution to Question 3:\nVitamin A deficiency, not Vitamin C deficiency is a risk factor for hydatidiform mole. Risk factors for hydatidiform mole are:\nMaternal age - pregnancy in teenage and women &gt;35 years\nPrevious history of gestational trophoblastic disease\nDietary deficiency - vitamin A deficiency, inadequate protein and animal fat intake\nAB blood group.\nSolution to Question 4:\nTheca lutein cysts are rare in partial molar pregnancy, but may be seen in 25-30% of patients with complete molar pregnancy.\nSerum \uf062-hCG levels are elevated more than expected for gestational age in a complete mole.\nThe sensitivity of most hCG tests is set to the pregnancy hCG range. An excessive \uf062-hCG hormone causes an oversaturation of the test assay giving a false negative UPT. This is called the hook effect.\nThe thyrotropin-like effects of hCG frequently cause serum free-T4 levels to be elevated which normalize after uterine evacuation.\nSolution to Question 5:\nThe given clinical scenario and USG showing snowstorm appearance is suggestive of a complete mole.\nThe snowstorm appearance is due to an echogenic uterine mass that has numerous anechoic cystic spaces. Fetus and amniotic sac are absent.\nInvestigations for molar pregnancy are:\nUSG - shows snowstorm appearance\nSerum \uf062 hCG - elevated to &gt;2 MoM (multiples of median) for corresponding gestational age\nHistological examination of products of conception Snowstorms in radiology:\nComplete hydatiform mole (ultrasound)\nExtracapsular breast implant rupture (ultrasound)\nCarcinoma thyroid - pulmonary metastases (chest X-ray).\nSolution to Question 6:\nThe given USG image shows theca lutein cysts in the ovary. These cysts are usually seen in patients with complete molar pregnancies. They are usually bilateral and are also seen in multiple pregnancies.\nTheca lutein cysts result from the overstimulation of lutein elements by massive amounts of \uf062\nhCG. The cystic fluid is rich in chorionic gonadotropin, estrogen, and progesterone.\nSolution to Question 7:\nUntwisting of the cyst is the only management in an asymptomatic patient with a twisted theca lutein cyst.\nLaparoscopic oophorectomy is done only when there is associated extensive necrosis or hemorrhage.\nTheca-lutein cysts regress within 2 months after pregnancy evacuation, and hence expectant management is preferred in uncomplicated cases. If the cysts are symptomatic, they can be aspirated trans-abdominally under ultrasound guidance.\nSolution to Question 8:\nThe given clinical scenario is suggestive of molar pregnancy which is managed by suction and evacuation, regardless of uterine size.\nIf the cervix is unfavorable, slow dilatation is done with vaginal PGE1. Volume resuscitation with IV fluids and parenteral antibiotics can be given as supportive therapy. Blood transfusion is done\nif the patient is anaemic.\nIntraoperative sonography is recommended to help ensure that the uterine cavity has been emptied.\nIndication for hysterectomy in molar pregnancy:\nWomen who have completed their family\nAge &gt;40 years\nUncontrolled hemorrhage\nPerforation during surgical evacuation.\nSolution to Question 9:\nIn the given scenario, the patient is followed up with serum \uf062 hCG every month for 6 months.\nFollow-up after the termination of molar pregnancy is done with serum \uf062 hCG levels. During the follow-up period, pregnancy must be avoided as it might interfere with the \uf062 hCG levels.\nThe initial \uf062-hCG level is obtained within 48 hours after evacuation and used as a baseline.\nIt is measured weekly till it becomes negative, and three consecutive normal values are obtained. This normally happens in 4-8 weeks.\nAfter this, \uf062 hCG levels are measured monthly for 6 months. Women who undergo chemotherapy must be followed up for 1 year.\nSolution to Question 10:\nThyrotoxicosis is seen as a complication of molar pregnancy, not hypothyroidism. Complications in molar pregnancy include:\nImmediate:\nEarly-onset pre-eclampsia - molar placentas produce more antiangiogenic proteins than normal placentas.\nThyrotoxicosis - as \uf0b0 component of hCG mimics TSH and causes thyroid storm\nAcute pulmonary insufficiency - due to embolization of trophoblastic cells\nElectrolyte imbalance i.e., hypokalemia, hyponatremia - due to hyperemesis caused by \uf062 hCG\nShock - hemorrhage due to the separation of vesicles and intra-peritoneal haemorrhage\nDisseminated intravascular coagulation\nLate: Choriocarcinoma.\nSolution to Question 11:\nA partial mole is not a gestational trophoblastic neoplasm (GTN).\nGestational trophoblastic disease (GTD) is the term used to describe a group of tumors due to abnormal trophoblast proliferation. Malignant forms of GTD are termed gestational trophoblastic neoplasia (GTN).\nModified WHO Classification of GTD\nMolar Pregnancies\nTrophoblastic tumors\nHydatidiform mole (benign) - PartialandCompleteInvasive mole (malignant)\nChoriocarcinoma (malignant) Placental site trophoblastic t umor (malignant)Epithelioid trophoblastic tumor (maligna nt)\nSolution to Question 12:\nInvasive mole is a molar trophoblastic neoplasm.\n\nSolution to Question 13:\nChorioadenoma destruens or invasive mole is the most common non-metastatic GTN that follows hydatidiform moles. Almost all invasive moles arise from partial or complete moles.\nInvasive mole is characterized by extensive tissue invasion by trophoblast and whole villi. They can penetrate deep into the myometrium, peritoneum, parametrium, or vaginal vault. They are locally aggressive and do not usually metastasize.\nThe most common GTN following term pregnancy or miscarriage is choriocarcinoma.\n\nSolution to Question 14:\nMaternal age &gt;40 years, \uf062-hCG levels &gt;100,000 mIU/mL and grand multiparity are risk factors for malignant change in a patient with molar pregnancy.\nRisk factors for malignant change are:\nPatient's age \uf0b3 40 years or &lt;20 years\nParity \uf0b33\nUterine size &gt;20 weeks\nPrevious history of molar pregnancy\nComplete moles have 15-20% risk of malignant transformation, partial moles have 1-5% risk\nSerum \uf062 hCG &gt;1,00,000 mIU/mL\nLarge theca lutein cysts &gt;6 cm in diamete\nPost-evacuation uterine sonographic surveillance can be used as a predictor of subsequent neoplasia. Findings indicative of malignant transformation are:\nSuburethral nodules\nMyometrial nodules\nHypervascularity.\nSolution to Question 15:\nIncreased number of theca lutein cysts is not an indicator of choriocarcinoma. Increased size or persistence of theca lutein cysts indicates choriocarcinoma.\nPlateau of high serum \uf062-hCG level for four measurements for \uf0b33 weeks is an indicator of choriocarcinoma.\nRisk factors for malignant change are:\nMolar pregnancy - complete moles have 15-20% risk, partial moles have 1-5% risk\nPatient's age \uf0b3 40 years or &lt;20 years\nParity \uf0b33\nSerum \uf062 hCG &gt;1,00,000 IU/mL\nUterine size &gt;20 weeks\nPrevious history of molar pregnancy\nLarge theca lutein cysts &gt;6 cm in diamete\nPost-evacuation uterine sonographic surveillance can be used as a predictor of subsequent neoplasia. Findings indicative of malignant transformation are:\nSuburethral nodules\nMyometrial nodules\nHypervascularity.\nSolution to Question 16:\nIUCD (intrauterine contraceptive device) is contraindicated in this patient as the uterus is friable and can cause further bleeding.\nAccepted methods of contraception after suction evacuation in molar pregnancy include:\nOral contraceptive pills\nDepot medroxyprogesterone acetate\nBarrier methods.\nSolution to Question 17:\nLow-risk GTN has a WHO score of 0 to 6. High-risk GTN has a WHO score of \uf0b3 7.\nFeatures\nLow risk\nHigh risk\nTotal score",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_16.jpeg",
      "OBGYN_img_205.jpeg",
      "OBGYN_img_16.jpeg",
      "OBGYN_img_206.jpeg",
      "OBGYN_img_16.jpeg",
      "OBGYN_img_207.jpeg",
      "OBGYN_img_16.jpeg",
      "OBGYN_img_207.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_0",
    "question_text": "6\n\uf0b37\nAge\n\uf0a339 years\n\uf0b340 years\nhCG\n\uf0a3105IU/L\n\uf0b3105IU/L\nFeatures\tLow risk\tHigh risk\nFeatures\tLow risk\tHigh risk\nFeatures\tLow risk\tHigh risk\nType of antecedent pregnanc y\nMolar pregnancy\nFull term pregnancy\nDuration of antecedent pregn ancy\n<4 months\n>12 months\nMetastasis site\nLungs, vagina\nBrain, liver\nNumber of metastases\n<4\n>8\nSize of the tumor\n<3 cm\n>5 cm\nAntecedent chemotherapy\nSingle-agent chemothera py\nMultiple-agent chemothera py\nSolution to Question 18:\nThe common sites of metastases of choriocarcinoma are in the following order:\nLungs - most common\nVagina - second most common\nVulva\n\u2022idneys\nLive\nOvaries\nBrain\nBowel\nLung metastases present as cannon-ball or snowstorm appearance on chest X-ray. Vaginal metastases present as purplish sub-urethral nodules.\nSolution to Question 19:\nMetastases in the lungs are considered stage III GTN (gestational trophoblastic neoplasia) in FIGO classification.\nInternational Federation of Gynecology and Obstetrics (FIGO) staging for GTN is as follows: The chest X-ray below shows lung metastasis - stage III GTN.\nStag e\nDescription\nI\nGTN confined to theuterus\nStag\tDescription e\nStag\tDescription e\nII\nGTN extends outside of the u terus but is limited to thegeni talstructures(adnexa, vagina, broad ligament)\nIII\nGTN extends to thelungs, wit h or without known genital tr act involvement\nIV\nAllothermetastatic sites i.e. ki dney, liver, brain, bowel, etc.\n\nGestational trophoblastic neoplasia (GTN) refers to the aggressive invasion of the endometrium and myometrium by trophoblast cells. It includes invasive mole, gestational choriocarcinoma, placental site trophoblastic tumors, and epithelioid trophoblastic tumors. GTN is diagnosed based on elevated \uf062-hCG levels. FIGO criteria for diagnosis of GTN:\nPersistence of \uf062-hCG level plateau in 4 measurements for 3 weeks or longe\nRise in \uf062-hCG levels in 3 or more consecutive measurements done weekly, over a period of 2 weeks or longe\nElevated \uf062-hCG level for 6 months or more\nHistologic diagnosis of choriocarcinoma\nTreatment for low-risk disease is chemotherapy with methotrexate, while those with high-risk disease are treated with etoposide, methotrexate, and dactinomycin alternating with cyclophosphamide and vincristine (EMA/CO) chemotherapy.\n\nSolution to Question 20:\nThe given clinical scenario is suggestive of high-risk (WHO) stage III choriocarcinoma which is treated with EMA-CO regimen. The given X-ray shows numerous, dense, bilateral metastatic nodules, of varying sizes indicative of lung metastases.\nThe components of EMA-CO are:\nEtoposide\nMethotrexate\nActinomycin D\nCyclophosphamide\nOncovin i.e. vincristine\nOption A: PSTT (placental-site trophoblastic tumor) and ETT (epithelioid trophoblastic tumors) are treated by hysterectomy only, as they are resistant to chemotherapy.\nOption B: R-CHOP regimen is used for B-cell non-Hodgkin's lymphoma. Option D: MVAC regimen is used for advanced bladder carcinoma.\nRisk\nCriteria\nTreatment\nLow\nFIGO stage I GTNFIGO Stag e II or III GTN with a WHO r isk score<6\nSingle agent chemotherapy w ith Methotrextate or Actinom ycin D.\nHigh\nStages II and III with WHO isk score>7Stage IV disease\nEMA-CO regimen\nSolution to Question 21:\nPlacental-site trophoblastic tumor arises from implantation site intermediate trophoblast. As syncytiotrophoblastic cells are generally absent in this site, it is composed mainly\nof cytotrophoblastic cells.\nPatients with placental site trophoblastic tumors present with vaginal bleeding and modestly elevated serum \uf062-hCG levels. Local invasion into the myometrium and lymphatics occurs.\nHysterectomy is the preferred treatment.\nSolution to Question 22:\nThe given clinical scenario is suggestive of placental-site trophoblastic tumor (PSTT). Hysterectomy is the treatment of choice because they are locally invasive tumors and resistant to chemotherapy.\nPSTT is a rare tumor arising from intermediate trophoblastic of the placental bed. Patients with placental site trophoblastic tumors present with vaginal bleeding and modestly elevated serum\n\uf062-hCG levels. They produce variant forms of hCG.\nAnemia in Pregnancy\nQuestion 1:\nA pregnant woman presented to the clinic with complaints of dizziness. On examination, pallor was present. She will be considered severely anemic if her hemoglobin is less than\n.\n4 g/dl\n5 g/dl\n7 g/dl",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_16.jpeg",
      "OBGYN_img_208.jpeg",
      "OBGYN_img_16.jpeg",
      "OBGYN_img_209.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_7",
    "question_text": "9 g/dl\nQuestion 2:\nWhich of the following is the second most common pathological cause of anemia in pregnancy?\nAnemia associated with chronic disease\nSickle cell anemia\nIron-deficiency anaemia\nMegaloblastic anemia\nQuestion 3:\nWhat is the average maternal requirement of iron during a singleton pregnancy?\n300 mg\n1000 mg\n400 mg\n800 mg\nQuestion 4:\nYou initiate iron and folic acid supplements for a woman at 13 weeks of gestation. According to the ministry of health &amp; family welfare (MoHFW), what is the minimum duration for\nwhich she should take these supplements?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_150",
    "question_text": "days",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_180",
    "question_text": "days",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_120",
    "question_text": "days",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_90",
    "question_text": "days\nQuestion 5:\nIdentify the correctly matched dose for folic acid supplementation that should be given in pregnant women with the following conditions?\nSickle cell anaemia - 5 mg\nPrevious child with neural tube defect - 1 mg\nThalassemia - 500 mcg\nEpilepsy - 8 mg\nQuestion 6:\nA pregnant woman at 10 weeks of gestation presented with insomnia due to a compulsive urge to keep moving her legs. Blood tests revealed a Hb value of 10.1 g/dl. Which of the following is the most sensitive indicator for her underlying condition?\nSerum iron levels\nSerum ferritin\nSerum transferrin\nSerum erythropoietin\nQuestion 7:\nA pregnant teacher presented with complaints of difficulty concentrating at work. Investigations revealed normal MCV with blood picture as shown below. What is the most likely diagnosis?\n\nIron deficiency anaemia\nDimorphic anemia\nSickle cell anaemia\nFolic acid deficiency\nQuestion 8:\nA woman at 36 weeks of gestation was brought to the clinic by her concerned husband. He mentioned that over the last few weeks he noticed her chewing on cardboard pieces and ice cream sticks on multiple occasions. On examination, pallor was present and Hb was 8.6 g/dl. What is the most appropriate treatment regimen?\nFerrous sulfate\nRed cell transfusion\nFerrous sucrose\nFerrous ascorbate\nQuestion 9:\nWhich of the following is the most effective parenteral iron preparation prescribed for postpartum women with iron deficiency anemia?\nFerrous sucrose\nFerrous biglycinate\nFerric carboxymaltose\nIron dextran\nQuestion 10:\nYou have been asked to start parenteral iron infusion for a woman at 38 weeks of gestation. What formula would you use to calculate the required dosage?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_16.jpeg",
      "OBGYN_img_210.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_2",
    "question_text": "4 \u00d7 (target Hb-actual Hb) \u00d7 body weight (kg)",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_2",
    "question_text": "4 \u00d7 (target Hb-actual Hb) \u00d7 body weight (kg) + 500 mg",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_2",
    "question_text": "4 \u00d7 (target Hb-actual Hb) \u00d7 body weight (kg) + 500 mcg",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_2",
    "question_text": "4 \u00d7 (target Hb-actual Hb) \u00d7 body weight (kg) + 50 mg/kg\nQuestion 11:\nWhich of the following is true regarding parenteral iron therapy for iron deficiency anemia in pregnant women?\nCan be given in first trimester\nAvoided in chronic liver disease\nSensitivity test is mandatory before administration\nCan be given alongside oral iron therapy\nQuestion 12:\nA G3P2 female patient who is an agricultural laborer presents with complaints of fatigue at 36 weeks of gestation. On examination, pallor and mild pedal edema are present. Her hemoglobin is 6.7 g/dl. How will you manage this patient?\nIron sucrose infusion\nFerric carboxymaltose infusion\nPacked cell transfusion\nIron dextran infusion\nQuestion 13:\nA pregnant woman was brought by her husband after fainting at home. He gave a history of her being clumsy and forgetful over the last few weeks. Investigations revealed high MCV\nwith hypersegmented neutrophils. How will you manage this patient?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_100",
    "question_text": "\uf06dg of IM cyanocobalamin",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_1000",
    "question_text": "\uf06dg of IM cyanocobalamin + folic acid",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_400",
    "question_text": "mcg of folic acid",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_500",
    "question_text": "\uf06dg of Oral cyanocobalamin\nQuestion 14:\nAn anxious primigravida with sickle cell trait comes to you for her first antenatal checkup. Which of the following is she at a higher risk of developing during the course of this pregnancy?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch72_4",
    "question_text": "&amp; 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch73_1",
    "question_text": ", 3, &amp; 5\nOnly 3",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch73_2",
    "question_text": "&amp; 4\nQuestion 15:\nA sexually active woman with sickle cell anemia comes to the clinic for advice regarding contraception. Which of the following is the ideal contraceptive for this patient?\nProgesterone implant\nOral contraceptive pills\nCopper IUD\nBarrier methods\nQuestion 16:\nA pregnant woman with thalassemia major presents to the clinic at 24 weeks of gestation with fatigue and shortness of breath. Which of the following is not true regarding the management of this condition?\nParenteral iron therapy is the treatment of choice\nOral iron therapy is contraindicated\nBreast feeding is safe after delivery\nRepeated transfusions are necessary to maintain Hb levels above 10 g/dl\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_1",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_2",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_3",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_4",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_5",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_6",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_7",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_8",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_9",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_10",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_11",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_12",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_13",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_14",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_15",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_16",
    "question_text": "\na\nSolution to Question 1:\nSevere anemia is defined as Hb &lt; 7 g/dL.\nAnemia in pregnancy is said to occur when Hb level is &lt;11 g/dL. It is classified as shown below:\nHemoglobin values (g/d L)\nWHO classification of anemi a in pregnancy\nICMR classification of anemi a in pregnancy\n\uf0b311\nNormalIn thesecond trimeste r, Hb\uf0b310.5g/dL is considered normal\nNormal",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_10",
    "question_text": "10.9\nMild\nMild",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_7",
    "question_text": "9.9\nModerate\nModerate\n<7\nSevere\nSevere\nHemoglobin values (g/d\tWHO classification of anemi\tICMR classification of anemi L)\ta in pregnancy\ta in pregnancy\nHemoglobin values (g/d\tWHO classification of anemi\tICMR classification of anemi L)\ta in pregnancy\ta in pregnancy\nHemoglobin values (g/d\tWHO classification of anemi\tICMR classification of anemi L)\ta in pregnancy\ta in pregnancy\n<4\n-\nVery severe\nSolution to Question 2:\nThe second most common pathological cause of anemia during pregnancy is anemia associated with chronic disease. The most common pathological cause of anemia during pregnancy is iron deficiency anemia.\nWomen with chronic disorders may develop anemia for the first time during pregnancy. Causes include:\nChronic renal insufficiency - the most common cause. Recombinant erythropoietin is used for treating anemia due to chronic renal failure.\nInflammatory bowel disease\nConnective tissue disorders\nGranulomatous infections\nMalignant neoplasms\nRheumatoid arthritis\nChronic suppurative conditions.\nNote: The most common cause of anemia in pregnancy is physiological. It is normally seen during pregnancy. This occurs due to the expansion of plasma volume by 30\u201340%. This increase is much more than the increase in red cell mass (20-30%) during pregnancy. This leads\nto hemodilution and an apparent decrease in hemoglobin levels.\nSolution to Question 3:\nMaternal requirement of iron during a singleton gestation averages close to 1000 mg.\nThe average iron stores in a non-pregnant female is around 300 mg. This falls short of the requirement of iron during pregnancy which is 1000 mg. Hence iron supplementation is necessary to prevent iron deficiency anemia during pregnancy. This also forms the basis for prophylactic iron supplementation during pregnancy.\nNote: The Federation of Obstetrics and Gynaecology (FOGSI) states that the iron requirement in pregnancy is 840 mg, as about 160 mg of iron is saved due to amenorrhea during pregnancy.\nIron requirement during pre gnancy\nFetus and placenta",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_300",
    "question_text": "\nmg\nIron requirement during pre gnancy\nIron requirement during pre gnancy\nExpansion of maternal hemo globin mass",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_500",
    "question_text": "\nmg\nLosses through normal excret ion routes",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_200",
    "question_text": "\nmg\nTotal",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_1000",
    "question_text": "\nmg\nSolution to Question 4:\nThe guideline recommends 60 mg of elemental iron and 500 \uf06dg of folic acid daily for at least 180 days, starting from the 4th month of pregnancy, and to be continued throughout\npregnancy. Ideally, this must be continued until 180 days postpartum.\nSolution to Question 5:\nThe amount of folic acid to be given to pregnant women suffering from sickle cell anemia is 5 mg.\nThis is to reduce the risk of neural tube defects and to compensate for the increased demand for folate during pregnancy.\nNormally in all sickle cell patients (irrespective of age or sex), 1mg of folic acid is given to prevent folate deficiency.\nNote: William's Obstetrics 26th Edition mentions folic acid 4 mg daily for pregnant women with sickle cell disease. However various other sources and RCOG guidelines mention it as 5 mg daily. Hence this is the best answer.\nSolution to Question 6:\nIn the given scenario, history suggestive of restless leg syndrome and Hb of 10.1g/dL points to a diagnosis of iron deficiency anemia. Serum ferritin is the most sensitive indicator of iron deficiency anemia in pregnant women.\nThis is because its concentrations are not affected by the recent intake of iron-rich foods. Serum ferritin concentration &lt;15 \uf06dg/L indicates iron deficiency anemia.\nHowever, treatment needs to be initiated when the concentration falls &lt;30 \uf06dg/L, as this indicates early iron depletion.\nRestless leg syndrome also called Willis-Ekbom Disease, causes unpleasant or uncomfortable sensations in the legs along with an irresistible urge to move them. It may be associated with iron deficiency anemia.\nSolution to Question 7:\nIn the given clinical scenario presence of microcytic hypochromic RBCs indicates iron deficiency anemia, and hyper segmented neutrophils indicate anemia due to folic acid or vitamin B12 deficiency. This is also known as dimorphic anemia.\nBlood picture in iron deficiency anemia:\nMicrocytic hypochromic RBCs\nTypical photo pencil cells\nPresence of poikilocytes (pre-erythrocytes)\nBlood picture in folic acid/vitamin B12 deficiency anemia:\nHyper segmented neutrophils - earliest change\nMacrocytic RBCs\n\nSolution to Question 8:\nThe given scenario is suggestive of pica associated with moderate iron-deficiency anemia. Since the anemia was diagnosed late in pregnancy, the most appropriate treatment is parenteral iron therapy. Ferrous sucrose is a form of parenteral iron given as an IV infusion.\nIf anemia is diagnosed:\nIn the first trimester - Oral iron therapy is preferred\nIn the second trimester - Oral iron therapy should be switched over to parenteral iron if Hb falls\n&lt;8g/dl or if serum ferritin is &lt;15ng/ml\nIn the third trimester - Parenteral iron therapy is preferred\nFerrous sucrose is the most commonly used preparation for IV infusion. It is safe and does not require a test dose.\nOther iron preparations include:\nOral preparations- Ferrous sulfate, ferrous gluconate, ferrous ascorbate\nIM preparations- Iron sorbitol, Iron polymaltose\nIV preparations- Ferric carboxymaltose\nBoth IM and IV- Iron dextran.\nSolution to Question 9:\nFerric carboxymaltose is considered superior to all other parenteral iron supplementation especially for iron deficiency anemia in postpartum women.\nFerric carboxymaltose (FCM) is a dextran-free IV iron preparation. It allows rapid administration of high doses of iron (up to 1000 mg iron in 15 min).\nIt is safe and effective in improving the mean Hb level. It avoids the need for blood transfusions.\nSolution to Question 10:\nThe formula for calculating dose of parenteral iron is:\nTotal dose in mg = 2.4 \u0161 (Target Hb - Actual Hb) \u0161 Body Wt. + 500 mg",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_16.jpeg",
      "OBGYN_img_211.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_2",
    "question_text": "4 - conversion factor\nTarget Hb - Hb you want to achieve\nActual Hb- level of current Hb\n500 mg - additional amount to replenish the iron stores\nIron sucrose must be diluted only using normal saline at a concentration of 1-2 mg of iron/mL of saline. It is given over 20-30 minutes intravenously.\nSolution to Question 11:\nParenteral iron therapy for iron deficiency anemia in pregnancy is avoided if the patient has a history of chronic liver disease.\nIt is used as an alternative therapy in people who cannot tolerate oral iron. Contraindications include:\nA history of prior anaphylactic reaction to parenteral iron therapy\nFirst trimester of pregnancy - there is no evidence on the use of IV iron in the first trimester of pregnancy\nChronic liver disease\nActive infection (acute or chronic)\nA sensitivity test prior to the infusion is not mandatory. IV iron should be given with caution even if previous administrations have been well tolerated.\nOral iron should be stopped at least 24 hours prior to therapy to avoid iron toxicity.\nSolution to Question 12:\nThe treatment of choice for severe anemia (&lt; 7g/dL) in the third trimester is packed cell transfusion. It is preferred over whole blood as it avoids volume overload.\nIndications of blood transfusion in pregnancy include:\nPregnancy &lt;34 weeks\nHb &lt;5 g/dL with or without signs of cardiac failure or hypoxia\nHb 5-7 g/dL \u2013 in presence of impending heart failure\nPregnancy &gt;34 weeks - Hb &lt;7 g/dL.\nSolution to Question 13:\nThe given scenario points to vitamin B12 deficiency. It is treated by vitamin B12 injections with folic acid supplementation. 1000 \uf06dg of IM cyanocobalamin should be given initially every week for 6 weeks, following which it should be given once every month.\nMegaloblastic anemia caused by Vit B12 deficiency should be identified and treated accordingly because folic acid supplementation alone will not help.\nCauses of Vit B12 deficiency leading to anemia in pregnancy:\nGastric resection\nAddisonian pernicious anemia\nCrohn\u2019s disease\nIleal resection\nBacterial overgrowth in the small bowel.\nSolution to Question 14:\nAmong the given options, patients with sickle cell trait are at a higher risk of developing urinary tract infections.\nSickle cell disease, on the other hand, is associated with increased risk of :\nMiscarriages\nFetal growth restriction\nPreterm labor\nVenous thromboembolism\nPre-eclampsia\nPlacental abruption\nFetal distress in labor\nNote: Sickle cell trait is a benign condition in which the affected person has only one abnormal hemoglobin beta gene allele whereas, in sickle cell disease, the affected person has two abnormal hemoglobin beta gene alleles and is hence severely symptomatic. Unlike individuals with sickle cell disease, those with sickle cell trait do not have symptoms related to sickling and mostly lead a normal life.\nSolution to Question 15:\nLow-dose oral progestins or progesterone injections or implants are ideal contraceptives in a patient with sickle cell anemia. Progesterone has been known to prevent painful sickle cell crises.\nIt is considered very safe in pregnancy. It is rated level 1 indicating that there is no restriction in their use.\nContraceptive methods and their safety profile in sickle cell anemia: Level 1 contraceptives (no restriction):\nProgestogen-only injection (DMPA)\nLevonorgestrel intrauterine system (Mirena)\nEmergency contraception containing progestins\nLevel 2 contraceptives (advantages outweigh disadvantages):\nCombined oral contraceptive\nCopper intrauterine device.\nSolution to Question 16:\nIn thalassemia major, both oral and parenteral iron preparations are avoided. This is because these patients are already in a state of iron overload due to multiple blood transfusions.\nPregnancy in patients with thalassemia major is very rare. In case pregnancy occurs the following strategies are adopted:\nIron chelating agents should be stopped\n5mg folic acid supplementation should be given daily\nPneumococcal vaccination and boosters are advised prior to pregnancy\nRepeated blood transfusions are given to maintain Hb levels above 10 g/dL\nBreastfeeding is safe and iron chelation therapy can be resumed post-delivery.\nHypertensive Disorders in Pregnancy\nQuestion 1:\nGestational hypertension is defined as:\nBP&gt;130/80 after 22 weeks of gestation\nBP &gt; 130/80 after 20 weeks of gestation\nBP &gt; 140/90 after 22 weeks of gestation\nBP &gt; 140/90 after 20 weeks of gestation\nQuestion 2:\nWhat is the minimum cut-off for defining proteinuria in a random urine sample?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_0",
    "question_text": "3 g/L",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_0",
    "question_text": "2 g/L",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_0",
    "question_text": "1 g/L",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_0",
    "question_text": "4 g/L\nQuestion 3:\nIn a normal pregnancy, when does the remodeling of spiral arteries begin?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_6",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_16",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_14",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch74_12",
    "question_text": "weeks\nQuestion 4:\nA 28-year-old G2P1 patient at 17 weeks of gestation comes for a routine antenatal visit. Her blood pressure is 142/94 mm of Hg. A repeat blood pressure after 4 hours is measured to be 148/92 mm Hg. What is the most likely diagnosis?\nPreeclampsia\nPreeclampsia superimposed on chronic hypertension\nChronic hypertension\nGestational hypertension\nQuestion 5:\nWhich of the following does not put a patient at an increased risk for preeclampsia?\nTwin pregnancy\nFamily history of hypertension\nNew paternity\nSmoking\nQuestion 6:\nWhich of the following does not occur in patients developing pre-eclampsia?\nAbnormal trophoblastic invasion of uterine vessels\nMaladaptive immunological tolerance to fetal antigens\nMaladaptation to cardiovascular changes of normal pregnancy\nIncreased placental perfusion due to inflammation\nQuestion 7:\nWhich of the following statements is false regarding the management of patients with an increased risk of pre-eclampsia?\nLow dose aspirin may reduce severity of disease\nCalcium supplementation above RDA reduces the incidence\nTreatment with magnesium lowers endothelin-1 concentrates\nMegadoses of vitamin C has no proven benefit\nQuestion 8:\nWhich of the following statements is false regarding the pathogenesis of pre-eclampsia?\nVascular sensitivity to angiotensin 2 is increased\nAngiotensinase activity is depressed\nThere is an increase in sFlt -1 levels\nA decrease in the level of soluble endoglin is seen\nQuestion 9:\nA 24-year-old primigravida at 22 weeks of gestation came for a regular antenatal checkup. Her BP is 152/96mmHg. \u2019rine analysis shows proteinuria of 3+. All of the following would be consistent with her probable diagnosis, except:\nThrombocytopenia\nHemolysis\nIncreased Hemoglobin\nLow fibronectin\nQuestion 10:\nWhich finding is most likely to be seen in a patient with pre-eclampsia?\nLow uric acid leve\nDecreased GFR\nLow serum creatinine leve\nHigh urinary calcium\nQuestion 11:\nOphthalmic manifestations in patients with preeclampsia syndrome include all, except:\nPurtscher\u2019s retinopathy causing reversible blindness\nCentral vision loss due to temporary scotoma\nPermanent visual loss due to retinal artery occlusion\nPermanent blindness due to serous retinal detachment\nQuestion 12:\nA patient, diagnosed with preeclampsia was brought to the emergency room with three episodes of generalized tonic-clonic seizures, urinary incontinence, and altered sensorium for 3 hours. After stabilization, an MRI revealed the following findings. Which of the following is\ntrue regarding this condition?\n\nAnterior circulation is most commonly involved\nThis lesions may be seen in most pre-eclampsia patients\nThe condition is reversible\nBasal ganglia are always spared\nQuestion 13:\nWhich of the following are indicators of severe disease in a patient with preeclampsia?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_16.jpeg",
      "OBGYN_img_17.jpeg",
      "OBGYN_img_212.jpeg",
      "OBGYN_img_213.jpeg",
      "OBGYN_img_214.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch75_1",
    "question_text": ", 3, 2, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch75_1",
    "question_text": ", 4, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch75_2",
    "question_text": ", 3, 4, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch76_1",
    "question_text": ", 3, 4\nQuestion 14:\nA patient at 32 weeks of gestation with pre-eclampsia is admitted to your ward. All of the following symptoms would warn you of impending eclampsia, except:\nAnkle clonus\nOliguria\nScotoma\nDecreased deep tendon reflex\nQuestion 15:\nA G2P1 woman with a history of pre-eclampsia presents at 24 weeks of gestation for an antenatal check-up. You decide to evaluate her risk of developing pre-eclampsia in the present pregnancy. Which of the following results is not an indicator?\nAbsence of diastolic notch on Doppler\nHigh resistance index in uterine artery Doppler in the second trimester\nAverage MAP &gt; 90 mmHg\nPresence of free fetal DNA in maternal serum\nQuestion 16:\nA 30-year-old G3P2 at 34 weeks of gestation was admitted as her BP was 150/90mmHg and urine dipstick was 2+ on antenatal checkup. Which of the following drugs is not suitable to control BP in this patient?\nMethyl dopa\nLabetalo\nHydralazine\nCaptopri\nQuestion 17:\nWhich is the drug of choice for controlling BP in a patient with severe pre-eclampsia?\nLabetalo\nHydralazine\nNifedipine\nMethyldopa\nQuestion 18:\nA G3P1A1, preeclamptic patient at 33 weeks of gestation came for a regular antenatal check-up. At present, her BP is 130/90 and an NST is reactive. What is the plan of management for this patient?\nWait till 37 weeks for delivery\nDeliver at term\nInduce at 34 weeks\nPerform LSCS at 34 weeks\nQuestion 19:\nA 33-week-pregnant lady with pre-eclampsia presents with features suggestive of HELLP syndrome. Which of the following is false about her condition?\nCorticosteroids aid in increasing platelet count\nIt is characterised by microangiopathic hemolysis\nMgSO4 can be used in the management of HELLP syndrome\nTermination of pregnancy is the definitive management\nQuestion 20:\nWhich among the following is false regarding HELLP syndrome?\nPT, PTT, fibrinogen levels are norma\nAll patients with HELLP syndrome have abnormal BP\nTennessee criteria is used for diagnosis\nIt usually manifests at 27-37 weeks\nQuestion 21:\nA G2P1 patient at 25 weeks of gestation is brought to the emergency with right upper quadrant pain and one episode of seizure. CBC reveals a Hb of 7.6gm/dl and a platelet count of 70,000/microL. What is the definitive management?\nTermination of pregnancy\nAdministration of steroids\nMgSO4 regimen\nPlatelet transfusion\nQuestion 22:\nA pre-eclamptic patient at 30 weeks of gestation is rushed to the hospital as she suddenly lost her vision 1 hour ago. During admission, she has a seizure. Which of the given statements is correct?\nConvulsions within 7 days of delivery are called postpartum eclampsia\nThrombocytosis is likely to be found\nBlindness due to this condition is usually reversible\nThe seizure is usually foca\nQuestion 23:\nA G3P2 patient with preeclampsia develops seizures and is started on the Pritchard regimen. What level of serum magnesium should be maintained in this patient in order to prevent seizures?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch76_4",
    "question_text": "7 meq/L",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch76_7",
    "question_text": "10 meq/L",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch77_1",
    "question_text": "3 meq/L",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch77_6",
    "question_text": "8 meq/L\nQuestion 24:\nThe mechanism of action of MgSo4 includes all, except:\nIt is a membrane stabiliser\nIt is a neuroprotector\nIt reduces motor endplate sensitivity to Ach\nIt blocks neuronal sodium influx\nQuestion 25:\nWhich of the following is an indication to skip the next dose in a patient with severe pre-eclampsia taking MgSO4 prophylactically?\n\u2122nee jerks are sluggish\n\u2019rine output exceeds 30 ml/hr\nRespiratory rate more than 14 /min\nHeart rate more than 100/min\nQuestion 26:\nA pregnant woman with pre-eclampsia is started on prophylactic MgSO4 in view of signs of impending eclampsia. An hour later, examination reveals RR - 16 breaths/minute and absent patellar reflexes. What is her plasma concentration of MgSO4 most likely to be?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch77_6",
    "question_text": "8 mEq/L",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch77_14",
    "question_text": "16 mEq/L",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch77_16",
    "question_text": "30 mEq/L",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch77_10",
    "question_text": "12 mEq/L\nQuestion 27:\nMagnesium sulphate has no role in:\nPrevention of seizures in severe pre-eclampsia\nPrevention of recurrent seizures in eclampsia\nPrevention of RDS in premature baby\nReducing contractility of uterus\nQuestion 28:\nA primigravida at 33 weeks of gestation was rushed to the hospital with recurrent seizures. Her husband says that prior to the seizures, she had complained of a headache and visual disturbances. She was on antihypertensives from the first trimester and there is no history of neurological disease. Which of the following is true regarding her management?\nFirst step of management is intravenous MgSO4\nDiazepam is recommended as an anticonvulsant if MgSO4 fails\nTreatment may be based on recommendations from the Magpie tria\nMaternal alkalosis commonly occurs and needs correction\nQuestion 29:\nWhich of the following is true regarding eclampsia?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch78_1",
    "question_text": ", 3",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch78_3",
    "question_text": ", 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch78_2",
    "question_text": ", 4",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_1",
    "question_text": ", 4\nQuestion 30:\nA pregnant lady with PIH was being monitored with bed rest in supine position. Which of the following is a complication of the below representation?\n\nAscending aorta syndrome\nSuperior vena caval syndrome\nAbdominal aorta syndrome\nSupine venacava syndrome\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_17.jpeg",
      "OBGYN_img_215.jpeg",
      "OBGYN_img_216.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_1",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_2",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_3",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_4",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_5",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_6",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_7",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_8",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_9",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_10",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_11",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_12",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_13",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_14",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_15",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_16",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_17",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_18",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_19",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_20",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_21",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_22",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_23",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_24",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_25",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_26",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_27",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_28",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_29",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_30",
    "question_text": "\nd\nSolution to Question 1:\nGestational hypertension is defined as BP &gt;140/90 after 20 weeks of gestation.\nHypertension in pregnancy is defined as BP of &gt;140/90 mmHg measured 2 times with at least a 4-hour interval.\nProteinuria is not an essential criterion to define pre-eclampsia. Pre-eclampsia is hypertension with any of the following features:\nProteinuria\nThrombocytopenia\nRenal insufficiency\nLiver involvement\nCerebral symptoms\nPulmonary edema.\nNote: A normotensive pregnant woman may have an acute increase in BP from baseline levels and develop eclamptic seizures/HELLP syndrome, despite being normotensive. This condition is known as delta hypertension.\nGestational hypertensio n\nPre-eclampsia\nChronic hypertension in p regnancy\nRise in BP\nAfter 20 weeks of pregn ancy\nAfter 20 weeks of pregnan cy\nBefore 20 weeks of gestati on\nProteinuria\nAbsent\nMay be present:>300 mg i n 24 hrs urine>30 mg/dl i n a random urine sample \u2019rine dipstick 2+\nAbsent\nFall in BP to normal lev els\nWithin 12 weeks of deliv ery\nWithin 12 weeks of deliver y\nDoes not return to normal\nSolution to Question 2:\nThe cut-off for defining proteinuria is \uf0b330 mg/dl (0.3 g/L) in a random urine sample. Proteinuria in preeclampsia is also defined by:\n\uf0b30.3 g protein in a 24-hour urine specimen.\nRandom urine protein: creatinine ratio (PCR) \uf0b30.3 mg protein/mg creatinine\nProtein \uf0b31+ on urine dipstick\nA urine dipstick is used only if the above quantitative methods are not available. Note: Proteinuria is not an essential criterion to define pre-eclampsia.\nSolution to Question 3:\nIn a normal pregnancy, the remodeling of spiral arteries begins at 12 weeks.\nRemodeling of arteries includes invasion of arteries by trophoblasts that convert them from low-flow, high-resistance to high-flow, low-resistance vessels. These modified vessels are more capable of meeting the demands of the developing fetus.\n\u2019teroplacental vessel development takes place in two stages:\nThe first stage occurs before 12 weeks post-fertilization. During this stage, invasion of spiral arteries up to myometrium occurs.\nThe second stage occurs between 12-16 weeks. It involves invasion of the endovascular trophoblasts into the intra-myometrial segments of spiral arteries. Interstitial trophoblasts surround the arteries.\nIncomplete trophoblastic invasion leads to pregnancy-induced hypertension (PIH) where the vessels remain in a state of high resistance leading to placental ischemia and release of inflammatory mediators and vasoactive substances leading to endothelial injury.\nAs the second stage of invasion occurs by 18 weeks, PIH develops after 20 weeks of pregnancy.\nSolution to Question 4:\nIn the above scenario of hypertension in a patient with gestational age &lt;20 weeks, the diagnosis is chronic hypertension.\nChronic hypertension is diagnosed when the patient is a known hypertensive (or) BP &gt; 140/90 mmHg before 20 weeks of gestation.\nGestational hypertension and preeclampsia are only diagnosed after 20 weeks of gestation.\nSolution to Question 5:\nSmoking is not a risk factor for pre-eclampsia rather it is protective.\nAlthough smoking during pregnancy causes various adverse pregnancy outcomes, it is associated with a reduced risk for hypertension in pregnancy.\nRisk factors for pre-eclampsia are:\nPrevious history of pre-eclampsia\nPrimigravida: young or elderly\nFamily history: Hypertension, pre-eclampsia.\nPlacental abnormalities:\nHyperplacentosis: excessive exposure to chorionic villi (molar pregnancy, twins, diabetes)\nPlacental ischemia\nThrombophilias: APLA, Protein C, Protein S deficiency, Factor V laden mutation, homocysteinemia\nTwin pregnancy\nMolar pregnancy\nRh-negative pregnancy\nNew paternity - A new partner for subsequent pregnancies\nSolution to Question 6:\nPlacental perfusion is reduced in patients developing pre-eclampsia. The development of pre-eclampsia may be explained by:\nAbnormal trophoblastic invasion of uterine vessels, leading to decreased placental perfusion.\nMaternal inflammatory response directed against foreign fetal antigens leading to immunological maladaptation.\nMaternal maladaptation to cardiovascular and inflammatory changes of normal pregnancy.\nGenetic factors and epigenetic influences.\nSolution to Question 7:\nCalcium supplementation above the RDA does not reduce the incidence of pre-eclampsia.\nHowever, women who have a calcium-deficient state may benefit from calcium supplementation to reduce their risk of preeclampsia.\nProphylactic measures for the prevention of pre-eclampsia include low-dose aspirin administration (50\u2013150 mg/day). It is started after the 1st trimester, continued throughout pregnancy, and is to be stopped 7 days before labor.\nMagnesium administration may be beneficial as it lowers endothelin-1 concentrates. There is no role of a low salt diet, anti-oxidants, or vitamin C.\nSolution to Question 8:\nIn pre-eclampsia, there is an increase in the level of soluble endoglin.\nExcessive amounts of antiangiogenic factors, increased sensitivity to angiotensin, and lowered angiotensinase levels worsen hypoxia at the uteroplacental interface.\nTrophoblast of women who develop preeclampsia overproduces at least two antiangiogenic peptides that enter the maternal circulation. They increase months before clinical preeclampsia develops.\nSoluble endoglin (sEng) is derived from the placenta and blocks endothelial nitric oxide-dependent vasodilatation. It also inhibits various TGF\uf062 isoforms from binding to endothelial receptors.\nSoluble Fms-like tyrosine kinase 1 (sFlt-1) is a variant of the Flt-1 receptor for placental growth factor (PlGF) and for VEGF. Increased maternal sFlt-1 levels inactivate and decrease circulating free PlGF and VEGF concentrations, leading to endothelial dysfunction.\nSolution to Question 9:\nThe given clinical picture is suggestive of pre-eclampsia and low fibronectin is not a feature of pre-eclampsia.\nFeatures associated with pre-eclampsia:\nFibronectin is a glycoprotein associated with vascular endothelial cell basement membrane and is elevated in women with preeclampsia.\nThrombocytopenia (HELLP syndrome)\nHemolysis (HELLP syndrome)\nIncreased hemoglobin, caused by a decrease in plasma volume.\nHemoconcentration is a hallmark of eclampsia. In preeclampsia, hemoconcentration is present but usually not marked.\nSolution to Question 10:\nDecreased GFR is seen in pre-eclampsia.\nDuring normal pregnancy, renal blood flow and GFR are increased. However, in pre-eclampsia, renal blood flow and GFR decrease due to increased renal afferent arteriolar resistance. The hallmark renal lesion is glomerular endotheliosis. Diminished filtration causes serum creatinine levels and plasma uric acid concentration levels to rise. The elevation is also due to enhanced tubular reabsorption.\nThe most common system involved in pre-eclampsia is the renal system.\nSeveral studies have demonstrated that pre-eclampsia is associated with low urinary calcium. This is often used as a predictive test.\nSolution to Question 11:\nSerous retinal detachment does not cause permanent visual loss. The most common visual symptom of preeclampsia is scotoma.\nBlindness can be due to occipital cortex edema, Purtscher\u2019s retinopathy (retinal ischemia), or retinal detachment. The blindness is mostly reversible and corrects automatically after delivery.\nRetinal artery occlusion sometimes causes permanent vision loss.\nSolution to Question 12:\nThe above clinical scenario and radiological image are suggestive of posterior reversible leukoencephalopathy syndrome (PRES). This condition is usually reversible.\nEndothelial dysfunction and cerebral autoregulation failure are implicated as etiologies of PRES. PRES lesions are almost universal in women with eclampsia but less frequent in\npre-eclampsia.\nPRES is characterized by the following:\nSevere headaches\nAltered sensorium\nSeizures\nVisual disturbances. Radiological findings in PRES:\nHyperintense T2 lesions in the subcortical and cortical regions of the parietal and occipital lobes.\nThe basal ganglia, brainstem, and cerebellum are commonly involved.\nPosterior circulation is commonly involved, and anterior circulation involvement is seen in severe cases.\nNeurological manifestations of preeclampsia include:\nHeadaches\nConvulsions\nCerebral edema\nBlindness\nCerebral hemorrhage.\nSolution to Question 13:\nAmong the given statements, the presence of pulmonary edema, scotoma, or epigastric pain is indicative of severe pre-eclampsia.\nCriteria for diagnosing severe preeclampsia include:\nSigns and symptoms of significant end-organ dysfunction are:\nNew-onset cerebral or visual disturbance i.e., photopsia, scotoma, altered mental status, and severe headache\nSevere, persistent right upper quadrant or epigastric pain, unresponsive to medication and not accounted for by an alternative diagnosis (OR) Serum transaminase concentration \uf0b32 times upper imit of normal.\nThrombocytopenia with platelets &lt;100,000/microL.\nProgressive renal insufficiency (serum creatinine &gt;1.1 mg/dL)\nPulmonary edema.\nSystolic BP\nDiastolic BP\nProteinur ia\nSigns of end-organ dama ge\n\uf0b3160 mm Hg\n\uf0b3110 mm Hg\n+\n+/-\n\uf0b3140 mm Hg\n\uf0b390 mmH g\n+/-\n+\nSolution to Question 14:\nDecreased deep tendon reflex is not a symptom of impending eclampsia. There will be increased deep tendon reflex i.e., hyperreflexia.\nSymptoms and signs of impending eclampsia include:\nSevere occipital or frontal headache\nOliguria - diminished urine output &lt;400 ml/day\nEpigastric pain\nVisual symptoms - blurring, scotomas, blindness\nDisturbed sleep\nAnkle clonus\nSevere elevation in blood pressure\nPulmonary edema.\nSolution to Question 15:\nIn this above scenario, the absence of a diastolic notch at 24 weeks on Doppler is not a predictor of pre-eclampsia.\nIn normal pregnant women, a diastolic notch in the uterine artery disappears by 24 weeks. Thus, a persistent diastolic notch present in uterine artery flow between 22-24 weeks is predictive of preeclampsia.\nPredictors of preeclampsia:\nFree fetal DNA in maternal plasma\nDiastolic notch present in uterine artery flow between 22-24 weeks (high resistance index in the second trimester)\nAverage MAP &gt;90 mmHg Predictors no longer used include:\nHemoconcentration\nElevated fibronectin\nIncrease in uric acid levels\nHypocalciuria - calcium in urine &lt;12mg/dl in 24 h\nIncreased homocysteine levels\nRoll-over test - screening test is done between 28-32 weeks.\nSolution to Question 16:\nCaptopril is an ACE inhibitor and it is contraindicated in pregnancy.\nHigh BP and proteinuria are diagnostic of preeclampsia. The following drugs are used for the management of pre-eclampsia.\nACE inhibitors inhibit the conversion of angiotensin I to the potent vasoconstrictor angiotensin-II. When given in the second and third trimesters, they can cause severe fetal malformations such as:\nBony malformations\nPersistent PDA\nRespiratory distress syndrome\nLimb contracture\nPulmonary hypoplasia.\nAnti-hypertensives to be avoided in pregnancy include:\nACE inhibitors\nAngiotensin receptor blockers\nDiuretics (contraindicated as anti-hypertensive but can be given in CCF)\nReserpine\nSodium nitroprusside (used only as a drug of last resort in refractory severe hypertension)\nDiazoxide.\nDrug\nDose\nLabetalol\n100 mg TID or \u203aID\nMethyl-d opa",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_250",
    "question_text": "\u2013500 mg TID or\n\u203aID\nNifedipin e",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_10",
    "question_text": "\u201320 mg BD\nHydralaz ine",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_10",
    "question_text": "\u201325 mg BD\nSolution to Question 17:\nIntravenous labetalol is the drug of choice for controlling BP in severe pre-eclampsia.\nIt is the first-line agent for urgent control of BP in pregnancy. It is effective, has a rapid onset of action, and has a good safety profile.\nLabetalol is a nonselective \uf062 blocker and vascular \uf0b0 blocker. It should be avoided in patients with asthma and congestive heart failure due to bronchoconstriction.\nOption B: Hydralazine causes maternal hypotension and fetal distress. Option C: Nifedipine causes reflex tachycardia and headache in the mother.\nOption D: In methyldopa, a change in BP is an indirect action. So it is less effective in controlling BP.\nNote: Experimental antihypertensive drugs for pre-eclampsia treatment are calcitonin gene-related peptide (CGRP) and anti-digoxin antibody Fab (DIF). DIF is directed against endogenous digitalis-like factors, also called cardiotonic steroids.\nChoice of anti-hypertensives i n pregnancy\nPIH /pre-eclampsia / severe p re-eclampsia\nLabetalol\nAcute hypertension/ Hyperte nsive crisis\nIV labetalol, nifedipine, hydr alazine\nChronic hypertension in preg nancy\nLabetalol > methyl dopa.\nSolution to Question 18:\nThe scenario is suggestive of mild pre-eclampsia as the patient has a BP of 130/90 mmHg and no fetal compromise. Hence, the plan of management would be to wait till 37 weeks for termination.\nIn all cases of hypertension during pregnancy, the preferred mode of delivery is vaginal. Cesarean is indicated only for any co-existing obstetrical reasons.\nHypertensive condition\nTime of delivery\nGestational hypertension",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_38",
    "question_text": "\u201339 weeks\nMild pre-eclampsia\n\uf0b337 weeks\nSevere pre-eclampsia\n\uf0b334 weeks\nEclampsia, HELLP syndr ome\nImmediate termination irres pective of gestational age\nSolution to Question 19:\nCorticosteroid treatment for thrombocytopenia is not recommended in patients with HELLP syndrome.\nHELLP syndrome is a serious complication in pregnancy characterized by HEmolysis, ELevated liver enzymes, and Low Platelet count. It occurs in 0.5-0.9% of all pregnancies and in 10\u201320% of patients with severe preeclampsia.\nManagement of HELLP syndrome is supportive, including:\nAntiseizure prophylaxis with MgSO4\nPlatelet tansfusion if platelet count &lt;50,000/mm3 , FFP transfusion\nPlasmapheresis\nImmediate termination of pregnancy in the interest of the mother.\nThe most common cause of maternal death in HELLP syndrome is abruptio placenta and DIC.\nSolution to Question 20:",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_15",
    "question_text": "% of pregnant women with HELLP syndrome have normal blood pressure.\nHELLP syndrome occurs at 27-37 weeks. PT, PTT, and fibrinogen levels are normal. This differs from DIC where PT and PTT are elevated while the plasma fibrinogen level is decreased.\nTennessee criteria is used for diagnosis and Mississippi classification is used to grade HELLP syndrome.\nTennessee criteria for diagnosis of true/complete HELLP\nPlatelet count &lt;1 lakh/cu mm\nAST &gt;70 I\u2019/L,\nLDH &gt;600 I\u2019/L\nMississippi classification divides HELLP into 3 grades based on the platelet count.\nSolution to Question 21:\nThe clinical scenario is suggestive of eclampsia and HELLP syndrome. The definitive management is the termination of pregnancy.\nIn cases of pre-eclampsia, indications for termination of pregnancy, irrespective of gestational age, are as follows:\nEclampsia (give MgSO4 followed by induction of labor)\nHELLP syndrome\nPersistent symptoms of severe pre-eclampsia or severe hypertension\nPulmonary edema\nSignificant renal dysfunction, coagulopathy\nAbruption of placenta\nFetal compromise\nIn mild pre-eclampsia, steroids are given and the patient is delivered at 37 weeks. In severe pre-eclampsia:\nIf pregnancy is &gt;34 weeks - MgSO4 is given for prophylaxis of eclampsia and the pregnancy is terminated.\nIf pregnancy is at 27-34 weeks - in the absence of contraindications, expectant management is followed and the baby is delivered at 34 weeks, as shown below in the flowchart.\n\nSolution to Question 22:\nThe clinical scenario is suggestive of eclampsia. Blindness due to eclampsia is usually reversible.\nBlindness due to eclampsia can be due to a central or peripheral cause. It is irreversible only if the etiology is a combination of retinal infarction and bilateral lateral geniculate nuclei lesions.\nOption A: Convulsions within 48 hours of delivery are called postpartum eclampsia.\nOption B: The most common hematological finding in pregnancy-induced hypertension is thrombocytopenia.\nOption D: The seizures are generalized seizures.\nNote: The most common cause of death in patients with eclampsia is intracerebral hemorrhage.\nSolution to Question 23:\nThe clinical picture is suggestive of eclampsia and to control fits, optimum serum magnesium levels of 4-7 mEq/L have to be maintained.\nMgSO4 regimens for management of eclampsia and severe pre-eclampsia:\nRegimen\nLoading Dose\nMaintenance Dose\nIntramuscular\t(Pritchar d)\n4 g (20% solution) IV over 3\u2013",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_17.jpeg",
      "OBGYN_img_217.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch79_5",
    "question_text": "minfollowed by10 g (50%),\ndeep IM (5 g in each buttock)\n5 g (50%) IM 4 hourly in alte rnate buttocks\nIntravenous (Zuspan or Sib ai)\n4g IV slow over 15\u201320 minut es",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch80_1",
    "question_text": "\u20132 g/hr IV infusion\nSolution to Question 24:\nMgSO4 blocks calcium influx, not sodium. Mechanism of action of MgSO4:\nIt is a membrane stabilizer and acts as a neuroprotector by reducing motor endplate sensitivity to Ach.\nIt blocks neuronal calcium influx.\nIt reduces the presynaptic release of the neurotransmitter glutamate.\nIt blocks glutaminergic NMDA receptors and potentiates adenosine action.\nSolution to Question 25:\nRepeat injections of MgSO4 are given only if knee jerks are present.\nThe next dose of MgSO4 is only given when all signs of magnesium toxicity are absent. Signs of magnesium toxicity:\nLoss of deep tendon reflexes\nDecreased respiratory rate (&lt;12 per min)\n\u2019rine output &lt;30 ml/hr\nChest pain, heart block Management of magnesium toxicity:\nStop magnesium therapy\nEstimation of serum magnesium and creatinine levels\nInjection of calcium gluconate 10 ml (10% solution) IV Side effects of MgSO4:\nAnuria\nPulmonary edema.\nSolution to Question 26:\nPatellar reflexes disappear when plasma magnesium concentration reaches 10 mEq/L. As there is no respiratory depression, the plasma concentration is likely to be 10-12 mEq/L.\nThe disappearance of the patellar reflex is the first sign of impending magnesium toxicity. MgSO4 is prophylactically used in impending eclampsia, severe pre-eclampsia, and HELLP syndrome.\nSigns of magnesium toxicit y\nPlasma concentrations of ma gnesium (mEq/L)\nLoss of patellar reflex",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch80_10",
    "question_text": "\u201312\nRespiratory depression",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch80_12",
    "question_text": "13\nCardiac arrest\n>30\nSolution to Question 27:\nMagnesium sulfate has no role in the prevention of respiratory distress syndrome (RDS) in a premature baby, where there is a deficit of surfactant (which results in alveolar collapse).\nMagnesium in the MgSO4 competes with calcium on voltage-gated calcium channels, thereby altering its uptake and release. Functions of MgSO4 include :\nMembrane protector and neuro stabilizer. It is used in the prevention of cerebral palsy in very ow birth weight neonates.\nReduction of motor endplate sensitivity to acetylcholine, and thus is used as an adjunct in the management of acute severe asthma in children and adults\nBlocking of neuronal calcium influx, and is thus used in the conservative management of pre-term labor (tocolytic, option D)\nInducing cerebral vasodilatation, dilating the uterine arteries, increasing the production of endothelial prostacyclin, and inhibiting platelet activation. Hence it is used in the management of pre-eclampsia (option A) and to prevent progression to eclampsia (option A).\nSolution to Question 28:\nThe clinical scenario is suggestive of eclampsia and management may be based on recommendations from the Magpie trial.\nThe Magpie trial showed that prophylactic use of magnesium sulfate lowers the risk of eclampsia.\nThe first step in the management of eclampsia is maintaining the airway, ensuring oxygen delivery to both mother and fetus. Then, MgSO4 is administered to control seizures.\nThiopentone &gt; phenobarbitone may be used to control seizures. No attempt should be made to shorten the convulsion using diazepam as it often leads to thrombophlebitis and respiratory depression.\nMaternal acidosis usually occurs and is corrected when present.\nSolution to Question 29:\nAntepartum eclampsia has the worst prognosis and the most common MRI finding of eclampsia is subcortical white matter edema.\nAntepartum eclampsia is the most common type of eclampsia. It has the highest rate of maternal mortality.\nThe outcome of eclampsia depends on the duration of hypertension and not severity. The most common cause of death in eclampsia and severe pre-eclampsia is intracranial bleeding.\nSolution to Question 30:\nSupine vena cava syndrome is the complication of the given representation. The image shows compression of the inferior vena cava by the gravid uterus which can sometimes lead to supine hypotension.\nDuring late pregnancy, the gravid uterus compresses the great vessels against the hard spine, when the patient is in the supine position. Of the two vessels, the vena cava is compressed, but the aorta, owing to its structure is relatively resistant.\nNormally, the vena cava compression results in opening up collateral circulation by means of paravertebral and azygous veins but in some cases, when the collateral circulation fails to open up, the venous return of the heart may be seriously curtailed resulting in hypotension, tachycardia, and syncope and is called supine vena cava syndrome.\nThe normal blood pressure is quickly restored by turning the patient to the lateral position.\nDiabetes in Pregnancy\nQuestion 1:\nWhich of the following are not risk factors for developing gestational diabetes?\nFamily history of diabetes\nGestational diabetes in previous pregnancy\nPersistent glucosuria\nObesity in first-degree relatives\nQuestion 2:\nYou discover that there is evidence of cardiac malformation in a fetus during a routine USG scan at 16 weeks. What is the minimum level of fasting blood sugar at which you can suspect overt diabetes?\n106 mg/dL\n126 mg/dL\n116 mg/dL\n130 mg/dL\nQuestion 3:\nA patient underwent a one-step procedure for gestational diabetes screening. Which of the following statements regarding this procedure is false?\nFasting blood glucose \uf0b3 92 mg/dL is diagnostic\n100 grams of glucose is given after overnight fast",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch81_1",
    "question_text": "hour blood glucose \uf0b3 180 mg/dL is diagnostic",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch81_2",
    "question_text": "hour blood glucose \uf0b3 153 mg/dL is diagnostic\nQuestion 4:\nA woman at 28 weeks of gestation is started on insulin therapy after being diagnosed with gestational diabetes mellitus. What should be the fasting blood glucose target in her?\n&lt;85mg/d\n&lt; 100 mg/d\n&lt;90 mg/dL\n&lt;95 mg/dL\nQuestion 5:\nAccording to Priscilla White's classification for diabetes in pregnancy, all of the following classes should be managed with insulin except\nB\nH\nA1\nF\nQuestion 6:\nWhich of the following statements is false regarding the management of hyperglycemia during pregnancy?\nMetformin crosses the placenta and has teratogenic effects on the fetus\nDiet control is the first line management\nHbA1c monitored at the end of the first trimester and then every 3 months thereafter\nInsulin is the first line pharmacological agent\nQuestion 7:\nA primigravida on screening was found to have a fasting blood glucose of more than 100 mg/dl. Which of the following medications will you not prescribe to her?\nGlyburide\nMetformin\nInsulin\nTolbutamide\nQuestion 8:\nA primigravida at 30 weeks of gestation is admitted with preterm labour contractions. She was diagnosed with gestational diabetes, on screening. Which of the following tocolytic drugs should be avoided in her?\nMagnesium Sulfate\nNifedipine\nTerbutaline\nIndomethacin\nQuestion 9:\nAccording to the American college of obstetricians, macrosomia is defined as the fetal birth weight of\t.\n\uf0b3 3 kg\n\uf0b3 3.5kg\n\uf0b3 4.5kg\n\uf0b35 kg\nQuestion 10:\nIn gestational diabetes, which of the following is an independent and substantial risk factor for macrosomia?\nBMI\nGlucose intolerance\nCord serum c peptide levels\nHbA1C\nQuestion 11:\nAccording to ACOG, routine cesarean delivery is advocated in a woman with gestational diabetes mellitus if the sonographically estimated fetal weight is \t g.\n&gt;3000\n&gt;3500\n&gt;4000\n&gt;4500\nQuestion 12:\nA pregnant woman has gestational diabetes mellitus (GDM) and her blood glucose levels are well controlled on insulin. What will be the appropriate gestational age for her delivery?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch81_37",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch81_39",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch81_38",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch81_40",
    "question_text": "weeks\nQuestion 13:\nWhich of the following complications is unlikely in a patient with gestational diabetes?\nAbortion\nPreeclampsia\nRespiratory distress syndrome\nOligohydramnios\nQuestion 14:\nOn screening, a primigravida is found to have fasting blood glucose of 110mg/dl. What is the likelihood that she will develop overt diabetes within the next 20 years?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch81_25",
    "question_text": "%",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch81_40",
    "question_text": "%",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch81_50",
    "question_text": "%",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch81_10",
    "question_text": "%\nQuestion 15:\nA 29-year-old woman with overt diabetes comes to you for pre-conception counseling. Which of the following congenital heart defects are least likely to occur if she were to have a child?\nTetrology of Fallot\nTransposition of great arteries\nVentricular septal defect\nDouble outlet right ventricle\nQuestion 16:\nHypocalcemia in a newborn is defined as serum calcium \t mg/dl.\n&lt; 8\n&lt; 8.5\n&lt; 9\n&lt; 7.5\nQuestion 17:\nYou are performing capillary blood glucose charting for newborns in the post-natal ward. Below what level is it considered hypoglycemia?\n&lt;40\n&lt;45\n&lt;50\n&lt;55\nQuestion 18:\nIdentify the maternal condition that can lead to the findings in the baby as shown below.\n\nPre-gestational diabetes\nGestational diabetes mellitus\nEffect of valproate\nHypertensive on ACE inhibitors\nQuestion 19:\nWhich of the following will be the most effective contraception in a female with hypertension and a history of gestational diabetes mellitus?\nOral contraceptives\nIntra uterine device\nBarrier methods\nDMPA injection\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_17.jpeg",
      "OBGYN_img_218.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch82_1",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch82_2",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch82_3",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch82_4",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch82_5",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch82_6",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch82_7",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch82_8",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch82_9",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch82_10",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch82_11",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch82_12",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch82_13",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch82_14",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch82_15",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch82_16",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch82_17",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch82_18",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch82_19",
    "question_text": "\nb\nSolution to Question 1:\nObesity in first-degree relatives is not a high-risk factor for gestational diabetes mellitus. However, severe obesity is a risk factor for developing gestational diabetes.\nGestational diabetes mellitus is defined as carbohydrate intolerance of variable severity with onset or first recognition during the present pregnancy.\nIt usually presents in the second or third trimester. More than 50% of women with GDM ultimately develop overt diabetes within 20 years.\nIt is recommended to screen for gestational diabetes mellitus in the presence of the following high-risk factors:\nSevere obesity\nStrong family history of type-2 diabetes\nPrevious history of gestational diabetes mellitus\nImpaired glucose metabolism or glucosuria.\nSolution to Question 2:\nOvert diabetes is when fasting blood sugar is \uf0b3 126 mg/dl. Overt diabetics are women who are known to have diabetes before pregnancy.\nA patient is said to have overt diabetes if:\nFasting blood sugar \uf0b3 126 mg/dL\nA random blood sugar of \uf0b3 200 mg/dL\nHbA1c of \uf0b3 6.5%\nThe maternal complication of diabetes:\nincreased Miscarriage and preterm labor.\nincreased incidence of preeclampsia\npolyhydramnios\nprolongation of labor due to shoulder dystocia, operative interference, and cephalo-pelvic disproportion.\nFetal and Neonatal complications of diabetes:\nfetal macrosomia (birth weight &gt; 4kg)\ncongenital malformations - Musculoskeletal, urogenital, and CNS anomalies.\nSolution to Question 3:\nIn one-step procedure, the patient is given 75g of glucose after an overnight fast, and blood glucose is measured hourly for 2 hours.\nDiagnostic criteria with one-step procedure is as follows:\nFasting \uf0b3 92 mg/dL",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch83_1",
    "question_text": "hour \uf0b3 180 mg/dL",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch83_2",
    "question_text": "hour \uf0b3 153 mg/dL\nIn two-step approach patient is given glucose and subsequent values measured in two separate steps.\nStep 1 - the patient is given 50 grams of glucose and blood glucose is measured after one hour. If it is \uf0b3140 mg/dl then the screen is positive and step 2 is done.\nStep 2 - the patient is given 100g of glucose and values measured hourly, for 3 hours. A diagnosis is made if at least two values are high using one of two methods.\nDIPSI (Diabetes In Pregnancy Societies of India) recommends a one-step procedure without regard to the time of the last meal. Here the patient is given 75 grams of oral glucose. A blood glucose value of \uf0b3140 mg/dL after 2-hours is diagnostic.\nSolution to Question 4:\nThe target fasting blood glucose level in a patient with gestational diabetes mellitus is 95 mg/dl. In gestational diabetes mellitus, the targets are:\nFasting \uf0a3 95 mg/d",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch84_1",
    "question_text": "h postprandial \uf0a3 140 mg/d",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch84_2",
    "question_text": "h postprandial \uf0a3 120 mg/d\nHbA1c \uf0a3 6.0%.\nSolution to Question 5:\nClass A1 is managed by diet therapy. Other than A1, all the other classes are managed by insulin therapy.\nPriscilla White's classification for diabetes in pregnancy is not used anymore. It was modified by the American College of Obstetricians and Gynaecologists in 1986.\nClass\nDescription\nGestational Diabetes Mellitus\nA1\nDiet-controlled GDM\nA2\nInsulin-controlled GDM\nDiabetes Mellitus\nB\nOnset >20yDuration <10y\nC\nOnset 10-19yDuration 10-19y\nD\nOnset <10yDuration >20yBe nign retinopathy\nF\nNephropathy\nR\nProliferative retinopathy\nH\nHeart disease\nSolution to Question 6:\nMetformin crosses the placenta. However, no teratogenic effects have been observed as yet.\nInsulin is the preferred treatment in gestational diabetes mellitus because it does not cross the placenta (American Diabetes Association).\nManagement of diabetes in pregnancy:\nPreconceptional counseling:\nTo achieve tight control of diabetes before the onset of pregnancy.\nHbA1C level measured to plan pregnancy.\nAppropriate advice about diet and insulin given\nAntenatal care (at monthly intervals up to 20 weeks and thereafter at 2 weeks intervals):\nDiabetic diet\u201430 \u2122cal/kg for normal BMI, 24 \u2122cal/kg for overweight women, and 12 \u2122cal/kg for morbidly obese women\nFrequent monitoring of blood glucose\nHbA1c determination at the end of the first trimester and then every 3 months thereafter. HbA1c evel of \uf0a36% is desirable\nInsulin therapy - initiated when diabetes is not controlled by diet alone\nOral hypoglycemic drugs- glibenclamide and metformin are safe.\nSolution to Question 7:\nTolbutamide is not used for the treatment of gestational diabetes.\nFirst-generation sulfonylureas such as tolbutamide and chlorpropamide can cause teratogenicity, neonatal hypoglycemia, and fetal hyperinsulinemia.\nFirst-line glycemic control agents in pregnancy:\nInsulin\nGlyburide\nMetformin\nSolution to Question 8:\nTerbutaline should be avoided in pregnant women with diabetes.\nTerbutaline (\uf062-mimetic drugs) given for tocolysis can cause hyperglycemia, which can cause diabetic ketoacidosis. Factors precipitating ketoacidosis in pregnancy:\nHyperemesis gravidarum\nInfection\nNon-compliance\nInsulin pump failure\n\uf062-sympathomimetic drugs\nCorticosteroids\nPoor glycemic contro\nSolution to Question 9:\nAccording to the American college of obstetricians (ACOG), macrosomia is defined as the fetal birth weight of \uf0b3 4.5 kg.\nMacrosomia refers to growth beyond a specific threshold, regardless of gestational age. In developed countries, the most commonly used threshold is the weight above 4.5 kg, but weight above 4 kg is also commonly used.\nThe WHO defines the cut-off at 4.0 kg for fetal macrosomia in its guidelines for the management of common maternal conditions. This is followed in India.\nSolution to Question 10:\nBMI (body mass index) is an independent and substantial risk factor for macrosomia in both diabetic and non-diabetic mothers.\nBMI levels are associated with increased birth weight, regardless of glucose levels. Gestational diabetes prevalence increases by approximately 1 percent for every 1 kg/m2 increase in BMI.\nBMI cutoffs for pregnancy:\nUnderweight - &lt; 18 kg/m2 Normal - 18.5 to 24.9 kg/m2\nOverweight - 25 to 29.9 kg/m2 Obese - &gt;30 kg/m2\nWeight distribution also seems to play a role because the risk of gestational diabetes is increased with truncal obesity. HbA1c levels are associated with fetal malformations in pre-gestational diabetes.\nSolution to Question 11:\nAccording to the American College of Obstetricians and Gynecologists (ACOG), routine cesarean delivery is advocated in a woman with gestational diabetes mellitus if the sonographically estimated fetal weight is \uf0b3 4500 g.\nSolution to Question 12:\nThe most appropriate time for the delivery in this patient would be 39 weeks as she has good glycemic control with insulin.\nThe timing for delivery in a pregnant woman with GDM would vary depending on the control of glucose levels &amp; mode of treatment.\nAppropriate timing for delive ry in gestational diabetes\nWell-controlledwith diet",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch84_39",
    "question_text": "weeks to 40 weeks +6 day s\nWell-controlledwithinsulin/or al agent",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch84_39",
    "question_text": "weeks to 39 weeks + 6 day s\nCo-morbidityor suboptimal c ontrol\nInduction before 39 weeks\nWithpoor glycemic control\nReasonable to deliver at 37 to 38 weeks + 6 days of gestati onIn extreme cases where all efforts for glycemic control h ave failed induction prior to 37 weeks (no clear cut guideli ne )\nSolution to Question 13:\nPolyhydramnios is a complication of diabetes, not oligohydramnios.\nGestational diabetes mellitus (GDM) is commonly defined as glucose intolerance first recognized during pregnancy.\nComplications of gestational diabetes:\nSpontaneous abortion\nPreterm labor\nUnexplained fetal demise\nHypoglycemia\nMalformations\nAltered fetal growth\nHypocalcemia\nHypertrophic cardiomyopathy\nPre-eclampsia\nRespiratory distress syndrome\nPolyhydramnios\nSolution to Question 14:",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch84_50",
    "question_text": "% of women with gestational diabetes develop overt diabetes within 20 years. Hence, they are recommended to undergo screening and revaluation from time to time.\nFasting blood glucose of \uf0b3 92 mg/dL indicates gestational diabetes.\nSolution to Question 15:\nTetrology of Fallot (TOF) is usually not seen in infants of diabetic mothers.\nVentricular septal defect and transposition of great arteries are the most common cardiac anomalies in infants of diabetic mothers.\nCardiac defects that present more often in infants of diabetic mothers are:\nTransposition of the great arteries (TGA)\nDouble outlet right ventricle (DORV)\nVentricular septal defect (VSD)\nTruncus arteriosus\nTricuspid atresia\nPatent ductus arteriosus (PDA)\nThe most common cardiac anomaly in an infant of a diabetic mother is a controversial topic. Most resources mention VSD and TGA are the most common and do not specify which among them is more common.\nSolution to Question 16:\nHypocalcemia in a newborn is defined as serum calcium &lt; 8 mg/dl.\nHypocalcemia is one of the potential metabolic derangements in neonates of diabetic mothers.\nThere is hypomagnesemia in the mother and the infant due to increased maternal urinary excretion of magnesium due to diabetes. There is maternal hyperparathyroidism due to hypomagnesemia which leads to increased maternal calcium.\nThis maternal calcium passes to the infant through the placenta and suppresses fetal PTH synthesis and impairs PTH response to postpartum hypocalcemia. PTH suppression, in this case, can be severe and lead to convulsions in the early neonatal period and may persist for months.\nSolution to Question 17:\nNeonatal hypoglycemia is defined as blood glucose levels &lt;45 mg/dL.\nMaternal hyperglycemia stimulates the fetal pancreas to secrete excess insulin, which causes increased neonatal fat deposition, abdominal girth, and macrosomia (Pederson's hypothesis). It also leads to a rapid drop in plasma glucose concentration after delivery.\nSolution to Question 18:\nThe image showing a poorly developed lower limb suggests the diagnosis of caudal regression sequence/sacral agenesis seen in pregestational diabetes. It is the most specific anomaly seen in diabetes.\nThe caudal regression sequence is a rare malformation, frequently associated with maternal pre-gestational diabetes. It consists of a spectrum of structural defects of the caudal region, including incomplete development of the sacrum and the lumbar vertebrae.\nE evated maternal HbA1c levels correlate with fetal malformations. It occurs approximately 200 times more frequently in infants of diabetic mothers than in other infants.\nOvert diabetes (pregestational diabetes) is associated with higher malformation rates than the general population. Neural tube defects (encephalocele, meningomyelocele, anencephaly), transposition of great vessels, ventricular septal defect, atrial septal defect, hypoplastic left heart, aortic stenosis and coarctation of the aorta are commonly seen.\nSmall left colon syndrome is a rare anomaly that develops in the second and third trimesters. Option B: Malformations are not associated with gestational diabetes mellitus (GDM).\nMalformations occur due to the disruption of organogenesis, usually occurring in the first\ntrimester. The abnormal glycemic status in GDM manifests only in the second trimester. Option C: Valproate leads to neural tube defects and not sacral agenesis.\nOption D: ACE inhibitors can cause oligohydramnios.\nSolution to Question 19:\nIntrauterine devices are the most effective contraceptive choice in patients with gestational diabetes mellitus and hypertension.\nIt is suitable in patients with diabetes and comorbidities like obesity, hypertension, or dyslipidemia. It is a method without potential cardiovascular consequences, unlike hormonal contraceptives.\nLow-dose hormonal contraceptives can be used safely in women with gestational diabetes if there are no associated comorbidities.\nEven though the barrier method will not lead to complications in such patients, the failure rate is high due to incorrect use and non-compliance. Hence it is not preferred.\nOption D: DMPA(depot-medroxyprogesterone acetate) is an injectable hormonal contraceptive that is contraindicated in diabetic pregnant women with co-morbidities.\nCardiovascular Conditions in Pregnancy\nQuestion 1:\nThe most common valvular heart disease in pregnancy is\nAortic stenosis\nMitral stenosis\nMitral regurgitatio\nMitral valve prolapse\nQuestion 2:\nWhat is the commonest congenital valvular lesion observed in pregnancy?\nMitral stenosis\nMitral regurgitatio\nMitral valve prolapse\nAortic stenosis\nQuestion 3:\nA 24-year-old lady with rheumatic mitral stenosis becomes pregnant. At what point during her pregnancy would you be least concerned about her developing cardiac failure?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch84_24",
    "question_text": "weeks of gestatio",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch84_30",
    "question_text": "weeks of gestatio\nDuring labor\nImmediate post-partum\nQuestion 4:\nAn intern posted in the antenatal OPD auscultates a patient who came for her routine checkup. Presence of which of the following features would not suggest a physiological change of pregnancy?\nLoud S1 with splitting\nEjection systolic murmur at left sternal border\nContinuous murmur at 2nd to 4th intercostal space\nLate systolic murmur\nQuestion 5:\nWhich of the following is not an absolute indication for therapeutic termination of pregnancy?\nPrimary pulmonary hypertensio\nEisenmenger's syndrome\nPulmonary venoocclusive disease\nProsthetic valve replacement\nQuestion 6:\nA pregnant lady with heart failure planned for valve replacement surgery is posted for cesarean section. Which of the following is not a cardiac indication for cesarean delivery?\nCoarctation of aorta\nAortic dissectio\nRecent myocardial infarctio\nPrimary pulmonary hypertensio\nQuestion 7:\nYou are performing CPR on a woman who is 38-weeks pregnant. She was admitted to the emergency after a massive pulmonary embolism led to cardio-pulmonary arrest. Despite the initial management of airway, oxygenation and vasopressor support, there is no improvement. What is the cut off time for perimortem cesarean delivery in this patient?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch85_1",
    "question_text": "minute",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch85_2",
    "question_text": "minutes",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch85_5",
    "question_text": "minutes",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch85_3",
    "question_text": "minutes\nQuestion 8:\nA G2P1 patient with mitral valve prolapse goes into labor. Which of the following should not be done in the management of this patient?\nCut short second stage of labour using ventouse\nFluid restrictio\nAntibiotic prophylaxis\nTrendelenburg position during first stage of labor\nQuestion 9:\nA pregnant woman with cardiac disease is on warfarin therapy. When will the final switch to heparin be advised?\nAt the onset of labour",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch85_34",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch85_36",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch85_40",
    "question_text": "weeks\nQuestion 10:\nA 28-year-old G2P1 was admitted to the labor room at 38 weeks of gestation. She is a known case of mitral valve prolapse. Which of the following is the best for managing the second stage of labor in this patient ?\nUnassisted vaginal delivery\nUsing ventouse delivery\nZavanelli maneuver\nEmergency cesarean sectio\nQuestion 11:\nGeneral anesthesia is the preferable mode of analgesia in pregnant women with\nAortic stenosis\nProsthetic heart valves\nMVP with MR\nIntracardiac shunts\nQuestion 12:\nA pregnant lady with mitral stenosis requires anticoagulation. Which of the following statements is false regarding her management?\nLMWH or UFH is used until 13 weeks of pregnancy\nFrom 13 weeks till close to delivery substitute UFH with warfari\nFollowing vaginal delivery, anticoagulation with LMWH or UFH is restarted after 6 hours\nWarfarin is contraindicated during lactatio\nQuestion 13:\nWhich of the following statements is false regarding hypertrophic cardiomyopathy in pregnancy?\nMost affected patients are asymptomatic during pregnancy\nDiuretics are generally not used in this patient\nShe may develop chest pain, palpitations, and syncope\nThe most common cause for death is cardiac failure\nQuestion 14:\nAll are true regarding peripartum cardiomyopathy except\nDevelopment of cardiac failure within 5 months of delivery\nLeft ventricular diastolic dysfunctio\nAbsence of identifiable cause\nDilated left ventricle\nQuestion 15:\nWhich of the following agents has been proposed to be responsible for peripartum cardiomyopathy?\nEstroge\nProgesterone\nBeta hCG\nProlacti\nQuestion 16:\nA P1L1 lady presents with complaints of fatigue and paroxysmal nocturnal dyspnea 3 months after her delivery. On examination, she has pedal edema and echo shows left ventricular systolic dysfunction. Which of the following drugs has shown to be effective for the treatment of her condition?\nRibaviri\nMisoprostol\nDanazol\nBromocriptine\nQuestion 17:\nA 34-year-old lady came to the antenatal OPD with 6 weeks of amenorrhea. Her UPT is positive. She is a known case of mitral stenosis for 5 years. Which is the best time to do surgery for mitral stenosis in this patient?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch85_8",
    "question_text": "\u201310 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch85_10",
    "question_text": "\u201314 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch85_14",
    "question_text": "\u201318 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch85_24",
    "question_text": "\u201326 weeks\nQuestion 18:\nA lady with ventricular septal defect becomes pregnant. Which of the following is not a common complication that is expected to occur in this patient?\nCongestive cardiac failure\nArrhythmia\nHypotensio\nLeft ventricular dysfunctio\nQuestion 19:\nWhat is the most common arrhythmia encountered in pregnancy?\nAtrial fibrillatio\nAtrial flutter\nPSVT\nBradyarrhythmia\nQuestion 20:\nWomen with the highest risk of endocarditis in pregnancy are those with",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch86_1",
    "question_text": ", 4 and 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch86_3",
    "question_text": "and 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch87_1",
    "question_text": "and 2",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch87_2",
    "question_text": ", 3 and 4\nQuestion 21:\nWhich of the following is associated with the highest risk of maternal mortality during pregnancy?\nCoarctation of aorta\nMitral stenosis\nEisenmenger syndrome\nAortic stenosis\nQuestion 22:\nA 32-year-old primigravida delivered a full-term male baby by vaginal delivery. She is a known case of rheumatic mitral stenosis for 4 years. After the delivery of the placenta, she started to bleed profusely. Which among the following should not be used to control bleeding?\nMethyl ergometrine\nCarboprost\nMisoprostol\nOxytoci\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_1",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_2",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_3",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_4",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_5",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_6",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_7",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_8",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_9",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_10",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_11",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_12",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_13",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_14",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_15",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_16",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_17",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_18",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_19",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_20",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_21",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch88_22",
    "question_text": "\na\nSolution to Question 1:\nMitral stenosis is the most common valvular heart disease in pregnancy.\nThe commonest cardiac lesions are of rheumatic origin followed by congenital conditions. The incidence of cardiac lesions is less than 1% amongst hospital deliveries. Rheumatic valvular lesions predominantly include mitral stenosis (80%).\nSolution to Question 2:\nMitral valve prolapse (MVP) is the commonest congenital valvular lesion observed in pregnancy. Mitral stenosis is the commonest acquired heart lesion during pregnancy.\nCondition in pregnancy\nMost common lesion\nCongenital heart disease\nAtrial septal defect\nCongenital valvular lesion\nMitral valve prolapse\nCyanotic Congenital Heart di sease\nTetrology of Fallot\nAcquired valvular heart disea se\nMitral stenosis > Mitral regur gitation > Aortic stenosis\nSolution to Question 3:\nCardiac failure in pregnancy is least likely to occur during 24 weeks, considering the given options.\nThe order of risk of cardiac failure in pregnancy is immediate postpartum &gt; 2nd stage of labor\n&gt; 30 weeks &gt; 22 weeks.\nMaternal cardiac risk predictors: [Mnemonic: NOPE] N-NYHA class &gt;2\nO-Obstructive lesions of left heart (Mitral valve area &lt;2 cm2 or aortic valve area &lt;1.5 cm2, peak LV outflow tract gradient &gt;30 mmHg)\nP-Prior cardiac events before pregnancy E-Ejection fraction &lt;40%\nScoring systems used to calculate risk are Cardiac Disease in Pregnancy (CARPREG) and ZAHARA scores.\nSolution to Question 4:\nLate systolic murmur is pathological in pregnancy. CVS physiological changes in pregnancy:\nPulse rate: Increases\nDiastolic BP: Decreases\nS1: Loud and split\nS2:Normal\nS3:prominent (occasional)\nJugular venous distension and venous hum\nMurmurs\nEjection systolic murmur at left sternal border.\nContinous murmur at 2nd-4th intercostal space (known as mammary souffle)\nHeart is displaced upwards and to the left\nECG changes\nLeft axis deviation (due to elevation of diaphragm)\nT wave inversion, biatrial enlargement\nMild ST changes in the inferior leads\nPremature atrial and ventricular contractions are relatively frequent.\nSolution to Question 5:\nProsthetic valve replacement is not an indication for therapeutic termination as it comes under the WHO category risk 3. Only conditions included under WHO category risk 4 are considered as indications for termination of pregnancy.\nWHO class 4 comprises of diseases with very high risk of maternal mortality or severe morbidity, such as:\nPulmonary arterial hypertensio\nSevere systemic ventricular dysfunction (NYHA III-IV or LVEF 30-40%)\nPrevious peripartum cardiomyopathy with any residual impairment of left ventricular functio\nSevere left heart obstructio\nMarfan syndrome with aorta dilated &gt;40 mm\nTermination of pregnancy is also advised in patients with Eisenmenger syndrome.\nSolution to Question 6:\nPrimary pulmonary hypertension is not a cardiac indication for caesarean delivery.\nIn primary pulmonary hypertension, maternal mortality is about 50% and the majority die (75%)\npostpartum.\nSimpson\u2019s criteria for cesarean delivery for cardiac disease in pregnancy:\nDilated aortic root &gt;4 cm or aortic aneurysm\nAcute severe congestive heart failure\nRecent myocardial infarctio\nSevere symptomatic aortic stenosis\nWarfarin administration within 2 weeks of delivery\nNeed for emergency valve replacement immediately after delivery\nCoarctation of the aorta and aortic dissection are other indications for cesarean delivery.\nIn general, vaginal delivery is preferred, and labor induction is usually safe. Cesarean delivery is limited to obstetric indications, and considerations are given for the specific cardiac lesions only. Epidural anesthesia is given during LSCS in heart disease. The major problem with epidural/spinal analgesia is maternal hypotension. This is especially dangerous in women with intracardiac shunts in whom flow may be reversed (blood passes from right to left and bypasses the lungs). So in case of a shunt lesion, only general anesthesia should be given.\nSolution to Question 7:\nPerimortem cesarean delivery should be considered if there is no return of spontaneous circulation in 5 minutes, according to the AHA 2020 Guidelines.\nThe goal of perimortem cesarean section (PMCS) should be primarily aimed at saving the life of the mother. PMCS improves maternal survival by decreasing compression of the IVC by the gravid uterus. This improves venous return and diaphragmatic displacement, which in turn improves respiratory dynamics.\n\nSolution to Question 8:\nLateral recumbent position is advised during the first stage of labor in this patient. Management of labor in patients with heart disease:\nFirst stage:\nLateral recumbent or propped up positio\nOxygen administration (5 to 6 L/min)\nAnalgesia by epidural\nFluids should not be infused more than 75 ml/h\nProphylactic antibiotics for bacterial endocarditis during labour and 48 h after delivery\nCentral venous pressure monitoring Second stage:\nNo maternal pushing\nCut short second stage by forceps or ventouse under pudendal and/or perineal block anaesthsia\nThe benefit of avoiding haemodynamic fluctuations resulting from pushing must be weighed against an increased risk of perineal trauma, haemorrhage and fetal head injury with forceps or vacuum delivery.\nThird stage:\nOxytocin by infusio\nIV frusemide if needed\nSolution to Question 9:\nThe final switch to heparin in a pregnant women is advised at 36 weeks of pregnancy and is continued till 7 days postpartum.\nThis switch is made from warfarin to heparin at 36 weeks, as warfarin is a strong anticoagulant which can cause post partum hemorrhage in the mother at the time of labour and can also cross the placenta into the fetal blood and can increase the risk of intracranial hemorrhage in the fetus\nThe below given algorithm is followed for administration of anticoagulants in a pregnant female: LMWH- low molecular weight heparin\nUFH- Unfractionated heparin\nPeriod of pregnancy\nAnticoagulation of choice\nFirst trimester\nIf dose of warfarin< 5mg/day \u2013continue warfarin till 36 we eksIf dose ofwarfarin > 5mg/ day or warfarin embryopathy present \u2013replace it with hepa rin / LMWH\nFrom12 weeks to 36 weeks\nwarfarin\nAt 36 weeks\nSwitch toLMWH",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_17.jpeg",
      "OBGYN_img_219.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch89_1",
    "question_text": "week before EDD / 3 days b efore EDD\nSwitch toUFH(as LMWH hav e longer T1/2\u2013 increased cha nces of PPH)\nOn the day of delivery\nStop all anticoagulant\nPeriod of pregnancy\tAnticoagulation of choice\nPeriod of pregnancy\tAnticoagulation of choice",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch89_6",
    "question_text": "hrs after vaginal delivery /",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch89_6",
    "question_text": "12 hrs after cesarean\nRestart UFH and Warfarin. When INR is 2.5 to 3 withdra w UFH & continue warfarin\nSolution to Question 10:\nThe best technique for managing the second stage of labor in a patient with heart disease is using ventouse.\nFor most cardiac patients, vaginal delivery is preferred and cesarean section is reserved for obstetric indications since the cesarean section is associated with more blood loss and higher thromboembolic and infection risk. If vaginal delivery is selected as the mode of choice, it will be conducted with the laboring woman in an upright position, or in the left decubitus position. This minimizes aortocaval compression.\nActive pushing during the second stage may also be limited, depending on the degree of cardiac compromise. In moderate to severe cardiac disease, it may be prudent to completely avoid an active second stage. Regional anesthesia can be used to allow the fetal head to descend to the perineum without active pushing. Delivery can be further facilitated by forceps or vacuum extraction.\nThe benefit of avoiding hemodynamic fluctuations resulting from pushing must be weighed against an increased risk of perineal trauma, hemorrhage, and fetal head injury with forceps or vacuum delivery.\nSome journals report that ventouse is preferable to forceps, as it can be applied without putting the patient in lithotomy position (raising the legs increases the cardiac load) however it is controversial.\nSolution to Question 11:\nIn pregnant ladies with intracardiac shunts, general anesthesia is the preferable mode of analgesia.\nThe major problem with epidural/spinal analgesia is maternal hypotension. This is especially dangerous in women with intracardiac shunts in whom flow may be reversed (blood passes from right to left and bypasses the lungs). So in case of a shunt lesion, only general anesthesia should be given.\nNote: Aortic stenosis will also be affected by the hypotension caused by epidural/spinal analgesia. However, in aortic stenosis, slow epidural anesthesia is adequate and doesn't compromise ventricular preload. Only a few severe cases of aortic stenosis warrant GA. Hence, in the context of this MCQ, 'intracardiac shunts' would be the most appropriate answer.\nSolution to Question 12:\nWarfarin is not contraindicated during lactation.\nWarfarin, low-molecular-weight heparin (LMWH), unfractionated heparin (UFH) do not accumulate in breast milk. They do not induce an anticoagulant effect in the infant.\nThe choice of anticoagulants is the main problem in pregnancy due to the following reasons:\nWarfarin: Although safe for the mother, can lead to warfarin embryopathy, miscarriage, IUGR, and stillbirths.\nHeparin: It is safe for the fetus as it does not cross the placenta but less effective than warfarin.\nLMWH: Inadequate and ACOG does not recommend its use in pregnant women with prosthetic heart valves.\nIf the patient delivers when the anticoagulant is still effective and bleeds excessively, then protamine sulfate is given intravenously.\nPeriod of gestation\nAnticoagulant\nTill 12 completed weeks\nLMWH or UFH",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch89_13",
    "question_text": "to 36 weeks\nWarfarin",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch89_36",
    "question_text": "weeks to 6 hours before d elivery\nLMWH or UFH",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch89_6",
    "question_text": "hours after vaginal and 24 hours after cesarian section\nLMWH or UFH (ACOG reco mmendation)\nSolution to Question 13:\nThe most common cause of death in HOCM in pregnant women is ventricular tachyarrhythmias. Most affected women are asymptomatic, but some patients may develop:\nDyspnea\nAnginal or atypical chest pai\nSyncope\nArrhythmias.\nStrenuous exercise is prohibited during pregnancy. Abrupt positional changes are avoided to prevent reflex vasodilation and decrease of preload. Diuretics and vasodilators are generally not used as they decrease preload. If angina develops, beta-blockers or calcium channel blockers are used.\nThe mode of delivery depends upon obstetric indications and if cesarean section is done, general anesthesia is considered the safest.\nSolution to Question 14:\nLeft ventricular systolic dysfunction is a feature of peripartum cardiomyopathy (also known as postpartum cardiomyopathy) and not diastolic dysfunction.\nPeripartum cardiomyopathy (PPCM) is a type of dilated cardiomyopathy. It develops during the last month of pregnancy or within the first 5 months following delivery.\nThe predisposing factors include Cardiac gene mutations involving several genes like TTNC1, TTN, and STAT3, Twin pregnancy/ multifetal gestation, Smoking, and Preeclampsia. Other proposed causes include viral myocarditis, abnormal immune response to pregnancy, malnutrition, inflammation, etc.\nPPCM is associated with increased secretion of prolactin by the pituitary and antiangiogenic molecule sFlt-1 (soluble fms-like tyrosine kinase) by the placenta at term gestation.\nPearson\u2019s diagnostic criteria for PPCM:\nDevelopment of cardiac failure in the last month of pregnancy or within 5 months after delivery\nAbsence of an identifiable cause for the cardiac failure\nAbsence of recognizable heart disease prior to the last month of pregnancy, and\nLeft ventricular systolic dysfunction demonstrated by echocardiographic criteria, such as ejection fraction &lt;45% or fractional shortening &lt;30% along with a dilated left ventricle.\nManagement involves treating the features of heart failure. Bromocriptine has been found useful in this condition. Many women recover within 6 months of delivery, while some continue to have residual effects.\nSolution to Question 15:\nProlactin has been proposed to be responsible for peripartum cardiomyopathy.\nOxidative stress during late pregnancy leads to the proteolytic cleavage of prolactin. The resulting 16-kDa prolactin fragment has been found to be cardiotoxic and can impair the metabolism and contractility of cardiomyocytes.\nThe etiology of peripartum cardiomyopathy remains unknown. Many potential causes have been proposed but are not proven.\nViral myocarditis\nAbnormal immune response to pregnancy\nAbnormal response to the increased hemodynamic burden of pregnancy\nMalnutritio\nInflammatio\nApoptosis\nProlacti\nSolution to Question 16:\nThe given scenario is suggestive of peripartum cardiomyopathy and bromocriptine is effective for its treatment.\nOxidative stress during late pregnancy leads to the proteolytic cleavage of prolactin. The resulting 16-kDa prolactin fragment has been found to be cardiotoxic and can impair the metabolism and contractility of cardiomyocytes. Based on this proposed mechanism, bromocriptine therapy has been suggested because it inhibits prolactin secretion.\nSolution to Question 17:\nThe best time of surgery for mitral stenosis in pregnancy is between 14\u201318 weeks.\nBalloon valvuloplasty is the procedure of choice for mitral stenosis in pregnancy. Any cardiac surgery in pregnancy should usually be postponed until after delivery, but if required, it can be performed safely in the 2nd trimester.\nSolution to Question 18:\nHypertension is a common maternal complication of congenital cardiac disease in pregnancy. The common maternal complications in patients with congenital cardiac disease include:\nCongestive cardiac failure\nPulmonary edema\nArrhythmia\nHypertensio\nSolution to Question 19:\nThe most common arrhythmia seen in reproductive-aged women is paroxysmal supraventricular tachycardia.\nSolution to Question 20:\nWomen at the highest risk for endocarditis are those with cyanotic cardiac disease and prosthetic valves.\nThe American heart association recommends prophylaxis for dental procedures with:\nProsthetic valves\nUnrepaired cyanotic heart defects\nValvulopathy after heart transplantatio\nAmerican College of Obstetricians and Gynecologists do not recommend endocarditis prophylaxis for either vaginal or cesarean delivery in the absence of pelvic infection.\nSolution to Question 21:\nEisenmenger syndrome is the heart disease with the worst prognosis, having a maternal mortality rate of 50%.\nThe most common cause of death in Eisenmenger\u2019s syndrome is right ventricular failure with cardiogenic shock. If antenatal diagnosis of Eisenmenger syndrome is made in the first trimester, termination of pregnancy is advised. Eisenmenger syndrome has the highest risk of maternal mortality. However, since mitral stenosis is the most common cardiac condition in pregnancy, it is the most common cause of maternal mortality overall.\nMitral regurgitation, mitral valve prolapse and pulmonary stenosis are well tolerated during pregnancy. Severe aortic stenosis can be life-threatening. However, women with mild to moderate aortic valve stenosis may have a relatively low-risk pregnancy.\nSolution to Question 22:\nThe given scenario indicates postpartum hemorrhage (PPH) in a primigravida with rheumatic mitral stenosis. Methyl ergometrine is contraindicated in patients with organic heart disease.\nContraindications of methyl ergometrine are:\nTwin pregnancy - Second baby gets compromised by tetanic contractions of uterus if given after delivery of first baby\nOrganic cardiac disease - Causes overloading of right heart by squeezing blood from uterine circulation.\nSevere pre-eclampsia and eclampsia\nRh negative mother - Increases chance of fetomaternal transfusion.\nRhesus Isoimmunization\nQuestion 1:\nThe Rhesus blood group antigen complex is located on which chromosome?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch89_16",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch89_14",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch89_4",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch90_1",
    "question_text": "\nQuestion 2:\nAntigens of which of the following blood group systems do not cause alloimmunization in a newborn/fetus?\nKidd\nMNS\nKell\nLewis\nQuestion 3:\nA pregnant Rh-negative woman presents for her regular antenatal visit. Her Indirect Coombs test is negative. When would you give her prophylactic Anti-D?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch90_28",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch90_24",
    "question_text": "weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch90_28",
    "question_text": "weeks and then monthly thereafter",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch90_24",
    "question_text": "weeks and then monthly thereafter\nQuestion 4:\nWhich of the following events in Rh-negative patients does not require Anti-D prophylaxis?\nMiscarriage\nChorionic villi sampling\nAmniocentesis\nPostpartum hemorrhage\nQuestion 5:\nChorionic villus sampling was performed on a G2P1 Rh-negative woman at 10 weeks of gestation. What is the dose of Anti-D immunoglobulin that should be administered?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch90_50",
    "question_text": "microgram",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch90_100",
    "question_text": "microgram",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch90_150",
    "question_text": "microgram",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch90_300",
    "question_text": "microgram\nQuestion 6:\nAn Rh-negative G2P1 mother delivered her Rh-positive baby by cesarean section. Kleihaeur Betke test, as shown in the image, was done. Which of the following statements is true regarding the test?\n\nFetal erythrocytes are the ghost cells\nThe red cells contain HbA\nThe reagent used is citric acid\nIt is a qualitative test\nQuestion 7:\nIf the volume of fetomaternal hemorrhage is greater than 30 mL whole blood, the dose of Rh-immunoglobulin calculated is:",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_17.jpeg",
      "OBGYN_img_18.jpeg",
      "OBGYN_img_220.jpeg",
      "OBGYN_img_221.jpeg",
      "OBGYN_img_222.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch90_10",
    "question_text": "\uf06dg for every 0.5 mL of fetal RBCs",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch90_10",
    "question_text": "\uf06dg for every 5 mL of fetal RBCs",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch90_0",
    "question_text": "5 \uf06dg for every 1 mL of fetal whole blood",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch90_5",
    "question_text": "\uf06dg for every 10 mL of fetal whole blood\nQuestion 8:\nA 25-year-old Rh-negative primigravida presents to the antenatal clinic at 12 weeks of pregnancy. Her husband is found to be Rh-positive. An Indirect Coombs test is also positive. At what critical titer of the test, would the fetus require monitoring for signs of anemia?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch91_1",
    "question_text": "4",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch91_1",
    "question_text": "8",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch91_1",
    "question_text": "16",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch91_1",
    "question_text": "18\nQuestion 9:\nIn modern obstetrics, which of the following investigations is used for monitoring the fetus of an Rh-negative sensitized mother?\nBiophysical profile\nFetal blood sampling\nAmniospectometry\nMCA doppler peak systolic velocity\nQuestion 10:\nIn modified Liley's (Queenan) chart, which zone represents a severely affected fetus?\nZone 1\nZone 2\nZone 3\nZone 4\nQuestion 11:\nu are performing a Doppler assessment of a fetal middle cerebral artery. What is the threshold value of its peak systolic velocity that would prompt you to consider fetal blood sampling?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch91_0",
    "question_text": "5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch91_1",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch91_1",
    "question_text": "5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch91_2",
    "question_text": "5\nQuestion 12:\nA 32-year-old G4P3 Rh-negative patient with an antibody titer of 1:32 presents to the clinic at 30 weeks. A USG reveals features of fetal edema, ascites, and polyhydramnios. Cordocentesis was done for fetal blood sampling. At what hematocrit value is intrauterine blood transfusion indicated?\n&lt;40%\n&lt;25%\n&lt;30%\n&lt;35%\nQuestion 13:\nA patient presented for an antenatal checkup at 25 weeks of gestation. She had bilateral pitting pedal edema and a history of mild headaches. While updating her antenatal card, a weight gain of 13 kgs in the past 2 weeks was noted. USG revealed gross fetal hydrops and a hyperechoic placenta. Which of the following is not true about the patient's condition?\nIt is also known as Ballantyne syndrome\nHydrops could be due to rhesus isoimmunization\nIt is associated with elevated liver enzymes\nIt is a not a form of pre-eclampsia\nQuestion 14:\nAn ultrasound was done on a pregnant Rh-negative patient to screen for hydrops fetalis. What is the earliest sign that may be seen on USG?\nScalp edema\nPleural effusion\nPericardial effusion\nAscites\nQuestion 15:\nAn Rh-negative patient who did not have access to antenatal care delivered a stillborn fetus as shown in the image. Which of the following is not associated with the fetal condition?\n\nOligohydramnios\nExtramedullary hematopoesis\nCardiac failure\nHepatosplenomegaly\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_18.jpeg",
      "OBGYN_img_223.jpeg",
      "OBGYN_img_224.jpeg",
      "OBGYN_img_225.png"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch92_1",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch92_2",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch92_3",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch92_4",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch92_5",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch92_6",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch92_7",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch92_8",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch92_9",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch92_10",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch92_11",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch92_12",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch92_13",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch92_14",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch92_15",
    "question_text": "\na\nSolution to Question 1:\nThe genetic locus for the Rh antigen complex is on the short arm of chromosome 1.\nRhCcEe and RhD are the two distinct genes located within the Rh locus. The presence of D antigen on one or both chromosomes 1, determines heterozygosity or homozygosity respectively.\nSolution to Question 2:\nThe Lewis antigens do not cause alloimmunization or hemolytic disease of the fetus and newborn.\nAlloimmunization/isoimmunisation is defined as an immune response to foreign antigens after exposure to genetically different cells or tissues.\nThe Kell blood group system is complex and contains many antigens that are highly immunogenic. These antigens are the third most potent, after those of the ABO and Rh blood groups, at triggering an immune reaction. Anti-Kell causes severe fetal anemia by suppressing fetal RBC synthesis.\nMNS and Kidd blood types cause alloimmunization. Hemolytic disease of newborn is mild with Kidd whereas MNS causes potentially severe anemia.\nSolution to Question 3:\nIn a non-immunized Rh-negative primigravida, Anti D is given at 28 weeks of gestation. It is also given within 72 hours of delivery.\nRoutine postpartum administration of anti-D immune globulin to at-risk pregnancies within 72 hours of delivery decreases the alloimmunization rate by 90 percent.\nAdditionally, the provision of Anti-D immunoglobulin at 28 weeks of gestation reduces the third-trimester alloimmunization rate from approximately 2 percent to 0.1 percent.\nSolution to Question 4:\nPostpartum hemorrhage is not an indication of Anti-D prophylaxis.\nAnti-D prophylaxis is administered to Rh-negative patients in the following circumstances:\nPregnancy loss due to:\nEctopic pregnancy\nSpontaneous abortion/hydatiform mole\nElective abortion\nFetal death (any trimester)\nProcedures:\nAmniocentesis\nChorionic villus sampling\nFetal blood sampling\nExternal cephalic version\nDelivery\nTrauma\nPlacental abruption\nUnexplained vaginal bleeding during pregnancy\nSolution to Question 5:\nThe dose of Anti-D immunoglobulin to be given in the first trimester is 50 \uf06dg.\nAll Rh-negative unsensitized women should receive 50 \uf06dg of Rh-immune globulin IM in the first trimester in the following conditions:\nWithin 72 hours of induced or spontaneous abortion\nEctopic/molar pregnancy\nChorionic villus sampling\nWomen with a pregnancy beyond 12 weeks should receive a full dose of 300 \uf06dg. Generally, a 300\n\uf06dg dose will protect a woman from fetal hemorrhage of up to 30 mL of fetal whole blood. The dose in the 3rd trimester and post-delivery is 300 \uf06dg or 1500 international units (IU).\nSolution to Question 6:\nThe reagent used for the Kleihauer-Betke test is citric acid.\nKleihauer-Betke test is the most commonly used quantitative test used to detect fetomaternal hemorrhage i.e., the approximate volume of fetal blood entering the maternal circulation. It is also known as the acid elution test.\nThe principle behind it is that fetal erythrocytes contain hemoglobin F, which is more resistant to acid elution than hemoglobin A.\nAfter exposure to acid, only fetal hemoglobin remains, such that after staining, the fetal erythrocytes appear red and adult cells appear as \u201cghosts.\u201d Fetal cells are counted and expressed as a percentage of adult cells.\nFlow cytometry is the best test for the quantification of fetomaternal hemorrhage. It is more sensitive and accurate as compared to the Kleihauer-Betke test.\nFlow cytometry can analyze a larger number of cells and is not influenced by maternal levels of fetal hemoglobin and fetal levels of maternal hemoglobin. It utilizes monoclonal antibodies to HbF or to the D antigen followed by quantification by fluorescence.\n\nSolution to Question 7:\nIf the volume of fetomaternal hemorrhage is greater than 30 mL whole blood, the dose of Rh-immune globulin calculated is 10 \uf06dg for every 0.5 mL of fetal RBCs.\nThe calculation is done as follows:",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_18.jpeg",
      "OBGYN_img_226.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch92_300",
    "question_text": "micrograms of Anti-D can neutralize 15 ml of fetal RBCs or 30ml of fetal whole blood.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch92_50",
    "question_text": "micrograms of Anti-D can neutralize 2.5 ml of fetal RBCs.\nThe half-life of anti D is 16-24 days. It is administered intramuscularly either in the deltoid or in the anterolateral aspect of the thigh.\nSolution to Question 8:\nThe critical titer for the indirect Coombs test (ICT ) is 1:16 Protocol for management Rh isoimmunisation is as follows:\n\nSolution to Question 9:\nMCA Doppler peak systolic velocity (PSV) is used for the monitoring of fetuses in Rh-negative sensitized mothers.\nThe middle cerebral artery is used as other fetal vessels require a larger insonating angle and confers significant measurement error.\nMCA PSV is enhanced due to increased cardiac output and decreased viscosity of fetal blood, which permits the reliable, noninvasive detection of fetal anemia in cases of blood-group alloimmunization.\nIf the MCA PSV exceeds 1.5 MoM (multiples of the median) and the gestational age is less than 34 or 35 weeks, fetal blood sampling should be considered. MCA Doppler PSV has replaced amniocentesis as the preferred test for the detection of anemia.\nSolution to Question 10:\nA severely affected fetus is represented by zone 3.\nLiley developed a chart of changing amniotic fluid bilirubin levels (delta OD450) and weeks\nof gestation. Amnionic fluid bilirubin is measured by a spectrophotometer and is demonstrable as a change in optical density absorbance at 450 nm (\uf044OD450).\nHowever, middle cerebral artery peak systolic velocity (MCA PCV) is non-invasive and more accurate than optical density at 450 nm, hence Liley\u2019s chart is no longer used in practice.\nLiley\u2019s chart has three zones as shown below, delineating the severity of rhesus disease.\nLiley\u2019s zone I (low zone) - mild disease.\nLiley\u2019s zone II (mid zone) - fetal anemia.\nLiley\u2019s zone III (high zone) - severely affected fetus and fetal death is imminent.\n\nSolution to Question 11:\nThreshold (critical value) of middle cerebral artery (MCA) peak systolic velocity is 1.5 multiples of the median (MoM).\nIf the MCA peak systolic velocity exceeds 1.5 MoM, further evaluation by fetal blood sampling is necessary to assess the need for fetal transfusion.\nThe anemic fetus shunts blood preferentially to the brain to maintain adequate oxygenation. The velocity increases because of increased cardiac output and decreased blood viscosity.\nIn many centers, serial measurement of the peak systolic velocity of the fetal middle cerebral artery has replaced amniocentesis for the detection of fetal anemia. This method provided 100 percent sensitivity.\nSolution to Question 12:\nIntrauterine transfusion is done if fetal haematocrit is &lt;30%.\nThe blood for transfusion is usually O negative and cross-matched with the mother's blood. It is highly packed to achieve a hematocrit of 75 -80%.\nIntrauterine transfusions may be done intraperitoneally where blood is absorbed through diaphragmatic lymphatics. It may also be done intravascularly through the umbilical vein. The segments of the umbilical vein used are the intrahepatic portion or at its insertion into the placenta.\nComplications of intrauterine transfusion include:\nFetal demise\nChorioamnionitis\nPlacental abruption\nPre-term labor\nBradycardia/tachyarrhythmia\nUmbilical cord hematoma\nSolution to Question 13:\nThe clinical scenario is suggestive of maternal mirror syndrome/Ballantyne syndrome. It may be considered a form of severe pre-eclampsia.\nMaternal mirror syndrome is the association between fetal hydrops and the development of maternal edema. The syndrome is named as such because the mother mirrors the fetus. It is characterized by triple edema i.e., the fetus, mother, and placenta become edematous.\nThe pathogenesis of mirror syndrome, although not well established, mimics trophoblastic damage and maternal vascular endothelial dysfunction, as is also seen in pre-eclampsia. Hence, these two conditions may have a similar clinical presentation, with common features such as:\nEdema\nHypertension\nProteinuria\nLiver enzyme elevation\nHeadache and visual disturbances.\nHowever, in contrast to preeclampsia, the following features are noted in maternal mirror syndrome:\nLow maternal hematocrit i.e., hemodilution rather than hemoconcentration\nPolyhydramnios rather than oligohydramnios\nThe fetus always shows signs of hydrops.\nThe etiology of fetal hydrops is not related to the development of mirror syndrome. Hydrops could be due to rhesus isoimmunization, twin-twin transfusion syndrome, congenital infections, fetal cystic hygroma, Ebstein anomaly, sacrococcygeal teratoma, vein of Galen aneurysms, etc.\nIn most cases with mirror syndrome, prompt delivery is indicated, because women with severe features of preeclampsia can deteriorate rapidly. In few cases, identification and treatment of the cause of fetal hydrops resulted in the resolution of symptoms for both the mother and baby for the remainder of the pregnancy.\nSolution to Question 14:\nThe earliest sign of hydrops fetalis on a USG is scalp edema. Subcutaneous scalp edema is also known as the Halo sign.\nOther USG signs include:\nAscites\nPleural effusion\nPericardial effusion\nTypical position termed as Buddha's position\nThe image below shows skin thickening at the level of the fetal skull, on ultrasonography:\n\nSolution to Question 15:\nThe pale, oedematous fetus in the image is suggestive of fetal hydrops. Fetal hydrops is associated with polyhydramnios, not oligohydramnios.\nIt often occurs as an effect of iso-immunization in an Rh-negative pregnancy. Other complications that may occur are fetal anemia and hyperbilirubinemia.\nFetal anemia occurs in the initial stage of iso-immunization. It is associated with polyhydramnios and increased placental thickening (hyper-placentosis). An increase in the right atrium size of the fetus is seen.\nFetal hydrops is usually accompanied by severe anemia. It results in stillbirth or fetal demise soon after birth. It is also associated with:\nCongestive cardiac failure\nAscites\nPleural effusion\nPericardial effusion\nHepatosplenomegaly.\n\nHepatic Disorders and Infections in Pregnancy\nQuestion 1:\nWhich of the following is not true regarding obstetric cholestasis?\nPruritus is worse at night\nSerum bilirubin &gt;5 mg/d\nPruritus usually develops in the third trimester\nAspartate transaminase &lt;200 IU /L\nQuestion 2:\nA woman at 34 weeks of gestation presents with severe itching over her palms and soles for 2 weeks. She gives a history of similar complaints in her last pregnancy. On examination, she is icteric. Which of the following is the preferred investigation to diagnose this condition?\nSerum bile acid\nSerum bilirubin\nAlanine amino transferase",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_18.jpeg",
      "OBGYN_img_227.jpeg",
      "OBGYN_img_18.jpeg",
      "OBGYN_img_228.jpeg",
      "OBGYN_img_18.jpeg",
      "OBGYN_img_229.jpeg",
      "OBGYN_img_18.jpeg",
      "OBGYN_img_230.png"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch92_5",
    "question_text": "' nucleosidase\nQuestion 3:\nA food critic at 32 weeks of gestation presents with nausea and mild right upper abdominal pain. She also gives a history of itching over palms and soles for 2 weeks. On examination, she is icteric. Investigations done are shown below. What is the preferred treatment in this condition?\nAntihistamines + nutritional support\nAntiviral therapy\nUrsodeoxycholic acid\nCholestyramine\nQuestion 4:\nWhich of the following features are not likely to be seen in a patient with acute fatty liver of pregnancy?\nOnly 1",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch92_2",
    "question_text": "&amp; 4",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch92_3",
    "question_text": ", 4 &amp; 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch93_1",
    "question_text": ", 3 &amp; 4\nQuestion 5:\nA woman at 37 weeks of gestation with icterus, nausea, and yellowish discoloration of urine has abnormal liver function tests. She is suspected to have acute fatty liver of pregnancy.\nWhich of the following is false regarding this condition?\nSymptoms improve post delivery\nMore common in first pregnancy\nAssociated with female fetus\nOccurs due to heterozygous defect for fatty acid oxidation\nQuestion 6:\nWhich of the following will not increase the risk for urinary tract infection in pregnant women?\nDiabetes\nHypertension\nSickle cell anaemia\nVesicoureteric reflux\nQuestion 7:\nA G3P2 lady at 13 weeks of gestation presented for a regular antenatal checkup. A urine routine revealed the presence of 2,00,000 gram-negative bacilli/mL. Repeat urinalysis showed the following results. Which of the following is not true about this condition?\nIncidence is similar to that in non pregnant women\nIt is higher in people with sickle cell trait\nAntibiotic therapy is required only if symptoms develop\nThere is risk of developing chronic renal lesions\nQuestion 8:\nA woman presented to the clinic with severe lower abdominal pain and dysuria at 28 weeks of gestation. Suprapubic tenderness was noted on palpation. Urine examination revealed pyuria with microscopic hematuria. All of the following can be used to treat this condition except?\nAmoxycillin\nCefazolin\nCiprofloxacin\nCefixime\nQuestion 9:\nWhich stage of pregnancy is most often complicated by acute pyelonephritis?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch93_1",
    "question_text": "st trimester",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch93_2",
    "question_text": "nd trimester",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch93_3",
    "question_text": "rd trimester\nPuerperium\nQuestion 10:\nWhich of the following congenital infections are associated with the triad of Gregg in a neonate?\nToxoplasma\nParvovirus\nVaricella zoster virus\nRubella\nQuestion 11:\nWhich of the following statements is true about toxoplasmosis in pregnancy?\nMaximum transmission and damage in 1st trimester\nMaximum transmission in 1st trimester and maximum damage in 3rd trimester\nMaximum damage in 1st trimester and maximum transmission in 3rd trimester\nMaximum transmission and damage in 3rd trimester\nQuestion 12:\nA woman presents for a regular antenatal check-up at 12 weeks of gestation. She works at a rescue center that held an adoption drive for cats a few weeks ago. On examination, mild cervical lymphadenopathy is noted. Sabin-Feldman dye test is positive. Which of the following will be used to treat this condition?\nSpiramycin\nPyrimethamine-sulfonamide\nDoxycycline\nCotrimoxazole\nQuestion 13:\nA per-vaginal examination performed on a lady in labor reveals multiple painful tiny vesicular ulcers over the vulva and vaginal walls. A slide showing the microscopic findings is given below. What is the best step in the management of delivery in this patient?\n\nVaginal delivery\nCesarean section\nGive tocolytics and treat the infection\nLocal application of antibiotic.\nQuestion 14:\nIn a pregnant woman with herpes simplex infection, the risk of transmission to the fetus will be maximum during which stage of the pregnancy?\nFirst trimester\nSecond trimester\nThird trimester\nLabour\nQuestion 15:\nThe risk of fetal varicella syndrome is maximum when the mother is infected between \t.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_18.jpeg",
      "OBGYN_img_231.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch93_6",
    "question_text": "to 10 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch93_8",
    "question_text": "to 12 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch93_13",
    "question_text": "to 20 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch93_20",
    "question_text": "to 28 weeks\nQuestion 16:\nA young woman delivered a baby with limb hypoplasia and cicatricial skin lesions. Which of the following infections did the mother most likely have during her pregnancy?\nRubella\nCytomegalovirus\nChicken pox\nToxoplasmosis\nQuestion 17:\nIn a pregnant woman with syphilis, the infection can get transmitted to the fetus during which stage in pregnancy?\nDuring delivery",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch93_28",
    "question_text": "32 weeks\nBefore 6 weeks",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch93_10",
    "question_text": "15 weeks\nQuestion 18:\nYou are posted in the labor room. While inspecting the placenta to rule out any abnormalities, you notice that it appears pale and enlarged. Which of the following infections does the mother most likely have?\nRubella\nMeasles\nSyphillis\nToxoplasmosis\nQuestion 19:\nA sexually active woman presents with amenorrhea for the past 3 months and a history of a painless genital ulcer. UPT is positive and routine antenatal tests revealed a reactive VDRL report. What is the dose of benzathine penicillin that should be given for this patient?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch93_3",
    "question_text": "\u20134 million units intravenously",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch93_2",
    "question_text": "4 million units intramuscularly as a single injection",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch93_2",
    "question_text": "4 million units intramuscularly daily, plus probenecid 500 mg orally for 14 days",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch93_2",
    "question_text": "4 million units intramuscularly weekly for three doses\nQuestion 20:\nA woman at 24 weeks of gestation presented with complaints of fatigue, joint pain, and the following rash for 3 weeks. Urinalysis showed proteinuria and anti-Smith antibodies were positive. Which of the following complications is least likely in this patient?\n\nThrombocytopenia\nEclampsia\nPost term delivery\nThrombophilia\nQuestion 21:\nA woman with HIV presents for a routine antenatal checkup at 35 weeks of gestation. Investigations revealed a viral load of &gt;1000 copies/ml. What will be the best mode of delivery in this patient?\nNormal vaginal delivery\nCesarean delivery\nForceps assisted vaginal delivery\nVacuum assisted vaginal delivery\nQuestion 22:\nA woman is diagnosed to be positive for HIV in her first trimester. What is the appropriate management?\nStart ART immediately and continue till 6 weeks after delivery\nStart ART after 1st trimester and continue life-long\nStart ART immediately and continue life-long\nStart ART after 1st trimester and continue till 6 weeks after delivery\nQuestion 23:\nA woman with HIV on antiretroviral therapy is in labor. Which of the following will be given to her newborn baby prophylactically?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_19.jpeg",
      "OBGYN_img_232.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch93_6",
    "question_text": "weeks of nevirapine",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch93_6",
    "question_text": "weeks of zidovudine and nevirapine",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch93_12",
    "question_text": "weeks of zidovudine, nevirapine and lamivudine",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch93_12",
    "question_text": "weeks of zidovudine and lamivudine\nQuestion 24:\nThe risk of developing a stroke is highest during what period of gestation in a pregnant woman?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch94_1",
    "question_text": "st trimester",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch94_2",
    "question_text": "nd trimester\nPostpartum period\nIntrapartum period\nQuestion 25:\nWhich of the following is false regarding epilepsy in pregnancy?\nIt increases risk of fetal malformations by 5%\nSeizure risk is more at the time of delivery\nSeizure frequency increases in 30% of women\nIdeal contraceptive in breast feeding mother with seizure disorder is DMPA\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_1",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_2",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_3",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_4",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_5",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_6",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_7",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_8",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_9",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_10",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_11",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_12",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_13",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_14",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_15",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_16",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_17",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_18",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_19",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_20",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_21",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_22",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_23",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_24",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch95_25",
    "question_text": "\na\nSolution to Question 1:\nObstetric cholestasis is a condition in which cholestasis occurs in pregnancy. Serum bilirubin increases very late in the disease and total plasma concentrations rarely exceed 5 mg/dL.\nHyperbilirubinemia results from the retention of conjugated pigment.\nIt is also referred to as recurrent jaundice of pregnancy, cholestatic hepatosis, and icterus gravidarum. There is a significant genetic influence. It may be more common in multifetal pregnancies.\nPatients present with pruritus that develops usually during the third trimester, typically involving the palms and soles. It is worse at night. Icterus may also be present.\nDisorder\nAST (SGOT)\nU/L\nBilirubin (mg/d L)\nCholestasis of pregnancy\nUp to 200",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch96_1",
    "question_text": "\u20135\nAcute fatty liver of pregnancy",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch96_200",
    "question_text": "\u2013800",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch96_4",
    "question_text": "\u201310\nHepatitis",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch96_2000",
    "question_text": "+",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch96_5",
    "question_text": "\u201320\nSolution to Question 2:\nThe given clinical picture is suggestive of cholestasis in pregnancy. Serum bile acid is the earliest and most consistent parameter to increase in obstetric cholestasis.\nSerum cholic acid is preferred compared to serum chenodeoxycholic acid.\nAlthough serum bile acid increases after meals it is still considered an important investigation among women with obstetric cholestasis. This is because serum bile acid levels remain significantly elevated in women with obstetric cholestasis in comparison to pregnant women without it.\nSolution to Question 3:\nThe given scenario is suggestive of obstetric cholestasis. Ursodeoxycholic acid is the drug of choice in obstetric cholestasis.\nIt relieves pruritus, lowers bile acid and serum enzyme levels (like SGOT, ALP). It may also reduce certain neonatal complications such as preterm birth, fetal distress, and respiratory distress syndrome.\nAntihistamines and topical emollients may provide some relief.\nCholestyramine causes decreased absorption of fat-soluble vitamins, which leads to vitamin K deficiency. Fetal coagulopathy may develop, which may lead to intracranial hemorrhage and stillbirth, and therefore it is not preferred.\nDisorder\nAST (SGOT)\nU/L\nBilirubin (mg/d L)\nCholestasis of pregnancy\nUp to 200",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch97_1",
    "question_text": "\u20135\nAcute fatty liver of pregnancy",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch97_200",
    "question_text": "\u2013800",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch97_4",
    "question_text": "\u201310\nHepatitis",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch97_2000",
    "question_text": "+",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch97_5",
    "question_text": "\u201320\nSolution to Question 4:\nHyperglycemia, hypercholesterolemia, and thrombocytosis are not likely to be seen in acute fatty liver of pregnancy (AFLP).\nClinical features of AFLP include:\nPersistent nausea and vomiting\nProgressive jaundice\nHypoglycemia\nHypertension\nProteinuria\nEdema\nThrombocytopenia\nModerate to severe liver dysfunction - manifested by:\nHypofibrinogenemia\nHypoalbuminemia\nHypocholesterolemia\nProlonged clotting time.\nSolution to Question 5:\nAcute fatty liver of pregnancy (AFLP) is more commonly associated with male fetuses and not female fetuses.\nAFLP is a rare, potentially fatal complication also known as acute fatty metamorphosis or acute yellow atrophy. It is more common in the third trimester. It is due to a defect in the\nlong-chain-3-hydroxy acyl-CoA-dehydrogenase (LCHAD) pathway. It is also associated with:\nFirst pregnancy - uncommon in subsequent pregnancies\nMaternal obesity\nMultiple pregnancies Investigations:\nLiver function tests such as AST, ALT, and serum bilirubin levels are raised.\nHemolysis with coagulopathy:\nDecreased platelets and fibrinogen\nElevated d-dimers and prothrombin time\nBiopsy reveals a characteristic microvesicular fatty infiltration.\nThe definitive management of AFLP is rapid delivery of the fetus and supportive care. Hepatic dysfunction usually normalizes within a week of delivery.\nSolution to Question 6:\nHypertension is not a risk factor for urinary infections in pregnancy. Risk factors for urinary infections in pregnancy include:\nUrinary retention\nVesicoureteric reflux of pregnancy\nDiabetes in pregnancy\nSickle cell anemia\nSolution to Question 7:\nThe given clinical scenario is suggestive of asymptomatic bacteriuria. Antibiotic therapy should be given regardless of the symptoms.\nAsymptomatic bacteriuria refers to persistent, actively multiplying bacteria within the urinary tract in asymptomatic women.\nOrganisms that cause urinary infections are those from the normal perineal flora. The most common causative agent is E.coli. Others include Klebsiella, and Proteus.\nIncidence is similar to that in non-pregnant women. Prevalence depends on parity (more in higher parity), race, socioeconomic status (more in low SES).\nIt is more common in patients with sickle cell anemia/trait, diabetes. There is a high risk of developing chronic renal lesions in later life.\nIt is also associated with:\nHypertension\nAnemia\nPremature labor\nIntrauterine growth retardation\nUrinary tract abnormalities in recurrent cases. Diagnostic criteria:\nA positive bacterial count of the same species - over 1,00,000/mL\nOrganisms in midstream clean-catch specimen of urine on two occasions\nNo symptoms of urinary infection Treatment:\nSingle-dose therapy - Amoxicillin 3g, Nitrofurantoin 200mg\nRegular 10-14 days therapy - Amoxicillin, Nitrofurantoin, Cephalexin, or Amoxiclav\nRecurrent cases need to be treated until delivery with prophylactic doses.\nSolution to Question 8:\nThe given clinical scenario is suggestive of cystitis. Ciprofloxacin, a fluoroquinolone antibiotic, is contraindicated in pregnancy as it causes cartilage and bone defects in the fetus.\nAntibiotics are used for treating cystitis in pregnancy. Antibiotics safe in pregnancy include:\nPenicillin group\nCephalosporins\nErythromycin\nMetronidazole (except in the 1st trimester) Antibiotics unsafe in pregnancy include:\nTetracycline\nAminoglycoside\nChloramphenico\nMetronidazole(in the first trimester)\nFluoroquinolones\nSolution to Question 9:\nAcute pyelonephritis in pregnancy most often complicates 2nd trimester of pregnancy.\nAcute pyelonephritis occurs more commonly in those with preexisting renal disease. It is caused by E. coli &gt;&gt; Streptococcus sp., S.aureus &gt; Enterobacter, Klebsiella sp.\nClinical features include:\nFever with chills\nLoin pain\nVomiting\nRight-sided renal angle tenderness\nPatients may develop acute respiratory distress syndrome due to endotoxin-mediated alveolar injury. Hemolysis can also occur due to endotoxins, leading to anemia.\nTreatment includes intravenous fluids with antibiotics.\nSolution to Question 10:\nTriad of Gregg is seen in a neonate infected congenitally with rubella virus. The features include:\nPatent ductus arteriosus (PDA)\nCataract\nSensorineural Hearing loss (SNHL)\nOther infections which cause congenital malformations are:\nOrganis m\nEffect\nToxopla sma\nHydro/microcephaly, convuls ions, chorioretinitis, cerebral calcification\nVaricell a\nSkin scarring, hypoplastic li mbs, eye defects, microcepha ly\nParvovir us\nNon-immune hydrops\nSyphilis\nHutchinson's triad:Interstitia l keratitisHutchinson's teeth Eighth nerve deafness\nSolution to Question 11:\nToxoplasmosis causes maximal complications in 1st trimester and is maximally transmitted in the 3rd trimester.\nThis is because the risk of transmission increases and the risk of damage decreases as pregnancy progresses further.\nClinical features of affected neonates include:\nHydrocephalus or microcephaly\nChorioretinitis\nIntracranial calcifications\nConvulsions\nLow birthweight\nHepatosplenomegaly\nJaundice\nAnemia\nSolution to Question 12:\nThe given scenario points to a diagnosis of maternal toxoplasmosis. It is treated using spiramycin.\nPyrimethamine-sulfonamide is used when fetal infections are confirmed. It should be avoided in the first trimester.\nToxoplasmosis is caused by Toxoplasma gondii. Cats are definitive hosts. It can be transmitted to humans either by ingestion of raw or inadequately cooked infected meat or by ingestion of oocysts via exposure to cat litter or soil.\nAcute infection is diagnosed either by the presence of IgG and IgM antibodies or by a four-fold increase in paired specimens 4 weeks apart.\nSolution to Question 13:\nPainful genital ulcers and painful inguinal lymphadenopathy are suggestive of herpes virus infection. The cytological image showing multinucleate giant cells, Tzanck cells confirms the diagnosis of HSV. The best step in the management of delivery in this patient is a cesarean section.\nHerpes infection in the newborn may occur during birth, particularly if the mother has genital lesions due to HSV-2. In such cases, a cesarean section may prevent neonatal infection.\n\nSolution to Question 14:\nThe maximum risk of HSV transmission from mother to child is during labor. This is due to the shedding of the virus from an active infection in the genital tract during delivery.\nHSV is a sexually transmitted infection. There is a higher risk of transmission during primary infections than with recurrences. Reactivations are less severe.\nCesarean delivery reduces the risk of vertical transmission during labor and is indicated in:\nCases of active genital lesions - both primary and recurrent\nProdromal symptoms - like vulval itching or burning\nSuspicious lesions should be sent for PCR testing or culture. Antiviral treatment with acyclovir should be given if found positive.\nWomen without active genital lesions, without symptoms, or those with active lesions in non-genital areas can undergo normal labor and delivery.\nManagement of HSV infection during pregnancy:\nPrimary or recurrent infections during pregnancy - Oral acyclovir or valacyclovir\nSevere or disseminated infection - IV acyclovir followed by oral acyclovir\nPain relief - Oral analgesics or topical anesthetics\nUrinary retention - catheterization.\nSolution to Question 15:\nThe risk of developing fetal varicella syndrome (congenital varicella syndrome) is highest when the mother develops varicella infection between 13 to 20 weeks.\nCongenital varicella syndrome occurs in 2% of infants with maternal varicella between 13 and 20 weeks of gestation and in 0.4% of infants before 13 weeks of gestation. It is rare after 20 weeks.\nCongenital varicella syndrome is characterized by cicatricial skin scarring in a zoster-like pattern (zig-zag scarring), and limb hypoplasia (shown below). They can also present with neurological abnormalities (microcephaly, cortical atrophy, mental retardation), ophthalmic features (chorioretinitis, microphthalmia, cataract), and renal and autonomic system abnormalities (hydronephrosis, neurogenic bladder). Low birth weight is also common.\nInfants born to mothers with varicella in the period from 5 days prior to delivery up to 2 days after delivery are at high risk for severe neonatal varicella. They acquire the infection transplacentally.\nSince the mother has not developed a strong antibody response, the infant lacks the protective effect of maternal anti-varicella-zoster virus (VZV) antibodies. Therefore varicella-zoster immune globulin (VZIG) should be administered as soon as possible after birth to newborns whose mothers have varicella 5 days before and up to 2 days after the delivery.\nSince perinatally acquired varicella can be potentially life-threatening, the infant should typically be treated with intravenous acyclovir (10 mg/kg every 8 hours) when lesions appear.\nFor pregnant women with uncomplicated primary varicella or herpes zoster that does not require hospitalization, the recommended treatment is oral acyclovir (800 mg five times daily for seven days).\n\nSolution to Question 16:\nThe given scenario is suggestive of congenital varicella syndrome. It is seen in babies born to mothers who had chickenpox infections during their pregnancy.\nFeatures of congenital varicella syndrome include:\nChorioretinitis\nLimb hypoplasia\nCicatricial skin lesions\nMicrophthalmia\nCerebral cortical atrophy\nGrowth restriction\nHydronephrosis\nThe image below shows limb hypoplasia in fetal varicella syndrome:\n\nSolution to Question 17:\nA pregnant woman with syphilis can transmit T. pallidum to the fetus at 10\u201315 weeks of gestation. Features of congenital syphilis include:\nHutchinson's triad - It is seen in late congenital syphilis.\nHutchinson\u2019s teeth - small widely spaced, peg-shaped, notched upper incisors\nInterstitial keratitis\nSensorineural hearing loss\nMulberry molars\nRhagades - deep fissuring of mucocutaneous junctions in the nares, lips, and anus\nFrontal bossing\nSaber shins - anterior tibial bowing\nClutton\u2019s joints - painless, symmetric hydrarthrosis of the knees and elbows The image below shows Hutchinson incisors.\n\nNote: The risk of fetal infection during untreated early maternal syphilis is ~75\u201395%, decreasing to ~35% for maternal syphilis of &gt;2 years duration.\nSolution to Question 18:\nEnlarged and pale placenta is due to infection by syphilis. Other clinical manifestations and complications include:\nSpontaneous abortion\nStillbirth\nNon-immune hydrops\nIntrauterine growth restriction\nPerinatal death.\nSolution to Question 19:\nThe given clinical scenario is suggestive of early syphilis in a pregnant woman. 2.4 million units of benzathine penicillin should be given intramuscularly as a single injection.\nTreatment of syphilis includes:\nEarly syphilis - Benzathine penicillin G, 2.4 million units intramuscularly as a single injection\nLate syphilis (&gt;1 year duration) - Benzathine penicillin G, 2.4 million units intramuscularly weekly for three doses\nTreatment of neurosyphilis:\nAqueous crystalline penicillin G, 3\u20134 million units intravenously every 4 hours for 10\u201314 days\nProcaine penicillin, 2.4 million units intramuscularly daily, plus probenecid 500 mg orally four times daily, both for 10\u201314 days.\nSolution to Question 20:\nThe above scenario points to a diagnosis of SLE. Preterm labor is a complication in pregnant women with SLE, not post-term delivery.\nComplications in a pregnant patient with SLE include:\nThrombophilia\nPreterm labor\nHypertension, eclampsia, and preeclampsia\nAnemia\nThrombocytopenia\nStroke\nRenal failure\nFeatures of neonatal lupus include:\nCardiac abnormalities - Complete heart blocks\nCutaneous lupus\nHepatobiliary diseases - liver failure, transient conjugated hyperbilirubinemia, transient transaminase elevations\nHematologic abnormalities - thrombocytopenia, neutropenia, or anemia\nSolution to Question 21:\nCesarean delivery is the preferred mode of delivery in a woman with HIV viral load above 1000 copies/ml at 34-36 weeks of gestation.\nCesarean delivery is usually scheduled at 38 weeks of gestation, or two weeks before the due date.\nPregnant women with HIV on ART throughout pregnancy, with a viral load &lt;1000 copies/mL evaluated within 4-6 weeks of delivery, may choose to have a vaginal delivery.\nSolution to Question 22:\nART should be initiated immediately and continued lifelong in all pregnant and breastfeeding women with HIV. This is regardless of their WHO clinical stage and CD4 cell count.\n*Note: Pearl attached below has been updated according to the NACO ART guidelines 2021. Efavirenz has been replaced by Dolutegravir as per the new guidelines.\nSolution to Question 23:\nIn India, according to the NACO guidelines, nevirapine is given in the syrup form for 6 weeks to an infant of a mother who is on long-term ART.\nIn infants born to mothers with HIV who are not on ART, syrup nevirapine should be continued for 12 weeks.\nAccording to the NIH guidelines, zidovudine should be given to the neonate for 4 weeks.\nSolution to Question 24:\nThe highest incidence of stroke in pregnancy is 5 days to 2 weeks postpartum. This is followed by the intrapartum period.\nThere is an increased risk of cerebrovascular thrombosis post-delivery due to a sudden reduction in the blood volume, a fall in the level of circulating antithrombotic factors, and venous stasis.\nRisk factors of stroke in pregnancy include:\nHypertensive disorders\nGestational diabetes\nAntepartum hemorrhage\nCesarean delivery.\nSolution to Question 25:\nUntreated epilepsy has no association with fetal malformations. Anti-epileptic medications such as valproate, phenytoin, etc., are responsible for fetal malformations.\nSeizure frequency is unchanged in 50%, increased in 30%, and decreased in 20% women. Seizure risk increases during labor as pain and hyperventilation decrease the seizure threshold.\nThe ideal contraceptive in a breastfeeding mother with a seizure disorder is depot medroxyprogesterone acetate (DMPA), as progestins increase the seizure threshold.\nDisorders of Menstruation\nQuestion 1:\nWhich of the following statements is true regarding amenorrhoea?\nMRKH syndrome is associated with secondary amenorrhoea\nPrimary amenorrhoea is seen in Turner syndrome\nPrimary amenorrhea is absence of menarche by 13 years\nSecondary amenorrhea is absence of menses for 6 months\nQuestion 2:\nWhile evaluating a patient with secondary amenorrhoea, you administer her estrogen and progesterone. However, withdrawal bleeding is not seen. What is the likely site of lesion here?\nPituitary\nEndometrium\nOvary\nHypothalamus\nQuestion 3:\nThe risk of Asherman syndrome is highest if D&amp;C is done for \t.\nDysfunctional uterine bleeding\nPostpartum haemorrhage\nMissed abortion\nMedical termination of pregnancy\nQuestion 4:\nWhich of the following statements is true regarding oligomenorrhea?\nRefers to frequent menstruation\nRegularly timed episodes of bleeding\nMenstruation occurring at an interval of more than 30 days\nCan progress to amenorrhea\nQuestion 5:\nA patient with uterine fibroids complains of frequent menstruation with an average cycle duration of 19-21 days. What is this menstrual irregularity called?\nHypomenorrhea\nPolymenorrhea\nOligomenorrhea\nMenorrhagia\nQuestion 6:\nWhich of the following statements is true regarding menorrhagia?\nHeavy and regularly timed episodes of bleeding\nCoagulation studies are routinely performed\nAmount of bleeding greater than 50 m\nDuration of bleeding greater than 5 days\nQuestion 7:\nA 33-year-old female patient comes with complaints of menorrhagia for the past 3 months. The duration and regularity of her menstrual cycles are normal. Non-hormonal management has been tried without success. What is the most appropriate next step?\nUterine artery embolisation\nEndometrial ablation\nHormonal therapy\nHysterectomy\nQuestion 8:\nWhich of the following is not a feature of menometrorrhagia?\nExcessive bleeding\nProlonged bleeding\nIrregularly timed bleeding\nInfrequent bleeding\nQuestion 9:\nA patient who had undergone a dilatation and curettage procedure comes to the clinic 6 months later for a follow-up visit. She informs you that since the procedure, she has had scanty blood loss during menses which only lasts for 1-2 days. What is this pattern of bleeding called?\nOligomenorrhea\nPolymenorrhea\nEpimenorrhea\nHypomenorrhea\nQuestion 10:\nA 36-year-old woman presents to the gynecology OPD with complaints of occasional bleeding PV between her usual menstrual cycles. Which of the following is true about her condition?\nBleeding is always pathologica\nBleeding is usually scanty\nOccurs between 2 abnormal cycles\nOccurs in consecutive cycles\nQuestion 11:\nA young girl with McCune-Albright syndrome is noted to have precocious menstruation. This condition is defined as the occurrence of menstruation at\t.\n&lt;8 years\n&lt;7 years\n&lt;10 years\n&lt;11 years\nQuestion 12:\nA 45-year-old woman presents with profuse, painless vaginal bleeding. She has a history of 6-8 weeks of amenorrhea and her UPT is negative. On ultrasound, endometrial thickness is 21mm. What is the likely diagnosis?\nSenile endometritis\nHalban disease\nMetropathia haemorrhagica\nEndometriosis\nQuestion 13:\nWhich does 'I' stand for in the PALM-COEIN classification for abnormal uterine bleeding?\nInfectious causes\nIatrogenic causes\nIdiopathic bleeding\nInflammatory causes\nQuestion 14:\nA 28-year-old P1L1 woman presented with heavy menstrual bleeding and occasional spotting between cycles. What is the first investigation to be done for her?\nUltrasound abdomen\nPap smear\nUrine beta-hCG\nTransvaginal ultrasound\nQuestion 15:\nA woman with AUB-E, who was unresponsive to medical management, underwent a hysteroscopic ablation. Which of the following is false about this procedure?\nSafe, effective with less morbidity\nQuicker recovery\nFertility is preserved\nMethod destroys 2-3 mm of myometrium\nQuestion 16:\nWhen is dilatation and curettage contraindicated?\nPelvic inflammatory disease\nEctopic pregnancy\nMenstrual irregularities\nEndometriosis\nQuestion 17:\nA 31-year-old woman presented with acute abdominal pain and spotting. UPT was negative. On examination, she was tachycardic and afebrile. Guarding and abdominal tenderness was present. CT abdomen showed air in the uterine wall and pneumoperitoneum. Which of the following is her condition most likely to be a complication of?\nEndometrial biopsy\nDilatation and curettage\nLaparoscopy\nHysteroscopy\nQuestion 18:\nAn 18-year-old girl presents to you with cramping abdominal pain. It starts at the onset of menses and is more pronounced in the first two days. Which condition is she likely suffering from?\nCongestive dysmenorrhoea\nSpasmodic dysmenorrhoea\nUnilateral dysmenorrhoea\nAcquired dysmenorrhoea\nQuestion 19:\nAn increase in which of the following is spasmodic pain during dysmenorrhoea attributed to?\nPGE1\nPGE2\nPGD2\nPGF2\uf0b0\nQuestion 20:\nA 28-year-old woman presents to the psychiatry OPD with complaints of mood swings and depression 10 days prior to her menses. This is associated with fatigue, breast tenderness, and bloating. Her symptoms resolve once menses begin. What is the treatment of choice in this case?\nEvening primrose oi\nLeuprolide\nFluoxetine\nDrospirenone\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_19.jpeg",
      "OBGYN_img_233.jpeg",
      "OBGYN_img_19.jpeg",
      "OBGYN_img_234.jpeg",
      "OBGYN_img_19.jpeg",
      "OBGYN_img_235.jpeg",
      "OBGYN_img_19.jpeg",
      "OBGYN_img_236.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch98_1",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch98_2",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch98_3",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch98_4",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch98_5",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch98_6",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch98_7",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch98_8",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch98_9",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch98_10",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch98_11",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch98_12",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch98_13",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch98_14",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch98_15",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch98_16",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch98_17",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch98_18",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch98_19",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch98_20",
    "question_text": "\nc\nSolution to Question 1:\nPrimary amenorrhoea is seen in Turner syndrome\nAmenorrhoea is a symptom and not a disease entity. It refers to the absence of menstruation that can be physiological or pathological.\nPrimary amenorrhea is defined as an absence of menstruation by the age of 15 years. At age 13 years, if no menses have occurred and there is a complete absence of secondary sexual characteristics such as breast development, evaluation for primary amenorrhea should\nbegin. Mullerian agenesis (MRKH syndrome), androgen insensitivity syndrome, and Turner syndrome present with primary amenorrhea. In Turner's syndrome, gonadal dysgenesis causes primary ovarian failure, resulting in hypogonadism and amenorrhea.\nSecondary amenorrhea is defined as the absence of menses for 3 or more months or fewer than 9 cycles per year after the establishment of regular menstrual cycles. Polycystic ovarian syndrome and hypothyroidism are associated with secondary amenorrhea. Pregnancy is the most common physiological cause of secondary amenorrhea.\nSolution to Question 2:\nThe absence of withdrawal bleeding after the estrogen-progesterone challenge test points towards a local endometrial lesion.\nEstrogen\u2013progesterone challenge test is indicated as an investigation in case of secondary amenorrhea. It depends on estrogen-primed endometrium being present in the uterus.\nProcedure:\nEthinyl estradiol 0.02 mg or conjugated equine estrogen 1.25 mg is to be taken daily for 25 days.\nMedroxyprogesterone acetate 10 mg daily is added from day 15\u201325.\nAlternately, one course of oral contraceptive pill is given and to observe whether withdrawa bleeding occurs or not.\nResults:\nIf there is no bleeding, a local endometrial lesion is present such as uterine synechiae. This is to be confirmed by HSG or hysteroscopy.\nIf withdrawal bleeding occurs, the endometrium is responsive but the endogenous estrogen production is inadequate. Hence, the defect lies in the ovary, hypothalamus, or pituitary.\nSolution to Question 3:\nThe risk of developing Asherman syndrome is the highest if D&amp;C is done for postpartum hemorrhage.\nThis is because the postpartum uterus is larger and bulkier. Hence, a greater area of the uterine wall is curetted. This increases the risk of developing Asherman syndrome.\nAsherman syndrome is the presence of uterine synechiae, due to the destruction of large areas of the endometrium. The treatment of Asherman syndrome is by hysteroscopic adhesiolysis.\nSolution to Question 4:\nOligomenorrhoea can progress to develop into amenorrhoea.\nOligomenorrhoea means infrequent, irregularly timed episodes of bleeding usually occurring at intervals of more than 38 days.\nSolution to Question 5:\nThe given case scenario is suggestive of polymenorrhoea, also known as epimenorrhea. It refers to frequent episodes of menstruation, usually occurring at intervals of 21 days or less.\nThe definitions of various menstrual cycle irregularities are:\nAmenorrhoea refers to the absence of menstruation.\nIntermenstrual bleeding refers to occasional episodes of bleeding (usually not excessive) that occur between otherwise normal menstrual cycles.\nHypomenorrhea refers to regularly timed cycles, but having scanty episodes of bleeding.\nMenorrhagia refers to regularly timed menstrual cycles with excessive bleeding (&gt;80 mL in amount) and/or increased duration of flow (&gt;8 days).\nMetrorrhagia refers to normal cyclical bleeding with superimposed irregularly timed episodes of bleeding.\nMenometrorrhagia refers to excessive, prolonged bleeding that occurs at irregularly timed and frequent intervals.\nOligomenorrhea refers to infrequent, irregularly timed cycles with intervals of more than 38 days. Precocious menstruation refers to the occurrence of menstruation before the age of 10 years.\nSolution to Question 6:\nMenorrhagia is defined as heavy but regular menstrual bleeding.\nMenorrhagia denotes regularly timed episodes of bleeding that are excessive in amount (&gt;80 mL) and/or duration of flow (&gt;8 days). Nowadays, menorrhagia has been replaced by the term heavy menstrual bleeding. This is defined as greater than 80 mL per cycle, which will result in anemia if recurrent\nInvestigations done in case of menorrhagia:\nComplete blood count (CBC) - to rule out anemia and thrombocytopenia.\nCoagulation studies are ordered only in case of clinical suspicion and correlation with CBC\nSonohysterography/Hysteroscopy - to diagnose endometrial polyps and fibroids\nEndometrial biopsy - in case of suspected endometrial hyperplasia\nTransvaginal ultrasound - supplements biopsy\nSolution to Question 7:\nHormonal therapy is the next best step in the given scenario of menorrhagia that is unresponsive to non-hormonal therapy.\nMenorrhagia/heavy menstrual bleeding is defined as heavy but regular menstrual bleeding, &gt;80mL of blood loss, or &gt;8 days of bleeding per menstrual period. It can be acute (&lt;6 months) or chronic (&gt;6 months).\nIt is managed as follows:\nMedical - first line of treatment.\nNSAIDs\nTranexamic acid\nOCPs/progestogens - if non-hormonal management fails\nMirena IUCD\nGnRH agonists\nBlood transfusion, if required\nSurgical - if medical management fails, depending on the diagnosis:\nEndometrial ablation - hysteroscopic, TCRE, RITEA, microwave, NovaSure, etc (option B)\nUterine artery embolization (option A)\nUterine tamponade\nHysterectomy - if all minimally invasive methods fail (option D)\nSolution to Question 8:\nMenometrorrhagia refers to menstrual bleeding at frequent intervals.\nMenometrorrhagia means excessive, prolonged bleeding that occurs at irregularly timed and frequent intervals. It can be caused by cervical cancer and granulosa cell tumors.\nSolution to Question 9:\nIn the given clinical scenario, the pattern of bleeding is called hypomenorrhea. Hypomenorrhea along with a prior history of dilatation and curettage are suggestive of partial Asherman's syndrome.\nHypomenorrhoea refers to regularly timed but scanty episodes of bleeding. It can be seen in:\nPartial Asherman's syndrome - uterine synechiae, causing scarring\nOral contraceptive use\nPerimenopausal age group\nSolution to Question 10:\nThe given case scenario is suggestive of intermenstrual bleeding, also known as metrorrhagia. Usually, this is scanty, and not excessive.\nIntermenstrual bleeding or metrorrhagia refers to irregularly timed episodes of bleeding superimposed on normal cyclical bleeding. It can be caused by:\nOvulation (physiological)\nPolyps\nCervical cancer\nLower genital tract infections etc.\nSolution to Question 11:\nPrecocious menstruation refers to the occurrence of menstruation before the age of 10 years.\nPrecocious puberty in a girl is the appearance of any of the secondary sexual characteristics before the age of 8 years or the occurrence of menarche before the age of 10 years.\nMcCune Albright syndrome is associated with cafe-au-lait spots, precocious puberty (and precocious menstruation), and polyostotic fibrous dysplasia leading to recurrent fractures. The image given below shows cafe-au-lait spots.\n\nSolution to Question 12:\nThe given case scenario is suggestive of metropathia hemorrhagica.\nMetropathia hemorrhagica is a form of anovulatory abnormal uterine bleeding. It is characterized by continuous painless vaginal bleeding at the onset of menses or preceded by a 6-8 week period of amenorrhea. It is usually seen in the age group of 40-45 years. A history of menorrhagia may be present.\nOn examination, the uterus is bulky and uniformly enlarged. Histopathological findings are:\nMyohyperplasia of the uterine wall - up to 2.5cm\nThick endometrium with cystic glandular hyperplasia appearing as swiss cheese pattern\nAbsence of secretory endometrium i.e absence of corkscrew glands\nThin, slender endometrial polyps project into the uterine cavity\nCorpus luteum is absent\nOne or both ovaries may contain a cyst\nOption A: Senile endometritis occurs after menopause when the endometrium is thin and atrophic. It may be associated with accumulation of pus in the uterine cavity.\nOption B: Halban's disease is irregular shedding and is due to persistent corpus luteum. Regular cycles with prolonged bleeding and normal flow is present.\nOption D: Endometriosis usually presents in the reproductive age group, with symptoms of menorrhagia, dysmenorrhea and chronic pelvic pain.\nSolution to Question 13:\nThe 'I' in the FIGO PALM-COEIN classification for abnormal uterine bleeding (AUB) stands for iatrogenic causes.\nAUB in the reproductive age group was previously known as dysfunctional uterine bleeding, however, that term is now obsolete. AUB can be acute or chronic:\nAcute AUB - it can start sporadically or be superimposed on chronic AUB.\nChronic AUB - it lasts for 3-6 months minimum. PALM-COEIN classification of AUB:\nPolyp (AUB-P):\nEndometrial polyps\nEndocervical polyps\nAdenomyosis (AUB-A)\nLeiomyoma (AUB-L). Fibroids are further classified as:\nSubmucosal (SM)\nOther (O)\nMalignancy and hyperplasia (AUB-M)\nEndometrial hyperplasia\nEndometrial carcinoma\nCoagulopathy (AUB-C)\nvon Willebrand's disease\nHemophilias\nOvarian causes (AUB-O)\nPCOD\nHypothyroidism\nHyperprolactinemia.\nEndometrial causes (AUB-E)\nTubercular or chlamydial endometritis\nIatrogenic causes (AUB-I)\nIntrauterine contraceptive devices\nAnticoagulants\nTricyclic antidepressants\nNot yet classified (AUB-N) includes rare causes such as\nArteriovenous malformations\nMyometrial hypertrophy\nSolution to Question 14:\nThe first investigation to be done in a case of abnormal uterine bleeding (AUB) in the reproductive age group is urine \uf062-hCG estimation. This is done to rule out pregnancy.\nIn the reproductive age group, anovulatory uterine bleeding is encountered less often. Therefore, pregnancy must be excluded. Pregnancy complications such as miscarriage, ectopic pregnancies, and molar pregnancies may present with AUB, hence these need to be ruled out by urine\n\uf062-hCG levels. This is done for all women in the reproductive age group.\nOther investigations to be done for AUB are:\nPap smear - to rule out cervical cancer and preinvasive lesions (CIN).\nTransabdominal ultrasound - to visualize the pelvic organs and lesions such as endometria hyperplasia, polyps, fibroids, etc.\nTransvaginal ultrasound - to visualize the pelvic organs. It is done after evaluating \uf062-hCG. This is more comfortable for a patient compared to a transabdominal ultrasound as it doesn't require a full bladder.\nSolution to Question 15:\nFertility is not preserved with ablative procedures, because the endometrium and superficial myometrium are destroyed.\nIn ablative procedures, the uterus is preserved, and hysterectomy is avoided. The endometrium along with 2-3mm of superficial myometrium is destroyed.\nVarious methods of endometrial ablation include:\nHysteroscopic endometrial ablation\nTranscervical endometrial resection (TCRE) - now replaced by bipolar electrode called Versapoint\nRadiofrequency induced thermal ablation (RITEA)\nMicrowave ablation\nNovaSure - impedance-controlled endometrial ablation\nBilateral uterine artery embolization\nUterine tamponade\nSolution to Question 16:\nDilatation and curettage (D&amp;C) is contraindicated in pelvic inflammatory disease (PID) as it increases the risk of ascending genital infection.\nD&amp;C is a minor gynecological procedure of dilating the cervix and curetting the endometrial tissue from the uterine cavity. Diagnostic indications of D&amp;C include AUB, secondary\namenorrhea to detect tubercular endometritis, postmenopausal bleeding to rule out endometrial cancer or hyperplasia, and infertility due to genital TB.\nTherapeutic indications of D&amp;C include missed abortion, incomplete abortion, retained products of conception, and endometrial polypectomy.\nAbsolute contraindication of D&amp;C includes Suspected/ desired pregnancy and lower genital tract infection. However, D&amp;C is performed in some cases with genital infections like septic abortion (where retained pieces of placenta act as a nidus and need to be removed) and pyometra (as there is cervical obstruction with superinfection of menstrual blood and cellular debris, D&amp;C is appropriate to remove the obstruction as well as the source of infection)\nComplications of D&amp;C include ascending infection, cervical tear with bleeding, incompetent os, uterine perforation, and ashermann syndrome.\n\nSolution to Question 17:\nThe given case scenario is suggestive of uterine perforation. In a non-pregnant uterus, uterine perforation is most likely to occur due to dilatation and curettage.\nIn pregnancy and uterine malignancies, the uterus is soft. Hence, uterine perforation is common during surgeries.\nThe etiology of uterine perforation is as follows:\nInsertion of intrauterine contraceptive devices (IUCD)- due to the lack of provider experience.\nSpontaneous migration of IUCD within the myometrium\nDilatation and curettage (D&amp;C)\nHysteroscopy - diagnostic (e.g, hysteroscopic biopsy) or therapeutic (adhesiolysis)\nLaparoscopy\nIt can present with fever, acute abdominal pain, nausea and vomiting, and bleeding pv. Imaging reveals air within the uterine wall or pneumoperitoneum.\nThe management is as follows:\nConservative management - Fundal injuries are managed conservatively, as the myometrium contracts around the defect.\nSurgical management:\nSmall defects can be repaired laparoscopically or hysteroscopically.\nEmergency laparotomy - as abdominal viscera may prolapse through the defect.\nHysterectomy - if the defect is large, and the patient has completed her family, hysterectomy is done as last resort.\nSolution to Question 18:\nThe given case scenario is suggestive of spasmodic dysmenorrhea. It presents with cramping pain at the onset of menses which is more pronounced in the first two days of menstruation.\nDysmenorrhoea is defined as cramping pain accompanying menstruation. It can be classified as follows:\nEtiological classification:\nPrimary dysmenorrhoea - no identifiable pelvic pathology. Commonly occurs in the age group of 18 to 25 years, with ovulatory cycles.\nSecondary (acquired) dysmenorrhoea - is associated with pelvic pathologies such as fibroids, adenomyosis, PID, and endometriosis.\nUnilateral dysmenorrhoea can occur in a rudimentary horn of a bicornuate uterus, IUCD users, and cervical stenosis.\nClinical classification:\nSpasmodic dysmenorrhoea:\nMost prevalent\nCramping pain at the onset of menses, more pronounced on the first 2 days.\nOccurs due to myometrial contractions due to increased PGF2\uf0b0\nCommon in adolescents and young women\nCongestive dysmenorrhoea:\nPelvic pain and pelvic discomfort occurs, a few days before menses begin\nOccurs due to pelvic venous congestion\nSeen in pelvic endometriosis, PID, fibroids, and IUCD users\nMembranous dysmenorrhoea:\nLeast prevalent\nThe endometrium is shed as a cast at the time of menstruation\nThe passage of the cast is associated with painful uterine cramps\nSolution to Question 19:\nSpasmodic pain is attributed to myometrial contractions occuring due to increased PGF2\uf0b0 . This is secreted under the effect of progesterone.\nProgesterone is secreted after ovulation by the corpus luteum. Hence, in anovulatory cycles, menstruation is not accompanied by spasmodic pain.\nSolution to Question 20:\nThe given case scenario is suggestive of premenstrual dysphoric disorder (PMDD). Selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine, sertraline, and paroxetine are the treatment of choice for PMDD.\nDSM-5 defines premenstrual dysphoric disorder (PMDD) as the presence of at least five of the associated symptoms most of the time during the premenstrual week. Symptoms improve within a few days after menses and are minimal in the postmenstrual period. These symptoms include:\nMarked emotional lability\nMarked irritability or anger\nMarked depressive mood, self-deprecating thoughts\nMarked anxiety\nDecreased interest in activities\nDifficulty in concentration\nLethargy\nAppetite changes\nBloating\nBreast tenderness\nWeight gain\nTreatment of PMDD is as follows:\nLifestyle changes such as - stress reduction, adequate sleep, and exercise, reduction in caffeine intake, smoking cessation\nSelective serotonin reuptake inhibitors (SSRIs) - fluoxetine, paroxetine, sertraline\nEvening primrose oil - to treat breast tenderness\nOvulation suppression - danazol, leuprolide, drospirenone\nOther less proven methods - cognitive behavioral therapy, calcium supplements, etc.\nNote: Premenstrual syndrome has no scientific definition. The constellation of symptoms is now defined under PMDD.\nUro-gynecology\nQuestion 1:\nA woman with urinary incontinence was diagnosed to have a vesicovaginal fistula. What is the most common cause of this condition?\nCongenital\nAcquired\nIdiopathic\nInfectious\nQuestion 2:\nWhich of the following types of genitourinary fistulas has not been reported?\nUreterovaginal\nVesicouterine\nUterourethral\nUrethrocervical\nQuestion 3:\nWhich of the following does not cause genitourinary fistulas?\nHysterectomy\nRadiotherapy\nProlonged obstructed labour\nHysteroscopy\nQuestion 4:\nA P1L1 woman presents with constant dribbling of urine. She gives a history of unattended vaginal delivery following a difficult and prolonged labor 3 months back. What is the most likely diagnosis?\nUreterovaginal fistula\nVesicouterine fistula\nVesicovaginal fistula\nUrethrovaginal fistula\nQuestion 5:\nWhat is the most useful test in vesicovaginal fistula?\nCystoscopy",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_19.jpeg",
      "OBGYN_img_237.jpeg",
      "OBGYN_img_19.jpeg",
      "OBGYN_img_238.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch98_3",
    "question_text": "swab test\nMRI\nCystometry\nQuestion 6:\nA patient comes with a complaint of dribbling of urine from the vagina during micturition. She has a history of obstructed labor. Methylene blue 3 swab test is done, and the lowest swab gets stained. What is the diagnosis?\nUreterovaginal fistula\nVesicovaginal fistula\nUrethrovaginal fistula\nVesicouterine fistula\nQuestion 7:\nA 40-year-old woman with a history of colporrhaphy is diagnosed with a vesicovaginal fistula. Which of the following investigations is not preferred in this patient?\nUrine culture\nUltrasound abdomen\nCystoscopy\nMRI\nQuestion 8:\nA 40-year-old woman came for a follow-up visit one week following a vaginal hysterectomy. You note she has developed a large vesicovaginal fistula. What is the best time for fistula repair in this case?\nImmediately\nAfter 3 weeks\nAfter 6 weeks\nAfter 3 months\nQuestion 9:\nA 34-year-old woman presents to the OPD with complaints of blood in her urine. She informs you that this happens every month for 1 week and stops on its own. She underwent a\nC-section 1 year ago and has no history of incontinence. During clinical examination, a catheter is inserted into the bladder, and the following finding is seen. What is the likely diagnosis?\n\nUrethrouterine fistula\nVesicouterine fistula\nVesicovaginal fistula\nUreterovaginal fistula\nQuestion 10:\nIntravenous pyelography in a patient suspected to have a genitourinary fistula revealed a ureteric fistula. Which of the following is false about this condition?\nIt is mostly caused by gynecological surgeries\nContinuous dribbling of urine occurs, but the patient can also micturate\nIn 3-swab test, the swab is stained blue\nHydronephrosis is present on the affected side\nQuestion 11:\nYou need to locate the ureter while performing an abdominal hysterectomy. Which of the following features will help you identify it?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_19.jpeg",
      "OBGYN_img_239.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch99_1",
    "question_text": ", 2, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch99_1",
    "question_text": ", 2, 3",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch99_2",
    "question_text": ", 3, 4",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch99_2",
    "question_text": ", 3, 5\nQuestion 12:\nDuring post-op rounds, you note one of the patients has developed fever and flank pain. The nurses inform you that her abdominal drain outputs have been consistently high. Which of the following procedures has the highest incidence of the complication suspected here?\nVaginal hysterectomy\nWertheim\u2019s hysterectomy\nAbdominal hysterectomy\nEmergency cesarean section\nQuestion 13:\nA patient with uterine fibroids is set to undergo a hysterectomy. While obtaining informed consent for the procedure, you counsel her about the potential risk of ureteric injury. Which of the following sites is the injury least likely to occur at?\nInfundibulopelvic ligament\nUreteric canal\nUterosacral ligament\nUreteropelvic junction\nQuestion 14:\nWhat is the most common cause of rectovaginal fistula?\nImproper suturing of perineal tears\nTuberculosis of the anus\nCarcinoma cervix\nRadiotherapy\nQuestion 15:\nWhich of the following is not a prerequisite for maintaining female urinary continence?\nNormal urethral closure pressure more than 20 cm of water\nUrethrovesical angle &gt; 100\nInternal urinary sphincter must lie above levator ani\nInnervation of internal sphincter by Onuf's nucleus\nQuestion 16:\nAn elderly woman presented with a mass per vaginum and incontinence. She complains that she has to push the mass inwards to be able to urinate normally. What is the type of incontinence seen here?\nUrge incontinence\nStress incontinence\nOverflow incontinence\nNeurogenic bladder\nQuestion 17:\nA gynecologist performs a Marshall and Bonney test in the OPD on an elderly woman. Which of the following conditions is this used to diagnose?\nVesicovaginal fistula\nGenuine stress incontinence\nProlapse\nRectovaginal fistula\nQuestion 18:\nA wrestler in the post-partum period complains of spurting of urine during weight-lifting practice. Which of the following investigations will help aid your diagnosis?\nQ-tip test\nMethylene blue 3 swab test\nIntravenous pyelography\nTransvaginal ultrasound\nQuestion 19:\nA young mother presented with dribbling of urine on coughing or sneezing. Marshall and Bonney's test was positive. What is the next step in management?\nConservative management\nVenlafaxine therapy\nBurch colposuspension\nMarshall\u2013Marchetti\u2013Krantz operation\nQuestion 20:\nA 24-year-old primiparous woman with Grade 2 genuine stress incontinence did not respond to conservative management. Which of the following surgeries will not be beneficial for her condition?\nPereyra operation\nTension-free vaginal taping\nBurch colposuspension\nLatzko procedure\nQuestion 21:\nA 62-year-old woman presented with complaints of urinary urgency followed by involuntary escape of urine. What is the etiology of the condition she's likely suffering from?\nPelvic mass in pouch of Douglas\nProlapse of anterior vaginal wall\nDetrusor instability\nRetroverted gravid uterus\nQuestion 22:\nWhich of the following patients with urinary incontinence will not have detrusor instability?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch100_1",
    "question_text": "and 4",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch100_2",
    "question_text": "and 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch100_2",
    "question_text": "only",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch100_3",
    "question_text": "only\nQuestion 23:\nA 34-year-old G3P2L2 woman presents to the ER with hypotension, tachycardia, and severe abdominal pain. On examination, fetal parts are palpable in the abdomen. USG abdomen revealed a large uterine wall defect. What's the most common cause of this condition?\nC-section scar dehiscence\nObstructed labor\nBlunt abdominal trauma\nProlonged induction of labor\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_1",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_2",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_3",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_4",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_5",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_6",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_7",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_8",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_9",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_10",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_11",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_12",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_13",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_14",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_15",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_16",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_17",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_18",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_19",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_20",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_21",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_22",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_23",
    "question_text": "\na\nSolution to Question 1:\nVesicovaginal fistulas are mostly acquired.\nIn developing countries, the most common cause is obstetric trauma. In developed countries, iatrogenic injury during pelvic surgery is responsible for 90% of the vesicovaginal fistulas.\nCongenital genitourinary fistulas and fistulas resulting from infectious conditions are rare.\nSolution to Question 2:\nUterourethral type of fistula has not been reported.\nA genitourinary fistula is defined as an abnormal communication between the urinary system\n(ureter, bladder, urethra) and the genital systems (vagina, cervix, uterus).\nMost genitourinary fistulas are acquired. In developing countries, the most common cause\nis obstetric trauma. In developed countries, iatrogenic injury during pelvic surgery is responsible\nfor 90% of the vesicovaginal fistulas.\nCongenital genitourinary fistulas are rare. If present, they are commonly associated with other renal or urogenital abnormalities.\nSolution to Question 3:\nHysteroscopy is not an etiology for genitourinary fistulae. It can occur following hysterectomy. Most genitourinary fistulas are acquired. Its causes are enumerated below:\nProlonged obstructed labor - major cause in developing countries\nDifficult instrumental or manipulative deliveries\nInjury to bladder or ureter during hysterectomy - major cause in developed contries\nCongenital (rare)\nOther causes include:\nRadiation\nMalignancy\nTrauma\nInfections - PID, tuberculosis etc.\nSolution to Question 4:\nThe given case scenario is suggestive of a vesicovaginal fistula. Vesicovaginal fistulas usually present with:\nConstant dribbling of urine from the vagina\nExcoriation in the groin region due to constant leakage of urine\nHistory of pelvic surgery, vaginal delivery or prolonged labor\nAmenorrhea may be present\nOn examination, the fistula may be visualized by observing urine collection in the vagina. Bimanual examination reveals its fixity and extent.\nNote: Ureterovaginal fistulas usually occur following accidental ureteric injury during C-sections in developing countries.\nSolution to Question 5:\nCystoscopy is the most useful test and also the investigation of choice for vesicovaginal fistula\n(VVF).\nCystoscopy or cystourethroscopy helps to visualize the size of the fistulas, the exact location of multiple fistulas and their proximity to the ureteral orifice. It can also assess the bladder mucosa for any injuries.\nThe 3-swab test (Option B) is done to identify the types of genitourinary fistula.\nIn this test, three sterile pieces of cotton swabs are serially placed in the vaginal cavity, while",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_50",
    "question_text": "100ml of methylene blue solution is instilled in the bladder using a catheter. The cotton swabs are placed one at the vault, one at the middle, and one just above the introitus.\nInterpretation:\nUppermost swab gets wet and not stained - the leak is from the ureter, as seen in ureterovaginal fistula\nMiddle swab gets stained - the leak is from the bladder, as seen in vesicovaginal fistula\nLowermost swab gets stained- the leak is from the urethra,as seen in urethrovaginal fistula The below image shows the 3-swab test.\n\nOption C: MRI is usually not needed for the diagnosis of VVF. They can be used to study vesicouterine fistulas.\nOption D: Cystometry is done to measure the capacity of the bladder. It is used to investigate urge incontinence.\nSolution to Question 6:\nThe given clinical scenario is suggestive of a urethrovaginal fistula. Urethrovaginal fistulas have the following clinical features:\nContinent and dry at rest\nUrinary dribbling during micturition\nFistulous opening is seen on per speculum examination\nIn the methylene blue 3-swab test, a catheter is introduced into the bladder through the urethra. The vaginal cavity is packed with three sterile cotton swabs. One at the vault, one at the middle, and one just above the introitus. 50\u2013100 mL of dilute methylene blue dye is injected into the bladder using a catheter.\nInterpretation:\nThe uppermost swab gets wet and not stained - the leak is from the ureter, seen in ureterovaginal fistula\nMiddle swab gets stained - the leak is from the bladder, seen in vesicovaginal fistula\nThe lowermost swab gets stained- the leak is from the urethra, seen in urethrovaginal fistula The given image shows the 3-swab test.\n\nSolution to Question 7:\nMRI is not preferred for a case of vesicovaginal fistula as other investigations are more specific and useful.\nInvestigations in VVF include:\nUrine culture - to treat concurrent UTI.\nUltrasound abdomen - kidney, bladder and ureter should be observed for the presence of a urinoma or hydronephrosis.\nIntravenous pyelography - to look for hydronephrosis\nCystoscopy - used to visualise the number of fistulae and their location.\nMethylene blue 3-swab test in urinary fistulae - A catheter is introduced into the bladder through the urethra and 50-100ml methylene blue is injected. The vaginal cavity is packed with three sterile cotton swabs. It is interpreted as follows:\nThe uppermost swab gets wet and not stained - the leak is from the ureter, seen in ureterovaginal fistula.\nMiddle swab gets stained - the leak is from the bladder, seen in vesicovaginal fistula.\nThe lowermost swab gets stained- the leak is from the urethra, seen in urethrovaginal fistula. The given image shows the methylene blue 3-swab test.\n\nSolution to Question 8:\nIn the given scenario, the best time to perform fistula repair is 6 weeks after the inciting surgery.\nIn uncomplicated fistulas, early surgical intervention is preferred within the first 24 to 48 hours following the inciting surgery. This avoids the brisk postoperative inflammatory response.\nHowever, if extensive and severe inflammation is present, repair of fistula can be delayed to 6 weeks after the surgery. This is usually done in a patient who has undergone major surgery,\nDuring this delay it is ensured that all the tissue inflammation has subsided, tissue vascularisation has improved and local infection has cleared. Estrogen therapy should be instituted in postmenopausal women in this time period.\nIn case the fistula repair fails, a second attempt is made only after 3 months.\nSolution to Question 9:\nThe given image shows the catheter emerging from the cervical os. This, along with the history of cyclical hematuria, is suggestive of Youssef syndrome seen in a case of vesicouterine fistula.\nVesicouterine fistulas can develop after cesarean section, uterine rupture, and placenta accreta. Most cases present weeks to years later.\nVesicouterine fistulas can present with cyclical hematuria, urinary incontinence or complete continence, menstrual abnormalities, and urinary tract infections. Youssef syndrome is seen in cases of vesicouterine fistulas, and it is associated with a classic triad:\nAmenorrhea\nCyclical hematuria - also called menouria: Menstrual blood trickles into the bladder through the fistula, causing hematuria\nUrinary continence (there is no vaginal leakage of urine) Hysteroscopy and cystoscopy are gold-standard investigations. Vesicouterine fistulas are treated as follows:\nProlonged bladder catheterization - leads to spontaneous closure\nSurgical repair via abdominal route\nSolution to Question 10:\nSwabs stained with methylene blue are obtained in a bladder fistula and not in a ureteric fistula. Ureteric fistulas can present with the following features:\nConstant urinary dribbling\nFlank pain or loin tenderness\nRenal angle tenderness\nFever\nHematuria\nOliguria\nUreteric fistulas are most commonly caused by iatrogenic trauma during pelvic surgeries, especially gynecological surgeries. An excretory urogram (intravenous pyelography) or a CT urogram are the investigations of choice. Hydronephrosis may be present on the affected side.\nIt is managed by performing a ureteroneocystostomy and percutaneous nephrostomy.\nSolution to Question 11:\nThe ureter is identified intraoperatively by the following features:\nOvarian artery crosses anterior to it\nIt is cord-like on palpation\nPeristalsis occurs on palpation\nIt has a pale, glistening appearance\nUterine artery crosses it, from lateral to medial, 2 cm lateral to the cervix\n\nSolution to Question 12:\nThe given case scenario is suggestive of ureteric injury. The highest incidence of this complication is seen with Wertheim\u2019s hysterectomy.\nUrinary tract injury occurs almost exclusively in major gynecologic surgery that involves surgical dissection in proximity to the ureters or bladder. Vaginal hysterectomy tends to have lower rates of ureteric injuries than open (abdominal, Wertheim) or laparoscopic routes. The highest risk for ureteric injury is associated with the following procedures:\nSurgical debulking of gynecological cancers\nAdvanced pelvic reconstructive surgery\nLaparoscopic hysterectomy\nPatients with ureteric injuries have a complicated post-operative period. They can present with the following features:\nFever\nFlank pain\nAbdominal distension\nProlonged paralytic ileus - bowel sounds are absent\nHigh drain outputs, in case abdominal drains are placed.\nCT urogram and retrograde pyelography are the investigations of choice. They reveal urinary extravasation from the ureter. Ureteric injuries are prevented by careful division of tissue planes during pelvic or genitourinary surgeries. The condition is managed by prompt surgical repair by ureteroureterostomy or percutaneous ureterostomy.\nSolution to Question 13:\nIatrogenic injury to the ureter is unlikely to occur at the ureteropelvic junction during gynaecological surgeries like a hysterectomy.\nUreteric injury is most commonly caused by gynecological surgeries such as laparoscopic hysterectomy, abdominal hysterectomy, etc. It can occur at:\nThe infundibulopelvic ligament on the lateral pelvic wall\nIn the ureteric canal when the uterine vessels are ligated\nNear the internal cervical os\nNear the uterosacral ligament\nSolution to Question 14:\nImproper suturing of complete perineal tears is the most common cause of rectovaginal fistula.\nRectovaginal fistulas occur most commonly due to obstetric causes such as perineal tears, obstructed labor, and instrumental deliveries. Other causes include:\nTuberculosis\nLymphogranuloma venerum\nBartholinitis - rupture of an abscess into the rectum can cause a fistula\nDiverticulitis\nCarcinoma cervix\nRadiotherapy - can cause ulceration which can develop into a fistula\nSolution to Question 15:\nThe external urinary sphincter is innervated by the Onuf's nucleus, but not the internal one. The following factors are prerequisites for continence in women:\nPosition of internal urinary sphincter lies above levator ani muscles\nNormal urethral closure pressure is &gt;20 cm of water\nUrethrovesical angle &gt;100\nThe tone of pelvic floor muscles\nSolution to Question 16:\nThe given case scenario is suggestive of a cystocele in a case of genital prolapse. Stress incontinence is seen in these cases.\nIn stress incontinence, involuntary leakage of urine occurs when there is increased intraabdominal pressure, such as during laughing, sneezing, or coughing. There is no normal urge to pass urine.\nOption A: Urge incontinence is the involuntary voiding of urine when there is an imminent urge to urinate.\nOption C: Overflow incontinence is an old term that refers to the inability to empty the bladder, with involuntary, continuous urinary dribbling. Currently, it refers to another presentation of urge incontinence.\nOption D: Neurogenic bladder occurs due to defects anywhere in the pathway of the micturition reflex, e.g., spinal cord trauma, diabetes etc. It presents with with urgency or urge incontinence.\nSolution to Question 17:\nMarshall and Bonney's test is used to diagnose genuine stress incontinence. It also helps in assessing how successful a surgical repair will be.\nIt is performed as follows:\nTest\nMarshall test\nBonney's test\nProcedure\nThe vagina in the region of th e bladder neck is infiltrated with local anesthetic and it is elevated.\nTwo fingers are placed in the vagina at the urethrovesical j unction and the bladder neck is elevated.\nPositive tes t\nAbsence of leakage of urine o n straining or coughing\nAbsence of leakage of urine o n straining or coughing\nSolution to Question 18:\nThe given case scenario is suggestive of stress incontinence. It can be diagnosed with the help of the Q-tip test.\nThis test is performed by placing a xylocaine-covered Q-tip cotton swab stick in the patient's urethra. Initially, the stick will be parallel to the floor. Then the patient is asked to strain or cough. Normally the stick will reach an angle of around 10-15\u00b0.\nIn genuine stress incontinence (GSI), this angle increases by 20\u00b0 or more. A positive test indicates a sufficient degree of bladder neck descent. Unfortunately, all patients with GSI may not have a positive test, and it is not specific.\nTests done for GSI(Genuine stress incontinence) include:\nStress test\nCotton swab stick test\nMarshall and Bonney test\nUrethroscopy\nUrodynamic evaluation- cystometry, urethrocystometry, uroflowmetry etc\nSolution to Question 19:\nThe given scenario is suggestive of stress incontinence. In this case, the first line of treatment is conservative management.\nStress incontinence is managed as follows:\nConservative management:\nIt is the first line of treatment.\nIt includes:\nKegel pelvic floor exercises for 4\u20136 months\nElectric/magnetic stimulation for nerve damage, magnetic stimulation\nArtificial urinary sphincter in neurological condition\nVaginal cones\nIt is also done in case surgery fails. Medical management:\nEstrogen cream in menopausal woman\nVenlafaxine 75 mg daily\nImipramine 10\u201320 mg BD Surgical management:\nKelly's repair - vaginal approac\nMarshall\u2013Marchetti\u2013Krantz operation - abdominal approach. It not done anymore as it causes osteitis of the pubis.\nBurch colposuspension\nCombined vaginal and abdominal suspension - Pereyra operation\nSlings\nTension-free vaginal taping\nTransobturator taping\nLaparoscopic suspension of the bladder neck\nPeriurethral collagen injection\nVaginal sling operations have the highest long term cure rate in cases of GSI (genuine stress incontinence). Their long term cure rate is more than 90%.\nSolution to Question 20:\nLatzko procedure is not beneficial for a patient with genuine stress incontinence as it is done for vesicovaginal fistula.\nThe various surgeries done for genuine stress incontinence (GSI) are as follows:\nVaginal approac\nKelly repair\nPacey repair\nMarshall-Marchetti-Krantz operation - abdominal approach. It is not done anymore as it causes osteitis of the pubis.\nBurch colposuspension\nCombined vaginal and abdominal suspension - Pereyra operation\nSlings\nTension-free vaginal taping\nTransobturator taping\nLaparoscopic suspension of the bladder neck\nPeriurethral collagen injection\nSolution to Question 21:\nThe given case scenario is suggestive of urge incontinence. It occurs due to detrusor instability.\nDuring normal micturition, the detrusor muscle contracts after being stimulated by the parasympathetic nerves. In detrusor instability, detrusor muscle contracts spontaneously or on provocation during filling of the bladder. It is often caused by overactivity of parasympathetic nerves. It is usually seen in older women and is caused by:\nDecreased bladder capacity - due to fibrosis\nDecreased sensation\nCentral nervous system (CNS) inhibition - due to stroke, multiple sclerosis, spinal cord involvement etc.\nIt is associated with the following symptoms:\nIncontinence\nUrge to urinate\nIncreased frequency\nNocturia\nUrination during sexual intercourse and with the sound of water, hand-washing.\nSolution to Question 22:\nIn patient 3, detrusor instability is not seen, as this is a case of functional incontinence.\nDuring normal micturition, the detrusor muscle contracts after being stimulated by the parasympathetic nerves. In detrusor instability, detrusor muscle contracts spontaneously or on provocation during filling of the bladder. It is often caused by the overactivity of parasympathetic nerves. It is seen usually in older women and is caused by:\nDecreased bladder capacity - due to fibrosis\nDecreased sensation\nCentral nervous system (CNS) inhibition - due to stroke, multiple sclerosis, spinal cord involvement etc.\nIt is associated with the following symptoms:\nIncontinence\nUrge to urinate\nIncreased frequency\nNocturia\nUrination during sexual intercourse and with the sound of water, hand-washing.\nTreatment is initially conservative and include decreasing caffeine intake, smoking cessation, fluid restriction and weight reduction. Anticholinergic drugs and bladder training may also be tried.\nNote: Functional incontinence occurs in patients with disabilities, whose bladder movements are normal. However, due to environmental or physical barriers, involuntary leakage of urine occurs.\nSolution to Question 23:\nThe given case scenario is suggestive of uterine rupture. The most common cause is scar dehiscence due to a previous cesarean section. This can occur due to trial of labour after C-section, or due to spontaneous labor in a patient with previous C-section. Other causes of uterine rupture are:\nProlonged induction or augmentation of labor\nObstructed labor\nBlunt abdominal trauma during pregnancy\nRupture of hematometra\nRupture of pyometra\nUterine rupture is managed as follows:\nImmediate cesarean section\nDepending upon the extent of rupture:\nSubtotal hysterectomy\nHysterectomy\nProlapse\nQuestion 1:\nWhich of the following is an uncommon etiology for prolapse?\nMenopause\nAtonicity of uterus\nObesity\nCongenita\nQuestion 2:\nWhat is the most important support of the pelvic viscera?\nLevator ani muscle\nAnogenital diaphragm\nUterosacral ligaments\nCardinal ligaments\nQuestion 3:\nA woman presented to you with the following finding. Which of the following is not a risk factor for this condition?\n\nVaginal delivery\nPremature bearing down\nEpisiotomy\nChronic bronchitis\nQuestion 4:\nA 64-year-old woman presents to the gynecology clinic with complaints of a mass descending PV. On examination, you note that the external os lies at the level of the introitus. What is the degree of uterine prolapse?\nFirst degree\nSecond degree\nThird degree\nProcidentia\nQuestion 5:\nWhich of the following is correctly matched between classification systems of prolapse and their reference point?\nBaden-Walker halfway system - Hymen\nPOP-Q system - Introitus\nPOP-Q system - Internal os\nShaws - Hymen\nQuestion 6:\nWhich of the following is seen in congenital elongation of the cervix?\nThe vaginal portion of the cervix gets elongated\nThe supravaginal portion of the cervix gets elongated\nBoth the vaginal and supravaginal portions of the cervix get elongated\nThere is no true elongation and it is a misnomer\nQuestion 7:\nWhich of the following differential diagnosis will you not consider in a case of prolapse?\nCervical fibroid\nUrethral diverticula\nChronic uterine inversion\nRetroverted uterus\nQuestion 8:\nA 57-year-old woman presents to you with complaints of mass descending per vaginum for the past 6 months. On examination, grade 3 uterovaginal prolapse and a decubitus ulcer are observed. What causes this ulcer?\nThrombosis\nVenous congestion\nInfection\nTrauma\nQuestion 9:\nA post-menopausal woman presents with a mass protruding from the vagina that increases in size on coughing and sneezing. Which of the following is not a complication of this condition?\nIncarceration\nHydronephrosis\nSquamous cell carcinoma\nUrge incontinence\nQuestion 10:\nA multiparous woman notices a bulge at the vulva that diminishes in size on lying down. She also finds it difficult to initiate micturition. What is the likely diagnosis?\nUterine prolapse\nVesicovaginal fistula\nCystocoele\nNeurogenic bladder\nQuestion 11:\nWhich of the following is correct about the POP-Q staging system?\nStage 4 involves complete eversion of the vagina.\nIn stage 3, the leading point is 1 cm above hymen.\nFive reference points are present in the vagina.\nThe points above the hymen are described as plus.\nQuestion 12:\nA 35-year-old woman presents with pelvic pain, and a mass descending PV with increases in size on coughing. She is posted for a Fothergill repair. Which of the following is false about this procedure?\nIt is also known as Manchester operation\nIt does not preserve the reproductive functions\nRecurrent abortions are a sequelae of this operation\nAmputation of cervix is done\nQuestion 13:\nA 55-year-old lady presents with third degree uterine prolapse. Which of the following is the best management for her?\nFothergill repair\nSling operation\nVaginal hysterectomy with pelvic floor repair\nShirodkar procedure\nQuestion 14:\nA 75-year-old woman diagnosed with procidentia is posted for operative repair. During a pre-anesthetic check-up, she was determined to be medically unfit for major surgery. Which of the following procedures is recommended in her?\nFothergill repair\nShirodkar's procedure\nLe Fort\u2019s repair\nManchester operation\nQuestion 15:\nA 25-year-old nulliparous woman presents to you with primary infertility. On examination, stage 2 uterine prolapse is present. What is the next step in management?\nRing pessary\nFothergill\u2019s operation\nSling operation\nColpocleisis\nQuestion 16:\nA 67-year-old woman diagnosed with uterine prolapse, now presented with dyspareunia and fecal incontinence. After manually reducing the prolapse, a peristaltic bulge is seen in the posterior vaginal wall. What is the preferred method of management in this case?\nMoschcowitz repair\nPurandare's operation\nMcCall culdoplasty\nLe Fort's repair\nQuestion 17:\nHow many degrees of vault prolapse are there?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_19.jpeg",
      "OBGYN_img_240.jpeg",
      "OBGYN_img_19.jpeg",
      "OBGYN_img_241.jpeg",
      "OBGYN_img_19.jpeg",
      "OBGYN_img_241.jpeg",
      "OBGYN_img_15.jpeg",
      "OBGYN_img_20.jpeg",
      "OBGYN_img_242.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_2",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_3",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_4",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch101_5",
    "question_text": "\nQuestion 18:\nA 55-year-old woman presented with a mass bulging into the vagina, difficult intercourse, and back pain. She has a history of hysterectomy 2 years back. On examination, you observe that the vaginal vault is protruding outside the introitus. What is the best management in this case?\nSacrospinous colpopexy\nColpocleisis\nKelly's repair\nBurch colposuspension\nQuestion 19:\nA young woman with uterine prolapse following pelvic trauma underwent a hysterectomy. A year later, she presents with vault prolapse. What would you not recommend for her?\nTransabdominal sacropexy\nTransvaginal sacrocolpopexy\nPosterior intravaginal slingplasty\nRing pessary\nQuestion 20:\nThe given instrument was used to treat a patient with uterine prolapse. Which of the following statements is false about this instrument?\n\nIt should be changed every 3 months.\nIt can be used in pregnant patients.\nIt is curative.\nIt may rarely cause carcinoma of vagina.\nQuestion 21:\nWhich of the following is the first step after fitting the pessary to check if the pessary is adequately retained?\nAsking the patient to void and see if the pessary is in place\nSeeing if the patient feels any discomfort, which means that the pessary is retained\nAsking the patient to perform the Valsalva manouvre and see if the pessary is in place\nBeing able to admit two fingers between the ring and the pessary.\nQuestion 22:\nThe deepest part of perineal body injury, which causes cystocoele, enterocoele and urethral descent is\nPubococcygeous\nBulbospongiosus\nIschiocavernous\nSuperficial transverse perinea\nQuestion 23:\nAll of the following are correctly matched regarding the management of prolapse except\nNulliparous - Abdominal sling operations\nVaginal pessary is contraindicated in pregnancy\nPostnatal - Ring pessary and pelvic floor exercises for 3\u20136 months\nWoman beyond 40 years and multipara - Vaginal hysterectomy and pelvic floor repair\nQuestion 24:\nAll of the following surgeries are done in vault prolapse except\nUterosacral suspension\nColposuspension\nSacral colpopexy\nSacrospinous ligament fixation\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_20.jpeg",
      "OBGYN_img_243.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_1",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_2",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_3",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_4",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_5",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_6",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_7",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_8",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_9",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_10",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_11",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_12",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_13",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_14",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_15",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_16",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_17",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_18",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_19",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_20",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_21",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_22",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_23",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch102_24",
    "question_text": "\nb\nSolution to Question 1:\nCongenital prolapse is an uncommon cause of prolapse.\nThe most important etiological factors that lead to prolapse are the atonicity of the uterus and asthenia, which occurs due to aging and follows menopause.\nThe other factors which lead to prolapse are as follows:\nPregnancy\nVaginal childbirth\nMenopause\nAging\nHypoestrogenism\nPeripheral nerve injury to the pudendal nerve\nPremature bearing down before full dilatation of the cervix\nChronically increased intra-abdominal pressure\nChronic bronchitis\nConstipation\nObesity\nSpina bifida occulta\nCongenital weakness of pelvic floor muscles\nAbdominoperineal excision of rectum\nSurgeries such as Stamey and Pereyra operation for stress incontinence\nSolution to Question 2:\nThe most important support of the pelvic viscera is the levator ani muscle. The levator ani forms a large portion of the pelvic floor. It is composed of three separate paired muscles:\nPubococcygeus\nPuborectalis\nIliococcygeus\nSupports of the genital organs are given by DeLancey's levels of support. However, the broad ligament is a fold of the peritoneum, which doesn't provide support to pelvic organs.\nSolution to Question 3:\nThe given image shows uterine prolapse, for which an episiotomy is not a risk factor. Episiotomy shortens the second stage of labor and prevents the atonicity of the uterus, thus reducing the risk of prolapse.\nThe risk factors for uterine prolapse are:\nPregnancy\nVaginal delivery\nMenopause\nAging\nHypoestrogenism\nPeripheral nerve injury to the pudendal nerve\nPremature bearing down before full dilatation of the cervix\nChronically increased intra-abdominal pressure\nChronic bronchitis\nConstipation\nObesity\nSpina bifida occulta\nCongenital weakness of pelvic floor muscles\nAbdominoperineal excision of rectum\nSurgeries such as Stamey and Pereyra operation for stress incontinence\nSolution to Question 4:\nThe given case scenario is suggestive of 2nd degree prolapse.\n\nSolution to Question 5:\nIn Baden-Walker halfway system of classification of prolapse, the reference point is the hymen.\nProlapse classification syste m\nReference poi nt\nShaws\nIntroitus\nBaden Walker halfway\nHymen\nPOP-Q\nHymen\nSolution to Question 6:\nIn congenital elongation of the cervix, the vaginal portion of the cervix is elongated. The fornices are hence deep, and there is no accompanying vaginal prolapse.\nIn 2nd and 3rd degree uterine prolapse, the supravaginal portion of the cervix gets stretched and elongated as it is well supported by the Mackenrodt\u2019s ligaments, while the vaginal portion of the cervix prolapses with the vagina. In prolapse, the cervix can elongate to as much as 10cm in length.\nHowever, in procidentia, the entire uterus slides with the vagina, and hence the cervix retains its normal length.\nSolution to Question 7:\nThe given case scenario is suggestive of uterine prolapse. A retroverted uterus is not a differential diagnosis for uterine prolapse.\nHowever, retroversion of the uterus does occur with uterine prolapse. Differential diagnoses of genital prolapse include:\nCongenital elongation of the cervix - vaginal part of the cervix is elongated. In genital prolapse, supravaginal part is elongated and vaginal part is prolapsed.\nVulval cyst and Gartner cyst - large cysts may mimic prolapse\nCyst of the anterior vaginal wall - tense with well-defined margins and cannot be reduced on pressure.\nUrethral diverticula - rare, small, and situated low in the anterior vaginal wall. Urethroscopy helps in the diagnosis.\nCervical fibroid polyp - cervix remains high up in its anatomical position.\nChronic inversion of the uterus - Uterine sound is used to confirm the diagnosis. USG and aparoscopy will show fundal depression and the absence of uterine fundus in the pelvis.\nRectal prolapse\nSolution to Question 8:\nDecubitus ulcer seen in uterine prolapse is due to venous congestion and local circulatory changes.\nDecubitus ulcer refers to the ulceration of prolapsed tissue which occurs due to the chronic dependent position causing venous congestion and stasis. It has a clean edge and usually heals well with prolapse reduction and daily packing with glycerine (hygroscopic agent) and acriflavine (antiseptic). It is a benign and non-infectious disease and does not require further investigation such as biopsy or culture.\nSolution to Question 9:\nThe given case scenario is suggestive of pelvic organ prolapse. Urge incontinence is not a complication of this condition.\nComplications of prolapse are:\nDamage to the ureter - can occur during\nSurgical repair\nKinking due to procidentia\nUrinary tract infection - due to retention of urine in a cystocele\nHydronephrosis and hydroureter\nIncarceration of the prolapse - the prolapsed organ becomes irreducible\nDecubitus ulcer\nStress incontinence\nSquamous cell carcinoma over the decubitus ulcer (rare)\nSolution to Question 10:\nThe given case scenario is suggestive of a cystocoele.\nA cystocele is the herniation of the urinary bladder into the vagina. It is usually associated with uterine prolapse, and presents with the following features:\nMass descending in the vagina -\nIncreases in size on straining and coughing\nReduces on lying down, or manual reduction\nDifficulty in micturition - difficulty initiating, straining required\nMass needs to be pushed inwards to urinate - repositioning of cystocele required\nIncreased frequency of micturition\nBackache - due to stretching of uterosacral ligaments\nSolution to Question 11:\nThe Pelvic Organ Prolapse Quantification (POP-Q) system was described by the International Continence Society and has the following features:\nThe hymen is taken as a fixed point.\nSix reference points are measured, using a scaled spatula:\nTwo on the anterior vaginal wa\nTwo on the apical vagina\nTwo on the posterior vaginal wa\nThree measurements: The genital hiatus, perineal body, and total vaginal length.\nThe points above the hymen are described as minus and points below as plus. Staging of pelvic organ prolapse according to the POP-Q system:\nStag e\nDescription\nStag e 0\nNo descent of pelvic organs\nStag e 1\nThe leading edge of the prola pse is>1 cm abovethe level of thehymen.\nStag e 2\nThe leading edge of the prola pse is<1 cmproximal or distal to the hymen.\nStag e 3\nThe leading point of prolapse is>1 cm belowthehymenbut protrudes no further than 2 c m less than the total length o f the vagina.\nStag e 4\nCompleteeversionof the vagin a\n\nSolution to Question 12:\nFothergill's operation preserves menstrual and reproductive functions.\nFothergill's repair is also known as Manchester's operation. It is suitable for women under 40 years who are desirous of retaining their menstrual and reproductive functions. The steps are:\nPreliminary D and C\nAnterior colporrhaphy with amputation of the cervix.\nRaw area covered with the vaginal mucosa.\nMackenrodt ligaments sutured in the front of the cervix\nColpoperineorrhaphy\nSince the uterus is preserved in this procedure, the patient is able to menstruate and can conceive and carry the pregnancy. However, fertility decreases due to the loss of cervical mucus. Moreover, cervical incompetence occurs, leading to recurrent abortions and preterm deliveries.\n\nShirodkar's modification of Fothergill's repair avoids cervical amputation, hence subsequent pregnancy complications are avoided.\n\nSolution to Question 13:\nIn the clinal scenario of a 55-year-old woman with third-degree uterine prolapse, the ideal management is vaginal hysterectomy with pelvic floor repair.\nUterine prolapse is the descent of the uterus from its normal position which usually occurs due to laxity of ligaments that offer support, seen often due to childbirth, aging, or trauma. The uterine descent is clinically categorized into:\nFirst degree: the external os remains above the vaginal introitus\nSecond degree: The external os protrudes below the vaginal introitus but the uterine body remains inside the vagina\nThird degree (Syn: Complete prolapse): The uterine, cervix, body, and fundus descend to lie outside the introitus\nProcidentia involves prolapse of the uterus with the entire vagina everted.\nThe patient usually presents with a sense of heaviness in the pelvic region with lower back discomfort. Based on the structures involved the patient can additionally have urinary symptoms (like incontinence and urgency), bowel disturbances (constipation and tenesmus), or sexual discomfort during intercourse.\nSymptomatic uterine prolapse is managed surgically with different procedures based on the profile of the patient. Conservative management is done for old asymptomatic women with mild degree prolapse.\nA vaginal hysterectomy is recommended for patients who satisfy the following criteria:\n&gt;40 years of age\nHave completed their families\nDo not wish to preserve menstrual and child-bearing function Other options:\nOption A: Fothergill repair or Manchester operation is a procedure done to preserve the reproductive function and vaginal prolapse with supravaginal cervix elongation. It initially involves preliminary curettage with low amputation of the cervix. After Mackenrodt's ligament is plicated, anterior colporrhaphy and colpoperineorrhaphy are performed.\nOption B: Sling operation (Purandare's operation) is indicated in congenital or nulliparous prolapse without cystocele. The procedure involves the extraperitoneal passage of rectus sheath strips joined to the anterior surface of the cervix by silk sutures.\nOption D: Shirodkar procedure is a type of abdominal sling surgery done in young women to retain menstrual and reproductive function. It involves using a sling to fix the cervix to the lumbosacral fascia.\nSolution to Question 14:\nLe Fort\u2019s repair is recommended in this case. This repair is done in patients who satisfy the following criteria:\nElderly (&gt;60 years)\nDo not wish to retain sexual function\nMedically unfit for major surgeries\nSolution to Question 15:\nSling operations are recommended in cases of nulliparous prolapse, who wish to retain menstrual and child-bearing function\nMackenrodt\u2019s and uterosacral ligaments of the uterus are strengthened, by using nylon or Dacron tapes as slings. Abdominal sling operations include:\nAbdominal wall cervicopexy - cervical supports are fixed to the abdominal wa\nShirodkar\u2019s sling operation - cervix is fixed to the lumbosacral fascia using Mersilene tape\nKhanna\u2019s abdominal sling operation - isthmus of the cervix is fixed to the anterior superior iliac spines. It is not done anymore due to the risk of periosteitis.\nVirkud's sling operation - the tape is fixed from the isthmus and attached to the rectus compartment\nJoshi's sling operation - the uterus is suspended from the pectineal ligaments.\nSolution to Question 16:\nThe given case scenario is suggestive of an enterocele associated with fecal incontinence. It is preferably repaired using an abdominal approach like Moschcowitz repair.\nAn enterocele is herniation of the pouch of Douglas and small bowel loops into the rectovaginal septum. Enteroceles are most commonly associated with uterine prolapse. Patients present with the following clinical features:\nFecal incontinence\nSexual dysfunction\nConstipation/diarrhea\nMass descending PV\nPelvic pain or pelvic discomfort\nA bulge in the posterior vaginal wall:\nUpper 1/3rd - enterocele\nLower 2/3rd - rectocele\nPeristalsis may be observed in the bulge Enterocele repair is done via the following methods:\nVaginal approach - it is usually preferred over an abdominal approach. In McCall's culdoplasty, the uterosacral ligaments are used to suspend the vaginal vault. The posterior peritoneum and uterosacral ligaments are approximated.\nAbdominal approach - it is preferred in cases where there is associated fecal incontinence. It includes:\nMoschcowitz repair - the pouch of Douglas is obliterated by several purse-string sutures.\nHalban's procedure - the peritoneal sac is obliterated using vertical sutures. This can also be done transvaginally.\nOption B: Purandare's sling operation is abdominal wall cervicopexy for uterine prolapse. It is done for young nulliparous women.\nOption D: Le Fort's repair is done in elderly patients with uterine prolapse, who are unfit for surgery.\nNote: Enteroceles may be present along with uterine prolapse. Failure to identify and repair it during vaginal hysterectomy can lead to vault prolapse.\nSolution to Question 17:\nThere are 3 degrees of vault prolapse.\nVault prolapse is a delayed complication of both abdominal and vaginal hysterectomy. It can also occur due to failure to identify and repair an enterocele during a hysterectomy.\nIn vault prolapse, level 1 supports become weak and deficient. Risk factors apart from past history of surgery are:\nAdvanced age\nMenopause - due to estrogen deficiency\nParity\nObesity\nChronic cough\nSolution to Question 18:\nThe given case scenario is suggestive of vault prolapse. Sacrospinous colpopexy is the gold standard management for vault prolapse.\nVault prolapse presents with pelvic or back pain, the descent of the vault through the vagina, difficulties in intercourse, and difficulty in walking due to the mass. It is commonly associated with a cystocele or a rectocele.\nIt can be prevented by identifying and repairing an enterocele and by attaching the uterosacral and cardinal ligaments to the vault during a hysterectomy.\nVault prolapse is managed as follows:\nIf the patient is fit for abdominal surgery: Transabdominal sacral colpopexy, i.e., uterosacra suspension\nIf the patient is not fit for abdominal surgery: Transvaginal sacrospinous ligament fixation/colpopexy - the gold standard\nLaparoscopic colpopexy\nIf the patient does not want to retain sexual function:\nColpocleisis\nLe Fort's repair\nAnterior colporrhaphy in case of cystocele\nPosterior colporrhaphy in case of rectocele\nIf the patient is unfit for surgery, ring pessaries can be tried\nPosterior intravaginal slingplasty\nNote: Kelly's repair and Burch colposuspension are done to manage stress incontinence.\nSolution to Question 19:\nIn a young patient with vault prolapse, ring pessary is not recommended. Vault prolapse is managed as follows:\nIf the patient is fit for abdominal surgery: Transabdominal sacral colpopexy, i.e., uterosacra suspension - The best method for vault prolapse.\nIf the patient is not fit for abdominal surgery: Transvaginal sacrospinous ligament fixation.\nLaparoscopic colpopexy\nIf the patient does not want to retain sexual function:\nColpocleisis\nLe Fort's repair\nAnterior colporrhaphy in case of cystocele\nPosterior colporrhaphy in case of rectocele\nIf the patient is unfit for surgery, ring pessaries can be tried\nPosterior intravaginal slingplasty\nSolution to Question 20:\nThe given image shows a ring pessary, which is only a palliative treatment for genital prolapse.\nA ring pessary is used for patients who cannot be surgically managed, such as pregnant patients and very elderly women. In these patients, it is used as an adjunct to pelvic floor physiotherapy.\nPessaries provide mechanical support to the pelvic organs. After being placed, they should be changed every 3 months. They may cause vaginitis; dyspareunia; and, rarely, carcinoma if retained for a long time.\nThe image below shows the types of pessaries:\n\n\nSolution to Question 21:\nThe first step after fitting the pessary to check if the pessary is adequately retained is to ask the patient to perform Valsalva's maneuver or cough and see if the pessary is in place.\nThere is some level of descent of the pessary with these maneuvers is to be expected, but the pessary should return to its normal position when these efforts are stopped. If the pessary descends to the introitus with these maneuvers, then a larger size pessary should be tried.\nThe pessary is well-fitted if you are able to slide the ring of the pessary up and down along the vaginal sidewall. It is well-fitted if you are able to insert one finger between the vaginal sidewall and the edge of the pessary. When the labia are separated, a well-supported pessary is not usually visible.\nThe patient should be comfortable, and able to void urine with the pessary in place before leaving the clinic.\n\nSolution to Question 22:\nPubococcygeus is the deepest part of the levator ani muscle. Injury to it can cause enterocele, cystocele, and urethral descent.\nLevator ani muscles are the most important muscles in the pelvic floor and maintain a constant state of contraction. They provide a stable floor and support the weight of the abdominopelvic contents against intra-abdominal forces. Weakening of levator ani and pelvic fascia from stretching or tearing during childbirth, may decrease support for the vagina, bladder, uterus, or rectum or alter the position of the neck of the bladder and urethra.\nThe levator ani muscle is a complex unit, which consists of 3 muscle components namely\nPubococcygeus (anterior fibers)\nPubovaginalis - elevates the urethra and hence contributes to urinary continence\nPuboperinealis - draws the perineal body towards the pubic symphysis\nPuboanalis - elevates the anus and keeps the urogenital hiatus narrowed\nPuborectalis (intermediate fibers)\nIliococcygeus (posterior fibers)\nOrigin: The levator ani muscle has a linear origin from the pelvic surface of the body of the pubis, a tendinous arch of obturator fascia, and the pelvic surface of the ischial spine.\nInsertion:\nThe anterior fibres form a sling around the prostate (levator prostatae) or vagina (sphincter vaginae) and are inserted into the perineal body (a mass of fibrous tissue) in front of the ana canal.\nThe intermediate fibres (puborectalis) form a sling around the anorectal junction to be inserted into the anococcygeal raphe (a fibrous raphe which extends from the anorectal junction to the tip of the coccyx).\nThe posterior fibres (iliococcygeus) are inserted into the anococcygeal raphe and the coccyx. Nerve supply:\nperineal branch of 4th sacral nerve (S4) from its pelvic surface.\nperineal branch of the pudendal nerve (S2, S3) from its perineal surface. Actions:\nThe levator ani muscles of two sides together support the pelvic viscera and resist the\nintra-abdominal pressure during straining and expulsive efforts of the anterior abdominal wa muscles.\nThey also subserve a sphincteric action on the anorectal junction to maintain the continence of faeces in both sexes and vagina in females.\n\nThe given image below shows the pelvic floor:\n\nSolution to Question 23:\nThe vaginal pessary is not contraindicated in pregnancy.\nDuring pregnancy, depending on the severity and patient preference, prolapse is managed conservatively as follows:\nIntravaginal pessaries - simple, effective, potentially effective in preventing preterm birth\nPelvic floor exercises\nPelvic physiotherapy\nElectrical therapy\nSolution to Question 24:\nColposuspension is done in stress urinary incontinence and not for vault prolapse. Management of Vault prolapse:\nIf the patient is fit for abdominal surgery: Transabdominal sacral colpopexy, i.e., uterosacra suspension\nThe best method for vault prolapse.\nIf the patient is not fit for abdominal surgery: Transvaginal sacrospinous ligament fixation.\nFibroid\nQuestion 1:\nWhich of the following statements is false about fibroids?\nMore common in Asians than African-Americans\nSmoking is a protective factor\nMore common in nulliparous women\nDoes not usually increase in size during pregnancy\nQuestion 2:\nWhich of the following genes is not associated with leiomyomas?\nMED12\nHMGA2\nCOL4A5-A6\nMLH1\nQuestion 3:\nLeiomyomas create a hyperestrogenic state by all of these mechanisms except:\nCells contain a greater density of estrogen receptors\nMetabolise androgens to estrogen\nHave higher levels of cytochrome P450 aromatase\nMaximally convert estradiol to estrone\nQuestion 4:\nInitially, all fibroids are \t.\nIntramura\nSubmucosa\nSubserous\nCervica\nQuestion 5:\nA 55-year-old lady comes with abnormal uterine bleeding. A hysterectomy was performed and the following specimen was retrieved. What is the diagnosis?\n\nLeiomyoma\nEndometrial carcinoma\nEndometrial polyp\nAdenomyosis\nQuestion 6:\nWhich of the following symptoms would you not expect in a patient diagnosed with uterine fibroids?",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_20.jpeg",
      "OBGYN_img_244.jpeg",
      "OBGYN_img_20.jpeg",
      "OBGYN_img_245.jpeg",
      "OBGYN_img_20.jpeg",
      "OBGYN_img_246.jpeg",
      "OBGYN_img_20.jpeg",
      "OBGYN_img_247.jpeg",
      "OBGYN_img_20.jpeg",
      "OBGYN_img_248.jpeg",
      "OBGYN_img_20.jpeg",
      "OBGYN_img_249.jpeg",
      "OBGYN_img_20.jpeg",
      "OBGYN_img_249.jpeg",
      "OBGYN_img_20.jpeg",
      "OBGYN_img_250.jpeg",
      "OBGYN_img_20.jpeg",
      "OBGYN_img_251.jpeg",
      "OBGYN_img_21.jpeg",
      "OBGYN_img_252.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch103_1",
    "question_text": "and 2",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch103_2",
    "question_text": "and 3",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch103_2",
    "question_text": ", 4 and 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch104_1",
    "question_text": ", 3 and 5\nQuestion 7:\nA patient presented with intermenstrual bleeding for the past 6 months. Which of the following types of fibroid is usually associated with this symptom?\nInterstitia\nSubserosa\nSubmucous\nCervica\nQuestion 8:\nA 46-year-old woman presented with heavy menstrual bleeding and dysmenorrhea. You suspect a diagnosis of submucous uterine fibroids. Which of the following investigations will help you confirm this?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch104_2",
    "question_text": "and 3",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch105_1",
    "question_text": ", 2 and 3",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch105_4",
    "question_text": "and 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_1",
    "question_text": ", 2 and 4\nQuestion 9:\nAn adnexal mass seen on ultrasound in a 38-year-old woman was diagnosed to be a secondary broad ligament fibroid. Which of the following is true about the same?\nIt arises from the broad ligament\nThe uterine vessels always lie medial to it\nThe ureter always lies lateral to it\nIt is also known as true broad ligament fibroid\nQuestion 10:\nWhich of the following is incorrect about fibroids?\nCalcification begins at the centre\nHyaline degeneration begins at the centre\nCentre is least vascular\nPseudocapsule is present\nQuestion 11:\nA patient with a history of miscarriage underwent a myomectomy. The specimen is shown below. Where does the degenerative change shown here begin from?\n\nCentre\nPeriphery\nSubcapsular area\nExtracapsular area\nQuestion 12:\nA 44-year-old woman presenting with acute abdominal pain had previously been diagnosed with uterine fibroids. Which of the following complications is most unlikely to have occurred here?\nHemorrhage into the fibroid\nHyaline degeneration\nRed degeneration\nSarcomatous change\nQuestion 13:\nA primigravida presented with severe abdominal pain and fever at 28 weeks of gestation. Ultrasound reveals a healthy fetus in utero and a large submucosal fibroid with multiple,\nhyperechoic areas within. Blood investigations reveal leukocytosis and a raised ESR. What is the diagnosis?\nRed degeneration of fibroid\nTorsion of fibroid\nInfection of fibroid\nSarcomatous change\nQuestion 14:\nA 34-year old woman with a history of fibroids presented with 1.5 months of amenorrhea. UPT is positive. Which of the following complications will you not expect in this patient?\nUterine inversion\nRed degeneration\nPostpartum hemorrhage\nFetal malformations\nQuestion 15:\nWhich of the following changes are not seen in fibroids?\nNecrosis\nSquamous metaplasia\nAtrophy\nSarcomatous changes\nQuestion 16:\nCT pelvis of a woman with fibroids is shown below. Which type of degeneration is seen here?\n\nHyaline degeneration\nCystic degeneration\nCalcific degeneration\nHemorrhagic degeneration\nQuestion 17:\nWhat is the least common secondary change seen in fibroids?\nHemorrhage into fibroid\nSarcomatous change\nAtrophy\nNecrosis\nQuestion 18:\nA 46-year-old woman presents with a lower abdominal mass for the past 2 years. She had undergone uterine artery embolisation for fibroids 5 years ago. Ultrasound showed a homogeneous mass near the uterine fundus. On exploratory laparotomy, the mass was observed to be attached to the greater omentum and it was excised. Histopathology of the mass is shown below. What is your diagnosis?\n\nPedunculated fibroid\nParasitic fibroid\nLeiomyosarcoma\nDisseminated intraperitoneal leiomyomatosis\nQuestion 19:\nA pregnant woman with a fibroid uterus develops severe acute pain abdomen at 28 weeks of gestation. There is no history of fever and the WBC count is 8000 cells/mL. The most likely diagnosis is:\nRed degeneration of fibroid\nPreterm labour\nTorsion of fibroid\nNone of the above\nQuestion 20:\nA primigravida at 24 weeks presents to you for a routine antenatal checkup. On ultrasound, you incidentally note the presence of two 3x3cm submucosal fibroids. How will you manage this case?\nEmergency laparoscopy\nMyomectomy\nCesarean section at 37 weeks\nConservative management\nQuestion 21:\nA 40-year-old woman presented with menorrhagia and increased frequency of micturition. Ultrasound abdomen shows the following picture. Which of the following drugs is not used in the management of her condition?\n\nMifepristone\nGoserelin\nCetrorelix\nMisoprosto\nQuestion 22:\nA patient diagnosed with leiomyoma was prescribed an intranasal spray to manage her disease. Which of the following drugs is it unlikely to contain?\nLeuprolide\nHistrelin\nNafarelin\nBuserelin\nQuestion 23:\nA pregnant woman was diagnosed with red degeneration of fibroid at 26 weeks of gestation. What is the next step in her management?\nLaparotomy\nTermination of pregnancy\nFibroid removal during Caesarean section\nAnalgesics\nQuestion 24:\nA 32-year-old woman presented with anemia due to heavy menstrual bleeding in spite of medical management of fibroids. She was posted for a myomectomy as she wanted to have children in the future. Which of the following is not an indication for this procedure?\nRecurrent pregnancy loss\nAssociated infertility\nRed degeneration\nPressure symptoms\nQuestion 25:\nWhich of the following modalities is not used for the treatment of leiomyomas?\nUterine artery embolisation\nMagnetic resonance guided focused ultrasound\nUltrasound guided transcervical metroplasty\nNd:YAG laser myolysis\nQuestion 26:\nThe following procedure was planned for a patient with uterine fibroids. Which of the following statements is false about this procedure?\n\nCan be done in nulliparous women\nOvarian failure is one of the complications\nPVA particles are used\nDone under radiological guidance\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_21.jpeg",
      "OBGYN_img_253.jpeg",
      "OBGYN_img_21.jpeg",
      "OBGYN_img_254.jpeg",
      "OBGYN_img_21.jpeg",
      "OBGYN_img_255.jpeg",
      "OBGYN_img_21.jpeg",
      "OBGYN_img_256.png",
      "OBGYN_img_21.jpeg",
      "OBGYN_img_257.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_1",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_2",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_3",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_4",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_5",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_6",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_7",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_8",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_9",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_10",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_11",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_12",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_13",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_14",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_15",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_16",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_17",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_18",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_19",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_20",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_21",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_22",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_23",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_24",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_25",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_26",
    "question_text": "\na\nSolution to Question 1:\nFibroids are more common in African-American women.\nUterine fibroids are benign, smooth muscle tumors present in the uterine musculature. They are most commonly seen during reproductive years. Estrogen and progesterone promote the development of fibroids.\nOption B: Hypoestrogenism occurs in smokers, therefore smoking is protective for fibroids.\nOption C: Estrogen exposure is increased in nulliparous women, therefore fibroids are more common. Increased parity is protective for fibroids.\nOption D: Most fibroids do not increase in size during pregnancy. Pregnancy can have an unpredictable effect on fibroids based on individual genetic and environmental factors.\nSolution to Question 2:\nMLH1 gene is not associated with leiomyomas. Its mutation leads to endometrial carcinoma.\nMED12 and HMGA2 are the most common genes associated with leiomyomas. Other genes involved are COL4A5-A6 and the gene for fumarate hydratase (FH). FH gene mutation leads to hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome.\nSolution to Question 3:\nLeiomyomas convert less estradiol to the weaker estrone.\nLeiomyomas create a hyperestrogenic environment, which is a requisite for their growth and maintenance. The hyperestrogenic environment is created by the following mechanisms:\nCompared to normal myometrium, leiomyoma cells contain a greater density of estrogen receptors, which results in greater estradiol binding.\nThese tumors convert less estradiol to the weaker estrone.\nThere are higher levels of cytochrome P450 aromatase in leiomyomas compared with norma myocytes. This specific enzyme catalyzes the conversion of androgens to estrogen.\nSolution to Question 4:\nInitially, all fibroids are intramural. Fibroids develop in the myometrium, as intramural/interstitial and then branch out to form the other types.\nClassification of fibroids based on anatomical location:\nBody (corporeal) fibroids-\nInterstitial/intramural fibroids: They are the most common (75%).\nSubserosal fibroids: They are the least common (10%). Interstitial fibroids grow outwards to form subserous fibroids and are covered by the peritoneum. These include wandering or parasitic fibroids and broad ligament fibroids.\nSubmucous fibroids: Interstitial fibroid grows inwards towards the uterine cavity. It is the most symptomatic type.\nCervical fibroids\n\nSolution to Question 5:\nThe given cut section image showing multiple nodules, well-circumscribed, firm, and white-greyish with a whorled appearance is Leiomyoma (Fibroid).\nLeiomyoma is the most common benign and the most common pelvic tumor in females and is more common in obese females(hyper-estrogenism). They are mostly asymptomatic and the most common symptom is menorrhagia.\nLeiomyomas can also present with bleeding areas, cystic degeneration, and calcifications. The uterine cavity is compressed.\nThe image below different types of uterine fibroids classified according to their locations:\n\nSub-mucous fibroids are the most symptomatic type and intra-mural fibroids are the most common type of uterine fibroids.\nOther options:\nOption B: Endometrial cancer presents as a polypoid mass protruding into the uterine cavity or as a diffuse thickening of the endometrium. The cut surface may appear white to yellow and may show areas of necrosis or hemorrhage.\nOption C: Endometrial polyps are usually small and may be single or multiple. Grossly, they appear as soft, red to pink, often pedunculated (attached by a stalk) masses protruding into the uterine cavity. It presents with heavy cyclic or intermenstrual bleeding, or without complaints as an incidental finding on imaging. Estrogen and progesterone have been implicated in the growth of endometrial polyps, and higher receptor levels are seen compared with the normal endometrium.\nOption D: In Adenomyosis (Endometriosis interna), the uterus may appear bulky and symmetrically enlarged. On the cut section, the myometrium may appear thickened and may show tiny cystic spaces filled with old blood (chocolate cysts). The preferred treatment is hysterectomy. Localised excision or levonorgestrel IUCD is tried in younger women.\nThe image below shows both the gross and histologic appearances of adenomyosis:\n\nSolution to Question 6:\nMenouria and hypomenorrhea are not seen in patients with uterine fibroids. Menouria occurs due to vesicouterine fistulas. Hypomenorrhea is seen in Asherman's syndrome and due to OCP use.\nFibroids present with the following clinical features:\nMenstrual symptoms such as:\nMenstrual irregularities - heavy menstrual bleeding/menorrhagia which is the most common symptom, polymenorrhoea, and intermenstrual bleeding (metrorrhagia)\nDysmenorrhea\nPostmenopausal bleeding\nAbdominal pain\nAbdominal distension, mass abdomen\nVaginal discharge\nInfertility\nRecurrent abortions\nPressure symptoms such as:\nUrinary retention\nIncreased frequency of urination\nConstipation\nBroad ligament fibroids can cause compression of the ureter leading to hydronephrosis or hydroureter.\nSolution to Question 7:\nIntermenstrual bleeding is common with submucous fibroids. Metrorrhagia or intermenstrual bleeding refers to bleeding that occurs during the middle of the menstrual cycle.\nMetrorrhagia in a woman over 40 years warrants a dilatation and curettage procedure to rule out endometrial cancer. This is associated with fibroids in 3% of cases.\nPolymenorrhoea in a patient with fibroids occurs when she has polycystic ovaries or pelvic inflammatory disease (PID).\nProgressive menorrhagia is seen in intramural and submucous myoma due to increased vascularity, endometrial hyperplasia, and an enlarged uterine cavity.\nNote: Further the distance of the fibroid from the cavity, lesser is the possibility of menorrhagia. For this reason, subserous and pedunculated fibroids do not cause menorrhagia.\nSolution to Question 8:\nInvestigations required to identify submucous fibroids include:\nUSG - most commonly done. Transvaginal USG is useful to assess the location, dimension, and associated adnexal pathology.\nMRI gives better soft tissue details but is not routinely done\nSaline infusion sonography and hysteroscopy - help to visualise submucous fibroid more clearly\nLaparoscopy - If uterus &lt;12 weeks size and associated pelvic pain and infertility and to detect pelvic endometriosis and tubal pathology.\nUterine curettage \u2013 A bump is felt in submucous fibroid during endometrial curettage. Dilatation and curettage is done in patients presenting with postmenopausal bleeding.\nHysterosalpingography \u2013 A filling defect is seen.\nCT abdomen is not very useful for the identification of submucous fibroids. These cannot be visualised on colposcopy either.\nThe image below shows the ultrasonographic appearance of a submucous fibroid (asterisk):\n\nThe image given below shows hysteroscopic view of a submucous fibroid:\n\nSolution to Question 9:\nThe ureter and uterine vessels lie lateral to a secondary broad ligament fibroid. There are 2 types of broad ligament fibroids:\nPrimary broad ligament fibroid:\nIt is also known as true broad ligament fibroid.\nThe arise from:\nUterosacral ligament\nRound ligament\nTissues in the broad ligament\nRelations:\nThe uterine vessels lie medial to it.\nThe ureter is usually beneath the fibroid. However, it can be present anywhere in relation to it. Secondary broad ligament fibroid:\nIt is also known as false broad ligament fibroid.\nThey arise from the lateral wall of the uterus or cervix, but grow laterally, between the two layers of the broad ligament.\nRelations - the uterine vessels and ureter lie lateral to it.\nSolution to Question 10:\nFibroid calcification begins at the periphery and spreads inwards along the vessels.\nA typical myoma is a well-circumscribed tumor with a pseudo-capsule and firm in consistency. Its cut surface has a whorled appearance.\nThe vessels that supply blood to the tumor lie in the capsule and send radial branches into the tumor. Therefore, the central portion of the tumour receives the least blood supply, and degeneration is noticeable early in this part of the tumour. However, fibroid calcification begins at the periphery.\nThe image given below show the gross appearance of fibroids.\n\nThe below image shows the histological appearance of fibroids.\n\nSolution to Question 11:\nThe given specimen shows red degeneration of fibroid. Degeneration is most likely to start from the centre of the fibroid.\nIn a fibroid, centre of the tumor is the least vascular part and hence degeneration is more common here. The only exception is calcareous degeneration where phosphates and carbonates of lime are deposited in the periphery along the course of the vessels.\nSolution to Question 12:\nHyaline degeneration of fibroids is unlikely here as it is usually painless and presents as an abdominal mass causing distension and heaviness.\nAcute pain in fibroids is seen in the case of:\nFibroid torsion\nHemorrhage into the fibroid\nRed degeneration\nSarcomatous change - seen in postmenopausal women.\nSolution to Question 13:\nThe given case scenario is suggestive of red degeneration of fibroid.\nIt is most common during the second trimester of pregnancy. The gross appearance is described as follows:\nFishy odor\nThrombosis of subcapsular vessels and vessels within the fibroid\nPurplish-red color due to diffusion of blood pigments from the thrombosed vessels.\nRed degeneration presents with acute abdominal pain, fever and, vomiting. Investigations reveal leukocytosis and a raised ESR. On radiology, the hemorrhagic areas appear hyperechoic within the fibroid.\nThe image given below shows the MRI appearance of red degeneration of fibroids\n\nOption B: Torsion of subserous pedunculated fibroid presents with severe pain abdomen, but fever and leukocytosis are absent.\nOption C: Infection is more common in puerperium and presents with blood-stained vaginal discharge.\nOption D: Sarcomatous changes occur very rarely, and are unlikely in patients &lt;40 years of age. They are more commonly seen in post-menopausal women.\nSolution to Question 14:\nFetal malformations have not been recorded to occur due to fibroids. Pregnancy complications due to fibroids are:\nIncreased risk of abortion or miscarriage\nPreterm labor\nAbnormal presentation\nFibroid degeneration (Red degenaration)\nAccidental hemorrhage\nDystocic labor\nPostpartum hemorrhage\nPuerperal sepsis\nUterine inversion\nSolution to Question 15:\nSquamous metaplasia is not seen in fibroid.\nSolution to Question 16:\nThe given image shows womb-stone appearance on CT, suggestive of calcific degeneration of fibroid.\nThese are also called calcareous myomas and are seen in old patients with long-standing myomas. This occurs due to the deposition calcium phosphates and calcium carbonates in the periphery of the fibroid, along the course of the vessels. It is easily visualized on radiography.\nSolution to Question 17:\nSarcomatous change is the least common secondary change in fibroids. Its incidence is &lt;0.5%.\nSarcomatous change leads to the development of malignant leiomyosarcomas. This is seen in postmenopausal women and is rare in women &lt;40 years of age. Intramural and submucous tumors have a higher potential for sarcomatous change than subserous tumors.\nIts gross appearance is described as follows:\nSoft consistency\nYellowish-grey\nHemorrhagic spots seen\nRadiology shows dark, irregular areas and air levels within the fibroid. These are indicative of sarcomatous change.\nThe image given below shows the CT appearance of a large fibroid that has undergone sarcomatous change. The image on the right shows a fluid level within the tumor.\n\nSolution to Question 18:\nThe given case scenario is suggestive of a parasitic fibroid. The given histopathological image shows interlacing bundles of uniform spindle-shaped smooth muscle cells with blunted nuclei that are characteristic of a fibroid.\nA parasitic fibroid or a wandering fibroid gets cut off from its uterine origin and derives its blood supply from the vessels of the organ it is attached to. Thus, it can continue to grow in spite of uterine artery embolisation. It is managed by complete resection.\nOption A: Pedunculated fibroids have a pedicle with which they're attached to the myometrium.\nOption C: Leiomyosarcoma commonly presents in postmenopausal women with sudden increase in size and postmenopausal bleeding. It would show nuclear atypia on histology.\nOption D: Disseminated intraperitoneal leiomyomatosis involves large areas of sub peritoneal surfaces. It is seen during pregnancy and while on oral contraceptives.\nSolution to Question 19:\nThe given scenario of severe acute abdominal pain without fever/leucocytosis in a pregnant woman with a fibroid is suggestive of fibroid torsion.\nThe incidence of fibroid in pregnancy is about 1 in 1,000. Due to increased vascularity in pregnancy, the fibroid increases in size and becomes softer. The torsion is seen in the subserous pedunculated fibroid where the venous return is blocked at its site of attachment in the uterus. This leads to severe acute abdominal pain. Due to the complication being more local than systemic, fever or leucocytosis are generally not seen.\nA transvaginal ultrasonogram is immediately done to detect the position and size of the fibroid, which is followed by laparotomic myomectomy as a part of emergency surgical management.\nOther options:\nOption A: Red degeneration of fibroid is seen commonly in the second half of pregnancy or puerperium. It is due to a hemorrhagic infarction of the tissue and typically presents as acute focal abdominal pain with fever and leucocytosis. Treatment is usually conservative with bed rest, analgesics, and sedatives.\nOption B: Preterm labor is where the labor starts before 37 completed weeks. It is characterized by true labor pain. The abdominal pain is slowly increasing in intensity and duration and is also accompanied by show (expulsion of the cervical mucus plug). There are intervals between episodes of contractions where the patient doesn't complain of abdominal pain.\nSolution to Question 20:\nThe given case scenario is suggestive of an uncomplicated fibroid during pregnancy. These are managed conservatively.\nSurgery is only indicated in the case of a pedunculated fibroid undergoes torsion.\nSolution to Question 21:\nThe given case scenario and ultrasound image showing a well-defined, heterogeneous hypoechoic mass are suggestive of a uterine fibroid. Misoprostol does not help to reduce the size of the fibroid and so is not recommended for its management.\nMedical management of fibroids helps to reduce their size. The drugs used in therapy are as follows:\nAntiprogesterone \u2013 Mifepristone / RU-486\nGnRH analogs\nAgonists \u2013 goserelin, leuprorelin, nafarelin, buserelin\nAntagonists \u2013 cetrorelix, ganirelix\nLevonorgestrel releasing intrauterine system\nSelective progesterone receptor modulator (SPRM) \u2013 Asoprisni\nDanazol - usually not used due to androgenic side effects.\nSolution to Question 22:\nThe nasal spray is unlikely to contain histrelin, as it is only available as a subcutaneous implant.\nGnRH analogues are used to treat leiomyomas. Intranasal preparations are available for leuprolide, nafarelin, and buserelin. However, leuprolide has maximal action as an intramuscular injection.\nGnRH analogue therapy in fibroids is given as follows:\nLeuprolide acetate (Lupron) - given intramuscularly. It is also available as an intranasal spray, but isn't commonly used.\nGoserelin (Zoladex) - subcutaneous depot implant\nTriptorelin (Trelstar) IM injection\nNafarelin and buserelin - given as intranasal sprays bd\nHistrelin - available as subcutaneous implants.\nSolution to Question 23:\nRed degeneration of fibroid is managed conservatively with bed rest and analgesics.\nIt is most common during the second trimester of pregnancy. Red degeneration presents with acute abdominal pain, fever and, vomiting. Investigations reveal leukocytosis and a raised ESR. On radiology, the hemorrhagic areas appear hyperechoic within the fibroid.\nSolution to Question 24:\nRed degeneration is not an indication of myomectomy. It is conservatively managed. Myomectomy is indicated in the following:\nSymptoms compromising the quality of life such as:\nHeavy menstrual bleeding, causing anemia\nPelvic pain\nUrinary symptoms and ureteric obstruction.\nThe patient is unwilling for hysterectomy\nThe patient wishes to preserve childbearing function\nFibroids causing infertility\nSolution to Question 25:\nUltrasound-guided transcervical metroplasty is not used in the treatment of leiomyomas. It is used for the resection of the uterine septum.\nUterine artery embolization/Uterine fibroid embolization (UAE/UFE) is an angiographic interventional procedure that delivers polyvinyl alcohol (PVA) microspheres or other synthetic particulate emboli into both uterine arteries thus producing ischemia and necrosis. The vessels serving leiomyomas have a larger caliber, hence these microspheres are preferentially directed to the tumors, thus sparing the surrounding myometrium.\nNd:YAG myolysis is laparoscopic myolysis performed with an Nd:YAG laser. It causes coagulation of a subserous fibroid.\nThe below image shows uterine artery embolization.\n\nMagnetic Resonance guided Focused Ultrasound (MRgFUS) is also called MR-guided high-intensity focused ultrasound (MR-HIFU).\nUltrasound energy is focused to heat and incite coagulative necrosis in selected myomas. Concurrent MR imaging enables precise targeting and provides real-time tissue temperature feedback to limit surrounding thermal injury.\nThe given image shows MRgFUS.\n\nSolution to Question 26:\nThe given image shows uterine artery embolization (UAE). UAE cannot be done in nulliparous women as embolization of ovarian vessels can cause ovarian failure and premature menopause.\nUnder local sedation, bilateral UAE is approached through percutaneous femoral catheterization. Embolization is done by releasing polyvinyl alcohol (PVA), gel foam particles or metal coils into the uterine artery.\nEndometriosis and Adenomyosis\nQuestion 1:\nWhich of the following accurately describes Sampson's theory for endometriosis?\nRetrograde menstruation\nCoelomic metaplasia\nHemogenous metastasis\nInduction of stem cells\nQuestion 2:\nWhich of the following statements is false about endometriosis?\nHormone dependent condition\nMore common in nulliparous women\nIn utero exposure to DES increases risk\nMost common site is the cervix\nQuestion 3:\nWhich of the following is the most common symptom associated with endometriosis?\nDysmenorrhea\nDyspareunia\nMenorrhagia\nInfertility\nQuestion 4:\nIn a patient diagnosed with endometriosis, which of the following symptoms would you not expect?\nVaginal discharge\nPremenstrual spotting\nPostmenstrual spotting\nMenorrhagia\nQuestion 5:\nA 2\u2026-year-old lady presented with complaints of severe pain on menstruation and heavy flow. She is subsequently diagnosed with endometriosis. The pain in this condition mainly correlates with\nDepth of penetration\nMultiple sites\nCA 125 levels\nStage of the disease\nQuestion 6:\nArrange the following sites of endometriosis in the order of frequency of occurrence.",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_21.jpeg",
      "OBGYN_img_258.jpeg",
      "OBGYN_img_21.jpeg",
      "OBGYN_img_259.jpeg",
      "OBGYN_img_21.jpeg",
      "OBGYN_img_22.jpeg",
      "OBGYN_img_260.jpeg",
      "OBGYN_img_261.jpeg",
      "OBGYN_img_262.jpeg",
      "OBGYN_img_22.jpeg",
      "OBGYN_img_263.png",
      "OBGYN_img_22.jpeg",
      "OBGYN_img_264.jpeg",
      "OBGYN_img_22.jpeg",
      "OBGYN_img_265.jpeg",
      "OBGYN_img_21.jpeg",
      "OBGYN_img_255.jpeg",
      "OBGYN_img_22.jpeg",
      "OBGYN_img_266.jpeg",
      "OBGYN_img_22.jpeg",
      "OBGYN_img_267.jpeg",
      "OBGYN_img_22.jpeg",
      "OBGYN_img_268.jpeg",
      "OBGYN_img_22.jpeg",
      "OBGYN_img_269.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_4",
    "question_text": "&gt; 5 &gt; 2 &gt; 1 &gt; 3",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_4",
    "question_text": "&gt; 1 &gt; 3 &gt; 2 &gt; 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_4",
    "question_text": "&gt; 5 &gt; 1 &gt; 3 &gt; 2",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch106_5",
    "question_text": "&gt; 4 &gt; 2 &gt; 3 &gt; 1\nQuestion 7:\nA middle-aged woman presented with dysmenorrhea, dyspareunia, and infertility. On examination, you note tender nodularity of the uterosacral ligaments. Which of the following is the most likely diagnosis?\nEndometrioma\nEndometriosis\nPelvic tuberculosis\nAdenomyosis\nQuestion 8:\nA young woman presented to your clinic with complaints of painful menstruation and postmenstrual spotting. On examination, you note tender nodules in the posterior fornix and a fixed retroverted uterus. Which of the following is the gold standard investigation to confirm the likely diagnosis?\nUltrasound\nLaparotomy\nLaparoscopy\nHysteroscopy\nQuestion 9:\nA diagnostic laparoscopy was performed on a 27-year-old woman with severe dysmenorrhoea and dyspareunia. The following finding was seen on the pelvic peritoneum. What is the most likely diagnosis?\n\nPelvic Inflammatory Disease\nAdenomyosis\nFitz Hugh Curtis syndrome\nEndometriosis\nQuestion 10:\nIn endometriotic lesion, histology represents its:\nHigh cholestero\nHigh estrogen\nHigh levels of prolactin\nHigh progesterone\nQuestion 11:\nWhich of the following operative procedures are least likely to be followed by scar endometriosis?\nHysterotomy\nCesarean section\nVentrofixation\nHysterectomy\nQuestion 12:\nA 39-year-old nulliparous woman presented with dysmenorrhea and a progressively growing, painless abdominal mass. USG scan revealed a cystic lesion of the left ovary which was excised. The below image shows the excised specimen. Which of the following statements is false about this condition?\n\nIt is seen in endometriosis of ovary\nIt is lined by columnar epithelium\nIt is usually a bilateral condition\nIt is a malignant cystic lesion\nQuestion 13:\nA patient is being evaluated for chronic abdominal pain. Her lab reports revealed elevated CA-125 levels. Which of the following conditions is the least likely diagnosis?\nEndometrioma\nChronic liver disease\nAbdominal tuberculosis\nMalignant pancreatic tumor\nQuestion 14:\nA 30-year-old woman with dyspareunia is diagnosed to have endometriosis. Which of the following drugs is not useful for her treatment?\nEstrogen\nProgesterone\nDanazo\nGnRH\nQuestion 15:\nA patient with endometriosis requires treatment with GnRH analogues. She is scared of injections so you plan to prescribe a nasal preparation for her. Which of the following GnRH agonists could you prescribe?\nNafarelin\nGoserelin\nLeuprolide\nTriptorelin\nQuestion 16:\nWhich of the following statements is true regarding adenomyosis?\nMore common in nulliparous women\nUterus is hard and tender\nMenorrhagia, dysmenorrhea are common symptoms\nEstrogens are used for treatment\nQuestion 17:\nA patient with menorrhagia and backache is diagnosed with adenomyosis. Which of the following is not associated with this condition?\nFibroid uterus\nEndometriosis\nSub involution of uterus\nEndometrial carcinoma\nQuestion 18:\nA 43-year-old multiparous woman presented with menorrhagia and secondary dysmenorrhea. On examination, Halban's sign was positive. The transvaginal USG findings are given below. Which of the following is the definitive treatment for her condition?\n\nHormonal therapy\nHysterectomy\nLaser ablation\nLocalised excision\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_22.jpeg",
      "OBGYN_img_270.jpeg",
      "OBGYN_img_22.jpeg",
      "OBGYN_img_271.jpeg",
      "OBGYN_img_23.jpeg",
      "OBGYN_img_272.png"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch107_1",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch107_2",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch107_3",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch107_4",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch107_5",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch107_6",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch107_7",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch107_8",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch107_9",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch107_10",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch107_11",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch107_12",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch107_13",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch107_14",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch107_15",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch107_16",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch107_17",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch107_18",
    "question_text": "\nb\nSolution to Question 1:\nSampson's theory describes the implantation of endometrial tissue due to retrograde menstruation.\nThe various theories for the etiology of endometriosis include:\nGiven below is an illustration showing retrograde menstrual flow that is leading to the development of patches of endometriosis.\nTheory\nMechanism\nSampson's implantation theo ry\nReflux of menstrual endomet rium and subsequent implant ation in the surrounding stru ctures\nTheory of coelomic metaplasi a by Meyer and Ivanoff\nMetaplastic changes in embr yonic mesothelium which res pond to hormone stimulation\nMetastatic theory by Halban\nEmbolization of menstrual fr agments through vascular an d lymphatic channels\nTheory of histogenesis by ind uction\nInduction of undifferentiated peritoneal cells to endometri al tissue by an endogenous fa ctor\n\nSolution to Question 2:\nThe most common site of occurrence of endometriosis is the ovary. Endometriosis of the ovary is known as endometrioma.\nBy definition, endometriosis is the occurrence of benign endometrial tissue (glands and stroma) outside the cavity of the uterus. Endometriosis can occur anywhere in the body (except spleen) including the abdominal wall, lung, pleura, brain, etc.\nIt is a proliferative, hormone-dependent disease of the childbearing period. Women between the age groups of 30-40 years are most commonly affected. Risk factors for endometriosis are as follows:\nFamily history (7-10x risk with a 1st-degree relative)\nNulliparity\nIn utero exposure to Diethylstilbestrol (DES)\nEstrogen dependent conditions/Estrogen therapy\nImmunological factor - Impaired T cell and NK cell activity and altered immunology in a woman may increase the susceptibility to proliferation and growth.\nSolution to Question 3:\nThe most common symptom of endometriosis is dysmenorrhea.\nPain begins before the onset of menstruation and builds up continuously until the flow starts. Thereafter, the pain gradually declines. This pattern of pain is called triple dysmenorrhea.\nSolution to Question 4:\nPatients diagnosed with endometriosis are not likely to present with vaginal discharge. Clinical features of endometriosis include:\nAbout 30% of the patients are asymptomatic.\nThe classic symptom complex includes:\nDysmenorrhoea\nDyspareunia\nMenorrhagia\nInfertility (30-40%)\nDysmenorrhoea - most common symptom\nDyspareunia - occurs when the pouch of Douglas and rectovaginal septum are involved.\nDeep-seated pelvic pain\nPremenstrual and postmenstrual spotting\nSolution to Question 5:\nPain in endometriosis mainly correlates with the depth of penetration.\nLesions penetrating more than 5mm are responsible for pain, dysmenorrhea and dyspareunia. The dysmenorrhea associated with endometriosis precedes menses by 24 to 48 hours and is less responsive to NSAIDs and combined OCPs.\nSolution to Question 6:\nThe sites of endometriosis arranged in the order of frequency of occurrence are: Ovary &gt; Pouch of Douglas &gt; Broad ligament &gt; Uterosacral ligament &gt; Fallopian tube.\nEndometriotic lesions have been identified on all organs except the spleen.\nSolution to Question 7:\nThe given clinical scenario along with the tender nodularity of the uterosacral ligament points towards a diagnosis of endometriosis.\nThe nodularity of the uterosacral ligament in endometriosis gives rise to the cobblestone appearance seen on laparoscopy. This is referred to as 'sine qua non of endometriosis'.\nThe below image shows the cobblestone appearance of the uterosacral ligament.\n\nNote: Endometrioma or chocolate cyst is endometriosis of the ovary. It presents as an adnexa mass.\nSolution to Question 8:\nThe given clinical scenario of dysmenorrhea with tender nodules in the posterior fornix and a retroverted uterus is suggestive of endometriosis. The gold standard investigation for the diagnosis of this condition is a visual inspection by laparoscopy, preferably with histological confirmation. It is also the investigation of choice for the condition.\nRole of laparoscopy in endometriosis:\nDetect and diagnose pelvic endometriosis\nLocate the site of endometriosis and staging\nTo take biopsy\nTo surgically treat endometriosis by ablation Other investigations for endometriosis include:\nEstimation of CA-125 levels - raised in endometriosis.\nEstimation of MCP-1 (Monocyte chemotactic protein) levels - raised in the peritoneal fluid of women with endometriosis.\nSolution to Question 9:\nThe given clinical history and the image showing characteristic powder burn spots seen over the pelvic peritoneum on laparoscopy point toward a diagnosis of pelvic endometriosis.\nOn laparoscopy, the typical endometriotic lesions appear like small black, dark brown or bluish dots. These are called powder burns or gunshot appearance of the serosal surfaces of the peritoneum. They are nodules or small cysts containing old haemorrhages surrounded by a variable degree of fibrosis.\nSubtle appearances of endometriosis seen on laparoscopy are:\nRed flame-shaped areas\nRed polypoid areas\nYellow-brown patches\nWhite peritoneal plaques or scarring\nPeritoneal defects - known as Allen Masters Syndrome\nSubovarian adhesions.\nThe lesions mentioned above are thought to be more active than the powder burn areas.\nEndometriotic lesions in the peritoneal cavity contain yellowish-brown fluid. This fluid contains prostaglandins that are responsible for the pain associated with this condition. Endometriosis of the ovary leads to formation of the chocolate cyst which is a true cyst with columnar epithelium lining.\nThe image below shows the laparoscopic appearance of endometriotic lesions in the pouch of Douglas and on the right, the sacrouterine ligament. Dyspareunia occurs when the pouch of Douglas and rectovaginal septum are involved.\n\nSolution to Question 10:\nIn endometriotic lesions, histology represents its high estrogen activity.\nEndometriosis is defined by the presence of \u201cectopic\u201d endometrial tissue at a site outside of the uterus. Endometriosis is a proliferative hormone-dependent disease of the childbearing period. It is extremely rare before menarche and disappears after menopause.\nThe endometriotic implants show certain differences when compared to normal endometrium. There is increased production of estrogen by endometriotic stromal cells due to high levels of the enzyme aromatase. This is absent in normal endometrial stroma.\nManagement of endometriosis:\n\nSolution to Question 11:\nAmong the given operative procedures, hysterectomy is least likely to be followed by scar endometriosis.\nOperations most likely to be followed by scar endometriosis are:\nHysterotomy\nClassical Cesarean section\nMyomectomy\nVentrofixation (fixing uterus to the abdominal wall)\nEpisiotomy\nSolution to Question 12:\nThe given clinical history and the image is suggestive of a chocolate cyst of the ovary which is a benign cystic lesion.\nChocolate cysts of the ovary are a manifestation of endometriosis. Both the ovaries are usually affected. On histology, the cyst is lined by columnar epithelium. Pseudoxanthoma cells are present which are large macrophages or scavenger cells that appear brown in colour due to ingested blood pigments such as haemosiderin. They are polyhedral in shape and resemble lutein cells.\nGiven below is a gross image of the chocolate cyst of the ovary.\n\nGiven below is a histopathological section of an endometriotic lesion showing the pseudoxanthoma cells.\n\nSolution to Question 13:\nCA-125 levels are not expected to be elevated in malignant pancreatic tumours.\nCA-125 is a glycoprotein and cell surface antigen. Its levels are raised in the following conditions:\nAbdominal or pelvic tuberculosis\nPelvic inflammatory disease\nEndometriosis\nMalignant epithelial ovarian tumour\nChronic liver disease",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_23.jpeg",
      "OBGYN_img_273.jpeg",
      "OBGYN_img_23.jpeg",
      "OBGYN_img_274.jpeg",
      "OBGYN_img_23.jpeg",
      "OBGYN_img_275.jpeg",
      "OBGYN_img_23.jpeg",
      "OBGYN_img_276.jpeg",
      "OBGYN_img_23.jpeg",
      "OBGYN_img_277.jpeg",
      "OBGYN_img_23.jpeg",
      "OBGYN_img_278.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch107_2",
    "question_text": "% of normal women, especially during menstruation.\nEndometrioma refers to ovarian endometriosis. CA-125 levels are raised to more than 35 U/mL in 80% of cases of endometriosis. The level is directly proportional to the extent of the disease.\nSolution to Question 14:\nEstrogen is not used in the treatment of endometriosis as the condition is estrogen-dependent.\nFor minimal disease, the drug of choice is NSAIDs. Oral contraceptive pills are given if associated menstrual complaints are present. OCPs inhibit gonadotropin release and decrease the menstrual flow.\nFor moderate to severe disease, oral progestogens are the first drugs to be started. They are known to antagonize estrogenic effects on the endometrium causing endometrial atrophy. The drug of choice is GnRH agonists.\n\nNote: The best time to conceive in a patient with endometriosis is immediately after surgery.\nSolution to Question 15:\nThe GnRH agonist available as a nasal preparation for the treatment of endometriosis is nafarelin.\nGnRH analogues are used in the management of endometriosis and are given by continuous administration. This suppresses the secretion of pituitary gonadotropins and leads to atrophy of the endometrial tissue in 90% of cases.\nLeuprolide and triptorelin are GnRH agonists which are given IM. Goserelin is available as a depot preparation.\nSolution to Question 16:\nPatients with adenomyosis commonly present with symptoms of menorrhagia and dysmenorrhea.\nAdenomyosis (endometriosis interna) is the ingrowth of stromal and glandular components of the endometrium directly into the myometrium. It usually occurs following vigorous curettage, repeated childbirth or in conditions with an excess of estrogen. Adenomyosis is more common in multiparous women aged 40 years and above. They commonly present with menorrhagia and dysmenorrhea. Other symptoms include pelvic discomfort, backache and dyspareunia.\nOn per-vaginal examination, there is a gross symmetrical enlargement of the uterus corresponding to 12-14 weeks size. The uterus is soft and tender on bimanual examination. This is known as Halban's sign.\nDiagnosis is mainly based on clinical assessment. A diagnostic hysteroscopy combined with curettage is the initial step in the management because of menorrhagia.\nTotal hysterectomy is the treatment of choice. Localised excision and levonorgestrel containing IUCD can be tried in younger patients.\nThe image below is an illustration of adenomyosis.\n\nThe image below shows adenomyosis as seen during laparoscopy. The uterus is soft and enlarged; the blue spots represent subserous endometriosis.\n\nSolution to Question 17:\nAdenomyosis is not associated with sub involution of the uterus.\nUterine subinvolution is impaired or retarded involution of the uterus. It is associated with uterine fibroid, cesarean section and conditions causing overdistension of the uterus like twin pregnancies or polyhydramnios.\nAdenomyosis often coexists with the following conditions:\nUterine fibromyomas\nPelvic endometriosis (15%)\nEndometrial carcinoma\nSolution to Question 18:\nThe given clinical vignette and the transvaginal ultrasound(TVS) showing the Venetian blind appearance is suggestive of adenomyosis. The definitive treatment for adenomyosis is hysterectomy.\nAdenomyosis (endometriosis interna) is the ingrowth of stromal and glandular components of the endometrium directly into the myometrium. Diagnosis is mainly based on clinical\nassessment. Painful, symmetrical enlargement of the uterus is suggestive of adenomyosis. On bimanual examination, the uterus is softened and tender. This is known as Halban's sign.\nTVS findings include salt and pepper appearance of the myometrium and the presence of subendometrial striations producing the Venetian blind appearance. MRI can also be done for diagnosis. However, the only definitive mode of diagnosis is histopathological examination.\nSince most women affected by the condition are past the childbearing age, total hysterectomy is the treatment of choice. Localized excision/Levonorgestrel containing IUCD can be tried in younger women.\n\nThe image below is of a sagittal MRI showing a uterus with adenomyosis in the posterior wall. Gross enlargement of the posterior wall is noted, with many foci of hyperintensity.\n\nDisorders of Ovary\nQuestion 1:\nA young lady who presented with oligomenorrhea and infertility is diagnosed with PCOS. Mutation of which of the following genes can cause this condition?\nCYP21\nCYP22\nCYP23\nCYP24\nQuestion 2:\nA teenage girl presented with complaints of excessive growth of coarse hair on her jawline and upper lip. Which of the following is the most common cause for this condition?\nAntiepileptic medications\nCushing's syndrome\nIdiopathic\nPolycystic ovarian syndrome (PCOS)\nQuestion 3:\nA mother brought her 15-year-old daughter to the OPD with concerns of excessive growth of coarse hair over her face and chest. Which scoring system is used to clinically grade this condition?\nDanforth and trotter score\nHalter score\nFerriman-Gallwey score\nPrader score\nQuestion 4:\nWhich of the following conditions is the Rotterdam criteria used to diagnose?\nMeig's syndrome\nAsherman syndrome\nStein-Leventhal syndrome\nMayer-Rokitansky-K\u00fcster-Hauser syndrome\nQuestion 5:\nAn adolescent girl was brought by her mother to the clinic with complaints of irregular periods and acne. A USG scan was performed which showed the following finding. Which of the following is the most likely diagnosis?\n\nPolycystic ovarian disease\nTheca lutein cysts\nCongenital adrenal hyperplasia\nOvarian endometriosis\nQuestion 6:\nA 26-year-old woman who presented with complaints of irregular cycles and weight gain was diagnosed with PCOS. This condition is characterised by multiple ovarian cysts that are less than \t in size.\n1 cm",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_23.jpeg",
      "OBGYN_img_276.jpeg",
      "OBGYN_img_23.jpeg",
      "OBGYN_img_279.jpeg",
      "OBGYN_img_23.jpeg",
      "OBGYN_img_280.jpeg",
      "OBGYN_img_23.jpeg",
      "OBGYN_img_281.jpeg",
      "OBGYN_img_24.jpeg",
      "OBGYN_img_282.jpeg",
      "OBGYN_img_24.jpeg",
      "OBGYN_img_283.png"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch108_1",
    "question_text": "5 cm\n2 cm",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch108_2",
    "question_text": "5 cm\nQuestion 7:\nA 29-year-old lady presented to your clinics with lesions as shown in the below images. Which of the following is a false statement regarding her condition?\n\nAssociated with polycystic ovarian disease\nAssociated with hypoinsulinemia\nMore frequent in obese women\nAssociated with adenocarcinoma stomach\nQuestion 8:\nA 25-year-old female patient presented with hirsutism. After further evaluation, a diagnosis of HAIR-AN syndrome was made. Which of the following statements is false regarding this condition?\nSevere insulin resistance is seen\nMild hyperandrogenism is seen\nTemporal balding is seen\nClitoromegaly is seen\nQuestion 9:\nA young lady being evaluated for infertility is diagnosed to have PCOS. Which of the following lab findings would you not expect to see in her?\nRaised triglyceride levels\nTestosterone levels elevated but &lt; 200 ng/dL\nRaised LDL levels\nRaised HDL levels\nQuestion 10:\nA teenage girl who recently got diagnosed with PCOS presented with skin lesions on her forehead as shown in the image below. On examination, hirsutism was also noted. Which of the following drugs would you prescribe to this patient?\n\nLetrozole\nOCPs with cyproterone acetate\nBromocriptine\nClomiphene citrate\nQuestion 11:\nA 31-year-old lady has been unable to conceive for the past 2 years in spite of regular intercourse. She has recently been diagnosed with PCOS. Which of the following is the FDA approved medication that you could recommend to her?\nCiproterone acetate\nClomiphene\nDexamethasone\nTamoxifen\nQuestion 12:\nIn a patient diagnosed with PCOS, which of the following is not an indication for surgical management?\nOvarian hyperstimulation\nInfertility\nPrevious pregnancy losses\nMorbid obesity\nQuestion 13:\nA woman with a history of infertility is on treatment with human menopausal gonadotropin. She presented with the following finding in the USG. What is the most likely diagnosis?\n\nOvarian hyperstimulation syndrome\nTheca lutein cyst\nPolycystic ovarian syndrome\nNone\nQuestion 14:\nA 21-year-old nulliparous woman presented with galactorrhoea and breast engorgement. Which of the following is a false statement regarding this condition?\nProlactin is the most important hormone involved in its pathophysiology\nProlactin levels more than 25 ng/ml cause this condition\nAll patients with hyperprolactinemia present with galactorrhoea\nThe drug of choice is Cabergoline\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_24.jpeg",
      "OBGYN_img_284.jpeg",
      "OBGYN_img_24.jpeg",
      "OBGYN_img_285.jpeg",
      "OBGYN_img_24.jpeg",
      "OBGYN_img_286.jpeg",
      "OBGYN_img_287.jpeg",
      "OBGYN_img_288.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch109_1",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch109_2",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch109_3",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch109_4",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch109_5",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch109_6",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch109_7",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch109_8",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch109_9",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch109_10",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch109_11",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch109_12",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch109_13",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch109_14",
    "question_text": "\nc\nSolution to Question 1:\nMutation of the CYP21 gene can cause polycystic ovarian syndrome.\nThe gene for 21-hydroxylase (CYP21) is located in the short arm of chromosome 6. Heterozygosity of the gene has been linked to the development of PCOS. Defects in this gene also lead to congenital adrenal hyperplasia.\nSolution to Question 2:\nThe given clinical history of excessive growth of coarse hair is suggestive of hirsutism. The most common cause for hirsutism in female patients is polycystic ovarian syndrome (PCOS).\nHirsutism is defined as excessive growth of androgen-dependent sexual hair or male distribution of hair in female patients. PCOS accounts for 70-80% of the cases of hirsutism, which typically begins in late adolescence or the early 20s.\nIdiopathic hirsutism is the second most frequent cause. The most common rapid onset of hirsutism in young females is a testosterone-producing tumour like granulosa cell or Sertoli-Leydig cell tumours.\nOther less common causes of hirsutism include:\nLate-onset congenital adrenal hyperplasia\nTumours of the ovary and adrenal glan\nCushing\u2019s syndrome\nDrug-induce\nVirilisation: Characterized by more extensive androgen-induced changes than hirsutism alone. It has the following features:\nAcne\nIncreased oily skin\nTemporal balding\nClitoromegaly\nDeepening of the voice\nDevelopment of male muscular pattern and body habitus\nAtrophy of breasts\nHypertrichosis: Excessive growth of non-sexual hair.\nSolution to Question 3:\nThe given clinical scenario is suggestive of hirsutism. The Ferriman-Gallwey score is used to clinically assess and quantify the degree of hirsutism.\nWithin this system, abnormal hair distribution is assessed at nine body areas and each of them scored from 0-4. Increasing numeric scores correspond to greater hair density within a given area. The maximum score is 36. The degree of hirsutism is mild if the score is \uf0b38. Moderate to\nsevere hirsutism is present if the score is \uf0b315.\nNote: Ferriman Gallwey score originally had 11 sites which were modified later to exclude 2 sites, viz., forearm, and legs.\nSolution to Question 4:\nThe Rotterdam criteria is used to diagnose Stein-Levinthal syndrome or PCOS. ESHRE/ASRM or Rotterdam criteria (2003):\nAny two out of these three must be present-\nClinical/ Biochemical hyperandrogenism\nOligo/anovulation\nPolycystic ovaries\nOther criteria used for diagnosing PCOS:\nNational Institute of Health (NIH) criteria (1990)\nTo include both\nClinical/Biochemicalhyperandrogenism\nOligo/anovulation\nAndrogen excess and PCOS society(AE-PCOS) criteria:\nTo include both:\nClinical/Biochemicalhyperandrogenism\nOligo/anovulation/polycystic ovaries\nOption A: Meig's syndrome refers to ascites and pleural effusions that accompany a benign ovarian tumor.\nOption B: Asherman's syndrome refers to the formation of intrauterine synechiae, usually following endometrial destructive procedures like curettage or ablation.\nOption C: Mayer-Rokitansky-K\u00fcster-Hauser syndrome is characterised by congenital absence of vagina, primary amenorrhoea, rudimentary cornua uteri and morphologically normal ovaries and Fallopian tubes situated on the pelvic sidewall.\nSolution to Question 5:\nThe given clinical history and the necklace appearance on ultrasound are suggestive of polycystic ovarian disease.\nThe original Rotterdam consensus defined polycystic ovaries when \uf0b312 follicles were seen per ovary on USG. Each follicle should measure between 2 and 9 mm, and/or an ovarian volume should be &gt;10 ml. Due to improvement in imaging modalities since that time, the threshold for\nfollicle number has now been raised to 20 per ovary.\nSolution to Question 6:\nPCOS is characterised by multiple small ovarian cysts, each less than 1 cm in size. Sonographic findings seen in PCOS are:\n\uf0b3 12 small cysts of 2 to 9 mm in diameter.\nIncreased ovarian volume (&gt; 10 mL) or both.\nA single ovary with these findings is sufficient to define PCOS. However, this criteria does not apply to women taking combined oral contraceptive pills.\nNote: In settings with improved sonographic imaging resolution, a follicle number \uf0b3 20 cysts per ovary can be considered significant for PCOS.\nSolution to Question 7:\nThe hyperpigmented areas in the given image are acanthosis nigricans and this is associated with hyperinsulinemia. This skin condition is thought to be a cutaneous marker of insulin resistance.\nAcanthosis nigricans is a velvety, darkening of the skin that usually occurs in the intertriginous areas. It has poorly defined borders, usually occurs in skin fold areas, such as the back of the neck, axilla, and groin, and may include thickening of the skin.\nThe pathogenesis of acanthosis nigricans is linked to growth factor levels and insulin-mediated activation of insulin-like growth factor (IGF) on keratinocytes and increased growth factor levels.\nAcanthosis nigricans is usually seen in people younger than 40 years of age and is associated with the following disorders:\nObesity\nHypothyroidism\nAcromegaly\nPolycystic ovary disease\nInsulin-resistant diabetes\nCushing\u2019s disease\nAddison\u2019s disease\nGastrointestinal malignancies such as adenocarcinoma of the stomach or pancreas.\nThe treatment for acanthosis nigricans is directed towards the management of the underlying cause.\nSolution to Question 8:\nHAIR-AN syndrome is not characterized by mild hyperandrogenism but marked hyperandrogenism (HA). It also includes insulin resistance (IR) and acanthosis nigricans (AN).\nHAIR-AN syndrome and ovarian hyperthecosis are exaggerated phenotypes of polycystic ovarian syndrome (PCOS). Women affected by HAIR-AN syndrome often present with symptoms of severe hyperandrogenism (hirsutism, acne) and may occasionally display signs of virilization like clitoromegaly, temporal balding and voice deepening.\nOvarian hyperthecosis is a rare condition characterized by nests of luteinized theca cells distributed throughout the ovarian stroma.\nSolution to Question 9:\nA depressed HDL level and elevated total cholesterol:HDL ratios are seen in patients with PCOS. The following are associated with PCOS:\nInsulin resistance\nImpaired glucose tolerance and type 2 diabetes mellitus\nDyslipidemia: Increased LDL and triglyceride levels, elevated total cholesterol levels:HDL ratios.\nInfertility/subfertility\nA three-fold increased risk of endometrial cancer\nMild elevations in testosterone levels &lt;200 ng/dL\nNormal range of testosterone in women is 20-70 ng/dL. A mild elevation in testosterone is consistent with the diagnosis of PCOS. However, values &gt; 200 ng/dL may suggest an ovarian tumour and warrant pelvic sonography.\nSolution to Question 10:\nThe lesions shown in the image are acne. The drugs used to treat acne and hirsutism in a patient with PCOS are OCPs with cyproterone acetate.\nThe first step in the management of PCOS is weight reduction. OCPs are the drugs of choice for regularisation of cycles. They are also the drugs of choice for hirsutism and acne. OCPs used for PCOS should contain a 3rd/4th generation progestagen like cyproterone acetate. OCPs induce regular menstrual cycles, lower androgen levels and causes thinning of the endometrium.\nInsulin sensitizers like metformin have been found to improve metabolic and gynecologic issues. It acts by reducing the insulin level and reducing hepatic production of glucose (liver neoglycolysis). Other benefits of metformin include improvement in fertility rate and reduction of the total and free testosterone levels. It also increases levels of sex hormone-binding globulin.\nMetformin is contraindicated in hepatic and renal disease.\nTreatment of infertility associated with PCOS is done using ovulation-inducing drugs like letrozole and clomiphene citrate. If medical management fails, surgical options like laparoscopic ovarian drilling can be considered.\nNote:\nFOGSI, in 2024, has replaced Letrozole as the first-line drug for induction of ovulation in patients with PCOS. However, the FDA approval for the same is still pending.\nSolution to Question 11:\nClomiphene is an FDA approved drug used for the treatment of infertility associated with PCOS.\nClomiphene induces ovulation in 80% of the cases and 40\u201350% patients conceive. However, abortions are common due to luteal phase defects. Ovarian hyperstimulation occurs in &lt;1% cases. Co-administration with dexamethasone leads to better outcomes. In resistant case, tamoxifen 20\u201340 mg daily for 5 days should be tried.\nCurrently, letrozole has proven to be more effective in ovarian infertility in obese women but its use in such cases is pending FDA approval.\nSolution to Question 12:\nSurgical management is indicated in all the above conditions except for morbid obesity. Indications of surgery in PCOS include:\nFailed medical therapy\nOvarian hyperstimulation\nInfertility\nPrevious pregnancy losses\nSurgery comprises of laparoscopic drilling or puncture of not more than four cysts in each ovary. It is done using a laser or by unipolar electrocautery. It restores the endocrine milieu and improves fertility for a year or so. Thereafter, pelvic adhesions caused by surgery may again reduce the fertility rate. The formation of adhesions can be reduced by hydrofloatation.\nThe advantages of surgery are as follows:\nTubal testing with chromotubation can be performed simultaneously\nOther causes of infertility like endometriosis can be looked for\nOne-time treatment\nIntense and prolonged monitoring for side effects is not require\nCost-effective compared to IVF\nReduces androgen and LH production\nFollowing surgery, single ovulation occurs with drugs, and hyperstimulation and multiple pregnancies are avoide\nOvulation occurs in 80\u201390% and pregnancy in 60\u201370% The disadvantages of surgery are as follows:\nIt involves giving anaesthesia and performing an invasive procedure like laparoscopy\nAdhesions may form postoperatively\nIf cautery is used, premature ovarian failure due to destruction of ovarian tissue may be seen\nSolution to Question 13:\nThe image showing enlarged ovaries with multiple large cysts along with the history of treatment for infertility with human menopausal gonadotropin suggests the diagnosis of ovarian hyperstimulation syndrome (OHSS).\nHuman menopausal gonadotropin (HMG) is a medication that is composed of FSH and LH. It is used to stimulate the release of ova in women who do not ovulate spontaneously. It can lead\nto ovarian hyperstimulation syndrome.\nOvarian Hyperstimulation Syndrome (OHSS) is a condition associated with ovarian enlargement due to exogenous gonadotropin therapy. Symptoms include abdominal pain, distention, ascites, gastrointestinal problems, respiratory compromise, oliguria, and thromboembolism. It can occur during ovulation induction or in early pregnancies conceived through exogenous ovarian stimulation.\nPredisposing factors for OHSS include multi-follicular ovaries (such as in PCOS), young age, high estradiol levels during ovulation induction, and pregnancy.\nVasoactive substances produced by the corpus luteum, such as vascular endothelial growth factor\n(VEGF) and angiotensin II, are believed to contribute to enhanced capillary\npermeability, resulting in the loss of fluid, protein, and electrolytes into the peritoneal cavity and hemoconcentration.\nSonographic examination reveals enlarged ovaries with numerous follicular cysts and ascites.\nMaintaining fluid balance with isotonic fluids like normal saline is crucial. Strategies to prevent OHSS during exogenous ovulation include reducing follicular stimulation (low FSH dose), coasting (withholding FSH administration one or more days prior to the hCG trigger), prophylactic volume expanders, and substituting hCG for FSH towards the end of ovarian stimulation.\nOther options:\nOption B: Theca lutein cysts are a rare form of follicular cysts characterized by luteinization and hypertrophy of the theca interna layer. Both ovaries are enlarged and cystic. This condition is commonly associated with gestational trophoblastic disease, multifetal gestation, and placentomegaly.\nOption C: Polycystic ovarian syndrome shows 12 or more small follicles each 2-9 mm in size placed peripherally (necklace pattern) (shown below). The patient presents with menstrual\nirregularities, hirsutism, acne, etc.\n\nSolution to Question 14:\nAll patients with hyperprolactinaemia do not present with galactorrhoea.\nGalactorrhoea is the secretion of milky fluid from the nipple which is unrelated to childbirth. Prolactin is the most important hormone involved in the pathophysiology of amenorrhoea and galactorrhoea. Majority of women (80%) with high prolactin levels present with galactorrhoea. However, some hyperprolactinemic women may not have this symptom.\nNormal prolactin level is 25 ng/mL and levels more than this can cause galactorrhoea. Levels up to 100 ng/mL occur in hyperprolactinaemia but prolactin level over 100 ng/mL is seen in pituitary tumours.\nGalactorrhoea is caused by pituitary adenoma and hyperprolactinemia. The condition is associated with amenorrhoea, oligomenorrhoea and infertility. The drug of choice for this condition is cabergoline.\nContraception and Sterilization\nQuestion 1:\nWhich of the following statements is false about the rhythm method?\nAnencephaly is seen on accidental conception\nIt is a cost effective method\nSafe period is determined using temperature or mucous method\nAbstinence is required for 7-10 days in a month\nQuestion 2:\nWhat does Billing's method of contraception refer to?\nBasal body temperature method\nCervical mucus method\nCalendar method\nCoitus interruptus method\nQuestion 3:\nIdentify the contraceptive shown in the given image.\n\nMale condom\nFemale condom\nDiaphragm\nCervical cap\nQuestion 4:\nA nulliparous woman has been using Today sponge as a contraceptive. What does this contain?\nNonoxynol 9\nOctoxynol 8\nMenfego\nTergito\nQuestion 5:\nWhich of the following is not a contraindication for the use of the contraceptive shown below?\n\nMultiple sex partners\nRecurrent UTI\nUterine prolapse\nHerpes vaginalis\nQuestion 6:\nYou are prescribing nonoxynol-9 jelly to a woman using a cervical diaphragm for contraception. What is its mechanism of action?\nAcrosomal enzyme inhibition\nCervical enzyme alteration\nGlucose uptake inhibition by sperms\nDisruption of cell membrane\nQuestion 7:\nA young woman who is using a cervical diaphragm asks for an alternative contraceptive. You suggest a recently launched contraceptive Phexxi. What is its composition?\nLactic acid, Citric Acid, Potassium bitartrate\nAscorbic acid, Citric acid, Calcium bitartrate\nLactic acid, Ascorbic acid, Potassium bitartrate\nAscorbic acid, Lactic acid, Calcium bitartrate.\nQuestion 8:\nA newly married woman was prescribed Mala-N at a PHC. What is its composition?\nLNG and ethinyl estradio\nNordesterol and ethinyl estradio\nDesogestrel and ethinyl estradio\nNorgestimate and ethinyl estradio\nQuestion 9:\nWhich of the following is not an advantage of norgestimate OCPs?\nReduces venous thrombosis\nLess metabolic side effects\nReduces acne and hirsutism\nLesser cardiovascular risk\nQuestion 10:\nWhich of the following is not a contraindication to the use of OCPs?\nIschemic heart disease\nHepatoma\nHypothyroidism\nBreast cancer\nQuestion 11:\nWhich of the following drugs do not lead to failure of OCPs?\nRifampicin\nPhenobarbitone\nValproate\nPhenytoin\nQuestion 12:\nWhich of the following is not the mechanism of action of progesterone only pills?\nThicken the cervical mucus\nPrevents ovulation\nKills the sperms in the cervical cana\nInhibits penetration of sperm\nQuestion 13:\nA patient has come to your clinic for contraceptive advice. As she has a family history of breast cancer, you suggest a non-hormonal oral contraceptive to her. What is the initial dose of this drug?\n30 mg on day 1 of cycle\n60 mg on day 1 of cycle\n60 mg on day 14 of cycle\n30 mg on day 14 of cycle\nQuestion 14:\nWhich of the following is the most effective reversible method of contraception?\nCombined pi\nNorplant\nMini pi\nMirena\nQuestion 15:\nWhich of the following is not a mechanism of action of the device given in the image below?\n\nChronic endometrial inflammation\nIncrease the motility of tubes\nEnzymatic changes to prevent implantation\nFormation of cervical mucus plug\nQuestion 16:\nIUCD insertion is being considered in a multiparous woman who wants long-term contraception. This method of contraception is absolutely contraindicated in all of the following except \t.\nUterine leiomyomas\nSuspected pregnancy\nHIV infection\nPelvic inflammatory disease\nQuestion 17:\nYou are inserting Nova-T in a patient for spacing of births. This device contains\t.\nCopper and silver\nCopper and aluminium\nOnly copper\nCopper and selenium\nQuestion 18:\nA nursing mother was prescribed progestasert for contraception. How much progesterone is released by this device?",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_24.jpeg",
      "OBGYN_img_289.png",
      "OBGYN_img_24.jpeg",
      "OBGYN_img_290.jpeg",
      "OBGYN_img_24.jpeg",
      "OBGYN_img_291.jpeg",
      "OBGYN_img_25.jpeg",
      "OBGYN_img_292.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch109_0",
    "question_text": "65 \uf06dg/day",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch109_65",
    "question_text": "\uf06dg/day",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch109_6",
    "question_text": "5 \uf06dg/day",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch109_6",
    "question_text": "5 mg/day\nQuestion 19:\nWhich of the following increases the risk of pelvic inflammatory disease?\nOCPs\nMirena\nDMPA injectables\nCopper IUCD\nQuestion 20:\nWhat is the most effective mode of contraception for a woman with heart disease?\nOral pills\nHormonal implants\nCondom\nIUCD\nQuestion 21:\nWhich of the following techniques of permanent contraception does not require an abdominal incision?\nPomeroy\nParkland\nEssure\nIrving\nQuestion 22:\nA woman has come to your clinic for a checkup following tubal ligation by Pomeroy technique. Which portion of the tube is ligated in this technique?\nInfundibulum\nAmpulla\nIsthmus\nInterstitium\nQuestion 23:\nFimbriectomy is also known as:\nPomeroy technique\nUchida's procedure\nKroener's procedure\nIrving's procedure\nQuestion 24:\nA 40-year-old male patient underwent a vasectomy. What is the failure rate of this procedure?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch109_0",
    "question_text": "5%",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch109_0",
    "question_text": "15%",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch109_3",
    "question_text": "%",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch110_1",
    "question_text": "%\nQuestion 25:\nA couple with a history of unprotected sexual intercourse requires emergency contraception. Which of the following is not a mechanism by which these drugs act?\nDelaying or inhibiting ovulation\nInhibiting fertilization\nPreventing the implantation of the fertilized egg\nInterrupting an early pregnancy\nQuestion 26:\nA 23-year-old woman comes to the clinic with a history of unprotected intercourse 2 days ago. Which of the following will you prescribe as a single dose contraceptive?\nLevonorgestrel 0.75 mg\nEthinyl estradiol 50 mcg\nLevonorgestrel 1.5 mg\nNorgestrel 0.25 mg\nQuestion 27:\nWhat is the dose of ulipristal for emergency contraception?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch110_60",
    "question_text": "\u00b5g\n3 mg\n30 mg",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch110_30",
    "question_text": "\u00b5g\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_1",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_2",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_3",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_4",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_5",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_6",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_7",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_8",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_9",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_10",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_11",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_12",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_13",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_14",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_15",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_16",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_17",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_18",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_19",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_20",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_21",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_22",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_23",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_24",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_25",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_26",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_27",
    "question_text": "\nc\nSolution to Question 1:\nAnencephaly is not seen in the case of accidental conception in a woman using the rhythm method. It occurs due to deficiency of folic acid in the mother.\nThe calendar method or the rhythm method is one of the natural methods of contraception by fertility awareness. The couple is advised avoidance of sexual intercourse around ovulation. Thus, it is very cost-effective but it can only be used by educated couples.\nAccording to this method, safe period in a normal 28-day cycle is from the 1st day of menstrual period to the 10th day and from the 18th to the 28th day. An alternate method is by calculating the risk period i.e., 3 days before and 3 days after ovulation. Ovulation can also be estimated by changes in cervical mucus and basal body temperature.\nAnother method of calculating the safe period is the Knaus\u2013Ogino method. The fertile period is determined by subtracting 18 days from the shortest cycle and 10 days from the longest cycle. This gives the first and the last day of the fertile period, respectively.\nSolution to Question 2:\nBilling\u2019s method of contraception refers to the cervical mucus method. It is also called ovulation method.\nThe properties of the cervical mucus change during the menstrual cycle. The female partner can predict the fertile period by examining her cervical mucus.\nUnder the influence of estrogen, the mucus increases in quantity and becomes more slippery and elastic i.e. wet days. This continues till it reaches a peak. After this, under the influence of progesterone, it becomes thicker, scanty i.e. dry days.\nAbstinence is advised during the wet days till 4 days after the peak day. The safe period includes the dry days after menses till the appearance of mucus and from the 4th day after the peak day.\nThe pattern of cervical mucus secretion during a menstrual cycle is given below.\n\nSolution to Question 3:\nThe given image shows a female condom. It consists of a pouch made of polyurethane which is 17 cm in length with a flexible ring at each end. The inner ring at the closed end is smaller than the outer ring.\nThe inner ring is inserted at the apex of the vagina and the outer ring remains outside. It covers the cervix, the entire vagina, and external genitalia. Hence, it provides protection against HIV and STDs. It has a failure rate of 5\u201315 per 100 woman-years, which is higher than that of a male condom.\nIt can be fitted by the patient hours before intercourse, and easily removed soon after. It covers the cervix, vagina, and external genitalia and is protective against sexually transmitted diseases. It can also be worn in the puerperal period, unlike the cervical diaphragm.\nThe female condom should not be used along with a male condom because if worn together they may slip, tear, or become displaced.\nThe given image below shows the insertion of a female condom:\n\nSolution to Question 4:\nToday sponge contains 1 g of nonoxynol 9. It is a mushroom-shaped polyurethane disposable sponge that is 2 inches wide and 1.25 inches thick.\nIt is provided with a loop for easy removal. It should be placed high up in the vagina with the concave side covering the cervix. It can remain effective for 24 h. It can be used only once.\nIt acts as a mechanical barrier preventing the entry of sperms into the cervical canal, absorbs semen, and contains a spermicidal agent. The failure rate is 9-16 per 100 woman-years.\n\nSolution to Question 5:\nThe given image shows a cervical diaphragm or Dutch cap. It can be used by women having multiple sex partners.\nContraindications of cervical diaphragm usage:\nProlapse, cystocele, rectocele - accurate fitting is not possible\nRecurrent urinary tract infection\nAllergy to rubber or spermicidal agent\nIt must be removed following intercourse as it can lead to toxic shock syndrome (TSS) if left in the vagina for a long period. TSS is caused by Streptococcus pyogenes or Staphylococcus\naureus infection.\nSolution to Question 6:\nNonoxynol-9 is one of the spermicidal agents which act by disruption of the sperm cell membrane.\nSpermicidal agents are chemical contraceptives as they contain surfactants, such as nonoxynol-9, octoxynol, menfegol and enzyme-inhibiting agents. These are available as:\nFoam tablets\nSoluble pessaries\nCreams\nJellies\nFilms\nThe spermicidal agent remains effective for 1\u20132 hours after the application. They are always used along with other contraceptives such as the diaphragm, cervical cap, and condom. When they are used alone, the failure rate is high i.e., 30 per 100 woman-years.\nChronic use of spermicides can cause vaginal irritation, abrasion, and ulceration. This increases the risk of HIV spread. Hence, spermicidal agents should not be recommended to HIV-positive couples.\nSolution to Question 7:\nPhexxi is a vaginal gel that contains lactic acid, citric acid, and potassium bitartrate.\nPhexxi is a vaginal pH regulator which is a non-hormonal contraceptive. It works by maintaining vaginal pH within the range of 3.5 to 4.5. This acidic environment is inhospitable for sperms.\nPhexxi comes in pre-filled vaginal applicators. A single dose must be applied before vaginal intercourse. If more than one act of vaginal intercourse occurs within one hour, an additional dose must be applied.\n\nSolution to Question 8:\nMala-N is a combined oral contraceptive containing 0.15 mg levonorgestrel (LNG) and 0.03 mg ethinyl estradiol. It is supplied free of cost through all PHC's, urban family welfare centers, etc.\nAll combined oral pills contain a mixture of ethinyl estradiol in a dose of 20-30 mcg and an orally active progestogen. Mala-D has the same composition as Mala-N but is available at a price of Rs 3/- per packet.\nCombined oral pill works by suppressing pituitary hormones, FSH, and LH peak which prevents ovulation. At the same time, progestogen causes atrophic changes in the endometrium and\nprevents implantation.\nProgestogen also acts on the cervical mucus making it thick and tenacious and impenetrable by sperms. It also interferes with tubal motility and alters tubal transport.\n, so the fertilized egg reaches the uterine cavity before the endometrium is receptive for implantation.\nThese tablets are taken starting on the first day of the cycle for 21 days. A new course of tablets should be commenced 7 days after the cessation of the previous course. They should be taken at bedtime, preferably after a meal.\nSolution to Question 9:\nNorgestimate is one of the 3rd generation progesterone agents. All OCPs have the disadvantage of increasing the risk of venous thrombosis.\nThird-generation progesterone agents are less androgenic and so reduce the occurrence of acne and hirsutism. They also have a lower risk of metabolic and cardiovascular disorders compared to the previous generation progesterone agents.\nBenefits of combined pills:\nEffective contraceptive\nUseful in menorrhagia and polymenorrhoea\nRelieves dysmenorrhoea and premenstrual tension\nPrevents anaemia by reducing the menstrual loss\nLower incidence of benign breast neoplasia (fibrocystic disease), functional ovarian cyst, ovarian and uterine malignancy\nReduced risk of PID - due to thick cervical mucus caused by progestogen, preventing the organisms from entering into the uterine cavity\nReduced incidence of ectopic pregnancy - due to suppression of ovulation and decreased risk of PID\nProtects against rheumatoid arthritis\nReduces the risk of anorectal cancer\nUseful in acne, PCOD, and endometriosis\nSolution to Question 10:\nThyroid disorders like hypothyroidism are not a contraindication for OCP usage. Contraindications of OCPs:\nAbsolute contraindications -\nBreast and genital cancers\nLiver disease\nHistory of thromboembolism\nCardiac abnormalities\nCongenital hyperlipidemia\nUndiagnosed abnormal uterine bleeding\nRelative contraindications -\nAge over 40 years, if smoker &gt;35 years\nMild hypertension\nChronic renal disease\nEpilepsy\nMigraine\nFirst 6 months of breastfeeding\nDiabetes mellitus\nGallbladder disease\nHistory of infrequent bleeding or amenorrhea\nSolution to Question 11:\nSodium valproate is an inhibitor of CYP enzymes that are responsible for OCP metabolism. Thus, it does not lead to OCP failure.\nDrugs leading to OCP failure are :\nRifampicin\nTetracyclines - interferes with enterohepatic circulation of estrogen\nPhenytoin\nPhenobarbitone\nAntifungals\nCephalosporin\nRitonavir for HIV - interferes with absorption of OCP\nMost of the anti-convulsants are enzyme inducers and hence increase the clearance of OCPs. This leads to OCP failure.\nSolution to Question 12:\nMinipills or progesterone-only pills (POP) do not kill sperm in the cervical canal. Progesterone-only pills act by thickening the cervical mucus (the main mechanism of all POPs\nexcept cerazette) that inhibits penetration of sperms, inhibiting tubal motility, and suppressing ovulation.\nOther advantages of POPs include a reduction in the incidence of pelvic inflammatory diseases and sexually transmitted diseases (due to thickened cervical mucus).\nDue to the inhibition of tubal motility, the absolute risk of all pregnancies including ectopic pregnancy decreases, while the relative risk of ectopic pregnancy increases. But a previous history of ectopic pregnancy is not a contraindication for POP.\nPOPs do not affect clotting, lipid metabolism, and carbohydrate metabolism. So they can safely be used by women who are obese, breastfeeding, hypertensive, have SLE or a history of thromboembolism, diabetic with vascular disease. Significant adverse effects of POPs are irregular bleeding (mostly scanty), and secondary amenorrhea after longtime usage as it causes endometrial atrophy.\nContraindications for POPs include undiagnosed vaginal bleeding, pregnancy, known or suspected breast cancer, and benign or malignant liver tumors.\nSolution to Question 13:\nCentchroman is a non-hormonal oral contraceptive that is started at a dose of 30 mg on the first day of the menstrual cycle. It can be given to women with a family history of breast cancer where hormonal contraceptives are contraindicated.\nCentchroman or ormeloxifene is a synthetic nonsteroidal contraceptive. Following the initial dose of 30 mg on the first day of menses, it is taken twice weekly for 12 weeks and weekly thereafter. It prevents implantation through endometrial changes. The return of fertility occurs within 6 months of stopping the drug.\nIt can also be used as a postcoital pill, given in 60 mg dose within 24 hours of coitus. It has a failure rate of 1.83 per 100 woman years. It does not provide protection against HIV and other STDs.\nSide effects of centchroman:\nHeadache, nausea, vomiting\nWeight gain\nDelay in return of fertility (up to 6 months)\nAtypical endometrial hyperplasia - prolonged use Contraindications of centchroman:\nPCOD\nHepatic dysfunction\nCervical dysplasia\nAllergy to the drug\nThis drug has been developed by Central Drug Research Institute, Lucknow. It has been released in India under the name of Chhaya (previously called Saheli) under the National Family Planning\nProgramme.\n\nSolution to Question 14:\nThe most effective reversible method of contraception among the given options is Norplant, which is a subdermal hormonal implant.\nThe most effective method of contraception overall is sterilization, which is one of the permament methods. Both methods belong to the first-tier category of contraceptives.\nThere are 2 types of subdermal implants:\nImplanon (which has replaced Norplant I)\nNorplant II\nThe implants work by inhibition of ovulation, endometrial atrophy, and thickening of cervical mucus. Implanon contains desogestrel and also reduces acne and osteoporosis.\nThe implants are inserted on the first day of the menstrual cycle, within 5 days of abortion, and 3 weeks after the delivery. The woman needs to use barrier contraception or abstain in the first 7 days of insertion.\nThe image below shows an implanon:\n\nThe image given below shows the insertion of a subdermal implant:\n\nAdvantages of implants:\nLong-acting with sustained effect\nGood compliance\nCoital-independent with no nuisance of daily oral or frequent injections\nFailure rate - 0.2 and 1.3 per 100 woman-years\nImplanon reduces acne and osteoporosis. Disadvantages of implants:\nBreakthrough bleeding\nIrregular cycles\nAmenorrhoea\nEctopic pregnancy\nLocal infection\nRequires insertion and removal with nonbiodegradable capsules\nExpensive.\nSolution to Question 15:\nThe given image shows Multiload Cu250, which is one of the copper containing IUCDs. Formation of cervical mucus plug is not one of its mechanisms of action. However, progesterone-containing IUCDs can alter the cervical mucus along with the local effects.\nThe various mechanisms of action of a copper-containing IUCD are:\nInterference with the migration of spermatozoa\nForeign body reaction releasing prostaglandins - provokes uterine contractility and increases the tubal peristalsis which interferes with implantation\nLeucocytic infiltration in the endometrium - macrophages engulf the fertilized egg if it enters the endometrial tissue\nEnzymatic and metabolic changes in the endometrial tissue which interferes with implantation of the fertilized ovum\nSome IUCDs like CuT-380A are effective for up to 10 years.\nThey are a good choice of method of contraception for the following groups of women:\nHaving low risk of STD\nMultiparous woman\nHaving a monogamous relationship\nWanting long-term reversible method of contraception\nUnreliable users of oral contraception or barrier contraception\nIUCDs are avoided in unmarried and nulliparous patients because of the risk of PID and subsequent tubal infertility. Copper IUCDs can also be used as emergency contraception following intercourse.\nSolution to Question 16:\nIUCDs can be used in HIV-affected women.\nIntrauterine contraceptive devices (IUCDs) provide long-term contraception by preventing fertilization.\nContraindications for IUCD insertion:\nSuspected pregnancy\nPelvic inflammatory disease (PID)\nLower genital tract infection\nPresence of fibroids\nSevere anaemia\nUncontrolled diabetes - due to increased pelvic infection\nScarred uterus eg, post caesarean section\nSeptate uterus\nMenorrhagia and dysmenorrhoea - if Copper T is used\nBreast cancer - if LNG IUCD is used Complications of IUCD usage:\nImmediate -\nVasovagal attack\nUterine cramps\nEarly -\nExpulsion of IUCD\nPerforation of uterus\nSpotting, menorrhagia\nDysmenorrhoea\nVaginal infection\nActinomycosis\nLate -\nPID\nEctopic pregnancy\nPerforation of uterus\nMenorrhagia\nDysmenorrhoea\nThe failure rate of IUCD is 1\u20133 per 100 woman-years.\nLevonorgestrel IUCD also causes hormonal adverse effects such as headache, acne, breast tenderness, and functional ovarian cysts. Amenorrhoea occurs in 35% of women after 2 years of use.\nSolution to Question 17:\nNova-T contains both copper and silver. The addition of the silver increases its effective lifespan.\n\nIn copper-carrying devices, copper wire is wrapped around the vertical stem of a polypropylene frame. Some of them have copper wire wrapped around the arms too. Based on the surface area, they are of various types:\nCopper T 380 A\nMultiload copper 250\nCopper T 200\nCopper 7\nCopper T 220\nNova-T\nThey are effective for 3\u20135 years. It is estimated that about 50 mcg of copper is eluted daily in the uterus. Copper T 380A, known as Paraguard, has a lifespan of 10 years. Nova T has a lifespan of 5 years.\n\nSolution to Question 18:\nProgestasert releases 65 \uf06dg of progesterone/day.\nProgestasert is a T-shaped device carrying 38 mg of progesterone in a silicon oil reservoir in the vertical stem. The progesterone released causes the formation of a thick plug of mucus at the cervical os. This prevents entry of the sperms in addition to the local contraceptive effect of IUCDs.\nThere is lesser incidence of menstrual problems like menorrhagia and dysmenorrhoea compared to copper-containing intrauterine devices. However, it is expensive and requires yearly replacement.\nSolution to Question 19:\nCopper IUCDs increase the risk of PID.\nOCPs, Mirena and DMPA injectables contain progesterone which causes thickening of the cervical mucus and decreases the motility of the female genital tract. Thus, they reduce the risk of PID by preventing the ascent of bacteria from the vagina.\nSolution to Question 20:\nIUCDs are the most effective mode of contraception for women with heart diseases. IUCDs are safe in these patients and come under the first-tier contraceptive methods.\nCondoms are not contraindicated in heart disease patients but they are third-tier contraceptives. Hence, they are not as effective as IUCDs.\nOCPs and hormonal implants are contraindicated in patients with heart diseases as the constituent hormones can cause thromboembolic disorders.\nSolution to Question 21:\nEssure permanent device is a method of hysteroscopic sterilization. Pomeroy, Parkland, and Irving procedures are methods for tubal ligation via an abdominal approach.\nEssure device consists of a micro-inserter with a flexible inner coil made of stainless steel and a dynamic outer coil made of nickel titanium alloy (nitinol).\nThis device is inserted into the fallopian tube by hysteroscopy. It acts by benign local fibrous tissue growth leading to occlusion of the tube. The failure rate is 3.5%.\nIts advantages are that there is no abdominal scar and the procedure can be done under local anaesthesia.\nDisadvantages of Essure:\nHysteroscopy required for the procedure and to confirm the blockage\nExpensive procedure\nExpertise required\nIrreversible - tuboplasty for reversal not possible",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_25.jpeg",
      "OBGYN_img_293.jpeg",
      "OBGYN_img_25.jpeg",
      "OBGYN_img_294.jpeg",
      "OBGYN_img_25.jpeg",
      "OBGYN_img_295.jpeg",
      "OBGYN_img_25.jpeg",
      "OBGYN_img_296.jpeg",
      "OBGYN_img_25.jpeg",
      "OBGYN_img_297.jpeg",
      "OBGYN_img_298.jpeg",
      "OBGYN_img_299.jpeg",
      "OBGYN_img_25.jpeg",
      "OBGYN_img_300.jpeg",
      "OBGYN_img_25.jpeg",
      "OBGYN_img_301.jpeg",
      "OBGYN_img_26.jpeg",
      "OBGYN_img_302.jpeg",
      "OBGYN_img_26.jpeg",
      "OBGYN_img_303.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_3",
    "question_text": "months waiting time to ensure sterility - HSG must be done after 3 months to confirm tuba blockage\nBilateral insertion difficult due to spasm\nCan cause perforation of the tube\n\nSolution to Question 22:\nIsthmus of the fallopian tube is ligated in Pomeroy technique. It is the most popular technique of tubal ligation.\nMidline, paramedian or transverse abdominal incision is made 2 inches above the pubic symphysis (1 inch in puerperal sterilisation). The fallopian tube is identified, made into a loop and tied at the base. The loop is then excised.\nThe operation is simple and requires a short period of hospitalization. The failure rate is only 0.4% and it is mainly due to spontaneous canalization. It is surgically reversible.\nThe below image shows Pomeroy\u2019s method of tubal ligation.\n\nSolution to Question 23:\nFimbriectomy is also known as Kroener's procedure. This procedure involves ligation of the distal ampulla of the tube with two permanent sutures. Then, resection of the infundibulum of the tube is done.\n\nSome more techniques of permanent sterilization include:\nPomeroy method - The fallopian tube is identified on each side, brought out through the incision. The middle portion is formed into a loop which is tied at the base with catgut and excised. This is the most commonly used technique.\n\nUchida's method - The tubal serosa is stripped off the muscular layer in the midsegment of the tube. The muscle layer is excised. The proximal end is ligated and buried in the broad ligament. This minimal excision of the tube preserves the potential for tuboplasty.\n\nIrving's procedure - The mid-portion of the tube is ligated and the intervening portion is excised. The proximal end is buried in the myometrium and the distal end is buried in the broad ligament. It is a reliable method but irreversible and may require a laparotomy incision.\n\nMadlener's procedure - A loop of the fallopian tube is crushed and then ligated with a nonabsorbable suture.\n\nSolution to Question 24:\nThe failure rate of vasectomy is 0.15%\nThis procedure is done under local anaesthesia. A small incision is made in the scrotum. The vas deferens are divided on both sides which disrupts the passage of sperms.\nThe no-scalpel technique has been now adopted. One single incision is made with special forceps and skin stitch is not required. Clips and plugs can be applied over the vas instead of cutting.\nThe sperms can remain in the reproductive tract for up to 3 months. Hence, sterility is not immediate. The couple must abstain from intercourse during this period or use other methods of contraception.\nApproximately, 20 ejaculates clear the semen of all sperms. Two semen analysis reports must confirm the absence of sperms before the man can be declared sterile.\n\nSolution to Question 25:\nEmergency contraceptives do not interrupt early pregnancy, once conception has occured. They are used to prevent pregnancy after unprotected intercourse. Hence, they are also\ncalled interceptives.\nThe main action of emergency contraceptives is to make the endometrium unsuitable for implantation. They can also delay or inhibit ovulation, and prevent fertilization of the egg by sperms.\nMethods of emergency contraception:\nDrug\nDose\nLevonorgestrel",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_26.jpeg",
      "OBGYN_img_304.jpeg",
      "OBGYN_img_26.jpeg",
      "OBGYN_img_305.jpeg",
      "OBGYN_img_26.jpeg",
      "OBGYN_img_306.jpeg",
      "OBGYN_img_26.jpeg",
      "OBGYN_img_307.jpeg",
      "OBGYN_img_26.jpeg",
      "OBGYN_img_308.jpeg",
      "OBGYN_img_26.jpeg",
      "OBGYN_img_309.jpeg",
      "OBGYN_img_26.jpeg",
      "OBGYN_img_310.jpeg",
      "OBGYN_img_26.jpeg",
      "OBGYN_img_311.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_0",
    "question_text": "75mg stat and repeat dose after 12 hours or1.5mg as a si ngle dose\nEthinyl estradiol 50 \uf06dg + Nor gestrel 0.25 mg",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_2",
    "question_text": "tabs stat and 2 tabs after 12 hours\nRU486 (Mifepristone)\nSingle dose of 25-50mg\nEthinyl Estradiol",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_2",
    "question_text": "5 mg BD X 5 days\nCopper IUDs\nInsertion within 5 days of int ercourse\nCentchroman",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch111_2",
    "question_text": "tabs(60 mg) to be taken twi ce at an interval of 12 hoursS hould be taken within 24 hou rs of intercourse.\nUlipristal\n30 mg within 5 days of interc ourse\nSolution to Question 26:\nLevonorgestrel (LNG) 1.5 mg i.e. 2 tablets of LNG 0.75 mg can be used as a single dose emergency contraceptive. This should be taken within 72 hours of unprotected intercourse.\nAlternatively, one tablet of LNG 0.75mg can be followed by another tablet 12 hours later. The tablets can be offered up to 120 hours but the efficacy decreases with the increase in interval between coitus and drug intake.\nLNG prevents ovulation and makes endometrium unsuitable for implantation. The failure rate is 1.1%. If pregnancy occurs as a result of contraceptive failure, the risk of ectopic pregnancy increases but it is not teratogenic.\nAdvantages of LNG:\nNo oestrogen and its associated side effects\nCan be used in hypertensive, cardiac and diabetic patients\nSuitable for lactating woman\nCan be given up to 120 hours after the unprotected intercourse\nSingle-dose therapy Contraindications of LNG:\nLiver disease\nThrombophlebitis\nMigraine\nGalactose allergy - as the tablet contains lactose\nSolution to Question 27:\nThe dose of ulipristal is 30 mg tablet and it should be taken within 5 days of intercourse.\nUlipristal is a synthetic progesterone receptor modulator. It attaches to the progesterone receptor and acts by:\nPreventing/delaying ovulation\nSuppressing endometrial and follicular growth\nInhibiting implantation\nSide effects are headaches and mood changes. It is contraindicated in women with severe hepatic dysfunction and severe asthma.\nNote: The use of ulipristal for the treatment of fibroids has been discontinued due to the increased incidence of severe liver injury.\nVaginal Infections\nQuestion 1:\nWhich of the following is not a risk factor for bacterial vaginosis?\nCigarette smoking\nIntrauterine device usage\nVaginal douching\nCaucasian race\nQuestion 2:\nA young woman was suspected to have bacterial vaginosis. Which of the following statements is false about this condition?\nGardnerella vaginalis is a causative agent\nAmsel\u2019s criteria is used for diagnosis\nVaginal itching is present\nOral metronidazole is given for treatment\nQuestion 3:\nA 30-year old woman presents to your OPD with complaints of foul-smelling vaginal discharge for the past 2 weeks. On examination, the discharge is adherent to the vaginal mucosa and has a fishy odour. What is the most likely cause?\nTrichomonas\nCandida\nGardnerella\nChlamydia\nQuestion 4:\nIn a patient with bacterial vaginosis, which of the following microscopic features would not be seen?\nAbundance of gram variable coccobacilli\nReduced number of lactobacilli\nAbundance of polymorphs\nPresence of clue cells\nQuestion 5:\nGiven below is the image of a smear prepared from the vaginal discharge of a patient. What is the most likely diagnosis?\n\nChlamydial vaginitis\nGonococcal vaginitis\nBacterial vaginosis\nTrichomonas vaginitis\nQuestion 6:\nA woman comes to the clinic with complaints of foul-smelling vaginal discharge. On examination, the discharge was profuse and had a fishy odour. Which of the following is the best criteria to confirm the diagnosis?\nBoer-Meisel's criteria\nLight's criteria\nAmsel's criteria\nNugent's criteria\nQuestion 7:\nIn a patient with suspected bacterial vaginosis, Nugent's criteria is used to quantify the following bacteria except....\nMycoplasma\nGardnerella\nLactobacillus\nMobiluncus\nQuestion 8:\nA gynaecology resident noted a frothy, greenish, offensive-smelling vaginal discharge in a young lady. Whiff test was positive. Which organism is most likely implicated?\nTrichomonas\nCandidia\nGardnerella\nChlamydia\nQuestion 9:\nA patient came to the gynaecology OPD with complaints of foul-smelling frothy vaginal discharge and intense itching. On examination, the cervix was spotted and had the appearance of a strawberry. Identify the causative organism.\nTrichomonas vaginalis\nGardnerella vaginalis\nNeisseria gonorrhoea\nCandida albicans\nQuestion 10:\nWhich of the following organisms can be detected on a hanging drop preparation?\nGardnerella vaginalis\nTrichomonas vaginalis\nCandida albicans\nMobiluncus\nQuestion 11:\nA 25-year-old woman came with complaints of greenish vaginal discharge. On saline microscopy, motile flagellated organisms were seen. What is the best treatment option for her?\nDoxycycline\nAmoxicillin\nFluconazole\nMetronidazole\nQuestion 12:\nA pregnant woman in her 7th week of gestation was diagnosed with trichomoniasis. Which of the following can be used to treat her condition?\nTopical clotrimazole\nOral metronidazole\nOral cotrimoxazole\nIntravenous azithromycin\nQuestion 13:\nA 60-year-old diabetic woman presents to your OPD with complaints of curdy white vaginal discharge and intense itching. What is the likely causative agent for her condition?\nTrichomonas vaginalis\nMobiluncus\nChlamydia trachomatis\nCandida albicans\nQuestion 14:\nIn an obese lady with complaints of vaginal discharge, a vaginal pH of 4.2 was detected. Which organism is implicated in this patient?\nTrichomonas\nCandida\nGardnerella\nMycoplasma\nQuestion 15:\nWhich of the following is not a risk factor for developing a candidal infection?\nOral contraceptive pills\nObesity\nPregnancy\nHypertension\nQuestion 16:\nA 32-year old woman presents to you with complaints of vaginal discharge and itching. On examination, you note a curdy white discharge and an inflamed vagina. What is the best treatment for her?\nMetronidazole\nFluconazole\nDoxycycline\nClindamycin\nQuestion 17:\nWhich of the following is not a primary site for gonococcal infection?\nUrethra\nBartholin\u2019s glands\nEctocervix\nSkene\u2019s gland\nQuestion 18:\nWhich of the following presentations is unlikely to be seen in a patient with gonorrhoea?\nIntermenstrual bleeding\nVaginal discharge\nProctitis\nHaematuria\nQuestion 19:\nWhat is the most common cause of non-gonococcal urethritis?\nChlamydia trachomatis\nTreponema pallidum\nCandida albicans\nStaphylococcus aureus\nQuestion 20:\nA 35-year-old sex worker was suspected to have chlamydial cervicitis. What is the most sensitive method for confirming the diagnosis?\nDirect fluorescent antibody test\nEnzyme immunoassay\nPolymerase chain reaction\nCulture on irradiated McCoy cells\nQuestion 21:\nA 25-year-old woman had complaints of lower abdominal pain and vaginal discharge. On microscopy, the following finding was present. What is the selective culture media used to isolate the causative organism?\n\nCulture on Thayer martin media\nCulture on McCoy cells\nCulture on bilayer human blood agar\nCulture on Vero cell lines\nQuestion 22:\nA patient with complaints of vaginal discharge was evaluated. On an endocervical biopsy, chlamydia was detected. How will you treat this patient?\nAzithromycin\nAzithromycin plus contact tracing\nDoxycycline and metronidazole\nMetronidazole\nQuestion 23:\nA 25-year-old lady complains of thick curdy white vaginal discharge with itching and burning. What is the route of administration of the first non-azole drug approved to treat this condition?\nOra\nIntraderma\nIntravenous\nTopica\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_27.jpeg",
      "OBGYN_img_312.jpeg",
      "OBGYN_img_313.jpeg",
      "OBGYN_img_314.jpeg",
      "OBGYN_img_27.jpeg",
      "OBGYN_img_315.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_1",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_2",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_3",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_4",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_5",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_6",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_7",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_8",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_9",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_10",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_11",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_12",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_13",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_14",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_15",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_16",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_17",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_18",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_19",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_20",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_21",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_22",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_23",
    "question_text": "\na\nSolution to Question 1:\nCaucasian race is not a risk factor for bacterial vaginosis. The risk factors for bacterial vaginosis are:\nOral sex\nVaginal douching\nAfrican race\nCigarette smoking\nSex during menses\nIntrauterine device\nEarly age of sexual intercourse\nNew or multiple sexual partners\nSexual activity with other women\nNote: Bacterial vaginosis is not an infection. It most commonly affects young women. Although it is not a sexually transmitted disease, the chances of developing bacterial vaginosis seem to increase with the number of sexual partners that a woman has had.\nSolution to Question 2:\nVaginal itching is not seen in bacterial vaginosis. It is a symptom of Trichomonas vaginitis.\nAbout half of the women having bacterial vaginosis are asymptomatic. Symptomatic women mostly present with a profuse, fishy vaginal discharge. It does not cause pruritus, dysuria, and dyspareunia.\nOption A: Bacterial vaginosis occurs due to the absence of lactobacilli. This causes an increase in the growth of other anaerobic bacteria namely Gardnerella vaginalis, Mobiluncus, and Myco- plasma\u25a1 hominis.\nOption B: Amsel's criteria is used for diagnosing bacterial vaginosis. 3 out of 4 criteria are needed to make a positive diagnosis.\nOption D: Oral metronidazole 500 mg twice daily for 7 days or oral clindamycin 300 mg twice daily for 7 days is given for the treatment of bacterial vaginosis. Treatment remains the same in pregnancy.\nSolution to Question 3:\nThe given clinical scenario is suggestive of bacterial vaginosis (BV) caused by Gardnerella.\nPatients with BV have profuse and yellowish vaginal discharge with a fishy odour. It is adherent to the vaginal mucosa. Dysuria, dyspareunia, and vaginal itching are absent. On microscopy, clue cells are visible.\nOption A: In trichomonas vaginitis, the vaginal discharge is frothy, greenish-yellow and has an offensive smell. Dysuria, dyspareunia, and vaginal itching are generally present.\nOption B: In candidal vaginitis, the discharge is thick and curdy white.\nOption D: In chlamydial infection, the vaginal discharge is generally scanty.\nSolution to Question 4:\nAn abundance of polymorphs is not a microscopic finding of bacterial vaginosis because it is not an inflammatory condition. It occurs due to an alteration in the normal vaginal flora.\nA swab of the discharge is taken from the vaginal wall and a smear is prepared. The microscopic evaluation is done using a gram stained smear. In bacterial vaginosis, this would reveal a clean background with an abundance of gram variable coccobacilli adhering to the epithelial cells. These are called clue cells. A few inflammatory cells, other pathogenic organisms, and a reduced number of Lactobacilli would also be seen.\nShown below is the Gram-stained smear of vaginal discharge of a patient diagnosed with bacterial vaginosis. It reveals vaginal epithelial cells that have a fuzzy border due to the adherence of bacteria. These are called clue cells.\n\nSolution to Question 5:\nThe presence of clue cells on microscopy is suggestive of bacterial vaginosis.\nA swab of the vaginal discharge is taken from the vaginal wall and a smear is prepared. The microscopic evaluation of the smear is done on a gram stained smear. It would reveal a clean background with an abundance of gram variable coccobacilli adhering to the epithelial cells. These are called clue cells. A few inflammatory cells, other pathogenic organisms, and a reduced number of Lactobacilli would also be seen.\nShown below is the Gram-stained smear of vaginal discharge of a patient diagnosed with bacterial vaginosis. It reveals vaginal epithelial cells that have a fuzzy border due to the adherence of bacteria. These are called clue cells.\n\nSolution to Question 6:\nThe given clinical scenario is suggestive of bacterial vaginosis which is confirmed by using Amsel\u2019s criteria.",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_27.jpeg",
      "OBGYN_img_316.jpeg",
      "OBGYN_img_27.jpeg",
      "OBGYN_img_316.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch112_3",
    "question_text": "out of 4 of the following criteria are needed, to make a positive diagnosis of bacterial vaginosis:\nA homogeneous, thin, greyish-white discharge that smoothly coats the vaginal walls.\nA vaginal pH &gt; 4.5.\nA positive whiff test - an amine like fishy odour is produced when a drop of 10% KOH is added to the sample of vaginal discharge.\nThe presence of &gt;20% clue cells on saline wet mount. These are vaginal epithelial cells studded with adherent coccobacilli at the edge of the cell.\nOption A: Boer-Miesel's criteria is used for the prognostic evaluation of pelvic inflammatory disease.\nOption B: Light's criteria is used for determining the nature of the pleural fluid i.e., transudate or exudate, in the diagnosis of pleural effusion.\nOption D: Nugent's criteria can also be used for diagnosing bacterial vaginosis. However, it is not the best confirmatory method.\nSolution to Question 7:\nNugent's criteria is used to evaluate three types of bacteria in a case of suspected bacterial vaginosis: Mobiluncus, Lactobacillus, and Gardnerella/Bacteroides. Bacteria are graded through gram stain of vaginal samples.\nThey are each graded on a scale of 1+ to 4+ where:",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch113_1",
    "question_text": "+ is &lt; 1 cell per field",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch113_2",
    "question_text": "+ is 1-5 cells per field",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch113_3",
    "question_text": "+ is 6-30 cells per field",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch113_4",
    "question_text": "+ is &gt;30 cells per field\nLactobacillus and Bacteroides/Gardnerella are given scores between 0-4, but Mobiluncus is graded only from 0-2. The total scores are then calculated and interpreted as follows:",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch113_0",
    "question_text": "3 - Norma",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch113_4",
    "question_text": "6 - Intermediate bacterial count",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch113_7",
    "question_text": "10 - Bacterial vaginosis\nSolution to Question 8:\nTrichomonas vaginalis is the likely organism implicated in this patient, causing trichomonas vaginitis.\nThe whiff test can be positive in both Trichomonas and Gardnerella infections. However, greenish frothy discharge is seen in trichomonas vaginitis.\nSolution to Question 9:\nIn the given clinical scenario, Trichomonas vaginalis is the likely causative agent.\nVaginal itching and foul-smelling frothy vaginal discharge are seen in trichomonas vaginitis.\nThe given image shows colpitis macularis or strawberry cervix, which is a characteristic finding of trichomoniasis. This is due to microscopic, punctate haemorrhages of the cervix.\n\nSolution to Question 10:\nTrichomonas vaginalis can be detected on a hanging drop preparation. Trichomonas vaginalis is a protozoan with four anterior flagellae, and a fifth posterior flagellum responsible for motility.\nThe image given below shows trophozoites of Trichomonas vaginalis with flagella.\n\nSolution to Question 11:\nThe given clinical scenario is suggestive of trichomonas vaginitis and the best treatment option for her is oral metronidazole 2 g stat.\nThe treatment regimen for trichomonas vaginitis is:\nAn oral dose of metronidazole 500 mg twice daily for 7 days or\nA single oral dose of metronidazole 2 g\nThe male partner should be treated with a single dose of oral metronidazole in case of recurrent infection. Treatment in pregnancy remains the same.\nSolution to Question 12:\nTrichomonas vaginitis is treated with oral metronidazole in pregnant women.\nAccording to the current guidelines, metronidazole is now considered safe for treating trichomonas vaginitis in pregnancy as it has no teratogenic effect.\nThe treatment regimen for trichomonas vaginitis in pregnant women include:\nAn oral dose of metronidazole 500 mg twice daily for 7 days or a single oral dose of metronidazole 2 g\nUsage of trichofuran suppositories\nVinegar douche to lower the vaginal pH\nBetadine ge\nThe male partner should be treated with a single dose of oral metronidazole in case of recurrent infection.\nSolution to Question 13:\nThe given clinical scenario is suggestive of moniliasis and Candida albicans is the likely causative agent.\nThe risk factors for moniliasis are:\nDiabetes mellitus\nObesity\nMultiple sexual partners\nImmunosuppression\nHIV\nPregnancy\nSteroid therapy\nFollowing long-term broad-spectrum antibiotic therapy\nOral contraceptive pills\nPoor personal hygiene.\nSolution to Question 14:\nThe likely causative agent in the given clinical scenario is Candida which is known to flourish in an acidic environment. The pH of the vaginal discharge in candidal vaginitis is in the range of",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_27.jpeg",
      "OBGYN_img_317.jpeg",
      "OBGYN_img_27.jpeg",
      "OBGYN_img_318.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch113_4",
    "question_text": "4.5.\nSolution to Question 15:\nHypertension does not increase the risk of developing a candidal infection. The risk factors for developing candidal vaginitis (moniliasis) are:\nDiabetes mellitus\nObesity\nMultiple sexual partners\nImmunosuppression\nHIV\nPregnancy\nSteroid therapy\nFollowing long-term broad-spectrum antibiotic therapy\nOral contraceptive pills\nPoor personal hygiene.\nSolution to Question 16:\nThe given clinical scenario is suggestive of candidal vaginitis. A single dose of fluconazole 150 mg is the best treatment for treating candidal vaginitis. Intravaginal antifungal (imidazole/miconazole/clotrimazole) vaginal pessaries or creams can also be used for 3\u20136 days.\n\nSolution to Question 17:\nEctocervix and vagina are lined by squamous epithelium which is resistant to gonococcal infection.\nThe principal sites of invasion for gonococcal infection are the columnar and transitional epithelium. Hence, gonococcus usually affects the following structures:\nEndocervix\nUrethra\nSkene\u2019s glands\nBartholin's glands.\nSolution to Question 18:\nHaematuria is unlikely to be seen in a patient with gonorrhoea. Gynaecological presentation of gonorrhoea is:\nExcessive vaginal discharge associated with pruritus and inflammation\nAcute unilateral pain and swelling over labia due to the involvement of Bartholin\u2019s gland\nIntermenstrual bleeding\nNon-gynaecological presentation of gonorrhoea is:\nPharyngeal infection\nDysuria\nRectal discomfort due to associated proctitis.\nSolution to Question 19:\nThe most common cause of non-gonococcal urethritis is Chlamydia trachomatis. The causes of non-gonococcal urethritis are:\nChlamydia trachomatis (most common)\nUreaplasma urealyticum\nAdenovirus\nHaemophillus vaginalis\nMycoplasma genitalium\nTricomonas vaginalis (rare)\nHerpes simplex virus (rare)\nSolution to Question 20:\nThe most sensitive method for confirming the diagnosis of chlamydial cervicitis is the polymerase chain reaction (PCR). It is fast, highly sensitive and specific (96%).\nSolution to Question 21:\nChlamydia trachomatis is the most likely causative organism. This is suggested by the presence of characteristic iodine-stained inclusion bodies in the McCoy cell culture of the patient's endocervical sample.\nChlamydia is a gram-negative coccobacillus. The gram stain of the cervical smear would show abundant leucocytes but no organisms.\nThe nucleic acid amplification test (NAAT) is currently done for the diagnosis of lymphogranuloma venereum.\nSolution to Question 22:\nA single dose of 1 g of azithromycin is given and contact tracing is done to treat a patient diagnosed with a chlamydial infection.\nTreatment of chlamydial infection:\nAzithromycin 1 g single dose (or)\nDoxycycline 100 mg orally BID \u00d7 7 days (or)\nOfloxacin 200 mg orally BID \u00d7 7 days (or)\nErythromycin 500 mg orally BID \u00d7 7 days\nContact tracing should always be done. The sexual partner should also be treated with the same regimen.\nSolution to Question 23:\nThe clinical history of thick curdy white vaginal discharge with itching and burning are suggestive of vulvovaginal candidiasis. The first and the only non-azole antifungal approved for the treatment of vulvovaginal candidiasis is Ibrexafungerp. The route of administration of this drug is oral.\nIbrexafungerp is a triterpenoid antifungal agent that acts by inhibiting glucan synthase. Glucan synthase is an enzyme involved in the formation of 1,3-beta-D-glucan which is an essential component of the fungal cell wall.\nThe recommended dosage is 600 mg orally as 2 divided doses 12 hrs apart. Contraindications include pregnancy and hypersensitivity to ibrexafungerp. The most frequent adverse reactions are diarrhea, nausea, abdominal pain, dizziness, and vomiting.\nVulval Infections\nQuestion 1:\nWhich of the following is the causative organism of vulval warts?\nHuman papilloma virus\nHerpes simplex virus\nHuman immunodeficiency virus\nCytomegalovirus\nQuestion 2:\nA young woman presented with the following lesion on her vulva. What is the most likely diagnosis?\n\nCondyloma acuminata\nMolluscum contagiosum\nVerruca vulgaris\nCondyloma lata\nQuestion 3:\nA sexually active woman presents with cauliflower-like lesions on the vulva. The biopsy of the lesion is taken and histopathology reveals the following picture. What is the most likely causative organism?\n\nPox virus\nHuman papilloma virus\nHerpes simplex virus type 1\nHerpes simplex virus type 2\nQuestion 4:\nWhich of the following serotypes are present in the bivalent vaccine against the human papillomavirus?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_27.jpeg",
      "OBGYN_img_319.jpeg",
      "OBGYN_img_27.jpeg",
      "OBGYN_img_320.jpeg",
      "OBGYN_img_27.jpeg",
      "OBGYN_img_321.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch113_6",
    "question_text": "and 11",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch113_16",
    "question_text": "and 18",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch113_11",
    "question_text": "and 16",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch113_6",
    "question_text": "and 18\nQuestion 5:\nWhich of the following is not a treatment option for a patient with genital warts?\nLocal application of 25% podophyllin\nLocal application of imiquimod cream\nIntralesional interferon injection\nLocal application of 5% trichloroacetic acid\nQuestion 6:\nA sexually active woman who presented with an ulcer over the vulva was diagnosed with primary syphilis. What is the characteristic feature associated with this condition?\nNon suppurative, tender, and enlarged nodes\nFirm, shotty, and painless nodes that do not suppurate\nPainful, tender, and matted nodes forming an abscess\nPainful, inflamed, necrotic nodes developing a chronic sinus\nQuestion 7:\nA 32-year-old woman known to have syphilis presented with the following lesions over the vulva. What is the stage of the disease?\n\nPrimary\nSecondary\nTertiary\nLatent\nQuestion 8:\nA sexually active patient was diagnosed with lymphogranuloma venereum. What is the causative organism for this condition?\nKlebsiella granulomatis\nChlamydia trachomatis\nTreponema pallidum\nHerpes virus\nQuestion 9:\nA 26-year-old sexually active man comes to the STD clinic with a painful genital ulcer. On examination, the ulcer and the right inguinal lymph nodes were tender. What is the causative organism?\nTreponema pallidum\nHaemophilus ducreyi\nChlamydia trachomatis\nTreponema pertenue\nQuestion 10:\nA sexually active man presents with complaints of painful swelling over the inguinal region. He also gives a history of a painless genital ulcer that resolved spontaneously. On examination, groove sign is seen. What is the likely diagnosis?\nGranuloma inguinale\nLymphogranuloma venerum\nSyphilis\nChancroid\nQuestion 11:\nA 20-year-old female sex worker presents with complaints of constipation and blood in stools for 3 months. On DRE, a circumferential constriction is felt beyond which the finger cannot be advanced. Which of the following is a probable cause for this complication?\nGranuloma inguinale\nLymphogranuloma venerum\nSyphilis\nChancroid\nQuestion 12:\nWhat is the causative agent for granuloma inguinale?\nCalymmatobacterium granulomatis\nChlamydia trachomatis\nUreaplasma urealyticum\nTreponema pallidum\nQuestion 13:\nA 19-year-old girl presented with multiple beefy-red ulcers over the labia. Microscopic examination of smear from the lesion showed intracytoplasmic inclusion bodies and gram-negative bacteria having a safety pin appearance. What is your likely diagnosis?\nLymphogranuloma inguinale\nGranuloma inguinale\nChancroid\nSyphilis\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_28.jpeg",
      "OBGYN_img_322.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch114_1",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch114_2",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch114_3",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch114_4",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch114_5",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch114_6",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch114_7",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch114_8",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch114_9",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch114_10",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch114_11",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch114_12",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch114_13",
    "question_text": "\nb\nSolution to Question 1:\nThe causative agent of vulval warts is the human papillomavirus (HPV).\nGenital warts/venereal warts/condyloma acuminata are verrucous growths that affect the skin of the labia majora, perineum, perianal region and vulva. The lesions may be discrete or coalesce to form cauliflower-like growth. The disease is sexually transmitted. The growth of the warts is favoured by vaginal discharge, the use of oral contraceptives, and pregnancy.\nHPV causes structural changes in the epithelial cells of the skin called koilocytes, and their presence is characteristic of HPV infection. The koilocytes have large hyperchromatic nuclei and a perinuclear halo, as shown below.\n\nThe diagnosis is made by colposcopic studies. The lesions on the vulva are stained by toluidine blue. The abnormal areas of the skin retain the blue dye. These areas are then biopsied for histopathological examination.\nThe given image below shows condyloma acuminata:\n\nSolution to Question 2:\nThe given image is suggestive of condyloma acuminata that shows cauliflower-like masses of tissue on and around the female anogenital region.\nCondyloma acuminatum is an epidermal manifestation of the human papillomavirus (HPV).\nHPV is transmitted through contact with infected skin or mucosa. The virus invades the cells of the epidermal basal layer through microabrasions. However, anogenital HPV infection is almost always acquired through sexual contact.\nWarts are not required for transmission but are highly infectious because of their high viral load.\nOption B: The image given below shows shiny, pearly white, umbilicated papules with a characteristic dimple at the centre. These are seen in molluscum contagiosum caused by the pox virus.\n\nOption C: The image given below shows firm papules with a rough horny surface. These are seen in verruca vulgaris caused by the human papillomavirus type 2.\n\nOption D: The image given below shows condyloma lata which is the characteristic feature of secondary syphilis. It is caused by Treponema pallidum.\n\nSolution to Question 3:\nThe given image shows koilocytes, a characteristic feature of infection with human papillomavirus\n(HPV).\nOther features that can also be seen on histology are:\nPerinuclear halo\nMultinucleation\nOrangeophilic cytoplasm\nAcanthosis\nChronic inflammatory infiltrate\nOption A: Henderson-Paterson bodies are seen in molluscum contagiosum, caused by poxvirus. Option C and D: Cowdry bodies are seen in herpes infection.\nSolution to Question 4:\nSerotypes 16 and 18 are present in the bivalent vaccine against the human papillomavirus (HPV).\nIt is called Cervarix. Cervarix is given at 0, 1 and 6 months.\nGardasil/Silgard is the quadrivalent vaccine against HPV. It has serotypes 6, 11, 16 and 18 and is given at 0, 2 and 6 months.\nGardasil 9 is the nonavalent vaccine against HPV. It has serotypes 6, 11, 16, 18, 31, 33, 45, 52 and",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_28.jpeg",
      "OBGYN_img_323.jpeg",
      "OBGYN_img_28.jpeg",
      "OBGYN_img_324.jpeg",
      "OBGYN_img_28.jpeg",
      "OBGYN_img_325.jpeg",
      "OBGYN_img_28.jpeg",
      "OBGYN_img_326.jpeg",
      "OBGYN_img_327.jpeg",
      "OBGYN_img_328.jpeg",
      "OBGYN_img_28.jpeg",
      "OBGYN_img_329.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch114_58",
    "question_text": "In 2020 it has received an expanded indication which now includes the prevention of oropharyngeal and head and neck cancers.\nSolution to Question 5:\nGenital warts are treated by a local application of 25% trichloracetic acid + 5% fluorouracil. Treatment of genital warts includes the local application of:\nPodophyllin 25% in alcohol/podophyllin 20% in tincture benzoin daily for 4 days (or)",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch114_25",
    "question_text": "% trichloracetic acid +5% fluorouracil daily for 4 days If this fails, the following treatment is given:\nInterferon ointment/cream or intralesional interferon injection\nImiquimod cream thrice a week for 4 months\nIf medical treatment fails then cryosurgery, diathermy or laser removal is done.\nSolution to Question 6:\nThe characteristic feature associated with primary syphilis is firm, shotty, painless nodes that do not suppurate.\nSyphilis is a sexually transmitted infection caused by the motile spirochete, Treponema pallidum. In primary syphilis, the classical lesion i.e., chancre appears within 9\u201390 days from the first exposure.\nThe macular lesion becomes papular and then ulcerates. The ulcer(s) is painless and firm, with a punched out base and rolled edges. If left unattended, these heal within 3\u20139 weeks. It is accompanied by painless inguinal discrete lymphadenopathy.\nSolution to Question 7:\nThe given image shows condyloma lata, a classic finding of secondary syphilis.\nMultiple moist well-demarcated papules and plaques are seen in condyloma lata. They are highly contagious, exophytic broad excrescences that ulcerate and are commonly seen on the vulva, perianal area and upper thighs.\nSolution to Question 8:\nThe causative agent for lymphogranuloma venereum is Chlamydia trachomatis (serotypes L1/L2/L3). Lymphogranuloma venereum (LGV) is a sexually transmitted disease that causes genital ulcers.\nIt has the following three stages of infection:\nChlamydia trachomatis is a small gram-negative bacterium and an obligate intracellular parasite that appears as an intracytoplasmic inclusion body. The gram stain of the cervical smear would show leucocytes but no organisms. Hence, selective culture media like the McCoy cells culture is used to isolate the organism.\nThe slide given below is an iodine-stained smear prepared from the patient's endocervical sample. It shows inclusion bodies characteristic of Chlamydia trachomatis.\nStage of LGV\nCharacteristic features\nPrimary stage\nPainless genital ulcerPapules Lymphangitis\nSecondary sta ge\nPainful unilateral/bilateral ly mphadenopathyBuboesGroov e sign\nLate stage\nStricture formationFibrosis a nd fistulae of the anogenital r egion\n\nSolution to Question 9:\nThe given clinical scenario is suggestive of chancroid caused by Haemophilus ducreyi which is a gram-negative anaerobe.\nChancroid is symptomatic in men. Both ulcer and lymphadenopathy are\npainful. Lymphadenopathy in chancroid is either unilateral or bilateral. Chancroid is generally asymptomatic in women but sometimes presents as painful lymphadenopathy.\nThe image below shows a chancroid ulcer with purulent and haemorrhagic discharge. It has a non-indurated, erythematous base.\n\n\nSolution to Question 10:\nThe pathognomic groove sign of Greenblatt is suggestive of lymphogranuloma venereum (LGV)\ncaused by Chlamydia trachomatis (serovars L1, L2, L3).\nThis image shows groove sign which is seen in \u25a0 of the cases in the secondary stage of LGV. It refers to the depression between the enlarged femoral and inguinal lymph nodes on either side of the inguinal ligament.\n\nLymphogranuloma venereum (LGV) is a sexually transmitted disease that causes genital ulcers. It has the following three stages of infection:\nStage of LGV\nCharacteristic features\nPrimary stage\nPainless genital ulcerPapules Lymphangitis\nSecondary sta ge\nPainful unilateral/bilateral ly mphadenopathyBuboesGroov e sign\nLate stage\nStricture formationFibrosis a nd fistulae of the anogenital r egion\nSolution to Question 11:\nThe given clinical scenario is suggestive of rectal stricture which is a complication of lymphogranuloma venereum (LGV).\nLGV is a sexually transmitted disease caused by Chlamydia trachomatis (serotypes L1/L2/L3). Rectal involvement is commonly seen in women as the primary disease often goes unnoticed and untreated. Anorectal involvement causes proctocolitis and causes rectal strictures. This occurs due to the contiguous spread of the primary infection from the perirectal nodes leading to scar tissue formation.\nThe complications of lymphogranuloma venereum include:\nRectal stricture formation may lead to:\nIntestinal obstruction\nRectovaginal fistulae\nProctitis\nVulvar cancer.\nSolution to Question 12:\nThe causative agent for granuloma inguinale (donovanosis) is Calymmatobacterium granulomatis. It is now called Klebsiella granulomatis and is a gram-negative bacillus causing chronic ulcerative infection of the vulva.\nIt is highly contagious and transmitted through repeated sexual or non-sexual contact. The incubation period is 1-12 weeks.\nClinical features:\nIt begins as a painless nodule which later ulcerates to form multiple beefy red painless ulcers that tend to coalesce; the vulva is progressively destroyed, and minimal adenopathy may occur.\nDiagnosis:\nMicroscopic examination of smears from the lesion/ biopsy specimens reveals pathognomonic intracytoplasmic Donovan bodies and clusters of bacteria with a bipolar (safety pin) appearance.\nB ue-black stained organisms are seen in the cytoplasm of mononuclear cells. Management:\nAzithromycin 1 g orally once per week or 500 mg daily for at least 3 weeks and until all lesions have completely healed.\nThe given image below shows the donovanosis in a female patient with a beefy red ulcer:\n\nSolution to Question 13:\nThe given clinical scenario is suggestive of granuloma inguinale which is caused by a gram-negative bacteria, Klebsiella granulomatis.\nGranuloma inguinale begins as a painless nodule that later ulcerates to form multiple beefy red painless ulcers. These ulcers tend to coalesce and bleed easily on contact. If secondarily infected, they may become painful. The ulcers heal by fibrosis, which can result in scarring resembling keloids.\nThe lymph nodes are usually uninvolved but can become enlarged. New lesions can appear along the lymphatic drainage channels.\nThe gross image below shows granuloma inguinale of the cervix with a beefy red appearance of the hypervascular intravaginal tissues.\n\nThe microscopic image below shows the pathognomonic intracytoplasmic Donovan bodies. It also shows clusters of gram-negative bacteria with a bipolar/safety-pin appearance.\n\nPelvic Inflammatory Disease\nQuestion 1:\nThe Pap smear of a healthy 30-year-old lady is given below. Identify the microorganism seen.\n\nDoderlein\u2019s bacillus\nGardnerella vaginalis\nTrichomonas vaginalis\nFrisch bacillus\nQuestion 2:\nAll of the following are risk factors for PID except\t.\nUnprotected sexual intercourse\nPregnancy\nIUD insertion\nEarly age of sexual intercourse\nQuestion 3:\nA 24-year-old woman is diagnosed with pelvic inflammatory disease. Which of the following is not included in this condition?\nEndometritis\nOophoritis\nCervicitis\nPeritonitis\nQuestion 4:\nWhat is the most common symptom seen in acute PID?\nBilateral lower abdominal pain\nUnilateral lower abdominal pain\nHigh fever with vomiting\nPain in the right upper quadrant of the abdomen\nQuestion 5:\nA young woman with fever and lower abdominal pain is diagnosed to have PID. Which is the most common cause for this condition?\nChlamydia\nMycoplasma\nStaphylococcus\nNeisseria\nQuestion 6:\nA 42-year-old woman presented to the emergency room with abdominal pain and fever for the last 48 hours. She has been using a Cu T 380A for contraception for the past 8 years. On examination, cervical motion tenderness was present. What is the most likely organism to have caused her condition?\nActinomyces\nChlamydia\nGonococcus\nStaphylococcus\nQuestion 7:\nWhat is the mechanism of the spread of gonococci to the tubes in pelvic inflammatory disease?\nHematogenous spread\nLymphatic spread\nParametrium spread\nMucosal spread\nQuestion 8:\nWhich infection causes more damage to the mucosa and the wall of the tube leading to fibrosis and tubal blockage?\nChlamydial infection\nGonococcal infection\nMycoplasma infection\nMobiluncus infection\nQuestion 9:\nWhich of the following is not a differential diagnosis of acute PID?\nSeptic abortion\nCholecystitis\nTwisted ovarian cyst\nPelvic endometriosis\nQuestion 10:\nA 26-year-old female with endometritis did not complete the course of antibiotics she was prescribed. Following this, her infection failed to resolve and she developed a tubo-ovarian mass. How can this mass manifest?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_28.jpeg",
      "OBGYN_img_330.jpeg",
      "OBGYN_img_28.jpeg",
      "OBGYN_img_331.jpeg",
      "OBGYN_img_29.jpeg",
      "OBGYN_img_332.jpeg",
      "OBGYN_img_29.jpeg",
      "OBGYN_img_333.jpeg",
      "OBGYN_img_29.jpeg",
      "OBGYN_img_334.jpeg",
      "OBGYN_img_29.jpeg",
      "OBGYN_img_335.jpeg",
      "OBGYN_img_29.jpeg",
      "OBGYN_img_336.jpeg",
      "OBGYN_img_337.jpeg",
      "OBGYN_img_338.jpeg",
      "OBGYN_img_29.jpeg",
      "OBGYN_img_339.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch115_1",
    "question_text": ", 3, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch115_1",
    "question_text": ", 3, 4",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch115_2",
    "question_text": ", 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch116_1",
    "question_text": ", 2, 4\nQuestion 11:\nWhich of the following statements is incorrect regarding the condition seen in the image given below?\n\nIt is often bilateral\nIts wall is opaque\nFlattening of tubal plicae is seen on histology\nIts ampullary region is filled with clear fluid\nQuestion 12:\nA patient with fever and abdominal pain presented to the emergency. On examination, you note mucopurulent vaginal discharge and cervical motion tenderness. You suspect she has PID. Which of these is not included in the criteria to diagnose this condition?\nOral temperature &gt;38.3\u00b0C\nCervical motion tenderness\nMucopurulent vaginal discharge\nBilateral abdominal pain\nQuestion 13:\nWhich of the following is not a definitive criterion used to diagnose PID?\nHistopathological evidence of endometritis\nTubo-ovarian abscess on sonography\nTemperature &gt; 38.3\u00b0C\nLaparoscopic abnormalities consistent with PID\nQuestion 14:\nA 24-year-old woman presented with bilateral abdominal pain for 3 days and a temperature of 102\u00b0F. She also had a mucopurulent vaginal discharge, cervical motion tenderness, and a negative urine pregnancy test. Which is the gold standard investigation to confirm her likely diagnosis?\nLaparoscopy\nUSG\nCuldocentesis\nVaginal discharge microscopy\nQuestion 15:\nThe laparoscopy report of a woman with pelvic inflammatory disease states she has Gainesville stage III PID. Which of the following presentations could have been seen in her?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_29.jpeg",
      "OBGYN_img_340.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch116_3",
    "question_text": "and 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch116_3",
    "question_text": "and 4",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_1",
    "question_text": "and 2",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_1",
    "question_text": "and 4\nQuestion 16:\nIn a patient with PID, laparoscopy shows the following appearance. What is true about the syndrome this patient likely has?\n\nPerihepatitis\nCholecystitis\nTuboovarian abscess\nGonococcal urethritis\nQuestion 17:\nIdentify the wrong statement with respect to silent PID.\nDysmenorrhea is a common presentation\nEctopic pregnancy is common\nAssociated with infertility\nMycobacterium can be grown from menstrual blood\nQuestion 18:\nA patient is admitted to the gynaecology ward for pelvic inflammatory disease. Which of the following is a part of this patient's treatment regimen?\nAdministration of cefotetan 2 g IV 12 hourly + doxycycline 100 mg IV BD\nRemoval of IUD irrespective of antibiotic response\nAdministration of a single dose of ceftriaxone 250 mg IM\nAdministration of 10 doses of Placentrex 2ml IM daily or on alternate days\nQuestion 19:\nA 30-year-old female presents to the OPD with fever, lower abdominal pain and purulent vaginal discharge. On examination, her vitals are stable and per vaginal examination reveals lower abdominal and cervical motion tenderness. What is the best treatment option for her?\nSingle IM injection of ceftriaxone 250 mg with oral doxycycline and metronidazole for 14 days\nSingle IM injection of ceftriaxone 250 mg with oral metronidazole 400 mg for 7 days\nOral doxycycline 100 mg BD with oral metronidazole 400 mg for 7 days\nOral ofloxacin 200 mg BD with oral metronidazole 400 mg for 14 days\nQuestion 20:\nWhich of the following would be an indication for surgery in a 30-year-old woman diagnosed with PID?\nA tubo-ovarian abscess of 2 cm\nPeritonitis\nSepsis\nIntestinal obstruction\nQuestion 21:\nWhich among the following is an indication for minimally invasive surgery for tubo-ovarian abscess?\nThe size of the abscess is more than 5 cm\nThe size of the abscess is more than 2cm\nThe abscess fails to respond to antibiotics in 48 - 72 h\nThe abscess fails to respond to antibiotics in 24 - 36 h\nQuestion 22:\nA 55-year-old multiparous woman who presented with chronic lower abdominal pain has been diagnosed with chronic PID. What is the treatment of choice for this patient?\nRadical hysterectomy\nSupracervical hysterectomy with tuboplasty\nAbdominal hysterectomy with bilateral salpingo-oophorectomy\nSupracervical hysterectomy with bilateral salpingectomy\nQuestion 23:\nWho has described the prognostic evaluation for PID?\nBoer\u2013Meisel\nGainesville\nBoth A and B\nWestrom\nQuestion 24:\nLong-standing pelvic inflammation may lead to which of the following conditions?\nPyometra\nUterine polyposis\nPseudocyesis\nEndometrial hyperplasia\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_29.jpeg",
      "OBGYN_img_341.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_1",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_2",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_3",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_4",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_5",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_6",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_7",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_8",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_9",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_10",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_11",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_12",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_13",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_14",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_15",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_16",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_17",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_18",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_19",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_20",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_21",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_22",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_23",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch117_24",
    "question_text": "\na\nSolution to Question 1:\nThe organism seen in the given image of a Pap smear is the Doderlien\u2019s bacillus, also known as Lactobacillus. This is a gram-positive, rod-shaped bacillus that grows in anaerobic conditions.\nIt is a part of the normal vaginal flora that is responsible for the vaginal defence mechanism. It is an estrogen-dependent bacillus and appears at puberty and disappears after menopause.\nIt converts glycogen into lactic acid and maintains the acidic ph in the vagina. This prevents the growth of pathogenic bacteria in the vagina. Its absence causes a condition called bacterial vaginosis where pathogenic organisms replaces the normal flora of the vagina. In this condition, clue cells are visible.\nOption B: Gardnerella vaginalis is the most common organism involved in bacterial vaginosis. As the patient in the given question is healthy, this is not the correct option.\nOption C: Trichomonas vaginalis is flagellated protozoa that causes trichomonas vaginitis. The organism and the nucleus of epithelial cells appear equal in size on the pap smear. This criterion is used for the identification of trichomonas as flagella are not visible on a pap smear.\nOption D: Frisch bacillus is another name for Klebsiella rhinoscleromatis. It is not seen on Pap smears.\nSolution to Question 2:\nPregnancy is not a risk factor for PID. Instead, it plays a protective role in this condition.\nThe risk factors for developing PID are:\nUnprotected sexual intercourse\nHaving multiple sex partners\nPrevious history of PID\nIUD insertion\nEarly age of sexual intercourse (&lt;18years)\nThe protective factors for PID are:\nPregnancy\nUsing barrier contraception like condoms, diaphragms\nOral contraceptive pills (OCPs)\nMenopause\nSolution to Question 3:\nCervicitis is not included in pelvic inflammatory disease (PID).\nPelvic inflammatory disease is a spectrum of infection and inflammation of the upper genital tract, typically causing:\nEndometritis\nSalpingitis\nOophoritis\nPeritonitis\nThe minimum criteria for diagnosis of PID are:\nPain in the lower abdomen + any one of the following:\nUterine tenderness\nCervical motion tenderness\nAdnexal tenderness\nCervicitis and vaginitis are lower genital tract infections.\nSolution to Question 4:\nThe most common symptom of acute PID is bilateral lower abdominal pain.\nThe pain is severe in acute stages and it may or may not be accompanied by a high temperature ( &gt;38.3 degrees C). It may be followed by vomiting.\nSome patients with PID can present with pain in the right upper quadrant of the abdomen. This is seen in Fitz-Hugh-Curtis syndrome which is a form of perihepatitis.\nIf PID occurs due to sexually transmitted organisms, dysuria and vaginal discharge may be seen.\nSolution to Question 5:\nChlamydia trachomatis is the most common cause of PID.\nPID is an infection of the upper genital tract. It is generally transmitted sexually as an ascending infection along with sperms. It is usually a polymicrobial infection,\nOrganisms causing PID include:\nSexually transmitted:\nChlamydia (most common)\nGonococcus\nMycoplasma\nTrichomonas Pyogenic Aerobes:\nStaphylococci\nStreptococci\nE Coli Anaerobes:\nBacteroides fragilis\nPeptostreptococcus\nClostridium\nActinomyces (most common in IUD users) Other:\nMycobacterium tuberculosis\nNote: Genital tuberculosis is the only PID that does not spread sexually. It has a hematogenous spread. Thus, it is the most common PID in virgin girls.\nSolution to Question 6:\nThe given clinical scenario points towards a diagnosis of PID in an IUCD user. The most common organism causing this condition is Actinomyces. It has been reported in 7% of IUCD users if the device is worn for more than 2 years.\nThis emphasizes the need for strict asepsis during insertion of the device and the need for strict follow up of women wearing these devices.\nOrganisms causing PID are:\nSexually transmitted:\nChlamydia (most common)\nGonococcus\nMycoplasma\nTrichomonas Pyogenic Aerobes:\nStaphylococci\nStreptococci\nE Coli Anaerobes:\nBacteroides fragilis\nPeptostreptococcus\nClostridium\nActinomyces (most common in IUD users) Other:\nMycobacterium tuberculosis\nSolution to Question 7:\nThe mechanism of the spread of gonococci to the tubes in pelvic inflammatory disease is mucosal.\nGonococci ascend to the tubes mainly through mucosal continuity. This is facilitated by sexually transmitted vectors such as sperms and Trichomonas.\nThe mucous membranes of the fallopian tubes are affected first. They become edematous and are infiltrated with leukocytes and plasma cells. Another route of spread is through the reflux of mucosal blood.\nOption A: Hematogenous spread is seen in genital tuberculosis.\nOption B: Lymphatics are involved in the spread of secondary organisms and in PID following post-abortal and puerperal infection.\nOption C: Parametrium facilitates the spread of Mycoplasma. The gut flora can directly spread to tubes.\nSolution to Question 8:\nAmong the given options, chlamydial infection causes the most amount of damage to the mucosa and the wall of the fallopian tubes leading to fibrosis and tubal blockage.\nChlamydial infection can remain asymptomatic in the endo-cervix. Hence, the infection goes unnoticed and untreated. Thus, it can lead to more damage and complications.\nGonococcal infection is more symptomatic than chlamydial infection. Hence, it is diagnosed early and causes less damage to the tubes than chlamydial infection.\nMycoplasma and Mobiluncus generally cause lower genital tract infections like cervicitis and vaginitis.\nSolution to Question 9:\nPelvic endometriosis is not a differential diagnosis of acute PID. It is a differential diagnosis of chronic PID.\nDifferential diagnosis of acute PID:\nAcute appendicitis\nSeptic abortion\nCholecystitis\nTwisted ovarian cyst\nEctopic pregnancy\nDiverticulitis\nRuptured endometriotic cyst Differential diagnosis of chronic PID:\nUterine fibroids\nPelvic endometriosis\nOvarian tumou\nTubercular tubo-ovarian mass\nSolution to Question 10:\nThe given scenario of development of a chronic tubo-ovarian mass following acute PID points towards a diagnosis of chronic PID. A chronic tubo-ovarian mass can manifest as a tubo-ovarian cyst, hydrosalpinx or even a chronic pyosalpinx.\nFailure to complete treatment of acute PID or drug resistance can lead to the development of chronic PID. This can lead to the development of chronic tubo-ovarian masses which may manifest as:\nHydrosalpinx\nChronic pyosalpinx\nChronic interstitial salpingitis\nTubo-ovarian cyst\nTuberculous form\nA twisted ovarian cyst and a ruptured endometriotic cyst are differential diagnoses of acute PID.\nSolution to Question 11:\nThe above image depicts a hydrosalpinx. Its wall is not opaque but translucent.\nIf a pyosalpinx responds to antibiotics, the pus present inside becomes sterile within 6 weeks of the initial attack. However, the damage to the tube remains as chronic pyosalpinx or hydrosalpinx. A hydrosalpinx represents the end result of previous acute salpingitis and is often bilateral.\nThe tube becomes retort shaped due to the enormous dilatation of the ampullary region that is filled with clear fluid.\nHistological examination shows a flattening of the tubal plicae and exfoliation of the lining epithelium.\nSolution to Question 12:\nBilateral abdominal pain is not included in the criteria to diagnose PID. Bilateral abdominal pain is a clinical symptom of PID.\nLower abdominal tenderness is included in the criteria to diagnose PID. CDC criteria for the diagnosis of PID:\nDefinitive criteria:\nHistopathologic evidence of endometritis on biopsy\nImaging study (TVS/MRI) evidence of thickened fluid-filled tubes (tubo-ovarian abscess)\nLaparoscopic evidence of PID Minimum criteria:\nCervical motion tenderness\nUterine tenderness\nAdnexal tenderness Additional criteria:\nOral temperature &gt;38.3 oC\nMucopurulent cervical or vaginal discharge, cervical friability\nRaised ESR or CRP\nLaboratory documentation of positive cervical infection with Gonorrhea or Chlamydia\nSolution to Question 13:\nA temperature of more than 38.3\u00b0C is an additional criterion and not a definitive criterion for the diagnosis of PID.\nCDC 2006 criteria for the diagnosis of PID:\nDefinitive criteria:\nHistopathologic evidence of endometritis on biopsy\nImaging studies (TVS/MRI) evidence of thickened fluid-filled tubes (Tubo-ovarian abscess)\nLaparoscopic evidence of PID Minimum criteria:\nLower abdominal tenderness\nAdnexal tenderness\nCervical motion tenderness Additional criteria:\nOral temperature&gt;38.3C\nMucopurulent cervical or vaginal discharge and cervical friability\nRaised ESR or CRP\nLaboratory documentation of positive cervical infection with Gonorrhea or Chlamydia\nSolution to Question 14:\nThe given clinical scenario is likely to be acute PID. Laparoscopy is the gold standard to confirm acute PID.\nLaparoscopy is not done routinely as it is an invasive procedure. It is reserved for only cases where the differential diagnosis is salpingitis, appendicitis, ectopic pregnancy or a case of a non-responding pelvic mass.\nThe diagnosis of PID is mostly clinical. If diagnosis is unclear, the investigation of choice for PID is USG and culdocentesis.\nCDC 2006 criteria for the diagnosis of PID:\nDefinitive criteria:\nHistopathologic evidence of endometritis on biopsy\nImaging studies (TVS/MRI) evidence of thickened fluid-filled tubes (tubo-ovarian abscess)\nLaparoscopic evidence of PID Minimum criteria:\nLower abdominal tenderness\nAdnexal tenderness\nCervical motion tenderness Additional criteria:\nOral temperature&gt;38.3C\nMucopurulent cervical or vaginal discharge and cervical friability\nRaised ESR or CRP\nLaboratory documentation of positive cervical infection with Gonorrhea or Chlamydia\nSolution to Question 15:\nGainesville stage III includes two forms of PID - acute salpingitis with superimposed tubal occlusion or tubo-ovarian complex.\nGainesville has described the stages of PID depending upon the severity of tubal damage as follows:\nStage\nCondition\nStage I\nAcute salpingitis without peri tonitis - no adhesions\nStage I I\nAcute salpingitis with periton itis - purulent discharge\nStage I II\nAcute salpingitis with superi mposed tubal occlusion or tu bo-ovarian complex\nStage I V\nRuptured tubo-ovarian absce ss\nStage V\nTubercular salpingitis\nSolution to Question 16:\nThe image shows the laparoscopic finding of violin string adhesions that are characteristic of Fitz-Hugh-Curtis syndrome. It is a form of perihepatitis that occurs in the setting of PID.\nIt is characterized by right upper quadrant pain with a pleuritic component, sometimes referred to the right shoulder. It rarely occurs in women with acute PID. The pathological mechanism is as follows:\nGonococcal / Chlamydial infection \uf0ae transperitoneal/vascular spread \uf0ae inflammation of the liver capsule and peritoneal surfaces \uf0ae adhesions and fibrosis in the perihepatic region \uf0ae\nFitz-Hugh-Curtis Syndrome\nCholecystitis and ruptured tubo-ovarian abscess are the differential diagnoses of Fitz-Hugh-Curtis syndrome. Violin string adhesions would not be seen in these conditions.\nSolution to Question 17:\nDysmenorrhea rarely occurs in PID. Pain is uncommon and is a result of subacute PID.\nSilent PID is thought to follow multiple or continuous low-grade infections in asymptomatic women. It is not a clinical diagnosis. Rather, it is an ultimate diagnosis given to women with tubal-factor infertility who lack a history of upper genital tract infection.\nOn laparoscopy or laparotomy, these women may have evidence of prior tubal infection such as adhesions, but for the most part, the fallopian tubes are grossly normal. They can have ectopic pregnancies due to tubal dysmotility. Silent PID can occur following infection with M. tuberculosis.\nSolution to Question 18:\nAdministration of cefotetan 2 g IV 12hourly + doxycycline 100 mg BD orally/ IV for 48 hours forms the crux of the treatment regimen for PID. This is followed by oral doxycycline 100 mg\n+/-metronidazole 400 mg for 14 days in all hospitalized patients having PID. Treatment of PID in hospitalized patients:\nCefotetan 2 g IV 12hourly + doxycycline 100 mg BD orally/ IV for 48 hours is given followed by oral doxycycline 100 mg +/- metronidazole 400 mg for 14 days\nCefoxitin 2 g IV 6hourly + doxycycline 100 mg IV followed by oral route.\nAzithromycin 500 mg IV 6 hourly for 2 days, then orally for Chlamydia. Outpatient treatment of PID (according to the current RCOG guidelines):\nA single dose of IM ceftriaxone 250 mg followed by oral doxycycline 100 mg BD +/-\nmetronidazole 400 mg BD x 14 days\nA single dose of IM ceftriaxone 250 mg followed by azithromycin 1 gm per week x 2 weeks.\nIUD is not removed in a woman who responds to antibiotics. It is removed only in case of a failed antibiotic response. Barrier contraceptives and OCPs are recommended only in women unresponsive to antibiotics.\nThe use of Placentrex (aqueous extract of the placenta) is outdated and is not recommended currently.\nSolution to Question 19:\nThe given clinical scenario of fever and lower abdominal pain associated with lower abdominal and cervical motion tenderness is suggestive of PID. The best treatment option for this patient is\noutpatient treatment with a single dose of IM ceftriaxone 250 mg + oral doxycycline 100 mg BD\n+/- metronidazole 400 mg BD x 14 days.\nOutpatient treatment of PID (according to the current RCOG guidelines):\nA single dose of IM ceftriaxone 250 mg + oral doxycycline 100 mg BD +/- metronidazole 400 mg BD x 14 days\nA single dose of IM ceftriaxone 250 mg followed by azithromycin 1 gm per week x 2 weeks. Treatment of PID in hospitalized patients:\nCefotetan 2 g IV 12hourly + doxycycline 100 mg BD orally/ IV for 48 hours is given followed by oral doxycycline 100 mg +/- metronidazole 400 mg for 14 days\nCefoxitin 2 g IV 6hourly + doxycycline 100 mg IV followed by oral route.\nAzithromycin 500 mg IV 6 hourly for 2 days, then orally for Chlamydia.\nSolution to Question 20:\nIntestinal obstruction would be an indication for surgery in a patient diagnosed with PID. Criteria for surgery in PID include:\nDrainage of pelvic abscess by colpotomy.\nDilatation and evacuation of septic products of conception or for haemorrhage in the postabortal period.\nAcute spreading peritonitis resistant to a full course of chemotherapy. Presence of pyoperitoneum mandates laparotomy.\nIntestinal obstruction\nSuspected intestinal injury as diagnosed in criminal abortion.\nRuptured tubo-ovarian abscess\nA tubo-ovarian abscess of 2 cm is not an indication for surgery. Minimally invasive surgery is done in a tubo-ovarian abscess measuring more than 10 cm, that fails to respond to antibiotics in 48-72 hours.\nPeritonitis and sepsis are not an indication for surgery. They should be managed medically first. If they do not respond to antibiotic treatment then surgical management should be done.\nSolution to Question 21:\nIf the abscess fails to respond to antibiotics in 48\u201372 h, minimally invasive surgery is indicated. Criteria for minimally invasive surgery in PID:\nThe size of the abscess is more than 10 cm\nThe abscess fails to respond to antibiotics in 48-72 hours\nThe abscess ruptures\nPyoperitoneum\nMinimal invasive surgery includes laparoscopic drainage of the tubo ovarian abscess or posterior colpotomy.\nSolution to Question 22:\nThe treatment of choice for an old multiparous woman with chronic PID is abdominal hysterectomy with bilateral salpingo-oophorectomy.\nA radical hysterectomy involves the removal of the whole uterus, tissue from the sides of the uterus, the cervix, and the upper part of the vagina. It is generally done only in cancer patients.\nA supracervical hysterectomy involves the removal of only the body of the uterus and is not done in chronic PID. It is done for the treatment of endometriosis, uterine fibroids, and uterine prolapse.\nSolution to Question 23:\nBoer-Meisel has described the prognostic evaluation for PID. It depends upon the following:\nExtent of adhesions\nNature of adhesions such as flimsy or dense.\nSize of hydrosalpinx\nMacroscopic condition of hydrosalpinx.\nThe thickness of the tubal wall.\nBoer-Meisel system is specifically used for predicting pregnancy outcomes in patients treated for PID.\nGainesville has described the stages of PID depending upon the severity of tubal damage.\nWestrom has reported that women with one previous attack of PID have a predisposition to another attack.\nStages of PID\nStage I\nAcute salpingitis without peri tonitis - no adhesions\nStage I I\nAcute salpingitis with periton itis- purulent discharge\nStage I II\nAcute salpingitis with superi mposed tubal occlusion or tu bo-ovarian complex\nStages of PID\nStages of PID\nStage I V\nRuptured tubo-ovarian absce ss\nStage V\nTuberculous salpingitis\nSolution to Question 24:\nLong-standing pelvic inflammation may lead to pyometra. This refers to the collection of pus in the uterine cavity.\nThe initial infection involves the cervix uteri and urethra which may extend to Bartholin glands, skene glands, endometrium, and fallopian tubes. Unilateral pain and swelling over the labia may be caused by the inflammation of the Bartholin glands.\nDepending on the extent of tissue involved, PID can be classified into five stages\nStage I - Acute salpingitis without peritonitis - No adhesions\nStage II - Acute salpingitis with peritonitis - purulent discharge\nStage III - Acute salpingitis with superimposed tubal occlusion or tubo ovarian complex\nStage IV - Ruptured tubo-ovarian abscess\nStage V - Tubercular salpingitis\nLong-standing pelvic inflammation may also lead to:\nDyspareunia\nInfertility\nEctopic pregnancy\nFormation of adhesions like hydrosalpinx, pyosalpinx, tubo-ovarian abscess\nChronic pelvic pain\nNote: Chronic pelvic inflammation leads to dense adhesions between the uterus and the appendages. Thus, it becomes difficult to define the uterus from the pelvic masses. They form a hard mass which is called the frozen pelvis.\nThe most common cause of the spread of PID: Ascending infection along with sperms\nThe only PID that does not spread with the sexual route is genital TB. It has a hematogenous spread.\nThe most common PID in virgin females is genital TB. Investigation of choice in PID: Abdominal USG\nThe surest sign of salpingitis is pus extruding from the fimbrial end of the tube.\nGenital Tuberculosis\nQuestion 1:\nWhich of the following is the most common site for genital tuberculosis?\nInfundibulum of fallopian tubes\nUterine endometrium\nAmpulla of fallopian tubes\nEndocervical part of the cervix\nQuestion 2:\nWhat is the most common mode of transmission of tuberculosis to the endometrium?\nHematogenous\nLymphatic spread\nRetrograde spread\nLocal spread\nQuestion 3:\nA young woman with fertility issues is diagnosed to have genital tuberculosis. Which of the following statements is false about this condition?\nThe causative agent is Mycobacterium bovis\nIt generally occurs secondary to a primary focus\nIt mostly spreads hematogenously\nIt commonly presents as a unilateral condition\nQuestion 4:\nWhat is the most common presenting symptom of genital tuberculosis in the reproductive age group?\nAsymptomatic\nInfertility\nMenstrual abnormalities\nFever\nQuestion 5:\nIn a patient with tubercular salpingitis, which of the following statements is false?\nThe tubes are enlarged, roughened, and may show presence of greyish tubercles\nThe ampulla of the tube appears dilated with the fimbrial end open and pouting\nThe granulomas and hyperplasia seen can be mistaken for carcinoma\nThe fimbriae are commonly involved in advanced tuberculous salpingitis\nQuestion 6:\nAn 18-year-old girl presents with a history of low-grade fever, weight loss, abdominal pain and amenorrhoea for six months. On examination, a pelvic mass is felt on the left side and signs of ascites are positive. What is your diagnosis?\nTuberculosis with tubo-ovarian mass\nOvarian malignancy\nEctopic pregnancy\nSubmucous fibroid\nQuestion 7:\nA gynaecologist suspects tuberculous salpingitis in a young woman and suggests some investigations to confirm the diagnosis. Which of the following statements is true about these investigations?\nA differential WBC count shows lymphocytosis in advanced disease.\nThe ESR is frequently raised and is non-specific in early disease.\nThe Mantoux test is positive and indicative of current exposure to tubercle bacilli.\nThe Quantiferon test is positive and indicates latent tuberculosis.\nQuestion 8:\nHysterosalpingography was done in a young woman with infertility and menstrual abnormalities. Which of the following findings would not point towards a diagnosis of tubercular salpingitis?\nA wedge shaped defect at the uterine isthmus\nBeading and variations in filling defect\nCalcification of the tube\nJagged fluffiness of the tubal outline\nQuestion 9:\nThe image below shows the hysterosalpingogram of a 37-year-old nulliparous woman. Identify the false statement about this finding.\n\nIt is a thick walled structure on sonography\nIt can be asymptomatic\nTubal plicae are flattened on histology\nSequelae of pelvic inflammatory disease\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_30.jpeg",
      "OBGYN_img_342.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch118_1",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch118_2",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch118_3",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch118_4",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch118_5",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch118_6",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch118_7",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch118_8",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch118_9",
    "question_text": "\na\nSolution to Question 1:\nThe ampulla of the fallopian tubes is the most common site for genital tuberculosis. The distribution of genital tuberculosis is given below:\nSite\nPercent age\nFallopian tubesAmpulla is th",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch118_90",
    "question_text": "100\ne most common site.Intramu\n%\nral part is the least common\nsite.Fimbriae are not involve\nd even in advanced genital T\nB.\nEndometrium",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch118_50",
    "question_text": "60%\nOvaries",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch118_20",
    "question_text": "30%\nCervix",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch118_5",
    "question_text": "15%\nVulva and vagina\n<1%\nSolution to Question 2:\nEndometrial tuberculosis is most commonly acquired by direct spread from the fallopian tubes. Hematogenous spread is thought to be the process by which the tubercle bacilli implant into the mucosa of the fallopian tubes and subsequently affect the endometrium by direct extension.\nFemale genital tuberculosis is an important cause of significant morbidity, short and long-term sequelae especially infertility. Genital tuberculosis usually occurs secondary to pulmonary (commonest) or extrapulmonary TB like gastrointestinal, renal, skeletal, and miliary TB. However, primary genital TB can rarely occur in women whose male partners have active genitourinary TB\n(e.g., tuberculosis epididymitis) by transmission through infected semen\nMost common site involved in secondary genital TB is fallopian tube (90-100%) &gt;endometrium (50-80%) &gt;ovaries (20-30%) &gt;cervix 5-15%) &gt;vulva. The most common symptom of genital TB is infertility.\nCauses of infertility in genital TB:\nTubal blockage\nIf tubes are patent, then also infertility occurs due to loss of tubal function.\nTubercular endometritis causes uterine scarring resulting in the destruction of the endometrium.\nOvarian damage with poor ovarian reserve and volume\nA laparoscopy and dye hydrotubation (lap and dye test) is the most reliable tool to diagnose genital TB, especially for tubal, ovarian and peritoneal disease. The test can be combined with hysteroscopy.\nMultiple drug therapy ( ATT regimen provided by DOTS) in adequate doses and for sufficient duration is the mainstay in the treatment of TB including genital tuberculosis.\nSolution to Question 3:\nGenital tuberculosis is a bilateral condition.\nIt can be caused by both Mycobacterium tuberculosis (95% cases) and Mycobacterium bovis (5% cases). It almost always occurs secondary to a primary focus elsewhere in the body. The most common primary focus is lungs &gt; lymph nodes &gt; abdomen &gt; generalised miliary infection.\nIt mostly spreads hematogenously. Lymphatic spread is also seen sometimes. It can rarely spread by direct contact with the affected intraabdominal organs or peritoneum.\nThe fallopian tubes are the first to be affected. The disease subsequently spreads to other genital organs and the peritoneum. This is followed by the involvement of bilateral pelvic lymph nodes. Vulvovaginal involvement is usually secondary to uterine involvement.\nThe most common presentation of genital tuberculosis in the reproductive age group is infertility.\nSolution to Question 4:\nThe most common presentation of genital tuberculosis in the reproductive age group is infertility.\nGenital tuberculosis mostly presents in young women in the reproductive age group. It can present as:\nInfertility is the only complaint in 35-60 % of cases. Of these, 75% of women present with primary infertility.\nMenstrual abnormalities are seen in 10-40% of cases.\nAsymptomatic in 10% of cases.\nOther symptoms like fever and malaise can be seen.\nThe treatment of infertility in women with genital TB depends on the condition of the endometrium. If the endometrium is receptive and the uterus is normal, then assisted reproductive techniques such as in-vitro fertilisation can be tried. If the endometrium is unfavourable then surrogacy may be considered.\nSolution to Question 5:\nThe fimbriae are often spared even in advanced forms of tubercular salpingitis.\nThe involvement of fallopian tubes is 100% and bilateral, secondary to hematogenous spread. The ampullary part of the tube appears dilated with the fimbrial end open and pouting. This gives the characteristic tobacco-pouch appearance as seen in the image below.\n\nThe external surface of the tubes are enlarged, roughened, and may show the presence of greyish tubercles. The cut section shows yellowish-grey caseous matter in the lumen. Sometimes, serosanguinous fluid can also be seen in the lumen of the fallopian tube. This is called tuberculous hematosalpinx.\nOn histopathological examination of the tubes, granulomas and chronic inflammatory infiltrate with hyperplasia is seen. This could be mistaken for malignancy as it also produces a similar histological image.\nSolution to Question 6:\nThe given clinical scenario with abdominal pain, amenorrhoea, pelvic mass and ascites is suggestive of genital tuberculosis.\nGenital tuberculosis:\nIt is caused by M. tuberculosis and almost always occurs secondary to primary infection elsewhere in the extragenital states. The sites and frequency of involvement are as follows:\nFallopian tubes (90-100%)\nEndometrium (50-60%)\nOvaries (20-30%)\nCervix (5-15%)\nVulva and vagina (&lt; 1%)\nPresentation is variable and it can be asymptomatic in 10-20% of cases, infertility, menstrual irregularities, abdominal pain and mass, vaginal discharge, fistula formation, ectopic pregnancy and ascites. The mass is made up of rolled-up omentum that is adherent to the uterus and adnexa.\nConstitutional symptoms such as fever, weakness, anorexia or night sweats may be present. Investigations:\nCBC, ESR and Mantoux test\nHysterosalpingography shows a lead-pipe appearance of the fallopian tube, calcification of the tube, beading and variation in the filling, cornual block, jagged fluffiness of tubal outline and tobacco pouch appearance of hydrosalpinx and pyosalpinx.\nLaparoscopy establishes the diagnosis of genital TB. It shows tuberculous lesions and perihepatic adhesions (if present).\nDifferential diagnosis:\nOvarian cyst, broad ligament cyst or encysted fluid\nPelvic inflammatory disease\nEctopic pregnancy\nCarcinoma cervix\nElephantiasis of the vulva\nPregnancy\nPuberty menorrhagia and postmenopausal bleeding\nFungal infection and sarcoidosis Management:\nIt is treated with anti-tubercular therapy for 6 months (DOT strategy): Indications and contraindications for surgery:\nTypes of surgery include vulvectomy (if vulval hypertrophy is present), removal of the adnexal mass, drainage of pyometra and fistula repair.\nTAH+BSO is rarely required nowadays. Tuboplasty is contraindicated.\nOption B: Ovarian tumors usually don't affect menstrual cycles. Though virilizing tumors can cause amenorrhoea, other features of virilization such as hirsutism, flattening of breasts, and enlargement of the clitoris are generally present.\nOption C: Though ectopic pregnancy may be suspected here, the tube is likely to rupture with exacerbation of pain, bleeding, and peritonitis before six months of gestation. Additionally, the absence of vaginal bleeding/spotting, and the presence of weight loss makes the diagnosis unlikely.\nOption D: Submucous fibroid is associated with menorrhagia.\nFirst 2 months\nNext 4 months\nIsoniazid 15 mg/ kg body wei ghtRifampicin 450-600 mgP yrazinamide 30 mg/body wei ghtEthambutol 30 mg/ kg bo dy weight3 times a week.\nIsoniazid 15 mg/kg body weig htRifampicin 450-600 mg3 ti mes a week\nIndications\nContraindications\nUnresponsiveness of the dise ase in spite of adequate antit ubercular chemotherapy.Tub ercular pyosalpinx, ovarian a bscess or pyometra.Persisten t menorrhagia and/or chronic pelvic pain causing deteriora ting health status\nPresence of active tuberculosi s in extragenital siteFavorabl e response to antimicrobial t herapy with the diminishing size of the pelvic massThe ac cidental discovery of tubercul ar tubo-ovarian mass on lapa rotomy in a young patient.\nSolution to Question 7:\nThe Quantiferon test will be positive in patients having genital TB. It is an indicator of latent tuberculosis. The Quantiferon test measures the release of interferon-gamma by T cells following stimulation by antigens unique to Mycobacterium tuberculosis.\nA differential WBC count shows lymphocytosis at all stages of genital tuberculosis. The ESR is frequently raised and is a non-specific investigation at any stage of the disease. None of these tests can be used for confirmation as these markers are raised in many infections.\nThe Mantoux test is positive in 90% of cases of genital TB. It is indicative of past exposure to the tubercle bacilli. It is not a confirmatory investigation but a negative result indicates tuberculosis to be unlikely.\nSolution to Question 8:\nA wedge-shaped defect is not suggestive of tubercular salpingitis. It is seen at the uterine isthmus in patients with a history of Cesarean section with a uterine scar.\nHysterosalpingography (HSG) features of genital tuberculosis are:\nLead pipe appearance due to rigid nonperistaltic pipe-like tube\nBeading and variation in filling defect\nCalcification of the tube\nJagged fluffiness of the tubal outline\nTobacco-pouch appearance of hydrosalpinx and pyosalpinx\nGolf club appearance with slight or moderate dilatation of the ampullary portion of the fallopian tube.\nRosette type appearance secondary to multiple small diverticular like outpouching surrounding the ampulla produced by caseous ulceration.\nHSG is contraindicated in genital tuberculosis as it causes dissemination of the infection. This further increases the damage to the fallopian tubes.\nThe investigation of choice in genital tuberculosis is an endometrial biopsy. The tubercle bacilli are present in the deeper layers of the endometrium. They come to the surface just before menstruation. Hence, an endometrial biopsy is done 1 or 2 days before menstruation.\nMenstrual blood can also be used for detecting mycobacteria.\nAn HSG showing the features of tuberculous salpingitis is given below.\n\nSolution to Question 9:\nThe given image shows bilateral hydrosalpinx. It appears as a thin-walled structure.\nA hydrosalpinx is a chronic cystic swelling of the fallopian tube that forms after a distal tubal obstruction. The tubes are enormously distended due to filling with clear serous fluid and become retort-shaped. On histology, the tubal plicae appear flattened. The interstitial end of the\ntube is open whereas the fimbrial end is indrawn and closed. This permits the dye to enter but not exit the tube during HSG.\nIt is caused due to:\nPelvic inflammatory disease\nEndometriosis\nTuberculosis - tubercular salpingitis may also cause tobacco-pouch appearance, lead pipe appearance and pyosalpinx\nFallopian tube neoplasms (rare)\nIt can be an incidental finding during a pelvic exam or ultrasound. The patient may be asymptomatic, or present with infertility or chronic pelvic pain.\nOn HSG, it appears as terminal sacculation and occlusion of both fallopian tubes with a normal uterine cavity. Usually, a thin-walled, hypoechoic, cystic structure is seen. However, it may appear as multiple hyperechoic mural nodules around the inner circumference of the tube creating a 'beads on a string' appearance.\nTreatment:\nTreat the underlying cause\nLaparoscopic salpingostomy - in mild disease\nIVF recommended for women with infertility and severe hydrosalpinx\n\nInfertility\nQuestion 1:\nWhat is the accepted minimum period of sexual cohabitation required to establish the diagnosis of infertility in a couple?\nOne year\nTwo years\nSix months\nNine months\nQuestion 2:\nWhat is the most common cause of male infertility?\nDisorders of spermatogenesis\nObstruction of the efferent ducts\nDisorders of sperm motility\nErectile dysfunction\nQuestion 3:\nThe secretion of FSH in men is inhibited by the negative feedback effect of \t.\nInhibin secreted by Sertoli cells\nInhibin secreted by Leydig cells\nTestosterone secreted by Sertoli cells\nAndrostenedione secreted by Leydig cells\nQuestion 4:\nA 25-year-old man underwent semen analysis as a part of an infertility workup. The results are given below. What is the most likely diagnosis?\nOligospermia\nNormospermia\nAsthenospermia\nTeratospermia\nQuestion 5:\nWhile going through a patient's file at an infertility clinic, you note his semen analysis is reported to be normal. What had his semen leukocyte level likely been?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_30.jpeg",
      "OBGYN_img_343.jpeg",
      "OBGYN_img_30.jpeg",
      "OBGYN_img_344.png",
      "OBGYN_img_30.jpeg",
      "OBGYN_img_344.png"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch119_1",
    "question_text": "5 million/ml",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch119_1",
    "question_text": "million/ml",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch119_2",
    "question_text": "million/ml\nTraces\nQuestion 6:\nWhat does azoospermia refer to?\nNo sperm in semen\nNo semen\nLow sperm count\nAbnormal motility of sperm\nQuestion 7:\nA young couple being treated for infertility require donor semen for artificial insemination. Which of the following is the likely cause of infertility here?\nOligospermia\nAzoospermia\nImpotence\nPresence of antisperm antibodies in the cervical mucucs\nQuestion 8:\nIndications for artificial insemination with donor's semen are all except\t.\nAzoospermia\nUncorrectable immunological factors\nMale with hereditary disease\nIdiopathic male infertility\nQuestion 9:\nA 50-year-old man with erectile dysfunction requires treatment with sildenafil. Which of the following is not a contraindication for the use of this drug?\nRetinitis pigmentosa\nDiabetic retinopathy\nConcurrent nitrate therapy\nPulmonary hypertension\nQuestion 10:\nWhat is the most common cause of infertility in women?\nOvarian causes\nUterine causes\nTubal causes\nCervical causes\nQuestion 11:\nA 34-year-old woman presented with secondary infertility following radiation therapy for Hodgkin's lymphoma. You plan to test her ovarian reserve. Which of the following is the best indicator of this parameter?\nLH level\nLH/FSH ratio\nFSH level\nOestradiol level\nQuestion 12:\nWhat will be the level of the anti-Mullerian hormone in low ovarian reserve?\n&lt;1",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_1",
    "question_text": "4\n&gt;7\n&gt;10\nQuestion 13:\nIn a woman diagnosed with infertility, which of the following antihormonal substance can be used to induce ovulation?\nMifepristone\nClomiphene citrate\nTamoxifen\nDanazol\nQuestion 14:\nA woman with irregular periods was evaluated for infertility, and underwent an endometrial biopsy. The histology image is given below. Which phase is seen here?\n\nSecretory phase\nProliferative phase\nMenstrual phase\nOvulation phase\nQuestion 15:\nThe microscopic appearance of the cervical mucus of a woman having irregular periods and infertility is shown in the image below. In which phase of the menstrual cycle was this sample likely taken?\n\nEstrogenic phase\nProgestogenic phase\nAt the time of ovulation\nSecretory phase\nQuestion 16:\nWhich of the following statements is false about the Miller-Kurzrok test?\nPenetration of &gt; 3 cm at 30 minutes is considered normal\nCervical mucus is placed alongside husband's semen on a glass slide\nIt is done at the time of ovulation\nJerky motility of sperm is considered normal\nQuestion 17:\nA post-coital test was done in a couple who presented with an inability to conceive despite staying together for 4 years and having unprotected intercourse. Which of the following conditions cannot be detected by this test?\nFallopian tube block\nCervical factor abnormality\nAbnormal sperm count\nAbnormal sperm morphology\nQuestion 18:\nDuring your posting in the infertility clinic, you notice the following instrument. Identify it.\n\nKarman cannula\nSpackman cannula\nMenstrual regulation syringe\nRubin's cannula\nQuestion 19:\nA patient with secondary amenorrhea and infertility is diagnosed to have Asherman syndrome. Hysteroscopic evaluation revealed 30% adhesions of the endometrial surfaces, but no agglutination of the uterine wall. How would you classify this patient?\nMild Asherman syndrome\nModerate Asherman syndrome\nSevere Asherman syndrome\nCannot be classified with the given information\nQuestion 20:\nA 30-year-old patient with complaints of inability to conceive underwent the following investigation. Which of the following is false about the same?\n\nThe best time to perform it is before ovulation\nIt is perfomed to detect uterine anomalies\nIt is the first-line investigation in genital tuberculosis\nPremedication can be done with atropine\nQuestion 21:\nA patient who has been trying to conceive for the past 6 months underwent hysterosalpingography (HSG). The findings are given below. What is your interpretation?\n\nNormal hysterosalpingogram\nHSG showing blocked tubes\nHSG showing a bicornuate uterus\nHSG showing a filling defect\nQuestion 22:\nWhich the following are not the advantages of fertiloscopy over laparoscopy?\nNo Trendelenburg position\u2014only lithotomy position\nTrauma is avoided as no trocar is needed\nNo CO2\u2014Hydroperitoneum with saline\nGood view of the anterior surface of the ovary and genital organs\nQuestion 23:\nA 26-year-old woman underwent a workup for primary infertility. On hysterosalpingography, there was a bilateral cornual block. What is the next step in management?\nTuboplasty\nHysteroscopy and laparoscopy-guided surgery\nHydrotubation\nIn-vitro fertilization\nQuestion 24:\nA woman came to the clinic complaining of amenorrhoea and inability to conceive. She had undergone hypophysectomy for a tumour a year ago. What would be the best line of management for her?\nClomiphene citrate\nLetrozole\nGnRH analogue\nHuman menopausal gonadotrophin, followed by hCG\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_30.jpeg",
      "OBGYN_img_345.jpeg",
      "OBGYN_img_30.jpeg",
      "OBGYN_img_346.jpeg",
      "OBGYN_img_30.jpeg",
      "OBGYN_img_347.jpeg",
      "OBGYN_img_30.jpeg",
      "OBGYN_img_348.png",
      "OBGYN_img_30.jpeg",
      "OBGYN_img_349.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_1",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_2",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_3",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_4",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_5",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_6",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_7",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_8",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_9",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_10",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_11",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_12",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_13",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_14",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_15",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_16",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_17",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_18",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_19",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_20",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_21",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_22",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_23",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_24",
    "question_text": "\nd\nSolution to Question 1:\nThe accepted minimum period of sexual cohabitation to establish the diagnosis of infertility in a couple is one year of regular, unprotected sexual intercourse.\nInfertility is an apparent failure of a couple to conceive while sterility is an absolute inability to conceive. Infertility is of two types:\nPrimary infertility - when there have been no previous pregnancies.\nSecondary infertility - when there has been a prior pregnancy (although not necessarily a live birth).\nSolution to Question 2:\nThe most common cause of male infertility is disorders of spermatogenesis.\nMale factor is the cause of infertility in about 20% of infertile couples. However, it is a contributing factor for infertility in 50% of cases.\nSolution to Question 3:\nThe secretion of FSH in men is inhibited by the negative feedback effect of inhibin secreted by Sertoli cells.\nGnRH stimulates the anterior pituitary gland to secrete FSH (follicle-stimulating hormone) and LH (luteinizing hormone). FSH acts on Sertoli cells while LH triggers testosterone secretion by the Leydig cells. Sertoli cells secrete inhibin B which in turn inhibits FSH but stimulate LH secretion.\n\nSolution to Question 4:\nIn the given clinical scenario, the most likely diagnosis is normospermia. Different types of disorders of sperms are as follows:\nAspermia is defined as the absence of semen.\nOligospermia is defined as a sperm concentration &lt;15 million/mL.\nSevere oligospermia is defined as a sperm concentration of &lt;5 million/mL.\nTeratospermia is defined as the presence of abnormal sperm morphology.\nAsthenospermia is defined as the absence of motile sperms or diminished sperm motility.\nNecrospermia is defined as the presence of dead sperms.\nNote: Morphology &gt; motility is the most important marker in sperm analysis.\nSolution to Question 5:\nThe normal leucocyte level in human semen is approximately 1 million/ml.\nThe semen sample should be collected after 2-7 days of ejaculatory abstinence. The patient should collect the sample by masturbation at the doctor's office. If not possible, then the sample may be collected at home and delivered to the laboratory within an hour of collection.\nSolution to Question 6:\nAzoospermia is defined as the complete absence of sperm in semen. Other types of sperm disorders are as follows:\nAspermia is defined as the absence of semen.\nOligospermia is defined as a sperm concentration &lt;15 million/mL.\nSevere oligospermia is defined as a sperm concentration of &lt;5 million/mL.\nTeratospermia is defined as the presence of abnormal sperm morphology.\nAsthenospermia is defined as the absence of motile sperms or diminished sperm motility.\nNecrospermia is defined as the presence of dead sperms.\nSolution to Question 7:\nArtificial insemination with donor semen is done in cases of infertility where the husband has azoospermia.\nAzoospermia is defined as a complete absence of sperms. Hence artificial insemination with the husband's/partner's semen cannot be performed.\nIndications for artificial insemination with husband's/partner's semen are:\nChronic medical disorder\nOligospermia after sperm washout\nImpotence\nPremature and retrograde ejaculation\nHypospadias\nAntisperm antibodies in cervical mucus\nUnexplained infertility- direct intraperitoneal insemination (DIPI) is done\nHIV-positive male or female\nX-Y fractionation of sperms for sex selection in cases of genetic and chromosomal abnormalities Indications for artificial insemination with donor semen are:\nAzoospermia\nUncorrectable immunological factors\nGenetic disease in husband/partner\nChronic ill health\nSperms can be frozen and used later for artificial insemination e.g. if the husband requires to undergo radiotherapy or chemotherapy, or if the husband is a frequent traveler and is not available at the time of ovulation.\nArtificial insemination techniques include:\nIntrauterine Insemination (IUI)\nIntrafallopian-tube Insemination\nIntracervical Insemination\nDirect Intraperitoneal Insemination (DIPI)\nSteps required to do artificial insemination are:\nThe semen is washed to remove abnormal sperms, debris, and seminal plasma containing antibodies. It is concentrated, and its quality is improved by the 'swim up technique' or by the use of the Percoll gradient.\nSemen with normal sperms and good motility is obtained.\nAround the time of ovulation, semen obtained is inseminated into the female genital tract. About",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_30.jpeg",
      "OBGYN_img_350.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_0",
    "question_text": "5 ml of semen is injected 36 hours after hCG injection when the ovarian follicle reaches 20 mm.\nSolution to Question 8:\nArtificial insemination with donor's semen is not indicated in idiopathic male infertility. The preferred treatment in such cases is in vitro fertilization (IVF).\nSolution to Question 9:\nPulmonary hypertension is an indication for the use of sildenafil. The contraindications for the use of sildenafil are:\nRetinitis pigmentosa\nDiabetic retinopathy\nPatient on antihypertensive drugs, nitrates\nCardiac disease, previous myocardial infarct, stroke\nIn the treatment of erectile dysfunction, sildenafil in the dose of 25\u2013100 mg is given 1 hour before intercourse. However, it does not improve libido.\nSolution to Question 10:\nThe most common cause for infertility in women is due to ovarian causes.\nAccording to WHO, female factor infertility was reported in 37% of infertile couples in developed countries. Male factor infertility was reported in 8% of infertile couples while 35% of couples had both male and female factor infertility.\nThe major ovarian causes of infertility are:\nAnovulation (PCOS)\nDecreased ovarian reserve, e.g., premature menopause\nIn women with ovulatory disorders, clomifene and metformin increase ovulation and pregnancy rates.\nLess common factors responsible for female infertility are:\nEndometriosis\nPelvic adhesions\nTubal blockage\nOther tubal abnormalities\nHyperprolactinemia\nSolution to Question 11:\nAmong the given options, the level of follicular stimulating hormone (FSH) is the best indicator of ovarian reserve.\nOvarian reserve is the capacity of the ovary to produce eggs. FSH levels are measured in the early follicular phase on day 2 or 3 of the menstrual cycle.\nA high FSH level indicates that the ovarian reserve is getting depleted and fewer oocytes are present in the ovary. FSH is high in ovarian hypofunction and postmenopausal women.\nAnti-Mullerian hormone (AMH) is a better marker than FSH for ovarian reserve. Unlike FSH, its levels can be estimated at any time of the cycle. AMH is produced by the granulosa cells in ovarian follicles.\nNote: Studies show that AMH levels decrease under the current use of oral contraceptive pills and tobacco smoking.\nSolution to Question 12:\nIn low ovarian reserve, the level of anti-Mullerian hormone (AMH) will be &lt;1 ng/ml.\nAMH is a glycoprotein secreted by the granulosa cells of the primordial follicle of the ovary. It helps in oocyte maturation and mono-follicular development. AMH is also used in assessing ovarian reserve.\nIn women, AMH is always absent during embryogenesis and is secreted by the granulosa cells after puberty. It helps in follicular development and oocyte maturation. Estimation of serum AMH is used in the study of ovarian reserve in female infertility and secondary amenorrhoea.\nIn men, AMH starts to be secreted by the Sertoli cells in the testes by the 7th week of intrauterine life. It continues until puberty. It inhibits the development of the M\u00fcllerian system. The absence of AMH results in the development of hermaphroditism.\nAMH levels in ng/ ml\nInterpretation",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_2",
    "question_text": "\u20136.8\nNormal\n<1\nPoor ovarian reserve\n>10\nPCODHyperstimulation synd rome\nSolution to Question 13:\nClomiphene citrate is an antihormonal substance used to induce ovulation in a patient diagnosed with infertility. Ovulation can be induced by giving clomiphene citrate 50 mg daily, starting from day 2 to day 6 of the menstrual cycle for 5 days.\nSolution to Question 14:\nThe image depicts the proliferative phase of the endometrium.\nDuring menstruation, the endometrium goes through three phases, namely; proliferative, secretory, and menstrual phases. Their histological features are given below:\nProliferative phase\nThe glands of the functional layer are simple tubules with regular epithelium.\nArteries become more coiled and spiralled.\nThe endometrium is thick, the stoma is compact and short straight glands are present. The image below shows proliferative endometrium\n\nSecretory phase\nThe secretory phase of the endometrium begins on the 15th day and persists until the onset of menstruation.\nSubnuclear vacuolation (presumptive evidence of progesterone activity)\nCorkscrew-shaped glands\nThe image below shows secretory endometrium\n\nMenstrual phase: Glands shrink with prominent vessels and haemorrhagic spots.\nSolution to Question 15:\nThe image shows the characteristic ferning pattern of cervical mucus which is seen in the estrogenic phase of the menstrual cycle.\nA specimen of cervical mucus is obtained using a platinum loop or pipette. This is spread on a clean glass slide and allowed to dry. When viewed under the low-power microscope, a palm leaf or fern type pattern is seen in the follicular phase. The ferning is due to the presence of sodium chloride in the mucus secreted under the effect of estrogen.\nThis pattern disappears after ovulation. If it was previously present, its disappearance is presumptive evidence of corpus luteum activity. Under the influence of progesterone, the cervical mucus becomes thick and tenacious and impenetrable to sperms and bacteria.\nThe below image shows the microscopic appearance of dried cervical mucus showing the fern appearance.\n\nSolution to Question 16:\nIn the Miller\u2013Kurzrok test, sperm acquiring jerky motility after penetrating cervical mucus is considered abnormal.\nThe Miller-Kurzrok test is a special test done in semen analysis to diagnose the cause of infertility. It is an in vitro test of sperm\u2013mucus interaction.\nIt is based on the basic principle that a normal cervical mucus permits invasion by motile sperms. It is done at the time of ovulation. The test consists of placing cervical mucus on a glass slide alongside the specimen of the husband's semen and studying the penetration of sperms under the microscope. The penetration of sperm &gt; 3 cm into the mucus at 30 minutes is considered normal.\nOther special tests in semen analysis include:\nSperm penetration test\nSemen\u2013cervical mucus contact test\nPostcoital test (Sims\u2019 or Huhner\u2019s test)\nSolution to Question 17:\nThe post-coital test can not detect a fallopian tube block. It can evaluate the following conditions:\nSperm count\nSperm morphology\nFerning during the estrogenic effect\nOvulation\nThe ability of the cervical mucous to allow sperm penetration\nDetection of anti-sperm antibodies in the cervical mucous\nIn the post-coital test, the couple is advised to have intercourse early in the morning close to the ovulation phase. The woman is asked to visit the clinic within 2 hours of having intercourse. The mucus is aspirated from the cervical canal and spread over a glass slide. Another smear made from the posterior fornix serves as a control.\nOn microscopy, 10\u201350 motile sperms are normally seen per high-power field. The cervical mucus is also examined for its quantity and viscosity. The post-coital test is useless in the presence of cervical infection.\nAn immunological factor causing infertility is encountered in around 5% of infertile couples.\nSolution to Question 18:\nThe instrument in the given image is Rubin's cannula.\nIt is used while performing a hysterosalpingogram (HSG). The cone prevents the retrograde spillage of the dye into the vagina, while the dye is instilled into the uterine cavity. This investigation is performed to study tubal patency in women.\nAnother cannula that can be used to perform HSG is Spackman cannula. It allows for the intra-operative manipulation of both anteverted and retroverted uterus.\nSolution to Question 19:\nThis patient would be classified as a case of moderate Asherman syndrome as 30% adhesions of the endometrial surfaces are present.\nAsherman syndrome (uterine synechiae) is classified as follows:\nMinimal: &lt;25% adhesion involves the uterine cavity, flimsy adhesions involving the fundus and tubal ostia.\nModerate: 25\u201370% adhesion of the endometrial surfaces, but no agglutination of the uterine wall.\nSevere: 75% adhesions with agglutination and thick adhesions. Asherman syndrome can present in the following ways:\nSecondary amenorrhea\nOligomenorrhoea\nDysmenorrhoea\nHabitual abortions\nInfertility\nThe causes of Asherman syndrome are:\nDilatation and curettage (D&amp;C)\nMedical termination of pregnancy (MTP), spontaneous abortions, recurrent abortions\nUterine packing in postpartum haemorrhage\nUterine infection\nTubercular endometritis\nSolution to Question 20:\nThe given image shows a hysterosalpingogram (HSG). HSG is contraindicated in genital tuberculosis.\nProcedure of HSG:\nIt is best performed in the period between the last day of menses to ovulation, usually on the 9th/10th day of the cycle.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_30.jpeg",
      "OBGYN_img_351.jpeg",
      "OBGYN_img_31.jpeg",
      "OBGYN_img_352.jpeg",
      "OBGYN_img_31.jpeg",
      "OBGYN_img_353.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_10",
    "question_text": "15ml radioopaque dye is injected into the uterine cavity via Leech-Wilkinson cannula, Rubin's cannula, or Foley's catheter.\nFluoroscopy is performed as the dye passes through the uterine cavity and fallopian tubes.\nIf the tubes are patent, the dye will spill out of the tubal ostia into the peritoneum, and smear the adjacent bowel.\nIt is used for the detection of:\nTubal block - It can be due to:\nStrictures - fibrotic block\nInspissated amorphous material\nTubal spasm - This can occur in apprehensive patients. It is prevented by premedication with atropine and analgesia.\nUterine anomalies\nUterine polyps\nUterine synechiae\nThe feasibility of tuboplasty, by studying the location and extent of tubal pathology. Contraindications:\nGenital tract infections, such as genital tuberculosis. This is due to the risk of spreading infection.\nBleeding\nSuspected pregnancy\nAllergy to the dye\nPremenstrual phase:\nIf by chance pregnancy has occurred, it may be dislodged.\nThick endometrium might prevent the smooth flow of the dye, at the cornual end.\nThere is a risk of embolism and endometriosis if HSG is done during this phase.\nSolution to Question 21:\nThe given image shows a normal hysterosalpingogram (HSG). Both fallopian tubes are patent with a spill into the peritoneal cavity.\nThe following images show the findings of an abnormal hysterosalpingogram:\nThe hysterosalpingogram given below shows bilateral dilated fallopian tubes with no free spill suggestive of bilateral hydrosalpinx:\n\nThe hysterosalpingogram given below shows a unicornuate uterus:\n\nThe hysterosalpingogram given below shows a bicornuate uterus/septate uterus:\nThere is an overlap in the appearance of the bicornuate uterus and septate/sub-septate uterus on HSG. The distinction lies in the shape of the uterine fundus, which is usually not visible on HSG. An ultrasound or MRI should be done to differentiate between these conditions if intervention is planned.\n\nThe hysterosalpingogram given below shows filling defects:\n\nSolution to Question 22:\nFertiloscopy helps in obtaining a good view of the posterior surface (and not the anterior surface) of the ovary and genital organs. This is an advantage of fertiloscopy over laparoscopy.\nThe other advantages of fertiloscopy over laparoscopy are:\nThe Trendelenburg position is not needed. The procedure can be done in a lithotomy position\nTrauma can be avoided as no trocar is needed\nNo CO2: Hydroperitoneum with saline\nPeritoneal spill can be seen\nFertiloscopy is a new mini-invasive diagnostic technique that allows the visualization of the posterior pelvis. In this technique, an optical device is introduced into the pouch of Douglas, through the posterior vaginal fornix, under general/local anaesthesia.\nIt can also be used for small interventions, such as adhesiolysis, ovarian drilling, coagulation of endometriosis spots and to perform chromosalpingoscopy and salpingoscopy. With fertiloscopy, surgical intervention can be avoided and it is a good alternative to diagnostic laparoscopy.\nThe image given below is of a fertiloscope.\n\nSolution to Question 23:\nIn the given clinical scenario, the next step in management will be hysteroscopy and laparoscopy-guided surgery.\nTubal contractions, particularly cornual spasms, can give an incorrect impression of proximal fallopian tube obstruction (a false-positive result) on hysterosalpingography. Laparoscopy with chromotubation is therefore considered to confirm the diagnosis of cornual spasm. Laparoscopy is both diagnostic and therapeutic in this condition.\nHysteroscopy is an operative procedure that provides an endoscopic view of the endometrial cavity and tubal ostia via the cervix, performed in the preovulatory phase. It can\nbe diagnostic or therapeutic. It is the gold standard investigation for visualizing the uterine cavity and tubal ostia.\nContraindications to hysteroscopy are as follows:\nAcute genital tract infection (Eg: genital herpes infection)\nViable intrauterine pregnancy\nDuring menstruation, the view is obscured, and the infection rate is high.\nScarred uterus and enlarged uterus of size \uf0b3 12 weeks are relative contraindications.\nCervical stenosis can cause cervical tears and uterine perforation.\nCardiopulmonary disorder due to increased risk of fluid overload and pulmonary edema.\nKnown cases of cervical cancer\nLaparoscopy is the gold standard for the evaluation of tubal factors in infertility, commonly done in the proliferative phase. It can be diagnostic or therapeutic.\nBenefits of laparoscopic evaluation:\nTubes: For detection of tubal patency, block (site and side), motility, hydrosalpinx change, eritubal adhesions, fimbrial agglutination\nOvaries: PCOS changes, endometriosis, PID, adhesions\nUterus: Anomalies, fibroids\nPeritoneal factors: Adhesions, PID, endometriosis, tuberculosis\nTherapy at the same sitting (as appropriate)\nTherapeuticindications of hys teroscopy\nDiagnosticindications of hyst eroscopy\nUterine septumAsherman sy ndromeRetained IUCDPolyp ectomySubmucous fibroidAb normal uterine bleedingTuba l sterilization using sclerosin g agents\nTo study the endocervical mu cosal liningCongenital malfor mations of the uterusEndom etrial tuberculosisMisplaced I UCDEndometrial lesionsEnd ometrial polypAsherman syn dromeCornual tubal blockage\nDiagnostic\nTherapeutic (Operative)\nAge >35 yearsHistory of pelvi c pain, dyspareunia, pelvic su rgery, adhesionsAbnormal H SGFailure to conceive after a reasonable period (6 months) with normal HSGWomen wi th comorbid pelvic pathology (PID, endometriosis)\nUnexplained infertilityRecon structive tubal surgeryAdhesi olysisFulguration of endomet riotic implantsOvarian drillin g in PCOSGIFT and ZIFT pro cedures\nSolution to Question 24:\nThe best line of management for the given patient is human menopausal gonadotropin (hMG)\nfollowed by hCG.\nThe patients who have undergone hypophysectomy i.e. removal of the pituitary gland, can not produce endogenous gonadotropins. Exogenous gonadotropins such as hMG are given to such patients. Timed administration of hCG is needed to induce ovulation after the follicle has matured.\nThe human menopausal gonadotropin is an extract of urine from postmenopausal women. It contains FSH and LH in the required ratio for follicular growth.\nClomiphene, letrozole, and GnRH analogs stimulate the release of gonadotropins from the pituitary gland. These are not helpful in a patient whose pituitary gland has been removed.\nPerimenopause, Menopause and Post-Menopausal Bleeding\nQuestion 1:\nMenopause is defined as cessation of menses for a period of \t.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_31.jpeg",
      "OBGYN_img_354.jpeg",
      "OBGYN_img_31.jpeg",
      "OBGYN_img_355.jpeg",
      "OBGYN_img_31.jpeg",
      "OBGYN_img_356.jpeg",
      "OBGYN_img_31.jpeg",
      "OBGYN_img_357.jpeg",
      "OBGYN_img_31.jpeg",
      "OBGYN_img_358.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_3",
    "question_text": "months",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_6",
    "question_text": "months",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_9",
    "question_text": "months",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_12",
    "question_text": "months\nQuestion 2:\nA woman with menorrhagia is diagnosed with uterine fibroids. Prior to starting treatment, you want to check if she is premenopausal. On which day of the menstrual cycle will you estimate her FSH levels?\nOn day 2-5 after last menstrual period\nOn day 11-14 after last menstrual period\nOn the day of menstruation\n\u2026ust before menstruation\nQuestion 3:\nWhat is the diagnostic value of FSH in menopause?\n&gt; 40 mIU/mL\n&gt;30 mIU/mL\n&gt;50 mIU/mL\n&gt;20 mIU/mL\nQuestion 4:\nWhat is the average age of menopause?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_55",
    "question_text": "years",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_47",
    "question_text": "years",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_45",
    "question_text": "years",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_50",
    "question_text": "years\nQuestion 5:\nA menopausal woman presents with complaints of hot flushes. Which of the following neurotransmitters are responsible for these symptoms?\nSerotonin and epinephrine\nSerotonin and norepinephrine\nAdrenaline and epinephrine\nNoradrenaline and epinephrine\nQuestion 6:\nA 53-year-old woman presents with episodes of sensation of intense heat involving the face and upper chest which rapidly spreads across the entire body. The episodes last about 2-4 minutes and are associated with profuse sweating. What is the most effective treatment for her?\nCombined Oral contraceptive pills\nClonidine\nEstrogen therapy\nDanazol\nQuestion 7:\nA 53-year-old postmenopausal lady presented with complaints of dyspareunia and vaginal spotting. On examination, the vagina appeared pale with small petechiae. Transvaginal ultrasound revealed a 3mm thick endometrium with no abnormality. Which among the following would be the next step in management?\nPipelle biopsy\nEstradiol-releasing vaginal ring\nMirena intrauterine device\nHysteroscopy\nQuestion 8:\nReduction in breast size in post-menopausal women is due to the withdrawal of \t.\nEstrogen\nProgesterone\nEstrogen and progesterone\nFSH\nQuestion 9:\nA 67-year-old woman is being screened for osteoporosis with a DEXA scan. Which of the following sites are useful for the detection of early rapid bone loss?\nLumbar vertebra\nRadius\nShaft of femur\nWrist\nQuestion 10:\nHormone replacement therapy is not indicated in which of the following patients?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_45",
    "question_text": "year-old woman with severe hot flushes",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_36",
    "question_text": "year-old woman with premature menopause\nAn adolescent with gonadal dysgenesis",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_50",
    "question_text": "year-old woman with ischemic heart disease\nQuestion 11:\nWhich of the following is not a contraindication for estrogen therapy?\nBreast cancer\nUterine cancer\nPrevious history of thromboembolic episode\nHypertension\nQuestion 12:\nWhich of the following is incorrect about hormone replacement therapy and breast cancer?\nCancer risk is not increased up to 3 years of combined HRT\nCancer risk is not increased up to 5 years of estrogen-only replacement therapy\nHRT impedes screening for breast cancer with mammography\nHRT may cause high grade breast cancer with poor prognosis\nQuestion 13:\nYou are prescribing estrogen therapy for a woman with hot flushes. What is the minimum number of days in a month during which you should combine it with progesterone?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_8",
    "question_text": "days",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_10",
    "question_text": "days",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_12",
    "question_text": "days",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_14",
    "question_text": "days\nQuestion 14:\nA 50-year-old woman presents with complaints of vaginal bleeding and mentions that her last menstrual period was 10 months ago. What is the minimum duration of amenorrhoea following which she should be evaluated for possible causes?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_3",
    "question_text": "months",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_6",
    "question_text": "months",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_9",
    "question_text": "months",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_12",
    "question_text": "months\nQuestion 15:\nWhat is the investigation of choice in a 55-year-old woman who presents with post-menopausal bleed?\nPap smear\nEndometrial biopsy\nFractional curettage\nCA-125 estimation\nQuestion 16:\nA 60-year-old woman presented with post-menopausal bleeding. Ultrasonography revealed a mass with feeding vessel as shown in the image below. What is the most likely diagnosis?\n\nFibroid uterus\nEndometrial polyp\nEndometrial carcinoma\nLeiomyosarcoma\nQuestion 17:\nA patient is planned to undergo hysteroscopic polypectomy using bipolar electrocautery. What is the ideal agent for distention?\nGlycine\nNormal saline\nCO2",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_31.jpeg",
      "OBGYN_img_359.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch120_70",
    "question_text": "% dextrose\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_1",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_2",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_3",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_4",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_5",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_6",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_7",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_8",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_9",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_10",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_11",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_12",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_13",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_14",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_15",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_16",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_17",
    "question_text": "\nb\nSolution to Question 1:\nMenopause is defined as cessation of ovarian function for 12 months resulting in permanent amenorrhoea. It is a retrospective diagnosis.\nSolution to Question 2:\nThe follicular stimulating hormone (FSH) level is studied on day 2\u20135 after the last menstrual period to detect the premenopausal stage.\nIt is a period of 3\u20134 years before menopause and is associated with mild ovarian hormonal deficiency leading to menstrual disorders, especially menorrhagia.\nThe climacteric phase is the phase of waning of ovarian activity. It begins 2 to 3 years before menopause and may continue 2-5 years after menopause. It marks the transition from active to inactive ovarian function and involves physical, sexual, and psychological adjustments.\nThe predictors of approaching menopause include:\nA fall in the level of inhibin B and a corresponding rise in FSH level\nA fall in the level of anti-Mullerian hormone (AMH) - This is a better marker of ovarian reserve and can be tested on any day of the cycle.\nSolution to Question 3:\nThe diagnostic value of FSH in menopause is &gt;40 mIU/mL. Hormone levels in menopausal women:\nHormone\nLevel\nEstradiol",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_5",
    "question_text": "to 25 pg/m l\nFSH\n>40 mIU/m L\nLH",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_50",
    "question_text": "100 mIU\nL/ml\nGrowth hormone, inhibin B, AMH\nDecreases\nSolution to Question 4:\nThe average age of menopause in India is 47 years, and ranges from 45 to 50 years.\nMenopause sets in when the follicle number falls below 1000. If this happens before 40 years, it is termed premature menopause while attaining it after 55 years is delayed menopause.\nThe age at which menopause is attained is not related to age at menarche, race, number of pregnancies, socio-economic status, or oral contraceptive pills usage. However, it is directly influenced by smoking and genetic disposition.\nSolution to Question 5:\nNorepinephrine and serotonin are responsible for hot flushes in menopausal women.\nA fall in the level of estrogen causes a reduction in hypothalamic endorphins. This causes a release of more norepinephrine and serotonin, which lower the set point in the thermoregulatory nucleus. As a result, the heat-loss mechanism is triggered by even subtle changes in core body temperature.\nRisk factors for hot flushes:\nLow estradiol levels\nHigh BMI\nSedentary lifestyle\nSurgical menopause has increased risk\nLow socioeconomic status\nHistory of premenstrual dysphoric disorder (PMDD)\nDepression.\nSolution to Question 6:\nThe clinical features are suggestive of vasomotor symptoms (hot flushes) in a menopausal woman for which the most effective treatment is estrogen therapy.\nTreatment options include:\nHormonal\nEstrogen therapy - most effective\nCombined OC pills - given when estrogen is contraindicated\nTibolone\nNon-hormonal\nClonidine\nSSRIs (eg: fluoxetine)\nDopamine antagonist\nNon-prescriptive\nVitamin E\nSoya\nIsoflavones\nHormone therapy is only indicated for the treatment of vasomotor symptoms, osteoporosis\n(prevention and treatment), and vaginal atrophy.\nEndometrial hyperplasia can occur after 6 months of estrogen therapy. Hence, for patients with a uterus, it is recommended to add micronized progesterone. This is not necessary for women who have undergone hysterectomy.\nNote: Even though OCPs contain both estrogen and progesterone, a lesser dosage of each component is given for the treatment of hot flushes.\nSolution to Question 7:\nThe clinical scenario is suggestive of atrophic vaginitis. The next step in management should be topical estrogen therapy such as the estradiol-releasing vaginal ring.\nAtrophic vaginitis is a common cause of post-menopausal bleeding due to low estradiol levels. Patients may present with dry vagina, dyspareunia and a purulent or blood-tinged discharge. The vagina appears pale, dry, and may show petechiae.\nTreatment of atrophic vaginitis involves topical estrogens in the form of creams, tablets, or rings. Estrogen replacement restores vaginal mucosal elasticity, vaginal fluid secretion levels, blood flow, and sensorimotor responses.\nSystemic therapy may help prevent recurrence. Vaginal lubricants and moisturizers can be given for symptomatic relief.\nFOGSI guidelines for evaluation of postmenopausal bleeding:\n\nSolution to Question 8:\nThe reduction in breast size in postmenopausal women is due to the withdrawal of estrogen and progesterone.\nEstrogen exerts proliferative effects on the ductal component, while progesterone exerts a proliferative effect on the glandular component.\nSolution to Question 9:\nEarly rapid bone loss can be determined from a dual-energy x-ray absorptiometry (DEXA) scan of the hip and lumbar vertebra.\nThe risk for most fractures is inversely proportional to bone density. The reference standard for the diagnostic purpose is DEXA at the hip (femoral neck or total hip). These sites are superior to the spine in predicting hip as well as an overall osteoporotic fracture.\nDEXA is used to assess bone mineral density (BMD). It is interpreted as follows:\nCondition\nT Score range\nNormal\n+2.5 and -1.0\nOsteopenia\n-1.0 and -2.5\nOsteoporosis\n-2.5 and below\nSevere or established osteopo rosis\n-2.5 and below with one or m ore fracturesOR-3.5 or below even in the absence of fractur es\nSolution to Question 10:\nHRT is no longer recommended for the management of menopausal women with ischemic heart disease.\nIndications for HRT is as follows:\nSevere hot flushes\nPremature menopause\nSurgical oophorectomy\nTurner syndrome (gonadal dysgenesis).\nSolution to Question 11:\nHypertension is not a contraindication for hormone replacement therapy (HRT). HRT can be initiated in patients with a history of hypertension, diabetes, or smoking; provided they are regularly monitored.\nContraindications of estrogen therapy:\nBreast cancer, uterine cancer, or family history of cancer\nPrevious history of thromboembolic episode\nLiver and gall bladder diseases\nUterine fibroids - as the fibroids may enlarge in size.\nSolution to Question 12:\nBreast cancer developing subsequent to HRT is of low grade and has a good prognosis.\nThe risk of breast cancer is not increased up to 3 years of HRT and 5 years of estrogen-only replacement therapy. Lower risk is seen with the use of dydrogesterone in HRT.\nHRT can cause recurrence of breast cancer and is, therefore, contraindicated in a woman who has been treated for breast cancer.\nHRT increases the density of breast tissue and subsequently impedes the screening for breast cancer with mammography.\nSolution to Question 13:\nA minimum of 12 days (in a month) of progesterone must be added to estrogen therapy. This reduces the risk of endometrial cancer to 2%.\nThe risk of cancer with estrogen therapy is dose and duration-dependent. Combined estrogen and progesterone provides better protection against endometrial cancer.\nTibolone is a safe drug and does not cause endometrial hyperplasia.\nSolution to Question 14:\nVaginal bleeding occurring after 6 months of amenorrhoea in women of menopausal age group should be considered as postmenopausal bleeding and investigated. This must be done irrespective of a previous diagnosis of menopause.\nAll postmenopausal women with unexpected uterine bleeding should be evaluated for endometrial carcinoma. Even in those women who are perimenopausal, endometrial carcinoma must be suspected if they fall under the above-mentioned clinical category.\nSolution to Question 15:\nEndometrial biopsy is the investigation of choice in a case of post-menopausal bleed, as the chances of endometrial cancer are quite high.\nFor those who undergo TVUS and have an EEC (endometrial echo complex) &gt;4 mm, localized thickening, or an indistinct or nonvisible EEC, endometrial sampling is a reasonable next step.\nInvestigations for endometrial carcinoma include:\nEndometrial aspiration biopsy is the first investigation in abnormal uterine bleeding, especially n females &gt;35 years.\nDilatation and fractional curettage was the best method to diagnose but now it is not used.\nHysteroscopy and biopsy is the investigation of choice for endometrial cancer.\nTransvaginal USG is used as an adjunct to endometrial biopsy.\nPap smear is not reliable to diagnose endometrial carcinoma. It is more useful as a screening tool rather than a diagnostic tool.\nIf symptoms of postmenopausal bleeding persist, imaging of the endometrial cavity should be performed with one or a combination of the following: TVUS, contrast sonography, or\nhysteroscopy.\nNote: Surgical staging is the gold standard investigation for staging endometrial carcinoma.\nSolution to Question 16:\nVisualization of a mass with a single feeding vessel on a color Doppler is characteristic of\nan endometrial polyp. In contrast, submucous leiomyomas often receive blood flow from multiple vessels (option A).\nEndometrial polyps are soft, fleshy growths within the uterus that consist of endometrial glands, fibrous stroma, and surface epithelium. Risk factors for endometrial polyps include increasing age, obesity, and tamoxifen use.\nThey are usually asymptomatic. When symptomatic, they present with heavy menstrual bleeding, prolonged bleeding, intermenstrual bleeding, or infertility.\nThe main diagnostic tools for endometrial polyps include transvaginal ultrasound (TVS) with applied color Doppler, saline infusion sonography, and hysteroscopy.\nThe risk factors for the malignant transformation include postmenopausal status, age older than 60, and abnormal bleeding. Other factors such as larger polyp size (&gt;1.5 cm), tamoxifen use, diabetes, and obesity may also contribute to a higher risk.\nHysteroscopic polypectomy may be considered most effective for symptomatic women or those with risk factors for malignant transformation.\nSolution to Question 17:\nNormal saline is the ideal fluid media used for bipolar electrocautery as it can function regardless of the fluid electrolyte content.\nNormal saline and lactated Ringer solutions are commonly used isotonic, electrolyte-containing fluids in operating rooms for diagnostic hysteroscopy procedures. These solutions can cause volume overload and, if rapidly absorbed in large volumes, may lead to pulmonary edema.\nIsotonic, electrolyte-containing fluids are contraindicated for use with monopolar electrosurgical devices because they conduct electrical current, dissipate instrument energy and render the instrument ineffective. Low-viscosity, electrolyte-poor fluids such as 1.5-percent glycine, 3-percent sorbitol, and 5-percent mannitol are preferred as they are non-conductive and can be safely used with monopolar electrosurgical energy devices.\nThe primary risk of using hypotonic, hypoosmolar solutions is the intravascular absorption of these fluids, which can lead to acute hyponatremia and hypo osmolality.\nThe criteria for terminating the procedure for electrolyte-deficient fluid is a deficit of 1 L and electrolyte-rich fluid is a deficit of 2.5 L.\nOvarian Tumors\nQuestion 1:\nWhich is the most common type of ovarian tumor?\nEpithelial tumor\nGranulosa cell tumor\nGonadoblastoma\nSex cord-stromal tumor\nQuestion 2:\nWhich of the following is the most carcinogenic gene in ovarian cancer?\nBRCA 1\nBRCA 2\nMLH1\nMSH2\nQuestion 3:\nWhich among the following reduces the risk of developing ovarian cancers?\nNulliparity\nPolycystic ovary syndrome\nHRT therapy\nBilateral tubectomy\nQuestion 4:\nWhich among the following is the largest benign ovarian tumor?\nSerous cystadenoma\nMucinous cystadenoma\nTeratoma\nDermoid cyst\nQuestion 5:\nWhich of the following is false regarding borderline ovarian tumors?\nMitotic figures are &lt; 4/10 high power field\nStromal invasion is seen",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_31.jpeg",
      "OBGYN_img_360.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_90",
    "question_text": "% survival rate\nSerous type is more common than mucinous type\nQuestion 6:\nWhich of the following statements is false regarding ovarian cysts?\nCobweb appearance is seen on USG in haemorrhagic cyst\nTheca lutein cyst regresses with a fall in hCG levels\nLeutoma of pregnancy is associated with multiple pregnancy\nFollicular cyst is a benign epithelial tumor\nQuestion 7:\nMeigs' syndrome was suspected in a woman with right-sided pleural effusion, ascites, and an ovarian tumor. Which of the following statements is false regarding this condition?\nCan be caused by ovarian fibroma\nThe tumor would be immobile with an irregular surface\nAscites and hydrothorax resolve after resection of the tumor\nPleural effusion is more common on the right side\nQuestion 8:\nAn elderly woman who was found to have an ovarian mass underwent staging laparotomy. Histopathological examination revealed the presence of Psammoma bodies. What is the most probable diagnosis?\nSerous cystadenocarcinoma\nMucinous cystadenocarcinoma\nEmbryonal cell carcinoma\nDermoid tumor\nQuestion 9:\nA 49-year-old woman presented with complaints of dull pain over the right lower abdomen for the past 2 months. CT scan revealed a left-sided multiloculated adnexal mass and exploratory laparotomy showed small mucoid implants scattered in the peritoneal cavity.\nWhich of the following is associated with this condition?\nSerous cystadenoma\nMucinous cystadenoma\nTeratoma\nEmbryonal cell carcinoma\nQuestion 10:\nA 22-year-old woman at 14 weeks of gestation was rushed to the ER with complaints of severe abdominal pain, nausea, and vomiting. USG showed an edematous right ovary with a large cyst and disruption in adnexal flow on Doppler. Which of the following most commonly leads to this condition?\nDysgerminoma\nTeratoma\nThecoma\nTheca lutein cyst\nQuestion 11:\nStaging laparotomy was performed in a teenage girl who presented with an adnexal mass. Histopathological examination showed the following. What is the diagnosis?\n\nMucinous cystadenoma\nKrukenberg tumor\nEndodermal sinus tumor\nDysgerminoma\nQuestion 12:\nWhat is the counterpart of seminoma in females?\nYolk sac tumor\nEmbryonal carcinoma\nEndodermal sinus tumor\nDysgerminoma\nQuestion 13:\nThe most common ovarian tumor in women less than 20 years of age is \t.\nEpithelial tumor\nGerm cell tumor\nGonadoblastoma\nSex-cord stromal tumor\nQuestion 14:\nWhich of the following tumors show raised CA-125 levels?\nDysgerminoma\nEndodermal sinus tumor\nTeratoma\nNon-mucinous cystadenocarcinoma\nQuestion 15:\nA young woman with an adnexal mass is diagnosed with dysgerminoma. Which of the following tumor markers are likely to be elevated in her?\nAlpha feto protein\nLactate Dehydrogenase\nCEA\nCA - 125\nQuestion 16:\nA post-menopausal woman is found to have an adnexal mass on evaluation. Above what risk of malignancy index (RMI) score is there a high risk of ovarian malignancy?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_31.jpeg",
      "OBGYN_img_361.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_180",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_200",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_150",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch121_100",
    "question_text": "\nQuestion 17:\nWhich of the following statements is false regarding Brenner tumor?\nIt resembles fibroma\nIt is associated with Meig's syndrome\nWalthard cell rests and coffee bean nuclei are seen\nIt is not a malignant tumor\nQuestion 18:\nA 31-year-old woman presenting with 12 weeks of amenorrhea and passage of vesicles per vagina is suspected to have a molar pregnancy. On transvaginal ultrasonography, the left ovary appears as shown below. Which of the statements is not true regarding this condition?\n\nRegresses spontaneously after removal of molar pregnancy\nIt is seen with clomiphene administration\nIt is usually bilateral\nOral contraceptive use is a risk factor\nQuestion 19:\nA woman noticed premature breast development in her 7-year-old daughter and brought her to the gynecology OPD. USG revealed a right-sided adnexal mass. The patient underwent laparotomy and the biopsy revealed Call-Exner bodies. Which of the following is true regarding this condition?\nMost common malignant tumor of ovary\nAssociated with endometrial carcinoma\nIt is bilateral\nInhibin A is elevated more than inhibin B\nQuestion 20:\nWhich among the following high-risk patients are suitable for prophylactic oophorectomy?\nNulliparous aged &gt; 35 years\nHistory of ovarian cancer in a 2nd-degree relative\nAbnormal ovary in reproductive age group woman\nOne ovary removed for benign neoplasm\nQuestion 21:\nA 63-year-old woman presented with complaints of pelvic and abdominal pain, and significant weight loss. On CT scan, a bilateral ovarian tumor with pelvic lymph node and liver capsule involvement was seen. What stage does this belong to?\nStage 4A\nStage 2B\nStage 3\nStage 4B\nQuestion 22:\nA 26-year-old nulliparous woman is diagnosed with early-stage ovarian cancer. Which surgery should be done in her case?\nUnilateral oophorectomy\nBilateral oophorectomy\nHysterectomy with bilateral oophorectomy\nDebulking surgery\nQuestion 23:\nWhich of the following ovarian tumors is the most radiosensitive?\nDysgerminoma\nDermoid cyst\nSerous cystadenoma\nTeratoma\nQuestion 24:\nA 62-year-old post-menopausal woman on HRT presented with abdominal pain for the past 6 months. On examination, a non-tender, right adnexal mass was palpable. USG showed a 3 x 3 cm smooth ovarian cyst. What is the next best step in her case?\nReassure and advise regular follow up once in 6 months\nConfirmation of USG findings by CT scan\nExploratory laparotomy for evaluation of cyst\nCA- 125 level estimation; if normal, advise regular follow-up\nQuestion 25:\nExamination of a resected specimen of an ovarian mass reveals signet ring cells are seen as shown below. Which of the following conditions is this associated with?\n\nMucinous cystadenoma\nKrukenberg tumor\nSerous cystadenoma\nYolk sac tumor\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_32.jpeg",
      "OBGYN_img_362.jpeg",
      "OBGYN_img_32.jpeg",
      "OBGYN_img_363.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_1",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_2",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_3",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_4",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_5",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_6",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_7",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_8",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_9",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_10",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_11",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_12",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_13",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_14",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_15",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_16",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_17",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_18",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_19",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_20",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_21",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_22",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_23",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_24",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_25",
    "question_text": "\nb\nSolution to Question 1:\nEpithelial tumors are the most common type of ovarian tumors.\nSolution to Question 2:\nBRCA 1 is the most carcinogenic gene in ovarian cancer.",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_5",
    "question_text": "\u201310% of malignant ovarian tumors are genetic. BRCA 1 is associated with hereditary breast-ovarian cancer syndrome.\nBRCA 1 is on chromosome 17q and BRCA 2 is on chromosome 13q.\nMSH2 and MLH1 gene mutation is seen in hereditary non-polyposis colorectal cancer (HNPCC). It is associated with malignancy of the colon, ovary, and endometrium.\nSolution to Question 3:\nBilateral tubectomy and hysterectomy reduce the risk of ovarian cancer.\nSome ovarian malignancies originate in the fallopian tubes as dysplastic lesions which later spread to the ovary (dropping down theory). Thus, bilateral tubectomy reduces the risk of ovarian malignancy.\nRisk factors for ovarian cancer:\nAdvancing age\nEarly menarche and late menopause\nTalc exposure to the perineum\nFamily history of breast / ovarian cancer\nOvulation induction therapy by clomiphene citrate Protective factors against ovarian cancer:\nUse of oral contraceptive pills\nMultiparity\nBreastfeeding\nAnovulation.\nSolution to Question 4:\nMucinous cystadenoma is the largest benign ovarian tumor.\nMucinous cystadenoma is a mucoid-containing, thick-walled cyst. It is usually multilocular and lined by single columnar epithelium.\nIt is the third most common epithelial tumor of the ovary. It has a 10% chance of becoming malignant. About 40% of dermoid cysts are found in conjunction with mucinous cystadenomas.\n\nSolution to Question 5:\nStromal invasion is not seen in borderline ovarian tumors.\nBorderline tumors of the ovary (also called tumors of low malignant potential) are a heterogeneous group of lesions defined histologically by atypical epithelial proliferation without stromal invasion.\nThe clinical progression of these tumors is distinct from ovarian carcinoma, so they are considered a distinct clinical entity.\nFeatures of borderline ovarian tumors:\nNo stromal invasion\nMitotic figures &lt;4/10 high power field\nSurvival rate is 90%\nUsually occurs between 35-55 years of age\nSerous type is the most common, followed by mucinous type.\nSolution to Question 6:\nFollicular cyst is a physiological/functional cyst of the ovary. Physiological/functional cysts of the ovary:\nFollicular cyst - Failure of rupture of the follicle during ovulation.\nTheca lutein cyst - Stimulation of atretic follicles by abnormal HCG levels. It regresses when hCG levels fall.\nLuteoma of pregnancy - Due to prolonged elevation of hCG, like in multiple pregnancies.\nHemorrhagic ovarian cysts usually occur due to bleeding into the corpus luteum or other functional cysts at the time of ovulation. Hemorrhagic cysts are normal findings in ovulatory women, generally resolving within 8 weeks.\nCobweb appearance on USG in a hemorrhagic cyst is shown below.\n\nSolution to Question 7:\nIn Meig's syndrome, a benign ovarian mass is likely to be seen. Irregular surface and immobility are features of malignant tumors.\nMeig\u2019s syndrome is characterized by a triad of:\nBenign ovarian tumors\nAscites\nRight-sided pleural effusion.\nThe pleural effusions are usually right-sided, even though the left-sided and bilateral effusions are possible.\nTumors causing Meigs' syndrome include ovarian fibroma, granulosa cell tumor, Brenner tumor, or thecoma.\nHowever, when the causative factor is ovarian secondaries, leiomyoma, and benign ovarian cysts\n(such as teratoma and mucinous cystadenoma), the condition is called Pseudo Meigs' syndrome. Resolution of ascites and pleural effusion is seen after the removal of the tumor.\nManagement:\nRepeated paracentesis for ascites.\nUnilateral salpingo-oophorectomy in young patients for preserving fertility\nTotal abdominal hysterectomy with bilateral salpingo-oophorectomy (TAH-BSO) in postmenopausal women.\nNote: Systemic lupus erythematosus (SLE) patients may also have a combination of ascites, pleural effusion, and elevated serum levels of CA-125. This is known as Tjalma syndrome or pseudo-pseudo Meigs\u2019 syndrome.\nSolution to Question 8:\nPsammoma bodies are a histopathological finding of serous cystadenocarcinoma of the ovary.\nThey are calcified structures seen in areas of cellular degeneration. Their presence does not denote malignancy.\nPsammoma bodies are seen in the following conditions:\nPapillary carcinoma of the thyroid\nPapillary serous carcinoma of the endometrium\nSerous cystadenocarcinoma of the ovary\nMeningioma\nThe image below shows Psammoma body.\n\nSolution to Question 9:\nThe above clinical scenario and findings point to a diagnosis of pseudomyxoma peritonei. It is associated with mucinous cystadenoma.\nPseudomyxoma peritonei (PMP) is a rare clinical entity characterized by diffuse intra-abdominal gelatinous and mucoid material on peritoneal surfaces. Spontaneous perforation of a mucinous\ncystadenoma leads to implantation of low-grade malignant tumor cells in the peritoneum. However, the most common cause of pseudomyxoma peritonei is carcinoma of the appendix.\nDiagnosis is by CT, MRI, and laparoscopy. Even after the removal of the ovarian tumor, these cells continue to secrete mucin. Recurrence rates are high.\nSolution to Question 10:\nThe above scenario is suggestive of ovarian torsion. Mature cystic teratoma (dermoid cyst) is the commonest tumor to undergo torsion, especially at the end of the 1st trimester or during puerperium.\nManagement includes derotation and cystectomy in pregnancy irrespective of gestational age. This is also done in non-pregnant women of reproductive age to preserve ovarian function.\nResection is reserved for patients in whom malignancy is suspected.\nDermoid cyst is the most common germ cell tumor. It is also the most common benign tumor of the ovary in the reproductive age group and in pregnancy. It is bilateral in 10-15% of cases.\nDermoid cyst is derived from all three germ cell layers, but ectodermal derivatives are most common. Rokitansky\u2019s protuberance is the most common site for the development of malignancy. It is seen as a projection covered by skin, sebaceous glands, sweat glands, teeth, and bones.\nSometimes thyroid tissue can be seen on histopathological examination, known as struma ovarii. The image below shows a dermoid cyst with Rokitansky protuberance.\n\n\nSolution to Question 11:\nThe given histopathological image shows Schiller-Duval bodies. It is suggestive of a yolk sac tumor\n(endodermal sinus tumor).\nIt is an aggressive malignant germ cell tumor of the ovaries. It occurs in ovaries or testes and sacrococcygeal areas in young children. It is usually unilateral. These tumors are usually associated with raised AFP and alpha 1 antitrypsin.\nThe image below depicts Schiller-Duval bodies. It consists of a central capillary surrounded by tumor cells, present within a cystic space that may be lined by flat to cuboidal tumor cells. 50% of yolk sac tumors have Schiller-Duval bodies and they are pathognomonic when present.\n\nSolution to Question 12:\nThe counterpart of seminoma in females is dysgerminoma. It is a germ cell tumor.\nIt usually arises in young women or in children. It is the most common malignant germ cell tumor diagnosed during pregnancy. They account for approximately 1/3rd of all malignant ovarian germ cell tumors.\nSerum lactate dehydrogenase (LDH) and the isoenzymes LDH-1 and LDH-2 may be used in monitoring individuals or disease recurrence.\nTreatment involves unilateral salpingo-oophorectomy. It is highly radiosensitive and has a good prognosis.\nDysgerminoma was considered to be the most common malignant germ cell tumor of the ovary. Recent data indicates that in the past few decades, their incidence has reduced considerably.\nImmature teratomas are now the most common type of malignant germ cell tumor of the ovary.\nThe image below shows the histopathology of a dygerminoma, characterized by uniform cells resembling primordial germ cells separated by fibrous septa with lymphocytes.\n\nSolution to Question 13:\nGerm cell tumors are the most common ovarian tumor in women aged less than 20 years.\nEpithelial tumours are the commonest tumours. It accounts for 80% of all ovarian malignant tumours.\nSolution to Question 14:\nNon-mucinous cystadenocarcinoma is an epithelial tumor of the ovary. It has elevated CA- 125 levels.\nCA-125 value &gt; 35 U/ml is suggestive of epithelial ovarian cancer. Malignant conditions with raised CA 125 levels:\nOvarian epithelial carcinoma (most common cause)\nEndometrial cancer\nPancreatic cancer\nColon cancer\nBreast cancer\nLung cancer\nLymphoma\nBenign conditions with raised CA 125 levels:\nPregnancy\nPelvic inflammatory disease\nEndometriosis\nUterine fibroid\nNormally elevated in 1% females\nAcute peritonitis\nSolution to Question 15:\nLactate dehydrogenase is the tumor marker in dysgerminoma.\nDysgerminomas are primitive neoplasms. They are the only germ cell malignancy with a significant rate of bilateral ovarian involvement (15-20%).\nIt is seen in young women with an average incidence of 20 years of age. It is the most common malignant germ cell tumor diagnosed during pregnancy. They account for approximately 1/3rd of all malignant ovarian germ cell tumors.\nIt secretes placental alkaline phosphatase (PALP), lactate dehydrogenase (LDH), and \uf062-hCG. Serum lactate dehydrogenase (LDH) and the isoenzymes LDH-1 and LDH-2 may be used in monitoring individuals or disease recurrence.\nTreatment involves unilateral salpingo-oophorectomy. It is highly radiosensitive and has a good prognosis.\nSolution to Question 16:\nRisk of malignancy index (RMI) score of 200 or more indicates a high risk for ovarian cancer in a patient with an adnexal mass.\nRisk of malignancy index (RMI) = U x M x CA125\nU = Ultrasound score\nThe ultrasound result is scored 1 point for each of the following characteristics: multilocular cysts, solid areas, metastases, ascites, and bilateral lesions.\nU = 0 (for an ultrasound score of 0)\nU = 1 (for an ultrasound score of 1)\nU = 3 (for an ultrasound score of 2\u20135).\nM = Menopausal status\nM= 1 (for pre-menopausal)\nM= 3 (for post-menopausal)\nCA-125 = Serum CA-125 level (in IU/ml)\nFor any post-menopausal woman with an ovarian cyst of size &gt;1cm, RMI should be calculated.\nSolution to Question 17:\nBrenner tumors are usually benign but rarely they can turn malignant.\nBrenner tumor (transitional cell tumor) is a benign, epithelial, unilateral tumor, resembling a fibroma. Histologically, Walthard cell rests and coffee bean nuclei are seen.\nBrenner tumor represent only 2-3% of all ovarian neoplasms, and &lt;2% of these tumors are malignant.\nIt is called Meigs' syndrome if the clinical picture is caused by an ovarian fibroma, granulosa cell tumor, Brenner tumor, or thecoma.\nMeig\u2019s syndrome is characterized by a triad of:\nBenign ovarian tumor\nAscites\nRight-sided pleural effusion.\nPseudo Meigs' syndrome is when the causative factor is ovarian secondaries, leiomyoma, and benign ovarian cysts such as teratoma and mucinous cystadenoma.\nThe image given below shows Walthard cell rest.\n\nThe image given below shows coffee bean nuclei.\n\nSolution to Question 18:\nThe above scenario points to a diagnosis of theca lutein cysts in association with molar pregnancy. Theca lutein cysts are not associated with the use of oral contraceptives.\nLutein cysts types :\nGranulosa lutein cysts - They occur due to failure of regression of corpus luteum after 14 days of vulation.\nTheca lutein cysts - They are found in association with hydatidiform moles, choriocarcinoma, and gonadotropin (hCG), or clomiphene therapy.\nTheca lutein cysts occur due to the hyperstimulation of ovaries as a result of high hCG levels in molar pregnancies and other conditions. They are usually bilateral.\nThese cysts usually regress spontaneously in a period of 2-4 months following the evacuation of a molar pregnancy.\nSometimes they can undergo torsion and cause marked pelvic pain. In such instances, laparoscopic untwisting of the cyst has to be done.\nSolution to Question 19:\nThe above clinical scenario points to a diagnosis of granulosa cell tumor. It is associated with carcinoma endometrium.\nGranulosa cell tumors cells are estrogen-secreting ovarian tumors. It is seen in 80% of women over 40 years and 5% of pre-pubertal girls. Precocious puberty is seen due to excess secretion of estrogen.\nIt is a low-grade malignancy. It is almost always unilateral. Tumor marker inhibin B is frequently elevated more than inhibin A. Surgical resection is the treatment of choice.\nOn histopathology, it has characteristic Call-Exner bodies. It appears as a rosette arrangement of cells around an eosinophilic fluid space, as shown below.\n\nSolution to Question 20:\nProphylactic oophorectomy is indicated if one ovary has already been removed for benign neoplasm.\nCandidates suitable for prophylactic oophorectomy:\nNulliparous aged &gt; 45 years\nAny age with a history of ovarian, endometrial, or colon cancer in a 1st-degree relative\nGrossly abnormal ovary in the premenopausal age group\nOne ovary removed for benign neoplasm\nPrevious history of breast carcinoma\nRadiation-induced menopause\nSolution to Question 21:\nStage 3 ovarian cancer is a unilateral or bilateral ovarian tumor with pelvic lymph node and/or regional lymph node involvement and liver capsule involvement.\nGrading of ovarian cancer:\nGrade 1 - well-differentiated cancers have cells that closely resemble normal cells and are less likely to spread or recur.\nGrade 2 - moderately differentiated cancer cells.\nGrade 3 - poorly differentiated cancers show increasing abnormality of appearance compared t normal cells. They are also more likely to spread and recur.\nSolution to Question 22:\nUnilateral oophorectomy is preferred in a young woman who has not completed her family in case of early-stage disease.\nSolution to Question 23:\nDysgerminoma is the most radiosensitive ovarian tumor. They are highly susceptible to radiotherapy.\nSolution to Question 24:\nCA-125 level measurement is the next best step according to the latest RCOG guidelines for post-menopausal ovarian cysts.\nManagement includes the following:\nCalculation of Risk of Malignancy Index (RMI) = U x M x Ca-125, where\nU = ultrasound score\nM = menopausal status\nCa 125 = serum levels\nLaparotomy/laparoscopy only indicated if size &gt;5 cm or RMI &gt;200.\nOption B - CT scan is not recommended for initial evaluation. It is done only for further evaluation and when RMI &gt; 200.\nSolution to Question 25:\nSignet ring cells are seen in Krukenberg tumor.\nA Krukenberg tumor is an ovarian malignancy that metastasized from a primary site, most commonly from the stomach (70%). Carcinomas of the colon, appendix, and breast (mainly invasive lobular carcinoma) are the next most common primary sites.\nThe route of spread may be:\nLymphatic\nHematogenous\nTranscoelomic\nThey are usually bilateral and have a smooth surface with a waxy consistency. They retain the shape of a normal ovary.\nGiven below are the images of the Krukenberg tumor's gross appearance and histological appearance with signet ring cells:\n\n\nVulval & Vaginal Malignancy\nQuestion 1:\nWhich among the following is not a premalignant lesion of vulva?\nPaget\u2019s disease\nLichen sclerosus\nCondyloma lata\nBowen's disease\nQuestion 2:\nWhich of the following is a common differential diagnosis of verrucuos carcinoma?\nCondyloma lata\nCondyloma acuminata\nAdenocarcinoma\nChancre\nQuestion 3:\nA sexually active woman presents with multiple lesions over her genital region as shown below. Which of the following organisms are implicated in this condition?\n",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_32.jpeg",
      "OBGYN_img_364.jpeg",
      "OBGYN_img_32.jpeg",
      "OBGYN_img_365.jpeg",
      "OBGYN_img_32.jpeg",
      "OBGYN_img_366.jpeg",
      "OBGYN_img_32.jpeg",
      "OBGYN_img_367.jpeg",
      "OBGYN_img_32.jpeg",
      "OBGYN_img_368.jpeg",
      "OBGYN_img_32.jpeg",
      "OBGYN_img_369.jpeg",
      "OBGYN_img_32.jpeg",
      "OBGYN_img_370.jpeg",
      "OBGYN_img_32.jpeg",
      "OBGYN_img_371.jpeg",
      "OBGYN_img_33.jpeg",
      "OBGYN_img_372.jpeg",
      "OBGYN_img_33.jpeg",
      "OBGYN_img_373.jpeg",
      "OBGYN_img_33.jpeg",
      "OBGYN_img_374.jpeg",
      "OBGYN_img_33.jpeg",
      "OBGYN_img_375.jpeg",
      "OBGYN_img_33.jpeg",
      "OBGYN_img_376.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch122_2",
    "question_text": ", 3 &amp; 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch123_1",
    "question_text": ", 3 &amp; 5\nOnly 4",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch123_2",
    "question_text": "&amp; 4\nQuestion 4:\nWhat is the earliest symptom in patients with vulval intraepithelial neoplasia?\nPruritus\nWhite discharge per vagina\nDyspareunia\nVaginal bleedin\nQuestion 5:\nA woman with vaginal itching is suspected to have vulval intraepithelial neoplasia. Which of the following is the most common cause of this condition?\nHPV 16\nHPV 18\nHSV 2\nGardnerella vaginalis\nQuestion 6:\nAn elderly woman is diagnosed with vulval intraepithelial neoplasia 3. Which of the following is false regarding this condition?\nSingle lesion\nAssociated with lichen sclerosis\nProgress to invasive cancer\nHuman papilloma virus +ve\nQuestion 7:\nSentinel lymph node biopsy is most useful in which of the following gynecological malignancies?\nCarcinoma vagina\nCarcinoma vulva\nCarcinoma cervix\nCarcinoma endometrium\nQuestion 8:\nWhich is most common type of vulval cancer?\nSquamous cell carcinoma\nAdenocarcinoma\nBasal cell carcinoma\nClear cell carcinoma\nQuestion 9:\nWhat is the most common type of vaginal cancer likely to be seen in a woman with a history of intrauterine di-ethyl stilbesterol exposure?\nSquamous cell carcinoma\nMelanoma\nClear cell adenocarcinoma\nFibrosarcoma\nQuestion 10:\nWhat is the most common site of vulval cancers?\nClitoris\nLabia majora\nLabia minora\nPerineal area\nQuestion 11:\nVulvar carcinoma was diagnosed in a 68-year-old woman who presented with itching and mass over the vulva for 6 months. Sentinel lymph node biopsy revealed positive inguinal nodes. What is the stage of the tumor?\nStage I\nStage II\nStage III\nStage IV\nQuestion 12:\nIn patients with vulval cancer, what is the least common route through which the malignancy spreads?\nDirect\nLymphatic\nVascular\nTranscoelomic\nQuestion 13:\nAn elderly woman is found to have abnormal cells on a pap smear. Further investigations reveal vaginal squamous cell carcinoma extending up to the pelvic wall. There is no evidence of distant metastasis. What is the stage of the tumor in this patient?\nStage I\nStage II\nStage III\nStage IV\nQuestion 14:\nA 70-year-old presented with a lesion over the vulva as shown below. Bilateral inguinal lymph nodes were palpable. Biopsy of the lesion revealed cells containing large, pleomorphic nuclei. Which of the following is false regarding this condition?\n\nIt is the 2nd most common vulval cancer\nThe most common site is clitoris\nIt may arise from a junctional naevus\nRadical vulvectomy with bilateral regional lymphadenectomy is the preferred treatment\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_33.jpeg",
      "OBGYN_img_377.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_1",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_2",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_3",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_4",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_5",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_6",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_7",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_8",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_9",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_10",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_11",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_12",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_13",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_14",
    "question_text": "\nb\nSolution to Question 1:\nCondyloma lata is not a premalignant lesion of vulva. Premalignant lesions of the vulva include:\nVulval intraepithelial neoplasia (VIN) - most common\nPaget\u2019s disease\nLichen sclerosus\nSquamous cell hyperplasia\nCondyloma acuminata\nBowen\u2019s disease (erythroplasia of Querat)\nSolution to Question 2:\nCondyloma acuminata is the common differential diagnosis of verrucous carcinoma. It refers to anogenital warts and has a verrucous appearance.\nVerrucous carcinoma is a variant of squamous cell carcinoma of the cervix. It is locally invasive and rarely metastasizes.\nCondyloma lata is a benign and painless cutaneous manifestation of secondary syphilis. It is characterized by gray to white lesions, typically located in the oro-genital region.\nChancre is a painless genital ulcer most commonly formed during the primary stage of syphilis.\nSolution to Question 3:\nThe given scenario and image are suggestive of genital warts. Human papillomavirus (HPV) 6 and 11 cause nearly all genital warts.\nIt is usually clinically diagnosed but if co-existing neoplasia is suspected then a biopsy is required. HPV serotyping is not required for routine diagnosis.\nSolution to Question 4:\nPruritus is the earliest symptom of VIN as well as vulvar cancer. Clinical features of VIN include:\nPruritus\nWhite discharge per vagina\nDyspareunia\nVaginal bleedin\nSolution to Question 5:\nHPV 16 is the most common cause of vulval intraepithelial neoplasia (VIN).\nCauses of VIN include:\nHPV 16, 18, 31, 33\nHSV 2\nSyphilis\nGonorrhea\nGardnerella vaginalis\nSolution to Question 6:\nElderly women with vulval intraepithelial neoplasia (VIN) - 3 are HPV negative. VIN 3 is of two types:\nYoung women \u2013 HPV +ve, multiple lesion, 90% regress\nElderly women \u2013 HPV \u2013ve, single lesion, associated with lichen sclerosis, often progress to invasive cancer\nSolution to Question 7:\nAmong the given gynecological malignancies, sentinel lymph node biopsy (SLNB) is most useful in vulval carcinomas.\nThis is because women with earlier stages of vulval cancer can have diseased lymph nodes even without palpable enlargement of nodes. Hence, sentinel lymph node biopsy helps in early diagnosis lymph node spread which can be managed by lymph node dissection.\nA sentinel lymph node is a physiologically, the first lymph node to receive tumor lymphatic drainage.\nMalignancies where sentinel lymph node biopsy is commonly done are :\nVulval carcinoma\nBreast carcinoma\nPenile carcinoma\nMalignant melanoma\nLymphatic mapping is similar technique to SLNB that can also be used in vulval cancers.\nSolution to Question 8:\nSquamous cell carcinoma is the most common type of vulval cancer. Other types of vulval cancer include:\nAdenocarcinoma\nMelanoma\nBasal cell carcinoma\nSarcoma\nSolution to Question 9:\nClear cell adenocarcinoma of the vagina is commonly seen in adoloscent girls with a history of intrauterine DES exposure.\nIt involves the upper third of the anterior vaginal wall. Radical hysterectomy, vaginectomy with pelvic lymphadenectomy is the treatment of choice.\nThe most common lesion due to DES exposure is vaginal adenosis and not clear cell adenocarcinoma. It is a benign condition.\nSolution to Question 10:\nThe most common site of vulval cancer is labia majora &gt; clitoris &gt; labia minora.\nSolution to Question 11:\nAccording to FIGO staging, tumor with positive inguinal lymph node is classified as stage III.\nSolution to Question 12:\nVascular route of spread is rare in vulval cancer. Lymphatic is the most common route of spread in vulval cancer.\nLymph node status is the most important prognostic factor. The sentinel lymph node biopsy is helpful for evaluating the spread of vulval cancer. Lymph nodes involved are, superficial inguinal nodes (sentinel node) &gt; deep inguinal nodes &gt; femoral group of nodes.\nSolution to Question 13:\nVaginal cancer extending up to the pelvic wall is stage III.\nVaginal cancer commonly affects females &gt;70 years of age. Squamous cell carcinoma is the most common histologic type. It commonly involves the upper third of the posterior wall of the vagina.\nPatients are mostly asymptomatic. They may present with painless abnormal vaginal bleeding, post-coital bleed, and foul-smelling discharge per vagina.\nVaginal cancer staging:\nStage 0 - Vaginal intraepithelial neoplasia\nStage I - Carcinoma limited to the vaginal wall\nStage II - Carcinoma extending beyond the vagina, but not extending to the pelvic walls\nStage III - Carcinoma extends up to the pelvic walls\nStage IVA - Carcinoma extending beyond the true pelvis/or involving the bladder and/or rectum, or evidence of distant metastasis\nStage IVB - Spread to the distant metastasis\nSolution to Question 14:\nThe given scenario is suggestive of vulval melanoma. The most commonly involved site is labia majora followed by labia minora and clitoris.\nVulval melanoma is the second most common vulval cancer. It may arise from junctional naevus. It has a high propensity for local and distant recurrence and has a poor prognosis.\nRadical vulvectomy and bilateral regional lymphadenectomy is the preferred treatment.\nCarcinoma Cervix\nQuestion 1:\nWhich serotype of HPV is responsible for carcinoma cervix?",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_6",
    "question_text": ", 11 31, 32",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_16",
    "question_text": ", 18, 31, 32",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_6",
    "question_text": ", 11, 16, 18",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_16",
    "question_text": ", 18, 31, 33\nQuestion 2:\nWhich of the following is not true regarding HPV?\nE1 and E2 are viral proteins needed for replication\nE6 and E7 are viral proteins needed for malignant transformation\nE6 acts via the retinoblastoma gene\nHPV 16 is the most common serotype causing carcinoma cervix\nQuestion 3:\nWhich is the HPV serotype most commonly associated with carcinoma cervix?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_16",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_18",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_31",
    "question_text": "",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_33",
    "question_text": "\nQuestion 4:\nWhich of the following is false about the Cervarix vaccine?\nProtects against HPV types 16 and 18\nDose is 0.5ml, intramuscular\nProtective against genital warts\nDosing schedule \u2013 0, 1 and 6 months\nQuestion 5:\nHPV nonavalent vaccine is active against which of the following serotypes?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_6",
    "question_text": ", 11, 16, 18, 20, 23, 35, 42, 52",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_6",
    "question_text": ", 11, 16, 19, 23, 33, 45, 58",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_6",
    "question_text": ", 11, 16, 18, 32, 34, 45, 52, 58",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch124_6",
    "question_text": ", 11, 16, 18, 31, 33, 45, 52, 58\nQuestion 6:\nA 45-year-old patient comes with repeated infections of trichomonas vaginitis, her physician advises for a Pap smear. She asks you regarding the purpose of this test. What would be your appropriate response?\nIt is a screening test for cervical cancer\nIt is a diagnostic test for trichomonas infection\nIt helps to diagnose cancer in her genital trac\nIt helps to diagnose other associated genital infections in her\nQuestion 7:\nA 24-year-old woman comes to the gynecology OPD for a routine Pap smear. The histopathology slide is shown below. Identify the cell marked as \"A\".\n\nSuperficial cell\nBasal cell\nParabasal cell\nIntermediate cell\nQuestion 8:\nMatch the following:\nA-2, B-1, C-4, D-5, E-3\nA-2, B-1, C-4, D-3, E-5\nA-1, B-2, C-4, D-5, E-3\nA-2, B-1, C-3, D-5, E-4\nQuestion 9:\nA 45-year-old lady complains of post-coital bleeding. She has a positive pap smear. What is the next line of management?\nColposcopy directed biopsy\nCone biopsy\nRepeat pap smear\nHysterectomy\nQuestion 10:\nA 30-year-old sex worker presented with irregular menses, post-coital bleeding, and occasional foul-smelling vaginal discharge. She was advised to undergo a Pap smear. What is the best time for this investigation?\nImmediately after menstruation\nAround ovulation\nSecretory phase\nDuring menstruation\nQuestion 11:\nWhich of the following is false about Schiller's test?\nLugol's iodine is used to paint the cervix\nThe epithelium is stained mahogany brown\nAbnormal vaginal epithelium is stained\nIt detects the presence of glycogen in the epithelium\nQuestion 12:\nWhich of the following would you not expect to see in the colposcopic biopsy of a patient with cervical intraepithelial neoplasia?\nDysplasia\nBreach in basement membrane\nAltered N:C ratio\nMitotic figures\nQuestion 13:\nWhich of the following methods is most commonly used for the treatment of CIN?\nCold-knife conization\nLarge loop excision of transformation zone\nElectrocoagulation\nNeedle excision of transformation zone\nQuestion 14:\nWhich among the following is the treatment of choice when microinvasion of cervix neoplasia is suspected?\nLLTEZ\nLEEP\nConization\nHysterectomy\nQuestion 15:\nA 40-year-old woman has cervical intraepithelial neoplasia III. What would be the management?\nHysterectomy\nTrachelectomy\nConization\nColposcopy with LEEP\nQuestion 16:\nWhich is the most common malignancy in women in India?\nCervical cancer\nBreast cancer\nEndometrial cancer\nOvarian cancer\nQuestion 17:\nWhich of the following is false regarding the transitional zone?\nCIN originates from this site\nIt is a dynamic poin\nNabothian cysts mark the original site\nIt is limited to external os\nQuestion 18:\nIdentify the false statement regarding adenocarcinoma of the cervix.\nMost common site is transformation zone\nCervical cancer is the second most common cancer among women in India\nMost common in OCP users\nAssociated with HPV 18\nQuestion 19:\nYou would suspect and evaluate for carcinoma cervix in patients presenting with which of the following conditions?\nMenorrhagia\nMetrorrhagia\nPolymenorrhea\nAmenorrhea\nQuestion 20:\nWhat is the most common site of hematogenous metastasis of cervical cancer?\nLung\nLiver\nBone\nBowel\nQuestion 21:\nA 65-year-old woman comes for follow-up a few months after surgery for carcinoma cervix. On evaluation, she is found to have a recurrence of the malignancy. Which of the following is true about her condition?\nMost common site of recurrence is pelvic lymph node\nMortality in patients with recurrence is due to pulmonary embolism\nTreatment involves surgery with lymph node dissection\nRecurrent tumor with largest diameter &lt;3cm has good prognosis\nQuestion 22:\nIdentify the true statement about the staging of cancer cervix.\nClinical examination is the first step in staging\nTumor markers are important for diagnosis of metastasis\nCT scan is the best method to assess principal tumors\nMRI is the best method to assess nodal metastasis\nQuestion 23:\nThe CT of a patient with cervical carcinoma revealed a lesion of 6 cm, extending to the upper part of the vagina and parametrium. What is the stage of the disease?\nStage II A\nStage II B\nStage III A\nStage III B\nQuestion 24:\nA 50-year-old woman presented to her gynecologist with postcoital bleeding. She was diagnosed with carcinoma cervix stage IB after evaluation. What is the treatment of choice for this patient?\nType I hysterectomy\nType II hysterectomy\nType III hysterectomy\nType IV hysterectomy\nQuestion 25:\nA 30-year-old woman is found to have a lesion in the cervix which is 7mm wide and has a depth of 4mm. She has one child and wishes to preserve fertility. What is the most\nappropriate management?\nCryoablation\nCone biopsy\nRadical trachelectomy with pelvic lymphadenectomy\nLEEP\nQuestion 26:\nWhich among the following are contraindications for radiotherapy in carcinoma cervix?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_33.jpeg",
      "OBGYN_img_378.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch125_1",
    "question_text": ", 2, 3",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch125_2",
    "question_text": ", 4, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch126_1",
    "question_text": ", 2, 3, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch126_1",
    "question_text": ", 2, 4, 5\nQuestion 27:\nYou are planning to administer radiotherapy to a 58-year-old woman diagnosed with carcinoma cervix. What is the dose to be administered at point B?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch126_7000",
    "question_text": "cGY",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch126_6000",
    "question_text": "cGY",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch126_5000",
    "question_text": "cGy",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch126_8000",
    "question_text": "cGy\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_1",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_2",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_3",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_4",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_5",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_6",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_7",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_8",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_9",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_10",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_11",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_12",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_13",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_14",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_15",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_16",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_17",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_18",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_19",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_20",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_21",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_22",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_23",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_24",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_25",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_26",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_27",
    "question_text": "\nb\nSolution to Question 1:\nHPV serotypes 16, 18, 31, 33, 35, 39, 45, 52, 56, 58, 59, 68 are associated with carcinoma cervix. Risk factors for carcinoma cervix include:\nHuman Papilloma virus (most important)\nSexual intercourse before 18 years\nMultiple sexual partners\nMultiparity\nPoor personal hygiene\nSmoking and drug abuse\nWomen with STD, HIV, HSV\nImmune suppression\nPolymerase chain reaction (PCR) or southern blot or Hybrid capture technique is used for HPV DNA detection.\nSolution to Question 2:\nE6 acts via the tumor suppression gene p53. It increases proteasome-dependent p53 degradation. E7 binds and acts via the retinoblastoma (Rb) gene.\nThe viral E6 and E7 oncoproteins encoded by the high-risk type HPVs (such as HPV 16 and HPV 18) are necessary for malignant transformation.\nE1 and E2 oncoproteins are responsible for viral replication.\nSolution to Question 3:\nHPV 16 is the most common type associated with carcinoma cervix.\nAssociations between human papilloma virus (HPV) serotypes and carcinoma cervix:\nMost common serotype - HPV 16\nMost malignant serotype - HPV 18\nMost specific serotype - HPV 18\nMost common serotype associated with\nSquamous cell carcinoma - HPV 16\nAdenocarcinoma - HPV 18 Cancers caused by HPV:\nMale - penile, oral, anal\nFemale - cervix, vagina, vulva\nSolution to Question 4:\nThe Cervarix vaccine is not protective against genital warts. It is mainly protective against CIN and cervical cancer.\nVaccine Type\nCervarix\nGardasil\nGardasil 9\nBivalent vaccine\nQuadrivalent vaccine\nNonavalent vaccine\nHPV types\nHPV 16,18\nHPV 6, 11, 16, 18\nHPV 6, 11, 16, 18, 31, 33, 45,",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_52",
    "question_text": ", and 58\nDosage",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_0",
    "question_text": "5 mL",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_0",
    "question_text": "5 mL",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_0",
    "question_text": "5 mL\nSchedule",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_0",
    "question_text": ", 1, 6 months",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_0",
    "question_text": ", 2, 6 months",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_0",
    "question_text": ", 2, 6months\nVaccine Type\nCervarix\nGardasil\nGardasil 9\nDiseases prevent ed\nCINCarcinoma cer vix\nCINCarcinoma cervixGenital warts\nCINCarcinomacervixGenital wartsVulvalcancerVaginalepit helial cancerOropharyngealca ncer\nAdjuvant\nAS04\nAlum\nAlum\nSolution to Question 5:\nHPV nonavalent vaccine (Gardasil 9 or HPV9) is active against HPV 6,11,16,18,31,33,45,52,58.\nCurrently, HPV nonnavalent vaccine has replaced Gardasil which is a quadrivalent vaccine acting against 6,11,16,18.\nVaccines available for HPV:\nBrand name\nCervarix\nGardasil\nGardasil-9\nCervavac\nCharacteristic and HPV subtypes\nBivalent:16,18\nQuadrivalent:6,11,1 6,18\nNonavalent:6,11,16, 18,31,33,45,52,58\nQuadrivalent:6,11,1 6,18\nProtects against:\nCINCA cervix\nAnogenital wartsCI NCA cervix\nAnogenital wartsCI NCA cervixVulvalin traepithelialneoplas iaVaginalintraepith elialneoplasiaAnal c ancerOropharyngea l cancerHead and n eck cancers\nAnogenital wartsCI NCA cervix\nDose",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_0",
    "question_text": "5 ml,IM.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_0",
    "question_text": "5 ml,IM.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_0",
    "question_text": "5 ml,IM.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_0",
    "question_text": "5 ml,IM.\nIdeal Age range:\nIdeally at 11-12 year s or9-26 years\nIdeally at 11-12 year s or9-26 years\nIdeally at 11-12 year s or9-26 years\nThe targeted age gr oup is 9-26 years\nSolution to Question 6:\nA pap smear is a screening test for cervical cancer. It is not a diagnostic test (option C). The presence of abnormal cells/ a positive test requires further evaluation by colposcopy, cervical biopsy, or fractional curettage.\nIf trichomonas is reported from Pap testing, it should be confirmed by saline microscopic preparation (option B).\nCervical cancer screening should start at age 21. Women aged 21-29 should have a Pap smear every 3 years, while women aged 30-65 should have both HPV and Pap co-test every 5\nyears. Women should stop having cervical cancer screening after the age of 65 years. If suspicious PAP, screening till 75 years. HIV+ women should have annual checkups until three consecutive negative tests followed by testing every 3 years for life.\nPap testing should be done prior to vaginal examination. Lubricants should not be used and the patient should not be menstruating during the pap test. The patient should not have intercourse 24hrs prior to the test. The ideal time is around ovulation.\nProcedure:\nThe patient is put in a dorsal position, and the labia are parted\nCusco\u2019s self-retaining speculum is introduced\nThe squamocolumnar junction is scraped with Ayer\u2019s spatula:\nBifid end - ectocervical sample\nBlunt end - vaginal cytology\nEndocervix is scraped with a cytobrush\nThe sample is spread on a glass slide\nThe slide is immediately fixed using 95% ethyl alcohol\nStained with Papanicolau stain or short-duration Papanicolau stain (SPS).\n\n\nSolution to Question 7:\nThe cell marked A is the superficial cell.\nACOG guidelines recommend cervical exfoliative cytology every 3 years starting 21 years as screening for cervical cancer.\nThe image below shows a superficial cell (a) and an intermediate cell (b):\n\nThe image below shows parabasal cells (marked by black arrows):\n\nKoilocytes are epithelial cells that contain eccentric, hyperchromatic, moderately enlarged nucleus hat is displaced by large perinuclear vacuole. It is a feature of HPV infection.\n\nSolution to Question 8:\nVarious systems of classification are used to describe cervical cytology after Pap smear such as:\nPapanicolaou classification - describes the exfoliative cytology of the cervix in a Pap smear.\nCervical intraepithelial neoplasia (CIN) - histopathological description of how much of the hickness of the cervical epithelium is replaced by dysplastic cells\nBethesda classification - it is another method to describe cervical dysplasia The various systems and their corresponding classes are given below:\nwhere, CIS: Carcinoma in situ, CIN: Cervical intraepithelial neoplasia, SCC: Squamous cell carcinoma, SIL: Squamous intraepithelial lesion, ASCUS: Atypical squamous cell of undetermined significance, HPV: Human papillomavirus.\nPap classification (1943)\nCervical intraepithelial neopl asia / CIN (WHO 1975)\nBethesda system\nGrade I\nNormal\nNormal\nGrade II\nInflammatory\nInflammatoryHPV ASCUS\nGrade III\nCIN I\nLow SIL\nGrade IV\nCIN II, CIN III, CIS\nHigh SIL\nGrade V\nSCC\nSCC\nSolution to Question 9:\nThe appropriate management of a 45-year-old with a positive pap smear and post-coital bleeding is a colposcopy-directed biopsy.\nA per speculum examination must be done whenever a female comes with post-coital bleeding in order to evaluate for carcinoma of the cervix. If growth is visible, a punch biopsy should be done, and else if no growth is visible, then a pap smear is done. A pap smear is a screening test for cervical cancer. The presence of abnormal cells/ a positive test requires further evaluation by colposcopy, cervical biopsy, or fractional curettage.\nCervical cancer screening should start at age 21. Women aged 21-29 should have a pap smear every 3 years, while women aged 30-65 should have both HPV and pap co-test every 5\nyears. Women should stop having cervical cancer screening after the age of 65 years. If a pap smear is suspicious, then screening is continued till 75 years. HIV+ve women should have annual checkups until three consecutive negative tests followed by testing every 3 years for life.\nPap testing should be done prior to vaginal examination. Lubricants should not be used and the patient should not be menstruating during the pap test. The patient should not have intercourse 24hrs prior to the test. The ideal time is around ovulation.\nSolution to Question 10:\nThe given case scenario is suggestive of cervical carcinoma. The best time to do a Pap smear is around ovulation, but it can be performed at any other time as well.\nPrerequisites of doing a Pap smear:\nIt should be done prior to vaginal examination\nLubricants should not be used\nThe patient should not be menstruating during the pap tes\nThe ideal time is around ovulation\nThe patient should not have intercourse 24hrs prior to the test.\nBased on Pap smear findings, dysplasia of cervical cells is graded using various classification systems such as WHO grading, CIN grading, and the Bethesda system.\n\nSolution to Question 11:\nThe abnormal cells remain unstained on performing Schiller's test.\nSchiller's test, also known as VILI (visual inspection with Lugol's iodine), involves painting the cervix with Lugol's iodine. It is used to detect any abnormal cytology in the cervix and vagina, such as in cases of carcinoma cervix.\nThe normal vaginal and cervical epithelium contains glycogen, therefore stains mahogany brown on being painted with Lugol's iodine. The abnormal cells remain unstained. These areas need to be biopsied and sent for histopathological examination.\nSolution to Question 12:\nThe basement membrane is intact in cervical intraepithelial neoplasia (CIN).\nFeatures of CIN:\nVarying degree of dysplasia\nAltered nuclear-cytoplasmic (N:C) ratio\nHyperchromatic nuclei\nMitotic figures\nIntact basement membrane.\nSolution to Question 13:\nLarge loop excision of the transformation zone (LLETZ) is the most commonly used treatment option for cervical intraepithelial neoplasia (CIN). It is also known as loop electrosurgical excision procedure (LEEP).\nIt is applicable for the treatment of CIN anywhere in the lower genital tract. This uses electric current through a monopolar wire electrode to either cut or coagulate cervical lesions. Like other excisional procedures, it is done in the immediate post menstrual phase.\nThe procedure involves minimal patient discomfort, cost, and complications. Since it can be performed using local anesthesia, it has become the primary outpatient treatment modality for high-grade cervical lesions.\nSolution to Question 14:\nConization is the treatment of choice when microinvasion is suspected.\nIndications of conization\nEndocervical dysplasia\nTransformation zone is not completely visualized\nWhen there is discrepancy of findings between cytolology, colposcopy &amp; biopsy\nMicroinvasion is suspected\nIndications of hysterectomy\nOlder &amp; parous women\nUterus is associated with fibroid, DUB, prolapsed\nRecurrence or persistent lesion\nIn-situ adenocarcinoma cervix\nSolution to Question 15:\nColposcopy with LEEP would be appropriate management for CIN III.\nLoop electrosurgical excision procedure (LEEP) is an opd procedure done under colposcopic view and local anesthesia.Here, a low voltage current is passed through the loop and a cone of tissue is removed from the cervix. This procedure causes minimal bleeding and the tissue removed is sent for histopathological examination (HPE). This is the treatment of choice for CIN 2&amp;3 of any age and parity.\nSolution to Question 16:\nBreast cancer is the most common cancer in women in India as well as globally. Cervical cancer is the most common genital cancer in India.\nLip and oral cavity cancer is the most common malignancy in men. Risk factors for carcinoma cervix include:\nHuman Papilloma virus (most important)\nSexual intercourse before 18 years\nMultiple sexual partners\nMultiparity\nPoor personal hygiene\nSmoking and drug abuse\nWomen with STD, HIV, HSV\nImmune suppression\nSolution to Question 17:\nThe transitional zone or squamocolumnar junction is well outside the external os during the reproductive period.\nIt is the site where the squamous epithelium lining the vagina merges with the columnar epithelium of the endocervix. The original squamocolumnar junction is marked by the presence of Nabothian cysts and glandular openings.\nIt is a dynamic part and moves with age and hormonal influence:\nDuring pregnancy and with oral contraceptives, it pouts out of os.\nFollowing menopause, it gets indrawn inside the os.\nThe cells here are highly sensitive to irritants, mutagens and viral agents such as HPV. Cancer screening using Pap smear involves scraping this area and studying the cells for nuclear changes.\nSolution to Question 18:\nThe most common site of adenocarcinoma is endocervix.\nIt commonly occurs in young females and OCP users, and is associated with HPV 18.\nSolution to Question 19:\nPatients with carcinoma cervix most commonly present with metrorrhagia, now known as intermenstrual bleeding.\nPost-coital bleeding is the most specific symptom of carcinoma cervix.\nSolution to Question 20:\nThe most common site of hematogenous metastasis of cervical cancer is the lung.\nAbout 1-2% of patients with cervical carcinomas present with lung metastases, and 5-35% eventually develop lung metastases.\nOther common sites of blood-borne metastases include bone, liver and bowel.\nSolution to Question 21:\nA recurrent tumor with the largest diameter of &lt;3cm is associated with a good prognosis.\nThe extent of recurrent disease and involvement of pelvic lymph nodes are prognostic factors for survival. An isolated central pelvic tumour with no involvement of the pelvic sidewall also has a good prognosis.\nMost recurrences are seen within 3 years and the prognosis is poor with uremia being the most common terminal event. Recurrences most commonly involve the pelvis than the para-aortic or pelvic lymph node.\nAll patients with a suspected recurrence should undergo PET/CT for evaluation and biopsy for confirmation.\nTreatment involves either radical chemoradiation or pelvic exenteration. Concurrent chemotherapy with cisplatin and/or 5-fluorouracil may improve the outcome.\nSolution to Question 22:\nClinical examination is the first step in staging carcinoma cervix.\nClinical examination was the principal method in staging until the 2018 FIGO guidelines which recommended the use of imaging and histological investigations when available. USG, CT, MRI, and PET-CT can be used to assess the extent of the tumor, nodal status, and local or systemic spread.\nMRI is the best method to assess the principal tumor while PET-CT is the best method to assess nodal metastasis.\nFIGO no longer mandates biochemical investigations, such as tumor markers, for diagnosis of metastasis.\nSolution to Question 23:\nThe stage of cervical carcinoma is II B as it involves the upper part of the vagina and parametrium.\nSolution to Question 24:\nType III hysterectomy is the treatment of choice in carcinoma cervix - stage IB. It involves radical hysterectomy with pelvic lymphadenectomy and para-aortic lymph node evaluation.\nStage IB is defined as a macroscopic lesion still confined to the cervix, with the depth of invasion\n\uf0b35mm. It is the first stage in which lesions become clinically visible. Hysterectomy types include:\nType I - Simple / extrafascial\nType II - Modified radical / Wertheim\nType III - Radical / Meigs-Wertheim\nType IV - Extended radical Hysterectomy\nType V - Exenteration.\nSolution to Question 25:\nThe woman has stage I A2 cervical cancer and the most appropriate management is radical trachelectomy with pelvic lymphadenectomy.\nRadical trachelectomy is a fertility-preserving surgical procedure. This involves the removal of the entire cervix and parametrium.\nCervical conization with laparoscopic or extraperitoneal pelvic lymphadenectomy is an alternative that also preserves fertility.\nSolution to Question 26:\nPost-menopausal status is not a contraindication for radiotherapy in carcinoma cervix. Contraindications for radiotherapy in carcinoma cervix include:\nPelvic inflammatory disease\nYoung patient (to preserve ovarian function)\nAssociated myoma, prolapse, ovarian tumor, genital fistula\nVaginal stenosis\nAdenocarcinoma or adenosquamous carcinoma \u2013 surgery preferred.\nSolution to Question 27:\nIn the treatment of carcinoma cervix, the dose to be administered at point B is 6000 cGy. Radiotherapy in carcinoma cervix:\nPoint A\nPoint B\nLocatio n\n2cm above and 2cm lateral to external os\n2cm above and 5cm lateral to external os\nStructu re\nParacervical/Parametrial lym ph node\nObturator lymph node\nDose",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_33.jpeg",
      "OBGYN_img_379.jpeg",
      "OBGYN_img_33.jpeg",
      "OBGYN_img_380.jpeg",
      "OBGYN_img_33.jpeg",
      "OBGYN_img_381.jpeg",
      "OBGYN_img_34.jpeg",
      "OBGYN_img_382.jpeg",
      "OBGYN_img_34.jpeg",
      "OBGYN_img_383.jpeg",
      "OBGYN_img_34.jpeg",
      "OBGYN_img_384.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_7000",
    "question_text": "8000 cGy",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_6000",
    "question_text": "cGy\n\nCarcinoma Endometrium\nQuestion 1:\nWhat is the most common cause of postmenopausal bleeding?\nSenile endometrial atrophy\nCervical cancer\nEndometrial cancer\nAtypical endometrial hyperplasia\nQuestion 2:\nA 58-year-old, postmenopausal woman presented with bleeding PV. Hysteroscopic biopsy revealed complex endometrial hyperplasia with atypia. What is the risk of progression of this condition to cancer?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_34.jpeg",
      "OBGYN_img_385.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_3",
    "question_text": "%",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_54",
    "question_text": "%",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_8",
    "question_text": "%",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch127_29",
    "question_text": "%\nQuestion 3:\nWhich is the most common benign cause of pyometra?\nEndometrial hyperplasia\nSenile endometritis\nPelvic inflammatory disease\nCervical stenosis\nQuestion 4:\nWhich among the following is an ideal treatment for a 55-year-old female with simple hyperplasia of the endometrium with atypia?\nSimple hysterectomy\nMedroxy progesterone acetate\nLevonorgesterol\nRadiotherapy\nQuestion 5:\nWhat is the minimum endometrial thickness on transvaginal ultrasonography, above which you perform a biopsy in a case of postmenopausal bleeding?\n3mm\n4mm\n7mm\n9mm\nQuestion 6:\nWhat is the most common histopathological variety of endometrial cancer?\nSquamous cell\nAdenocarcinoma\nClear cell\nSerous\nQuestion 7:\nWhich of the following predisposes a patient to develop type 2 carcinoma endometrium?\nKRAS mutation\nPremenopausal age group\nPTEN mutation\nAtrophic endometrium\nQuestion 8:\nWhich of the following constitute corpus cancer syndrome?",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_1",
    "question_text": ", 2, 3, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_1",
    "question_text": ", 3, 4, 6",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_1",
    "question_text": ", 2, 4, 5",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_1",
    "question_text": ", 3, 4, 5\nQuestion 9:\nA gynecologist is performing the following procedure in a woman with postmenopausal bleeding. Identify it.\n\nTransvaginal sonography\nBalloon endometrial ablation\nSaline infusion sonography\nHysterosalpingography\nQuestion 10:\nA menopausal patient suspected to have endometrial carcinoma is undergoing a transvaginal ultrasound. Which of the following findings would be inconsistent with her diagnosis?\nEndometrial thickness of 7 mm\nHyperechoic endometrium\nIncreased vascular resistance\nFluid in uterine cavity\nQuestion 11:\nA 52-year-old\u25a0 woman with postmenopausal bleeding has an endometrial thickness of 7 mm on ultrasound. What is the next step in her management?\nFollow up USG after 3 months\nHysterectomy\nEndometrial biopsy\nProgesterone therapy\nQuestion 12:\nA 54-year-old woman with postmenopausal bleeding is suspected to have an endometrial lesion. What is the gold standard investigation to confirm her diagnosis?\nFractional curettage\nDilatation and curettage\nHysteroscopic biopsy\nLaparoscopic biopsy\nQuestion 13:\nA 62-year-old woman presents with vaginal bleeding 11 years after she had attained menopause. An endometrial biopsy reveals adenocarcinoma. What is the gold standard method for staging her condition?\nMRI\nSurgery\nEndometrial biopsy\nPET-CT\nQuestion 14:\nWhich lymph nodes are most commonly involved in patients with endometrial carcinoma?\nFemoral\nInguinal\nPara-aortic\nPara-colic\nQuestion 15:\nA patient presented with carcinoma endometrium involving &gt;50% myometrium, extending to the vagina but with no involvement of para-aortic and pre aortic nodes. What is the stage of her disease?\nIII A\nIII B\nIII C1\nIII C2\nQuestion 16:\nWhich of the following is indicated for the treatment of a patient with early endometrial cancer?\nHysterectomy, B/L salpingo-oophorectomy, lymph node sampling\nHysterectomy, B/L salpingo-oophorectomy, chemoradiation\nHysterectomy, radiotherapy\nChemoradiation\nQuestion 17:\nA woman with endometrial carcinoma is undergoing radiotherapy. Which of the following is true?\nIntensity is inversely proportional to squared distance\nSmall blood vessels are most radioresistant\nRapidly proliferating cells are most radioresistant\nSmall bowel is most radioresistant\nQuestion 18:\nWhich among the following is the mainstay of treatment in a patient diagnosed with Stage III endometrial cancer?\nSurgery\nChemotherapy\nExternal beam radiotherapy\nBrachytherapy\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_34.jpeg",
      "OBGYN_img_386.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_1",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_2",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_3",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_4",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_5",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_6",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_7",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_8",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_9",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_10",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_11",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_12",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_13",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_14",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_15",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_16",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_17",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch128_18",
    "question_text": "\nb\nSolution to Question 1:\nThe most common cause of postmenopausal bleeding all over the world is senile endometrial atrophy.\nIn a menopausal woman, hypoestrogenism causes atrophy of the endometrium and vagina.The atrophic endometrial surfaces contain little or no fluid to prevent intracavitary friction. This\nresults in micro-erosions of the surface epithelium and a subsequent chronic inflammatory reaction, making the endometrium prone to light bleeding or spotting.\nH rmone replacement therapy is the second most common cause of post-menopausal bleeding all ver the world.\nCervical cancer is the most common cause of postmenopausal bleeding in India, while endometrial cancer is the most common cause of postmenopausal bleeding in developed countries.\nNote: Endometrial cancer accounts for only 10 % of cases of post-menopausal bleeding. Still, all postmenopausal women with unexpected uterine bleeding should be evaluated for endometrial carcinoma, since this is a potentially lethal disease.\nSolution to Question 2:\nComplex hyperplasia with atypia has a 29% increased risk of progression to endometrial cancer. It has the highest risk of progressing to carcinoma compared to other varieties of endometrial hyperplasia.\nThe risk of endometrial hyperplasia progressing to cancer is tabulated below.\nType of hyperplasia\nProgression to cance r\nSimple without atypia",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch129_1",
    "question_text": "%\nComplex without atyp ia",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch129_3",
    "question_text": "%\nSimple with atypia",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch129_8",
    "question_text": "%\nComplex with atypia",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch129_29",
    "question_text": "%\nSolution to Question 3:\nThe most common cause of pyometra is senile endometritis.\nPyometra refers the collection of pus in the uterus. The most common cancer that causes pyometra is carcinoma cervix followed by carcinoma endometrium.\nSolution to Question 4:\nSimple hysterectomy is the best treatment in a case of atypical endometrial hyperplasia in a peri-menopausal and post-menopausal female.\nEndometrial hyperplasia with atypia carries 29% risk of developing into endometrial carcinoma and hence, must be treated with total abdominal hysterectomy (simple hysterectomy ).\nThe presence of any concomitant endometrial cancer must be ruled out by doing fractional curettage (or dilatation and curettage) before doing a hysterectomy.\nIf a premenopausal woman does not desire to undergo hysterectomy, progesterone can be given and the patient is followed up every 3-6 months. If the atypia persists during the follow-up hysterectomy should be performed.\nThe table below summarizes the management of patients with endometrial hyperplasia\nManagement of Endometrial hyperplasia\nHyperplasia without atypia\nPre-menopausal women\nProgesterone therapy\nPostmenopausal women:Sim ple hyperplasia without atypi aComplex hyperplasia withou t atypia\nFollow up without therapyPr ogesterone therapy\nHyperplasia with atypia\nPre-menopausal women\nIf patient wishes to preserve uterus,give High-dose proges terone therapyIf atypia persis ts, then perform Total abdom inal hysterectomy\nPeri-menopausal women\nTotal abdominal hysterectom y\nPost-menopausal women\nTotal abdominal hysterectom y +BSO (bilateral salphingo-o phorectomy)\nSolution to Question 5:\nA finding of endometrial thickness \uf0b3 4 mm (according to ACOG) in a postmenopausal women requires further evaluation, such as endometrial biopsy.\nIf the endometrial thickness is \uf0a34 mm in a post menopausal female, malignancy is rare and hence, can be managed by tranexamic acid. If the bleeding still persists, the patient needs to undergo fractional curettage and hysteroscopy.\nThe algorithm for next step for abnormal uterine bleeding in different age groups is as follows:\nAge group\nEndometrial thickness on T VS\nAction\nAge <40years\n>12mm\nEndometrial sampling/Endo metrial biopsy\nAge>40 years or Age >45 yea rs\n-\nEndometrial sampling/Endo metrial biopsy is done irrespe ctive of usg findings\nAge group\tEndometrial thickness on T\tAction VS\nAge group\tEndometrial thickness on T\tAction VS\nAge group\tEndometrial thickness on T\tAction VS\nPost menopausal women\n\uf0b34mm\nEndometrial sampling/Endo metrial biopsy\nPost menopausal women\n<4mm\nReassurance+tranexamic aci dIf, bleeding still persists the n do endometrial biopsy\n\nSolution to Question 6:\nThe most common variety of endometrial cancer is adenocarcinoma.\nThe other varieties of endometrial cancer are squamous cell, clear cell, and serous. The most malignant varieties are clear cell carcinoma and papillary serous tumor.\nSolution to Question 7:\nType 2 carcinoma endometrium is commonly seen in menopausal women with atrophic endometrium.\nHistological classification of endometrial cancer:\nNote: Type 1 (estrogen-dependent) endometrial CA is the more common type.\nType 1 (Endometrioid)\nType 2 (Nonendometriod)\nEstrogen dependent\nEstrogen independent\nOccurs in Pre- and Peri-meno pausal women\nOccurs in post-menopausal w omen\nType 1 (Endometrioid)\tType 2 (Nonendometriod)\nType 1 (Endometrioid)\tType 2 (Nonendometriod)\nHyperplasia present\nHyperplasia absent\nGood prognosis\nPoor prognosis\nAssociated with PTEN/KRAS mutation\nAssociated with p53 mutatio n\nSolution to Question 8:\nCorpus cancer syndrome constitutes of:\nDiabetes mellitus\nObesity\nHypertension\nCancer of the body of the uterus.\nEtiology of endometrial carcinoma: (Mnemonic: Family Has OLD AUNTI)\nFamily history\nHypertension\nObesity\nLate menopause/Early menarche\nDiabetes\nAtypical endometrial hyperplasia\nUnopposed estrogen/increased estrogen \uf0ae Hormone replacement therapy, fibroid, PCOD\nNulliparous\nTamoxifen therapy (Raloxifene has no genito-urinary action)\nInfertility/irregular menses.\nProtective factors against endometrial carcinoma include the use of OCPs, smoking, and multiparity.\nSolution to Question 9:\nThe image depicts saline infusion sonography (SIS), also known as sonohysterography. It is usually done after a transvaginal ultrasound, to assess the detailed anatomy of the uterine cavity.\nIn this procedure, a balloon catheter is inserted through the cervix and the endometrial cavity is distended with 20-40ml of sterile saline. The balloon is inflated to block the backflow of the infused sterile saline and transvaginal ultrasound is performed to visualize the cavity.\nIt is used:\nTo determine the endometrial thickness\nTo determine the cause in cases of infertility\nTo identify Mullerian anomalies\nTo visualize endometrial polyps and pedunculated fibroids\nThe image given below shows the appearance of the uterus on SIS.\n\nOption A: Transvaginal ultrasound is the initial evaluation for postmenopausal bleeding.\nOption B: In balloon endometrial ablation, a balloon is inserted into the uterus and inflated with glycine or 5% glucose. It is then heated up, and the endometrium is ablated by the tamponade effect.\nOption D: In hysterosalpingography, contrast dye is inserted into the uterus via a catheter, and the uterine and fallopian tube anatomy is visualized.\nSolution to Question 10:\nDecreased vascular resistance with increased tumor vascularity is seen in carcinoma endometrium.\nUSG findings in carcinoma endometrium include:\nEndometrial thickness &gt;4 mm in postmenopausal women and &gt;10 mm in perimenopausal women\nHyperechoic endometrium with irregular outlines\nIncreased tumor vascularity with low vascular resistance\nFluid in uterine cavity\nSolution to Question 11:\nThe next line of management in a patient with increased endometrial thickness is an endometrial biopsy.\nIn a postmenopausal woman, the normal endometrium should not exceed 4 mm in thickness. If it exceeds 4 mm, then histopathological examination (HPE) of the endometrium is mandatory, irrespective of the presence or absence of symptoms. In a perimenopausal woman, the cutoff for normal endometrial thickness is 10mm.\nHysteroscopy and biopsy is preferred over other blind curettage methods for HPE. A biopsy is made from suspicious areas after visualization so chances of missing the lesion are reduced.\nSolution to Question 12:\nHysteroscopic inspection and selective biopsy is now considered the gold standard in the diagnosis of an endometrial lesion. It is preferred for the initial evaluation of women with bleeding suspicious for malignancy.\nEndometrial sampling can be done by hysteroscopic biopsy. It is more sensitive for focal endometrial lesions. Dilatation and curettage may also aid the sampling of endometrial lesions.\nUltrasound, CT, and MRI are adjuvant to other investigations. Diagnostic laparoscopy will be required to study the nature of the tumor and its spread if ultrasound picks up a pelvic tumor.\nThe image given below shows the procedure of hysteroscopy.\n\nSolution to Question 13:\nThe given scenario depicts endometrial carcinoma and the gold standard method for staging this condition is surgery.\nAccording to FIGO/TNM classification system, a total hysterectomy with bilateral\nsalpingo-oophorectomy and pelvic and para-aortic lymph node dissection is the standard staging procedure for endometrial cancer.\nOption A: Contrast-enhanced magnetic resonance imaging (MRI) appears to be the best radiographic modality for detecting myometrial invasion or cervical involvement.\nOption C: Hysteroscopy visualizes the entire uterine lining and a biopsy is taken from suspicious areas. This is not 100% predictive, as an early lesion can be missed. Recently, the concern has been raised regarding the spilling of cancer cells into the peritoneal cavity during hysteroscopy.\nOption D: PET\u2013CT reveals metabolic activity in the tissue and is highly sensitive and specific for detecting positive pelvic and/or para-aortic lymphadenopathy as well as distant metastases in selected high-risk patients with endometrial cancer.\nSolution to Question 14:\nPelvic and para-aortic lymph nodes are commonly involved in endometrial cancer. The spread is through the infundibulopelvic ligament.\nRarely, inguinal &amp; femoral lymph nodes are involved.\nSolution to Question 15:\nCarcinoma endometrium involving the vagina but having no lymph node involvement is classified as stage IIIB.\nSolution to Question 16:\nEarly endometrial cancer (stages I &amp; II) is primarily managed surgically. The surgery performed here is abdominal hysterectomy, B/L salpingo-oophorectomy, omentectomy and pelvic &amp; para-aortic lymph node sampling.\nPostoperative management of endometrial cancer:\nIn low-risk endometrial cancer, no further treatment is required. In intermediate-risk, radiotherapy is done.\nIn high risk, chemotherapy + radiotherapy is done.\nSolution to Question 17:\nThe intensity of radiation is inversely proportional to the squared distance. This is known as the inverse square law in radiotherapy.\nChemoradiation is the mainstay of treatment of stage III and IV endometrial cancers. They are treated with brachytherapy followed by external radiation. Brachytherapy is a form of radiation therapy in which the radiation source is placed close to the tumor.\nOther options:\nOption B: Larger blood vessels are more radioresistant than microvasculature.\nOption C: Permanent non-dividing cells are more radioresistant than rapidly proliferating cells.\nOption D: Small intestinal epithelial cells (intestinal crypts), which divide rapidly with no differentiation are the most radiosensitive.\nSolution to Question 18:\nChemotherapy is the mainstay of treatment in Stage III endometrial cancer.\nIn order to stage carcinoma endometrium, total abdominal hysterectomy with bilateral salpingo-oophorectomy and lymphadenectomy is done (surgical staging).\nThus the management, once staging is done, is mainly postoperative. Up to stage II, radiotherapy can be given. Stages III &amp; IV are managed by chemotherapy such as doxorubicin,\ncisplatin, and paclitaxel.\nNote: Stage III is said to be inoperable but debulking surgery is sometimes attempted. However, the mainstay of treatment for stage III disease remains chemotherapy.\nInstruments\nQuestion 1:\nYou notice the following instrument being used to monitor a primigravida in the first stage of labor. What is the investigation being performed here?\n\nFetal doppler\nNonstress test\nCardiotocography\nBiophysical profiling\nQuestion 2:\nDuring your OBG posting, one of the senior residents asks you to induce labor in a primigravida admitted at 40 weeks of gestation. Identify the following device that you can use for this purpose.\n\nMirena\nFenton\u2019s dilator\nCervidil vaginal insert\nLippes loop\nQuestion 3:\nThe following instrument is used to augment labour in a 28-year-old primigravida via low rupture of membranes. Identify this instrument.\n\nCrile artery forceps\nKelly artery forceps\nKocher's artery forceps\nRochester-Pean artery forceps\nQuestion 4:\nA primigravida was diagnosed with a prolonged second stage of labor due to the fetus being in occipitoposterior position. The obstetrician decided to give a posterior mediolateral cut at the introitus to facilitate delivery. Which of the following instruments would she use for the same?\n\nA\nD\nC\nB\nQuestion 5:\nThe following instrument is used on an exhausted primigravida during crowning of the fetal head. Which of the following is false about this instrument?\n\nIt can be used in caesarean sections.\nIt can be used to deliver aftercoming head in breech.\nIt is a type of outlet forceps.\nIt provides traction force.\nQuestion 6:\nWhile assisting in the caesarean section of a multigravida, you see the senior obstetrician using the following instrument. Identify it.\n\nGreen-Armytage forceps\nKocher's clamp\nLahey's tissue holding forceps\nAllis tissue holding forceps\nQuestion 7:\nAn obstetrician performs an aspiration of the endometrial cavity in a woman with complaints of a missed period 2 weeks back. Identify the following instrument. What is the procedure it is used for?\n\nEndometrial ablation\nSuction and evacuation\nDilatation and curettage\nMenstrual regulation\nQuestion 8:\nA 20-year-old woman at 9 weeks of gestation comes to the clinic for check-up following an MTP. On ultrasound, retained tissue was found and the following instrument was used for its removal. What is this instrument?\n\nKarmann syringe\nSuction apparatus\nManual vacuum aspiration syringe\nMenstrual regulation syringe\nQuestion 9:\nIdentify the following instrument that is commonly used in a dilatation and curettage procedure.\n\nHawkin dilator\nHegar dilator\nBakes dilator\nFenton dilator\nQuestion 10:\nA 25-year-old woman presents with dyspareunia due to scarring secondary to perineal tears from previous vaginal delivery. The gynaecologist advises the use of the following dilator to widen the introitus. Identify this instrument.\n\nHegar dilator\nHawkin dilator\nPratt dilator\nFenton dilator\nQuestion 11:\nYou have posted a 43-year-old woman with abnormal uterine bleeding for dilatation and curettage in the minor OT. Identify the following instrument used in this procedure.\n\nBlake's uterine curette\nSim's curette\nSimpson's uterine sound\nSim's anterior vaginal wall retractor\nQuestion 12:\nThe following instrument is used for all except:\n\nRemoval of embedded IUD\nCheck curettage after MTP\nUterine length measurement\nBlunt curettage in abortions\nQuestion 13:\nWhich of the following is a false statement about the instrument given below?\n\nIt measures the uterine cavity and the cervical lengt\nIt differentiates between chronic inversion and fibroid polyp\nIt retracts the posterior vaginal wall to expose the cervix\nIt is used to diagnose cervical stenosis\nQuestion 14:\nYou see a resident use the following instrument to grasp the anterior lip of the cervix in a patient posted for a vaginal hysterectomy. What is this instrument known as?\n\nAllis forceps\nVulsellum forceps\nKocher's artery forceps\nLahey tissue grasping forceps\nQuestion 15:\nIdentify the following instrument.\n\nSponge holding forceps\nTowel holding clip\nFilshie clip\nSmall curved artery forceps\nQuestion 16:\nYou are assisting a case of vaginal hysterectomy where your assistant professor asks you to hold the retractor shown in the image. What is this retractor known as?\n\nDoyen's retractor\nSimon retractor\nBalfor retractor\nCzerny retractor\nQuestion 17:\nIdentify the instrument.\n\nSims speculum\nGraves vaginal speculum\nCusco vaginal speculum\nAuvard speculum\nQuestion 18:\nYour senior resident uses the following instrument while performing a pap smear test for screening of cervical cancer in a 36-year-old woman. Identify the same.\n\nCervex brus\nEndocervical brus\nAyres spatula\nAylesbury spatula\nQuestion 19:\nA 32-year-old working IT professional came for a mobile cervical cancer screening camp planned at her workplace. What is the following instrument used to perform this screening test?\n\nAylesbury spatula\nCervex brus\nAyre's spatula\nVaginal spatula\nQuestion 20:\nA 35-year-old lady who had tested positive for HPV is undergoing an investigation where the following device is used. Which of the following statements is false about this investigation?\n\nThis device provides binocular vision\nIt is used in lithotomy position\nGreen filter is used to study vascular pattern\nExternal os is visualised at a distance of 50 cm\nQuestion 21:\nThe following instrument is used for a young lady with fibroids posted for open myomectomy. Identify it.\n\nManual trocar\nLaparoscopic myoma screw\nDoyen myoma screw\nAuto insertion trocar\nQuestion 22:\nIdentify the use of the instrument given below:\n\nFor tubal ligation\nFor ligation of uterine artery during hysterectomy\nOvarian cystectomy\nEctopic pregnancy\nAnswer Key\nQuestion No.\nCorrect Option",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_34.jpeg",
      "OBGYN_img_387.jpeg",
      "OBGYN_img_34.jpeg",
      "OBGYN_img_388.png",
      "OBGYN_img_34.jpeg",
      "OBGYN_img_389.jpeg",
      "OBGYN_img_35.jpeg",
      "OBGYN_img_390.jpeg",
      "OBGYN_img_35.jpeg",
      "OBGYN_img_391.png",
      "OBGYN_img_35.jpeg",
      "OBGYN_img_392.jpeg",
      "OBGYN_img_35.jpeg",
      "OBGYN_img_393.jpeg",
      "OBGYN_img_35.jpeg",
      "OBGYN_img_394.jpeg",
      "OBGYN_img_395.jpeg",
      "OBGYN_img_396.jpeg",
      "OBGYN_img_35.jpeg",
      "OBGYN_img_397.jpeg",
      "OBGYN_img_398.jpeg",
      "OBGYN_img_399.jpeg",
      "OBGYN_img_36.jpeg",
      "OBGYN_img_400.jpeg",
      "OBGYN_img_36.jpeg",
      "OBGYN_img_401.png",
      "OBGYN_img_402.jpeg",
      "OBGYN_img_403.jpeg",
      "OBGYN_img_36.jpeg",
      "OBGYN_img_404.jpeg",
      "OBGYN_img_36.jpeg",
      "OBGYN_img_405.jpeg",
      "OBGYN_img_36.jpeg",
      "OBGYN_img_406.jpeg",
      "OBGYN_img_36.jpeg",
      "OBGYN_img_407.png",
      "OBGYN_img_408.jpeg",
      "OBGYN_img_37.jpeg",
      "OBGYN_img_409.jpeg",
      "OBGYN_img_410.jpeg",
      "OBGYN_img_411.jpeg",
      "OBGYN_img_37.jpeg",
      "OBGYN_img_412.jpeg",
      "OBGYN_img_37.jpeg",
      "OBGYN_img_413.jpeg",
      "OBGYN_img_37.jpeg",
      "OBGYN_img_414.jpeg",
      "OBGYN_img_37.jpeg",
      "OBGYN_img_415.jpeg",
      "OBGYN_img_37.jpeg",
      "OBGYN_img_416.jpeg",
      "OBGYN_img_37.jpeg",
      "OBGYN_img_417.jpeg",
      "OBGYN_img_37.jpeg",
      "OBGYN_img_418.jpeg",
      "OBGYN_img_38.jpeg",
      "OBGYN_img_419.jpeg",
      "OBGYN_img_38.jpeg",
      "OBGYN_img_420.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_1",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_2",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_3",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_4",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_5",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_6",
    "question_text": "\na",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_7",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_8",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_9",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_10",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_11",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_12",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_13",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_14",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_15",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_16",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_17",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_18",
    "question_text": "\nb",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_19",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_20",
    "question_text": "\nd",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_21",
    "question_text": "\nc",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_22",
    "question_text": "\na\nSolution to Question 1:\nThe image shows a cardiotocograph (electronic fetal monitor) that is used to perform cardiotocography in labor.\nIt can be used in both antenatal and intranatal mothers. It measures fetal heart rate and uterine contractions. It is used to perform the non-stress test (NST) in the antenatal period and cardiotocography during labor.\nSolution to Question 2:\nThis is an image of cervidil vaginal insert. It is used for cervical ripening and improves the Bishop's score.\nIt contains 10 mg of dinoprostone designed to release at a rate of approximately 0.3 mg/hr over 10-hours.\nSolution to Question 3:\nThe given instrument is Kocher's artery forceps and is identified by the presence of a single tooth at the tip.\nKocher's artery forceps are used to achieve hemostasis by holding bleeding vessels. They are also used in low rupture of membranes to augment labour or for the surgical induction of labour.\nThe difference between artery forceps and needle holders is in the edge and smoothness of corrugations. Artery forceps have smooth edges and single lined corrugations whereas, needle holders have rough edges and crossed lines forming square to diamond shaped corrugations.\nSolution to Question 4:\nThe given scenario of prolonged second stage of labor can be managed by performing an episiotomy. In the given figure, the instrument marked as \"D\" corresponds to episiotomy scissors.\nAn episiotomy is done to prevent posterior extention leading to obstetric anal sphincteric injuries.\n\nSolution to Question 5:\nThe given image shows Wrigley's forceps.\nThese are used as outlet forceps for the extraction of the fetal head. It is used to provide traction force. It can also be used in C-section for delivery of the baby.\nThe instrument is light and short due to a reduction in the length of the shanks and handles. It has a marked cephalic curve with a slight pelvic curve.\nConditions that require to be fulfilled for the use of outlet forceps are:\nThe fetal scalp is visible without separating the labia (crowning)\nThe fetal skull has reached the pelvic floor, or is on the perineum\nThe sagittal suture is in the anteroposterior diameter or right or left occiput anterior or posterior position (rotation does not exceed 45\u00b0)\nNote: Delivery of aftercoming head in breech is done with Pipers forceps.\nSolution to Question 6:\nThe given instrument is Green-Armytage forceps.\nIts tips are broad and hence can compress a wide area. During lower segment caesarean section\n(LSCS), these forceps are applied at the bleeding cut uterine edges for hemostasis.\nSolution to Question 7:\nThe instrument is Karman\u2019s cannula and syringe, which is also used for menstrual regulation.\nMenstrual regulation is the aspiration of the endometrial cavity within 14 days of a missed period in a woman with a previous normal cycle.\nUnder aseptic precautions, the cervix may be gently dilated using 4-5 mm size dilators. Then",
    "options": [],
    "correct_option": "",
    "explanation": "Detailed Explanations",
    "images": [
      "OBGYN_img_38.jpeg",
      "OBGYN_img_421.jpeg"
    ],
    "subject": "OBGYN"
  },
  {
    "id": "OBGYN_Ch130_5",
    "question_text": "6mm Karman\u2019s cannula is inserted and attached to a 50ml syringe for suction. The cannula is rotated, and pushed in and out with gentle strokes.\nThis procedure is contraindicated in advanced pregnancy and in the presence of local pelvic inflammation. The drawbacks of the procedure include a missed implanted zygote or an unrecognized ectopic pregnancy.\nThis procedure is not commonly done anymore.\nSolution to Question 8:\nThe image shows a manual vacuum aspiration (MVA) syringe.\nManual vacuum aspiration can be safely done upto 12 weeks of gestation. However, WHO recommends it as the procedure of choice for MTP only upto 10 weeks of gestation .\nThe indications of this procedure are given as follows:\nMedical termination of pregnancy\nIncomplete abortion or missed abortion\nMolar pregnancy\nEndometrial aspiration\n\nSolution to Question 9:\nThe given image shows Hegar's double-ended dilator which is used to dilate the cervix in dilation and curettage procedure.\nPratt dilator is also a double-ended dilator but has a more linear shape as compared to the curved Hegar's dilators. The image given below shows a Pratt dilator.\n\nOption A: Hawkin dilator is a single-ended dilator. The image given below shows a Hawkin dilator.\n\nOption C: Bakes rosebud dilator is a single-ended dilator used to dilate the urethra. It is called so since its tip is similar to a rosebud. The image given below shows a Bakes dilator.\n\nOption D: Fenton dilator is also double-ended but it has a notch in the middle. The image given below shows a Fenton dilator.\n\nSolution to Question 10:\nThe image shows a Fenton dilator. These can be identified by the neck/notch at the centre.\nFenton's or modified Fenton's procedure is performed to widen the introitus in women with superficial dyspareunia secondary to scarring. The narrowing of introitus could be due to scarring secondary to perineal tears during childbirth or from conditions such as lichen sclerosus or vestibulitis.\nFenton dilators come in sizes numbered from 3-10 and the sizes of the dilators range from 3mm to 26mm.\nOption B: Hawkins dilator is single-ended.\nOptions A and C: Hegar and Pratt dilators are also double-ended dilators but they do not have a notch at the centre. Pratt dilator is more linear in appearance compared to Hegar dilator.\nSolution to Question 11:\nThe instrument shown in the image is Sim's curette. It is a single-ended uterine curette used for dilatation and curettage.\nIt is designed to remove tough tissue from the lining of the uterus for biopsy or excision. The curette features a sharp loop tip to aid in the removal of the uterine tissue.\n\nSolution to Question 12:\nThe image shows a double-ended uterine curette with a sharp and a blunt end. It is not used in uterine length measurement.\nUterine length measurement is done with a uterine sound which is given below.\n\nSolution to Question 13:\nThe given instrument is Simpson\u2019s uterine sound. It is not used to retract the vagina for cervical examination. This is done using Sim's speculum.\nThe instrument is held like a pencil with the thumb and the first 2 fingers and introduced into the uterine cavity by keeping it in the midline and ensuring it is not forced.\nThe uses are given as follows:\nTo measure uterine cavity and cervical lengt\nTo diagnose cervical stenosis\nTo sound a polyp, IUCD or uterine septum\nTo break adhesions\nTo differentiate between chronic inversion and fibroid polyp\nSolution to Question 14:\nThe image shows vulsellum forceps. It is used to grasp the cervical lip and steady the cervix during vaginal surgery. It is a long instrument with a gentle curve so that the line of vision is not obstructed.\nOption A: Allis forceps can be identified by continuous teeth, equal on both ends. It is used to hold structures with a firm grip.\n\nOption C: Kocher's artery forceps are non-traumatic with a single tooth at the tip. They help in achieving hemostasis by firm pressure.\nOption D: Lahey's tissue grasping forceps has teeth similar to dinner forks. They are used to hold fibrous tissue and they give a firm grip without slippage.\nSolution to Question 15:\nThe given instrument is a towel-holding clip. It is used to secure drapings and towels during surgery.\n\nSponge-holding forceps are non-traumatic forceps. They are used for painting and preparation of parts preoperatively.\nFilshie clips are used for laparoscopic tubal sterilisation. They are made of titanium on the outer side and sialistic material on the inner side.\n\nSolution to Question 16:\nThe image shown is that of a Simon vaginal retractor, used to retract vaginal walls during examination and vaginal procedures.\nThe below image is of Doyen's retractor. It is used during abdominal procedures like C-section.\n\nSolution to Question 17:\nThe instrument shown in the image is Auvard speculum. It retracts the posterior vaginal wall during vaginal hysterectomy and is self retractory due to the circular structure on its handle which is heavy.\nThe image given below shows Sim's speculum.\n\nThe image given below shows Cusco's self retaining bivalved speculum.\n\nSolution to Question 18:\nThe image shows an endocervical brush. It is used to collect samples from the endocervix cervix, especially from deep lesions.\nOption A: Cervex brush is ideal for collecting samples for liquid-based cytological studies.\nOption C: Ayres spatula is used to collect samples from the ectocervix and the endocervix for cytological studies.\nOption D: Aylesbury spatula has a sharper and longer tip than Ayers spatula.\nSolution to Question 19:\nThe given instrument used in the patient's pap smear preparation is Ayre's spatula.\nSharpness on the end can differentiate between Ayre's and Aylesbury spatula. Aylesbury spatula has a more sharp and longer tip than Ayer's spatula. So, Aylesbury spatula is superior to Ayre's in collecting endocervical samples.\nThe image given below shows a slide holding bottle i.e. Kopliks jar with Ayre's spatula.\n\nSolution to Question 20:\nThe device shown in the image is a colposcope. It is used to perform colposcopy where the cervix is visualized at a distance of around 20 cm with the patient in the lithotomy position.\nThis instrument provides binocular vision with a magnification of 6x-15x. A green filter is used to study vascular pattern as the vessels appear black. Abnormal areas can be identified by their peculiar vascular pattern such as mosaic, reticular, and punctate.\nSolution to Question 21:\nThe given image shows a Doyen myoma screw.\nIt is used to perform an open myomectomy. The handle present in this can be used to distinguish it from a laparoscopic myoma screw which also has a similar tip.\nSolution to Question 22:\nThe given instrument is a fallope ring applicator. It is used in tubal ligation.\nFalope ring sterilization is accomplished by applying silicone rubber bands to the fallopian tubes. The major advantage is the elimination of thermocoagulation. The occlusion is only in a short segment and can allow for tubal reconstruction.",
    "options": [],
    "correct_option": "",
    "explanation": "",
    "images": [
      "OBGYN_img_38.jpeg",
      "OBGYN_img_422.jpeg",
      "OBGYN_img_38.jpeg",
      "OBGYN_img_423.jpeg",
      "OBGYN_img_38.jpeg",
      "OBGYN_img_424.jpeg",
      "OBGYN_img_38.jpeg",
      "OBGYN_img_425.jpeg",
      "OBGYN_img_38.jpeg",
      "OBGYN_img_426.jpeg",
      "OBGYN_img_39.jpeg",
      "OBGYN_img_427.jpeg",
      "OBGYN_img_39.jpeg",
      "OBGYN_img_428.jpeg",
      "OBGYN_img_39.jpeg",
      "OBGYN_img_429.jpeg",
      "OBGYN_img_39.jpeg",
      "OBGYN_img_430.jpeg",
      "OBGYN_img_39.jpeg",
      "OBGYN_img_431.jpeg",
      "OBGYN_img_39.jpeg",
      "OBGYN_img_432.jpeg",
      "OBGYN_img_39.jpeg",
      "OBGYN_img_433.jpeg",
      "OBGYN_img_39.jpeg",
      "OBGYN_img_434.jpeg",
      "OBGYN_img_39.jpeg",
      "OBGYN_img_435.jpeg"
    ],
    "subject": "OBGYN"
  }
]